course_id,course_code,course_name,test_id,ques_id,sequence,question_text,question_answer_id,answer_sequence,answer_text,correct
9604,Elearning-0000-826,DIALYSIS COMMUNICATION UPDATE 2021(2),n13664,61539,0,I have read and understand the contents of the CBL Dialysis Communication Update 2021(2) and agree to follow the expectations outlined.,204558,0,TRUE,1
9604,Elearning-0000-826,DIALYSIS COMMUNICATION UPDATE 2021(2),n13664,61539,0,I have read and understand the contents of the CBL Dialysis Communication Update 2021(2) and agree to follow the expectations outlined.,204559,1,FALSE,0
8342,Elearning-0000-1218,COLOR BLINDNESS TEST FOR AMNIOTEST,n2612,10802,0,I certify that I completed the color blindness test and the results of my testing demonstrated one of the following:,26687,0,"I had at least 10 correct responses for all of  the color plates.  Therefore, I have normal color vision.",1
8342,Elearning-0000-1218,COLOR BLINDNESS TEST FOR AMNIOTEST,n2612,10802,0,I certify that I completed the color blindness test and the results of my testing demonstrated one of the following:,26688,1,"I had 5 or more plates with incorrect responses.  Therefore, I may have a color vision defect.  I certify that I will bring this to the attention of my supervisor before I proceed in interpreting any tests that require interpretation of color changes.",0
9530,Elearning-0000-759,C-250 - ADCT301-002 AMENDMENT 4,n5313,24022,0,I have read and understand the contents of the C-250 - ADCT301-002 AMENDMENT 4 CBL.,70667,0,TRUE,1
9530,Elearning-0000-759,C-250 - ADCT301-002 AMENDMENT 4,n5313,24022,0,I have read and understand the contents of the C-250 - ADCT301-002 AMENDMENT 4 CBL.,70668,1,FALSE,0
9529,Elearning-0000-758,C-272 - SGN33A VERSION 03.27.17,n5314,24023,0,I have read and understand the contents of the C-272 - SGN33A VERSION 03.27.17 CBL.,70669,0,TRUE,1
9529,Elearning-0000-758,C-272 - SGN33A VERSION 03.27.17,n5314,24023,0,I have read and understand the contents of the C-272 - SGN33A VERSION 03.27.17 CBL.,70670,1,FALSE,0
9105,Elearning-0000-372,NSH1165 - ADCT-402 AMENDMENT 5,n5316,24028,0,I have read and understand the contents of the NSH1165 - ADCT-402 AMENDMENT 5 CBL.,70690,0,TRUE,1
9105,Elearning-0000-372,NSH1165 - ADCT-402 AMENDMENT 5,n5316,24028,0,I have read and understand the contents of the NSH1165 - ADCT-402 AMENDMENT 5 CBL.,70691,1,FALSE,0
9056,Elearning-0000-328,NSH1173 - BPX-501 T-CELL INFUSION,n5317,24029,0,This study's objective is to:,70692,0,"a.	Evaluate the effectiveness of Revlimid in post-transplant patients",0
9056,Elearning-0000-328,NSH1173 - BPX-501 T-CELL INFUSION,n5317,24029,0,This study's objective is to:,70693,1,"b.	Determine effect of doses of Rimiducid on mitigating GVHD",1
9056,Elearning-0000-328,NSH1173 - BPX-501 T-CELL INFUSION,n5317,24029,0,This study's objective is to:,70694,2,"c.	Assess time to relapse after transplant",0
9056,Elearning-0000-328,NSH1173 - BPX-501 T-CELL INFUSION,n5317,24029,0,This study's objective is to:,70695,3,"d.	Estimate time to engraftment of donor cells",0
9056,Elearning-0000-328,NSH1173 - BPX-501 T-CELL INFUSION,n5317,24030,1,This is a randomized trial where patients will either receive BPX-501 or Rimiducid to reduce GVHD.,70696,0,TRUE,0
9056,Elearning-0000-328,NSH1173 - BPX-501 T-CELL INFUSION,n5317,24030,1,This is a randomized trial where patients will either receive BPX-501 or Rimiducid to reduce GVHD.,70697,1,FALSE,1
9056,Elearning-0000-328,NSH1173 - BPX-501 T-CELL INFUSION,n5317,24031,2,Patients will receive BPX-501:,70698,0,"a.	On Days -6 to -2",0
9056,Elearning-0000-328,NSH1173 - BPX-501 T-CELL INFUSION,n5317,24031,2,Patients will receive BPX-501:,70699,1,"b.	Beginning on Day +1 through Day +30",0
9056,Elearning-0000-328,NSH1173 - BPX-501 T-CELL INFUSION,n5317,24031,2,Patients will receive BPX-501:,70700,2,"c.	In 28-day cycles starting at Cycle 2",0
9056,Elearning-0000-328,NSH1173 - BPX-501 T-CELL INFUSION,n5317,24031,2,Patients will receive BPX-501:,70701,3,"d.	In 30-day intervals: Day 0, Day 30, and Day 60",1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24172,0,Arterial sheath pull and hemostasis can be performed by any licensed medical professional?,71155,0,TRUE,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24172,0,Arterial sheath pull and hemostasis can be performed by any licensed medical professional?,71156,1,FALSE,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24173,1,Where should pulses be checked and documented pre and post femoral sheath removal?,71157,0,a. Carotid,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24173,1,Where should pulses be checked and documented pre and post femoral sheath removal?,71160,1,b. Pedal,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24173,1,Where should pulses be checked and documented pre and post femoral sheath removal?,71158,2,c. Radial,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24173,1,Where should pulses be checked and documented pre and post femoral sheath removal?,71159,3,d. Brachial,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24174,2,"The definition of bleeding, as it relates to femoral sheath removal is:",71161,0,a. Inadequate hemostasis after the application of pressure for at least 10 minutes.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24174,2,"The definition of bleeding, as it relates to femoral sheath removal is:",71164,1,b. Inadequate hemostasis after the application of pressure for at least 20 minutes.,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24174,2,"The definition of bleeding, as it relates to femoral sheath removal is:",71162,2,c. Inadequate hemostasis after the application of pressure for at least 60 minutes.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24174,2,"The definition of bleeding, as it relates to femoral sheath removal is:",71163,3,d. Inadequate hemostasis after the application of pressure for at least 5 minutes.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24175,3,"If oozing at the site occurs after pressure has been released from a venous or arterial site, pressure should be re-applied for a minimum of _______ additional minutes?",71165,0,a. 45 minutes,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24175,3,"If oozing at the site occurs after pressure has been released from a venous or arterial site, pressure should be re-applied for a minimum of _______ additional minutes?",71168,1,b. 5 minutes,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24175,3,"If oozing at the site occurs after pressure has been released from a venous or arterial site, pressure should be re-applied for a minimum of _______ additional minutes?",71166,2,c. 15 minutes,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24175,3,"If oozing at the site occurs after pressure has been released from a venous or arterial site, pressure should be re-applied for a minimum of _______ additional minutes?",71167,3,d. 30 minutes,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24176,4,Which of the following interventions are appropriate for the treatment of a vasovagal response after femoral sheath removal?,71169,0,a. Administer Atropine IV push 0.5mg x 1 as ordered.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24176,4,Which of the following interventions are appropriate for the treatment of a vasovagal response after femoral sheath removal?,71170,1,b. Infuse up to 250ml saline IV in 125ml increments.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24176,4,Which of the following interventions are appropriate for the treatment of a vasovagal response after femoral sheath removal?,71171,2,c. Immediately turn off the nitroglycerin drip if infusing,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24176,4,Which of the following interventions are appropriate for the treatment of a vasovagal response after femoral sheath removal?,71173,3,d. All of the above,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24176,4,Which of the following interventions are appropriate for the treatment of a vasovagal response after femoral sheath removal?,71172,4,e. None of the above,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24177,5,Post procedure patients generally are on bed rest for a total of _____ hours post procedure post hemostasis?,71174,0,a. 2-4 hours,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24177,5,Post procedure patients generally are on bed rest for a total of _____ hours post procedure post hemostasis?,71175,1,b. 4-6 hours,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24177,5,Post procedure patients generally are on bed rest for a total of _____ hours post procedure post hemostasis?,71176,2,c. 6-8 hours,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24177,5,Post procedure patients generally are on bed rest for a total of _____ hours post procedure post hemostasis?,71177,3,d. According to physician order - bed rest may vary depending on closure device utilization and/or sheath size.,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24178,6,"If bleeding re-occurs after pressure has been released from an arterial site, pressure should be re-applied for a minimum of ______ minutes?",71178,0,a. 5 minutes,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24178,6,"If bleeding re-occurs after pressure has been released from an arterial site, pressure should be re-applied for a minimum of ______ minutes?",71179,1,b. 40 minutes,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24178,6,"If bleeding re-occurs after pressure has been released from an arterial site, pressure should be re-applied for a minimum of ______ minutes?",71180,2,c. 30 minutes,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24178,6,"If bleeding re-occurs after pressure has been released from an arterial site, pressure should be re-applied for a minimum of ______ minutes?",71181,3,d. 15 minutes,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24179,7,"If a hematoma develops after sheath removal, the operator should apply firm manual pressure over the puncture site for _____ minutes or until hemostasis is obtained?",71182,0,a. 5 minutes,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24179,7,"If a hematoma develops after sheath removal, the operator should apply firm manual pressure over the puncture site for _____ minutes or until hemostasis is obtained?",71185,1,b. 20 minutes,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24179,7,"If a hematoma develops after sheath removal, the operator should apply firm manual pressure over the puncture site for _____ minutes or until hemostasis is obtained?",71183,2,c. 30 minutes,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24179,7,"If a hematoma develops after sheath removal, the operator should apply firm manual pressure over the puncture site for _____ minutes or until hemostasis is obtained?",71184,3,d. 60 minutes,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24180,8,Retroperitoneal hematomas usually occur within 12 hours of the procedure. Signs of retroperitoneal hematoma include ALL of the following EXCEPT?,71186,0,a. Hypotension,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24180,8,Retroperitoneal hematomas usually occur within 12 hours of the procedure. Signs of retroperitoneal hematoma include ALL of the following EXCEPT?,71187,1,"b. Back, flank, or leg pain",0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24180,8,Retroperitoneal hematomas usually occur within 12 hours of the procedure. Signs of retroperitoneal hematoma include ALL of the following EXCEPT?,71191,2,c. Rectal bleeding,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24180,8,Retroperitoneal hematomas usually occur within 12 hours of the procedure. Signs of retroperitoneal hematoma include ALL of the following EXCEPT?,71188,3,d. Mental Status Changes,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24180,8,Retroperitoneal hematomas usually occur within 12 hours of the procedure. Signs of retroperitoneal hematoma include ALL of the following EXCEPT?,71189,4,e. Neurological changes to the extremity on the side of the procedure.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24180,8,Retroperitoneal hematomas usually occur within 12 hours of the procedure. Signs of retroperitoneal hematoma include ALL of the following EXCEPT?,71190,5,f. Diaphoresis,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24181,9,"Which of the following parameters should be assessed and documented before, during and after site compression?",71192,0,a. Peripheral neurovascular assessment,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24181,9,"Which of the following parameters should be assessed and documented before, during and after site compression?",71193,1,b. Puncture site assessment,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24181,9,"Which of the following parameters should be assessed and documented before, during and after site compression?",71195,2,c. ALL of the above and below,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24181,9,"Which of the following parameters should be assessed and documented before, during and after site compression?",71194,3,d. Vital signs,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24182,10,Patient and family education during hemostasis should include notifying the nurse for any of the following:,71196,0,a. Sensation change to the affected extremity.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24182,10,Patient and family education during hemostasis should include notifying the nurse for any of the following:,71197,1,"b. Warm, moist sensation around the groin site.",0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24182,10,Patient and family education during hemostasis should include notifying the nurse for any of the following:,71198,2,c. Pressure and hardness in the area where the sheath was inserted.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24182,10,Patient and family education during hemostasis should include notifying the nurse for any of the following:,71199,3,d. Chest discomfort and back/flank pain.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24182,10,Patient and family education during hemostasis should include notifying the nurse for any of the following:,71200,4,e. All of the above.,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24183,11,"Following sheath removal, site checks and distal pulses should be assessed?",71204,0,a. Every 5 min during compression; then every 15 min x 4; every 30min x 2; then every hour x 4 unless otherwise ordered by physician.,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24183,11,"Following sheath removal, site checks and distal pulses should be assessed?",71201,1,b. Every 30min x2; every hour x 2; then every 4 hours while on bed rest.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24183,11,"Following sheath removal, site checks and distal pulses should be assessed?",71202,2,c. Every hour until discharge.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24183,11,"Following sheath removal, site checks and distal pulses should be assessed?",71203,3,d. Every hour x 4; then every 4 hours until discharge.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24184,12,Femostop device can be utilized for?,71205,0,a. Control of hematoma.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24184,12,Femostop device can be utilized for?,71206,1,b. Suspected bleeding from site.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24184,12,Femostop device can be utilized for?,71207,2,c. Extended sheath hold hemostasis.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24184,12,Femostop device can be utilized for?,71209,3,d. All of the above,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24184,12,Femostop device can be utilized for?,71208,4,e. None of the above,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24185,13,"If a patient has oozing or suspected bleeding from the site, your first action should be?",71210,0,a. Call the physician.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24185,13,"If a patient has oozing or suspected bleeding from the site, your first action should be?",71211,1,b. Check the orders in the chart for post care instructions.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24185,13,"If a patient has oozing or suspected bleeding from the site, your first action should be?",71212,2,c. Change dressing.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24185,13,"If a patient has oozing or suspected bleeding from the site, your first action should be?",71213,3,d. Apply firm pressure to the site to gain control of oozing or bleeding.,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24186,14,The operator and one additional healthcare provider should be present for the first 5 to 10 minutes of hemostasis and sheath pull procedure?,71215,0,TRUE,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24186,14,The operator and one additional healthcare provider should be present for the first 5 to 10 minutes of hemostasis and sheath pull procedure?,71214,1,FALSE,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24187,15,Which of the following statements are true?,71216,0,"a. Following sheath pull, a pressure dressing should be applied and left in place for 24 hours.",0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24187,15,Which of the following statements are true?,71217,1,b. The initial gauze dressing should remain in place for 3 days and then the site left open to air.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24187,15,Which of the following statements are true?,71219,2,"c. After achieving adequate hemostasis, a dressing should be placed on the site that allows for visualization of region for continued post care monitoring.",1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24187,15,Which of the following statements are true?,71218,3,d. The initial gauze dressing should be removed once the patient is off bedrest and the site left open to air.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24188,16,Which of the following are potential temporary signs and symptoms of appropriate occlusive pressure being held to arterial site?,71220,0,a. Mottling of lower extremity.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24188,16,Which of the following are potential temporary signs and symptoms of appropriate occlusive pressure being held to arterial site?,71221,1,b. Loss of distal pulses,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24188,16,Which of the following are potential temporary signs and symptoms of appropriate occlusive pressure being held to arterial site?,71222,2,c. Tingling and numbness of the extremity.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24188,16,Which of the following are potential temporary signs and symptoms of appropriate occlusive pressure being held to arterial site?,71223,3,d. All of the above.,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24189,17,The Femoral Artery is located?,71227,0,a. Between the femoral vein and femoral nerve,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24189,17,The Femoral Artery is located?,71224,1,b. Medial to all other structures in femoral area,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24189,17,The Femoral Artery is located?,71225,2,c. Lateral to all other structures in femoral area,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24189,17,The Femoral Artery is located?,71226,3,d. None of the above,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24190,18,Femoral hemostasis complications can be linked to?,71228,0,a. Patient anatomy.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24190,18,Femoral hemostasis complications can be linked to?,71229,1,b. Puncture technique.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24190,18,Femoral hemostasis complications can be linked to?,71230,2,c. Anticoagulation medications.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24190,18,Femoral hemostasis complications can be linked to?,71231,3,d. Hemostasis technique.,0
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24190,18,Femoral hemostasis complications can be linked to?,71232,4,e. All of the above.,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24191,19,Bleeding is the most common complication?,71234,0,TRUE,1
9283,Elearning-0000-534,NORTHSIDE HOSPITAL FORSYTH HEMOSTASIS AND ACCESS MANAGEMENT-PCU,n5337,24191,19,Bleeding is the most common complication?,71233,1,FALSE,0
9131,Elearning-0000-396,HIPAA FOLLOW UP TRAINING,n5346,24315,0,I have read and understand the contents of the HIPAA FOLLOW UP TRAINING CBL.,71734,0,TRUE,1
9131,Elearning-0000-396,HIPAA FOLLOW UP TRAINING,n5346,24315,0,I have read and understand the contents of the HIPAA FOLLOW UP TRAINING CBL.,71735,1,FALSE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1033,0,Most pain felt in the workplace is caused by a single traumatic injury.,784,0,TRUE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1033,0,Most pain felt in the workplace is caused by a single traumatic injury.,785,1,FALSE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1034,1,Most injuries are the result of which of the following?,786,0,months or years of poor body mechanics,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1034,1,Most injuries are the result of which of the following?,787,1,stress-free living,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1034,1,Most injuries are the result of which of the following?,788,2,good work habits,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1034,1,Most injuries are the result of which of the following?,789,3,all of the above,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1035,2,Injuries may be the result of a loss of flexibility and a general lack of physical fitness.,790,0,TRUE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1035,2,Injuries may be the result of a loss of flexibility and a general lack of physical fitness.,791,1,FALSE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1036,3,Most injuries can be avoided by using good prevention methods.,792,0,TRUE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1036,3,Most injuries can be avoided by using good prevention methods.,793,1,FALSE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1037,4,"An awareness of ""good"" body mechanics does not help prevent injuries.",794,0,TRUE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1037,4,"An awareness of ""good"" body mechanics does not help prevent injuries.",795,1,FALSE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1038,5,"The five principles of body mechanics include posture, how you hold objects, facing objects, symmetry, and using a wide base of support.",796,0,TRUE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1038,5,"The five principles of body mechanics include posture, how you hold objects, facing objects, symmetry, and using a wide base of support.",797,1,FALSE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1039,6,"When using posture as a principle of body mechanics, what should you do?",798,0,keep your chin level and slightly tucked,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1039,6,"When using posture as a principle of body mechanics, what should you do?",799,1,keep your chest down and out,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1039,6,"When using posture as a principle of body mechanics, what should you do?",800,2,lock your knees,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1039,6,"When using posture as a principle of body mechanics, what should you do?",801,3,all of the above,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1040,7,You can keep objects close to your body by keeping your elbows close to your sides and holding the objects close to your stomach.,802,0,TRUE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1040,7,You can keep objects close to your body by keeping your elbows close to your sides and holding the objects close to your stomach.,803,1,FALSE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1041,8,There is no way to properly align the hips and shoulders when you face objects.,804,0,TRUE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1041,8,There is no way to properly align the hips and shoulders when you face objects.,805,1,FALSE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1042,9,How can you use symmetry as a principle of body mechanics?,806,0,by using only one hand whenever possible,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1042,9,How can you use symmetry as a principle of body mechanics?,807,1,by using both sides of your body equally,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1042,9,How can you use symmetry as a principle of body mechanics?,808,2,by doing both of the above,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1043,10,"When standing, your legs should be at least shoulder-width apart.  They can be either side to side or one in front of the other.",809,0,TRUE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1043,10,"When standing, your legs should be at least shoulder-width apart.  They can be either side to side or one in front of the other.",810,1,FALSE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1044,11,"When sitting, you should keep your weight unevenly distributed in the chair.",811,0,TRUE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1044,11,"When sitting, you should keep your weight unevenly distributed in the chair.",812,1,FALSE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1045,12,"When you are sitting, you should not slump-sit or lean forward or downward to reach for or look at your work.",813,0,TRUE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1045,12,"When you are sitting, you should not slump-sit or lean forward or downward to reach for or look at your work.",814,1,FALSE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1046,13,Sitting for more than 15 to 30 minutes without getting up or changing position is a way to practice good body mechanics.,815,0,TRUE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1046,13,Sitting for more than 15 to 30 minutes without getting up or changing position is a way to practice good body mechanics.,816,1,FALSE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1047,14,You should sit close to your work and sit in a chair that is low enough that both feet are on the floor.,817,0,TRUE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1047,14,You should sit close to your work and sit in a chair that is low enough that both feet are on the floor.,818,1,FALSE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1048,15,"A chair should never support your back in a slightly arched position, and it should not allow you to work with your elbows bent at 90 degrees with shoulders relaxed.",819,0,TRUE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1048,15,"A chair should never support your back in a slightly arched position, and it should not allow you to work with your elbows bent at 90 degrees with shoulders relaxed.",820,1,FALSE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1049,16,Good balance is essential when standing.,821,0,TRUE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1049,16,Good balance is essential when standing.,822,1,FALSE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1051,17,You should not stand bent forward at your waist or neck.,823,0,TRUE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1051,17,You should not stand bent forward at your waist or neck.,824,1,FALSE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1052,18,It is a good idea to elevate or incline the work surface to bring your work closer to you.,825,0,TRUE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1052,18,It is a good idea to elevate or incline the work surface to bring your work closer to you.,826,1,FALSE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1053,19,"When standing for long periods of time, you should try to put one foot up, sway back and forth, or squat down occasionally.",827,0,TRUE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1053,19,"When standing for long periods of time, you should try to put one foot up, sway back and forth, or squat down occasionally.",828,1,FALSE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1055,21,"When pushing objects, you should do which of the following?",829,0,pull when you can push,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1055,21,"When pushing objects, you should do which of the following?",830,1,twist your body,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1055,21,"When pushing objects, you should do which of the following?",831,2,neither of the above,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1056,22,"When moving objects, you should try to push rather than pull whenever possible.",832,0,TRUE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1056,22,"When moving objects, you should try to push rather than pull whenever possible.",833,1,FALSE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1057,23,"When carrying objects, you should not carry with one hand or twist.",834,0,TRUE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1057,23,"When carrying objects, you should not carry with one hand or twist.",835,1,FALSE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1058,24,"You should carry objects with a bent-over, stooped posture.",836,0,TRUE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1058,24,"You should carry objects with a bent-over, stooped posture.",837,1,FALSE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1059,25,"When carrying a load, you should carry the load in front of you and pivot with your feet.",838,0,TRUE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1059,25,"When carrying a load, you should carry the load in front of you and pivot with your feet.",839,1,FALSE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1060,26,"When carrying a load, you should never make multiple trips.  It is better to try to carry everything at once.",840,0,TRUE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1060,26,"When carrying a load, you should never make multiple trips.  It is better to try to carry everything at once.",841,1,FALSE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1061,27,When reaching for an object you should always reach with one hand or twist your body.,842,0,TRUE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1061,27,When reaching for an object you should always reach with one hand or twist your body.,843,1,FALSE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1062,28,There is no such thing as an unsafe surface.,844,0,TRUE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1062,28,There is no such thing as an unsafe surface.,845,1,FALSE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1063,29,It is a good idea to stand on a stable step-stool to reach high items.,846,0,TRUE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1063,29,It is a good idea to stand on a stable step-stool to reach high items.,847,1,FALSE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,1064,30,You should make a point to use good posture when lifting an object.,848,0,TRUE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,1064,30,You should make a point to use good posture when lifting an object.,849,1,FALSE,0
9322,Elearning-0000-57,BODY MECHANICS,n1003,2005,20,Keeping your work at a comfortable height and standing on an anti-fatigue mat are two ways to implement good body mechanics.,1950,0,TRUE,1
9322,Elearning-0000-57,BODY MECHANICS,n1003,2005,20,Keeping your work at a comfortable height and standing on an anti-fatigue mat are two ways to implement good body mechanics.,1951,1,FALSE,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24399,0,"Based on the National Comprehensive Cancer Network (NCCN) definition of neutropenic fever, which of the following is considered febrile neutropenia (FN)?",72079,0,a.  Absolute neutrophil count (ANC) <500 neutrophils/uL,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24399,0,"Based on the National Comprehensive Cancer Network (NCCN) definition of neutropenic fever, which of the following is considered febrile neutropenia (FN)?",72080,1,b.  ANC <1500 neutrophils/uL,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24399,0,"Based on the National Comprehensive Cancer Network (NCCN) definition of neutropenic fever, which of the following is considered febrile neutropenia (FN)?",72081,2,c.  ANC <500 and temperature of 39 degrees C; orally,1
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24399,0,"Based on the National Comprehensive Cancer Network (NCCN) definition of neutropenic fever, which of the following is considered febrile neutropenia (FN)?",72082,3,d.  ANC <500 and temperature of 37 degrees C; orally,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24400,1,"All of the following measures may be implemented in prevention of FN, except:",72083,0,a.  Handwashing,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24400,1,"All of the following measures may be implemented in prevention of FN, except:",72084,1,b.  Antifungal prophylaxis,1
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24400,1,"All of the following measures may be implemented in prevention of FN, except:",72085,2,c.  Frequent tooth brushing and flossing,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24400,1,"All of the following measures may be implemented in prevention of FN, except:",72086,3,d.  Myeloid growth factors,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24401,2,"When determining appropriateness of primary prophylactic use of myeloid colony stimulating factors, the clinician should evaluate which of the following:",72087,0,a.  Chemotherapy regimen,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24401,2,"When determining appropriateness of primary prophylactic use of myeloid colony stimulating factors, the clinician should evaluate which of the following:",72088,1,b.  Treatment intent,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24401,2,"When determining appropriateness of primary prophylactic use of myeloid colony stimulating factors, the clinician should evaluate which of the following:",72089,2,c.  Patient specific factors,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24401,2,"When determining appropriateness of primary prophylactic use of myeloid colony stimulating factors, the clinician should evaluate which of the following:",72090,3,d.  All of the above are correct,1
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24402,3,"According to NCCN guidelines, which chemotherapy regimen is correctly matched to its risk of febrile neutropenia and granulocyte colony stimulating factor (G-CSF) recommendation?",72091,0,"a.  CMF (Breast): intermediate risk, consider G-CSF based on patient risk factors",1
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24402,3,"According to NCCN guidelines, which chemotherapy regimen is correctly matched to its risk of febrile neutropenia and granulocyte colony stimulating factor (G-CSF) recommendation?",72092,1,"b.  FOLFOX (Colorectal): high risk, administer G-CSF",0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24402,3,"According to NCCN guidelines, which chemotherapy regimen is correctly matched to its risk of febrile neutropenia and granulocyte colony stimulating factor (G-CSF) recommendation?",72093,2,"c.  Topotecan (Small Cell Lung): high risk, consider G-CSF based on patient risk factors",0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24402,3,"According to NCCN guidelines, which chemotherapy regimen is correctly matched to its risk of febrile neutropenia and granulocyte colony stimulating factor (G-CSF) recommendation?",72094,3,"d.  Dose-dense AC (Breast): low risk, no G-CSF recommended",0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24403,4,"AA is a 77 year old male, newly diagnosed with small cell lung cancer. He is starting chemotherapy on etoposide/carboplatin and the provider asks your recommendation on whether or not to initiate pegfilgrastim/Neulasta; following cycle 1. Na-137, K-3.7, SCr-1.36, CrCl-38.6, bilirubin-1.3, ALT/AST-6/13",72095,0,a.  Pegfilgrastim is not indicated - regimen is low risk,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24403,4,"AA is a 77 year old male, newly diagnosed with small cell lung cancer. He is starting chemotherapy on etoposide/carboplatin and the provider asks your recommendation on whether or not to initiate pegfilgrastim/Neulasta; following cycle 1. Na-137, K-3.7, SCr-1.36, CrCl-38.6, bilirubin-1.3, ALT/AST-6/13",72096,1,"b.  Pegfilgrastim is not indicated - regimen is intermediate risk, patient has no risk factors",0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24403,4,"AA is a 77 year old male, newly diagnosed with small cell lung cancer. He is starting chemotherapy on etoposide/carboplatin and the provider asks your recommendation on whether or not to initiate pegfilgrastim/Neulasta; following cycle 1. Na-137, K-3.7, SCr-1.36, CrCl-38.6, bilirubin-1.3, ALT/AST-6/13",72097,2,c.  Pegfilgrastim is indicated - regimen is high risk,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24403,4,"AA is a 77 year old male, newly diagnosed with small cell lung cancer. He is starting chemotherapy on etoposide/carboplatin and the provider asks your recommendation on whether or not to initiate pegfilgrastim/Neulasta; following cycle 1. Na-137, K-3.7, SCr-1.36, CrCl-38.6, bilirubin-1.3, ALT/AST-6/13",72098,3,"d.  Pegfilgrastim is indicated - regimen is intermediate risk, patient has at least two risk factors",1
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24404,5,Which of the following are adverse effects commonly associated with pegfilgrastim?,72099,0,"a.  Bruising, leukopenia, bone pain",0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24404,5,Which of the following are adverse effects commonly associated with pegfilgrastim?,72100,1,"b.  Bruising, leukocytosis, bone pain",1
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24404,5,Which of the following are adverse effects commonly associated with pegfilgrastim?,72101,2,"c.  Flushing, thrombosis, bone pain",0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24404,5,Which of the following are adverse effects commonly associated with pegfilgrastim?,72102,3,"d.  Fatigue, thrombosis, bone pain",0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24405,6,"EW is a 70 year old female ongoing treatment for ovarian cancer with weekly topotecan. She presents prior to cycle 3 today with the following laboratory values: WBC-1.7, ANC-200, Temperature (oral)-98.1 degrees F.<br><br> What is the role of G-CSF for her today?",72103,0,a.  Does not meet secondary prophylaxis criteria - use is not recommended,1
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24405,6,"EW is a 70 year old female ongoing treatment for ovarian cancer with weekly topotecan. She presents prior to cycle 3 today with the following laboratory values: WBC-1.7, ANC-200, Temperature (oral)-98.1 degrees F.<br><br> What is the role of G-CSF for her today?",72104,1,"b.  Benefit of shortened recovery time, use is recommended",0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24406,7,"EW returns to clinic the next day for follow-up monitoring with the following laboratory values: WBC-1.5, ANC-0.1, Temperature (oral)-101 degrees F, CrCl 65, Wt-200 lbs, NKDA. The provider wishes to initiate filgrastim-sndz/Zarxio; and oral antibiotics.<br><br> What is your recommendation?",72105,0,a.  Filgrastim-sndz 300mcg SQ + levofloxacin 750mg PO daily,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24406,7,"EW returns to clinic the next day for follow-up monitoring with the following laboratory values: WBC-1.5, ANC-0.1, Temperature (oral)-101 degrees F, CrCl 65, Wt-200 lbs, NKDA. The provider wishes to initiate filgrastim-sndz/Zarxio; and oral antibiotics.<br><br> What is your recommendation?",72106,1,b.  Filgrastim-sndz 480mcg SQ + levofloxacin 750mg PO daily,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24406,7,"EW returns to clinic the next day for follow-up monitoring with the following laboratory values: WBC-1.5, ANC-0.1, Temperature (oral)-101 degrees F, CrCl 65, Wt-200 lbs, NKDA. The provider wishes to initiate filgrastim-sndz/Zarxio; and oral antibiotics.<br><br> What is your recommendation?",72107,2,c.  Filgrastim-sndz 300mcg SQ + levofloxacin 750mg PO daily + amoxicillin/clavuanate 875mg PO Q12H,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24406,7,"EW returns to clinic the next day for follow-up monitoring with the following laboratory values: WBC-1.5, ANC-0.1, Temperature (oral)-101 degrees F, CrCl 65, Wt-200 lbs, NKDA. The provider wishes to initiate filgrastim-sndz/Zarxio; and oral antibiotics.<br><br> What is your recommendation?",72108,3,d.  Filgrastim-sndz 480mcg SQ + ciprofloxacin 500mg PO BID + amoxicillin/clavulanate 500mg PO Q8H,1
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24407,8,All of the following are <b>commonly</b> encountered pathogens implicated in febrile neutropenia except:,72109,0,a.  P. aeruginosa,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24407,8,All of the following are <b>commonly</b> encountered pathogens implicated in febrile neutropenia except:,72110,1,b.  S. aureus,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24407,8,All of the following are <b>commonly</b> encountered pathogens implicated in febrile neutropenia except:,72111,2,c.  P. jiroveci,1
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24407,8,All of the following are <b>commonly</b> encountered pathogens implicated in febrile neutropenia except:,72112,3,d.  S. epidermidis,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24408,9,Which of the following is correct?,72113,0,a.  Pegfilgrastim delivery kits should not be kept at room temperature for >12 hours.,1
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24408,9,Which of the following is correct?,72114,1,b.  All G-CSF formulations should be stored in the freezer.,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24408,9,Which of the following is correct?,72115,2,c.  Filgrastim-sndz can be stored at room temperature for up to 48 hours.,0
8263,Elearning-0000-1147,RPH FEBRILE NEUTROPENIA CBL,n5353,24408,9,Which of the following is correct?,72116,3,d.  Pegfilgrastim syringes may be stored at room temperature for up to 12 hours.,0
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24516,0,How often do you need to chart neurovascular assessments?,72521,0,a.  Once per shift,0
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24516,0,How often do you need to chart neurovascular assessments?,72522,1,b.  Q8H,0
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24516,0,How often do you need to chart neurovascular assessments?,72523,2,"c.  With assessment, Q4H and with acute changes",1
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24517,1,What section of the Nursing Tab do you chart the neurovascular checks?,72524,0,a.  Musculoskeletal,1
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24517,1,What section of the Nursing Tab do you chart the neurovascular checks?,72525,1,b.  Cardiovascular,0
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24517,1,What section of the Nursing Tab do you chart the neurovascular checks?,72526,2,c.  Neurological,0
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24518,2,With <u>shift assessment</u> do you need a <u>full</u> neurovascular check under musculoskeletal section?,72527,0,a. Yes,1
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24518,2,With <u>shift assessment</u> do you need a <u>full</u> neurovascular check under musculoskeletal section?,72528,1,b. No,0
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24518,2,With <u>shift assessment</u> do you need a <u>full</u> neurovascular check under musculoskeletal section?,72529,2,c. If I feel like it,0
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24519,3,Is this a requirement from the Clinical Practice Guidelines on the Total Joint Order Set?,72530,0,a. No,0
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24519,3,Is this a requirement from the Clinical Practice Guidelines on the Total Joint Order Set?,72531,1,b. Yes,1
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24520,4,What are some of the possible complications that can be prevented with timely neurovascular assessments?,72532,0,a.  DVT,0
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24520,4,What are some of the possible complications that can be prevented with timely neurovascular assessments?,72533,1,b.  Falls,0
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24520,4,What are some of the possible complications that can be prevented with timely neurovascular assessments?,72534,2,c.  PE,0
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24520,4,What are some of the possible complications that can be prevented with timely neurovascular assessments?,72535,3,d.  Compartment Syndrome,0
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24520,4,What are some of the possible complications that can be prevented with timely neurovascular assessments?,72536,4,e.  All the above,1
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24521,5,Do you need to notify the Orthopedic Surgeon of a deviation from an expected neurovascular assessment?,72537,0,a.  No,0
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24521,5,Do you need to notify the Orthopedic Surgeon of a deviation from an expected neurovascular assessment?,72538,1,b.  Yes,1
8276,Elearning-0000-1159,3T/8T POST-OPERATIVE TOTAL JOINT PATIENTS NEUROVASCULAR ASSESSMENTS,n5370,24521,5,Do you need to notify the Orthopedic Surgeon of a deviation from an expected neurovascular assessment?,72539,2,c.  Maybe when I have time,0
8261,Elearning-0000-1145,TOTAL HIP AND KNEE REPLACEMENT PERFORMANCE INDICATORS,n5374,24554,0,"I acknowledge that I have read and understand the information in the ""Total Hip and Knee Replacement Performance Indicators"" CBL in its entirety.",72631,0,TRUE,1
8261,Elearning-0000-1145,TOTAL HIP AND KNEE REPLACEMENT PERFORMANCE INDICATORS,n5374,24554,0,"I acknowledge that I have read and understand the information in the ""Total Hip and Knee Replacement Performance Indicators"" CBL in its entirety.",72632,1,FALSE,0
9059,Elearning-0000-330,NSH 1171 - SANOFI T-ALL,n5378,24565,0,Patients enrolled on this trial have special blood product requirements. Which of the following is INCORRECT?,72670,0,"a.	The initial type and screen at Screening will be shipped to the American Red Cross for genotyping.",0
9059,Elearning-0000-330,NSH 1171 - SANOFI T-ALL,n5378,24565,0,Patients enrolled on this trial have special blood product requirements. Which of the following is INCORRECT?,72671,1,"b.	CD28 monoclonal antibodies DO NOT interfere with blood bank serologic tests.",1
9059,Elearning-0000-330,NSH 1171 - SANOFI T-ALL,n5378,24565,0,Patients enrolled on this trial have special blood product requirements. Which of the following is INCORRECT?,72672,2,"c.	Subsequent type and screens need to have 4 EDTA tubes drawn instead of the regular 2.",0
9059,Elearning-0000-330,NSH 1171 - SANOFI T-ALL,n5378,24565,0,Patients enrolled on this trial have special blood product requirements. Which of the following is INCORRECT?,72673,3,"d.	Patients are to carry their study card with them at all times to notify nurses of participation in a CD38 monoclonal antibody trial.",0
9059,Elearning-0000-330,NSH 1171 - SANOFI T-ALL,n5378,24566,1,Patients with T-LBL and T-ALL will be enrolled in this trial.,72674,0,TRUE,0
9059,Elearning-0000-330,NSH 1171 - SANOFI T-ALL,n5378,24566,1,Patients with T-LBL and T-ALL will be enrolled in this trial.,72675,1,FALSE,1
9059,Elearning-0000-330,NSH 1171 - SANOFI T-ALL,n5378,24567,2,Patients will receive Isatuximab:,72676,0,"a.	Every week for 4 weeks in the Induction Period.",0
9059,Elearning-0000-330,NSH 1171 - SANOFI T-ALL,n5378,24567,2,Patients will receive Isatuximab:,72677,1,"b.	Every 2 weeks in the Maintenance Period.",0
9059,Elearning-0000-330,NSH 1171 - SANOFI T-ALL,n5378,24567,2,Patients will receive Isatuximab:,72678,2,"c.	Every 3 weeks in the Induction & Maintenance Period.",0
9059,Elearning-0000-330,NSH 1171 - SANOFI T-ALL,n5378,24567,2,Patients will receive Isatuximab:,72679,3,"d.	A and B only.",1
9369,Elearning-0000-612,LOSS OF FETAL SIGNAL: STRATEGIES FOR CONFIRMING FETAL SOURCE FOR FETAL HEART RATE MONITORING,n5381,24579,0,"I have read the CBL Loss of Fetal Signal: Strategies for Confirming Fetal Source for Fetal Heart Rate Monitoring. I understand the clinical implications for patient care in L&D. If I have any questions regarding this CBL, I will ask my supervisor.",72727,0,TRUE,1
9369,Elearning-0000-612,LOSS OF FETAL SIGNAL: STRATEGIES FOR CONFIRMING FETAL SOURCE FOR FETAL HEART RATE MONITORING,n5381,24579,0,"I have read the CBL Loss of Fetal Signal: Strategies for Confirming Fetal Source for Fetal Heart Rate Monitoring. I understand the clinical implications for patient care in L&D. If I have any questions regarding this CBL, I will ask my supervisor.",72728,1,FALSE,0
9433,Elearning-0000-670,CUSTOMER SERVICE AND YOU (JUNE 2017),n5401,24666,0,I acknowledge that I have read and understand in its entirety the Customer Service and You (June 2017) content.,73112,0,TRUE,1
9433,Elearning-0000-670,CUSTOMER SERVICE AND YOU (JUNE 2017),n5401,24666,0,I acknowledge that I have read and understand in its entirety the Customer Service and You (June 2017) content.,73113,1,FALSE,0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24801,0,"1.	Name the Patient Identifiers required for the Smart ID MPI Search.",73557,0,"a.	Name, DOB, Gender",1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24801,0,"1.	Name the Patient Identifiers required for the Smart ID MPI Search.",73558,1,"b.	Address and Insurance Card",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24801,0,"1.	Name the Patient Identifiers required for the Smart ID MPI Search.",73559,2,"c.	Photo ID and Insurance Card",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24802,1,"2.	A patient may have three medical record numbers (one for each facility) and only one corporate ID number.",73560,0,TRUE,1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24802,1,"2.	A patient may have three medical record numbers (one for each facility) and only one corporate ID number.",73561,1,FALSE,0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24803,2,"3.	The patient's name should be entered on the Patient Information Form in which of the following formats?",73562,0,"a.	First Name followed by comma (,) no space(s) followed by Last Name.",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24803,2,"3.	The patient's name should be entered on the Patient Information Form in which of the following formats?",73563,1,"b.	First Name followed by Middle Name comma (,) then Last Name.",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24803,2,"3.	The patient's name should be entered on the Patient Information Form in which of the following formats?",73564,2,"c.	Last Name followed by comma (,) no space(s) then First Name followed by one space then Middle Name",1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24804,3,"4.	Patients with dual last names should have a space instead of a hyphen to separate the two last names.",73565,0,TRUE,0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24804,3,"4.	Patients with dual last names should have a space instead of a hyphen to separate the two last names.",73566,1,FALSE,1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24805,4,"5.	Entering the patient's zip code in the City Field on the Patient Information Form will automatically populate the City, State and Zip code fields if entering a Georgia zip code.",73567,0,TRUE,1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24805,4,"5.	Entering the patient's zip code in the City Field on the Patient Information Form will automatically populate the City, State and Zip code fields if entering a Georgia zip code.",73568,1,FALSE,0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24806,5,"6.	The Registration Representative is to ask the patient for their home address instead of their mailing address.",73569,0,TRUE,0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24806,5,"6.	The Registration Representative is to ask the patient for their home address instead of their mailing address.",73570,1,FALSE,1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24807,6,"7.  The preferred method for entering an address as approved by the US Postal service is to enter an address using the street suffix abbreviations (i.e. St, Ave, Hwy, etc.)",73571,0,TRUE,1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24807,6,"7.  The preferred method for entering an address as approved by the US Postal service is to enter an address using the street suffix abbreviations (i.e. St, Ave, Hwy, etc.)",73572,1,FALSE,0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24808,7,8.  Who of the following should be entered as the guarantor when registering an account for an adult patient whose spouse is the policy holder/subscriber of the insurance plan?,73573,0,"a.	Patient",1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24808,7,8.  Who of the following should be entered as the guarantor when registering an account for an adult patient whose spouse is the policy holder/subscriber of the insurance plan?,73574,1,b. Spouse,0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24808,7,8.  Who of the following should be entered as the guarantor when registering an account for an adult patient whose spouse is the policy holder/subscriber of the insurance plan?,73575,2,c. Legal Guardian,0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24809,8,9. What is the definition of a Guarantor?,73576,0,"a.	The policy holder/subscriber of an insurance plan",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24809,8,9. What is the definition of a Guarantor?,73577,1,"b.	The financially responsible party",1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24809,8,9. What is the definition of a Guarantor?,73578,2,"c.	The court appointed Legal Guardian",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24810,9,"10. The policy holder/subscriber of the insurance plan will be named as the	Guarantor on a Patient's registration.",73579,0,TRUE,0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24810,9,"10. The policy holder/subscriber of the insurance plan will be named as the	Guarantor on a Patient's registration.",73580,1,FALSE,1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24811,10,"11.  When registering a minor patient who is accompanied by the mother and the father is the policy holder/subscriber of the insurance, who would be the guarantor on the patient's account?",73581,0,"a.	Patient",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24811,10,"11.  When registering a minor patient who is accompanied by the mother and the father is the policy holder/subscriber of the insurance, who would be the guarantor on the patient's account?",73582,1,"b.	Mother",1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24811,10,"11.  When registering a minor patient who is accompanied by the mother and the father is the policy holder/subscriber of the insurance, who would be the guarantor on the patient's account?",73583,2,"c.	Father",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24812,11,"12.  Married minors, emancipated minors, and pregnant minors presenting for pregnancy related services should be entered as the guarantor of their own account.",73584,0,TRUE,1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24812,11,"12.  Married minors, emancipated minors, and pregnant minors presenting for pregnancy related services should be entered as the guarantor of their own account.",73585,1,FALSE,0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24813,12,13.   What is the format to be used when populating the Medical Comment Field found on the Medical Information Form when a Non-Northside Physician has been selected?,73586,0,"a.	Physician first name, Physician last name, Physician home address, Physician home phone number using no spaces, or punctuation marks.",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24813,12,13.   What is the format to be used when populating the Medical Comment Field found on the Medical Information Form when a Non-Northside Physician has been selected?,73587,1,"b.	Physician office phone number, Physician office fax number using no spaces or punctuation marks.",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24813,12,13.   What is the format to be used when populating the Medical Comment Field found on the Medical Information Form when a Non-Northside Physician has been selected?,73588,2,"c.	Physician last name, Physician first name, NPI#, Physician office phone number, Physician office address, Physician office fax number using no spaces and separated by commas.",1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24814,13,"14. Occurrence code 11, Onset of illness, means the beginning date of the patient's symptoms relative to the services being rendered.",73589,0,TRUE,1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24814,13,"14. Occurrence code 11, Onset of illness, means the beginning date of the patient's symptoms relative to the services being rendered.",73590,1,FALSE,0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24815,14,15.  The Unit number is the same as the Medical Record Number.,73591,0,TRUE,1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24815,14,15.  The Unit number is the same as the Medical Record Number.,73592,1,FALSE,0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24816,15,16. What two items are required to be requested from every patient at the time of registration?,73593,0,"a.	Insurance Card and physician order",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24816,15,16. What two items are required to be requested from every patient at the time of registration?,73594,1,"b.	ID and pre-certification letter",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24816,15,16. What two items are required to be requested from every patient at the time of registration?,73595,2,"c.	Photo ID and insurance card",1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24817,16,17.  Which of the following statements is NOT found in the Assignment of Benefits section of the Annual Acknowledgement Form?,73596,0,"a.	The patient authorizes the hospital to bill their insurance company.",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24817,16,17.  Which of the following statements is NOT found in the Assignment of Benefits section of the Annual Acknowledgement Form?,73597,1,"b.	The patient is still responsible for any charges for this visit that are not paid by the insurance company.",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24817,16,17.  Which of the following statements is NOT found in the Assignment of Benefits section of the Annual Acknowledgement Form?,73598,2,"c.	The patient will receive payments from the insurance company to submit to the hospital.",1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24818,17,18.  Which of the following statements is NOT found in the About Your Billing section of the Annual Acknowledgement Form?,73599,0,"a.	The patient will receive a bill from Northside Hospital.",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24818,17,18.  Which of the following statements is NOT found in the About Your Billing section of the Annual Acknowledgement Form?,73600,1,"b.	Professional services' phone numbers",1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24818,17,18.  Which of the following statements is NOT found in the About Your Billing section of the Annual Acknowledgement Form?,73601,2,"c.	The patient may receive separate bills for the professional component of their treatment.",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24819,18,19.  Which of the following statements is NOT found in the Precertification section of the Annual Acknowledgement Form?,73602,0,"a.	The patient's insurance policy may require compliance with a utilization program to review the appropriateness of his/her treatment plan.",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24819,18,19.  Which of the following statements is NOT found in the Precertification section of the Annual Acknowledgement Form?,73603,1,"b.	If the utilization review program denies authorization for a patient's procedure, Northside will cover the costs of the procedure.",1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24819,18,19.  Which of the following statements is NOT found in the Precertification section of the Annual Acknowledgement Form?,73604,2,"c.	It is the patient's responsibility to review his/her obligations with his/her physician, insurance company and utilization review program to prevent unnecessary financial loss.",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24820,19,20. This section of the Annual Acknowledgement Form explains a bill may be received from the hospital and the physicians practice for Hospital Based Physician Practices.,73605,0,"a.	Assignment of Benefits",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24820,19,20. This section of the Annual Acknowledgement Form explains a bill may be received from the hospital and the physicians practice for Hospital Based Physician Practices.,73606,1,"b.	Precertification",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24820,19,20. This section of the Annual Acknowledgement Form explains a bill may be received from the hospital and the physicians practice for Hospital Based Physician Practices.,73607,2,"c.	About Your Billing",1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24821,20,"21. The form used to alert staff of duplicate accounts and is scanned to the ""Duplicate Account Notification"" folder in ILE is called the:",73608,0,"a.	Re-Label Chart Form",1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24821,20,"21. The form used to alert staff of duplicate accounts and is scanned to the ""Duplicate Account Notification"" folder in ILE is called the:",73609,1,"b.	Cancel Account Form",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24821,20,"21. The form used to alert staff of duplicate accounts and is scanned to the ""Duplicate Account Notification"" folder in ILE is called the:",73610,2,"c.	Worker's Compensation Form",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24822,21,"22. When multiple medical records are found for the same patient, this form is completed and sent to the Medical Records department:",73611,0,"a.	About Your Billing",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24822,21,"22. When multiple medical records are found for the same patient, this form is completed and sent to the Medical Records department:",73612,1,"b.	Re-label Chart Form",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24822,21,"22. When multiple medical records are found for the same patient, this form is completed and sent to the Medical Records department:",73613,2,"c.	Duplicate Medical Record Form",1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24823,22,"23. Registration resources such as Agreed Upon Responses (AUR), Standard Note Codes (SNC), and the Global Downtime Workbook are located on the.",73614,0,"a.	Revenue Cycle Website",1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24823,22,"23. Registration resources such as Agreed Upon Responses (AUR), Standard Note Codes (SNC), and the Global Downtime Workbook are located on the.",73615,1,"b.	Northside Intranet",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24823,22,"23. Registration resources such as Agreed Upon Responses (AUR), Standard Note Codes (SNC), and the Global Downtime Workbook are located on the.",73616,2,"c.	All of the above",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24824,23,24.    All AHIQA Error pop-ups should be corrected by what point in time?,73617,0,"a.	Next Day",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24824,23,24.    All AHIQA Error pop-ups should be corrected by what point in time?,73618,1,"b.	End of shift",1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24824,23,24.    All AHIQA Error pop-ups should be corrected by what point in time?,73619,2,"c.	End of week",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24825,24,"25.	 Mrs. Reynold's doctor has ordered a test for her to have at Northside.  It is decided that Medicare may not cover the test.  Which form will need to be completed in order to provide Mrs. Reynolds information to make an informed decision about whether or not to have the test?",73620,0,"a.	Advance Directive Acknowledgement",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24825,24,"25.	 Mrs. Reynold's doctor has ordered a test for her to have at Northside.  It is decided that Medicare may not cover the test.  Which form will need to be completed in order to provide Mrs. Reynolds information to make an informed decision about whether or not to have the test?",73621,1,"b.	Advance Beneficiary Notice of Non-Coverage",1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24825,24,"25.	 Mrs. Reynold's doctor has ordered a test for her to have at Northside.  It is decided that Medicare may not cover the test.  Which form will need to be completed in order to provide Mrs. Reynolds information to make an informed decision about whether or not to have the test?",73622,2,"c.	Medicare Outpatient Observation Notice",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24826,25,"26.	The Advance Beneficiary Notice of Non-Coverage is used to inform patients of which of the following?",73623,0,"a.	They cannot have the service because Medicare may not to pay",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24826,25,"26.	The Advance Beneficiary Notice of Non-Coverage is used to inform patients of which of the following?",73624,1,"b.	They will be financially responsible because Medicare may not pay",1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24826,25,"26.	The Advance Beneficiary Notice of Non-Coverage is used to inform patients of which of the following?",73625,2,"c.	They will have to reschedule until Medicare says they will pay",0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24827,26,"27.	It is not important when the Advance Beneficiary Notice of Non-Coverage is given to the patient as long as the patient does receive it at some point.",73626,0,TRUE,0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24827,26,"27.	It is not important when the Advance Beneficiary Notice of Non-Coverage is given to the patient as long as the patient does receive it at some point.",73627,1,FALSE,1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24828,27,"28.	 Patient Type PRS is a shell account.",73628,0,TRUE,1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24828,27,"28.	 Patient Type PRS is a shell account.",73629,1,FALSE,0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24829,28,"29.	 If a patient account has already been scheduled as a shell account, when the patient arrives for services registration will choose ""Select Visit"" on the STAR Patient View.",73630,0,TRUE,1
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24829,28,"29.	 If a patient account has already been scheduled as a shell account, when the patient arrives for services registration will choose ""Select Visit"" on the STAR Patient View.",73631,1,FALSE,0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24830,29,"30.	It is not necessary to have the patient sign the Chart Copy/Face Sheet at the end of the registration.",73632,0,TRUE,0
9824,Questions-0000-118,RCT: GLOBAL PROCESS & SYSTEMS UNIVERSITY TEST,n5420,24830,29,"30.	It is not necessary to have the patient sign the Chart Copy/Face Sheet at the end of the registration.",73633,1,FALSE,1
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24975,0,Infant security can best be provided by,74176,0,A. The presence and use of an electronic tagging and surveillance system,0
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24975,0,Infant security can best be provided by,74177,1,B. Controlling access to nurseries,0
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24975,0,Infant security can best be provided by,74178,2,"C. Educating both staff and parents, using an electronic IPS and camera surveillance, controlling access to sensitive areas, and restricting availability of patient information.",1
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24975,0,Infant security can best be provided by,74179,3,D. Use of camera surveillance in infant care areas.,0
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24976,1,"When the electronic IPS alarms, all personnel (even if working on an adjacent unit) are responsible for investigating and making sure there is an immediate response to the alarm.",74180,0,TRUE,1
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24976,1,"When the electronic IPS alarms, all personnel (even if working on an adjacent unit) are responsible for investigating and making sure there is an immediate response to the alarm.",74181,1,FALSE,0
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24977,2,"If a Check Tag Tightness Event is not corrected within seconds, the following alarm will occur",74182,0,A. Tag Exit Alarm,0
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24977,2,"If a Check Tag Tightness Event is not corrected within seconds, the following alarm will occur",74183,1,B. Tag Loose Alarm,1
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24977,2,"If a Check Tag Tightness Event is not corrected within seconds, the following alarm will occur",74184,2,C. Tamper Alarm,0
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24977,2,"If a Check Tag Tightness Event is not corrected within seconds, the following alarm will occur",74185,3,D. Portal Alarm,0
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24978,3,Initiate a BABY COUNT whenever,74186,0,A. There's suspicion that a baby is missing,0
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24978,3,Initiate a BABY COUNT whenever,74187,1,B. A baby cannot be located when you are responding to any IPS alarm,0
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24978,3,Initiate a BABY COUNT whenever,74188,2,C. Something unusual or suspicious occurs regarding infant security,0
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24978,3,Initiate a BABY COUNT whenever,74189,3,D. A and C only,0
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24978,3,Initiate a BABY COUNT whenever,74190,4,"E. A, B, and C",1
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24979,4,A CODE PINK can be initiated,74191,0,A. Only by nursing leadership,0
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24979,4,A CODE PINK can be initiated,74192,1,B. By anyone (by calling the campus emergency number) whenever a baby cannot be quickly located or something unusual/suspicious occurs.,1
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24979,4,A CODE PINK can be initiated,74193,2,C. Only by the Security Department.,0
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24979,4,A CODE PINK can be initiated,74194,3,D. Automatically by the electronic IPS.,0
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24980,5,Staff members who are aware of any family conflict or circumstance which may compromise the safety/security of a the mother or infant should notify their supervisor immediately.,74195,0,TRUE,1
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24980,5,Staff members who are aware of any family conflict or circumstance which may compromise the safety/security of a the mother or infant should notify their supervisor immediately.,74196,1,FALSE,0
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24981,6,"If a fire pull station is activated in the Women's Center, a baby count should performed immediately.",74197,0,TRUE,1
9729,Elearning-0000-94,WOMENS CENTER INFANT SECURITY,n5432,24981,6,"If a fire pull station is activated in the Women's Center, a baby count should performed immediately.",74198,1,FALSE,0
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25077,0,"<b>Clinical Scenario 1</b><br><br> Mr. Johnson, a 57 year old male undergoes a laparoscopic cholecystectomy. The intraoperative course was uneventful and the patient has orders to be discharged from PACU to ERU. The patient was given 2mg Hydromorphone in the OR. Mr. Johnson was extubated, and is sleepy but arousable. Shortly after arrival to PACU, the patient develops acute respiratory distress. His respiratory rate increases to 33 breaths per minute, SpO2 is 90%;, heart rate increases to 110 bpm, blood pressure 98/50. On examination, his pupils are pinpoint but reacting, he is moving air into both of his lungs but there is little air entry into his lung bases. It was decided by anesthesia to order a chest x-ray which showed pulmonary edema. The anesthesiologist ordered a non-rebreather facemask with O2 of 95%; and Lasix 20mg IV. During the next 1   hours in PACU, The patient received 2 mg of Hydromorphone for pain and his VS became more stable: Respirations 24 breaths per minutes, HR is 96 bpm and BP is 102/60.  After working with the patient, the nurse was able to wean Mr. Johnson to 5 Liters per nasal cannula and O2 sats were now 94%;.<br><br> The patient is awake and sitting up in bed, but remains slightly drowsy due to the pain medication. 30 minutes later, the nurse assessed the patient and decided it was appropriate to begin weaning the patient to room air. The O2 saturation decreased immediately to 88% on room air. The nasal cannula was reapplied at 5 Liters and the patient's O2 sat increased to 94.<br><br>The patient does not appear to be in any distress at this time and the charge nurse is asking how much longer does the patient need for recovery in PACU? How should the nurse respond?<br><br> <b>Is this patient appropriate for ERU?</b>",74448,0,"A.  Yes, the patient is maintaining his O2 saturation at 94%;, which is acceptable for ERU.",0
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25077,0,"<b>Clinical Scenario 1</b><br><br> Mr. Johnson, a 57 year old male undergoes a laparoscopic cholecystectomy. The intraoperative course was uneventful and the patient has orders to be discharged from PACU to ERU. The patient was given 2mg Hydromorphone in the OR. Mr. Johnson was extubated, and is sleepy but arousable. Shortly after arrival to PACU, the patient develops acute respiratory distress. His respiratory rate increases to 33 breaths per minute, SpO2 is 90%;, heart rate increases to 110 bpm, blood pressure 98/50. On examination, his pupils are pinpoint but reacting, he is moving air into both of his lungs but there is little air entry into his lung bases. It was decided by anesthesia to order a chest x-ray which showed pulmonary edema. The anesthesiologist ordered a non-rebreather facemask with O2 of 95%; and Lasix 20mg IV. During the next 1   hours in PACU, The patient received 2 mg of Hydromorphone for pain and his VS became more stable: Respirations 24 breaths per minutes, HR is 96 bpm and BP is 102/60.  After working with the patient, the nurse was able to wean Mr. Johnson to 5 Liters per nasal cannula and O2 sats were now 94%;.<br><br> The patient is awake and sitting up in bed, but remains slightly drowsy due to the pain medication. 30 minutes later, the nurse assessed the patient and decided it was appropriate to begin weaning the patient to room air. The O2 saturation decreased immediately to 88% on room air. The nasal cannula was reapplied at 5 Liters and the patient's O2 sat increased to 94.<br><br>The patient does not appear to be in any distress at this time and the charge nurse is asking how much longer does the patient need for recovery in PACU? How should the nurse respond?<br><br> <b>Is this patient appropriate for ERU?</b>",74449,1,"B.  No, the patient is on 5 Liters O2 per nasal cannula which is unacceptable for ERU.",1
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25078,1,"<b>Clinical Scenario 1</b><br><br> Mr. Johnson, a 57 year old male undergoes a laparoscopic cholecystectomy. The intraoperative course was uneventful and the patient has orders to be discharged from PACU to ERU. The patient was given 2mg Hydromorphone in the OR. Mr. Johnson was extubated, and is sleepy but arousable. Shortly after arrival to PACU, the patient develops acute respiratory distress. His respiratory rate increases to 33 breaths per minute, SpO2 is 90%;, heart rate increases to 110 bpm, blood pressure 98/50. On examination, his pupils are pinpoint but reacting, he is moving air into both of his lungs but there is little air entry into his lung bases. It was decided by anesthesia to order a chest x-ray which showed pulmonary edema. The anesthesiologist ordered a non-rebreather facemask with O2 of 95%; and Lasix 20mg IV. During the next 1   hours in PACU, The patient received 2 mg of Hydromorphone for pain and his VS became more stable: Respirations 24 breaths per minutes, HR is 96 bpm and BP is 102/60 .  After working with the patient, the nurse was able to wean Mr. Johnson to 5 Liters per nasal cannula and O2 sats were now 94%;.<br><br> The patient is awake and sitting up in bed, but remains slightly drowsy due to the pain medication. 30 minutes later, the nurse assessed the patient and decided it was appropriate to begin weaning the patient to room air. The O2 saturation decreased immediately to 88% on room air. The nasal cannula was reapplied at 5 Liters and the patient's O2 sat increased to 94.<br><br> The patient does not appear to be in any distress at this time and the charge nurse is asking how much longer does the patient need for recovery in PACU? How should the nurse respond?<br><br> <b>What is the nurse's most appropriate course of action now?</b>",74450,0,A.  Continue watching the patient to ensure they are stable to transfer from PACU.,0
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25078,1,"<b>Clinical Scenario 1</b><br><br> Mr. Johnson, a 57 year old male undergoes a laparoscopic cholecystectomy. The intraoperative course was uneventful and the patient has orders to be discharged from PACU to ERU. The patient was given 2mg Hydromorphone in the OR. Mr. Johnson was extubated, and is sleepy but arousable. Shortly after arrival to PACU, the patient develops acute respiratory distress. His respiratory rate increases to 33 breaths per minute, SpO2 is 90%;, heart rate increases to 110 bpm, blood pressure 98/50. On examination, his pupils are pinpoint but reacting, he is moving air into both of his lungs but there is little air entry into his lung bases. It was decided by anesthesia to order a chest x-ray which showed pulmonary edema. The anesthesiologist ordered a non-rebreather facemask with O2 of 95%; and Lasix 20mg IV. During the next 1   hours in PACU, The patient received 2 mg of Hydromorphone for pain and his VS became more stable: Respirations 24 breaths per minutes, HR is 96 bpm and BP is 102/60 .  After working with the patient, the nurse was able to wean Mr. Johnson to 5 Liters per nasal cannula and O2 sats were now 94%;.<br><br> The patient is awake and sitting up in bed, but remains slightly drowsy due to the pain medication. 30 minutes later, the nurse assessed the patient and decided it was appropriate to begin weaning the patient to room air. The O2 saturation decreased immediately to 88% on room air. The nasal cannula was reapplied at 5 Liters and the patient's O2 sat increased to 94.<br><br> The patient does not appear to be in any distress at this time and the charge nurse is asking how much longer does the patient need for recovery in PACU? How should the nurse respond?<br><br> <b>What is the nurse's most appropriate course of action now?</b>",74451,1,B.  Update the anesthesiologist on the events that have occurred relating to the patient's respiratory status.,0
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25078,1,"<b>Clinical Scenario 1</b><br><br> Mr. Johnson, a 57 year old male undergoes a laparoscopic cholecystectomy. The intraoperative course was uneventful and the patient has orders to be discharged from PACU to ERU. The patient was given 2mg Hydromorphone in the OR. Mr. Johnson was extubated, and is sleepy but arousable. Shortly after arrival to PACU, the patient develops acute respiratory distress. His respiratory rate increases to 33 breaths per minute, SpO2 is 90%;, heart rate increases to 110 bpm, blood pressure 98/50. On examination, his pupils are pinpoint but reacting, he is moving air into both of his lungs but there is little air entry into his lung bases. It was decided by anesthesia to order a chest x-ray which showed pulmonary edema. The anesthesiologist ordered a non-rebreather facemask with O2 of 95%; and Lasix 20mg IV. During the next 1   hours in PACU, The patient received 2 mg of Hydromorphone for pain and his VS became more stable: Respirations 24 breaths per minutes, HR is 96 bpm and BP is 102/60 .  After working with the patient, the nurse was able to wean Mr. Johnson to 5 Liters per nasal cannula and O2 sats were now 94%;.<br><br> The patient is awake and sitting up in bed, but remains slightly drowsy due to the pain medication. 30 minutes later, the nurse assessed the patient and decided it was appropriate to begin weaning the patient to room air. The O2 saturation decreased immediately to 88% on room air. The nasal cannula was reapplied at 5 Liters and the patient's O2 sat increased to 94.<br><br> The patient does not appear to be in any distress at this time and the charge nurse is asking how much longer does the patient need for recovery in PACU? How should the nurse respond?<br><br> <b>What is the nurse's most appropriate course of action now?</b>",74452,2,C.  Reconsider ERU admission if the patient's condition does not improve and contact the surgeon to discuss the events that have occurred.,0
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25078,1,"<b>Clinical Scenario 1</b><br><br> Mr. Johnson, a 57 year old male undergoes a laparoscopic cholecystectomy. The intraoperative course was uneventful and the patient has orders to be discharged from PACU to ERU. The patient was given 2mg Hydromorphone in the OR. Mr. Johnson was extubated, and is sleepy but arousable. Shortly after arrival to PACU, the patient develops acute respiratory distress. His respiratory rate increases to 33 breaths per minute, SpO2 is 90%;, heart rate increases to 110 bpm, blood pressure 98/50. On examination, his pupils are pinpoint but reacting, he is moving air into both of his lungs but there is little air entry into his lung bases. It was decided by anesthesia to order a chest x-ray which showed pulmonary edema. The anesthesiologist ordered a non-rebreather facemask with O2 of 95%; and Lasix 20mg IV. During the next 1   hours in PACU, The patient received 2 mg of Hydromorphone for pain and his VS became more stable: Respirations 24 breaths per minutes, HR is 96 bpm and BP is 102/60 .  After working with the patient, the nurse was able to wean Mr. Johnson to 5 Liters per nasal cannula and O2 sats were now 94%;.<br><br> The patient is awake and sitting up in bed, but remains slightly drowsy due to the pain medication. 30 minutes later, the nurse assessed the patient and decided it was appropriate to begin weaning the patient to room air. The O2 saturation decreased immediately to 88% on room air. The nasal cannula was reapplied at 5 Liters and the patient's O2 sat increased to 94.<br><br> The patient does not appear to be in any distress at this time and the charge nurse is asking how much longer does the patient need for recovery in PACU? How should the nurse respond?<br><br> <b>What is the nurse's most appropriate course of action now?</b>",74454,3,D.  A & B only,0
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25078,1,"<b>Clinical Scenario 1</b><br><br> Mr. Johnson, a 57 year old male undergoes a laparoscopic cholecystectomy. The intraoperative course was uneventful and the patient has orders to be discharged from PACU to ERU. The patient was given 2mg Hydromorphone in the OR. Mr. Johnson was extubated, and is sleepy but arousable. Shortly after arrival to PACU, the patient develops acute respiratory distress. His respiratory rate increases to 33 breaths per minute, SpO2 is 90%;, heart rate increases to 110 bpm, blood pressure 98/50. On examination, his pupils are pinpoint but reacting, he is moving air into both of his lungs but there is little air entry into his lung bases. It was decided by anesthesia to order a chest x-ray which showed pulmonary edema. The anesthesiologist ordered a non-rebreather facemask with O2 of 95%; and Lasix 20mg IV. During the next 1   hours in PACU, The patient received 2 mg of Hydromorphone for pain and his VS became more stable: Respirations 24 breaths per minutes, HR is 96 bpm and BP is 102/60 .  After working with the patient, the nurse was able to wean Mr. Johnson to 5 Liters per nasal cannula and O2 sats were now 94%;.<br><br> The patient is awake and sitting up in bed, but remains slightly drowsy due to the pain medication. 30 minutes later, the nurse assessed the patient and decided it was appropriate to begin weaning the patient to room air. The O2 saturation decreased immediately to 88% on room air. The nasal cannula was reapplied at 5 Liters and the patient's O2 sat increased to 94.<br><br> The patient does not appear to be in any distress at this time and the charge nurse is asking how much longer does the patient need for recovery in PACU? How should the nurse respond?<br><br> <b>What is the nurse's most appropriate course of action now?</b>",74455,4,E.  Transfer the patient to ERU to prevent delays occurring in the OR.,0
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25078,1,"<b>Clinical Scenario 1</b><br><br> Mr. Johnson, a 57 year old male undergoes a laparoscopic cholecystectomy. The intraoperative course was uneventful and the patient has orders to be discharged from PACU to ERU. The patient was given 2mg Hydromorphone in the OR. Mr. Johnson was extubated, and is sleepy but arousable. Shortly after arrival to PACU, the patient develops acute respiratory distress. His respiratory rate increases to 33 breaths per minute, SpO2 is 90%;, heart rate increases to 110 bpm, blood pressure 98/50. On examination, his pupils are pinpoint but reacting, he is moving air into both of his lungs but there is little air entry into his lung bases. It was decided by anesthesia to order a chest x-ray which showed pulmonary edema. The anesthesiologist ordered a non-rebreather facemask with O2 of 95%; and Lasix 20mg IV. During the next 1   hours in PACU, The patient received 2 mg of Hydromorphone for pain and his VS became more stable: Respirations 24 breaths per minutes, HR is 96 bpm and BP is 102/60 .  After working with the patient, the nurse was able to wean Mr. Johnson to 5 Liters per nasal cannula and O2 sats were now 94%;.<br><br> The patient is awake and sitting up in bed, but remains slightly drowsy due to the pain medication. 30 minutes later, the nurse assessed the patient and decided it was appropriate to begin weaning the patient to room air. The O2 saturation decreased immediately to 88% on room air. The nasal cannula was reapplied at 5 Liters and the patient's O2 sat increased to 94.<br><br> The patient does not appear to be in any distress at this time and the charge nurse is asking how much longer does the patient need for recovery in PACU? How should the nurse respond?<br><br> <b>What is the nurse's most appropriate course of action now?</b>",74456,5,"F.  A, B & C",1
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25079,2,"<b>Clinical Scenario 2</b><br><br>  Mr. Doe has undergone an open umbilical hernia repair. Upon admission to PACU, The vital signs are as follows: Temp 97.8, BP 160/85, HR76, Resp 16, SPO2 98%; on 5L per nasal cannula and an EBL of 500 mls. The patient takes two antihypertensive medications and baby aspirin daily. The patient received his Beta blocker this morning but held his aspirin and ace inhibitor per MD order. The patient is sleeping and appears to be in stable condition. He also has an abdominal dressing that is CDI and physician orders to be admitted to ERU.<br><br>One hour after arriving to PACU, you (the nurse) notices the blood pressure has decreased to 130/80 with a heart rate of 89 bpm. You also noticed serous sanguineous drainage on the abdominal dressing. The drainage is approximately the size of a baseball in diameter. Anesthesia has come to the bedside to check on the patient and you update him on the current blood pressure, heart rate and breakthrough bleeding. The nurse attributes the change in vital signs to anesthetic medications received in the OR and is not completely alarmed by the change in blood pressure and heart rate. The anesthesiologist states the following: ""He looks fine, we'll just watch him"". You proceed to reinforce the dressing and continue recovering the patient.<br><br>Approximately an hour later, the patient is sleepy but arousable and has been weaned to room air (SPO2 95% on RA). He does not appear to be in any distress but the blood pressure is now 109/69, HR 99 bpm and you notice breakthrough bleeding on the reinforced dressing. The drainage appears to be the size of a baseball (in diameter) once again.<br><br><b>What is the most appropriate NEXT step the PACU nurse should take? Before answering, think about if this patient appropriate to go to ERU? Think about what could be occurring with the patient? What could these subtle findings indicate?</b>",74457,0,A.  Reinforce the dressing for the second time and call report to ERU. Prepare the patient for discharge from PACU.,0
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25079,2,"<b>Clinical Scenario 2</b><br><br>  Mr. Doe has undergone an open umbilical hernia repair. Upon admission to PACU, The vital signs are as follows: Temp 97.8, BP 160/85, HR76, Resp 16, SPO2 98%; on 5L per nasal cannula and an EBL of 500 mls. The patient takes two antihypertensive medications and baby aspirin daily. The patient received his Beta blocker this morning but held his aspirin and ace inhibitor per MD order. The patient is sleeping and appears to be in stable condition. He also has an abdominal dressing that is CDI and physician orders to be admitted to ERU.<br><br>One hour after arriving to PACU, you (the nurse) notices the blood pressure has decreased to 130/80 with a heart rate of 89 bpm. You also noticed serous sanguineous drainage on the abdominal dressing. The drainage is approximately the size of a baseball in diameter. Anesthesia has come to the bedside to check on the patient and you update him on the current blood pressure, heart rate and breakthrough bleeding. The nurse attributes the change in vital signs to anesthetic medications received in the OR and is not completely alarmed by the change in blood pressure and heart rate. The anesthesiologist states the following: ""He looks fine, we'll just watch him"". You proceed to reinforce the dressing and continue recovering the patient.<br><br>Approximately an hour later, the patient is sleepy but arousable and has been weaned to room air (SPO2 95% on RA). He does not appear to be in any distress but the blood pressure is now 109/69, HR 99 bpm and you notice breakthrough bleeding on the reinforced dressing. The drainage appears to be the size of a baseball (in diameter) once again.<br><br><b>What is the most appropriate NEXT step the PACU nurse should take? Before answering, think about if this patient appropriate to go to ERU? Think about what could be occurring with the patient? What could these subtle findings indicate?</b>",74458,1,B.  Notify anesthesia and the surgeon of the current vital signs and dressing appearance.,1
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25079,2,"<b>Clinical Scenario 2</b><br><br>  Mr. Doe has undergone an open umbilical hernia repair. Upon admission to PACU, The vital signs are as follows: Temp 97.8, BP 160/85, HR76, Resp 16, SPO2 98%; on 5L per nasal cannula and an EBL of 500 mls. The patient takes two antihypertensive medications and baby aspirin daily. The patient received his Beta blocker this morning but held his aspirin and ace inhibitor per MD order. The patient is sleeping and appears to be in stable condition. He also has an abdominal dressing that is CDI and physician orders to be admitted to ERU.<br><br>One hour after arriving to PACU, you (the nurse) notices the blood pressure has decreased to 130/80 with a heart rate of 89 bpm. You also noticed serous sanguineous drainage on the abdominal dressing. The drainage is approximately the size of a baseball in diameter. Anesthesia has come to the bedside to check on the patient and you update him on the current blood pressure, heart rate and breakthrough bleeding. The nurse attributes the change in vital signs to anesthetic medications received in the OR and is not completely alarmed by the change in blood pressure and heart rate. The anesthesiologist states the following: ""He looks fine, we'll just watch him"". You proceed to reinforce the dressing and continue recovering the patient.<br><br>Approximately an hour later, the patient is sleepy but arousable and has been weaned to room air (SPO2 95% on RA). He does not appear to be in any distress but the blood pressure is now 109/69, HR 99 bpm and you notice breakthrough bleeding on the reinforced dressing. The drainage appears to be the size of a baseball (in diameter) once again.<br><br><b>What is the most appropriate NEXT step the PACU nurse should take? Before answering, think about if this patient appropriate to go to ERU? Think about what could be occurring with the patient? What could these subtle findings indicate?</b>",74459,2,C.  Increase the IV Fluid rate.,0
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25080,3,"<b>Clinical Scenario 2 Continued....</b><br><br> Before calling, you check the most current blood pressure at this time. Your current findings are as follows: BP 99/60, HR 110, SPO2 95%; on RA, Resp 18, Temp 98.0. The patient still seems to be in no distress and is resting in bed. The nurse calls the anesthesiologist and the surgeon to report the findings. Anesthesia is not alarmed and signs the patient out. The surgeon insists that the patient is ""probably having minor bleeding and this is unlikely to be serious."" The surgeon also states ""I want my patient to go to ERU, he will go home in the morning"". The nurse continues to have concerns about this patient going to ERU. <br><br> <b>What is the most appropriate next step?</b>",74460,0,"A.  Activate your chain of command: Charge Nurse, Supervisor, and Operations Coordinator.",1
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25080,3,"<b>Clinical Scenario 2 Continued....</b><br><br> Before calling, you check the most current blood pressure at this time. Your current findings are as follows: BP 99/60, HR 110, SPO2 95%; on RA, Resp 18, Temp 98.0. The patient still seems to be in no distress and is resting in bed. The nurse calls the anesthesiologist and the surgeon to report the findings. Anesthesia is not alarmed and signs the patient out. The surgeon insists that the patient is ""probably having minor bleeding and this is unlikely to be serious."" The surgeon also states ""I want my patient to go to ERU, he will go home in the morning"". The nurse continues to have concerns about this patient going to ERU. <br><br> <b>What is the most appropriate next step?</b>",74461,1,B.  Follow the MD orders and send the patient to ERU.,0
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25080,3,"<b>Clinical Scenario 2 Continued....</b><br><br> Before calling, you check the most current blood pressure at this time. Your current findings are as follows: BP 99/60, HR 110, SPO2 95%; on RA, Resp 18, Temp 98.0. The patient still seems to be in no distress and is resting in bed. The nurse calls the anesthesiologist and the surgeon to report the findings. Anesthesia is not alarmed and signs the patient out. The surgeon insists that the patient is ""probably having minor bleeding and this is unlikely to be serious."" The surgeon also states ""I want my patient to go to ERU, he will go home in the morning"". The nurse continues to have concerns about this patient going to ERU. <br><br> <b>What is the most appropriate next step?</b>",74462,2,C.  Keep the patient for another hour in PACU for observation purposes.,0
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25121,4,"<b>Clinical Scenerio 3</b><br><br> Mr. Williams underwent a Cystoscopy Transurethral Resection of the prostate. Upon admission to PACU, a CBI (continous bladder irrgation) has been initiated with the first 2 liter bag of  irrigation soluiton running wide open through a 3-way catheter. You notice orders for the patient to be admitted to ERU and foley to be discontinued in the AM if the urine is no longer bloody and the patient voids upon foley removal. The urine is slightly pink to yellow without any blood clots. When further reviewing the PACU orders, the nurse notices an order to ""titirate CBI to keep urine light yellow to clear, Do not let CBI run dry, irrigate foley as needed"". You decide to slow down the drip rate since the urine is now clear yellow without clots. 30 minutes later you noticed the urine has turned bloody with 2-3 dime sized clots noted in the foley bag. You irrigate the catheter and remove 1 large clot. You then proceed to run the CBI drip wide open. 1 hour later, you have changed out (3) 2 Liter bags and the 5th bag is infusing. You have also attempted to titrate the drip to a slower rate numerous times within the last hour and found that the urine turns bloody almost immediately when the CBI is slowed. <br><br><b>What is the most appropriate next step the nurse should take?</b>",74622,0,"A.  Since the urine remains clear at a wide open rate, the nurse should keep the CBI running at a fast rate, continue observing the patient's urine and prepare to call report to the ERU nurse.",0
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25121,4,"<b>Clinical Scenerio 3</b><br><br> Mr. Williams underwent a Cystoscopy Transurethral Resection of the prostate. Upon admission to PACU, a CBI (continous bladder irrgation) has been initiated with the first 2 liter bag of  irrigation soluiton running wide open through a 3-way catheter. You notice orders for the patient to be admitted to ERU and foley to be discontinued in the AM if the urine is no longer bloody and the patient voids upon foley removal. The urine is slightly pink to yellow without any blood clots. When further reviewing the PACU orders, the nurse notices an order to ""titirate CBI to keep urine light yellow to clear, Do not let CBI run dry, irrigate foley as needed"". You decide to slow down the drip rate since the urine is now clear yellow without clots. 30 minutes later you noticed the urine has turned bloody with 2-3 dime sized clots noted in the foley bag. You irrigate the catheter and remove 1 large clot. You then proceed to run the CBI drip wide open. 1 hour later, you have changed out (3) 2 Liter bags and the 5th bag is infusing. You have also attempted to titrate the drip to a slower rate numerous times within the last hour and found that the urine turns bloody almost immediately when the CBI is slowed. <br><br><b>What is the most appropriate next step the nurse should take?</b>",74623,1,"B.  Notify the surgeon that you have concerns about the liklihood that the patient may not be able to be discharged in the morning. You report that when the drip is slowed slightly, it begins to clot off and get bloody. Also, you report that within 1   hours you have changed out 5 bags.",1
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25121,4,"<b>Clinical Scenerio 3</b><br><br> Mr. Williams underwent a Cystoscopy Transurethral Resection of the prostate. Upon admission to PACU, a CBI (continous bladder irrgation) has been initiated with the first 2 liter bag of  irrigation soluiton running wide open through a 3-way catheter. You notice orders for the patient to be admitted to ERU and foley to be discontinued in the AM if the urine is no longer bloody and the patient voids upon foley removal. The urine is slightly pink to yellow without any blood clots. When further reviewing the PACU orders, the nurse notices an order to ""titirate CBI to keep urine light yellow to clear, Do not let CBI run dry, irrigate foley as needed"". You decide to slow down the drip rate since the urine is now clear yellow without clots. 30 minutes later you noticed the urine has turned bloody with 2-3 dime sized clots noted in the foley bag. You irrigate the catheter and remove 1 large clot. You then proceed to run the CBI drip wide open. 1 hour later, you have changed out (3) 2 Liter bags and the 5th bag is infusing. You have also attempted to titrate the drip to a slower rate numerous times within the last hour and found that the urine turns bloody almost immediately when the CBI is slowed. <br><br><b>What is the most appropriate next step the nurse should take?</b>",74624,2,C.  Slow down the CBI because you are tired of changing the bags so frequently.,0
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25122,5,"<b>Clinical Scenerio 4</b><br><br> Mrs. Knight has undergone right breast modified radical mastectomy, right axillary sentinel node biopsy and left breast prophylactic mastectomy. The patient was admitted to Breast Care PACU at 1000. She arrived with a blood pressure of 145/87, HR-85, Temp-97.6, Resp-16 and an O2 saturation of 94%; on 4L per nasal cannula. The patient has a history of morbid obesity, diabetes, depression, ex-smoker (pt. quit 1 month ago), and appendicitis as a child. You also notice orders for admission to ERU.  The patient complained of pain 6/10 to her right breast surgical site at 1015. The nurse administered Hydromorphone 0.2 mg IV at 1020. When re-assessed at 1035 the patient is sleeping and appears to be in no distress, but her O2 Saturation level has decreased to 90%; on 4 Liters. The nurse increases the oxygen to 5 Liters and the O2 saturation improves to 96%;. <br><br>The patient awakens at 1105 and states that her pain is much better, stating ""it's now a 2/10"". You begin to attempt to wean the patient's oxygen flow rate, but are finding difficulty doing so. When weaned to 4 Liters, Mrs. Knight's O2 saturation decreases to 86-87%;. She still does not seem to be in any distress and her current blood pressure/HR/Temperature and respiration rate are stable and WNL. You proceed to increase her oxygen flow rate back to 5 liters and her O2 saturation improves to 96%; per nasal cannula. You begin to encourage Mrs. Knight to take deep breaths and you educate her on the incentive spirometer. The patient begins to follow your instructions and continues using the incentive spirometer until 1145 when you attempt to wean her once again.<br><br>On 4 liters, Mrs. Knight's O2 saturation is now 90%;. You decide to call the anesthesiologist and report your trouble with weaning the patient. Anesthesia states ""she probably needs a little more time waking up or the pain medication might be affecting her saturation, let's watch her a little longer"". You increase the oxygen flow rate back to 5 Liters, but you suspect that there might be something more occurring with this patient. The patient now states her pain is 4/10, but tolerable.<br><br><b>The most appropriate next step is:</b>",74625,0,A.)  Call report to ERU and let the receiving nurse know that the patient remains on 5 liters.,0
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25122,5,"<b>Clinical Scenerio 4</b><br><br> Mrs. Knight has undergone right breast modified radical mastectomy, right axillary sentinel node biopsy and left breast prophylactic mastectomy. The patient was admitted to Breast Care PACU at 1000. She arrived with a blood pressure of 145/87, HR-85, Temp-97.6, Resp-16 and an O2 saturation of 94%; on 4L per nasal cannula. The patient has a history of morbid obesity, diabetes, depression, ex-smoker (pt. quit 1 month ago), and appendicitis as a child. You also notice orders for admission to ERU.  The patient complained of pain 6/10 to her right breast surgical site at 1015. The nurse administered Hydromorphone 0.2 mg IV at 1020. When re-assessed at 1035 the patient is sleeping and appears to be in no distress, but her O2 Saturation level has decreased to 90%; on 4 Liters. The nurse increases the oxygen to 5 Liters and the O2 saturation improves to 96%;. <br><br>The patient awakens at 1105 and states that her pain is much better, stating ""it's now a 2/10"". You begin to attempt to wean the patient's oxygen flow rate, but are finding difficulty doing so. When weaned to 4 Liters, Mrs. Knight's O2 saturation decreases to 86-87%;. She still does not seem to be in any distress and her current blood pressure/HR/Temperature and respiration rate are stable and WNL. You proceed to increase her oxygen flow rate back to 5 liters and her O2 saturation improves to 96%; per nasal cannula. You begin to encourage Mrs. Knight to take deep breaths and you educate her on the incentive spirometer. The patient begins to follow your instructions and continues using the incentive spirometer until 1145 when you attempt to wean her once again.<br><br>On 4 liters, Mrs. Knight's O2 saturation is now 90%;. You decide to call the anesthesiologist and report your trouble with weaning the patient. Anesthesia states ""she probably needs a little more time waking up or the pain medication might be affecting her saturation, let's watch her a little longer"". You increase the oxygen flow rate back to 5 Liters, but you suspect that there might be something more occurring with this patient. The patient now states her pain is 4/10, but tolerable.<br><br><b>The most appropriate next step is:</b>",74626,1,"B.)  Continue to monitor the patient for little while longer and if still unable to wean the patient, suggest a respiratory consult to the anesthesiologist and call the surgeon to notify him that his patient does not meet admission criteria for ERU due to their current oxygenation state.",1
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25122,5,"<b>Clinical Scenerio 4</b><br><br> Mrs. Knight has undergone right breast modified radical mastectomy, right axillary sentinel node biopsy and left breast prophylactic mastectomy. The patient was admitted to Breast Care PACU at 1000. She arrived with a blood pressure of 145/87, HR-85, Temp-97.6, Resp-16 and an O2 saturation of 94%; on 4L per nasal cannula. The patient has a history of morbid obesity, diabetes, depression, ex-smoker (pt. quit 1 month ago), and appendicitis as a child. You also notice orders for admission to ERU.  The patient complained of pain 6/10 to her right breast surgical site at 1015. The nurse administered Hydromorphone 0.2 mg IV at 1020. When re-assessed at 1035 the patient is sleeping and appears to be in no distress, but her O2 Saturation level has decreased to 90%; on 4 Liters. The nurse increases the oxygen to 5 Liters and the O2 saturation improves to 96%;. <br><br>The patient awakens at 1105 and states that her pain is much better, stating ""it's now a 2/10"". You begin to attempt to wean the patient's oxygen flow rate, but are finding difficulty doing so. When weaned to 4 Liters, Mrs. Knight's O2 saturation decreases to 86-87%;. She still does not seem to be in any distress and her current blood pressure/HR/Temperature and respiration rate are stable and WNL. You proceed to increase her oxygen flow rate back to 5 liters and her O2 saturation improves to 96%; per nasal cannula. You begin to encourage Mrs. Knight to take deep breaths and you educate her on the incentive spirometer. The patient begins to follow your instructions and continues using the incentive spirometer until 1145 when you attempt to wean her once again.<br><br>On 4 liters, Mrs. Knight's O2 saturation is now 90%;. You decide to call the anesthesiologist and report your trouble with weaning the patient. Anesthesia states ""she probably needs a little more time waking up or the pain medication might be affecting her saturation, let's watch her a little longer"". You increase the oxygen flow rate back to 5 Liters, but you suspect that there might be something more occurring with this patient. The patient now states her pain is 4/10, but tolerable.<br><br><b>The most appropriate next step is:</b>",74627,2,C.)  Medicate the patient with a second dose of Dilaudid.,0
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25122,5,"<b>Clinical Scenerio 4</b><br><br> Mrs. Knight has undergone right breast modified radical mastectomy, right axillary sentinel node biopsy and left breast prophylactic mastectomy. The patient was admitted to Breast Care PACU at 1000. She arrived with a blood pressure of 145/87, HR-85, Temp-97.6, Resp-16 and an O2 saturation of 94%; on 4L per nasal cannula. The patient has a history of morbid obesity, diabetes, depression, ex-smoker (pt. quit 1 month ago), and appendicitis as a child. You also notice orders for admission to ERU.  The patient complained of pain 6/10 to her right breast surgical site at 1015. The nurse administered Hydromorphone 0.2 mg IV at 1020. When re-assessed at 1035 the patient is sleeping and appears to be in no distress, but her O2 Saturation level has decreased to 90%; on 4 Liters. The nurse increases the oxygen to 5 Liters and the O2 saturation improves to 96%;. <br><br>The patient awakens at 1105 and states that her pain is much better, stating ""it's now a 2/10"". You begin to attempt to wean the patient's oxygen flow rate, but are finding difficulty doing so. When weaned to 4 Liters, Mrs. Knight's O2 saturation decreases to 86-87%;. She still does not seem to be in any distress and her current blood pressure/HR/Temperature and respiration rate are stable and WNL. You proceed to increase her oxygen flow rate back to 5 liters and her O2 saturation improves to 96%; per nasal cannula. You begin to encourage Mrs. Knight to take deep breaths and you educate her on the incentive spirometer. The patient begins to follow your instructions and continues using the incentive spirometer until 1145 when you attempt to wean her once again.<br><br>On 4 liters, Mrs. Knight's O2 saturation is now 90%;. You decide to call the anesthesiologist and report your trouble with weaning the patient. Anesthesia states ""she probably needs a little more time waking up or the pain medication might be affecting her saturation, let's watch her a little longer"". You increase the oxygen flow rate back to 5 Liters, but you suspect that there might be something more occurring with this patient. The patient now states her pain is 4/10, but tolerable.<br><br><b>The most appropriate next step is:</b>",74628,3,D.)  Both A&C,0
8273,Elearning-0000-1156,CRITICAL THINKING AND PATIENT ADVOCACY,n5493,25122,5,"<b>Clinical Scenerio 4</b><br><br> Mrs. Knight has undergone right breast modified radical mastectomy, right axillary sentinel node biopsy and left breast prophylactic mastectomy. The patient was admitted to Breast Care PACU at 1000. She arrived with a blood pressure of 145/87, HR-85, Temp-97.6, Resp-16 and an O2 saturation of 94%; on 4L per nasal cannula. The patient has a history of morbid obesity, diabetes, depression, ex-smoker (pt. quit 1 month ago), and appendicitis as a child. You also notice orders for admission to ERU.  The patient complained of pain 6/10 to her right breast surgical site at 1015. The nurse administered Hydromorphone 0.2 mg IV at 1020. When re-assessed at 1035 the patient is sleeping and appears to be in no distress, but her O2 Saturation level has decreased to 90%; on 4 Liters. The nurse increases the oxygen to 5 Liters and the O2 saturation improves to 96%;. <br><br>The patient awakens at 1105 and states that her pain is much better, stating ""it's now a 2/10"". You begin to attempt to wean the patient's oxygen flow rate, but are finding difficulty doing so. When weaned to 4 Liters, Mrs. Knight's O2 saturation decreases to 86-87%;. She still does not seem to be in any distress and her current blood pressure/HR/Temperature and respiration rate are stable and WNL. You proceed to increase her oxygen flow rate back to 5 liters and her O2 saturation improves to 96%; per nasal cannula. You begin to encourage Mrs. Knight to take deep breaths and you educate her on the incentive spirometer. The patient begins to follow your instructions and continues using the incentive spirometer until 1145 when you attempt to wean her once again.<br><br>On 4 liters, Mrs. Knight's O2 saturation is now 90%;. You decide to call the anesthesiologist and report your trouble with weaning the patient. Anesthesia states ""she probably needs a little more time waking up or the pain medication might be affecting her saturation, let's watch her a little longer"". You increase the oxygen flow rate back to 5 Liters, but you suspect that there might be something more occurring with this patient. The patient now states her pain is 4/10, but tolerable.<br><br><b>The most appropriate next step is:</b>",74629,4,E.)  Both B&C,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25656,0,Components of Universal Protocol include:,76689,0,A. Conducting a pre-procedure verification process.,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25656,0,Components of Universal Protocol include:,76690,1,B. Marking the procedure site,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25656,0,Components of Universal Protocol include:,76691,2,C. Performing a time-out before the procedure,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25656,0,Components of Universal Protocol include:,76692,3,D. A and C,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25656,0,Components of Universal Protocol include:,76693,4,"E. A, B, and C",1
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25657,1,"The purpose of Universal Protocol is to make sure that any procedure performed is the correct procedure, performed on the correct patient, and, if applicable, on the correct side.",76695,0,TRUE,1
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25657,1,"The purpose of Universal Protocol is to make sure that any procedure performed is the correct procedure, performed on the correct patient, and, if applicable, on the correct side.",76694,1,FALSE,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25658,2,Northside Hospital policy for correct patient identification using two approved patient identifiers is not needed for the Universal Protocol process.,76696,0,TRUE,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25658,2,Northside Hospital policy for correct patient identification using two approved patient identifiers is not needed for the Universal Protocol process.,76697,1,FALSE,1
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25659,3,"During the pre-procedure verification process, it is not necessary to involve the patient.",76698,0,TRUE,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25659,3,"During the pre-procedure verification process, it is not necessary to involve the patient.",76699,1,FALSE,1
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25660,4,Sites are marked when there is more than one possible location for the procedure and when performing the procedure in a different location would negatively affect quality or safety.,76701,0,TRUE,1
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25660,4,Sites are marked when there is more than one possible location for the procedure and when performing the procedure in a different location would negatively affect quality or safety.,76700,1,FALSE,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25661,5,The physician may delegate site marking to an individual who is permitted by the hospital to participate in the procedure and who performs duties requiring a supervisory agreement with the delegating physician.,76703,0,TRUE,1
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25661,5,The physician may delegate site marking to an individual who is permitted by the hospital to participate in the procedure and who performs duties requiring a supervisory agreement with the delegating physician.,76702,1,FALSE,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25662,6,"At Northside Hospital, a permanent marking pen is used (except on premature infants) to mark the physician's initials on all procedure sites involving laterality, adjacent structures, or levels.",76705,0,TRUE,1
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25662,6,"At Northside Hospital, a permanent marking pen is used (except on premature infants) to mark the physician's initials on all procedure sites involving laterality, adjacent structures, or levels.",76704,1,FALSE,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25663,7,The patient is scheduled for a right breast mastectomy and a left breast sentinel node biopsy.  This qualifies as a bilateral breast procedure and does not require marking.,76706,0,TRUE,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25663,7,The patient is scheduled for a right breast mastectomy and a left breast sentinel node biopsy.  This qualifies as a bilateral breast procedure and does not require marking.,76707,1,FALSE,1
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25664,8,Marking is not required for:,76708,0,A. Procedures for which the catheter or instrument insertion site is not predetermined,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25664,8,Marking is not required for:,76709,1,B. Premature infants,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25664,8,Marking is not required for:,76710,2,C. Unilateral or single organ procedures,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25664,8,Marking is not required for:,76711,3,D. Bilateral sites are scheduled for the same procedure,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25664,8,Marking is not required for:,76712,4,"E. Cases performed in non-surgical procedural areas in which the physician performing the procedure is in continuous attendance with the patient from the time of decision to perform the procedure, the consent is obtained, and the procedure is performed.",0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25664,8,Marking is not required for:,76713,5,"F. A, B, C, E",0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25664,8,Marking is not required for:,76714,6,"G. A, B, C, D, E",1
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25665,9,"At a minimum, during time-out, the entire procedural team must agree on the",76715,0,A. Correct patient,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25665,9,"At a minimum, during time-out, the entire procedural team must agree on the",76716,1,B. Correct procedure,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25665,9,"At a minimum, during time-out, the entire procedural team must agree on the",76717,2,C. Correct site/side,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25665,9,"At a minimum, during time-out, the entire procedural team must agree on the",76719,3,"D. A, B, C",1
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25665,9,"At a minimum, during time-out, the entire procedural team must agree on the",76718,4,"E. A, B",0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25666,10,An additional time-out is required when:,76720,0,A. Two or more procedures are being performed on the same patient and the person performing the procedure changes,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25666,10,An additional time-out is required when:,76721,1,B. The patient's position is changed during the procedure,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25666,10,An additional time-out is required when:,76722,2,C. The circulator/procedural nurse changes,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25666,10,An additional time-out is required when:,76724,3,D. Both A and B,1
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25666,10,An additional time-out is required when:,76723,4,"E. A, B, C",0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25667,11,"If questions or concerns cannot be resolved during the time-out, the procedure can continue but the Chain of Command should be initiated.",76725,0,TRUE,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25667,11,"If questions or concerns cannot be resolved during the time-out, the procedure can continue but the Chain of Command should be initiated.",76726,1,FALSE,1
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25668,12,"During pre-procedure verification, a checklist is used to ensure the following are available:",76727,0,A. H&P and Consent,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25668,12,"During pre-procedure verification, a checklist is used to ensure the following are available:",76728,1,B. Nursing Assessment,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25668,12,"During pre-procedure verification, a checklist is used to ensure the following are available:",76729,2,C. Pre-anesthesia Assessment,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25668,12,"During pre-procedure verification, a checklist is used to ensure the following are available:",76730,3,"D. If applicable, labeled diagnostic and/or radiology results",0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25668,12,"During pre-procedure verification, a checklist is used to ensure the following are available:",76731,4,"E. Any required blood products, implants, devices and/or special equipment for the procedure",0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25668,12,"During pre-procedure verification, a checklist is used to ensure the following are available:",76732,5,"F. A, C, D",0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25668,12,"During pre-procedure verification, a checklist is used to ensure the following are available:",76733,6,G. All of the above,1
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25669,13,It is not necessary to document completion of the time-out as long as you follow the process.,76734,0,TRUE,0
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25669,13,It is not necessary to document completion of the time-out as long as you follow the process.,76735,1,FALSE,1
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25670,14,Every member of the procedure team is accountable to ensuring Universal Protocol occurs on every patient undergoing a procedure.,76737,0,TRUE,1
8260,Elearning-0000-1144,NATIONAL PATIENT SAFETY GOAL: UNIVERSAL PROTOCOL,n5547,25670,14,Every member of the procedure team is accountable to ensuring Universal Protocol occurs on every patient undergoing a procedure.,76736,1,FALSE,0
9065,Elearning-0000-336,NSH 1148 - MILS AMENDMENT 5,n5551,25676,0,I have read and understand the contents of the NSH 1148 - MILS AMENDMENT 5 CBL.,76752,0,TRUE,1
9065,Elearning-0000-336,NSH 1148 - MILS AMENDMENT 5,n5551,25676,0,I have read and understand the contents of the NSH 1148 - MILS AMENDMENT 5 CBL.,76753,1,FALSE,0
9025,Elearning-0000-30,MEDICAL OFFICE SURVEY ON PATIENT SAFETY,n5555,25731,0,"I acknowledge that I have completed the ""Medical Office Survey on Patient Safety"".",76983,0,TRUE,1
9025,Elearning-0000-30,MEDICAL OFFICE SURVEY ON PATIENT SAFETY,n5555,25731,0,"I acknowledge that I have completed the ""Medical Office Survey on Patient Safety"".",76984,1,FALSE,0
9255,Elearning-0000-509,ITSM - MYNORTHSIDEIT CBL,n5571,25764,0,I acknowledge that I have read and understand the myNorthsideIT Training Guide CBL,77062,0,TRUE,1
9255,Elearning-0000-509,ITSM - MYNORTHSIDEIT CBL,n5571,25764,0,I acknowledge that I have read and understand the myNorthsideIT Training Guide CBL,77063,1,FALSE,0
9054,Elearning-0000-326,NSH 1184 - BMT CTN 1507 SICKLE CELL DISEASE,n5620,26219,0,This study focuses on patients diagnosed with:,78772,0,a. Severe aplastic anemia (SAA) patients undergoing allo transplant,0
9054,Elearning-0000-326,NSH 1184 - BMT CTN 1507 SICKLE CELL DISEASE,n5620,26219,0,This study focuses on patients diagnosed with:,78773,1,b. Acute myeloid leukemia (AML) FLT3/ITD patients undergoing allo transplant,0
9054,Elearning-0000-326,NSH 1184 - BMT CTN 1507 SICKLE CELL DISEASE,n5620,26219,0,This study focuses on patients diagnosed with:,78774,2,c. Sickle cell disease (SCD) undergoing allo transplant,1
9054,Elearning-0000-326,NSH 1184 - BMT CTN 1507 SICKLE CELL DISEASE,n5620,26219,0,This study focuses on patients diagnosed with:,78775,3,d. Multiple Myeloma (MM) patient undergoing auto transplant,0
9054,Elearning-0000-326,NSH 1184 - BMT CTN 1507 SICKLE CELL DISEASE,n5620,26220,1,Patients cannot enroll on study if they come to Northside Hospital already taking Hydrea.,78776,0,TRUE,0
9054,Elearning-0000-326,NSH 1184 - BMT CTN 1507 SICKLE CELL DISEASE,n5620,26220,1,Patients cannot enroll on study if they come to Northside Hospital already taking Hydrea.,78777,1,FALSE,1
9054,Elearning-0000-326,NSH 1184 - BMT CTN 1507 SICKLE CELL DISEASE,n5620,26221,2,A liver MRI is required when:,78778,0,a. Patients receive =8 packed RBC transfusions in =1 year.,0
9054,Elearning-0000-326,NSH 1184 - BMT CTN 1507 SICKLE CELL DISEASE,n5620,26221,2,A liver MRI is required when:,78779,1,b. Patients receive =20 packed RBC transfusions cumulative lifetime.,0
9054,Elearning-0000-326,NSH 1184 - BMT CTN 1507 SICKLE CELL DISEASE,n5620,26221,2,A liver MRI is required when:,78780,2,c. All patients need a liver MRI when enrolling on this study.,0
9054,Elearning-0000-326,NSH 1184 - BMT CTN 1507 SICKLE CELL DISEASE,n5620,26221,2,A liver MRI is required when:,78781,3,d. None of the above.,0
9054,Elearning-0000-326,NSH 1184 - BMT CTN 1507 SICKLE CELL DISEASE,n5620,26221,2,A liver MRI is required when:,78782,4,e. A and B only.,1
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26761,0,Which item(s) are used to orient patients to the infusion room?,80705,0,A. The Taking Control book,0
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26761,0,Which item(s) are used to orient patients to the infusion room?,80706,1,B. The Welcome to Your Treatment Center pages,1
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26761,0,Which item(s) are used to orient patients to the infusion room?,80707,2,C. The survivorship brochure,0
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26761,0,Which item(s) are used to orient patients to the infusion room?,80708,3,D. A and C,0
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26762,1,When is the Living Well Binder given to patients?,80709,0,A. Before treatment is started,1
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26762,1,When is the Living Well Binder given to patients?,80710,1,B. After a few treatments have been completed,0
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26762,1,When is the Living Well Binder given to patients?,80711,2,C. After a few treatments have been completed,0
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26762,1,When is the Living Well Binder given to patients?,80712,3,D. Close to the end of treatment,0
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26763,2,What are patients supposed to do with the Living Well Binder?,80713,0,A. Read through the materials,0
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26763,2,What are patients supposed to do with the Living Well Binder?,80714,1,B. Bring the binder to appointments,0
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26763,2,What are patients supposed to do with the Living Well Binder?,80715,2,C. Keep papers in the binder and write down questions and answers,0
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26763,2,What are patients supposed to do with the Living Well Binder?,80716,3,D. All of the above,1
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26764,3,Where can Symptom Management Sheets be found?,80717,0,"A. Available in ""Taking Control: A Guide to Managing Your Care"" book",0
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26764,3,Where can Symptom Management Sheets be found?,80718,1,B. Available on the NHCI Intranet in the Document Library,0
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26764,3,Where can Symptom Management Sheets be found?,80719,2,"C. Available in ""Finding Your True North"" booklet",0
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26764,3,Where can Symptom Management Sheets be found?,80720,3,D. All of the above,0
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26764,3,Where can Symptom Management Sheets be found?,80721,4,E. Only A & B,1
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26764,3,Where can Symptom Management Sheets be found?,80722,5,F. Only B & C,0
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26765,4,When is Finding Your True North given to patients?,80723,0,A. Before treatment begins,0
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26765,4,When is Finding Your True North given to patients?,80724,1,B. Halfway through curative treatment,0
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26765,4,When is Finding Your True North given to patients?,80725,2,C. At the end of curative treatment,1
8257,Elearning-0000-1141,MY GUIDE TO LIVING WELL,n5683,26765,4,When is Finding Your True North given to patients?,80726,3,D. None of the above,0
4354,ILT-0000-19564,STAFF MEETING,n5685,26767,0,I have read and understand the contents of the STAFF MEETING CBL.,80729,0,TRUE,1
4354,ILT-0000-19564,STAFF MEETING,n5685,26767,0,I have read and understand the contents of the STAFF MEETING CBL.,80730,1,FALSE,0
1495,ILT-0000-6259,ED URINARY CATHETERIZATION EDUCATION,n5689,26798,0,"I acknowledge that I have read and understand the ""ED URINARY CATHETERIZATION EDUCATION"" CBL in its entirety.",80846,0,TRUE,1
8271,Elearning-0000-1154,ED URINARY CATHETERIZATION EDUCATION,n5689,26798,0,"I acknowledge that I have read and understand the ""ED URINARY CATHETERIZATION EDUCATION"" CBL in its entirety.",80846,0,TRUE,1
1495,ILT-0000-6259,ED URINARY CATHETERIZATION EDUCATION,n5689,26798,0,"I acknowledge that I have read and understand the ""ED URINARY CATHETERIZATION EDUCATION"" CBL in its entirety.",80847,1,FALSE,0
8271,Elearning-0000-1154,ED URINARY CATHETERIZATION EDUCATION,n5689,26798,0,"I acknowledge that I have read and understand the ""ED URINARY CATHETERIZATION EDUCATION"" CBL in its entirety.",80847,1,FALSE,0
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26865,0,All breastfeeding mothers who have babies admitted to the NICU should start pumping within what time frame?,81076,0,Within 6 hours of delivery,1
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26865,0,All breastfeeding mothers who have babies admitted to the NICU should start pumping within what time frame?,81077,1,Within 6 hours of admission to FCC,0
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26865,0,All breastfeeding mothers who have babies admitted to the NICU should start pumping within what time frame?,81078,2,24 hours after delivery,0
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26865,0,All breastfeeding mothers who have babies admitted to the NICU should start pumping within what time frame?,81079,3,Any time before discharge,0
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26866,1,How many times should a mother whose baby is in NICU pump during a 24 hour period?,81080,0,5 times for 15-20 minutes,0
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26866,1,How many times should a mother whose baby is in NICU pump during a 24 hour period?,81081,1,At least 8 times for 15 minutes,1
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26866,1,How many times should a mother whose baby is in NICU pump during a 24 hour period?,81082,2,Every 4 hours,0
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26866,1,How many times should a mother whose baby is in NICU pump during a 24 hour period?,81083,3,As many times as she can,0
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26867,2,Which of the following lists the 3 step communication process?,81084,0,"Open-ended concerns, validate, educate",0
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26867,2,Which of the following lists the 3 step communication process?,81085,1,"Open-ended questions, validation/affirmation, share information",1
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26867,2,Which of the following lists the 3 step communication process?,81086,2,"Ask questions, confirm mom's fears, educate all of the family",0
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26867,2,Which of the following lists the 3 step communication process?,81087,3,Any of the above,0
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26868,3,When educating parents you should remember:,81088,0,Adults learn more with small amounts of information in repeated conversations,0
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26868,3,When educating parents you should remember:,81089,1,Adults are more interested in solutions than rules or policies,0
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26868,3,When educating parents you should remember:,81090,2,Adults respect information they are interested in,0
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26868,3,When educating parents you should remember:,81091,3,All of the above,1
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26869,4,A formula feeding mother asks how much she should feed her 1 day old infant. What is the appropriate response?,81092,0,As much as he will eat.,0
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26869,4,A formula feeding mother asks how much she should feed her 1 day old infant. What is the appropriate response?,81093,1,No more than 15 ml at a time,1
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26869,4,A formula feeding mother asks how much she should feed her 1 day old infant. What is the appropriate response?,81094,2,No more than an ounce per feeding,0
860,ILT-0000-3122,BREASTFEEDING INITIATORS CLASS,n5718,26869,4,A formula feeding mother asks how much she should feed her 1 day old infant. What is the appropriate response?,81095,3,About a teaspoon is all he needs,0
8272,Elearning-0000-1155,DUODENAL SWITCH,n5733,26912,0,"I acknowledge that I read and understand the ""Duodenal Switch"" in its entirety.",81226,0,TRUE,1
8272,Elearning-0000-1155,DUODENAL SWITCH,n5733,26912,0,"I acknowledge that I read and understand the ""Duodenal Switch"" in its entirety.",81227,1,FALSE,0
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27002,0,Pre-procedure reprocessing occurs at the point of care immediate after use on the patient.,81589,0,TRUE,0
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27002,0,Pre-procedure reprocessing occurs at the point of care immediate after use on the patient.,81590,1,FALSE,1
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27003,1,The following endoscopes need to be pre-procedure reprocessed per Northside policy:,81591,0,"A.	Duodenoscopes",0
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27003,1,The following endoscopes need to be pre-procedure reprocessed per Northside policy:,81592,1,"B.	Linear EUS scopes",0
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27003,1,The following endoscopes need to be pre-procedure reprocessed per Northside policy:,81593,2,"C.	Bronchoscopes",0
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27003,1,The following endoscopes need to be pre-procedure reprocessed per Northside policy:,81594,3,"D.	A & B only",0
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27003,1,The following endoscopes need to be pre-procedure reprocessed per Northside policy:,81595,4,"E.	A, B & C",1
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27004,2,"When removing a scope from the cabinet for use, complete the following steps:",81596,0,"A.	Verify the colored tag with the scope tracking system",0
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27004,2,"When removing a scope from the cabinet for use, complete the following steps:",81597,1,"B.	Initial next to the date on the AER ticket",0
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27004,2,"When removing a scope from the cabinet for use, complete the following steps:",81598,2,"C.	A only",0
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27004,2,"When removing a scope from the cabinet for use, complete the following steps:",81599,3,"D.	A & B",1
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27005,3,"Once it has been determined an endoscope is in need of repair, the following steps must be completed:",81600,0,"A.	Enter a BioMed work order",0
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27005,3,"Once it has been determined an endoscope is in need of repair, the following steps must be completed:",81601,1,"B.	Reprocess the scope per IFU guidelines",0
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27005,3,"Once it has been determined an endoscope is in need of repair, the following steps must be completed:",81602,2,"C.	Inform your supervisor",0
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27005,3,"Once it has been determined an endoscope is in need of repair, the following steps must be completed:",81603,3,"D.	Attach BioMed work order print out to outside of scope case",0
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27005,3,"Once it has been determined an endoscope is in need of repair, the following steps must be completed:",81604,4,"E.	Enter an Incident Report",0
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27005,3,"Once it has been determined an endoscope is in need of repair, the following steps must be completed:",81605,5,"F.	A & C",0
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27005,3,"Once it has been determined an endoscope is in need of repair, the following steps must be completed:",81606,6,"G.	All of the above",1
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27006,4,It is not necessary to initial the date on the AER ticket when I remove an endoscope from the cabinet.,81607,0,TRUE,0
8264,Elearning-0000-1148,REMOVING A FLEXIBLE ENDOSCOPE FROM STORAGE,n5742,27006,4,It is not necessary to initial the date on the AER ticket when I remove an endoscope from the cabinet.,81608,1,FALSE,1
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27007,0,When may a provider order Tranexamic Acid (TXA) for treatment of postpartum hemorrhage?,81609,0,If the second line uterotonic agent (Pitocin being the first) fails to control bleeding,0
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27007,0,When may a provider order Tranexamic Acid (TXA) for treatment of postpartum hemorrhage?,81610,1,If the bleeding continues for 30 minutes after first dose,0
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27007,0,When may a provider order Tranexamic Acid (TXA) for treatment of postpartum hemorrhage?,81611,2,If bleeding restarts within 24 hours after first dose,0
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27007,0,When may a provider order Tranexamic Acid (TXA) for treatment of postpartum hemorrhage?,81612,3,All of the above,1
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27008,1,Where does the provider (or nurse if telephone order)  place the order for Tranexamic Acid (TXA)?,81613,0,The OB Medications iForm/FOD,1
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27008,1,Where does the provider (or nurse if telephone order)  place the order for Tranexamic Acid (TXA)?,81614,1,The Postpartum Vaginal/Cesarean Section Delivery iForm/FOD,0
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27008,1,Where does the provider (or nurse if telephone order)  place the order for Tranexamic Acid (TXA)?,81615,2,The Postpartum Hemorrhage Physician Orders,0
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27008,1,Where does the provider (or nurse if telephone order)  place the order for Tranexamic Acid (TXA)?,81616,3,The Postpartum Emergency Physician Orders,0
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27009,2,Where can the nurse find the Tranexamic Acid (TXA) if the patient is not in L&D?,81617,0,The Accudose machine,0
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27009,2,Where can the nurse find the Tranexamic Acid (TXA) if the patient is not in L&D?,81618,1,The Main Pharmacy will dispense to unit,1
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27009,2,Where can the nurse find the Tranexamic Acid (TXA) if the patient is not in L&D?,81619,2,The Emergency Box,0
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27009,2,Where can the nurse find the Tranexamic Acid (TXA) if the patient is not in L&D?,81620,3,None of the above,0
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27010,3,What considerations should be made if a patient is going to receive Tranexamic Acid (TXA)?,81621,0,If the patient has fluid or medication infusing in their 1st IV line a 2nd IV line is needed,0
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27010,3,What considerations should be made if a patient is going to receive Tranexamic Acid (TXA)?,81622,1,"Tranexamic Acid (TXA) cannot be administered with any other medications, should always be given alone",0
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27010,3,What considerations should be made if a patient is going to receive Tranexamic Acid (TXA)?,81623,2,Use with caution in patients with thromboembolic disease,0
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27010,3,What considerations should be made if a patient is going to receive Tranexamic Acid (TXA)?,81624,3,All of the above,1
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27011,4,How should Tranexamic Acid (TXA) be administered?,81625,0,via IV infusion pump,0
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27011,4,How should Tranexamic Acid (TXA) be administered?,81626,1,over 20 minutes,0
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27011,4,How should Tranexamic Acid (TXA) be administered?,81627,2,IV push,0
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27011,4,How should Tranexamic Acid (TXA) be administered?,81628,3,Both A and B,1
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27012,5,What is the potential danger to the patient related to rapid infusion of Tranexamic Acid (TXA)?,81629,0,Hypotension,1
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27012,5,What is the potential danger to the patient related to rapid infusion of Tranexamic Acid (TXA)?,81630,1,Increased bleeding,0
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27012,5,What is the potential danger to the patient related to rapid infusion of Tranexamic Acid (TXA)?,81631,2,Pain,0
8344,Elearning-0000-122,TRANEXAMIC ACID FOR POSTPARTUM HEMORRHAGE,n5743,27012,5,What is the potential danger to the patient related to rapid infusion of Tranexamic Acid (TXA)?,81632,3,There are no risks,0
8379,Elearning-0000-1251,FOCUS PDCA OVERVIEW,n5744,27013,0,I have read and understand the contents of the FOCUS PDCA OVERVIEW CBL.,81633,0,TRUE,1
8379,Elearning-0000-1251,FOCUS PDCA OVERVIEW,n5744,27013,0,I have read and understand the contents of the FOCUS PDCA OVERVIEW CBL.,81634,1,FALSE,0
8376,Elearning-0000-1249,GREENWAY PATIENT PORTAL,n5754,27061,0,I have reviewed the content within the GREENWAY PATIENT PORTAL CBL and acknowledge that I have watched the video in its entirety.,81810,0,TRUE,1
8376,Elearning-0000-1249,GREENWAY PATIENT PORTAL,n5754,27061,0,I have reviewed the content within the GREENWAY PATIENT PORTAL CBL and acknowledge that I have watched the video in its entirety.,81811,1,FALSE,0
8268,Elearning-0000-1151,FEEDING TUBES: CARE OF THE PATIENT IN ERU,n5758,27073,0,"I acknowledge that I have read and understand the ""Feeding Tubes: Care of the Patient in ERU"" CBL in its entirety.",81846,0,TRUE,1
8268,Elearning-0000-1151,FEEDING TUBES: CARE OF THE PATIENT IN ERU,n5758,27073,0,"I acknowledge that I have read and understand the ""Feeding Tubes: Care of the Patient in ERU"" CBL in its entirety.",81847,1,FALSE,0
191,SCORM-0000-27,CULTURE OF ACCOUNTABILITY,n5784,27293,0,I have read and understand the contents of the Culture of Accountability CBL.,82698,0,TRUE,1
191,SCORM-0000-27,CULTURE OF ACCOUNTABILITY,n5784,27293,0,I have read and understand the contents of the Culture of Accountability CBL.,82699,1,FALSE,0
8909,Elearning-0000-194,NURSE SCOPE OF PRACTICE,n5792,27319,0,I have read and understand the contents of the NURSE SCOPE OF PRACTICE CBL.,82794,0,TRUE,1
8909,Elearning-0000-194,NURSE SCOPE OF PRACTICE,n5792,27319,0,I have read and understand the contents of the NURSE SCOPE OF PRACTICE CBL.,82795,1,FALSE,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27325,0,What does NEWT-OB stand for?,83655,0,New Triggers for OB,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27325,0,What does NEWT-OB stand for?,83656,1,Northside Early Warning Triggers for Obstetrics,1
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27325,0,What does NEWT-OB stand for?,83657,2,Northside OB Early Warning,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27325,0,What does NEWT-OB stand for?,83658,3,None of the Above,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27651,1,NEWT-OB will replace the OBEWS system for all obstetric patients?,83659,0,TRUE,1
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27651,1,NEWT-OB will replace the OBEWS system for all obstetric patients?,83660,1,FALSE,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27652,2,A patient currently has a BP of 165/95. You repeat in 15 minutes and the BP is 166/98. You know patient has orders for IV labetalol for BP's >/= 160/110. According to NEWT-OB what will your next actions be?,83661,0,Notify the provider and request them to come to the bedside.,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27652,2,A patient currently has a BP of 165/95. You repeat in 15 minutes and the BP is 166/98. You know patient has orders for IV labetalol for BP's >/= 160/110. According to NEWT-OB what will your next actions be?,83662,1,The patient has chronic hypertension so this is an expected BP. Continue to monitor.,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27652,2,A patient currently has a BP of 165/95. You repeat in 15 minutes and the BP is 166/98. You know patient has orders for IV labetalol for BP's >/= 160/110. According to NEWT-OB what will your next actions be?,83663,2,Treat the patient according to the labetalol orders and notify the provider.,1
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27652,2,A patient currently has a BP of 165/95. You repeat in 15 minutes and the BP is 166/98. You know patient has orders for IV labetalol for BP's >/= 160/110. According to NEWT-OB what will your next actions be?,83664,3,Treat the patient according to the labetalol orders.,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27653,3,Your patient has an elevated BP above the threshold of 160/110 that is sustained for 15 mins. This patient does not currently have an antihypertensive guideline order. What would  your next nursing action be?,83665,0,Notify the provider to request an emergent antihypertensive medication.,1
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27653,3,Your patient has an elevated BP above the threshold of 160/110 that is sustained for 15 mins. This patient does not currently have an antihypertensive guideline order. What would  your next nursing action be?,83666,1,Recheck the BP in 15 more minutes,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27653,3,Your patient has an elevated BP above the threshold of 160/110 that is sustained for 15 mins. This patient does not currently have an antihypertensive guideline order. What would  your next nursing action be?,83667,2,Turn the patient on their left side and recheck BP in one hour,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27653,3,Your patient has an elevated BP above the threshold of 160/110 that is sustained for 15 mins. This patient does not currently have an antihypertensive guideline order. What would  your next nursing action be?,83668,3,This patient has chronic hypertension so continue to monitor VS every 4 hours.,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27654,5,The patient has a temperature elevation that is outside of the parameters set for your population and/or department. There are no other positive parameters. What should your nursing actions be?,83669,0,Notify the provider and assess VS every 4 hours until temperature abnormality resolves,1
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27654,5,The patient has a temperature elevation that is outside of the parameters set for your population and/or department. There are no other positive parameters. What should your nursing actions be?,83670,1,Repeat a temperature only and notify provider if still elevated.,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27654,5,The patient has a temperature elevation that is outside of the parameters set for your population and/or department. There are no other positive parameters. What should your nursing actions be?,83671,2,Check temperature hourly for the rest of your shift,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27654,5,The patient has a temperature elevation that is outside of the parameters set for your population and/or department. There are no other positive parameters. What should your nursing actions be?,83672,3,Continue to monitor until the patient has 2 or more positive parameters.,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27655,6,"If MAP is the only positive parameter, the nurse should assess patient meets the sepsis criteria and notify the provider.",83673,0,TRUE,1
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27655,6,"If MAP is the only positive parameter, the nurse should assess patient meets the sepsis criteria and notify the provider.",83674,1,FALSE,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27667,7,If a patient has a positive parameter what is your first nursing action? (Not hypertension),83714,0,Repeat a full set of VS in 30 mins,1
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27667,7,If a patient has a positive parameter what is your first nursing action? (Not hypertension),83715,1,Repeat a full set of VS is 1 hour,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27667,7,If a patient has a positive parameter what is your first nursing action? (Not hypertension),83716,2,Repeat the positive parameter in 30 mins,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27667,7,If a patient has a positive parameter what is your first nursing action? (Not hypertension),83717,3,Notify the provider immediately,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27668,8,Documentation of if a NEWT-OB parameter is met should occur with each set of VS in HED.,83718,0,TRUE,1
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27668,8,Documentation of if a NEWT-OB parameter is met should occur with each set of VS in HED.,83719,1,FALSE,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27809,4,Your patient has an elevated BP above the threshold of 160/110 that is sustained for 15 mins. This patient does not currently have an antihypertensive guideline order. You call the provider. What actions do you expect by the provider?,84179,0,The provider gives you an order for an anti-hypertensive,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27809,4,Your patient has an elevated BP above the threshold of 160/110 that is sustained for 15 mins. This patient does not currently have an antihypertensive guideline order. You call the provider. What actions do you expect by the provider?,84180,1,The provider does not provide an order for an anti-hypertensive but does state they will come to the bedside.,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27809,4,Your patient has an elevated BP above the threshold of 160/110 that is sustained for 15 mins. This patient does not currently have an antihypertensive guideline order. You call the provider. What actions do you expect by the provider?,84181,2,None of the above,0
9134,Elearning-0000-399,NORTHSIDE EARLY WARNING TRIGGERS FOR OBSTETRICS,n5796,27809,4,Your patient has an elevated BP above the threshold of 160/110 that is sustained for 15 mins. This patient does not currently have an antihypertensive guideline order. You call the provider. What actions do you expect by the provider?,84182,3,Both A & B are correct options,1
9490,Elearning-0000-722,EKG CRITICAL RESULTS FOR EKG TECHS AND RESPIRATORY THERAPISTS,n5798,27326,0,I have read and understand the contents of the EKG CRITICAL RESULTS FOR EKG TECHS AND RESPIRATORY THERAPISTS CBL.,82810,0,TRUE,1
9490,Elearning-0000-722,EKG CRITICAL RESULTS FOR EKG TECHS AND RESPIRATORY THERAPISTS,n5798,27326,0,I have read and understand the contents of the EKG CRITICAL RESULTS FOR EKG TECHS AND RESPIRATORY THERAPISTS CBL.,82811,1,FALSE,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,129,0,There are three stages of adulthood.,123,0,TRUE,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,129,0,There are three stages of adulthood.,124,1,FALSE,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,130,1,Which of the following statements is true of early adulthood?,125,0,Early adults are from thirty to forty-four years of age,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,130,1,Which of the following statements is true of early adulthood?,126,1,Early adulthood begins at age forty-five and ends at age sixty-four,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,130,1,Which of the following statements is true of early adulthood?,127,2,Early adults are between the ages of eighteen and twenty-nine years,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,130,1,Which of the following statements is true of early adulthood?,128,3,None of the above statements are true,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,132,2,"In early adulthood, a career never leads to personal satisfaction.",129,0,TRUE,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,132,2,"In early adulthood, a career never leads to personal satisfaction.",130,1,FALSE,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,134,3,"Health problems of early, young, and middle aged adults are identical.",131,0,TRUE,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,134,3,"Health problems of early, young, and middle aged adults are identical.",132,1,FALSE,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,135,4,"Early adulthood health problems include deaths related to violence, traumatic accidents, suicides, and homicides.",133,0,TRUE,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,135,4,"Early adulthood health problems include deaths related to violence, traumatic accidents, suicides, and homicides.",134,1,FALSE,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,136,5,"In early adulthood, anxiety and depression are seldom related to the pressures of independence, competition, and acceptance by peers.",135,0,TRUE,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,136,5,"In early adulthood, anxiety and depression are seldom related to the pressures of independence, competition, and acceptance by peers.",136,1,FALSE,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,137,6,The stress and new-found freedom of early adulthood often leads to experimentation with various lifestyles.,137,0,TRUE,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,137,6,The stress and new-found freedom of early adulthood often leads to experimentation with various lifestyles.,138,1,FALSE,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,138,7,Common illnesses of early adulthood include,139,0,orthopedic injuries,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,138,7,Common illnesses of early adulthood include,140,1,menopause,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,138,7,Common illnesses of early adulthood include,141,2,strokes,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,138,7,Common illnesses of early adulthood include,142,3,heart attack,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,139,8,The goals of young adulthood are not an extension of early adulthood goals.,143,0,TRUE,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,139,8,The goals of young adulthood are not an extension of early adulthood goals.,144,1,FALSE,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,140,9,Goals of early adulthood may include,145,0,managing a household,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,140,9,Goals of early adulthood may include,146,1,rearing children,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,140,9,Goals of early adulthood may include,147,2,developing a career,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,140,9,Goals of early adulthood may include,148,3,all of the above,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,141,10,Young adult health problems may be aggravated by factors such as marital problems.,149,0,TRUE,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,141,10,Young adult health problems may be aggravated by factors such as marital problems.,150,1,FALSE,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,142,11,Deaths do not differ in relation to sex and race.,151,0,TRUE,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,142,11,Deaths do not differ in relation to sex and race.,152,1,FALSE,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,143,12,African Americans have a higher incidence of,153,0,strokes,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,143,12,African Americans have a higher incidence of,154,1,sickle cell anemia,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,143,12,African Americans have a higher incidence of,155,2,both of the above,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,144,13,Certain blood diseases are more common in people of Middle Eastern ancestry.,156,0,TRUE,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,144,13,Certain blood diseases are more common in people of Middle Eastern ancestry.,157,1,FALSE,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,145,14,Women are more likely to have,158,0,breast cancer,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,145,14,Women are more likely to have,159,1,multiple sclerosis,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,145,14,Women are more likely to have,160,2,both of the above,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,146,15,Which of the following is characteristic of middle aged adults?,161,0,"They often learn to enjoy their ""empty nests""",1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,146,15,Which of the following is characteristic of middle aged adults?,162,1,They are not free from many of young adulthood's responsibilities,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,146,15,Which of the following is characteristic of middle aged adults?,163,2,They are not likely to experience role reversal with aging parents,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,147,16,Which of the following is true of Middle Adulthood?,164,0,Middle aduls seldom need to accept and adjust to physical changes.,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,147,16,Which of the following is true of Middle Adulthood?,165,1,Middle adults often maintain a healthy lifestyle as they plan for retirement.,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,147,16,Which of the following is true of Middle Adulthood?,166,2,Neither of the above is true of middle adulthood.,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,148,17,Cardiovascular diseases such as heart attack are not a major cause of death in middle age.,167,0,TRUE,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,148,17,Cardiovascular diseases such as heart attack are not a major cause of death in middle age.,168,1,FALSE,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,149,18,"In middle adulthood, the top five causes of mortality include",169,0,lung cancer,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,149,18,"In middle adulthood, the top five causes of mortality include",170,1,breast cancer,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,149,18,"In middle adulthood, the top five causes of mortality include",171,2,chronic respiratory disease,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,149,18,"In middle adulthood, the top five causes of mortality include",172,3,all of the above,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,150,19,Patient care measures for adulthood include,173,0,encouraging lifestyle habits with an emphasis on weight control,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,150,19,Patient care measures for adulthood include,174,1,encouraging lack of exercise,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,150,19,Patient care measures for adulthood include,175,2,encouraging poor family planning,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,150,19,Patient care measures for adulthood include,176,3,all of the above,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,151,20,Child care and home management are concerns of adulthood.,177,0,TRUE,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,151,20,Child care and home management are concerns of adulthood.,178,1,FALSE,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,152,21,Patient care measures of adulthood should include,179,0,an emphasis on maintaining a moderate alcohol intake and a drug-free environment.,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,152,21,Patient care measures of adulthood should include,180,1,recommending at least one thorough health assessment,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,152,21,Patient care measures of adulthood should include,181,2,both of the above,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,153,22,"Good health practices seldom preserve and prolong high energy levels, social activity, and good mental health.",182,0,TRUE,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,153,22,"Good health practices seldom preserve and prolong high energy levels, social activity, and good mental health.",183,1,FALSE,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,67,23,Some patients regress emotionally or mentally when they are ill.,1,0,TRUE,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,67,23,Some patients regress emotionally or mentally when they are ill.,2,1,FALSE,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,68,24,You should never adjust a treatment plan to meet the age-related needs of a patient.,3,0,TRUE,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,68,24,You should never adjust a treatment plan to meet the age-related needs of a patient.,4,1,FALSE,1
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,70,25,All patient care measures are the same.,5,0,TRUE,0
9355,Elearning-0000-60,AGE APPROPRIATE CARE - ADULTS,n1059,70,25,All patient care measures are the same.,6,1,FALSE,1
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,154,0,Geriatric patients are age 65 or older.,184,0,TRUE,1
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,154,0,Geriatric patients are age 65 or older.,185,1,FALSE,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,155,1,Which of the following is true of geriatric patients?,186,0,"They may lead active, positive lives.",0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,155,1,Which of the following is true of geriatric patients?,187,1,They often experience more freedom than in middle adulthood.,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,155,1,Which of the following is true of geriatric patients?,188,2,Intelligence does not decrease during the geriatric years.,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,155,1,Which of the following is true of geriatric patients?,189,3,All of the above statements are true of geriatric patients.,1
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,156,2,Bone loss is common only among female geriatric patients.,190,0,TRUE,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,156,2,Bone loss is common only among female geriatric patients.,191,1,FALSE,1
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,157,3,Which of the following is true of geriatric patients?,192,0,Geriatric women may have as much as 5% bone loss in one year.,1
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,157,3,Which of the following is true of geriatric patients?,193,1,It is uncommon for geriatric patients to experience some hair loss.,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,157,3,Which of the following is true of geriatric patients?,194,2,Neither of the above statements are true of geriatric patients.,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,158,4,Most medications and treatments should not be adjusted to an individual's body system.,195,0,TRUE,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,158,4,Most medications and treatments should not be adjusted to an individual's body system.,196,1,FALSE,1
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,160,5,Geriatric patients may have limited movement of extremities or body parts,197,0,TRUE,1
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,160,5,Geriatric patients may have limited movement of extremities or body parts,198,1,FALSE,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,161,6,Geriatric patients seldom have decreased hearing and a degree of dependence on the nursing staff.,199,0,TRUE,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,161,6,Geriatric patients seldom have decreased hearing and a degree of dependence on the nursing staff.,200,1,FALSE,1
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,162,7,1. Patient care measures for geriatric patients include which of the following?,201,0,Discourage patients from participating in as many activities as possible.,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,162,7,1. Patient care measures for geriatric patients include which of the following?,202,1,"Allow adequate time for decision making, verbal expression, and activities.",1
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,162,7,1. Patient care measures for geriatric patients include which of the following?,203,2,"Do not provide direct, supportive care.",0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,162,7,1. Patient care measures for geriatric patients include which of the following?,204,3,All of the above are geriatric patient care measur,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,163,8,2. Patient care measures for geriatric patients include which of the following?,205,0,Use safety measures to prevent physical injuries,1
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,163,8,2. Patient care measures for geriatric patients include which of the following?,206,1,Discourage visits from family and significant others,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,163,8,2. Patient care measures for geriatric patients include which of the following?,207,2,Never obtain assistive devices such as walkers and magnifying glasses,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,163,8,2. Patient care measures for geriatric patients include which of the following?,208,3,All of the above are geriatric patient care measures,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,164,9,You should be flexible and adjust care for the good of the patient.,209,0,TRUE,1
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,164,9,You should be flexible and adjust care for the good of the patient.,210,1,FALSE,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,165,10,Special needs should never affect patient care measures.,211,0,TRUE,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,165,10,Special needs should never affect patient care measures.,212,1,FALSE,1
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,166,11,You should explain procedures to your patients using words and examples to which they can relate.,213,0,TRUE,1
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,166,11,You should explain procedures to your patients using words and examples to which they can relate.,214,1,FALSE,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,167,12,You should never adjust the dose and method of administration of medications to meet a patient's needs.,215,0,TRUE,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,167,12,You should never adjust the dose and method of administration of medications to meet a patient's needs.,216,1,FALSE,1
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,1956,16,"If a patient speaks another language, call Interpretation Services or the language line for assistance.",1891,0,TRUE,1
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,1956,16,"If a patient speaks another language, call Interpretation Services or the language line for assistance.",1892,1,FALSE,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,67,13,Some patients regress emotionally or mentally when they are ill.,1,0,TRUE,1
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,67,13,Some patients regress emotionally or mentally when they are ill.,2,1,FALSE,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,68,14,You should never adjust a treatment plan to meet the age-related needs of a patient.,3,0,TRUE,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,68,14,You should never adjust a treatment plan to meet the age-related needs of a patient.,4,1,FALSE,1
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,70,15,All patient care measures are the same.,5,0,TRUE,0
9344,Elearning-0000-59,AGE APPROPRIATE CARE - GERIATRICS,n1060,70,15,All patient care measures are the same.,6,1,FALSE,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27604,0,What are the four communication styles that make up the DISC theory?,83518,0,"a.	Dominance, Independent, Compliance, Stubborn",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27604,0,What are the four communication styles that make up the DISC theory?,83519,1,"b.	Dominance, Influence, Compliance, Steadiness",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27604,0,What are the four communication styles that make up the DISC theory?,83520,2,"c.	Dominance, Insecure, Confident, Steadiness",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27605,1,Which of the following statements is NOT true about stress?,83521,0,"a.	Stress can be affected by what a person eat and drinks.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27605,1,Which of the following statements is NOT true about stress?,83522,1,"b.	The need to be a perfectionist can increase stress levels.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27605,1,Which of the following statements is NOT true about stress?,83523,2,"c.	Getting plenty of sleep has no real effect on stress.",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27606,2,"Attitude consists of three parts, which are what we think, what we do and:",83524,0,"a.	How we act and react.",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27606,2,"Attitude consists of three parts, which are what we think, what we do and:",83525,1,"b.	How we relate to others.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27606,2,"Attitude consists of three parts, which are what we think, what we do and:",83526,2,"c.	How we view others' beliefs.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27607,3,"When assisting a caller, it is acceptable to tell the caller that their issue does not fall in your department and that you can't help him/her.",83527,0,TRUE,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27607,3,"When assisting a caller, it is acceptable to tell the caller that their issue does not fall in your department and that you can't help him/her.",83528,1,FALSE,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27608,4,Internal customers include which of the following:,83529,0,"a.	Vendors and Administration",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27608,4,Internal customers include which of the following:,83530,1,"b.	Coworkers and other Northside employees",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27608,4,Internal customers include which of the following:,83531,2,"c.	Both a and b",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27609,5,"The ""H"" in Disney's H.E.A.R.D. technique for assisting difficult customer stand for HEAR.  Which of the following statements is true?",83532,0,"a.	It is okay to interrupt the customer if you need clarification.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27609,5,"The ""H"" in Disney's H.E.A.R.D. technique for assisting difficult customer stand for HEAR.  Which of the following statements is true?",83533,1,"b.	The customer should be allowed to tell their story without interruption.",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27609,5,"The ""H"" in Disney's H.E.A.R.D. technique for assisting difficult customer stand for HEAR.  Which of the following statements is true?",83534,2,"c.	Don't worry about taking any notes on what the customer is saying.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27610,6,Which of the following phrases can kill the caller's experience with you?,83535,0,"a.	It's company policy.",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27610,6,Which of the following phrases can kill the caller's experience with you?,83536,1,"b.	I will be happy to assist you.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27610,6,Which of the following phrases can kill the caller's experience with you?,83537,2,"c.	Let's see what I can do to resolve this.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27611,7,People with a negative attitude think they cannot do something and believe they are in control of their lives.,83538,0,TRUE,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27611,7,People with a negative attitude think they cannot do something and believe they are in control of their lives.,83539,1,FALSE,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27612,9,Which of the following statements is true when dealing with callers with accents?,83540,0,"a.	Never let the caller know you are having trouble understanding him/her.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27612,9,Which of the following statements is true when dealing with callers with accents?,83541,1,"b.	Make sure to ask open-ended questions.",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27612,9,Which of the following statements is true when dealing with callers with accents?,83542,2,"c.	Always pretend you understand the caller even if you do not.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27613,10,"In regard to communication, which of the following is NOT true about communicating with a senior aged caller?",83543,0,"a.	They should be address by title and last name (i.e. Mrs. Smith).",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27613,10,"In regard to communication, which of the following is NOT true about communicating with a senior aged caller?",83544,1,"b.	Their ability to process information has slowed down.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27613,10,"In regard to communication, which of the following is NOT true about communicating with a senior aged caller?",83545,2,"c.	Their role or culture and their lifestyle should be considered.",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27614,11,Which of the following actions does NOT help brighten a person's mood or lower stress?,83546,0,"a.	Getting outdoors for a change of scenery.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27614,11,Which of the following actions does NOT help brighten a person's mood or lower stress?,83547,1,"b.	Staying in control of everything.",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27614,11,Which of the following actions does NOT help brighten a person's mood or lower stress?,83548,2,"c.	Accessorizing their desk with photos or a plant.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27615,12,"When processing a Single Line payment in Wells Fargo, the Customer Service Department should select Miscellaneous for the Service Line.",83549,0,TRUE,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27615,12,"When processing a Single Line payment in Wells Fargo, the Customer Service Department should select Miscellaneous for the Service Line.",83550,1,FALSE,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27616,13,A person can help to decrease his/her stress level by becoming their own best friend and by not trying to control everything.,83551,0,TRUE,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27616,13,A person can help to decrease his/her stress level by becoming their own best friend and by not trying to control everything.,83552,1,FALSE,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27617,15,"When processing a patient payment that was received in the mail or by fax, the Customer Service representative should select A.CUST SVC INSURANCE as the Outlet.",91090,0,TRUE,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27617,15,"When processing a patient payment that was received in the mail or by fax, the Customer Service representative should select A.CUST SVC INSURANCE as the Outlet.",91091,1,FALSE,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27618,16,"When dealing with a difficult caller, it is important to show empathy and let the caller know you understand how they feel.",83556,0,TRUE,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27618,16,"When dealing with a difficult caller, it is important to show empathy and let the caller know you understand how they feel.",83557,1,FALSE,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27619,17,"When assisting a very chatty caller, which of the following actions should a part of your communication with the caller?",83558,0,"a.	Ask direct questions.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27619,17,"When assisting a very chatty caller, which of the following actions should a part of your communication with the caller?",83559,1,"b.	Explain everything very clearly.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27619,17,"When assisting a very chatty caller, which of the following actions should a part of your communication with the caller?",83560,2,"c.	Both a and b",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27620,18,Which of the following actions are essential when properly placing a caller on hold?,83561,0,"a.	Ask the caller's permission to place on hold and wait for an answer.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27620,18,Which of the following actions are essential when properly placing a caller on hold?,83562,1,"b.	Thank the caller for holding.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27620,18,Which of the following actions are essential when properly placing a caller on hold?,83563,2,"c.	Both a and b",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27621,19,"To be a Customer Service Super Hero the representative should practice excellent listening skills, verbal communication skills and proper phone and email etiquette.",83564,0,TRUE,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27621,19,"To be a Customer Service Super Hero the representative should practice excellent listening skills, verbal communication skills and proper phone and email etiquette.",83565,1,FALSE,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27622,21,External customers are those from outside of our organization that come to Northside for services and ultimately provide the revenue stream.,83566,0,TRUE,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27622,21,External customers are those from outside of our organization that come to Northside for services and ultimately provide the revenue stream.,83567,1,FALSE,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27623,22,"When talking to a caller with an accent, you should avoid using medical terms and jargon, as well as idioms.",83568,0,TRUE,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27623,22,"When talking to a caller with an accent, you should avoid using medical terms and jargon, as well as idioms.",83569,1,FALSE,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27624,23,"In Walt Disney's H.E.A.R.D. technique for dealing with difficult customers, the letters stand for the five steps which are:",83570,0,"a.	Help, Empathize, Answer, Resolve, Diagnose",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27624,23,"In Walt Disney's H.E.A.R.D. technique for dealing with difficult customers, the letters stand for the five steps which are:",83571,1,"b.	Hear, Empathize, Apologize, Resolve, Diagnose",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27624,23,"In Walt Disney's H.E.A.R.D. technique for dealing with difficult customers, the letters stand for the five steps which are:",83572,2,"c.	Hear, Energy, Apologize, Resolve, Duration",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27625,24,Which of the following are common payment types that are taken in the Customer Service Department?,83573,0,"a.	Manual Credit Card payments",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27625,24,Which of the following are common payment types that are taken in the Customer Service Department?,83574,1,"b.	Telephone Check payments",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27625,24,Which of the following are common payment types that are taken in the Customer Service Department?,83575,2,"c.	Both A & B",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27626,25,"When processing a payment in Wells Fargo, the Provider and Outlet should be entered.  For the Customer Service Department, the Provider is normally entered as Atlanta and the Outlet as Customer Service Department.",83576,0,TRUE,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27626,25,"When processing a payment in Wells Fargo, the Provider and Outlet should be entered.  For the Customer Service Department, the Provider is normally entered as Atlanta and the Outlet as Customer Service Department.",83577,1,FALSE,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27627,26,"When processing a payment in Wells Fargo, which of the following pieces of information is not required to be entered in the Wells Fargo payment screen?",83578,0,"a.	Routing Number",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27627,26,"When processing a payment in Wells Fargo, which of the following pieces of information is not required to be entered in the Wells Fargo payment screen?",83579,1,"b.	Patient Name",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27627,26,"When processing a payment in Wells Fargo, which of the following pieces of information is not required to be entered in the Wells Fargo payment screen?",83580,2,"c.	CVN Number",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27628,28,Patient payment receipts can be emailed to the patient if he/she chooses.,83581,0,TRUE,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27628,28,Patient payment receipts can be emailed to the patient if he/she chooses.,83582,1,FALSE,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27629,30,All written correspondence from a patient is placed in the CS: CORR FROM PATIENT queue.,83583,0,TRUE,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27629,30,All written correspondence from a patient is placed in the CS: CORR FROM PATIENT queue.,83584,1,FALSE,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27630,31,Customer calls that need to be referred to another department should be placed in which of the following queues?,83585,0,"a.	CS: CORR FROM PATIENT",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27630,31,Customer calls that need to be referred to another department should be placed in which of the following queues?,83586,1,"b.	CS: CORR ADDRESS CHANGE",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27630,31,Customer calls that need to be referred to another department should be placed in which of the following queues?,83587,2,"c.	CS: SUPV/LEAD REF FROM REPS QUEUE",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27631,33,"If a patient wants to pay on more than one account, on which screen in Wells Fargo would the payment be processed?",83588,0,"a.	Single Line Item",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27631,33,"If a patient wants to pay on more than one account, on which screen in Wells Fargo would the payment be processed?",83589,1,"b.	Multiple Line Items",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27631,33,"If a patient wants to pay on more than one account, on which screen in Wells Fargo would the payment be processed?",83590,2,"c.	None of the above",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27632,34,Which of the following statement(s) about the Multiple Line Items feature in Wells Fargo is a helpful benefit to staff?,83591,0,"a.	Ability to enter payments on several accounts.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27632,34,Which of the following statement(s) about the Multiple Line Items feature in Wells Fargo is a helpful benefit to staff?,83592,1,"b.	Only one payment needs to be processed.",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27632,34,Which of the following statement(s) about the Multiple Line Items feature in Wells Fargo is a helpful benefit to staff?,83593,2,"c.	All of the above.",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27633,35,"When searching for a patient in One Content, the search can be done using the patient's Encounter, DOB, MRN, Name and SSN.",83594,0,TRUE,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,27633,35,"When searching for a patient in One Content, the search can be done using the patient's Encounter, DOB, MRN, Name and SSN.",83595,1,FALSE,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,40382,8,Which of the following statements is TRUE about managing up?,129422,0,Managing Up happens when you go to your supervisor every time a coworker does something wrong.,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,40382,8,Which of the following statements is TRUE about managing up?,129423,1,Managing Up aligns your skills and the skills of your coworkers to Northside's goals for service excellence and patient satisfaction.,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,40382,8,Which of the following statements is TRUE about managing up?,129424,2,Staff should never manage up themselves.,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,40383,14,The key message of THANK YOU in the A.I.D.E.T. Model is to make sure patients feel they are appreciated.,129425,0,TRUE,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,40383,14,The key message of THANK YOU in the A.I.D.E.T. Model is to make sure patients feel they are appreciated.,129426,1,FALSE,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,40384,20,"An Agreed Upon Response (AUR) is a script that can assist staff in asking patients for certain information, in explaining payment options and in answering patient questions.",129427,0,TRUE,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,40384,20,"An Agreed Upon Response (AUR) is a script that can assist staff in asking patients for certain information, in explaining payment options and in answering patient questions.",129428,1,FALSE,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,40385,27,Which of the following is NOT true about Standard Note Codes?,129429,0,An SNC is required documentation entered during registration in order to inform other users of key information on the account.,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,40385,27,Which of the following is NOT true about Standard Note Codes?,129430,1,SNCs on an account assist Customer Service representatives in answering caller questions because they tell the story of the account.,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,40385,27,Which of the following is NOT true about Standard Note Codes?,129431,2,SNCs are only used by Registration and are not vital in determining the best course of action for reimbursement and collections.,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,40386,29,What are the five behaviors of the A.I.D.E.T. Model?,129432,0,"Anticipate, Introduce, Duration, Expect, Thank You",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,40386,29,What are the five behaviors of the A.I.D.E.T. Model?,129433,1,"Acknowledge, Introduce, Duration, Empathy, Think",0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,40386,29,What are the five behaviors of the A.I.D.E.T. Model?,129434,2,"Acknowledge, Introduce, Duration, Explanation, Thank You",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,40387,32,Each of the minors below are being registered for surgery or are being admitted.  Which one would NOT need the Advance Directive process completed?,129435,0,"A minor being scheduled for surgery, who is thinking about enlisting in the Navy",1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,40387,32,Each of the minors below are being registered for surgery or are being admitted.  Which one would NOT need the Advance Directive process completed?,129436,1,Emancipated minor being admitted,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,40387,32,Each of the minors below are being registered for surgery or are being admitted.  Which one would NOT need the Advance Directive process completed?,129437,2,Married minor having surgery,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,66165,36,Patients will be able to create payment plans within the PatientWallet.,221256,0,TRUE,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,66165,36,Patients will be able to create payment plans within the PatientWallet.,221257,1,FALSE,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,66166,37,Payments previously taken in Wells Fargo should be reviewed in:,221258,0,Patientco,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,66166,37,Payments previously taken in Wells Fargo should be reviewed in:,221259,1,Wells Fargo,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,66166,37,Payments previously taken in Wells Fargo should be reviewed in:,221260,2,RevRunner,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,66167,38,Each bill is assigned a unique:,221261,0,9-digit SecureHealthCode,1
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,66167,38,Each bill is assigned a unique:,221262,1,Username,0
9818,Questions-0000-112,RCT: CUSTOMER SERVICE UNIVERSITY TEST,n5835,66167,38,Each bill is assigned a unique:,221263,2,Color,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27634,0,Which of the following equipment should be available at all outpatient imaging sites which administer IV contrast?,83596,0,a. Ambu bags,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27634,0,Which of the following equipment should be available at all outpatient imaging sites which administer IV contrast?,83597,1,b. Pulse oximeter,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27634,0,Which of the following equipment should be available at all outpatient imaging sites which administer IV contrast?,83598,2,c. Stethoscope,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27634,0,Which of the following equipment should be available at all outpatient imaging sites which administer IV contrast?,83599,3,d. IV pole,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27634,0,Which of the following equipment should be available at all outpatient imaging sites which administer IV contrast?,83600,4,e. All of the above,1
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27635,1,911 should be called anytime a patient has a suspected contrast reaction?,83601,0,TRUE,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27635,1,911 should be called anytime a patient has a suspected contrast reaction?,83602,1,FALSE,1
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27636,2,Which activities should be documented as part of the record of care?,83603,0,a. Use of AED,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27636,2,Which activities should be documented as part of the record of care?,83604,1,b. Medications given,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27636,2,Which activities should be documented as part of the record of care?,83605,2,c. Vital signs,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27636,2,Which activities should be documented as part of the record of care?,83606,3,d. Time of EMS call and their arrival,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27636,2,Which activities should be documented as part of the record of care?,83607,4,e. Any patient care measures,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27636,2,Which activities should be documented as part of the record of care?,83608,5,f. All of the above,1
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27637,3,"Once a contrast reaction is suspected, the first action a technologist should take is",83609,0,a. Call 911,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27637,3,"Once a contrast reaction is suspected, the first action a technologist should take is",83610,1,b. Notify the physician,1
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27637,3,"Once a contrast reaction is suspected, the first action a technologist should take is",83611,2,c. Place the patient on oxygen,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27637,3,"Once a contrast reaction is suspected, the first action a technologist should take is",83612,3,d. Gather emergency supplies,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27638,4,A technologist should only obtain vital signs while under the supervision of a physician.,83613,0,TRUE,1
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27638,4,A technologist should only obtain vital signs while under the supervision of a physician.,83614,1,FALSE,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27639,5,When should vital signs be obtained during an emergency event?,83615,0,a. At the beginning,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27639,5,When should vital signs be obtained during an emergency event?,83616,1,b. At the end,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27639,5,When should vital signs be obtained during an emergency event?,83617,2,c. Every 2-5 minutes,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27639,5,When should vital signs be obtained during an emergency event?,83618,3,d. Prior to discharge,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27639,5,When should vital signs be obtained during an emergency event?,83619,4,e. All of the above,1
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27640,6,A physician must always be present for IV contrast administration.,83620,0,TRUE,1
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27640,6,A physician must always be present for IV contrast administration.,83621,1,FALSE,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27641,7,What is the first sound detected when obtaining a manual blood pressure reading?,83622,0,a. White noise,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27641,7,What is the first sound detected when obtaining a manual blood pressure reading?,83623,1,b. Diastolic pressure,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27641,7,What is the first sound detected when obtaining a manual blood pressure reading?,83624,2,c. Systolic pressure,1
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27641,7,What is the first sound detected when obtaining a manual blood pressure reading?,83625,3,d. Lung sounds,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27642,8,Which of the following vital signs measurement is out of normal range and should be reported to the physician?,83626,0,a. BP of 110/75,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27642,8,Which of the following vital signs measurement is out of normal range and should be reported to the physician?,83627,1,b. Pulse of 65 bmp,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27642,8,Which of the following vital signs measurement is out of normal range and should be reported to the physician?,83628,2,c. Respiration rate of 12/minute,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27642,8,Which of the following vital signs measurement is out of normal range and should be reported to the physician?,83629,3,d. Oxygen saturation of 93%,1
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27643,9,"A technologist must never administer an EpiPen to a patient, even under the supervision of a physician.",83630,0,TRUE,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27643,9,"A technologist must never administer an EpiPen to a patient, even under the supervision of a physician.",83631,1,FALSE,1
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27644,10,Which of the following is NOT considered a risk factor for an adverse reaction to contrast?,83632,0,a. Asthma,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27644,10,Which of the following is NOT considered a risk factor for an adverse reaction to contrast?,83633,1,b. Previous allergies to contrast,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27644,10,Which of the following is NOT considered a risk factor for an adverse reaction to contrast?,83634,2,c. Anxiety,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27644,10,Which of the following is NOT considered a risk factor for an adverse reaction to contrast?,83635,3,d. Metformin,1
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27645,11,What drug has been added to the contrast reaction kits to provide a non-drowsy medication alternative for outpatients?,83636,0,a. Allegra,1
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27645,11,What drug has been added to the contrast reaction kits to provide a non-drowsy medication alternative for outpatients?,83637,1,b. Prilosec,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27645,11,What drug has been added to the contrast reaction kits to provide a non-drowsy medication alternative for outpatients?,83638,2,c. Claritin,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27645,11,What drug has been added to the contrast reaction kits to provide a non-drowsy medication alternative for outpatients?,83639,3,d. Flonase,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27646,12,EpiPen dosages can be differentiated by color. The adult dose is _________ and the pediatric dose is ____________.,83640,0,"a. Green, Yellow",0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27646,12,EpiPen dosages can be differentiated by color. The adult dose is _________ and the pediatric dose is ____________.,83641,1,"b. Yellow, Green",1
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27646,12,EpiPen dosages can be differentiated by color. The adult dose is _________ and the pediatric dose is ____________.,83642,2,"c. Green, Red",0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27646,12,EpiPen dosages can be differentiated by color. The adult dose is _________ and the pediatric dose is ____________.,83643,3,"d. Yellow, Red",0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27647,13,All of the following should be done after an emergency event EXCEPT for the following:,83644,0,a. Complete an incident report,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27647,13,All of the following should be done after an emergency event EXCEPT for the following:,83645,1,b. Conduct a debrief with staff,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27647,13,All of the following should be done after an emergency event EXCEPT for the following:,83646,2,c. Call Patient Relations,1
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27647,13,All of the following should be done after an emergency event EXCEPT for the following:,83647,3,d. Return the re-sealed Contrast Reaction Kit with Order Charge Sheet to the Pharmacy.,0
8270,Elearning-0000-1153,EMERGENCY RESPONSE TRAINING FOR OUTPATIENT RADIOLOGY STAFF,n5836,27647,13,All of the following should be done after an emergency event EXCEPT for the following:,83648,4,e. Provide patient with discharge instructions,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,1197,9,Access to an MSDS must be provided.,972,0,for all hazardous chemicals used on site.,1
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,1197,9,Access to an MSDS must be provided.,973,1,for only the most hazardous chemicals,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,1197,9,Access to an MSDS must be provided.,974,2,only if sent with the chemical.,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,1197,9,Access to an MSDS must be provided.,975,3,None of the above is correct.,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,1970,7,"In the event of a Hazardous Material exposure, you are to notify your immediate supervisor and seek medical treatment from Employee Health or the Emergency Dept.",1900,0,TRUE,1
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,1970,7,"In the event of a Hazardous Material exposure, you are to notify your immediate supervisor and seek medical treatment from Employee Health or the Emergency Dept.",1901,1,FALSE,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,1978,6,If you have a question about Hazardous Materials used or stored in your area you should contact:,1904,0,Your immediate supervisor.,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,1978,6,If you have a question about Hazardous Materials used or stored in your area you should contact:,1905,1,Safety officer.,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,1978,6,If you have a question about Hazardous Materials used or stored in your area you should contact:,1906,2,Employee Health.,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,1978,6,If you have a question about Hazardous Materials used or stored in your area you should contact:,1907,3,Any of the above.,1
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,2066,8,You are not allowed to read Material Safety Data Sheets (MSDS),2072,0,TRUE,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,2066,8,You are not allowed to read Material Safety Data Sheets (MSDS),2073,1,FALSE,1
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,2067,10,A copy of the Hazard Communication Program is found in the Emergency Preparedness Manual.,2074,0,TRUE,1
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,2067,10,A copy of the Hazard Communication Program is found in the Emergency Preparedness Manual.,2075,1,FALSE,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,316,0,This facility has a Hazardous Communication Program.,471,0,TRUE,1
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,316,0,This facility has a Hazardous Communication Program.,472,1,FALSE,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,318,1,Individual departments should not maintain a current chemical inventory.,475,0,TRUE,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,318,1,Individual departments should not maintain a current chemical inventory.,476,1,FALSE,1
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,320,2,There is no written copy of the Hazard Communication Program.,477,0,TRUE,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,320,2,There is no written copy of the Hazard Communication Program.,478,1,FALSE,1
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,325,3,"This facility does not have a plan for working with hazardous materials, health hazards,  and physical hazards.",485,0,TRUE,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,325,3,"This facility does not have a plan for working with hazardous materials, health hazards,  and physical hazards.",486,1,FALSE,1
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,371,4,Containers within a department must have,584,0,a label that clearly identifies the chemical,1
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,371,4,Containers within a department must have,585,1,no hazard warning,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,371,4,Containers within a department must have,586,2,a price sticker,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,371,4,Containers within a department must have,587,3,all of the above,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,372,5,The Dept. Director or Manager should do which of the following?,588,0,Regularly delete from chemical list any hazardous materials no longer in use,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,372,5,The Dept. Director or Manager should do which of the following?,589,1,Add new chemicals to the list,0
9190,Elearning-0000-45,HAZARD COMMUNICATION,n1063,372,5,The Dept. Director or Manager should do which of the following?,590,2,Both of the above,1
9461,Elearning-0000-696,CODE GREEN: QUICK REGISTRATION PROCESS,n5851,27739,0,I acknowledge that I have read and understand in its entirety the Code Green: Quick Registration Process content.,83970,0,TRUE,1
9461,Elearning-0000-696,CODE GREEN: QUICK REGISTRATION PROCESS,n5851,27739,0,I acknowledge that I have read and understand in its entirety the Code Green: Quick Registration Process content.,83971,1,FALSE,0
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27740,0,Maintaining a safe environment at work is the responsibility of,83972,0,"a.	Everybody",1
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27740,0,Maintaining a safe environment at work is the responsibility of,83973,1,"b.	The Life Safety Department",0
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27740,0,Maintaining a safe environment at work is the responsibility of,83974,2,"c.	The Quality Improvement Department",0
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27740,0,Maintaining a safe environment at work is the responsibility of,83975,3,"d.	All clinical staff",0
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27741,1,A culture of safety promotes safety for,83976,0,"a.	Patients",0
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27741,1,A culture of safety promotes safety for,83977,1,"b.	Visitors",0
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27741,1,A culture of safety promotes safety for,83978,2,"c.	Staff members",0
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27741,1,A culture of safety promotes safety for,83979,3,"d.	Everyone",1
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27742,2,What is the correct response after determining that a patient is a high-risk transfer?,83980,0,"a.	Call 911",0
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27742,2,What is the correct response after determining that a patient is a high-risk transfer?,83981,1,"b.	Cancel the procedure",0
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27742,2,What is the correct response after determining that a patient is a high-risk transfer?,83982,2,"c.	Ask a family member for help",0
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27742,2,What is the correct response after determining that a patient is a high-risk transfer?,83983,3,"d.	Schedule the patient at a hospital location",1
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27743,3,Which of the following are not commonly available in outpatient locations to assist with safe patient handling and movement:,83984,0,"a.	Gait belts",0
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27743,3,Which of the following are not commonly available in outpatient locations to assist with safe patient handling and movement:,83985,1,"b.	Wheelchairs",0
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27743,3,Which of the following are not commonly available in outpatient locations to assist with safe patient handling and movement:,83986,2,"c.	Walkers",0
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27743,3,Which of the following are not commonly available in outpatient locations to assist with safe patient handling and movement:,83987,3,"d.	Mechanical lifts",1
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27743,3,Which of the following are not commonly available in outpatient locations to assist with safe patient handling and movement:,83988,4,"e.	PinkSlips",0
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27744,4,Which type of fall should be reported via Incident Reporting on the Intranet?,83989,0,"a.	Witnessed fall",0
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27744,4,Which type of fall should be reported via Incident Reporting on the Intranet?,83990,1,"b.	Assisted fall",0
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27744,4,Which type of fall should be reported via Incident Reporting on the Intranet?,83991,2,"c.	Unwitnessed fall",0
8262,Elearning-0000-1146,SAFE PATIENT HANDLING AND MOVEMENT IN THE OUTPATIENT RADIOLOGY SETTING,n5852,27744,4,Which type of fall should be reported via Incident Reporting on the Intranet?,83992,3,"d.	All of the above",1
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27758,0,"When answering a phone call in the work environment, you should NOT let the phone ring more than______ times?",84021,0,"A.	2",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27758,0,"When answering a phone call in the work environment, you should NOT let the phone ring more than______ times?",84022,1,"B.	1",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27758,0,"When answering a phone call in the work environment, you should NOT let the phone ring more than______ times?",84023,2,"C.	3",1
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27758,0,"When answering a phone call in the work environment, you should NOT let the phone ring more than______ times?",84024,3,"D.	The amount of time the phone rings is insignificant to phone etiquette.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27759,1,Why are telephone greetings so important?,84025,0,"A.	It gives the caller a first impression of the organization itself.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27759,1,Why are telephone greetings so important?,84026,1,"B.	Telephone greetings are not important at all.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27759,1,Why are telephone greetings so important?,84027,2,"C.	It shows how enthusiastic and committed you are to your job.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27759,1,Why are telephone greetings so important?,84028,3,"D.	Both A & C",1
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27760,2,What is important about your voice when answering or placing a call?,84029,0,"A.	The volume",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27760,2,What is important about your voice when answering or placing a call?,84030,1,"B.	The speed",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27760,2,What is important about your voice when answering or placing a call?,84031,2,"C.	The tone",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27760,2,What is important about your voice when answering or placing a call?,84032,3,"D.	All of the above",1
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27761,3,"When placing a caller on hold, you should first ___________________________.",84033,0,"A.	Ask the caller's permission to be placed on hold.",1
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27761,3,"When placing a caller on hold, you should first ___________________________.",84034,1,"B.	Immediately place the caller on hold to avoid the caller from becoming frustrated.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27761,3,"When placing a caller on hold, you should first ___________________________.",84035,2,"C.	There is no need to ever place a caller on hold.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27761,3,"When placing a caller on hold, you should first ___________________________.",84036,3,"D.	Explain the reason for putting them on hold.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27762,4,"When transferring a call, you should first________________________________.",84037,0,"a.	Transfer the call immediately to avoid a prolonged wait for the caller.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27762,4,"When transferring a call, you should first________________________________.",84038,1,"b.	Explain to the caller that you are transferring them and state the department name of which you are transferring them to.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27762,4,"When transferring a call, you should first________________________________.",84039,2,"c.	Speak to the party whom the caller is being transferred to and attempt to provide as much information about the caller's inquiry.",1
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27762,4,"When transferring a call, you should first________________________________.",84040,3,"d.	Give the caller your information.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27763,5,"When a caller reaches you, you should always____________________________.",84041,0,"A.	Be helpful and courtesy.",1
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27763,5,"When a caller reaches you, you should always____________________________.",84042,1,"B.	Answer the call in a flat, monotone voice.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27763,5,"When a caller reaches you, you should always____________________________.",84043,2,"C.	Screen the call as soon as you answer.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27763,5,"When a caller reaches you, you should always____________________________.",84044,3,"D.	Say ""hello"" initially, and provide as little information as possible to the caller to protect the privacy of the organization.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27764,6,Who should end a phone call first?,84045,0,"a.	The person who answered",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27764,6,Who should end a phone call first?,84046,1,"b.	The person who called",1
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27764,6,Who should end a phone call first?,84047,2,"c.	It doesn't matter who ends a call first",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27765,7,What item(s) listed below are considered OK while answering the phone?,84048,0,"A.	Chewing gum",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27765,7,What item(s) listed below are considered OK while answering the phone?,84049,1,"B.	Listening to the low music in the background.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27765,7,What item(s) listed below are considered OK while answering the phone?,84050,2,"C.	Smoking",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27765,7,What item(s) listed below are considered OK while answering the phone?,84051,3,"D.	You shouldn't have any distractions of any kind.",1
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27766,8,You are having a conversation with your colleague and the phone rings. What do you do?,84052,0,"a.	Ignore the phone call.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27766,8,You are having a conversation with your colleague and the phone rings. What do you do?,84053,1,"b.	Answer the call, and immediately place the caller on hold to finish your conversation.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27766,8,You are having a conversation with your colleague and the phone rings. What do you do?,84054,2,"c.	Take the call, ask for the caller's phone number and call him/her back when you are done with your conversation.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27766,8,You are having a conversation with your colleague and the phone rings. What do you do?,84055,3,"d.	End your conversation with your colleague and proceed to answer the phone call.",1
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27767,9,"When dealing with a difficult caller, you should ______________________.",84056,0,"a.	Explain to the caller that their request/concern is not your job to solve.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27767,9,"When dealing with a difficult caller, you should ______________________.",84057,1,"b.	Tell the caller to call back later when they have calmed down.",0
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27767,9,"When dealing with a difficult caller, you should ______________________.",84058,2,"c.	Listen to the caller's concerns and politely state their question back to them for clarification before attempting to help them.",1
8400,Elearning-0000-1270,PHONE ETIQUETTE,n5858,27767,9,"When dealing with a difficult caller, you should ______________________.",84059,3,"d.	Hang up the phone.",0
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27774,0,A Code Green is a status to indicate that a situation has occurred within a reasonable vicinity of the hospital with the potential to result in which of the following?,84079,0,"A.	Tornado",0
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27774,0,A Code Green is a status to indicate that a situation has occurred within a reasonable vicinity of the hospital with the potential to result in which of the following?,84080,1,"B.	Fire",0
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27774,0,A Code Green is a status to indicate that a situation has occurred within a reasonable vicinity of the hospital with the potential to result in which of the following?,84081,2,"C.	Mass causalities presenting to the ED",1
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27775,1,Which of the following is true about Code Green patient accounts?,84082,0,"A.	They will be immediately available and ready for use by staff in the event of a Code Green.",1
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27775,1,Which of the following is true about Code Green patient accounts?,84083,1,"B.	They will need to be created once the Code Green is called.",0
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27775,1,Which of the following is true about Code Green patient accounts?,84084,2,"C.	Code Green patients will be registered in the normal manner.",0
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27776,2,"Code Green patients will be registered with CODEGREEN,ER MD listed in STAR as the physician, and the patient account will be updated with the actual ED physician during the registration process.",84105,0,TRUE,1
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27776,2,"Code Green patients will be registered with CODEGREEN,ER MD listed in STAR as the physician, and the patient account will be updated with the actual ED physician during the registration process.",84106,1,FALSE,0
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27777,3,Code Green patient accounts will be set up using the unique patient type of PTA/PTC/PTF.,84088,0,TRUE,1
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27777,3,Code Green patient accounts will be set up using the unique patient type of PTA/PTC/PTF.,84089,1,FALSE,0
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27778,4,Patient Access will retrieve a patient registration assignment from the person manning the Code Green Log.  Registration will be given a/an _____________________________ found in the Global Downtime Workbook?,84090,0,"A.	FET downtime letter",0
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27778,4,Patient Access will retrieve a patient registration assignment from the person manning the Code Green Log.  Registration will be given a/an _____________________________ found in the Global Downtime Workbook?,84091,1,"B.	Patient Tracking Card",1
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27778,4,Patient Access will retrieve a patient registration assignment from the person manning the Code Green Log.  Registration will be given a/an _____________________________ found in the Global Downtime Workbook?,84092,2,"C.	Wells Fargo downtime sheet",0
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27779,5,"In the event of a Code Green, ED Clinical and Registration staff will receive notification of the event and will begin preparations to receive Code Green patients.",84093,0,TRUE,1
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27779,5,"In the event of a Code Green, ED Clinical and Registration staff will receive notification of the event and will begin preparations to receive Code Green patients.",84094,1,FALSE,0
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27780,6,Who will complete the Quick ER account registration for patients arriving via the walk-in entrance to the Emergency Department?,84095,0,"A.	Patient Access Registration",0
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27780,6,Who will complete the Quick ER account registration for patients arriving via the walk-in entrance to the Emergency Department?,84096,1,"B.	Special Volunteers",0
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27780,6,Who will complete the Quick ER account registration for patients arriving via the walk-in entrance to the Emergency Department?,84097,2,"C.	ED Clinical Staff",1
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27781,7,"Once a Code Green is initiated, a Patient Access Representative will be stationed in the Ambulance Bay to do which of the following tasks for all patients who are not able to communicate?",84107,0,"A.	Direct the Ambulance personnel on where to take the patient.",0
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27781,7,"Once a Code Green is initiated, a Patient Access Representative will be stationed in the Ambulance Bay to do which of the following tasks for all patients who are not able to communicate?",84108,1,"B.	Manage the Code Green Log and distribute Code Green packets.",1
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27781,7,"Once a Code Green is initiated, a Patient Access Representative will be stationed in the Ambulance Bay to do which of the following tasks for all patients who are not able to communicate?",84109,2,"C.	To get all the patients registered using a mobile registration cart.",0
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27782,8,"Facesheets, green armbands and labels for Code Green patient accounts have been prepared and stored in the Patient Access ED area in each Northside Hospital facility.",84101,0,TRUE,1
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27782,8,"Facesheets, green armbands and labels for Code Green patient accounts have been prepared and stored in the Patient Access ED area in each Northside Hospital facility.",84102,1,FALSE,0
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27783,9,"Once a Code Green is announced, Room Control, who will maintain a copy of the Code Green Log, will work with Patient Access Registration to convert 10 of each of the PTA/PTC/PTF patient accounts to QER/QEC/QEF.",84103,0,TRUE,1
9460,Elearning-0000-695,CODE GREEN_PAS,n5860,27783,9,"Once a Code Green is announced, Room Control, who will maintain a copy of the Code Green Log, will work with Patient Access Registration to convert 10 of each of the PTA/PTC/PTF patient accounts to QER/QEC/QEF.",84104,1,FALSE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,1966,31,CODE GREEN is the code word for exernal disaster,1893,0,TRUE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,1966,31,CODE GREEN is the code word for exernal disaster,1894,1,FALSE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,1967,32,The code word for bomb threat is CODE ORANGE.,1895,0,TRUE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,1967,32,The code word for bomb threat is CODE ORANGE.,1896,1,FALSE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,1968,33,"During a bomb threat you should,",1897,0,Search your area and report anything suspicious to security by telephone.,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,1968,33,"During a bomb threat you should,",1898,1,Continue your normal duties.,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,1968,33,"During a bomb threat you should,",1899,2,Notify your supervison that you are going home.,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,2042,34,In handling a violent patient or visitor you should,2013,0,Protect yourself and others from harm,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,2042,34,In handling a violent patient or visitor you should,2014,1,Exit the area if you are able,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,2042,34,In handling a violent patient or visitor you should,2015,2,notify your supervisor and security,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,2042,34,In handling a violent patient or visitor you should,2016,3,all of the above,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,392,0,Employees should not know the correct way to deal with hostage situations.,643,0,TRUE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,392,0,Employees should not know the correct way to deal with hostage situations.,644,1,FALSE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,393,1,"When the disaster plan is activated, employees should not complete their present duty in a timely manner.",645,0,TRUE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,393,1,"When the disaster plan is activated, employees should not complete their present duty in a timely manner.",646,1,FALSE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,394,2,Employees should not maintain patient confidentiality.,647,0,TRUE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,394,2,Employees should not maintain patient confidentiality.,648,1,FALSE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,395,3,Employees should not discuss disaster information with anyone other than appropriate staff.,649,0,TRUE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,395,3,Employees should not discuss disaster information with anyone other than appropriate staff.,650,1,FALSE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,396,4,"During a disaster,  a telephone line should not be available at all times.",651,0,TRUE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,396,4,"During a disaster,  a telephone line should not be available at all times.",652,1,FALSE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,397,5,What should an employee do during a bomb threat?,653,0,Remember as much as possible about the caller's voice and what was said,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,397,5,What should an employee do during a bomb threat?,654,1,"Remember background noises such as planes, automobiles, music, or bells.",0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,397,5,What should an employee do during a bomb threat?,655,2,Both of the above.,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,398,6,"When employees receive a bomb threat, they should keep calm.",656,0,TRUE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,398,6,"When employees receive a bomb threat, they should keep calm.",657,1,FALSE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,399,7,"When an evacuation is required, employees should evacuate the area in a routine and orderly fashion.",658,0,TRUE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,399,7,"When an evacuation is required, employees should evacuate the area in a routine and orderly fashion.",659,1,FALSE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,400,8,Employees in the immediate area of a bomb threat should remember to turn lights on and off repeatedly.,660,0,TRUE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,400,8,Employees in the immediate area of a bomb threat should remember to turn lights on and off repeatedly.,661,1,FALSE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,401,9,Employees in the immediate area of a bomb threat should use two-way radios and cellular phones.,662,0,TRUE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,401,9,Employees in the immediate area of a bomb threat should use two-way radios and cellular phones.,663,1,FALSE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,402,10,Employees in the immediate area of a bomb threat should check public access areas first.,664,0,TRUE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,402,10,Employees in the immediate area of a bomb threat should check public access areas first.,665,1,FALSE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,403,11,An employee who finds a suspicious packages should pick up the package and listen for a ticking sound.,666,0,TRUE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,403,11,An employee who finds a suspicious packages should pick up the package and listen for a ticking sound.,667,1,FALSE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,404,12,There is no plan for the evacuation of patients in the case of an emergency.,668,0,TRUE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,404,12,There is no plan for the evacuation of patients in the case of an emergency.,669,1,FALSE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,405,13,Our staff has no legal and ethical duty to keep any person from harming himself or others.,670,0,TRUE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,405,13,Our staff has no legal and ethical duty to keep any person from harming himself or others.,671,1,FALSE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,406,14,Behavior escalation does not occur by itself.  Someone lets the situation get out of control.,672,0,TRUE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,406,14,Behavior escalation does not occur by itself.  Someone lets the situation get out of control.,673,1,FALSE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,407,15,Staff members who work with potentially violent individuals have no impact on how the violent person behaves.,674,0,TRUE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,407,15,Staff members who work with potentially violent individuals have no impact on how the violent person behaves.,675,1,FALSE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,408,16,"Employees can never offset a violent person's behavior with a helpful, calming response.",676,0,TRUE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,408,16,"Employees can never offset a violent person's behavior with a helpful, calming response.",677,1,FALSE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,409,17,"If talking with the violent person does not help a situation, you should go ahead and get in a fight.",678,0,TRUE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,409,17,"If talking with the violent person does not help a situation, you should go ahead and get in a fight.",679,1,FALSE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,410,18,Any employee who recognizes the development of a hostage situation should completely ignore the situation.,680,0,TRUE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,410,18,Any employee who recognizes the development of a hostage situation should completely ignore the situation.,681,1,FALSE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,411,19,"When a hostage situation develops, employees should never try to move people from the area.",682,0,TRUE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,411,19,"When a hostage situation develops, employees should never try to move people from the area.",683,1,FALSE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,412,20,"You should prevent other staff, visitors, and patients from entering an area during a hostage situation.",684,0,TRUE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,412,20,"You should prevent other staff, visitors, and patients from entering an area during a hostage situation.",685,1,FALSE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,413,21,Employees should not know and follow hospital procedures for safety and security.,686,0,TRUE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,413,21,Employees should not know and follow hospital procedures for safety and security.,687,1,FALSE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,414,22,Employees should be aware of situations which may develop into a safety or security threat.,688,0,TRUE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,414,22,Employees should be aware of situations which may develop into a safety or security threat.,689,1,FALSE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,415,23,Employees should not know and understand employee responses to all emergency codes.,690,0,TRUE,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,415,23,Employees should not know and understand employee responses to all emergency codes.,691,1,FALSE,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,419,24,Employees should know the correct way to deal with,700,0,internal or external disasters,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,419,24,Employees should know the correct way to deal with,701,1,bomb threats,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,419,24,Employees should know the correct way to deal with,702,2,patients or staff member who are in physical danger,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,419,24,Employees should know the correct way to deal with,703,3,all of the above,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,420,25,An employee receiving a bomb threat by phone should,704,0,hang up immediately,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,420,25,An employee receiving a bomb threat by phone should,705,1,immediately notify a coworker to alert security,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,420,25,An employee receiving a bomb threat by phone should,706,2,not worry about information received from the caller,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,420,25,An employee receiving a bomb threat by phone should,707,3,none of the above,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,421,26,"When employees receive a bomb threat, they should",708,0,note if the caller is familiar with the hospital by their description of locations,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,421,26,"When employees receive a bomb threat, they should",709,1,announce in a clear voice that a bomb threat has been made,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,421,26,"When employees receive a bomb threat, they should",710,2,do both of the above,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,422,27,Employees in the immediate area of a bomb threat should,711,0,"move, jar, or touch suspicious objects or anything attached to the object",0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,422,27,Employees in the immediate area of a bomb threat should,712,1,search for and report any suspicious objects,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,422,27,Employees in the immediate area of a bomb threat should,713,2,do neither of the above,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,423,28,"When there is a bomb threat, employees should check public access areas.  These areas include",714,0,rest rooms and locker rooms,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,423,28,"When there is a bomb threat, employees should check public access areas.  These areas include",715,1,vacant areas and telephone booths,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,423,28,"When there is a bomb threat, employees should check public access areas.  These areas include",716,2,"admitting, the ER, and waiting areas",0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,423,28,"When there is a bomb threat, employees should check public access areas.  These areas include",717,3,patient rooms,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,423,28,"When there is a bomb threat, employees should check public access areas.  These areas include",718,4,all of the above.,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,424,29,An employee who receives a bomb threat by mail should,719,0,immediately notify security,1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,424,29,An employee who receives a bomb threat by mail should,720,1,handle and shake the letter or package,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,424,29,An employee who receives a bomb threat by mail should,721,2,tell everyone he/she sees that a bomb threat has been received,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,424,29,An employee who receives a bomb threat by mail should,722,3,do all of the above.,0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,425,30,Which of the following statements is false?,723,0,"In a hostage situation, employees should try to identify the number of hostages.",0
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,425,30,Which of the following statements is false?,724,1,"In a hostage situation, employees should not try to identify any suspects.",1
1544,ILT-0000-6470,EMERGENCY MANAGEMENT,n1070,425,30,Which of the following statements is false?,725,2,"In a hostage situation, employees should identify weapons used.",0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27960,0,When should the New Beginnings booklet be provided to the patient?,84741,0,On admission to FCC,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27960,0,When should the New Beginnings booklet be provided to the patient?,84742,1,"Whenever you have time, it is only a gift",0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27960,0,When should the New Beginnings booklet be provided to the patient?,84743,2,Any time after the first 24 hours after delivery,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27960,0,When should the New Beginnings booklet be provided to the patient?,84744,3,Provide it to the patient as part of their discharge education,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27961,1,Which fliers are included in the pocket of the A New Beginning booklet?,84745,0,What Every Parent Should Know,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27961,1,Which fliers are included in the pocket of the A New Beginning booklet?,84746,1,What Should I Expect Trifold,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27961,1,Which fliers are included in the pocket of the A New Beginning booklet?,84747,2,Bedside Shift Report Information,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27961,1,Which fliers are included in the pocket of the A New Beginning booklet?,84748,3,All of the above,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27962,2,The following information can be located in the Mom Care chapter:,84749,0,Changes After Birth,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27962,2,The following information can be located in the Mom Care chapter:,84750,1,Important Physical Changes,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27962,2,The following information can be located in the Mom Care chapter:,84751,2,Self-Care Tips,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27962,2,The following information can be located in the Mom Care chapter:,84752,3,Information for Fathers and Partners,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27962,2,The following information can be located in the Mom Care chapter:,84753,4,All of the above,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27963,3,What pages of the New Beginnings book will you use to educate a mother on admission to FCC regarding expected changes after birth?,84754,0,Pages 15-20,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27963,3,What pages of the New Beginnings book will you use to educate a mother on admission to FCC regarding expected changes after birth?,84755,1,Pages 38-51,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27963,3,What pages of the New Beginnings book will you use to educate a mother on admission to FCC regarding expected changes after birth?,84756,2,Pages 5-8,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27963,3,What pages of the New Beginnings book will you use to educate a mother on admission to FCC regarding expected changes after birth?,84757,3,Pages 11-14,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27964,4,What page will you find information regarding maternal hygiene (bathing and showering)?,84758,0,Pages 22-23,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27964,4,What page will you find information regarding maternal hygiene (bathing and showering)?,84759,1,Page 38,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27964,4,What page will you find information regarding maternal hygiene (bathing and showering)?,84760,2,Page 16,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27964,4,What page will you find information regarding maternal hygiene (bathing and showering)?,84761,3,Page 6,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27965,5,In which section will you locate information regarding emotional changes and postpartum depression?,84762,0,Other Important Physical Changes,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27965,5,In which section will you locate information regarding emotional changes and postpartum depression?,84763,1,Changes After Birth,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27965,5,In which section will you locate information regarding emotional changes and postpartum depression?,84764,2,Self-Care Tips,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27965,5,In which section will you locate information regarding emotional changes and postpartum depression?,84765,3,Newborn Senses,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27966,6,"As you are reviewing discharge instructions with your patient, what page can you show her to reinforce when she should notify her provider.",84766,0,Page 4,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27966,6,"As you are reviewing discharge instructions with your patient, what page can you show her to reinforce when she should notify her provider.",84767,1,Page 14,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27966,6,"As you are reviewing discharge instructions with your patient, what page can you show her to reinforce when she should notify her provider.",84768,2,Page 24,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27966,6,"As you are reviewing discharge instructions with your patient, what page can you show her to reinforce when she should notify her provider.",84769,3,Page 50,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27967,7,During the admission process we teach parents how to safely use the bulb syringe. What chapter and page in the booklet can you show to the parents to assist you in this education?,84770,0,"Going Home, page 59",0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27967,7,During the admission process we teach parents how to safely use the bulb syringe. What chapter and page in the booklet can you show to the parents to assist you in this education?,84771,1,"Feeding, page 42",0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27967,7,During the admission process we teach parents how to safely use the bulb syringe. What chapter and page in the booklet can you show to the parents to assist you in this education?,84772,2,"Baby Care, page 27",0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27967,7,During the admission process we teach parents how to safely use the bulb syringe. What chapter and page in the booklet can you show to the parents to assist you in this education?,84773,3,"Baby Care, page 15",1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27968,8,"Per the purple call out box located in the Jaundice section of the booklet, when should a patient immediately call their provider?",84774,0,"Skin and body becomes more yellow, white of the eyes are yellow, your baby is hard to wake up",1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27968,8,"Per the purple call out box located in the Jaundice section of the booklet, when should a patient immediately call their provider?",84775,1,"Your baby wants to eat 8-12 times per day, your baby has more than 8 wet diapers per day, the stool becomes yellow and seedy",0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27968,8,"Per the purple call out box located in the Jaundice section of the booklet, when should a patient immediately call their provider?",84776,2,"Your baby is fussy, your baby has a red rash in the diaper area, your baby is spitting up more than usual",0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27968,8,"Per the purple call out box located in the Jaundice section of the booklet, when should a patient immediately call their provider?",84777,3,Jaundice is always normal and you should not need to call your provider once you are discharged home,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27969,9,"Per the purple call out box in the Umbilical Cord section of the booklet, when should a patient call their newborn's provider?",84778,0,Foul odor,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27969,9,"Per the purple call out box in the Umbilical Cord section of the booklet, when should a patient call their newborn's provider?",84779,1,Green discharge,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27969,9,"Per the purple call out box in the Umbilical Cord section of the booklet, when should a patient call their newborn's provider?",84780,2,Area around navel is swollen,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27969,9,"Per the purple call out box in the Umbilical Cord section of the booklet, when should a patient call their newborn's provider?",84781,3,All of the above,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27970,10,"Your patient asks you the risks versus benefits of a circumcision. After reminding them they should ultimately discuss this with their provider, what page can you refer them to?",84782,0,Circumcision page 20,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27970,10,"Your patient asks you the risks versus benefits of a circumcision. After reminding them they should ultimately discuss this with their provider, what page can you refer them to?",84783,1,Circumcision page 13,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27970,10,"Your patient asks you the risks versus benefits of a circumcision. After reminding them they should ultimately discuss this with their provider, what page can you refer them to?",84784,2,Circumcision page 30,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27970,10,"Your patient asks you the risks versus benefits of a circumcision. After reminding them they should ultimately discuss this with their provider, what page can you refer them to?",84785,3,Circumcision page 15,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27971,11,"A parent asks you when they can trim their baby's fingernails. Using the information from page 23, select the appropriate response below:",84786,0,"It is difficult to determine where the nail ends and the skin starts, so you want to use a soft emery board",1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27971,11,"A parent asks you when they can trim their baby's fingernails. Using the information from page 23, select the appropriate response below:",84787,1,"You can begin trimming their nails anytime as long as you use small, infant scissors",0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27971,11,"A parent asks you when they can trim their baby's fingernails. Using the information from page 23, select the appropriate response below:",84788,2,Most cultures prefer to bite off the finger nails to assist with bonding,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27971,11,"A parent asks you when they can trim their baby's fingernails. Using the information from page 23, select the appropriate response below:",84789,3,Anytime as long as you use the hospital baby nail clippers,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27972,12,Your patient asks you for information on taking their baby's temperature. Which page will you turn to in the New Beginnings book?,84790,0,Page 5,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27972,12,Your patient asks you for information on taking their baby's temperature. Which page will you turn to in the New Beginnings book?,84791,1,Page 16,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27972,12,Your patient asks you for information on taking their baby's temperature. Which page will you turn to in the New Beginnings book?,84792,2,Page 25,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27972,12,Your patient asks you for information on taking their baby's temperature. Which page will you turn to in the New Beginnings book?,84793,3,Page 39,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27973,13,"A patient asks you what they should do when their baby cries. Locate the section titled ""Soothing/Calming a Fussy Baby."" After reading the section, select the best response below:",84794,0,It is important to not respond immediately to your baby's crying during the first few months because you don't want to spoil them.,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27973,13,"A patient asks you what they should do when their baby cries. Locate the section titled ""Soothing/Calming a Fussy Baby."" After reading the section, select the best response below:",84795,1,"It is importantly to respond to your baby's cries. First make sure your baby is warm, dry and fed.",0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27973,13,"A patient asks you what they should do when their baby cries. Locate the section titled ""Soothing/Calming a Fussy Baby."" After reading the section, select the best response below:",84796,2,"Many parents find that swaddling, rocking, singing or talking to their fussy baby helps.",0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27973,13,"A patient asks you what they should do when their baby cries. Locate the section titled ""Soothing/Calming a Fussy Baby."" After reading the section, select the best response below:",84797,3,B and C only,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27974,14,It is an expectation that FCC staff provides Safe Sleep Education to all our patients. What pages can you instruct them to read to re-enforce your education?,84798,0,Page 31,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27974,14,It is an expectation that FCC staff provides Safe Sleep Education to all our patients. What pages can you instruct them to read to re-enforce your education?,84799,1,Page 32,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27974,14,It is an expectation that FCC staff provides Safe Sleep Education to all our patients. What pages can you instruct them to read to re-enforce your education?,84800,2,Page 33,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27974,14,It is an expectation that FCC staff provides Safe Sleep Education to all our patients. What pages can you instruct them to read to re-enforce your education?,84801,3,All of the above,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27975,15,What chapter of the New Beginnings book discusses skin to skin contact?,84802,0,Mom Care,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27975,15,What chapter of the New Beginnings book discusses skin to skin contact?,84803,1,Baby Care,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27975,15,What chapter of the New Beginnings book discusses skin to skin contact?,84804,2,Feeding,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27975,15,What chapter of the New Beginnings book discusses skin to skin contact?,84805,3,Going Home,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27976,16,What pages in the book discuss breastfeeding?,84806,0,Pages 42-43,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27976,16,What pages in the book discuss breastfeeding?,84807,1,Pages 53-56,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27976,16,What pages in the book discuss breastfeeding?,84808,2,Pages 38-51,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27976,16,What pages in the book discuss breastfeeding?,84809,3,Pages 35-56,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27977,17,Your patient asks you if you can recommend a tool for them to track their newborn's feeding and diaper changes while they are in the hospital. What chapter and page of the booklet will you direct them to?,84810,0,"Baby Care, page 31",0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27977,17,Your patient asks you if you can recommend a tool for them to track their newborn's feeding and diaper changes while they are in the hospital. What chapter and page of the booklet will you direct them to?,84811,1,"Feeding, page 49",0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27977,17,Your patient asks you if you can recommend a tool for them to track their newborn's feeding and diaper changes while they are in the hospital. What chapter and page of the booklet will you direct them to?,84812,2,"Feeding, page 52",1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27977,17,Your patient asks you if you can recommend a tool for them to track their newborn's feeding and diaper changes while they are in the hospital. What chapter and page of the booklet will you direct them to?,84813,3,"Going Home, page 63",0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27978,18,"A patient asks you if the black, tarry stool in their baby's diaper is normal. What page can you direct them to reassure them their infant is stooling normally?",84814,0,Page 40 Newborn Feeding Patterns,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27978,18,"A patient asks you if the black, tarry stool in their baby's diaper is normal. What page can you direct them to reassure them their infant is stooling normally?",84815,1,Page 52 Feeding and Output Log,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27978,18,"A patient asks you if the black, tarry stool in their baby's diaper is normal. What page can you direct them to reassure them their infant is stooling normally?",84816,2,Page 43 Diaper Chart,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27978,18,"A patient asks you if the black, tarry stool in their baby's diaper is normal. What page can you direct them to reassure them their infant is stooling normally?",84817,3,B and C,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27979,19,On what pages can you locate a diagram that depicts the stages of the infant's stomach growth?,84818,0,Pages 40 and 53,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27979,19,On what pages can you locate a diagram that depicts the stages of the infant's stomach growth?,84819,1,Pages 39 and 54,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27979,19,On what pages can you locate a diagram that depicts the stages of the infant's stomach growth?,84820,2,A and B,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27979,19,On what pages can you locate a diagram that depicts the stages of the infant's stomach growth?,84821,3,None of the above,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27980,20,Your patient requests help with hand expression but you are not immediately available. How can you utilize the New Beginnings booklet to assist her until you can come to the room?,84822,0,Instruct her to read the section on baby care,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27980,20,Your patient requests help with hand expression but you are not immediately available. How can you utilize the New Beginnings booklet to assist her until you can come to the room?,84823,1,Tell her to review the steps of hand expression on page 45,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27980,20,Your patient requests help with hand expression but you are not immediately available. How can you utilize the New Beginnings booklet to assist her until you can come to the room?,84824,2,Call a Lactation nurse to inquire if someone is available to work with her,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27980,20,Your patient requests help with hand expression but you are not immediately available. How can you utilize the New Beginnings booklet to assist her until you can come to the room?,84825,3,All of the above,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27981,21,What parent tools are provided in the Going Home chapter of the booklet?,84826,0,Immunization Schedule,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27981,21,What parent tools are provided in the Going Home chapter of the booklet?,84827,1,Tummy Time Table,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27981,21,What parent tools are provided in the Going Home chapter of the booklet?,84828,2,Sleep and Feeding Pattern,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27981,21,What parent tools are provided in the Going Home chapter of the booklet?,84829,3,Feeding and Output Log,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27982,22,How frequently should you review the What Should I Expect? trifold with your patient?,84830,0,At least every shift,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27982,22,How frequently should you review the What Should I Expect? trifold with your patient?,84831,1,On admission and discharge only,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27982,22,How frequently should you review the What Should I Expect? trifold with your patient?,84832,2,Whenever you need to supplement your education,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27982,22,How frequently should you review the What Should I Expect? trifold with your patient?,84833,3,A and C,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27983,23,Your patient's husband asks what time they will be able to leave. What is the best way to help him better understand what needs to be completed before he and his family can leave the hospital?,84834,0,Review the Discharge Orders with the father,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27983,23,Your patient's husband asks what time they will be able to leave. What is the best way to help him better understand what needs to be completed before he and his family can leave the hospital?,84835,1,Pull out the Discharge Checklist from the green discharge folder,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27983,23,Your patient's husband asks what time they will be able to leave. What is the best way to help him better understand what needs to be completed before he and his family can leave the hospital?,84836,2,Review with him the Mom's Discharge Checklist and Baby's Discharge Checklist in the What Should I Expect? trifold.,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27983,23,Your patient's husband asks what time they will be able to leave. What is the best way to help him better understand what needs to be completed before he and his family can leave the hospital?,84837,3,Refer him to the Going Home section of the New Beginnings booklet.,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27984,24,Both the post-vaginal and post-cesarean section expectation checklists are located in the What Should I Expect? pamphlet.,84838,0,TRUE,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27984,24,Both the post-vaginal and post-cesarean section expectation checklists are located in the What Should I Expect? pamphlet.,84839,1,FALSE,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27985,25,What is the purpose of the Discharge Prep Checklist?,84840,0,To provide a tool for communicating the patient's progression toward discharge and to ensure that preparation for discharge is occurring throughout the patient's stay,1
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27985,25,What is the purpose of the Discharge Prep Checklist?,84841,1,To get discharges out on time,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27985,25,What is the purpose of the Discharge Prep Checklist?,84842,2,To ensure that all the correct paperwork is placed in the patient's yellow discharge envelope,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27985,25,What is the purpose of the Discharge Prep Checklist?,84843,3,All of the Above,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27986,26,Which of the following statements is true regarding the Discharge Prep Checklist?,84844,0,Secretaries will place the form on the front of all Mom charts,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27986,26,Which of the following statements is true regarding the Discharge Prep Checklist?,84845,1,The same checklist is used for vaginal and C-section deliveries,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27986,26,Which of the following statements is true regarding the Discharge Prep Checklist?,84846,2,The checklist is not a part of the permanent medical record,0
1693,ILT-0000-7260,FCC - A NEW BEGINNING BOOKLETS,n5886,27986,26,Which of the following statements is true regarding the Discharge Prep Checklist?,84847,3,All of the Above,1
9488,Elearning-0000-720,DO WE NEED AN ETHICS CONSULTATION?,n5888,27988,0,I acknowledge that I have read and understand in its entirety the DO WE NEED AN ETHICS CONSULTATION? content.,84850,0,TRUE,1
9488,Elearning-0000-720,DO WE NEED AN ETHICS CONSULTATION?,n5888,27988,0,I acknowledge that I have read and understand in its entirety the DO WE NEED AN ETHICS CONSULTATION? content.,84851,1,FALSE,0
8957,Elearning-0000-238,QUANTIFICATION OF BLOOD LOSS FY18,n5912,28138,0,"1. If a mark is unable to be drawn on the under buttocks drape after delivery of the infant, what should the delivery team members do?",85370,0,"a.	Blind guess the amount",0
8957,Elearning-0000-238,QUANTIFICATION OF BLOOD LOSS FY18,n5912,28138,0,"1. If a mark is unable to be drawn on the under buttocks drape after delivery of the infant, what should the delivery team members do?",85371,1,"b.	Count all fluid toward blood loss",0
8957,Elearning-0000-238,QUANTIFICATION OF BLOOD LOSS FY18,n5912,28138,0,"1. If a mark is unable to be drawn on the under buttocks drape after delivery of the infant, what should the delivery team members do?",85372,2,"c.	Provider and nursing come to a quick consensus and verbalize amount the amount of amniotic fluid and urine in the under buttocks drape",1
8957,Elearning-0000-238,QUANTIFICATION OF BLOOD LOSS FY18,n5912,28139,1,2. What does the Surgical Tech need to do with the remaining saline left in the basin at the completion of the C-section?,85373,0,"a.	Put Isolyser in the basin and throw it away in the red bag",0
8957,Elearning-0000-238,QUANTIFICATION OF BLOOD LOSS FY18,n5912,28139,1,2. What does the Surgical Tech need to do with the remaining saline left in the basin at the completion of the C-section?,85374,1,"b.	Suction the remaining saline into the Neptune to accurately account for all of the irrigation fluid in the QBL formula",1
8957,Elearning-0000-238,QUANTIFICATION OF BLOOD LOSS FY18,n5912,28139,1,2. What does the Surgical Tech need to do with the remaining saline left in the basin at the completion of the C-section?,85375,2,"c.	Mix the irrigation with the remaining sterile water",0
8957,Elearning-0000-238,QUANTIFICATION OF BLOOD LOSS FY18,n5912,28140,2,3.  Communication and Team Work play key roles in the success of QBL.,85376,0,TRUE,1
8957,Elearning-0000-238,QUANTIFICATION OF BLOOD LOSS FY18,n5912,28140,2,3.  Communication and Team Work play key roles in the success of QBL.,85377,1,FALSE,0
8957,Elearning-0000-238,QUANTIFICATION OF BLOOD LOSS FY18,n5912,28141,3,"4. After completion of a vaginal delivery, the under buttocks drape pouch has a total fluid accumulation of 400 mL.  The pouch was marked at 200 mL after delivery of infant.  The total weighted amount of the items containing blood is 475 grams.  The total dry weight of those items is 330 grams.  What is your QBL? Hint: (total wet weight - dry weight) + (pouch total volume - pouch volume immediately after delivery) = QBL",85378,0,"a.	345",1
8957,Elearning-0000-238,QUANTIFICATION OF BLOOD LOSS FY18,n5912,28141,3,"4. After completion of a vaginal delivery, the under buttocks drape pouch has a total fluid accumulation of 400 mL.  The pouch was marked at 200 mL after delivery of infant.  The total weighted amount of the items containing blood is 475 grams.  The total dry weight of those items is 330 grams.  What is your QBL? Hint: (total wet weight - dry weight) + (pouch total volume - pouch volume immediately after delivery) = QBL",85379,1,"b.	675",0
8957,Elearning-0000-238,QUANTIFICATION OF BLOOD LOSS FY18,n5912,28141,3,"4. After completion of a vaginal delivery, the under buttocks drape pouch has a total fluid accumulation of 400 mL.  The pouch was marked at 200 mL after delivery of infant.  The total weighted amount of the items containing blood is 475 grams.  The total dry weight of those items is 330 grams.  What is your QBL? Hint: (total wet weight - dry weight) + (pouch total volume - pouch volume immediately after delivery) = QBL",85380,2,"c.	200",0
8957,Elearning-0000-238,QUANTIFICATION OF BLOOD LOSS FY18,n5912,28142,4,5. Critical thinking: What do you do if the patient precipitous delivers without the under buttock drape?,85381,0,"a.	Skip doing QBL",0
8957,Elearning-0000-238,QUANTIFICATION OF BLOOD LOSS FY18,n5912,28142,4,5. Critical thinking: What do you do if the patient precipitous delivers without the under buttock drape?,85382,1,"b.	Place under buttocks drape under the patient before delivery of the placenta and start QBL",0
8957,Elearning-0000-238,QUANTIFICATION OF BLOOD LOSS FY18,n5912,28142,4,5. Critical thinking: What do you do if the patient precipitous delivers without the under buttock drape?,85383,2,"c.	Place under buttocks drape under the patient before delivery of the placenta, start QBL and continue QBL in the recovery phase.",1
8929,Elearning-0000-212,HUMAN FACTORS AND SAFETY AWARENESS IN PERINATAL SAFETY 2017,n5900,28029,0,"1.  During a cesarean section, the peritoneum cavity count is incorrect.  The Surgical Tech and Circulator inform the surgeon that the count is incorrect.  The surgeon continues with the surgery.  They repeat for a second time that the count is incorrect.  The surgeon continues with the surgery.  What is the next appropriate step?",84980,0,"a) Surgical Tech withholds further closing materials, and the Circulator immediately calls for OR Charge Nurse to come into the OR",1
8929,Elearning-0000-212,HUMAN FACTORS AND SAFETY AWARENESS IN PERINATAL SAFETY 2017,n5900,28029,0,"1.  During a cesarean section, the peritoneum cavity count is incorrect.  The Surgical Tech and Circulator inform the surgeon that the count is incorrect.  The surgeon continues with the surgery.  They repeat for a second time that the count is incorrect.  The surgeon continues with the surgery.  What is the next appropriate step?",84981,1,b) Continue and document that count was incorrect,0
8929,Elearning-0000-212,HUMAN FACTORS AND SAFETY AWARENESS IN PERINATAL SAFETY 2017,n5900,28029,0,"1.  During a cesarean section, the peritoneum cavity count is incorrect.  The Surgical Tech and Circulator inform the surgeon that the count is incorrect.  The surgeon continues with the surgery.  They repeat for a second time that the count is incorrect.  The surgeon continues with the surgery.  What is the next appropriate step?",84982,2,c) Continue and document count correct and write an incident report at a later time,0
8929,Elearning-0000-212,HUMAN FACTORS AND SAFETY AWARENESS IN PERINATAL SAFETY 2017,n5900,28030,1,"2.  Which is an example of Assertive ""CUS"" Communication?",84983,0,a) You are being Unreasonable,0
8929,Elearning-0000-212,HUMAN FACTORS AND SAFETY AWARENESS IN PERINATAL SAFETY 2017,n5900,28030,1,"2.  Which is an example of Assertive ""CUS"" Communication?",84984,1,b) I am Concerned,1
8929,Elearning-0000-212,HUMAN FACTORS AND SAFETY AWARENESS IN PERINATAL SAFETY 2017,n5900,28030,1,"2.  Which is an example of Assertive ""CUS"" Communication?",84985,2,c) This is Scary,0
8929,Elearning-0000-212,HUMAN FACTORS AND SAFETY AWARENESS IN PERINATAL SAFETY 2017,n5900,28031,2,3.  SBAR Communication helps to facilitate:,84986,0,a) A confusing script to follow when speaking to the patient about their plan of care,0
8929,Elearning-0000-212,HUMAN FACTORS AND SAFETY AWARENESS IN PERINATAL SAFETY 2017,n5900,28031,2,3.  SBAR Communication helps to facilitate:,84987,1,b) Concerns to pharmacy regarding medications,0
8929,Elearning-0000-212,HUMAN FACTORS AND SAFETY AWARENESS IN PERINATAL SAFETY 2017,n5900,28031,2,3.  SBAR Communication helps to facilitate:,84988,2,c) Critical Information that requires immediate attention and action concerning a patient's condition,1
8929,Elearning-0000-212,HUMAN FACTORS AND SAFETY AWARENESS IN PERINATAL SAFETY 2017,n5900,28032,3,"4.  In ""Just a Routine Operation"", the majority of the surgical team members were novices and inexperienced providers.",84989,0,TRUE,0
8929,Elearning-0000-212,HUMAN FACTORS AND SAFETY AWARENESS IN PERINATAL SAFETY 2017,n5900,28032,3,"4.  In ""Just a Routine Operation"", the majority of the surgical team members were novices and inexperienced providers.",84990,1,FALSE,1
8929,Elearning-0000-212,HUMAN FACTORS AND SAFETY AWARENESS IN PERINATAL SAFETY 2017,n5900,28033,4,5. When would you initiate a new Time Out after the surgery has already begun?,84991,0,a) If there is a new procedure,0
8929,Elearning-0000-212,HUMAN FACTORS AND SAFETY AWARENESS IN PERINATAL SAFETY 2017,n5900,28033,4,5. When would you initiate a new Time Out after the surgery has already begun?,84992,1,b) If there is a change of Surgeon or Surgical Assistant,0
8929,Elearning-0000-212,HUMAN FACTORS AND SAFETY AWARENESS IN PERINATAL SAFETY 2017,n5900,28033,4,5. When would you initiate a new Time Out after the surgery has already begun?,84993,2,c) Both A & B,1
8929,Elearning-0000-212,HUMAN FACTORS AND SAFETY AWARENESS IN PERINATAL SAFETY 2017,n5900,28143,5,"I verify that I have watched the video, ""Just a Routine Operation,"" in its entirety and am responsible for understanding its content.",85390,0,TRUE,1
8929,Elearning-0000-212,HUMAN FACTORS AND SAFETY AWARENESS IN PERINATAL SAFETY 2017,n5900,28143,5,"I verify that I have watched the video, ""Just a Routine Operation,"" in its entirety and am responsible for understanding its content.",85391,1,FALSE,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28192,0,"1. An individual cartridge may be used after standing 5 minutes, in its pouch at room temperature. An entire box should stand at room temperature for 1 hour before cartridges are used.",85608,0,TRUE,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28192,0,"1. An individual cartridge may be used after standing 5 minutes, in its pouch at room temperature. An entire box should stand at room temperature for 1 hour before cartridges are used.",85609,1,FALSE,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28193,1,2. Cartridges may be returned to the refrigerator once they have been at room temperature.,85610,0,TRUE,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28193,1,2. Cartridges may be returned to the refrigerator once they have been at room temperature.,85611,1,FALSE,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28194,2,"3. If the i-STAT test cartridge has a flip closure and not a slide closure, it is important not to exert  too much pressure on the         closure which may push the sample beyond the fill mark.",85612,0,TRUE,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28194,2,"3. If the i-STAT test cartridge has a flip closure and not a slide closure, it is important not to exert  too much pressure on the         closure which may push the sample beyond the fill mark.",85613,1,FALSE,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28195,3,4.  Which of the following is/are true regarding i-STAT1 cartridge testing?,85614,0,a. You must scan the actual cartridge barcode.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28195,3,4.  Which of the following is/are true regarding i-STAT1 cartridge testing?,85615,1,"b.  The instrument must be on a flat, nonvibrating surface.",0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28195,3,4.  Which of the following is/are true regarding i-STAT1 cartridge testing?,85616,2,c.  You must not pick up and move the analyzer once the cartridge is inserted in the analyzer.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28195,3,4.  Which of the following is/are true regarding i-STAT1 cartridge testing?,85617,3,d.  All of the above.,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28196,4,"5.  The i-STAT CG4+(lactates), CHEM8+ & CREA cartridges have the same testing time (sample add to  result)  once the cartridge is placed into the analyzer, how long before the result is displayed?",85618,0,a.  3 Minutes,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28196,4,"5.  The i-STAT CG4+(lactates), CHEM8+ & CREA cartridges have the same testing time (sample add to  result)  once the cartridge is placed into the analyzer, how long before the result is displayed?",85619,1,b.  2 Minutes,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28196,4,"5.  The i-STAT CG4+(lactates), CHEM8+ & CREA cartridges have the same testing time (sample add to  result)  once the cartridge is placed into the analyzer, how long before the result is displayed?",85620,2,c.  5 Minutes,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28196,4,"5.  The i-STAT CG4+(lactates), CHEM8+ & CREA cartridges have the same testing time (sample add to  result)  once the cartridge is placed into the analyzer, how long before the result is displayed?",85621,3,d. 10 Minutes,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28197,6,"6.  A result that is flagged with ""***"" means that: 			    .",85622,0,a.  The result is not reportable,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28197,6,"6.  A result that is flagged with ""***"" means that: 			    .",85623,1,b.  The test should be repeated with another cartridge.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28197,6,"6.  A result that is flagged with ""***"" means that: 			    .",85624,2,"c.  If seen again on a second cartridge, a lab test should be ordered and the specimen sent to the lab.",0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28197,6,"6.  A result that is flagged with ""***"" means that: 			    .",85625,3,d.  All of the above.,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28198,7,7.  A result that is flagged with < or > can mean that:,85626,0,a.  The cartridge is defective,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28198,7,7.  A result that is flagged with < or > can mean that:,85627,1,b.  The test result is outside the cartridge's measurement range,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28198,7,7.  A result that is flagged with < or > can mean that:,85628,2,c.  The cartridge was overfilled.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28198,7,7.  A result that is flagged with < or > can mean that:,85629,3,d.  All of the above,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28199,8,"8.  If any result is flagged with < or >, the sample should be:",85630,0,a.  Repeated on the i-STAT1 analyzer.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28199,8,"8.  If any result is flagged with < or >, the sample should be:",85631,1,"b.  On repeat, if the sample has a > flag, order a lab test and send the sample to the lab.",0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28199,8,"8.  If any result is flagged with < or >, the sample should be:",85632,2,"c.  On repeat, if the sample has a < flag, accept the results as less than that value.",0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28199,8,"8.  If any result is flagged with < or >, the sample should be:",85633,3,d.  Put in the refrigerator until the following shift.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28199,8,"8.  If any result is flagged with < or >, the sample should be:",85634,4,"e.  a, b, and c",1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28200,9,"9.  When the cartridge locked prompt is displayed, it is important to not:",85635,0,a.  Leave the i-STAT analyzer unattended.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28200,9,"9.  When the cartridge locked prompt is displayed, it is important to not:",85636,1,b.  Pull the cartridge out.,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28200,9,"9.  When the cartridge locked prompt is displayed, it is important to not:",85637,2,c. Talk to the patient.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28200,9,"9.  When the cartridge locked prompt is displayed, it is important to not:",85638,3,d.  All of the above,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28201,10,"10.  When replacing the i-STAT1 analyzer batteries, which is true?",85639,0,a. You can use a rechargeable battery pack.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28201,10,"10.  When replacing the i-STAT1 analyzer batteries, which is true?",85640,1,b. Two disposable lithium 9 volt batteries may be used.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28201,10,"10.  When replacing the i-STAT1 analyzer batteries, which is true?",85641,2,c. Stored results are not lost when replacing batteries.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28201,10,"10.  When replacing the i-STAT1 analyzer batteries, which is true?",85642,3,d. All of the above.,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28202,11,"11. Proper sample handling, a part of the pre-analytical testing process, includes:",85643,0,a. Mixing the sample well and discarding the first few drops.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28202,11,"11. Proper sample handling, a part of the pre-analytical testing process, includes:",85644,1,b. Checking for the correct patient with at least two identifiers.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28202,11,"11. Proper sample handling, a part of the pre-analytical testing process, includes:",85645,2,c. Filling the cartridge within the recommended time frame.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28202,11,"11. Proper sample handling, a part of the pre-analytical testing process, includes:",85646,3,d. All of the above.,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28203,12,12. Which of the following are true regarding cartridge usage?,85647,0,a. All cartridges must be at room temperature for 1 hour per box or 5 minutes each.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28203,12,12. Which of the following are true regarding cartridge usage?,85648,1,b. Air bubbles trapped in the sample well will affect testing.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28203,12,12. Which of the following are true regarding cartridge usage?,85649,2,c. Samples should be dispensed slowly and steadily until it reaches the fill mark.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28203,12,12. Which of the following are true regarding cartridge usage?,85650,3,d. All of the above.,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28204,13,"13.	How long can the i-STAT troponin, CHEM8+ and CREA cartridges (it's the same for all 3 cartridges) be stored at room temperatures and still be used for patient testing?",85651,0,a. 48 hours,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28204,13,"13.	How long can the i-STAT troponin, CHEM8+ and CREA cartridges (it's the same for all 3 cartridges) be stored at room temperatures and still be used for patient testing?",85652,1,b. 3 weeks,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28204,13,"13.	How long can the i-STAT troponin, CHEM8+ and CREA cartridges (it's the same for all 3 cartridges) be stored at room temperatures and still be used for patient testing?",85653,2,c. 2 weeks,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28204,13,"13.	How long can the i-STAT troponin, CHEM8+ and CREA cartridges (it's the same for all 3 cartridges) be stored at room temperatures and still be used for patient testing?",85654,3,d. 1 week,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28205,14,"14.	When should the i-STAT meter be docked:",85655,0,a. Once a day.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28205,14,"14.	When should the i-STAT meter be docked:",85656,1,b. Once a week.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28205,14,"14.	When should the i-STAT meter be docked:",85657,2,c. Immediately when you finish running a patient sample.,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28205,14,"14.	When should the i-STAT meter be docked:",85658,3,d. Never. There is not a docking station for the i-STAT analyzer.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28206,15,"15. For testing on the i-STAT, samples should not be used unless the light green (lithium heparin) blood collection tube is:",85659,0,a. Filled fully (stated collection volume of tube),1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28206,15,"15. For testing on the i-STAT, samples should not be used unless the light green (lithium heparin) blood collection tube is:",85660,1,b. Filled at least half full.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28206,15,"15. For testing on the i-STAT, samples should not be used unless the light green (lithium heparin) blood collection tube is:",85661,2,c. Filled  at least   full.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28206,15,"15. For testing on the i-STAT, samples should not be used unless the light green (lithium heparin) blood collection tube is:",85662,3,d. Filled with at least 5 drops of blood.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28206,15,"15. For testing on the i-STAT, samples should not be used unless the light green (lithium heparin) blood collection tube is:",85663,4,e. None of the above.,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28207,16,16.  It is okay to pull the testing cartridge from the i-STAT before the result is displayed and testing is completed.,85664,0,TRUE,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28207,16,16.  It is okay to pull the testing cartridge from the i-STAT before the result is displayed and testing is completed.,85665,1,FALSE,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28208,18,17. The purpose of performing the i-STAT Creatinine test prior to administering contrast is to check patient's renal function.,85666,0,TRUE,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28208,18,17. The purpose of performing the i-STAT Creatinine test prior to administering contrast is to check patient's renal function.,85667,1,FALSE,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28209,19,18. A light green top (lithium heparin) tube is the specimen of choice when collecting a blood sample  for i-STAT testing.,85668,0,TRUE,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28209,19,18. A light green top (lithium heparin) tube is the specimen of choice when collecting a blood sample  for i-STAT testing.,85669,1,FALSE,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28210,21,19. The iSTAT should be cleaned using  approved hospital disinfectant wipes after each use and whenever visibly soiled.,85670,0,TRUE,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28210,21,19. The iSTAT should be cleaned using  approved hospital disinfectant wipes after each use and whenever visibly soiled.,85671,1,FALSE,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28211,23,20. Two levels of external controls should be run on each iSTAT at least monthly and with new lots or shipments of cartridges.,85672,0,TRUE,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28211,23,20. Two levels of external controls should be run on each iSTAT at least monthly and with new lots or shipments of cartridges.,85673,1,FALSE,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28365,5,"5.  The i-STAT CG4+(lactates), CHEM8+ & CREA cartridges have the same testing time (sample add to  result)  once the cartridge is placed into the analyzer, how long before the result is displayed?",86170,0,a.  1 Minutes,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28365,5,"5.  The i-STAT CG4+(lactates), CHEM8+ & CREA cartridges have the same testing time (sample add to  result)  once the cartridge is placed into the analyzer, how long before the result is displayed?",86171,1,b.  2 Minutes,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28365,5,"5.  The i-STAT CG4+(lactates), CHEM8+ & CREA cartridges have the same testing time (sample add to  result)  once the cartridge is placed into the analyzer, how long before the result is displayed?",86172,2,c.  5 Minutes,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28365,5,"5.  The i-STAT CG4+(lactates), CHEM8+ & CREA cartridges have the same testing time (sample add to  result)  once the cartridge is placed into the analyzer, how long before the result is displayed?",86173,3,d. 10 Minutes,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28366,17,"16. If the meter is malfunctioning, contact the point of care team at your facility for help with troubleshooting.",86174,0,TRUE,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28366,17,"16. If the meter is malfunctioning, contact the point of care team at your facility for help with troubleshooting.",86175,1,FALSE,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28367,20,18. The control values must fall within the manufacturer ranges in order for tests to be performed.,86176,0,TRUE,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28367,20,18. The control values must fall within the manufacturer ranges in order for tests to be performed.,86177,1,FALSE,0
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28368,22,19. The iSTAT meter should be cleaned with PDI Super Sani-Cloths or 10% bleach (when used on patients with C-diff) after each use and whenever visibly soiled to prevent the spread of blood-borne pathogens.,86178,0,TRUE,1
9592,Elearning-0000-815,ABBOTT I-STAT,n5917,28368,22,19. The iSTAT meter should be cleaned with PDI Super Sani-Cloths or 10% bleach (when used on patients with C-diff) after each use and whenever visibly soiled to prevent the spread of blood-borne pathogens.,86179,1,FALSE,0
9122,Elearning-0000-388,PBX TRAINING: CODE BLUE RADIO,n5918,28214,0,I have read and understand the contents of the PBX TRAINING: CODE BLUE RADIO CBL.,85684,0,TRUE,1
9122,Elearning-0000-388,PBX TRAINING: CODE BLUE RADIO,n5918,28214,0,I have read and understand the contents of the PBX TRAINING: CODE BLUE RADIO CBL.,85685,1,FALSE,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28245,0,"When claims require additional research y AUDIT or CODING, the biller places them on HOLD in SSI.",85798,0,TRUE,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28245,0,"When claims require additional research y AUDIT or CODING, the biller places them on HOLD in SSI.",85799,1,FALSE,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28246,1,AUDIT issues are handled via The Tool - Coding Work list?,85800,0,TRUE,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28246,1,AUDIT issues are handled via The Tool - Coding Work list?,85801,1,FALSE,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28247,2,What is the Source of Payer Code specific to Commercial billing?,85802,0,"a. M ( Work comp) , X ( Other Non-Government Insurance) , G (BCBS of GA)",0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28247,2,What is the Source of Payer Code specific to Commercial billing?,85803,1,b. B ( Work Comp) F ( Other Non-Government Insurance) G ( BCBS of GA and H (Champus/Tricare),1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28247,2,What is the Source of Payer Code specific to Commercial billing?,85804,2,c. None of the above,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28248,3,The Commercial INPATIENT claims :,85805,0,a. Have Room and Board Charges and their Type of Bill is 11X,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28248,3,The Commercial INPATIENT claims :,85806,1,b. Should never have any dates on any charges,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28248,3,The Commercial INPATIENT claims :,132839,2,c. The Value Code 80 and the Room and Board Charges should always be the same,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28248,3,The Commercial INPATIENT claims :,132840,3,d. All of the above,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28249,4,All Edits Errors should be worked before working the Late Charges and Audit Report.,85808,0,TRUE,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28249,4,All Edits Errors should be worked before working the Late Charges and Audit Report.,85809,1,FALSE,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28250,5,What is the Type of Bill for Outpatient Claims?,85810,0,a. 13X,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28250,5,What is the Type of Bill for Outpatient Claims?,85811,1,b. 111,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28250,5,What is the Type of Bill for Outpatient Claims?,85812,2,c. 112,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28251,6,"In SSI, a green face represents:",85813,0,a. Error claim,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28251,6,"In SSI, a green face represents:",85814,1,b. Hold claim,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28251,6,"In SSI, a green face represents:",85815,2,c. Validated claim,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28252,7,"In SSI, when placing claims on Hold,  the biller MUST add a reason why on Custom Field 1.",85816,0,TRUE,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28252,7,"In SSI, when placing claims on Hold,  the biller MUST add a reason why on Custom Field 1.",85817,1,FALSE,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28253,8,"In SSI, a Red Sad Face Represents:",85818,0,a. The claim is on HOLD in SSI,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28253,8,"In SSI, a Red Sad Face Represents:",85819,1,b. The claim in in ERROR status and needs to be worked,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28253,8,"In SSI, a Red Sad Face Represents:",85820,2,c. The claim is validated,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28254,9,"In SSI, a Claim Destination X Demonstrates:",85821,0,a. A paper claim,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28254,9,"In SSI, a Claim Destination X Demonstrates:",85822,1,b. An Electronic claim,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28254,9,"In SSI, a Claim Destination X Demonstrates:",85823,2,c. A and B,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28255,10,"In SSI, what tab allows the biller to place the claim on HOLD?",85824,0,a. Checkmark,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28255,10,"In SSI, what tab allows the biller to place the claim on HOLD?",85825,1,b. Claim,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28255,10,"In SSI, what tab allows the biller to place the claim on HOLD?",85826,2,c. Charges,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28256,11,"On INPATIENT claims, the Value code 80 represents:",85827,0,a. The coinsurance amount,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28256,11,"On INPATIENT claims, the Value code 80 represents:",85828,1,b. The number of times the patient has visited the hospital,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28256,11,"On INPATIENT claims, the Value code 80 represents:",85829,2,c. The number of days the patient stay in the hospital,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28257,12,Coding Issues are entered via STAR.,85830,0,TRUE,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28257,12,Coding Issues are entered via STAR.,85831,1,FALSE,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28258,13,How would you work the following Edit 160950?,85832,0,a. Combine the charges,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28258,13,How would you work the following Edit 160950?,85833,1,b. Look in STAR to see if the missing OR HCPCs can be located,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28258,13,How would you work the following Edit 160950?,85834,2,"c. Look in STAR to see if the missing OR HCPCs can be located. If not, add the account to The Tool - Coding Worklist.",1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28258,13,How would you work the following Edit 160950?,85835,3,d. All of the above,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28259,14,"In SSI, the Coding CCI Edits are Bypassed in all the Claims except Champus/Tricare Claims.",85836,0,TRUE,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28259,14,"In SSI, the Coding CCI Edits are Bypassed in all the Claims except Champus/Tricare Claims.",85837,1,FALSE,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28260,15,"When billing a Secondary Insurance, the biller has to make sure the Primary Insurance Remit exist?",85838,0,a. True,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28260,15,"When billing a Secondary Insurance, the biller has to make sure the Primary Insurance Remit exist?",85839,1,b. False,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28261,16,"When the NPI and Doctor's Name is missing, the biller will:",85841,0,a. Open the Account in STAR; Go to Medical Information > Adm Medical Information > Medical Comment to find the Doctor's Name followed by going to the NPI Registry to find the NPI number,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28261,16,"When the NPI and Doctor's Name is missing, the biller will:",85842,1,b. Bypass the edit as the physician name and NPI is not important,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28261,16,"When the NPI and Doctor's Name is missing, the biller will:",85843,2,c. Ask the Supervisor for the Doctor's name and NPI,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28262,17,"When billing Secondary claims, the PR Adjustment Code represents:",85844,0,a. The payment,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28262,17,"When billing Secondary claims, the PR Adjustment Code represents:",85845,1,b. The Date of the Remit,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28262,17,"When billing Secondary claims, the PR Adjustment Code represents:",85846,2,c. Any coinsurance or deductibles,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28263,18,How do you access The Tool - Coding Worklist?,85847,0,a. STAR,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28263,18,How do you access The Tool - Coding Worklist?,85848,1,b. SSI,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28263,18,How do you access The Tool - Coding Worklist?,132841,2,c. One Content,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28263,18,How do you access The Tool - Coding Worklist?,85849,3,d. The Revenue Cycle Website,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28264,19,The purpose of the Coding Work list is:,85850,0,a. To view all codes on all accounts,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28264,19,The purpose of the Coding Work list is:,85851,1,b. To retrieve coding issues in order to code the accounts in STAR accordingly,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28264,19,The purpose of the Coding Work list is:,85852,2,c. To Request Coding to review Coding issues and assure Correct Billing,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28265,20,To access the Coding Worklist the biller will click:,85853,0,a. M,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28265,20,To access the Coding Worklist the biller will click:,85854,1,b. ATB,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28265,20,To access the Coding Worklist the biller will click:,85855,2,c. AIA,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28265,20,To access the Coding Worklist the biller will click:,85856,3,d. CW,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28266,21,Commercial Billers are responsible to work RADCERT accounts in the Coding Work List.,85857,0,TRUE,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28266,21,Commercial Billers are responsible to work RADCERT accounts in the Coding Work List.,85858,1,FALSE,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28267,22,The Standard Note Code used to route accounts to AUDIT from billing is:,85859,0,a. Standard Note Code 25,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28267,22,The Standard Note Code used to route accounts to AUDIT from billing is:,85860,1,b. Standard Note Code 221,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28267,22,The Standard Note Code used to route accounts to AUDIT from billing is:,85861,2,c. Standard Note Code 1724,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28268,24,The Late Charge report is sent via Email every day.,85862,0,TRUE,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28268,24,The Late Charge report is sent via Email every day.,85863,1,FALSE,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28269,25,"When Late Charges are added to an account, the dollar amount is always dropped under the Patient's bucket.",85864,0,TRUE,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28269,25,"When Late Charges are added to an account, the dollar amount is always dropped under the Patient's bucket.",85865,1,FALSE,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28270,26,The Editor Clean Up is the process on which the billers review the claims on HOLD in SSI?,85866,0,a. True,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28270,26,The Editor Clean Up is the process on which the billers review the claims on HOLD in SSI?,85867,1,b. False,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28271,27,The Commercial Post Payment Review team works the Late Charge report?,85869,0,a. True,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28271,27,The Commercial Post Payment Review team works the Late Charge report?,85870,1,b. False,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28272,28,Occurrence code 18 represents the patients retirement date:,85872,0,TRUE,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28272,28,Occurrence code 18 represents the patients retirement date:,85873,1,FALSE,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28273,29,QG BMT accounts are billed and documented in STAR,85874,0,TRUE,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28273,29,QG BMT accounts are billed and documented in STAR,85875,1,FALSE,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28274,30,What is the definition of Occurrence Code 11?,85876,0,a. The Patient's retirement date,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28274,30,What is the definition of Occurrence Code 11?,85877,1,b. The day the patient started to have symptoms,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,28274,30,What is the definition of Occurrence Code 11?,85878,2,c. Occurrence code 11 should never be used.,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,41324,23,How often is the Audit report sent via Email?,132842,0,a. Once a Week,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,41324,23,How often is the Audit report sent via Email?,132843,1,b. Daily,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,41324,23,How often is the Audit report sent via Email?,132844,2,c. Every Other Week,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,41324,23,How often is the Audit report sent via Email?,132845,3,d. Twice a Day,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,41325,31,What is the correct definition of LMRP?,132846,0,a. Local Medical Review Policy,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,41325,31,What is the correct definition of LMRP?,132847,1,b. Local Modern Room Process,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,41325,31,What is the correct definition of LMRP?,132848,2,c. Local Medical Retirement Policy,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,41325,31,What is the correct definition of LMRP?,132849,3,d. No definition,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,41326,32,What is the correct Standard Note Code used when working the Late Charge report?,132850,0,a. Standard Note Code 25,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,41326,32,What is the correct Standard Note Code used when working the Late Charge report?,132851,1,b. Standard Note Code 200,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,41326,32,What is the correct Standard Note Code used when working the Late Charge report?,132852,2,c. Standard Note Code 82,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,41327,33,How often do you have to complete the Commercial Billing Productivity Report?,132853,0,a. Weekly - Every Friday,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,41327,33,How often do you have to complete the Commercial Billing Productivity Report?,132854,1,b. Daily - At the end of Business Day,1
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,41327,33,How often do you have to complete the Commercial Billing Productivity Report?,132855,2,c. Never - The Supervisor will gather this information,0
9813,Questions-0000-108,RCT: COMMERCIAL BILLING UNIVERSITY TEST,n5927,41327,33,How often do you have to complete the Commercial Billing Productivity Report?,132856,3,d. Twice a Week - At the end of Business Day,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28291,0,Claims that required additional intervention by AUDIT or Coding are placed on hold in SSI:,85936,0,TRUE,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28291,0,Claims that required additional intervention by AUDIT or Coding are placed on hold in SSI:,85937,1,FALSE,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28292,1,AUDIT issues are handled via the Coding Work list?,85938,0,TRUE,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28292,1,AUDIT issues are handled via the Coding Work list?,85939,1,FALSE,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28293,2,The Source of payer codes specific to Medicare is:,85940,0,a. D,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28293,2,The Source of payer codes specific to Medicare is:,85941,1,b. C,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28293,2,The Source of payer codes specific to Medicare is:,85942,2,c. None of the above,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28294,3,"In the UB-04, INPATIENT claims :",85943,0,a. Have Room and Board Charges and their Type of Bill are 11X,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28294,3,"In the UB-04, INPATIENT claims :",85944,1,b. Should not have any dates in any charge line,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28294,3,"In the UB-04, INPATIENT claims :",85945,2,c. All of the above,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28295,4,All Edits Errors should be worked before working the late charges and audit report?,85946,0,TRUE,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28295,4,All Edits Errors should be worked before working the late charges and audit report?,85947,1,FALSE,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28296,5,"In SSI, a green face represents:",85948,0,a. Error claim,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28296,5,"In SSI, a green face represents:",85949,1,b. Hold claim,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28296,5,"In SSI, a green face represents:",85950,2,c. Validated claim,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28297,6,"In SSI, when placing claims on hold, the biller MUST add a reason why on Custom Field 1:",85951,0,TRUE,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28297,6,"In SSI, when placing claims on hold, the biller MUST add a reason why on Custom Field 1:",85952,1,FALSE,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28298,7,"In SSI, red face represents:",85953,0,a. The claim is on HOLD in SSI,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28298,7,"In SSI, red face represents:",85954,1,b. The claim in in ERROR status and needs to be worked,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28298,7,"In SSI, red face represents:",85955,2,c. The claim is validated,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28299,8,Claim destination X represents:,85956,0,a. A paper claim,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28299,8,Claim destination X represents:,85957,1,b. An Electronic claim,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28299,8,Claim destination X represents:,85958,2,c. A and B,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28330,9,Which tab in SSI allows the biller to place the claim on hold,86043,0,a. Checkmark,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28330,9,Which tab in SSI allows the biller to place the claim on hold,86044,1,b. Claim,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28330,9,Which tab in SSI allows the biller to place the claim on hold,86045,2,c. Charges,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28331,10,"On INPATIENT claims, Value code 80 represents:",86046,0,a. The coinsurance amount,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28331,10,"On INPATIENT claims, Value code 80 represents:",86047,1,b. The number of times the patient has visited the hospital,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28331,10,"On INPATIENT claims, Value code 80 represents:",86048,2,c. The number of days the patient stay in the hospital,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28332,11,Coding Issues are entered via STAR:,86049,0,TRUE,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28332,11,Coding Issues are entered via STAR:,86050,1,FALSE,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28333,15,How should the edit 25491 be resolved?  The biller will:,86051,0,a. Combine the charges,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28333,15,How should the edit 25491 be resolved?  The biller will:,86052,1,b. Look in STAR to see if the missing OR HCPCs can be located,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28333,15,How should the edit 25491 be resolved?  The biller will:,86053,2,"c. Look in STAR to see if the missing OR HCPCs can be located. If not, the account will be added to the Coding Work list.",1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28333,15,How should the edit 25491 be resolved?  The biller will:,86054,3,d. All of the above,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28334,14,Coding CCI edits in SSI are bypassed in all accounts:,86055,0,TRUE,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28334,14,Coding CCI edits in SSI are bypassed in all accounts:,86056,1,FALSE,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28335,13,What operating systems do you use in Medicare Traditional Billing?,86057,0,"a. SSI, The Tool and One Content",0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28335,13,What operating systems do you use in Medicare Traditional Billing?,86058,1,"b. SSI, STAR, The Tool, One Content, and FSS0",1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28335,13,What operating systems do you use in Medicare Traditional Billing?,86059,2,"c. SSI, One Content and FSS0",0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28336,12,"When billing Secondary claims, the PR adjustment code represents:",86060,0,a. The payment,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28336,12,"When billing Secondary claims, the PR adjustment code represents:",86061,1,b. The Date of the Remit,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28336,12,"When billing Secondary claims, the PR adjustment code represents:",86062,2,c. Any coinsurance or deductibles,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28337,16,The Coding Worklist is accessed via:,86063,0,a. STAR,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28337,16,The Coding Worklist is accessed via:,86064,1,b. SSI,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28337,16,The Coding Worklist is accessed via:,86065,2,c. The Revenue Cycle Website,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28337,16,The Coding Worklist is accessed via:,160327,3,The Tool - CW,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28338,17,The purpose of the Coding Work list is:,86066,0,a. To view all codes on all accounts,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28338,17,The purpose of the Coding Work list is:,86067,1,b. To retrieve coding issues in order to code the accounts in STAR accordingly,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28338,17,The purpose of the Coding Work list is:,86068,2,c. To request coding review on certain issues to assure correct billing.,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28339,18,What tab will take the biller to the Coding Worklist:,86069,0,a. M,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28339,18,What tab will take the biller to the Coding Worklist:,86070,1,b. ATB,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28339,18,What tab will take the biller to the Coding Worklist:,86071,2,c. AIA,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28339,18,What tab will take the biller to the Coding Worklist:,86072,3,d. CW,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28340,19,Medicare Billers are responsible to work RADCERT accounts in the Coding Work List?,86073,0,TRUE,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28340,19,Medicare Billers are responsible to work RADCERT accounts in the Coding Work List?,86074,1,FALSE,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28341,20,Billers route accounts that need AUDIT review via:,86075,0,a. SSI,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28341,20,Billers route accounts that need AUDIT review via:,86076,1,b. STAR,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28341,20,Billers route accounts that need AUDIT review via:,86077,2,c. Coding Work List,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28342,21,The Standard Note Code used to route accounts to AUDIT from billing:,86078,0,a. Standard Note Code 25,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28342,21,The Standard Note Code used to route accounts to AUDIT from billing:,86079,1,b. Standard Note Code 221,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28342,21,The Standard Note Code used to route accounts to AUDIT from billing:,86080,2,c. Standard Note Code 1724,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28343,22,Accounts that carry a RED font on the AUDIT report are accounts that:,86081,0,a. A new account,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28343,22,Accounts that carry a RED font on the AUDIT report are accounts that:,86082,1,b. There are no RED accounts in the AUDIT report,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28343,22,Accounts that carry a RED font on the AUDIT report are accounts that:,86083,2,c. An unworked account that is considered out of compliance not worked the previous day.,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28344,23,Why a free note is ALWAYS needed when sending accounts to AUDIT?,86084,0,a. Because it tells the coders to review our account,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28344,23,Why a free note is ALWAYS needed when sending accounts to AUDIT?,86085,1,b. Because it tells the AUDIT department why we need them to review the claim,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28344,23,Why a free note is ALWAYS needed when sending accounts to AUDIT?,86086,2,c. A and B,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28345,24,Standard Note Code 1724 will create what note in STAR?,86087,0,a. 16) REF TO AUDIT FROM BILLING,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28345,24,Standard Note Code 1724 will create what note in STAR?,86088,1,b. (8) AUDIT COMPLETED BILLING REFERAL,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28345,24,Standard Note Code 1724 will create what note in STAR?,86089,2,c. 12) Valid Claim Billed,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28346,25,What Standard Note Code is used to close the AUDIT referral after taken the necessary action:,86090,0,a. Standard Note Code 1724,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28346,25,What Standard Note Code is used to close the AUDIT referral after taken the necessary action:,86091,1,b. Standard Note Code 25,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28346,25,What Standard Note Code is used to close the AUDIT referral after taken the necessary action:,86092,2,c. Standard Note Code 2452,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28346,25,What Standard Note Code is used to close the AUDIT referral after taken the necessary action:,86093,3,d. None of the above,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28347,26,The Late Charges always drops under the Patient:,86094,0,TRUE,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28347,26,The Late Charges always drops under the Patient:,86095,1,FALSE,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28348,27,Late Charges - Inpatient Claims billing threshold is:,86096,0,a. Less than $200,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28348,27,Late Charges - Inpatient Claims billing threshold is:,86097,1,b. Less than $2000,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28348,27,Late Charges - Inpatient Claims billing threshold is:,86098,2,c. Less than $1000,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28349,28,"When working the late charge report and the claim needs to be billed with the new additional charges, the biller will:",86099,0,a. Drop a claim to bill in STAR,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28349,28,"When working the late charge report and the claim needs to be billed with the new additional charges, the biller will:",86100,1,b. Give the account to the Team Lead to bill the claim,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28349,28,"When working the late charge report and the claim needs to be billed with the new additional charges, the biller will:",86101,2,c. Ignore,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28350,29,How often does the biller work the Editor Clean up?,86102,0,a. Once a month,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28350,29,How often does the biller work the Editor Clean up?,86103,1,b. At least once a week,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,28350,29,How often does the biller work the Editor Clean up?,86104,2,c. This duty is performed by the respective Team Lead,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,49025,30,What is the correct definition of LMRP?,160328,0,a. No definition,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,49025,30,What is the correct definition of LMRP?,160329,1,b. Local Modern Room Process,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,49025,30,What is the correct definition of LMRP?,160330,2,c. Local Medical Review Policy,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,49026,31,What is the definition of CCI?,160331,0,a. Cope Cake Industry,0
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,49026,31,What is the definition of CCI?,160332,1,b. Corrective Coding Initiative,1
9835,Questions-0000-128,RCT: MEDICARE TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n5928,49026,31,What is the definition of CCI?,160333,2,c. None of the above,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28300,0,All Inpatient CMO claims requires Authorization from the Payer?,85959,0,TRUE,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28300,0,All Inpatient CMO claims requires Authorization from the Payer?,85960,1,FALSE,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28301,1,AUDIT issues are handled via the Coding Work List.,85961,0,TRUE,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28301,1,AUDIT issues are handled via the Coding Work List.,85962,1,FALSE,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28302,2,The Source of Payer Code specific to Medicaid Billing is:,85963,0,a. C,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28302,2,The Source of Payer Code specific to Medicaid Billing is:,85964,1,b. B,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28302,2,The Source of Payer Code specific to Medicaid Billing is:,85965,2,c. D,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28302,2,The Source of Payer Code specific to Medicaid Billing is:,85966,3,d. None of the above,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28303,3,"In SSI , what is Custom Field 1 use for:",85967,0,a. To add the biller's initials,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28303,3,"In SSI , what is Custom Field 1 use for:",85968,1,"b. To describe the reason why the claim was placed on HOLD, PEND, AUDIT or MGMT",1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28303,3,"In SSI , what is Custom Field 1 use for:",85969,2,c. To add a Payer,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28303,3,"In SSI , what is Custom Field 1 use for:",160689,3,d. To send the account to Audit,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28304,4,"On the UB-04, INPATIENT claims :",85970,0,a. Have Room and Board charges and their type of bill is 11X.,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28304,4,"On the UB-04, INPATIENT claims :",85971,1,b. Should have NO dates on any charge,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28304,4,"On the UB-04, INPATIENT claims :",160690,2,c. Authorization is obtained from the payer's website,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28304,4,"On the UB-04, INPATIENT claims :",85972,3,d. All of the above,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28305,32,The biller MUST work all the errors prior from going home.,85973,0,TRUE,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28305,32,The biller MUST work all the errors prior from going home.,85974,1,FALSE,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28306,6,Outpatient claims are identified by the following bill type:,85975,0,a. 13x,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28306,6,Outpatient claims are identified by the following bill type:,85976,1,b. 11x,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28306,6,Outpatient claims are identified by the following bill type:,85977,2,c. 112,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28307,30,"In SSI, a green face represents:",85978,0,a. An Error claim,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28307,30,"In SSI, a green face represents:",85979,1,b. A hold Claim,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28307,30,"In SSI, a green face represents:",85980,2,c. A Validated claim,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28308,31,"In SSI, a red face represents:",85981,0,a. A claim that is on hold,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28308,31,"In SSI, a red face represents:",85982,1,b. An Error claim that must be worked,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28308,31,"In SSI, a red face represents:",85983,2,c. A claim that has been validated,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28309,9,Claim destination X represents :,85984,0,a. A paper Claim,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28309,9,Claim destination X represents :,85985,1,b. An Electronic claim,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28309,9,Claim destination X represents :,85986,2,c. Both A &B,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28310,33,Which tab in SSI allows the biller to place the claim on hold:,85987,0,a. Checkmark,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28310,33,Which tab in SSI allows the biller to place the claim on hold:,85988,1,b. Claim,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28310,33,Which tab in SSI allows the biller to place the claim on hold:,85989,2,c. Charges,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28311,11,"On INPATIENT claims , Value code 80 represents:",85990,0,a. The coinsurance amount,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28311,11,"On INPATIENT claims , Value code 80 represents:",85991,1,b. The number of times the patient has visited the hospital,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28311,11,"On INPATIENT claims , Value code 80 represents:",85992,2,c. The number of days the patient stay in the hospital,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28312,34,"On INPATIENT claims , revenue code 636 gets changed to Revenue code 250:",85993,0,TRUE,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28312,34,"On INPATIENT claims , revenue code 636 gets changed to Revenue code 250:",85994,1,FALSE,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28313,35,Revenue Code 174 ( Nursery IV) represents a healthy baby:,85995,0,TRUE,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28313,35,Revenue Code 174 ( Nursery IV) represents a healthy baby:,85996,1,FALSE,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28314,14,CMO authorizations can be retrieved from the GAMMIS portal.,85997,0,TRUE,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28314,14,CMO authorizations can be retrieved from the GAMMIS portal.,85998,1,FALSE,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28315,36,"Once in GAMMIS,  Where does the biller find the request ID number?",85999,0,a. SSI,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28315,36,"Once in GAMMIS,  Where does the biller find the request ID number?",86000,1,b. STAR,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28315,36,"Once in GAMMIS,  Where does the biller find the request ID number?",86001,2,c. One Content,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28315,36,"Once in GAMMIS,  Where does the biller find the request ID number?",86002,3,d. CCMS,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28316,37,On this edit:,86003,0,a. The biller will bypass the edit,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28316,37,On this edit:,86004,1,b. The biller will change Revenue Code 305 to Revenue Code 300,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28316,37,On this edit:,86005,2,c. The biller will change Revenue Code 305to Revenue Code 636,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28317,39,"This claim is missing the principal diagnosis code as indicated on the edit below:  With this edit, the biller will:",86006,0,a. Bypass the Edit,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28317,39,"This claim is missing the principal diagnosis code as indicated on the edit below:  With this edit, the biller will:",86007,1,b. The Biller will place the claim on hold and send the account to AUDIT,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28317,39,"This claim is missing the principal diagnosis code as indicated on the edit below:  With this edit, the biller will:",86008,2,c. The biller will place the claim on hold and send the account to Coding via the Coding Worklist.,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28317,39,"This claim is missing the principal diagnosis code as indicated on the edit below:  With this edit, the biller will:",86009,3,d. The biller will bill the claim via One Content,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28318,38,"If the Doctor's NPI is missing in SSI and there is no place to be found, the biller will:",86010,0,a. Bypass the edit and bill the claim,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28318,38,"If the Doctor's NPI is missing in SSI and there is no place to be found, the biller will:",86011,1,b. Send the account to Coding to get the NPI,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28318,38,"If the Doctor's NPI is missing in SSI and there is no place to be found, the biller will:",86012,2,c. Place the claim on HOLD in SSII and someone internally will get the NPI,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28319,19,"In order to bill Medicaid Secondary, there has to be a deductible or coinsurance.",86013,0,TRUE,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28319,19,"In order to bill Medicaid Secondary, there has to be a deductible or coinsurance.",86014,1,FALSE,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28320,40,"In the Coding Worklist, what is the place to add a request to get an authorization for Traditional Medicaid accounts:",86015,0,a. ESA,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28320,40,"In the Coding Worklist, what is the place to add a request to get an authorization for Traditional Medicaid accounts:",86016,1,b. PENDING,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28320,40,"In the Coding Worklist, what is the place to add a request to get an authorization for Traditional Medicaid accounts:",86017,2,c. CCI,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28320,40,"In the Coding Worklist, what is the place to add a request to get an authorization for Traditional Medicaid accounts:",86018,3,d. RADCERT,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28321,42,What would be the correct theory in regards of CCI Conflicts?,86019,0,a. CCI Conflict is a conflict between two Revenue Codes with different dates,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28321,42,What would be the correct theory in regards of CCI Conflicts?,86020,1,b. CCI Conflict is an issue between two HCPC codes performed the same day,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28321,42,What would be the correct theory in regards of CCI Conflicts?,86021,2,c. CCI conflict is a conflict between two diagnosis that must be worked by AUDIT,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28322,41,The AUDIT report MUST be worked every day.,86022,0,TRUE,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28322,41,The AUDIT report MUST be worked every day.,86023,1,FALSE,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28323,43,How the AUDIT report gets distributed among the Medicaid Staff?,86024,0,a. The AUDIT report is printed every day by the Manager,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28323,43,How the AUDIT report gets distributed among the Medicaid Staff?,86025,1,b. Via Email,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28323,43,How the AUDIT report gets distributed among the Medicaid Staff?,86026,2,c. A and B,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28324,44,"If the biller needs to send a referral or a request to AUDIT, what is the SNC (Standard Note Code) used to accomplish this task?",86027,0,a. SNC 25,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28324,44,"If the biller needs to send a referral or a request to AUDIT, what is the SNC (Standard Note Code) used to accomplish this task?",86028,1,b. SNC 200,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28324,44,"If the biller needs to send a referral or a request to AUDIT, what is the SNC (Standard Note Code) used to accomplish this task?",86029,2,c. SNC 1724,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28325,25,72 hour overlaps are referred to :,86030,0,a. The Coding Department,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28325,25,72 hour overlaps are referred to :,86031,1,b. The AUDIT department,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28325,25,72 hour overlaps are referred to :,86032,2,c. Management works them,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28326,26,Once the AUDIT referral is worked by the Medicaid representative:,86033,0,a. The referral MUST be closed using SNC 2452,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28326,26,Once the AUDIT referral is worked by the Medicaid representative:,86034,1,b. No action taken by the Medicaid Representative,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28326,26,Once the AUDIT referral is worked by the Medicaid representative:,86035,2,c. The referral MUST stay opened,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28326,26,Once the AUDIT referral is worked by the Medicaid representative:,142376,3,d. Ignore and move to the next Audit,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28327,45,Medicaid and CMO uses the following SNC when they have to adjust a late charge,86036,0,a. SNC 25,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28327,45,Medicaid and CMO uses the following SNC when they have to adjust a late charge,86037,1,b. SNC 582 or SNC 576,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28327,45,Medicaid and CMO uses the following SNC when they have to adjust a late charge,86038,2,c. SNC 1724,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28328,46,Adjustments entered via the Adjustment Processor are adjusted real time,86039,0,TRUE,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28328,46,Adjustments entered via the Adjustment Processor are adjusted real time,86040,1,FALSE,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28329,47,ONE CONTENT is accessed via the Revenue Cycle Website,86041,0,TRUE,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,28329,47,ONE CONTENT is accessed via the Revenue Cycle Website,86042,1,FALSE,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43932,48,All Inpatient CMO claims requires Authorization from the Payer.,142377,0,TRUE,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43932,48,All Inpatient CMO claims requires Authorization from the Payer.,142378,1,FALSE,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43933,49,"In SSI , what is Custom Field 1 use for?",142379,0,To add the biller's initials,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43933,49,"In SSI , what is Custom Field 1 use for?",142380,1,"To describe the reason why the claim was placed on HOLD, PEND, AUDIT, MGMT",1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43933,49,"In SSI , what is Custom Field 1 use for?",142381,2,To add a Payer,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43933,49,"In SSI , what is Custom Field 1 use for?",142382,3,To send the account to Audit,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43934,50,The Medicaid CMO INPATIENT claims :,142383,0,Have Room and Board charges and their type of bill is 11X,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43934,50,The Medicaid CMO INPATIENT claims :,142384,1,Should have NO dates on any charge,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43934,50,The Medicaid CMO INPATIENT claims :,142385,2,Authorization is obtained from the Payer's website,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43934,50,The Medicaid CMO INPATIENT claims :,142386,3,All of the above,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43935,5,"When billing CMO's as Secondary Insurance, the biller must:",142387,0,Make sure the Primary Remit Exist and have a copy of the Primary Remit Prior to Billing Secondary Insurance.,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43935,5,"When billing CMO's as Secondary Insurance, the biller must:",142388,1,Request Medical Records,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43935,5,"When billing CMO's as Secondary Insurance, the biller must:",142389,2,Adjust off the remaining of the Bill,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43935,5,"When billing CMO's as Secondary Insurance, the biller must:",142390,3,Send the Account to Audit,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43937,7,The Coding Worklist is used:,142393,0,To Print the Remits,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43937,7,The Coding Worklist is used:,142394,1,To Place Claims on HOLD,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43937,7,The Coding Worklist is used:,142395,2,To Add Referrals that Require Coding Review,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43937,7,The Coding Worklist is used:,142396,3,To Close the Account,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43938,8,The correct Standard Note Code used to send an account to Audit is:,142397,0,222 - Claim is on HOLD,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43938,8,The correct Standard Note Code used to send an account to Audit is:,142398,1,2452 - Completed Audit,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43938,8,The correct Standard Note Code used to send an account to Audit is:,142399,2,1724 - Referred to Audit from Billing,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43938,8,The correct Standard Note Code used to send an account to Audit is:,142400,3,1954 - Billing Review Completed,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43939,10,"In SSI, to place a claim on Hold, go to:",142401,0,Charges,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43939,10,"In SSI, to place a claim on Hold, go to:",142402,1,Remit,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43939,10,"In SSI, to place a claim on Hold, go to:",142403,2,Claim,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43939,10,"In SSI, to place a claim on Hold, go to:",142404,3,Forms,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43940,12,"In OUTPATIENT Claims, Revenue Codes 302 & 305 gets changed to Revenue Code 300.",142405,0,TRUE,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43940,12,"In OUTPATIENT Claims, Revenue Codes 302 & 305 gets changed to Revenue Code 300.",142406,1,FALSE,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43941,13,Revenue Code 360 always change the Units to 1.,142407,0,TRUE,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43941,13,Revenue Code 360 always change the Units to 1.,142408,1,FALSE,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43942,15,Payspan is a remit tool where the Billers can view the Remits for Wellcare and Peach State?,142409,0,TRUE,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43942,15,Payspan is a remit tool where the Billers can view the Remits for Wellcare and Peach State?,142410,1,FALSE,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43943,16,The Timely Filing for CareSource on New Claims is 90 Days?,142411,0,TRUE,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43943,16,The Timely Filing for CareSource on New Claims is 90 Days?,142412,1,FALSE,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43944,17,EDIT # 171 - No Diagnosis on Claim. How would you work this Edit?,142413,0,Diagnosis Code issues need to go to Coding via the Coding Worklist,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43944,17,EDIT # 171 - No Diagnosis on Claim. How would you work this Edit?,142414,1,"SSI, place the Claim on HOLD",0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43944,17,EDIT # 171 - No Diagnosis on Claim. How would you work this Edit?,142415,2,The biller will add a request in the Coding Worklist under PENDING - Diagnosis,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43944,17,EDIT # 171 - No Diagnosis on Claim. How would you work this Edit?,142416,3,All of the Above,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43945,18,If the Doctor's NPI is missing:,142417,0,Bypass the edit and bill the claim without the NPI,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43945,18,If the Doctor's NPI is missing:,142418,1,Look for the NPI number in STAR and/or search in the NPI Registry,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43945,18,If the Doctor's NPI is missing:,142419,2,Skip the Edit and move to the Next Edit,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43945,18,If the Doctor's NPI is missing:,142420,3,Place the account on HOLD,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43946,20,When there is issues with Two HCPCS Codes Procedures the biller will:,142421,0,Send the account to PENDING,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43946,20,When there is issues with Two HCPCS Codes Procedures the biller will:,142422,1,Send the account to CCI,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43946,20,When there is issues with Two HCPCS Codes Procedures the biller will:,142423,2,Send the account to LMRP,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43946,20,When there is issues with Two HCPCS Codes Procedures the biller will:,142424,3,Send the account to RADCERT,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43947,21,What Transaction Code is used to work Late Charges?,142425,0,Code 582,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43947,21,What Transaction Code is used to work Late Charges?,142426,1,Code 81,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43947,21,What Transaction Code is used to work Late Charges?,142427,2,Code 1724,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43947,21,What Transaction Code is used to work Late Charges?,142428,3,Code 222,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43948,22,The AUDIT report is worked once a month.,142429,0,TRUE,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43948,22,The AUDIT report is worked once a month.,142430,1,FALSE,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43949,23,The AUDIT report is distributed to the Medicaid Staff via email and/or Printed by the Manager.,142431,0,TRUE,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43949,23,The AUDIT report is distributed to the Medicaid Staff via email and/or Printed by the Manager.,142432,1,FALSE,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43950,24,What Standard Note Code is used when working the Late Charge Report?,142433,0,Standard Note Code 25,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43950,24,What Standard Note Code is used when working the Late Charge Report?,142434,1,Standard Note Code 200,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43950,24,What Standard Note Code is used when working the Late Charge Report?,142435,2,Standard Note Code 1724,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43950,24,What Standard Note Code is used when working the Late Charge Report?,142436,3,Standard Note Code 82,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43951,27,"The Timely Filing for Amerigroup, Peach State and Wellcare on New Claims is:",142437,0,120 Days,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43951,27,"The Timely Filing for Amerigroup, Peach State and Wellcare on New Claims is:",142438,1,180 Days,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43951,27,"The Timely Filing for Amerigroup, Peach State and Wellcare on New Claims is:",142439,2,90 Days,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43951,27,"The Timely Filing for Amerigroup, Peach State and Wellcare on New Claims is:",142440,3,30 Days,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43952,28,What is the Financial Class for Medicaid CMO?,142441,0,WM,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43952,28,What is the Financial Class for Medicaid CMO?,142442,1,W2,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43952,28,What is the Financial Class for Medicaid CMO?,142443,2,W,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43952,28,What is the Financial Class for Medicaid CMO?,142444,3,W3,0
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43953,29,"In ONE CONTENT the biller is able to verified the Patient's Insurance Information, Medical Records, UB04, and Workqueues?",142445,0,TRUE,1
9829,Questions-0000-122,RCT: MEDICAID CMO BILLING UNIVERSITY TEST (CURRENT),n5929,43953,29,"In ONE CONTENT the biller is able to verified the Patient's Insurance Information, Medical Records, UB04, and Workqueues?",142446,1,FALSE,0
9186,Elearning-0000-446,MALIGNANT HYPERTHERMIA FOR CATH LAB,n5936,28416,0,"1. Which medication, commonly used during intubation, can cause Malignant Hyperthermia?",86307,0,"a.	Etomidate",0
9186,Elearning-0000-446,MALIGNANT HYPERTHERMIA FOR CATH LAB,n5936,28416,0,"1. Which medication, commonly used during intubation, can cause Malignant Hyperthermia?",86308,1,"b.	Succinylcholine",1
9186,Elearning-0000-446,MALIGNANT HYPERTHERMIA FOR CATH LAB,n5936,28416,0,"1. Which medication, commonly used during intubation, can cause Malignant Hyperthermia?",86309,2,"c.	Propofol",0
9186,Elearning-0000-446,MALIGNANT HYPERTHERMIA FOR CATH LAB,n5936,28416,0,"1. Which medication, commonly used during intubation, can cause Malignant Hyperthermia?",86310,3,"d.	Versed",0
9186,Elearning-0000-446,MALIGNANT HYPERTHERMIA FOR CATH LAB,n5936,28417,1,2. Which of the following is NOT a symptom of Malignant Hyperthermia?,86311,0,"a.	Hypoxemia",0
9186,Elearning-0000-446,MALIGNANT HYPERTHERMIA FOR CATH LAB,n5936,28417,1,2. Which of the following is NOT a symptom of Malignant Hyperthermia?,86312,1,"b.	Fever",0
9186,Elearning-0000-446,MALIGNANT HYPERTHERMIA FOR CATH LAB,n5936,28417,1,2. Which of the following is NOT a symptom of Malignant Hyperthermia?,86313,2,c. Dilated pupils,1
9186,Elearning-0000-446,MALIGNANT HYPERTHERMIA FOR CATH LAB,n5936,28417,1,2. Which of the following is NOT a symptom of Malignant Hyperthermia?,86314,3,"d.	Tachycardia",0
9186,Elearning-0000-446,MALIGNANT HYPERTHERMIA FOR CATH LAB,n5936,28418,2,3. What should you do FIRST when Malignant Hyperthermia is suspected in the Cath Lab or ARU?,86315,0,"a.	Have someone call OR/Anesthesia",1
9186,Elearning-0000-446,MALIGNANT HYPERTHERMIA FOR CATH LAB,n5936,28418,2,3. What should you do FIRST when Malignant Hyperthermia is suspected in the Cath Lab or ARU?,86316,1,"b.	Insert a temp-sensing foley catheter",0
9186,Elearning-0000-446,MALIGNANT HYPERTHERMIA FOR CATH LAB,n5936,28418,2,3. What should you do FIRST when Malignant Hyperthermia is suspected in the Cath Lab or ARU?,86317,2,"c.	Notify the patient's family",0
9186,Elearning-0000-446,MALIGNANT HYPERTHERMIA FOR CATH LAB,n5936,28418,2,3. What should you do FIRST when Malignant Hyperthermia is suspected in the Cath Lab or ARU?,86318,3,"d.	Give Lasix IV",0
9186,Elearning-0000-446,MALIGNANT HYPERTHERMIA FOR CATH LAB,n5936,28419,3,4. What is the primary medication used to treat Malignant Hyperthermia?,86319,0,"a.	Acetaminophen",0
9186,Elearning-0000-446,MALIGNANT HYPERTHERMIA FOR CATH LAB,n5936,28419,3,4. What is the primary medication used to treat Malignant Hyperthermia?,86320,1,"b.	Diazepam",0
9186,Elearning-0000-446,MALIGNANT HYPERTHERMIA FOR CATH LAB,n5936,28419,3,4. What is the primary medication used to treat Malignant Hyperthermia?,86321,2,"c.	Sodium Bicarb",0
9186,Elearning-0000-446,MALIGNANT HYPERTHERMIA FOR CATH LAB,n5936,28419,3,4. What is the primary medication used to treat Malignant Hyperthermia?,86322,3,"d.	Dantrolene",1
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28548,0,1. ALL is more prevalent among children than adults.,86682,0,TRUE,1
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28548,0,1. ALL is more prevalent among children than adults.,86683,1,FALSE,0
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28549,1,2. Ph + ALL has worse prognosis compared to Ph - ALL.,86684,0,TRUE,1
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28549,1,2. Ph + ALL has worse prognosis compared to Ph - ALL.,86685,1,FALSE,0
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28550,2,3. Intrathecal chemo is given to ALL patients for,86686,0,"a.	Treating metastasis in the brain",0
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28550,2,3. Intrathecal chemo is given to ALL patients for,86687,1,"b.	CNS prophylaxis",1
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28550,2,3. Intrathecal chemo is given to ALL patients for,86688,2,"c.	Treatment of altered mental status",0
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28551,3,4. Secondary AML is caused,86689,0,"a.	As a progression from MDS",0
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28551,3,4. Secondary AML is caused,86690,1,"b.	By prior exposure to chemotherapy",0
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28551,3,4. Secondary AML is caused,86691,2,c.  Both a and b,1
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28552,4,5. Flow cytometry is a very important diagnostic lab test because,86692,0,"a.	It helps differentiate between AML Vs. ALL",1
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28552,4,5. Flow cytometry is a very important diagnostic lab test because,86693,1,b. It tells you about the flow of the leukemia cells.,0
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28552,4,5. Flow cytometry is a very important diagnostic lab test because,86694,2,"c.	It helps in staging of the disease.",0
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28553,5,6. The following oral drug is given to reduce leukocytosis in leukemia,86695,0,"a.	Cytarabine",0
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28553,5,6. The following oral drug is given to reduce leukocytosis in leukemia,86696,1,"b.	Hydrea",1
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28553,5,6. The following oral drug is given to reduce leukocytosis in leukemia,86697,2,"c.	Zarxio",0
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28554,6,7. Acute Promyelocytic Leukemia (APL) is a type of leukemia with a very high cure rate.,86698,0,TRUE,1
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28554,6,7. Acute Promyelocytic Leukemia (APL) is a type of leukemia with a very high cure rate.,86699,1,FALSE,0
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28555,7,8. ATRA Syndrome or Differentiation Syndrome is caused by,86700,0,"a.	The inflammatory response to differentiating effect of ATRA on blast cells - ""Cytokine Storm"" causing clinical features like: leukocytosis, fever, hypotension, and dyspnea.",1
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28555,7,8. ATRA Syndrome or Differentiation Syndrome is caused by,86701,1,"b.	ATRA causing altered mental status in leukemia patients thereby making them behave ""differently"".",0
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28555,7,8. ATRA Syndrome or Differentiation Syndrome is caused by,86702,2,"c.	ATRA causing DIC in APL patients.",0
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28556,8,"9. In case of Multiple Myeloma, Allogeneic Transplant is recommended if there is a relapse of disease after an Autologous Transplant.",86703,0,TRUE,1
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28556,8,"9. In case of Multiple Myeloma, Allogeneic Transplant is recommended if there is a relapse of disease after an Autologous Transplant.",86704,1,FALSE,0
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28557,9,10. A Preparative Regimen consists of,86705,0,"a.	Drugs given to leukemia patients in order to prepare them to receive the bad news of their diagnosis.",0
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28557,9,10. A Preparative Regimen consists of,86706,1,"b.	Drugs given to leukemia patients to achieve remission.",0
9284,Elearning-0000-535,HEME-ONC PATIENT CARE: HEMATOLOGICAL MALIGNANCIES & TREATMENT OVERVIEW,n5945,28557,9,10. A Preparative Regimen consists of,86707,2,"c.	Lethal doses of chemo +/- total body irradiation given prior to transplant in order to eradicate the disease and suppress the immune system.",1
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28446,0,Please list the location for this activity.,86433,0,Atlanta,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28446,0,Please list the location for this activity.,86434,1,Forsyth,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28446,0,Please list the location for this activity.,86435,2,Cherokee,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28446,0,Please list the location for this activity.,86436,3,Other,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28447,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",86437,0,Strongly Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28447,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",86438,1,Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28447,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",86439,2,No Opinion,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28447,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",86440,3,Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28447,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",86441,4,Strongly Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28448,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",86442,0,Strongly Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28448,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",86443,1,Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28448,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",86444,2,No Opinion,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28448,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",86445,3,Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28448,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",86446,4,Strongly Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28449,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",86447,0,Strongly Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28449,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",86448,1,Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28449,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",86449,2,No Opinion,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28449,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",86450,3,Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28449,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",86451,4,Strongly Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28450,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",86452,0,Strongly Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28450,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",86453,1,Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28450,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",86454,2,No Opinion,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28450,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",86455,3,Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28450,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",86456,4,Strongly Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28451,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",86457,0,Strongly Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28451,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",86458,1,Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28451,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",86459,2,No Opinion,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28451,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",86460,3,Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28451,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",86461,4,Strongly Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28452,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",86462,0,Strongly Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28452,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",86463,1,Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28452,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",86464,2,No Opinion,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28452,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",86465,3,Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28452,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",86466,4,Strongly Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28453,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",86467,0,Strongly Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28453,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",86468,1,Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28453,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",86469,2,No Opinion,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28453,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",86470,3,Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28453,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",86471,4,Strongly Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28454,8,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,86472,0,Strongly Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28454,8,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,86473,1,Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28454,8,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,86474,2,No Opinion,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28454,8,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,86475,3,Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28454,8,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,86476,4,Strongly Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28455,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,86477,0,Strongly Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28455,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,86478,1,Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28455,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,86479,2,No Opinion,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28455,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,86480,3,Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28455,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,86481,4,Strongly Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28456,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",86482,0,Strongly Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28456,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",86483,1,Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28456,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",86484,2,No Opinion,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28456,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",86485,3,Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28456,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",86486,4,Strongly Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28457,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",86487,0,Strongly Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28457,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",86488,1,Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28457,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",86489,2,No Opinion,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28457,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",86490,3,Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28457,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",86491,4,Strongly Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28458,12,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,86492,0,Strongly Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28458,12,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,86493,1,Agree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28458,12,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,86494,2,No Opinion,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28458,12,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,86495,3,Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28458,12,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,86496,4,Strongly Disagree,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28459,13,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN </ol>",86497,0,Excellent,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28459,13,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN </ol>",86498,1,Very Good,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28459,13,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN </ol>",86499,2,Good,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28459,13,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN </ol>",86500,3,Fair,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28459,13,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN </ol>",86501,4,Poor,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28460,14,"Overall, this activity was:",86502,0,Excellent,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28460,14,"Overall, this activity was:",86503,1,Very Good,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28460,14,"Overall, this activity was:",86504,2,Good,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28460,14,"Overall, this activity was:",86505,3,Fair,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28460,14,"Overall, this activity was:",86506,4,Poor,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28461,15,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",86507,0,Yes,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28461,15,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",86508,1,No,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28461,15,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",86509,2,N/A,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28464,18,How would you improve this class?,86510,0,Reduce content covered in class,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28464,18,How would you improve this class?,86511,1,Increase content covered in class,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28464,18,How would you improve this class?,86512,2,Update content covered in class,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28464,18,How would you improve this class?,86513,3,Improve the instructional methods,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28464,18,How would you improve this class?,86514,4,Make course activities more stimulating,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28464,18,How would you improve this class?,86515,5,Slow the pace of the class,0
3487,ILT-0000-15319,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING - NSA 11.8.17,n5938,28464,18,How would you improve this class?,86516,6,"Nothing: (appropriate content, speaker, setting, setting.)",0
9480,Elearning-0000-713,CELLULAR PROCESS THERAPY OVERVIEW AND COMPLICATIONS,n5946,28558,0,"1.	For Allogeneic transplants the sources of cells are",86708,0,"a.	Related donor (Parent/Sibling/Child)",0
9480,Elearning-0000-713,CELLULAR PROCESS THERAPY OVERVIEW AND COMPLICATIONS,n5946,28558,0,"1.	For Allogeneic transplants the sources of cells are",86709,1,"b.	Unrelated donor (from NMDP-National Marrow Donor Program, UCB-Umbilical Cord Blood)",0
9480,Elearning-0000-713,CELLULAR PROCESS THERAPY OVERVIEW AND COMPLICATIONS,n5946,28558,0,"1.	For Allogeneic transplants the sources of cells are",86710,2,"c.	All of the above",1
9480,Elearning-0000-713,CELLULAR PROCESS THERAPY OVERVIEW AND COMPLICATIONS,n5946,28559,1,2.  Tumor Lysis Syndrome is characterized by high levels of,86711,0,"a.	Iron",0
9480,Elearning-0000-713,CELLULAR PROCESS THERAPY OVERVIEW AND COMPLICATIONS,n5946,28559,1,2.  Tumor Lysis Syndrome is characterized by high levels of,86712,1,"b.	Uric acid",1
9480,Elearning-0000-713,CELLULAR PROCESS THERAPY OVERVIEW AND COMPLICATIONS,n5946,28559,1,2.  Tumor Lysis Syndrome is characterized by high levels of,86713,2,"c.	Sodium",0
9480,Elearning-0000-713,CELLULAR PROCESS THERAPY OVERVIEW AND COMPLICATIONS,n5946,28559,1,2.  Tumor Lysis Syndrome is characterized by high levels of,86714,3,"d.	Magnesium",0
9480,Elearning-0000-713,CELLULAR PROCESS THERAPY OVERVIEW AND COMPLICATIONS,n5946,28560,2,3. The ICU nurse's responsibility when a neutropenic BMT patient becomes febrile (first neutropenic fever) is to,86715,0,"a.	Draw blood cultures, urine culture, lactate, start antibiotics STAT and notify the BMT physician.",1
9480,Elearning-0000-713,CELLULAR PROCESS THERAPY OVERVIEW AND COMPLICATIONS,n5946,28560,2,3. The ICU nurse's responsibility when a neutropenic BMT patient becomes febrile (first neutropenic fever) is to,86716,1,"b.	Wait until the BMT interdisciplinary team rounds on the patient before taking any action.",0
9480,Elearning-0000-713,CELLULAR PROCESS THERAPY OVERVIEW AND COMPLICATIONS,n5946,28560,2,3. The ICU nurse's responsibility when a neutropenic BMT patient becomes febrile (first neutropenic fever) is to,86717,2,"c.	Give Acetaminophen.",0
9480,Elearning-0000-713,CELLULAR PROCESS THERAPY OVERVIEW AND COMPLICATIONS,n5946,28561,3,4. Immunosuppressants are important for post allogeneic transplant patients,86718,0,"a.	To prevent GVHD",1
9480,Elearning-0000-713,CELLULAR PROCESS THERAPY OVERVIEW AND COMPLICATIONS,n5946,28561,3,4. Immunosuppressants are important for post allogeneic transplant patients,86719,1,"b.	To prevent infections",0
9480,Elearning-0000-713,CELLULAR PROCESS THERAPY OVERVIEW AND COMPLICATIONS,n5946,28561,3,4. Immunosuppressants are important for post allogeneic transplant patients,86720,2,"c.	To prevent disease relapse",0
9480,Elearning-0000-713,CELLULAR PROCESS THERAPY OVERVIEW AND COMPLICATIONS,n5946,28562,4,"5. For a BMT patient receiving chemotherapeutic drugs, the primary nurse's responsibility is to",86721,0,"a.	Order a chemo caddy, wear appropriate PPE when handling blood and body fluids.",1
9480,Elearning-0000-713,CELLULAR PROCESS THERAPY OVERVIEW AND COMPLICATIONS,n5946,28562,4,"5. For a BMT patient receiving chemotherapeutic drugs, the primary nurse's responsibility is to",86722,1,"b.	Do nothing, if not administering chemo, there is no need to worry about PPE.",0
9480,Elearning-0000-713,CELLULAR PROCESS THERAPY OVERVIEW AND COMPLICATIONS,n5946,28562,4,"5. For a BMT patient receiving chemotherapeutic drugs, the primary nurse's responsibility is to",86723,2,"c.	Dispose chemo PPE after use in regular trash bin.",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28589,0,"1.	Frequency of bacteremia is highest during which period?",86833,0,"a.	Pre-engraftment",1
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28589,0,"1.	Frequency of bacteremia is highest during which period?",86834,1,"b.	Post engraftment",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28589,0,"1.	Frequency of bacteremia is highest during which period?",86835,2,"c.	Late engraftment",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28590,1,2. Steps to take with first neutropenic fever include,86836,0,"a.	Draw 2 sets of blood cultures STAT",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28590,1,2. Steps to take with first neutropenic fever include,86837,1,"b.	Draw Lactate STAT",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28590,1,2. Steps to take with first neutropenic fever include,86838,2,"c.	Draw urine culture",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28590,1,2. Steps to take with first neutropenic fever include,86839,3,"d.	Start empiric antibiotic STAT",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28590,1,2. Steps to take with first neutropenic fever include,86840,4,"e.	All of the above",1
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28591,2,3. Supportive care for C Diff infection includes,86841,0,"a.	Correcting fluid and electrolyte imbalances",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28591,2,3. Supportive care for C Diff infection includes,86842,1,"b.	Discontinuing treatment of implicated antibiotic, if applicable and feasible",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28591,2,3. Supportive care for C Diff infection includes,86843,2,"c.	Avoiding use of antiperistaltic medications",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28591,2,3. Supportive care for C Diff infection includes,86844,3,"d.	All of the above",1
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28592,3,4. Which of the factors stated below presents a greater risk for viral infections,86845,0,"a.	Degree of HLA mismatch between donor and recipient",1
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28592,3,4. Which of the factors stated below presents a greater risk for viral infections,86846,1,"b.	Patient's age",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28592,3,4. Which of the factors stated below presents a greater risk for viral infections,86847,2,"c.	Patient's immunization status",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28593,4,5. CMV monitoring by drawing CMV PCRs on Standard Risk Allogeneic transplant recipients starts on,86848,0,"a.	Day 1 and weekly thereafter every Monday until Day +100",1
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28593,4,5. CMV monitoring by drawing CMV PCRs on Standard Risk Allogeneic transplant recipients starts on,86849,1,"b.	3 times a week",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28593,4,5. CMV monitoring by drawing CMV PCRs on Standard Risk Allogeneic transplant recipients starts on,86850,2,"c.	Every other day",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28593,4,5. CMV monitoring by drawing CMV PCRs on Standard Risk Allogeneic transplant recipients starts on,86851,3,"d.	Twice a week",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28594,5,6. One of the adverse effects of Ganciclovir is,86852,0,"a.	Alopecia",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28594,5,6. One of the adverse effects of Ganciclovir is,86853,1,"b.	Rash",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28594,5,6. One of the adverse effects of Ganciclovir is,86854,2,"c.	Neutropenia",1
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28594,5,6. One of the adverse effects of Ganciclovir is,86855,3,"d.	Dry eyes",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28595,6,7. For patients on Foscarnet for the treatment of CMV disease which labs are important to    monitor,86856,0,"a.	Calcium and Phosphorus",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28595,6,7. For patients on Foscarnet for the treatment of CMV disease which labs are important to    monitor,86857,1,"b.	Potassium and Magnesium",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28595,6,7. For patients on Foscarnet for the treatment of CMV disease which labs are important to    monitor,86858,2,"c.	SCr",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28595,6,7. For patients on Foscarnet for the treatment of CMV disease which labs are important to    monitor,86859,3,"d.	All of the above",1
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28596,7,8. Fluoroquinolone (Levofloxacin) is ordered for BK virus prophylaxis for,86860,0,"a.	Cord/Haplo Transplant recipients",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28596,7,8. Fluoroquinolone (Levofloxacin) is ordered for BK virus prophylaxis for,86861,1,"b.	Patients receiving post-transplant Cytoxan",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28596,7,8. Fluoroquinolone (Levofloxacin) is ordered for BK virus prophylaxis for,86862,2,"c.	All of the above",1
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28597,8,9. Azole antifungals can increase the levels of immunosuppressants like Prograf.,86863,0,TRUE,1
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28597,8,9. Azole antifungals can increase the levels of immunosuppressants like Prograf.,86864,1,FALSE,0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28598,9,10. One of the medications used for PCP prophylaxis in Transplant recipients is,86865,0,"a.	Levaquin",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28598,9,10. One of the medications used for PCP prophylaxis in Transplant recipients is,86866,1,"b.	Acyclovir",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28598,9,10. One of the medications used for PCP prophylaxis in Transplant recipients is,86867,2,"c.	Micafungin",0
9265,Elearning-0000-518,INFECTIOUS PROCESS MANAGEMENT IN THE BMT PATIENT,n5950,28598,9,10. One of the medications used for PCP prophylaxis in Transplant recipients is,86868,3,"d.	Pentamidine inhalation once a month",1
9147,Elearning-0000-410,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT FOR ICU,n5952,28604,0,1. Neutropenia can occur in leukemia patients,86885,0,"a.	As a result of overcrowding of marrow due to disease",0
9147,Elearning-0000-410,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT FOR ICU,n5952,28604,0,1. Neutropenia can occur in leukemia patients,86886,1,"b.	As a result of chemotherapy/radiation",0
9147,Elearning-0000-410,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT FOR ICU,n5952,28604,0,1. Neutropenia can occur in leukemia patients,86887,2,"c.	Both a and b",1
9147,Elearning-0000-410,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT FOR ICU,n5952,28605,1,2. Factors affecting Engraftment include,86888,0,"a.	Effect of past chemotherapy/radiation",0
9147,Elearning-0000-410,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT FOR ICU,n5952,28605,1,2. Factors affecting Engraftment include,86889,1,"b.	Type of transplant/number of cells in transplant",0
9147,Elearning-0000-410,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT FOR ICU,n5952,28605,1,2. Factors affecting Engraftment include,86890,2,"c.	Growth factors such as Zarxio",0
9147,Elearning-0000-410,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT FOR ICU,n5952,28605,1,2. Factors affecting Engraftment include,86891,3,"d.	All of the above",1
9147,Elearning-0000-410,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT FOR ICU,n5952,28606,2,"3. Growth factor, Zarxio comes in two doses: 300 mcg and 480 mcg.",86892,0,TRUE,1
9147,Elearning-0000-410,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT FOR ICU,n5952,28606,2,"3. Growth factor, Zarxio comes in two doses: 300 mcg and 480 mcg.",86893,1,FALSE,0
9147,Elearning-0000-410,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT FOR ICU,n5952,28607,3,"4. STAT notification of the BMT Team, STAT blood cultures and STAT initiation of antibiotics is required on neutropenic patients when",86894,0,"a.	Temp is >/= 100.5F",0
9147,Elearning-0000-410,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT FOR ICU,n5952,28607,3,"4. STAT notification of the BMT Team, STAT blood cultures and STAT initiation of antibiotics is required on neutropenic patients when",86895,1,"b.	If temp > 103F",0
9147,Elearning-0000-410,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT FOR ICU,n5952,28607,3,"4. STAT notification of the BMT Team, STAT blood cultures and STAT initiation of antibiotics is required on neutropenic patients when",86896,2,"c.	If the patient has rigors",0
9147,Elearning-0000-410,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT FOR ICU,n5952,28607,3,"4. STAT notification of the BMT Team, STAT blood cultures and STAT initiation of antibiotics is required on neutropenic patients when",86897,3,"d.	All of the above",1
9147,Elearning-0000-410,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT FOR ICU,n5952,28608,4,5. Nursing interventions for Neutropenic patients include,86898,0,"a.	Meticulous CVL care",0
9147,Elearning-0000-410,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT FOR ICU,n5952,28608,4,5. Nursing interventions for Neutropenic patients include,86899,1,"b.	Frequent oral care",0
9147,Elearning-0000-410,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT FOR ICU,n5952,28608,4,5. Nursing interventions for Neutropenic patients include,86900,2,"c.	Daily CHG bath and linen change",0
9147,Elearning-0000-410,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT FOR ICU,n5952,28608,4,5. Nursing interventions for Neutropenic patients include,86901,3,"d.	Thorough hand hygiene",0
9147,Elearning-0000-410,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT FOR ICU,n5952,28608,4,5. Nursing interventions for Neutropenic patients include,86902,4,"e.	All of the above",1
8551,Elearning-0000-142,SUPPORTIVE THERAPY,n5954,28639,0,"1.	Which one of these is not a risk factor for nausea/vomiting.",87030,0,"a.	Female",0
8551,Elearning-0000-142,SUPPORTIVE THERAPY,n5954,28639,0,"1.	Which one of these is not a risk factor for nausea/vomiting.",87031,1,"b.	Younger age",0
8551,Elearning-0000-142,SUPPORTIVE THERAPY,n5954,28639,0,"1.	Which one of these is not a risk factor for nausea/vomiting.",87032,2,"c.	Male",1
8551,Elearning-0000-142,SUPPORTIVE THERAPY,n5954,28639,0,"1.	Which one of these is not a risk factor for nausea/vomiting.",87033,3,"d.	Previous CINV",0
8551,Elearning-0000-142,SUPPORTIVE THERAPY,n5954,28640,1,"2.	A prior history of morning/motion sickness increases your risk of nausea/vomiting.",87034,0,TRUE,1
8551,Elearning-0000-142,SUPPORTIVE THERAPY,n5954,28640,1,"2.	A prior history of morning/motion sickness increases your risk of nausea/vomiting.",87035,1,FALSE,0
8551,Elearning-0000-142,SUPPORTIVE THERAPY,n5954,28641,2,"3.	Antiemetics are most effective when used as needed instead of as prophylaxis.",87036,0,TRUE,0
8551,Elearning-0000-142,SUPPORTIVE THERAPY,n5954,28641,2,"3.	Antiemetics are most effective when used as needed instead of as prophylaxis.",87037,1,FALSE,1
8551,Elearning-0000-142,SUPPORTIVE THERAPY,n5954,28642,3,"4.	Which one is not a sign/symptom of mucositis?",87038,0,"a.	Dysphagia",0
8551,Elearning-0000-142,SUPPORTIVE THERAPY,n5954,28642,3,"4.	Which one is not a sign/symptom of mucositis?",87039,1,"b.	Increased appetite",1
8551,Elearning-0000-142,SUPPORTIVE THERAPY,n5954,28642,3,"4.	Which one is not a sign/symptom of mucositis?",87040,2,"c.	Oral infections",0
8551,Elearning-0000-142,SUPPORTIVE THERAPY,n5954,28642,3,"4.	Which one is not a sign/symptom of mucositis?",87041,3,"d.	Erythema, ulceration",0
8551,Elearning-0000-142,SUPPORTIVE THERAPY,n5954,28643,4,"5.	Poor oral hygiene decreases your risk of developing mucositis.",87042,0,TRUE,0
8551,Elearning-0000-142,SUPPORTIVE THERAPY,n5954,28643,4,"5.	Poor oral hygiene decreases your risk of developing mucositis.",87043,1,FALSE,1
8551,Elearning-0000-142,SUPPORTIVE THERAPY,n5954,28644,5,"6.	______ can be used to prevent Hemorrhagic Cystitis.",87044,0,"a.	Anti-spasmodics",0
8551,Elearning-0000-142,SUPPORTIVE THERAPY,n5954,28644,5,"6.	______ can be used to prevent Hemorrhagic Cystitis.",87045,1,"b.	Mesna",1
8551,Elearning-0000-142,SUPPORTIVE THERAPY,n5954,28644,5,"6.	______ can be used to prevent Hemorrhagic Cystitis.",87046,2,"c.	Cytoxan",0
8551,Elearning-0000-142,SUPPORTIVE THERAPY,n5954,28644,5,"6.	______ can be used to prevent Hemorrhagic Cystitis.",87047,3,"d.	Ifosfamide",0
9269,Elearning-0000-521,IMMUNOSUPPRESSIVE THERAPY,n5956,28646,0,"1.	Immunosuppressants are used for",87050,0,"a.	Prevention of GVHD",0
9269,Elearning-0000-521,IMMUNOSUPPRESSIVE THERAPY,n5956,28646,0,"1.	Immunosuppressants are used for",87051,1,"b.	Treatment for GVHD",0
9269,Elearning-0000-521,IMMUNOSUPPRESSIVE THERAPY,n5956,28646,0,"1.	Immunosuppressants are used for",87052,2,"c.	Both a and b",1
9269,Elearning-0000-521,IMMUNOSUPPRESSIVE THERAPY,n5956,28647,1,2. Immunosuppressive medications interfere with T-cell proliferation and subsequent                        amplification of tissue destructive signals.,87053,0,TRUE,1
9269,Elearning-0000-521,IMMUNOSUPPRESSIVE THERAPY,n5956,28647,1,2. Immunosuppressive medications interfere with T-cell proliferation and subsequent                        amplification of tissue destructive signals.,87054,1,FALSE,0
9269,Elearning-0000-521,IMMUNOSUPPRESSIVE THERAPY,n5956,28648,2,3. Prograf (Tacrolimus) is:,87055,0,"a.	Infused through the grey lumen and levels are drawn through any lumen.",0
9269,Elearning-0000-521,IMMUNOSUPPRESSIVE THERAPY,n5956,28648,2,3. Prograf (Tacrolimus) is:,87056,1,"b.	Infused through the white lumen and levels are drawn through the red lumen.",1
9269,Elearning-0000-521,IMMUNOSUPPRESSIVE THERAPY,n5956,28648,2,3. Prograf (Tacrolimus) is:,87057,2,"c.	Infused through any lumen and levels are drawn through the red lumen.",0
9269,Elearning-0000-521,IMMUNOSUPPRESSIVE THERAPY,n5956,28649,3,4. Sub therapeutic levels of Immunosuppressants can cause GVHD.,87058,0,TRUE,1
9269,Elearning-0000-521,IMMUNOSUPPRESSIVE THERAPY,n5956,28649,3,4. Sub therapeutic levels of Immunosuppressants can cause GVHD.,87059,1,FALSE,0
9269,Elearning-0000-521,IMMUNOSUPPRESSIVE THERAPY,n5956,28650,4,5. Side effects of Prograf include:,87060,0,"a.	Tremors",0
9269,Elearning-0000-521,IMMUNOSUPPRESSIVE THERAPY,n5956,28650,4,5. Side effects of Prograf include:,87061,1,"b.	Encephalopathy",0
9269,Elearning-0000-521,IMMUNOSUPPRESSIVE THERAPY,n5956,28650,4,5. Side effects of Prograf include:,87062,2,"c.	AMS",0
9269,Elearning-0000-521,IMMUNOSUPPRESSIVE THERAPY,n5956,28650,4,5. Side effects of Prograf include:,87063,3,"d.	Hyperkalemia",0
9269,Elearning-0000-521,IMMUNOSUPPRESSIVE THERAPY,n5956,28650,4,5. Side effects of Prograf include:,87064,4,"e.	All of the above",1
9027,Elearning-0000-301,ONCOLOGIC EMERGENCIES,n5965,28735,0,"1.	What is the cure for DIC?",87415,0,"a.	Antibiotics",0
9027,Elearning-0000-301,ONCOLOGIC EMERGENCIES,n5965,28735,0,"1.	What is the cure for DIC?",87416,1,"b.	IV Fluids",0
9027,Elearning-0000-301,ONCOLOGIC EMERGENCIES,n5965,28735,0,"1.	What is the cure for DIC?",87417,2,"c.	Treating the underlying cause and blood product support",1
9027,Elearning-0000-301,ONCOLOGIC EMERGENCIES,n5965,28735,0,"1.	What is the cure for DIC?",87418,3,"d.	Chemotherapy",0
9027,Elearning-0000-301,ONCOLOGIC EMERGENCIES,n5965,28736,1,"2.	Which one of these is not a s/s of Super Vena Cava Syndrome?",87419,0,"a.	Edema of the face",0
9027,Elearning-0000-301,ONCOLOGIC EMERGENCIES,n5965,28736,1,"2.	Which one of these is not a s/s of Super Vena Cava Syndrome?",87420,1,"b.	SOB",0
9027,Elearning-0000-301,ONCOLOGIC EMERGENCIES,n5965,28736,1,"2.	Which one of these is not a s/s of Super Vena Cava Syndrome?",87421,2,"c.	Edema of the lower limbs",1
9027,Elearning-0000-301,ONCOLOGIC EMERGENCIES,n5965,28736,1,"2.	Which one of these is not a s/s of Super Vena Cava Syndrome?",87422,3,"d.	Neck and chest venous distension",0
9027,Elearning-0000-301,ONCOLOGIC EMERGENCIES,n5965,28737,2,"3.	In Spinal Cord Compression numbness starts peripherally and moves to the level of the compression.",87423,0,TRUE,1
9027,Elearning-0000-301,ONCOLOGIC EMERGENCIES,n5965,28737,2,"3.	In Spinal Cord Compression numbness starts peripherally and moves to the level of the compression.",87424,1,FALSE,0
9027,Elearning-0000-301,ONCOLOGIC EMERGENCIES,n5965,28738,3,"4.	What is usually the first symptom of Spinal Cord Compression?",87425,0,"a.	Diminished pain sensation",0
9027,Elearning-0000-301,ONCOLOGIC EMERGENCIES,n5965,28738,3,"4.	What is usually the first symptom of Spinal Cord Compression?",87426,1,"b.	Sexual dysfunction",0
9027,Elearning-0000-301,ONCOLOGIC EMERGENCIES,n5965,28738,3,"4.	What is usually the first symptom of Spinal Cord Compression?",87427,2,"c.	Back pain",1
9027,Elearning-0000-301,ONCOLOGIC EMERGENCIES,n5965,28738,3,"4.	What is usually the first symptom of Spinal Cord Compression?",87428,3,"d.	Loss of bowel and bladder function",0
9027,Elearning-0000-301,ONCOLOGIC EMERGENCIES,n5965,28739,4,"5.	Which of the following is not a risk factor in Tumor Lysis Syndrome?",87429,0,"a.	Elevated creatinine",0
9027,Elearning-0000-301,ONCOLOGIC EMERGENCIES,n5965,28739,4,"5.	Which of the following is not a risk factor in Tumor Lysis Syndrome?",87430,1,"b.	Decreased urine output",0
9027,Elearning-0000-301,ONCOLOGIC EMERGENCIES,n5965,28739,4,"5.	Which of the following is not a risk factor in Tumor Lysis Syndrome?",87431,2,"c.	Bulky tumor",0
9027,Elearning-0000-301,ONCOLOGIC EMERGENCIES,n5965,28739,4,"5.	Which of the following is not a risk factor in Tumor Lysis Syndrome?",87432,3,"d.	Increased urine output",1
9295,Elearning-0000-545,GROWTH FACTORS,n5966,28740,0,"1.	Growth Factors such as Zarxio are used in BMT patients to",87433,0,"a.	Decrease the length of neutropenia thereby decreasing the risk for infection",0
9295,Elearning-0000-545,GROWTH FACTORS,n5966,28740,0,"1.	Growth Factors such as Zarxio are used in BMT patients to",87434,1,"b.	Mobilization in pre-autologous transplant patients.",0
9295,Elearning-0000-545,GROWTH FACTORS,n5966,28740,0,"1.	Growth Factors such as Zarxio are used in BMT patients to",87435,2,"c.	Both a and b",1
9295,Elearning-0000-545,GROWTH FACTORS,n5966,28741,1,"2.	 Nurses need to be chemo certified to be able to administer Zarxio.",87436,0,TRUE,0
9295,Elearning-0000-545,GROWTH FACTORS,n5966,28741,1,"2.	 Nurses need to be chemo certified to be able to administer Zarxio.",87437,1,FALSE,1
9295,Elearning-0000-545,GROWTH FACTORS,n5966,28742,2,"3.	Zarxio is a refrigerated med but must be brought down to room temperature before administration.",87438,0,TRUE,1
9295,Elearning-0000-545,GROWTH FACTORS,n5966,28742,2,"3.	Zarxio is a refrigerated med but must be brought down to room temperature before administration.",87439,1,FALSE,0
9295,Elearning-0000-545,GROWTH FACTORS,n5966,28743,3,"4.	Some of the adverse effects of Zarxio are:",87440,0,"a.	Bone/Joint pain",1
9295,Elearning-0000-545,GROWTH FACTORS,n5966,28743,3,"4.	Some of the adverse effects of Zarxio are:",87441,1,"b.	Mucositis",0
9295,Elearning-0000-545,GROWTH FACTORS,n5966,28743,3,"4.	Some of the adverse effects of Zarxio are:",87442,2,"c.	Visual disturbances",0
9295,Elearning-0000-545,GROWTH FACTORS,n5966,28744,4,"5.	The following lab value must be carefully monitored for patients receiving Zarxio.",87443,0,"a.	Hematocrit",0
9295,Elearning-0000-545,GROWTH FACTORS,n5966,28744,4,"5.	The following lab value must be carefully monitored for patients receiving Zarxio.",87444,1,"b.	Platelets",0
9295,Elearning-0000-545,GROWTH FACTORS,n5966,28744,4,"5.	The following lab value must be carefully monitored for patients receiving Zarxio.",87445,2,"c.	ANC",1
9497,Elearning-0000-729,IRON MOUNTAIN CONNECT RECORDS MANAGEMENT TRAINING MODULE,n5975,28788,0,"1.      Where does all transactional activity such as requesting pick-ups and retrievals take place on ""Connect'?",87602,0,a.      Record Center,1
9497,Elearning-0000-729,IRON MOUNTAIN CONNECT RECORDS MANAGEMENT TRAINING MODULE,n5975,28788,0,"1.      Where does all transactional activity such as requesting pick-ups and retrievals take place on ""Connect'?",87603,1,b.      Report Center,0
9497,Elearning-0000-729,IRON MOUNTAIN CONNECT RECORDS MANAGEMENT TRAINING MODULE,n5975,28788,0,"1.      Where does all transactional activity such as requesting pick-ups and retrievals take place on ""Connect'?",87604,2,c.      Shopping Center,0
9497,Elearning-0000-729,IRON MOUNTAIN CONNECT RECORDS MANAGEMENT TRAINING MODULE,n5975,28788,0,"1.      Where does all transactional activity such as requesting pick-ups and retrievals take place on ""Connect'?",87605,3,d.      Hospital Center,0
9497,Elearning-0000-729,IRON MOUNTAIN CONNECT RECORDS MANAGEMENT TRAINING MODULE,n5975,28826,1,I have read and understand the contents of the IRON MOUNTAIN CONNECT RECORDS MANAGEMENT CONNECT RECORDS MANAGEMENT TRAINING MODULE CBL.,87751,0,TRUE,1
9497,Elearning-0000-729,IRON MOUNTAIN CONNECT RECORDS MANAGEMENT TRAINING MODULE,n5975,28826,1,I have read and understand the contents of the IRON MOUNTAIN CONNECT RECORDS MANAGEMENT CONNECT RECORDS MANAGEMENT TRAINING MODULE CBL.,87752,1,FALSE,0
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28958,0,A written order is not needed for the collection of  blood for PRP.,88268,0,TRUE,0
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28958,0,A written order is not needed for the collection of  blood for PRP.,88269,1,FALSE,1
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28959,1,Blood that is drawn for PRP in Pre-Op remains with the patient and is transported with the patient to the OR.,88270,0,TRUE,1
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28959,1,Blood that is drawn for PRP in Pre-Op remains with the patient and is transported with the patient to the OR.,88271,1,FALSE,0
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28960,2,PRP blood that is drawn in Pre-op will be placed in a bag with labels that remain with the patient.,88272,0,TRUE,1
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28960,2,PRP blood that is drawn in Pre-op will be placed in a bag with labels that remain with the patient.,88273,1,FALSE,0
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28961,3,"Upon arrival to OR,  OR RN and Autotransfusionist confirm patient ID using 2 identifiers, correctly labeled blood draw syringe, and order verification. Autotransfusionist transports specimen to centrifuge for preparation, one patient specimen at a time.",88274,0,TRUE,1
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28961,3,"Upon arrival to OR,  OR RN and Autotransfusionist confirm patient ID using 2 identifiers, correctly labeled blood draw syringe, and order verification. Autotransfusionist transports specimen to centrifuge for preparation, one patient specimen at a time.",88275,1,FALSE,0
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28962,4,"PRP is verified, adhering to the ""Identification of Patient""  policy, during all of the following points of care, EXCEPT:",88276,0,a) In Pre-op prior to the blood draw,0
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28962,4,"PRP is verified, adhering to the ""Identification of Patient""  policy, during all of the following points of care, EXCEPT:",88277,1,b) At Hand Off from Pre-Op or OR,0
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28962,4,"PRP is verified, adhering to the ""Identification of Patient""  policy, during all of the following points of care, EXCEPT:",88278,2,c) Upon entering the OR,0
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28962,4,"PRP is verified, adhering to the ""Identification of Patient""  policy, during all of the following points of care, EXCEPT:",88279,3,d) At time of PRP delivery to the sterile field,0
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28962,4,"PRP is verified, adhering to the ""Identification of Patient""  policy, during all of the following points of care, EXCEPT:",88280,4,e) After the PRP is administered to the patient,1
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28963,5,"<b>After</b> PRP is delivered to the sterile field, the PRP will be checked again.  The doctor's order & <b>Patient's Identification</b> will be confirmed by the circulating nurse, Autotransfusionist and scrub.",88281,0,TRUE,0
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28963,5,"<b>After</b> PRP is delivered to the sterile field, the PRP will be checked again.  The doctor's order & <b>Patient's Identification</b> will be confirmed by the circulating nurse, Autotransfusionist and scrub.",88282,1,FALSE,1
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28964,6,"At Hand Off of PRP from Autotransfusionist to OR RN, patient identification using 2 identifiers, correctly labeled blood draw syringe, correctly labeled PRP syringe and order are verified.",88283,0,TRUE,1
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28964,6,"At Hand Off of PRP from Autotransfusionist to OR RN, patient identification using 2 identifiers, correctly labeled blood draw syringe, correctly labeled PRP syringe and order are verified.",88284,1,FALSE,0
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28965,7,Refer to Perioperative Guideline for Blood Recovery and Reinfusion for Chain of Custody Platelet Rich Plasma (PRP),88285,0,TRUE,1
8104,Elearning-0000-1003,PRP PLATELET - RICH PLASMA AND CHAIN OF CUSTODY PROCESS,n5986,28965,7,Refer to Perioperative Guideline for Blood Recovery and Reinfusion for Chain of Custody Platelet Rich Plasma (PRP),88286,1,FALSE,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29092,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, did the program met your educational needs?</ol>",88579,0,Strongly Agree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29092,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, did the program met your educational needs?</ol>",88580,1,Agree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29092,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, did the program met your educational needs?</ol>",88581,2,No Opinion,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29092,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, did the program met your educational needs?</ol>",88582,3,Disagree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29092,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, did the program met your educational needs?</ol>",88583,4,Strongly Disagree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29093,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, did the program met your professional needs? </ol>",88584,0,Strongly Agree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29093,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, did the program met your professional needs? </ol>",88585,1,Agree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29093,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, did the program met your professional needs? </ol>",88586,2,No Opinion,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29093,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, did the program met your professional needs? </ol>",88587,3,Disagree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29093,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, did the program met your professional needs? </ol>",88588,4,Strongly Disagree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29094,2,<ol><b>LEARNING OBJECTIVES</b></ol> <ol>The clinical experiences were positive and encouraging. </ol>,88589,0,Strongly Agree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29094,2,<ol><b>LEARNING OBJECTIVES</b></ol> <ol>The clinical experiences were positive and encouraging. </ol>,88590,1,Agree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29094,2,<ol><b>LEARNING OBJECTIVES</b></ol> <ol>The clinical experiences were positive and encouraging. </ol>,88591,2,No Opinion,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29094,2,<ol><b>LEARNING OBJECTIVES</b></ol> <ol>The clinical experiences were positive and encouraging. </ol>,88592,3,Disagree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29094,2,<ol><b>LEARNING OBJECTIVES</b></ol> <ol>The clinical experiences were positive and encouraging. </ol>,88593,4,Strongly Disagree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29095,4,<ol><b>LEARNING OBJECTIVES</b></ol> <ol>My preceptor(s) was/were positive and encouraging.</ol>,88594,0,Strongly Agree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29095,4,<ol><b>LEARNING OBJECTIVES</b></ol> <ol>My preceptor(s) was/were positive and encouraging.</ol>,88595,1,Agree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29095,4,<ol><b>LEARNING OBJECTIVES</b></ol> <ol>My preceptor(s) was/were positive and encouraging.</ol>,88596,2,No Opinion,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29095,4,<ol><b>LEARNING OBJECTIVES</b></ol> <ol>My preceptor(s) was/were positive and encouraging.</ol>,88597,3,Disagree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29095,4,<ol><b>LEARNING OBJECTIVES</b></ol> <ol>My preceptor(s) was/were positive and encouraging.</ol>,88598,4,Strongly Disagree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29096,3,<ol><b>LEARNING OBJECTIVES</b></ol> <ol>The unit clinician(s) was/were positive and encouraging.</ol>,88599,0,Strongly Agree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29096,3,<ol><b>LEARNING OBJECTIVES</b></ol> <ol>The unit clinician(s) was/were positive and encouraging.</ol>,88600,1,Agree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29096,3,<ol><b>LEARNING OBJECTIVES</b></ol> <ol>The unit clinician(s) was/were positive and encouraging.</ol>,88601,2,No Opinion,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29096,3,<ol><b>LEARNING OBJECTIVES</b></ol> <ol>The unit clinician(s) was/were positive and encouraging.</ol>,88602,3,Disagree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29096,3,<ol><b>LEARNING OBJECTIVES</b></ol> <ol>The unit clinician(s) was/were positive and encouraging.</ol>,88603,4,Strongly Disagree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29097,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>Overall, instructors were knowledgeable </ol>",88604,0,Strongly Agree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29097,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>Overall, instructors were knowledgeable </ol>",88605,1,Agree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29097,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>Overall, instructors were knowledgeable </ol>",88606,2,No Opinion,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29097,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>Overall, instructors were knowledgeable </ol>",88607,3,Disagree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29097,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>Overall, instructors were knowledgeable </ol>",88608,4,Strongly Disagree,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29102,10,"Overall, how would you rate this internship?",88609,0,Poor,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29102,10,"Overall, how would you rate this internship?",88610,1,Adequate,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29102,10,"Overall, how would you rate this internship?",88611,2,Good,0
936,ILT-0000-3374,CARDIOLOGY SPECIALTY TRAINING- OCTOBER-NOVEMBER 2017,n6007,29102,10,"Overall, how would you rate this internship?",88612,3,Excellent,0
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29189,0,True or False?  Newborns have a protective mechanism that allows them to keep warm even in a cool environment.,88940,0,TRUE,0
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29189,0,True or False?  Newborns have a protective mechanism that allows them to keep warm even in a cool environment.,88941,1,FALSE,1
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29190,1,True or False?  Infants can sense anxiety in their caregivers.,88942,0,TRUE,1
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29190,1,True or False?  Infants can sense anxiety in their caregivers.,88943,1,FALSE,0
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29191,2,A two-year old screams when you try to listen to his lungs with a stethoscope.  What should you do?,88944,0,A.  Tell him to be quiet and be a good boy,0
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29191,2,A two-year old screams when you try to listen to his lungs with a stethoscope.  What should you do?,88945,1,B.  Chart that you were unable to listen to his lungs,0
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29191,2,A two-year old screams when you try to listen to his lungs with a stethoscope.  What should you do?,88946,2,C.  Let him see/play with the stethoscope to lessen his fear,1
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29191,2,A two-year old screams when you try to listen to his lungs with a stethoscope.  What should you do?,88947,3,D.  Hold him tightly until he is quiet enough to listen to his lungs,0
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29192,3,You need to start an IV on a five-year old.  What should you do?,88948,0,A.  Be honest with her.  Tell her that it will hurt for a little bit,0
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29192,3,You need to start an IV on a five-year old.  What should you do?,88949,1,B.  Tell her that it is to help her feel better,0
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29192,3,You need to start an IV on a five-year old.  What should you do?,88950,2,C.  Use distraction techniques,0
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29192,3,You need to start an IV on a five-year old.  What should you do?,88951,3,D.  All of the above,1
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29193,4,"True or False?  School-aged children are too young to be embarrassed about their bodies, so it is not as important to keep them covered during an exam.",88952,0,TRUE,0
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29193,4,"True or False?  School-aged children are too young to be embarrassed about their bodies, so it is not as important to keep them covered during an exam.",88953,1,FALSE,1
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29194,5,"True or False?  When interviewing an adolescent patient about alcohol, drugs, or sexual activity, it may be helpful to do so away from parents or caregivers.",88954,0,TRUE,1
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29194,5,"True or False?  When interviewing an adolescent patient about alcohol, drugs, or sexual activity, it may be helpful to do so away from parents or caregivers.",88955,1,FALSE,0
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29195,6,True or False?  Young adults do not experience anxiety or depression because they are young and healthy.,88956,0,TRUE,0
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29195,6,True or False?  Young adults do not experience anxiety or depression because they are young and healthy.,88957,1,FALSE,1
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29196,7,Which of the following is a common stressor for middle-aged adults?,88958,0,A.  Establishing a family,0
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29196,7,Which of the following is a common stressor for middle-aged adults?,88959,1,B.  Loss of independence,0
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29196,7,Which of the following is a common stressor for middle-aged adults?,88960,2,C.  Caring for elderly parents,1
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29196,7,Which of the following is a common stressor for middle-aged adults?,88961,3,D.  Fitting in with peers,0
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29197,8,"When caring for a patient who is 70 years old, what should you keep in mind?",88962,0,"A.  Not all mature adults are weak, frail, or helpless",0
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29197,8,"When caring for a patient who is 70 years old, what should you keep in mind?",88963,1,B.  Some mature adults may have hearing loss or decreased visual acuity,0
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29197,8,"When caring for a patient who is 70 years old, what should you keep in mind?",88964,2,C.  Many mature adults fear the loss of their independence,0
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29197,8,"When caring for a patient who is 70 years old, what should you keep in mind?",88965,3,D.  All of the above,1
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29198,9,True or False?  The age of a patient does not automatically dictate their health status.,88966,0,TRUE,1
9578,Elearning-0000-802,AGE-SPECIFIC COMPETENCIES FOR ED STAFF,n6021,29198,9,True or False?  The age of a patient does not automatically dictate their health status.,88967,1,FALSE,0
8254,Elearning-0000-1139,CARE OF PATIENTS EXPERIENCING WITHDRAWAL & CIWA SCORING ASSESSMENTS,n6065,29431,0,All patients who experience withdrawal experience the same symptoms.,89530,0,TRUE,0
8254,Elearning-0000-1139,CARE OF PATIENTS EXPERIENCING WITHDRAWAL & CIWA SCORING ASSESSMENTS,n6065,29431,0,All patients who experience withdrawal experience the same symptoms.,89531,1,FALSE,1
8254,Elearning-0000-1139,CARE OF PATIENTS EXPERIENCING WITHDRAWAL & CIWA SCORING ASSESSMENTS,n6065,29432,1,"When the Med/Surg Withdrawal orders are implemented, the physician will determine if medications in column A or B will be used, but also have the option to add column C if the patient is also a smoker.",89532,0,TRUE,1
8254,Elearning-0000-1139,CARE OF PATIENTS EXPERIENCING WITHDRAWAL & CIWA SCORING ASSESSMENTS,n6065,29432,1,"When the Med/Surg Withdrawal orders are implemented, the physician will determine if medications in column A or B will be used, but also have the option to add column C if the patient is also a smoker.",89533,1,FALSE,0
8254,Elearning-0000-1139,CARE OF PATIENTS EXPERIENCING WITHDRAWAL & CIWA SCORING ASSESSMENTS,n6065,29433,2,"When the physician selects a column of desired medications to manage patient symptoms, ALL items in the column are to be selected at one time to account for fluctuating CIWA scores.",89534,0,TRUE,0
8254,Elearning-0000-1139,CARE OF PATIENTS EXPERIENCING WITHDRAWAL & CIWA SCORING ASSESSMENTS,n6065,29433,2,"When the physician selects a column of desired medications to manage patient symptoms, ALL items in the column are to be selected at one time to account for fluctuating CIWA scores.",89535,1,FALSE,1
8254,Elearning-0000-1139,CARE OF PATIENTS EXPERIENCING WITHDRAWAL & CIWA SCORING ASSESSMENTS,n6065,29434,3,"When the physician selects a column of desired medications to manage patient symptoms, ONE section in the column should be chosen based on the patients initial CIWA score.",89536,0,TRUE,1
8254,Elearning-0000-1139,CARE OF PATIENTS EXPERIENCING WITHDRAWAL & CIWA SCORING ASSESSMENTS,n6065,29434,3,"When the physician selects a column of desired medications to manage patient symptoms, ONE section in the column should be chosen based on the patients initial CIWA score.",89537,1,FALSE,0
8254,Elearning-0000-1139,CARE OF PATIENTS EXPERIENCING WITHDRAWAL & CIWA SCORING ASSESSMENTS,n6065,29435,4,CIWA assessments should be completed according to MD order and documented in real time.,89538,0,TRUE,1
8254,Elearning-0000-1139,CARE OF PATIENTS EXPERIENCING WITHDRAWAL & CIWA SCORING ASSESSMENTS,n6065,29435,4,CIWA assessments should be completed according to MD order and documented in real time.,89539,1,FALSE,0
8254,Elearning-0000-1139,CARE OF PATIENTS EXPERIENCING WITHDRAWAL & CIWA SCORING ASSESSMENTS,n6065,29436,5,"If the withdrawal patients CIWA scores are rising, indicating the patients symptoms are not being prevented adequately, notify the physician for a change in orders.",89540,0,TRUE,1
8254,Elearning-0000-1139,CARE OF PATIENTS EXPERIENCING WITHDRAWAL & CIWA SCORING ASSESSMENTS,n6065,29436,5,"If the withdrawal patients CIWA scores are rising, indicating the patients symptoms are not being prevented adequately, notify the physician for a change in orders.",89541,1,FALSE,0
8254,Elearning-0000-1139,CARE OF PATIENTS EXPERIENCING WITHDRAWAL & CIWA SCORING ASSESSMENTS,n6065,29437,6,"If the patient is showing signs of oversedation, hold the PRN anti-anxiety medications but continue giving the scheduled anti-anxiety medications.",89542,0,TRUE,0
8254,Elearning-0000-1139,CARE OF PATIENTS EXPERIENCING WITHDRAWAL & CIWA SCORING ASSESSMENTS,n6065,29437,6,"If the patient is showing signs of oversedation, hold the PRN anti-anxiety medications but continue giving the scheduled anti-anxiety medications.",89543,1,FALSE,1
8241,Elearning-0000-1127,PHARMACY PSEUDOEPHEDRINE SALES TRAINING,n6092,29601,0,"I self-certify that I am in compliance with all provisions related to the sale of ephedrine, pseudoephedrine, or phenylpropanolamine as required by the Combat Methamphetamine Epidemic Act Requirements.",90061,0,TRUE,1
8241,Elearning-0000-1127,PHARMACY PSEUDOEPHEDRINE SALES TRAINING,n6092,29601,0,"I self-certify that I am in compliance with all provisions related to the sale of ephedrine, pseudoephedrine, or phenylpropanolamine as required by the Combat Methamphetamine Epidemic Act Requirements.",90062,1,FALSE,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29626,0,Case Scenario #1-1,90153,0,Call MD,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29626,0,Case Scenario #1-1,90153,0,Call MD,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29626,0,Case Scenario #1-1,90154,1,"Recheck vital signs in 30 minutes.  If abnormal after the recheck, notify MD and ask to come to bedside",1
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29626,0,Case Scenario #1-1,90154,1,"Recheck vital signs in 30 minutes.  If abnormal after the recheck, notify MD and ask to come to bedside",1
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29626,0,Case Scenario #1-1,90155,2,Do nothing,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29626,0,Case Scenario #1-1,90155,2,Do nothing,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29627,1,Case Scenario #1-2,90156,0,Temperature,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29627,1,Case Scenario #1-2,90156,0,Temperature,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29627,1,Case Scenario #1-2,90157,1,Pulse,1
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29627,1,Case Scenario #1-2,90157,1,Pulse,1
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29627,1,Case Scenario #1-2,90158,2,Respiratory Rate,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29627,1,Case Scenario #1-2,90158,2,Respiratory Rate,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29627,1,Case Scenario #1-2,90159,3,Blood pressure,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29627,1,Case Scenario #1-2,90159,3,Blood pressure,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29628,2,Case Scenario #2-1,90160,0,MD,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29628,2,Case Scenario #2-1,90160,0,MD,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29628,2,Case Scenario #2-1,90161,1,RRT,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29628,2,Case Scenario #2-1,90161,1,RRT,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29628,2,Case Scenario #2-1,90162,2,MD and RRT,1
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29628,2,Case Scenario #2-1,90162,2,MD and RRT,1
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29628,2,Case Scenario #2-1,90163,3,No one.  Her vital signs are normal.,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29628,2,Case Scenario #2-1,90163,3,No one.  Her vital signs are normal.,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29629,3,Case Scenario #2-2,90164,0,Yes,1
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29629,3,Case Scenario #2-2,90164,0,Yes,1
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29629,3,Case Scenario #2-2,90165,1,No,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29629,3,Case Scenario #2-2,90165,1,No,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29630,4,Case Scenario #3-1,90166,0,Yes,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29630,4,Case Scenario #3-1,90166,0,Yes,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29630,4,Case Scenario #3-1,90167,1,No,1
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29630,4,Case Scenario #3-1,90167,1,No,1
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29631,5,Case Scenario #4-1,90168,0,Continue to monitor,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29631,5,Case Scenario #4-1,90168,0,Continue to monitor,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29631,5,Case Scenario #4-1,90169,1,Administer another dose of labetalol,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29631,5,Case Scenario #4-1,90169,1,Administer another dose of labetalol,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29631,5,Case Scenario #4-1,90170,2,Administered schedule PO labetalol 1 hour early,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29631,5,Case Scenario #4-1,90170,2,Administered schedule PO labetalol 1 hour early,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29631,5,Case Scenario #4-1,90171,3,Repeat BP in 15 min. If still elevated notify the provider for a new emergent anti-hypertensive order,1
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29631,5,Case Scenario #4-1,90171,3,Repeat BP in 15 min. If still elevated notify the provider for a new emergent anti-hypertensive order,1
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29632,6,Case Scenario #5-1,90172,0,Continue to monitor VS every 30 minutes until parameter is no longer considered a positive trigger.,1
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29632,6,Case Scenario #5-1,90172,0,Continue to monitor VS every 30 minutes until parameter is no longer considered a positive trigger.,1
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29632,6,Case Scenario #5-1,90173,1,Monitor VS every 4 hours,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29632,6,Case Scenario #5-1,90173,1,Monitor VS every 4 hours,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29632,6,Case Scenario #5-1,90174,2,Monitor VS every hour,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29632,6,Case Scenario #5-1,90174,2,Monitor VS every hour,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29632,6,Case Scenario #5-1,90175,3,I do not increase VS frequency because the provider is coming to the bedside.,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29632,6,Case Scenario #5-1,90175,3,I do not increase VS frequency because the provider is coming to the bedside.,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29633,7,Case Scenario #5-2,90176,0,Monitor VS every 4 hours,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29633,7,Case Scenario #5-2,90176,0,Monitor VS every 4 hours,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29633,7,Case Scenario #5-2,90177,1,Monitor VS every shift,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29633,7,Case Scenario #5-2,90177,1,Monitor VS every shift,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29633,7,Case Scenario #5-2,90178,2,Monitor VS every hour for the remainder of the shift,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29633,7,Case Scenario #5-2,90178,2,Monitor VS every hour for the remainder of the shift,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29633,7,Case Scenario #5-2,90179,3,Monitor VS every 30 minutes for 2 hours,1
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29633,7,Case Scenario #5-2,90179,3,Monitor VS every 30 minutes for 2 hours,1
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29634,8,Case Scenario #6-1,90180,0,Yes,1
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29634,8,Case Scenario #6-1,90180,0,Yes,1
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29634,8,Case Scenario #6-1,90181,1,No,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29634,8,Case Scenario #6-1,90181,1,No,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29635,9,Case Scenario #6-2,90182,0,Yes,1
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29635,9,Case Scenario #6-2,90182,0,Yes,1
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29635,9,Case Scenario #6-2,90183,1,No,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29635,9,Case Scenario #6-2,90183,1,No,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29636,10,Case Scenario #6-3,90184,0,Every 5 minutes,1
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29636,10,Case Scenario #6-3,90184,0,Every 5 minutes,1
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29636,10,Case Scenario #6-3,90185,1,Every 10 minutes,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29636,10,Case Scenario #6-3,90185,1,Every 10 minutes,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29636,10,Case Scenario #6-3,90186,2,Every 15 minutes,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29636,10,Case Scenario #6-3,90186,2,Every 15 minutes,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29636,10,Case Scenario #6-3,90187,3,Every 30 minutes,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29636,10,Case Scenario #6-3,90187,3,Every 30 minutes,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29637,11,Case Scenario #7-1,90188,0,Yes,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29637,11,Case Scenario #7-1,90188,0,Yes,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29637,11,Case Scenario #7-1,90189,1,No,1
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29637,11,Case Scenario #7-1,90189,1,No,1
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29638,12,Case Scenario #8-1,90190,0,Every 30 minutes x 2 hours and then hourly for four hours,1
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29638,12,Case Scenario #8-1,90190,0,Every 30 minutes x 2 hours and then hourly for four hours,1
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29638,12,Case Scenario #8-1,90191,1,Hourly for 2 hours,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29638,12,Case Scenario #8-1,90191,1,Hourly for 2 hours,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29638,12,Case Scenario #8-1,90192,2,Hourly for 4 hours,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29638,12,Case Scenario #8-1,90192,2,Hourly for 4 hours,0
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29639,13,Case Scenario #8-2,90193,0,Yes,1
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29639,13,Case Scenario #8-2,90193,0,Yes,1
2941,ILT-0000-14109,NEWT/QBL TRAINING,n6097,29639,13,Case Scenario #8-2,90194,1,No,0
9136,Elearning-0000-400,NEWT/QBL TRAINING,n6097,29639,13,Case Scenario #8-2,90194,1,No,0
9408,Elearning-0000-648,TELEMETRY MONITORING & ALARMS FOR ED NURSES,n6103,29649,0,I have read and understand the contents of the Telemetry Monitoring and Alarms for ED Nurses CBL.,90213,0,TRUE,1
9408,Elearning-0000-648,TELEMETRY MONITORING & ALARMS FOR ED NURSES,n6103,29649,0,I have read and understand the contents of the Telemetry Monitoring and Alarms for ED Nurses CBL.,90214,1,FALSE,0
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29697,0,Cleaning supplies needed for breast pump parts:,90397,0,"1 yellow basin, bottle brush",0
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29697,0,Cleaning supplies needed for breast pump parts:,90398,1,"Dish soap, bottle brush",0
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29697,0,Cleaning supplies needed for breast pump parts:,90399,2,Bottle brush,0
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29697,0,Cleaning supplies needed for breast pump parts:,90400,3,"2 yellow basins, bottle brush, dish soap",1
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29698,1,"One basin should be labeled ""wash"" and the other basin labeled ""dry"".",90401,0,TRUE,1
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29698,1,"One basin should be labeled ""wash"" and the other basin labeled ""dry"".",90402,1,FALSE,0
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29699,2,It is appropriate to use hand soap to clean the pump parts.,90403,0,TRUE,0
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29699,2,It is appropriate to use hand soap to clean the pump parts.,90404,1,FALSE,1
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29700,3,When should the pump parts be cleaned?,90405,0,After every pumping session,1
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29700,3,When should the pump parts be cleaned?,90406,1,After two consecutive pumping sessions,0
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29700,3,When should the pump parts be cleaned?,90407,2,Once per day,0
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29700,3,When should the pump parts be cleaned?,90408,3,When lactation makes rounds,0
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29701,4,"The ""wash"" basin should be placed inside the ""dry"" basin for storage.",90409,0,TRUE,0
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29701,4,"The ""wash"" basin should be placed inside the ""dry"" basin for storage.",90410,1,FALSE,1
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29702,5,"Any colostrum collected, no matter what the amount, should be collected, labeled and delivered to the SCN refrigerator.",90411,0,TRUE,1
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29702,5,"Any colostrum collected, no matter what the amount, should be collected, labeled and delivered to the SCN refrigerator.",90412,1,FALSE,0
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29703,6,How soon after pumping or hand expression should any collected colostrum be delivered to SCN?,90413,0,1 hour,1
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29703,6,How soon after pumping or hand expression should any collected colostrum be delivered to SCN?,90414,1,5 hours,0
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29703,6,How soon after pumping or hand expression should any collected colostrum be delivered to SCN?,90415,2,By the end of shift,0
9144,Elearning-0000-408,NEW BREAST PUMP PARTS CLEANING GUIDELINES,n6109,29703,6,How soon after pumping or hand expression should any collected colostrum be delivered to SCN?,90416,3,When lactation rounds,0
8255,Elearning-0000-114,CLINICAL ALARMS POLICY UPDATE,n6118,29721,0,I have reviewed this education on Updates to the Clinical Alarms Policy and understand my responsibilities as it relates to clinical alarms.,90466,0,TRUE,1
8255,Elearning-0000-114,CLINICAL ALARMS POLICY UPDATE,n6118,29721,0,I have reviewed this education on Updates to the Clinical Alarms Policy and understand my responsibilities as it relates to clinical alarms.,90467,1,FALSE,0
8355,Elearning-0000-123,INFUSION ORDER CHANGES: IMPLICATION & APPLICATION,n6120,29723,0,"1. Provider order states:  + Midazolam (Versed) inf IV 100mg/100mL (1mg/mL) Initiate infusion at   4  mg/hr. If RASS greater than or equal to 2 above RASS goal of -2: titrate to RASS goal by titrating infusion rate by ? 2 mg/hour every 15 min prn in addition to ordered bolus. Max rate: 20mg/hr.  Midazolam (Versed) inj IV 2mg Bolus q15min prn to achieve RASS goal of -2. If increased titration indicated per drip order- bolus with titration. Pt is at RASS -1, elderly pt, on several vasopressor gtts, and was very sensitive to previous Versed boluses. May you as the ICU bedside RN bolus with 1mg of Versed instead of ordered 2mg?",90472,0,"a. Yes, as long as I document ""clinical judgment per VS""",0
8355,Elearning-0000-123,INFUSION ORDER CHANGES: IMPLICATION & APPLICATION,n6120,29723,0,"1. Provider order states:  + Midazolam (Versed) inf IV 100mg/100mL (1mg/mL) Initiate infusion at   4  mg/hr. If RASS greater than or equal to 2 above RASS goal of -2: titrate to RASS goal by titrating infusion rate by ? 2 mg/hour every 15 min prn in addition to ordered bolus. Max rate: 20mg/hr.  Midazolam (Versed) inj IV 2mg Bolus q15min prn to achieve RASS goal of -2. If increased titration indicated per drip order- bolus with titration. Pt is at RASS -1, elderly pt, on several vasopressor gtts, and was very sensitive to previous Versed boluses. May you as the ICU bedside RN bolus with 1mg of Versed instead of ordered 2mg?",90473,1,"b. No, I must always blindly follow provider orders",0
8355,Elearning-0000-123,INFUSION ORDER CHANGES: IMPLICATION & APPLICATION,n6120,29723,0,"1. Provider order states:  + Midazolam (Versed) inf IV 100mg/100mL (1mg/mL) Initiate infusion at   4  mg/hr. If RASS greater than or equal to 2 above RASS goal of -2: titrate to RASS goal by titrating infusion rate by ? 2 mg/hour every 15 min prn in addition to ordered bolus. Max rate: 20mg/hr.  Midazolam (Versed) inj IV 2mg Bolus q15min prn to achieve RASS goal of -2. If increased titration indicated per drip order- bolus with titration. Pt is at RASS -1, elderly pt, on several vasopressor gtts, and was very sensitive to previous Versed boluses. May you as the ICU bedside RN bolus with 1mg of Versed instead of ordered 2mg?",90474,2,c. I should call the provider and obtain an order to bolus with 1mg of Versed instead of previously ordered 2mg Versed,1
8355,Elearning-0000-123,INFUSION ORDER CHANGES: IMPLICATION & APPLICATION,n6120,29724,1,2. Provider order states: Monitor sedation level utilizing RASS scale every 2 hours; Goal RASS ( -1 ) Propofol inf IV 1000mg/100mL. Initiate infusion at 8 mcg/kg/min. Titrate to RASS goal of -1 by titrating infusion rate by  5 mcg/kg/min every 15 min prn. This drip was ordered 2 days ago and the Propofol has now been titrated to a rate of 28 mcg/kg/min.  It is night shift and the patient has had a taxing day.  The RASS is assessed at -2.   What is the ICU bedside RN's titration action for this medication?,90475,0,a. Nothing. Reassess RASS in 2 hours.  Patient is at goal & resting!,0
8355,Elearning-0000-123,INFUSION ORDER CHANGES: IMPLICATION & APPLICATION,n6120,29724,1,2. Provider order states: Monitor sedation level utilizing RASS scale every 2 hours; Goal RASS ( -1 ) Propofol inf IV 1000mg/100mL. Initiate infusion at 8 mcg/kg/min. Titrate to RASS goal of -1 by titrating infusion rate by  5 mcg/kg/min every 15 min prn. This drip was ordered 2 days ago and the Propofol has now been titrated to a rate of 28 mcg/kg/min.  It is night shift and the patient has had a taxing day.  The RASS is assessed at -2.   What is the ICU bedside RN's titration action for this medication?,90476,1,b. Titrate down by 5mcg/kg/min to a rate of 23 and reassess RASS in 15min.,1
8355,Elearning-0000-123,INFUSION ORDER CHANGES: IMPLICATION & APPLICATION,n6120,29724,1,2. Provider order states: Monitor sedation level utilizing RASS scale every 2 hours; Goal RASS ( -1 ) Propofol inf IV 1000mg/100mL. Initiate infusion at 8 mcg/kg/min. Titrate to RASS goal of -1 by titrating infusion rate by  5 mcg/kg/min every 15 min prn. This drip was ordered 2 days ago and the Propofol has now been titrated to a rate of 28 mcg/kg/min.  It is night shift and the patient has had a taxing day.  The RASS is assessed at -2.   What is the ICU bedside RN's titration action for this medication?,90477,2,"c.  Titrate down by 2mcg/kg/min first to assess responsiveness to medication decrease- then, if tolerated- titrate down by another 2-3mcg/kg/min in 5-15 min, then re-check RASS in 15min.",0
8355,Elearning-0000-123,INFUSION ORDER CHANGES: IMPLICATION & APPLICATION,n6120,29725,2,3. Provider order states:  Midazolam (Versed) Initiate infusion at 4mg/hr. If RASS greater than or equal to 2 above RASS goal of -3: titrate to RASS goal by titrating infusion rate by 2 mg/hour every 15 min prn in addition to ordered bolus. Max rate: 20mg/hr  Versed) inj IV 2mg Bolus q15min prn to achieve RASS goal of -3. If increased titration indicated per drip order- bolus with titration. Versed inj IV 2mg Bolus q15min prn to achieve RASS goal of -3. If increased titration indicated per drip order- bolus with titration. See above order.  Which statement indicates that the ICU bedside RN understands how to properly manage Versed titration per this order?,90478,0,a. If the patient's RASS is at -2: I will bolus & titrate to achieve RASS goal.,0
8355,Elearning-0000-123,INFUSION ORDER CHANGES: IMPLICATION & APPLICATION,n6120,29725,2,3. Provider order states:  Midazolam (Versed) Initiate infusion at 4mg/hr. If RASS greater than or equal to 2 above RASS goal of -3: titrate to RASS goal by titrating infusion rate by 2 mg/hour every 15 min prn in addition to ordered bolus. Max rate: 20mg/hr  Versed) inj IV 2mg Bolus q15min prn to achieve RASS goal of -3. If increased titration indicated per drip order- bolus with titration. Versed inj IV 2mg Bolus q15min prn to achieve RASS goal of -3. If increased titration indicated per drip order- bolus with titration. See above order.  Which statement indicates that the ICU bedside RN understands how to properly manage Versed titration per this order?,90479,1,b. If patient's RASS is at -1: I will simply titrate up as ordered since I already tried the Versed bolus 15 min ago.,0
8355,Elearning-0000-123,INFUSION ORDER CHANGES: IMPLICATION & APPLICATION,n6120,29725,2,3. Provider order states:  Midazolam (Versed) Initiate infusion at 4mg/hr. If RASS greater than or equal to 2 above RASS goal of -3: titrate to RASS goal by titrating infusion rate by 2 mg/hour every 15 min prn in addition to ordered bolus. Max rate: 20mg/hr  Versed) inj IV 2mg Bolus q15min prn to achieve RASS goal of -3. If increased titration indicated per drip order- bolus with titration. Versed inj IV 2mg Bolus q15min prn to achieve RASS goal of -3. If increased titration indicated per drip order- bolus with titration. See above order.  Which statement indicates that the ICU bedside RN understands how to properly manage Versed titration per this order?,90480,2,c. If patient's RASS is at -2: I will bolus only and reassess RASS in 15min.,1
8355,Elearning-0000-123,INFUSION ORDER CHANGES: IMPLICATION & APPLICATION,n6120,29725,2,3. Provider order states:  Midazolam (Versed) Initiate infusion at 4mg/hr. If RASS greater than or equal to 2 above RASS goal of -3: titrate to RASS goal by titrating infusion rate by 2 mg/hour every 15 min prn in addition to ordered bolus. Max rate: 20mg/hr  Versed) inj IV 2mg Bolus q15min prn to achieve RASS goal of -3. If increased titration indicated per drip order- bolus with titration. Versed inj IV 2mg Bolus q15min prn to achieve RASS goal of -3. If increased titration indicated per drip order- bolus with titration. See above order.  Which statement indicates that the ICU bedside RN understands how to properly manage Versed titration per this order?,90481,3,d. If Patient's RASS is at -4: I will not titrate or bolus.,0
8355,Elearning-0000-123,INFUSION ORDER CHANGES: IMPLICATION & APPLICATION,n6120,29726,3,4. You receive report back from the night shift RN for the 3rd day worked in a row with the same assignment.  You are performing your bedside report in the room and assess that your patient is opening eyes and moving.  The patient has been on Propofol and Fentanyl drips for the last few days- and you are very familiar with titrating per these orders.  BP is stable.,90482,0,"a. Draw out a Propofol bolus from the tubing and give to patient to ensure no agitation, reassess RASS in 15min",0
8355,Elearning-0000-123,INFUSION ORDER CHANGES: IMPLICATION & APPLICATION,n6120,29726,3,4. You receive report back from the night shift RN for the 3rd day worked in a row with the same assignment.  You are performing your bedside report in the room and assess that your patient is opening eyes and moving.  The patient has been on Propofol and Fentanyl drips for the last few days- and you are very familiar with titrating per these orders.  BP is stable.,90483,1,b. Go ahead and increase Propofol drip per memorized orders- reassess RASS in 15min.,0
8355,Elearning-0000-123,INFUSION ORDER CHANGES: IMPLICATION & APPLICATION,n6120,29726,3,4. You receive report back from the night shift RN for the 3rd day worked in a row with the same assignment.  You are performing your bedside report in the room and assess that your patient is opening eyes and moving.  The patient has been on Propofol and Fentanyl drips for the last few days- and you are very familiar with titrating per these orders.  BP is stable.,90484,2,"c.  Double-check current orders prior to any intervention to ensure that the RASS goals, rates, concentrations, and increment options have not changed.",1
8355,Elearning-0000-123,INFUSION ORDER CHANGES: IMPLICATION & APPLICATION,n6120,29727,4,5. Pt. arrives to the ICU from the ED on Versed at 8 and Fentanyl at 100.  The ICU bedside RN knows that they will need to communicate with ordering provider:,90485,0,a. Nothing.  The provider will order drips as they deem appropriate.,0
8355,Elearning-0000-123,INFUSION ORDER CHANGES: IMPLICATION & APPLICATION,n6120,29727,4,5. Pt. arrives to the ICU from the ED on Versed at 8 and Fentanyl at 100.  The ICU bedside RN knows that they will need to communicate with ordering provider:,90486,1,b. Current drip rates pt arrived on from the ED so that provider will input this as initial starting rate for these drips.,1
719,ILT-0000-2579,BARIATRIC SENSITIVITY,n6131,29809,0,I have read and understood the content within the Bariatric Sensitivity CBL.,90794,0,TRUE,1
719,ILT-0000-2579,BARIATRIC SENSITIVITY,n6131,29809,0,I have read and understood the content within the Bariatric Sensitivity CBL.,90795,1,FALSE,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29827,0,TASS is caused by the introduction of a foreign substance into the _____________________ chamber of the eye.,90843,0,a) Posterior,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29827,0,TASS is caused by the introduction of a foreign substance into the _____________________ chamber of the eye.,90844,1,b) Anterior,1
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29827,0,TASS is caused by the introduction of a foreign substance into the _____________________ chamber of the eye.,90845,2,c) Medial,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29827,0,TASS is caused by the introduction of a foreign substance into the _____________________ chamber of the eye.,90846,3,d) Lateral,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29828,1,"TASS is not an infection; instead, it is a toxic inflammatory reaction that can lead to blindness.",90847,0,a) True,1
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29828,1,"TASS is not an infection; instead, it is a toxic inflammatory reaction that can lead to blindness.",90848,1,b) False,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29829,2,Causes of TASS may include:,90849,0,"a) Solutions, ointment, or medications used during surgery",0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29829,2,Causes of TASS may include:,90850,1,b) Enzymes or detergents use to clean instruments,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29829,2,Causes of TASS may include:,90851,2,c) Heat-stable endotoxins from sources involved in reprocessing instruments,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29829,2,Causes of TASS may include:,90852,3,d) Cleaning solutions not completely rinsed after cleaning,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29829,2,Causes of TASS may include:,90853,4,e) all the above,1
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29830,3,All ophthalmic instruments should be processed:,90854,0,a) Manually,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29830,3,All ophthalmic instruments should be processed:,90855,1,b) In an automatic washer,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29830,3,All ophthalmic instruments should be processed:,90856,2,c) In an ultrasonic cleaner,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29830,3,All ophthalmic instruments should be processed:,90857,3,d) According to the instrument manufacturer's IFU,1
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29831,4,"After the surgical procedure is completed, but before transporting ophthalmic instruments to the decontamination area, the instruments should:",90858,0,a) Be placed in a basin of water to keep the instruments moist,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29831,4,"After the surgical procedure is completed, but before transporting ophthalmic instruments to the decontamination area, the instruments should:",90859,1,b) Be placed back on the instrument stringer for protection during transport According to the instrument manufacturer's IFU,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29831,4,"After the surgical procedure is completed, but before transporting ophthalmic instruments to the decontamination area, the instruments should:",90860,2,c) Have gross debris removed,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29831,4,"After the surgical procedure is completed, but before transporting ophthalmic instruments to the decontamination area, the instruments should:",90861,3,d) All of the above,1
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29832,5,After using the Ultrasonic Cleaner:,90862,0,a) Rinse instruments thoroughly with copious amounts of water,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29832,5,After using the Ultrasonic Cleaner:,90863,1,"b) Flush all lumens with 120 mL of sterile water, distilled water, or deionized water",0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29832,5,After using the Ultrasonic Cleaner:,90864,2,c) Expel the rinse fluid from the lumen into a drain and not back into the rinse water,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29832,5,After using the Ultrasonic Cleaner:,90865,3,d) Flush with approximately 120 mL air.,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29832,5,After using the Ultrasonic Cleaner:,90866,4,e) All of the above,1
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29833,6,"To allow for appropriate decontamination and sterilization of cases, healthcare facilities should:",90867,0,a) Have sufficient inventory of intraocular instruments,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29833,6,"To allow for appropriate decontamination and sterilization of cases, healthcare facilities should:",90868,1,b) Provide adequate time to reprocess the instruments properly,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29833,6,"To allow for appropriate decontamination and sterilization of cases, healthcare facilities should:",90869,2,c) Routinely use immediate use steam sterilization (otherwise known as flash),0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29833,6,"To allow for appropriate decontamination and sterilization of cases, healthcare facilities should:",90870,3,d) A and B above,1
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29833,6,"To allow for appropriate decontamination and sterilization of cases, healthcare facilities should:",90871,4,e) All the above,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29834,7,Special precautions are needed when reprocessing eye instruments because:,90872,0,a) The instruments are owned by the surgeon,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29834,7,Special precautions are needed when reprocessing eye instruments because:,90873,1,b) The instruments are complex and delicate,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29834,7,Special precautions are needed when reprocessing eye instruments because:,90874,2,c) The eye is very sensitive,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29834,7,Special precautions are needed when reprocessing eye instruments because:,90875,3,d) B and C above,1
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29834,7,Special precautions are needed when reprocessing eye instruments because:,90876,4,e) All of the above,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29835,8,Immediate Use Steam Sterilization of ophthalmic instruments:,90877,0,a) Is the sterilization cycle of choice for most ophthalmic instruments?,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29835,8,Immediate Use Steam Sterilization of ophthalmic instruments:,90878,1,b) Is approved by most eye instrument manufacturers,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29835,8,Immediate Use Steam Sterilization of ophthalmic instruments:,90879,2,c) Should only be used if approved by the instrument manufacturers,1
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29835,8,Immediate Use Steam Sterilization of ophthalmic instruments:,90880,3,d) Should only be used if approved by the sterilizers manufacturer,0
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29836,9,Maintenance and repair of cleaning and sterilization equipment should be completed by qualified personnel?,90881,0,a) True,1
8238,Elearning-0000-1124,TASS-CLEANING AND REPROCESSINGOPHTHALMIC INSTRUMENTS,n6134,29836,9,Maintenance and repair of cleaning and sterilization equipment should be completed by qualified personnel?,90882,1,b) False,0
8243,Elearning-0000-1129,OUTPATIENT DISCHARGE INSTRUCTIONS,n6141,29878,0,"I acknowledge that I have read and understand the ""Outpatient Discharge Instructions"" CBL in its entirety.",91037,0,TRUE,1
8243,Elearning-0000-1129,OUTPATIENT DISCHARGE INSTRUCTIONS,n6141,29878,0,"I acknowledge that I have read and understand the ""Outpatient Discharge Instructions"" CBL in its entirety.",91038,1,FALSE,0
9148,Elearning-0000-411,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT,n6138,29842,0,1. Neutropenia can occur in leukemia patients:,90898,0,"a.	As a result of overcrowding of marrow due to disease",0
9148,Elearning-0000-411,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT,n6138,29842,0,1. Neutropenia can occur in leukemia patients:,90899,1,"b.	As a result of chemotherapy/radiation",0
9148,Elearning-0000-411,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT,n6138,29842,0,1. Neutropenia can occur in leukemia patients:,90900,2,"c.	Both a and b",1
9148,Elearning-0000-411,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT,n6138,29843,1,2. Factors affecting Engraftment include:,90901,0,"a.	Effect of past chemotherapy/radiation",0
9148,Elearning-0000-411,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT,n6138,29843,1,2. Factors affecting Engraftment include:,90902,1,"b.	Type of transplant/number of cells in transplant",0
9148,Elearning-0000-411,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT,n6138,29843,1,2. Factors affecting Engraftment include:,90903,2,"c.	Growth factors such as Zarxio",0
9148,Elearning-0000-411,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT,n6138,29843,1,2. Factors affecting Engraftment include:,90904,3,"d.	All of the above",1
9148,Elearning-0000-411,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT,n6138,29844,2,"3. Growth factor, Zarxio comes in two doses: 300 mcg and 480 mcg.",90905,0,TRUE,1
9148,Elearning-0000-411,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT,n6138,29844,2,"3. Growth factor, Zarxio comes in two doses: 300 mcg and 480 mcg.",90906,1,FALSE,0
9148,Elearning-0000-411,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT,n6138,29845,3,"4. STAT notification of the BMT Team, STAT blood cultures and STAT initiation of antibiotics is required on neutropenic patients when:",90907,0,"a.	Temp is >/= 100.5F",0
9148,Elearning-0000-411,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT,n6138,29845,3,"4. STAT notification of the BMT Team, STAT blood cultures and STAT initiation of antibiotics is required on neutropenic patients when:",90908,1,"b.	If temp > 103F",0
9148,Elearning-0000-411,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT,n6138,29845,3,"4. STAT notification of the BMT Team, STAT blood cultures and STAT initiation of antibiotics is required on neutropenic patients when:",90909,2,"c.	If the patient has rigors",0
9148,Elearning-0000-411,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT,n6138,29845,3,"4. STAT notification of the BMT Team, STAT blood cultures and STAT initiation of antibiotics is required on neutropenic patients when:",90910,3,"d.	All of the above",1
9148,Elearning-0000-411,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT,n6138,29846,4,5. Nursing interventions for Neutropenic patients include:,90911,0,"a.	Meticulous CVL care",0
9148,Elearning-0000-411,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT,n6138,29846,4,5. Nursing interventions for Neutropenic patients include:,90912,1,"b.	Frequent oral care",0
9148,Elearning-0000-411,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT,n6138,29846,4,5. Nursing interventions for Neutropenic patients include:,90913,2,"c.	Daily CHG bath and linen change",0
9148,Elearning-0000-411,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT,n6138,29846,4,5. Nursing interventions for Neutropenic patients include:,90914,3,"d.	Thorough hand hygiene",0
9148,Elearning-0000-411,NEUTROPENIA AND NEUTROPENIC FEVER MANAGEMENT,n6138,29846,4,5. Nursing interventions for Neutropenic patients include:,90915,4,"e.	All of the above",1
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30095,0,Technologists can scan patients with the Micra Pacemaker at outpatient radiology locations as long as the MRI scanner meets the conditions in the Medtronics MRI Technical Manual.,91806,0,TRUE,0
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30095,0,Technologists can scan patients with the Micra Pacemaker at outpatient radiology locations as long as the MRI scanner meets the conditions in the Medtronics MRI Technical Manual.,91807,1,FALSE,1
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30096,1,Patients who have the Micra pacemakers can be scanned at all 3 NSH Hospital campuses.,91808,0,TRUE,0
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30096,1,Patients who have the Micra pacemakers can be scanned at all 3 NSH Hospital campuses.,91809,1,FALSE,1
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30097,2,Patients who have the Micra Pacemaker do not have the typical chest bump or scars that other pacemaker patients have.,91810,0,TRUE,1
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30097,2,Patients who have the Micra Pacemaker do not have the typical chest bump or scars that other pacemaker patients have.,91811,1,FALSE,0
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30098,3,Patients who have the Micra Pacemaker do not have pacing leads.,91812,0,TRUE,1
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30098,3,Patients who have the Micra Pacemaker do not have pacing leads.,91813,1,FALSE,0
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30099,4,The Micra Pacemaker is controlled by an external Programmer.,91814,0,TRUE,1
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30099,4,The Micra Pacemaker is controlled by an external Programmer.,91815,1,FALSE,0
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30100,5,The Micra Pacemaker is placed into the Right Ventricle of the heart during an Interventional procedure.,91816,0,TRUE,1
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30100,5,The Micra Pacemaker is placed into the Right Ventricle of the heart during an Interventional procedure.,91817,1,FALSE,0
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30101,6,The only thing that remains in a patient following implantation of the Micra Pacemaker is the pacing device and the leads.,91818,0,TRUE,0
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30101,6,The only thing that remains in a patient following implantation of the Micra Pacemaker is the pacing device and the leads.,91819,1,FALSE,1
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30102,7,Technologists should refer to the following policy in LuciDoc for further directions on MRI patients who have the Micra Pacemaker:,91820,0,"a.	""MRI Safety""",0
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30102,7,Technologists should refer to the following policy in LuciDoc for further directions on MRI patients who have the Micra Pacemaker:,91821,1,"b.	""MRI Patients with Pacemakers""",1
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30102,7,Technologists should refer to the following policy in LuciDoc for further directions on MRI patients who have the Micra Pacemaker:,91822,2,"c.	""Radiology Patients with Pacemakers""",0
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30103,8,What are acceptable methods of verifying that a patient has a Micra Sure Scan system?,91823,0,"a.	Use the patient ID card to identify the device, then verify MR conditional at http:/www.mrisurescan.com",0
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30103,8,What are acceptable methods of verifying that a patient has a Micra Sure Scan system?,91824,1,"b.	Use the patient records to verify a Micra Sure Scan system has been implanted and MRI Conditions are met.",0
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30103,8,What are acceptable methods of verifying that a patient has a Micra Sure Scan system?,91825,2,"c.	Call Medtronic at 1-800-551-5544 to verify the patient's current implant system.",0
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30103,8,What are acceptable methods of verifying that a patient has a Micra Sure Scan system?,91826,3,"d.	All of the above.",1
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30104,9,"The Micra Pacemaker programmer  can be turned to ""MRI SureScan On"" during an MRI procedure ONLY by:",91827,0,"a.	The MRI Technologist",0
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30104,9,"The Micra Pacemaker programmer  can be turned to ""MRI SureScan On"" during an MRI procedure ONLY by:",91828,1,"b.	A Trained/ Qualified individual",1
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30104,9,"The Micra Pacemaker programmer  can be turned to ""MRI SureScan On"" during an MRI procedure ONLY by:",91829,2,"c.	The Radiologist",0
8247,Elearning-0000-1132,NEW PACEMAKER TECHNOLOGY AND THE IMPACT ON RADIOLOGY,n6175,30104,9,"The Micra Pacemaker programmer  can be turned to ""MRI SureScan On"" during an MRI procedure ONLY by:",91830,3,"d.	None of the above",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30611,0,Google Chrome is the preferred web browser for users to launch Med-Metrix.,93796,0,TRUE,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30611,0,Google Chrome is the preferred web browser for users to launch Med-Metrix.,93796,0,TRUE,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30611,0,Google Chrome is the preferred web browser for users to launch Med-Metrix.,93797,1,FALSE,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30611,0,Google Chrome is the preferred web browser for users to launch Med-Metrix.,93797,1,FALSE,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30612,1,_________ continually follow up with payors who are past the deadline for reimbursing the hospital.,93798,0,"a.	Pre-Registration Staff",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30612,1,_________ continually follow up with payors who are past the deadline for reimbursing the hospital.,93798,0,"a.	Pre-Registration Staff",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30612,1,_________ continually follow up with payors who are past the deadline for reimbursing the hospital.,93799,1,"b.	Collectors",1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30612,1,_________ continually follow up with payors who are past the deadline for reimbursing the hospital.,93799,1,"b.	Collectors",1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30612,1,_________ continually follow up with payors who are past the deadline for reimbursing the hospital.,93800,2,"c.	Patients",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30612,1,_________ continually follow up with payors who are past the deadline for reimbursing the hospital.,93800,2,"c.	Patients",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30613,2,What is the most commonly used Event Trigger by Commercial Collections Representatives?,206107,0,Inbound Call,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30613,2,What is the most commonly used Event Trigger by Commercial Collections Representatives?,206107,0,Inbound Call,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30613,2,What is the most commonly used Event Trigger by Commercial Collections Representatives?,206108,1,Outbound Call,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30613,2,What is the most commonly used Event Trigger by Commercial Collections Representatives?,206108,1,Outbound Call,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30613,2,What is the most commonly used Event Trigger by Commercial Collections Representatives?,206109,2,Reviewed Account,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30613,2,What is the most commonly used Event Trigger by Commercial Collections Representatives?,206109,2,Reviewed Account,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30614,3,______ are tagged to accounts via user action,206110,0,Event Triggers,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30614,3,______ are tagged to accounts via user action,206110,0,Event Triggers,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30614,3,______ are tagged to accounts via user action,206111,1,Flags,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30614,3,______ are tagged to accounts via user action,206111,1,Flags,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30614,3,______ are tagged to accounts via user action,206112,2,Actions,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30614,3,______ are tagged to accounts via user action,206112,2,Actions,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30615,4,"ATB is an abbreviation for ""Aged Trial Balance.""",93806,0,TRUE,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30615,4,"ATB is an abbreviation for ""Aged Trial Balance.""",93806,0,TRUE,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30615,4,"ATB is an abbreviation for ""Aged Trial Balance.""",93807,1,FALSE,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30615,4,"ATB is an abbreviation for ""Aged Trial Balance.""",93807,1,FALSE,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30616,5,"In the Tool, which Collection environment should be used by non-government collectors?",93808,0,"a.	Government Environment",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30616,5,"In the Tool, which Collection environment should be used by non-government collectors?",93808,0,"a.	Government Environment",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30616,5,"In the Tool, which Collection environment should be used by non-government collectors?",93809,1,"b.	Commercial Environment",1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30616,5,"In the Tool, which Collection environment should be used by non-government collectors?",93809,1,"b.	Commercial Environment",1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30616,5,"In the Tool, which Collection environment should be used by non-government collectors?",93810,2,"c.	Administrative Environment",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30616,5,"In the Tool, which Collection environment should be used by non-government collectors?",93810,2,"c.	Administrative Environment",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30617,6,"In Med-Metrix, Event Triggers are the logic that determines which account should take priority when assigning accounts to users.",206113,0,TRUE,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30617,6,"In Med-Metrix, Event Triggers are the logic that determines which account should take priority when assigning accounts to users.",206113,0,TRUE,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30617,6,"In Med-Metrix, Event Triggers are the logic that determines which account should take priority when assigning accounts to users.",206114,1,FALSE,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30617,6,"In Med-Metrix, Event Triggers are the logic that determines which account should take priority when assigning accounts to users.",206114,1,FALSE,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30618,7,How often are Collection goals set?,93814,0,"a.	Daily",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30618,7,How often are Collection goals set?,93814,0,"a.	Daily",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30618,7,How often are Collection goals set?,93815,1,"b.	Weekly",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30618,7,How often are Collection goals set?,93815,1,"b.	Weekly",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30618,7,How often are Collection goals set?,93816,2,"c.	Monthly",1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30618,7,How often are Collection goals set?,93816,2,"c.	Monthly",1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30619,8,Notes from Med-Metrix automatically transfer to STAR.,93817,0,TRUE,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30619,8,Notes from Med-Metrix automatically transfer to STAR.,93817,0,TRUE,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30619,8,Notes from Med-Metrix automatically transfer to STAR.,93818,1,FALSE,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30619,8,Notes from Med-Metrix automatically transfer to STAR.,93818,1,FALSE,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30620,9,"Which column in the ""My Productivity"" function displays the total number of notes submitted for the day?",93819,0,"a.	Payment promised",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30620,9,"Which column in the ""My Productivity"" function displays the total number of notes submitted for the day?",93819,0,"a.	Payment promised",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30620,9,"Which column in the ""My Productivity"" function displays the total number of notes submitted for the day?",93820,1,"b.	Collection Contacts",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30620,9,"Which column in the ""My Productivity"" function displays the total number of notes submitted for the day?",93820,1,"b.	Collection Contacts",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30620,9,"Which column in the ""My Productivity"" function displays the total number of notes submitted for the day?",93821,2,"c.	Total Transactions",1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30620,9,"Which column in the ""My Productivity"" function displays the total number of notes submitted for the day?",93821,2,"c.	Total Transactions",1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30621,10,"For an account to reach a Collector's Follow up ATB, the account must have an AR or PA status and a zero balance.",93822,0,TRUE,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30621,10,"For an account to reach a Collector's Follow up ATB, the account must have an AR or PA status and a zero balance.",93822,0,TRUE,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30621,10,"For an account to reach a Collector's Follow up ATB, the account must have an AR or PA status and a zero balance.",93823,1,FALSE,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30621,10,"For an account to reach a Collector's Follow up ATB, the account must have an AR or PA status and a zero balance.",93823,1,FALSE,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30622,11,Each account served in Med-Metrix requires users to select an appropriate ______ to document work.,206115,0,Action,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30622,11,Each account served in Med-Metrix requires users to select an appropriate ______ to document work.,206115,0,Action,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30622,11,Each account served in Med-Metrix requires users to select an appropriate ______ to document work.,206116,1,SmartFeed,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30622,11,Each account served in Med-Metrix requires users to select an appropriate ______ to document work.,206116,1,SmartFeed,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30622,11,Each account served in Med-Metrix requires users to select an appropriate ______ to document work.,206117,2,Flag,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30622,11,Each account served in Med-Metrix requires users to select an appropriate ______ to document work.,206117,2,Flag,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30623,12,What is MRO used for?,206118,0,Requesting Medical Records,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30623,12,What is MRO used for?,206118,0,Requesting Medical Records,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30623,12,What is MRO used for?,206119,1,Request of Information,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30623,12,What is MRO used for?,206119,1,Request of Information,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30623,12,What is MRO used for?,206120,2,Release of Integrity,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30623,12,What is MRO used for?,206120,2,Release of Integrity,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30624,13,"In the Tool, every column in the ATB can be sorted ________or ________, depending on the data type.",93829,0,"a.	Count or goals",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30624,13,"In the Tool, every column in the ATB can be sorted ________or ________, depending on the data type.",93829,0,"a.	Count or goals",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30624,13,"In the Tool, every column in the ATB can be sorted ________or ________, depending on the data type.",93830,1,"b.	Alphabetically or numerically",1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30624,13,"In the Tool, every column in the ATB can be sorted ________or ________, depending on the data type.",93830,1,"b.	Alphabetically or numerically",1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30624,13,"In the Tool, every column in the ATB can be sorted ________or ________, depending on the data type.",93831,2,"c.	Pivot or Excel",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30624,13,"In the Tool, every column in the ATB can be sorted ________or ________, depending on the data type.",93831,2,"c.	Pivot or Excel",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30625,14,Which of these is true about accounts with a Z status?,93832,0,"a.	Sleeping accounts",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30625,14,Which of these is true about accounts with a Z status?,93832,0,"a.	Sleeping accounts",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30625,14,Which of these is true about accounts with a Z status?,93833,1,"b.	Zero balance accounts",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30625,14,Which of these is true about accounts with a Z status?,93833,1,"b.	Zero balance accounts",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30625,14,Which of these is true about accounts with a Z status?,93834,2,"c.	New accounts",1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30625,14,Which of these is true about accounts with a Z status?,93834,2,"c.	New accounts",1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30626,15,"In Med-Metrix, an account can be checked out to multiple users at the same time.",93835,0,TRUE,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30626,15,"In Med-Metrix, an account can be checked out to multiple users at the same time.",93835,0,TRUE,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30626,15,"In Med-Metrix, an account can be checked out to multiple users at the same time.",93836,1,FALSE,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30626,15,"In Med-Metrix, an account can be checked out to multiple users at the same time.",93836,1,FALSE,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30627,16,Which application does a collector use to request medical records?,93837,0,"a.	HPF ""Search""",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30627,16,Which application does a collector use to request medical records?,93837,0,"a.	HPF ""Search""",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30627,16,Which application does a collector use to request medical records?,93838,1,"b.	STAR ""Med Rec Request""",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30627,16,Which application does a collector use to request medical records?,93838,1,"b.	STAR ""Med Rec Request""",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30627,16,Which application does a collector use to request medical records?,93839,2,"c.	The Tool ""Med Rec Request""",1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30627,16,Which application does a collector use to request medical records?,93839,2,"c.	The Tool ""Med Rec Request""",1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30628,17,Account escalations take place in Med-Metrix?,206123,0,TRUE,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30628,17,Account escalations take place in Med-Metrix?,206123,0,TRUE,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30628,17,Account escalations take place in Med-Metrix?,206124,1,FALSE,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30628,17,Account escalations take place in Med-Metrix?,206124,1,FALSE,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30629,18,Notes from the Tool transfers to STAR.,93843,0,TRUE,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30629,18,Notes from the Tool transfers to STAR.,93843,0,TRUE,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30629,18,Notes from the Tool transfers to STAR.,93844,1,FALSE,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30629,18,Notes from the Tool transfers to STAR.,93844,1,FALSE,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30630,19,Collectors utilize the _______ in STAR to follow the life cycle of an account.,206125,0,actions,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30630,19,Collectors utilize the _______ in STAR to follow the life cycle of an account.,206125,0,actions,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30630,19,Collectors utilize the _______ in STAR to follow the life cycle of an account.,206126,1,triggers,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30630,19,Collectors utilize the _______ in STAR to follow the life cycle of an account.,206126,1,triggers,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30630,19,Collectors utilize the _______ in STAR to follow the life cycle of an account.,206127,2,notes,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30630,19,Collectors utilize the _______ in STAR to follow the life cycle of an account.,206127,2,notes,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30631,20,In which box on the UB claim form does the authorization for the services appear?,93848,0,"a.	Box 7",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30631,20,In which box on the UB claim form does the authorization for the services appear?,93848,0,"a.	Box 7",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30631,20,In which box on the UB claim form does the authorization for the services appear?,93849,1,"b.	Box 45",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30631,20,In which box on the UB claim form does the authorization for the services appear?,93849,1,"b.	Box 45",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30631,20,In which box on the UB claim form does the authorization for the services appear?,93850,2,"c.	Box 63",1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30631,20,In which box on the UB claim form does the authorization for the services appear?,93850,2,"c.	Box 63",1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30632,21,What is the name of the screen in STAR that collector use to find an authorization?,93851,0,"a.	Account Inquiry",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30632,21,What is the name of the screen in STAR that collector use to find an authorization?,93851,0,"a.	Account Inquiry",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30632,21,What is the name of the screen in STAR that collector use to find an authorization?,93852,1,"b.	Insurance Processing",1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30632,21,What is the name of the screen in STAR that collector use to find an authorization?,93852,1,"b.	Insurance Processing",1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30632,21,What is the name of the screen in STAR that collector use to find an authorization?,93853,2,"c.	Billing",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30632,21,What is the name of the screen in STAR that collector use to find an authorization?,93853,2,"c.	Billing",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30633,22,Which is the best practice to search for a patient in STAR?,93854,0,"a.	Patient's name",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30633,22,Which is the best practice to search for a patient in STAR?,93854,0,"a.	Patient's name",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30633,22,Which is the best practice to search for a patient in STAR?,93855,1,"b.	Patient's DOB",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30633,22,Which is the best practice to search for a patient in STAR?,93855,1,"b.	Patient's DOB",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30633,22,Which is the best practice to search for a patient in STAR?,93856,2,"c.	Patient's account number",1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30633,22,Which is the best practice to search for a patient in STAR?,93856,2,"c.	Patient's account number",1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30634,23,Which of the following is NOT one of the Insurance Follow-Up Fundamentals?,93857,0,"a.	Contact the Patient",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30634,23,Which of the following is NOT one of the Insurance Follow-Up Fundamentals?,93857,0,"a.	Contact the Patient",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30634,23,Which of the following is NOT one of the Insurance Follow-Up Fundamentals?,93858,1,"b.	Be Assertive",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30634,23,Which of the following is NOT one of the Insurance Follow-Up Fundamentals?,93858,1,"b.	Be Assertive",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30634,23,Which of the following is NOT one of the Insurance Follow-Up Fundamentals?,93859,2,"c.	Work Fast",1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30634,23,Which of the following is NOT one of the Insurance Follow-Up Fundamentals?,93859,2,"c.	Work Fast",1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30635,24,How many fundamentals of effective follow up were discussed in class?,93860,0,"a.	Six",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30635,24,How many fundamentals of effective follow up were discussed in class?,93860,0,"a.	Six",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30635,24,How many fundamentals of effective follow up were discussed in class?,93861,1,"b.	Five",1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30635,24,How many fundamentals of effective follow up were discussed in class?,93861,1,"b.	Five",1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30635,24,How many fundamentals of effective follow up were discussed in class?,93862,2,"c.	Eight",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30635,24,How many fundamentals of effective follow up were discussed in class?,93862,2,"c.	Eight",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30636,25,What law requires that Insurance Companies must either make a payment or request additional information from a provider?,93863,0,"a.	The Timely Filing Amendment",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30636,25,What law requires that Insurance Companies must either make a payment or request additional information from a provider?,93863,0,"a.	The Timely Filing Amendment",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30636,25,What law requires that Insurance Companies must either make a payment or request additional information from a provider?,93864,1,"b.	Georgia Prompt Pay Act",1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30636,25,What law requires that Insurance Companies must either make a payment or request additional information from a provider?,93864,1,"b.	Georgia Prompt Pay Act",1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30636,25,What law requires that Insurance Companies must either make a payment or request additional information from a provider?,93865,2,"c.	Payroll Deduction Form",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30636,25,What law requires that Insurance Companies must either make a payment or request additional information from a provider?,93865,2,"c.	Payroll Deduction Form",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30637,26,Guidelines set by payers to indicate how long after a discharge date a claim may be filed is known as:,93866,0,"a.	Timely Filing Guidelines",1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30637,26,Guidelines set by payers to indicate how long after a discharge date a claim may be filed is known as:,93866,0,"a.	Timely Filing Guidelines",1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30637,26,Guidelines set by payers to indicate how long after a discharge date a claim may be filed is known as:,93867,1,"b.	Prompt Filing Guidelines",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30637,26,Guidelines set by payers to indicate how long after a discharge date a claim may be filed is known as:,93867,1,"b.	Prompt Filing Guidelines",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30637,26,Guidelines set by payers to indicate how long after a discharge date a claim may be filed is known as:,93868,2,"c.	Prompt Pay Guidelines",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30637,26,Guidelines set by payers to indicate how long after a discharge date a claim may be filed is known as:,93868,2,"c.	Prompt Pay Guidelines",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30638,27,Georgia prompt pay law only applies to what type of plans?,93869,0,"a.	Self-Funded Plans",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30638,27,Georgia prompt pay law only applies to what type of plans?,93869,0,"a.	Self-Funded Plans",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30638,27,Georgia prompt pay law only applies to what type of plans?,93870,1,"b.	Fully insured Plans",1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30638,27,Georgia prompt pay law only applies to what type of plans?,93870,1,"b.	Fully insured Plans",1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30638,27,Georgia prompt pay law only applies to what type of plans?,93871,2,"c.	Government Plans",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30638,27,Georgia prompt pay law only applies to what type of plans?,93871,2,"c.	Government Plans",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30639,28,"By default, Med-Metrix serves you the highest priority account from your highest priority SmartFeed.",206121,0,TRUE,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30639,28,"By default, Med-Metrix serves you the highest priority account from your highest priority SmartFeed.",206121,0,TRUE,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30639,28,"By default, Med-Metrix serves you the highest priority account from your highest priority SmartFeed.",206122,1,FALSE,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30639,28,"By default, Med-Metrix serves you the highest priority account from your highest priority SmartFeed.",206122,1,FALSE,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30640,29,What is one of the biggest issues that cause a delay in insurance payments?,93875,0,"a.	Claim not on file",1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30640,29,What is one of the biggest issues that cause a delay in insurance payments?,93875,0,"a.	Claim not on file",1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30640,29,What is one of the biggest issues that cause a delay in insurance payments?,93876,1,"b.	Patient Address",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30640,29,What is one of the biggest issues that cause a delay in insurance payments?,93876,1,"b.	Patient Address",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30640,29,What is one of the biggest issues that cause a delay in insurance payments?,93877,2,"c.	NSH phone no. not on file",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,30640,29,What is one of the biggest issues that cause a delay in insurance payments?,93877,2,"c.	NSH phone no. not on file",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43169,30,"ATB is an abbreviation for ""Account Trial Balance"".",139607,0,TRUE,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43169,30,"ATB is an abbreviation for ""Account Trial Balance"".",139607,0,TRUE,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43169,30,"ATB is an abbreviation for ""Account Trial Balance"".",139608,1,FALSE,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43169,30,"ATB is an abbreviation for ""Account Trial Balance"".",139608,1,FALSE,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43170,31,Which of the following is a common reason for delay in receipt of insurance payment?,139609,0,"a.	Claim not on file",1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43170,31,Which of the following is a common reason for delay in receipt of insurance payment?,139609,0,"a.	Claim not on file",1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43170,31,Which of the following is a common reason for delay in receipt of insurance payment?,139610,1,"b.	Patient Address",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43170,31,Which of the following is a common reason for delay in receipt of insurance payment?,139610,1,"b.	Patient Address",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43170,31,Which of the following is a common reason for delay in receipt of insurance payment?,139611,2,"c.	NSH phone number not on file",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43170,31,Which of the following is a common reason for delay in receipt of insurance payment?,139611,2,"c.	NSH phone number not on file",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43171,32,The Timely Filing Matrix can be accessed via the Revenue Cycle Website.,139612,0,TRUE,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43171,32,The Timely Filing Matrix can be accessed via the Revenue Cycle Website.,139612,0,TRUE,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43171,32,The Timely Filing Matrix can be accessed via the Revenue Cycle Website.,139613,1,FALSE,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43171,32,The Timely Filing Matrix can be accessed via the Revenue Cycle Website.,139613,1,FALSE,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43172,33,Which system is used to access the Receivables Workstation (RWS)?,139614,0,"a.	The Tool",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43172,33,Which system is used to access the Receivables Workstation (RWS)?,139614,0,"a.	The Tool",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43172,33,Which system is used to access the Receivables Workstation (RWS)?,139615,1,"b.	OneContent",0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43172,33,Which system is used to access the Receivables Workstation (RWS)?,139615,1,"b.	OneContent",0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43172,33,Which system is used to access the Receivables Workstation (RWS)?,139616,2,"c.	STAR",1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43172,33,Which system is used to access the Receivables Workstation (RWS)?,139616,2,"c.	STAR",1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43173,34,STAR can be accessed from the Revenue Cycle Website.,139617,0,TRUE,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43173,34,STAR can be accessed from the Revenue Cycle Website.,139617,0,TRUE,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43173,34,STAR can be accessed from the Revenue Cycle Website.,139618,1,FALSE,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43173,34,STAR can be accessed from the Revenue Cycle Website.,139618,1,FALSE,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43174,35,Scanned documents can be viewed in STAR.,206138,0,TRUE,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43174,35,Scanned documents can be viewed in STAR.,206138,0,TRUE,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43174,35,Scanned documents can be viewed in STAR.,206139,1,FALSE,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43174,35,Scanned documents can be viewed in STAR.,206139,1,FALSE,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43175,36,MRO can be accessed via the ______________________.,206128,0,Med-Metrix,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43175,36,MRO can be accessed via the ______________________.,206128,0,Med-Metrix,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43175,36,MRO can be accessed via the ______________________.,206129,1,Revenue Cycle Website,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43175,36,MRO can be accessed via the ______________________.,206129,1,Revenue Cycle Website,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43175,36,MRO can be accessed via the ______________________.,206130,2,Internet Explorer,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43175,36,MRO can be accessed via the ______________________.,206130,2,Internet Explorer,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43176,37,"In STAR, free form notes are manually entered by users to document action taken on an account.",206131,0,TRUE,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43176,37,"In STAR, free form notes are manually entered by users to document action taken on an account.",206131,0,TRUE,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43176,37,"In STAR, free form notes are manually entered by users to document action taken on an account.",206132,1,FALSE,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43176,37,"In STAR, free form notes are manually entered by users to document action taken on an account.",206132,1,FALSE,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43177,38,Standard Note Codes are predefined notes that utilize a shortened numerical code to notate an action on an account for quick insertion in STAR.,206133,0,TRUE,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43177,38,Standard Note Codes are predefined notes that utilize a shortened numerical code to notate an action on an account for quick insertion in STAR.,206133,0,TRUE,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43177,38,Standard Note Codes are predefined notes that utilize a shortened numerical code to notate an action on an account for quick insertion in STAR.,206134,1,FALSE,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43177,38,Standard Note Codes are predefined notes that utilize a shortened numerical code to notate an action on an account for quick insertion in STAR.,206134,1,FALSE,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43178,39,OneContent is used to calculate patient financial responsibility.,139630,0,TRUE,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43178,39,OneContent is used to calculate patient financial responsibility.,139630,0,TRUE,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43178,39,OneContent is used to calculate patient financial responsibility.,139631,1,FALSE,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43178,39,OneContent is used to calculate patient financial responsibility.,139631,1,FALSE,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43179,40,Which system allows users to document medical records were requested using Event Triggers and Actions?,206135,0,OneContent,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43179,40,Which system allows users to document medical records were requested using Event Triggers and Actions?,206135,0,OneContent,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43179,40,Which system allows users to document medical records were requested using Event Triggers and Actions?,206136,1,STAR,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43179,40,Which system allows users to document medical records were requested using Event Triggers and Actions?,206136,1,STAR,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43179,40,Which system allows users to document medical records were requested using Event Triggers and Actions?,206137,2,Med-Metrix,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43179,40,Which system allows users to document medical records were requested using Event Triggers and Actions?,206137,2,Med-Metrix,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43180,41,"According to the Georgia Prompt Pay Law, insurers have 30 working days for electronic claims or 60 calendar days for paper claims to mail or send electronically a letter or electronic notice which states the reasons the insurer may have for failing to pay the claim.",139635,0,TRUE,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43180,41,"According to the Georgia Prompt Pay Law, insurers have 30 working days for electronic claims or 60 calendar days for paper claims to mail or send electronically a letter or electronic notice which states the reasons the insurer may have for failing to pay the claim.",139635,0,TRUE,0
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43180,41,"According to the Georgia Prompt Pay Law, insurers have 30 working days for electronic claims or 60 calendar days for paper claims to mail or send electronically a letter or electronic notice which states the reasons the insurer may have for failing to pay the claim.",139636,1,FALSE,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43180,41,"According to the Georgia Prompt Pay Law, insurers have 30 working days for electronic claims or 60 calendar days for paper claims to mail or send electronically a letter or electronic notice which states the reasons the insurer may have for failing to pay the claim.",139636,1,FALSE,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43181,42,"To access the Receivables Workstation in STAR, Collectors must select ""Financials"" before clicking the Login button.",139637,0,TRUE,1
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43181,42,"To access the Receivables Workstation in STAR, Collectors must select ""Financials"" before clicking the Login button.",139637,0,TRUE,1
4055,ILT-0000-18036,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43181,42,"To access the Receivables Workstation in STAR, Collectors must select ""Financials"" before clicking the Login button.",139638,1,FALSE,0
9814,Questions-0000-109,RCT: COMMERCIAL COLLECTIONS UNIVERSITY TEST 2019,n6232,43181,42,"To access the Receivables Workstation in STAR, Collectors must select ""Financials"" before clicking the Login button.",139638,1,FALSE,0
8253,Elearning-0000-1138,EMERGENCY DEPARTMENT:  MANAGEMENT OF THE PATIENT REQUIRING RESTRAINTS OR SECLUSION,n6234,30642,0,True or False?  Having both side rails up on an ED stretcher is considered a restraint.,93880,0,a. True,0
8253,Elearning-0000-1138,EMERGENCY DEPARTMENT:  MANAGEMENT OF THE PATIENT REQUIRING RESTRAINTS OR SECLUSION,n6234,30642,0,True or False?  Having both side rails up on an ED stretcher is considered a restraint.,93881,1,b. False,1
8253,Elearning-0000-1138,EMERGENCY DEPARTMENT:  MANAGEMENT OF THE PATIENT REQUIRING RESTRAINTS OR SECLUSION,n6234,30643,1,True or False?  Seclusion is the preferred method of restraint in the ED.,93882,0,a. True,0
8253,Elearning-0000-1138,EMERGENCY DEPARTMENT:  MANAGEMENT OF THE PATIENT REQUIRING RESTRAINTS OR SECLUSION,n6234,30643,1,True or False?  Seclusion is the preferred method of restraint in the ED.,93883,1,b. False,1
8253,Elearning-0000-1138,EMERGENCY DEPARTMENT:  MANAGEMENT OF THE PATIENT REQUIRING RESTRAINTS OR SECLUSION,n6234,30644,2,"True or False?  If a sedating medication is being given as part of the standard treatment for that patient's condition, it is not considered to be a chemical restraint.",93884,0,a. True,1
8253,Elearning-0000-1138,EMERGENCY DEPARTMENT:  MANAGEMENT OF THE PATIENT REQUIRING RESTRAINTS OR SECLUSION,n6234,30644,2,"True or False?  If a sedating medication is being given as part of the standard treatment for that patient's condition, it is not considered to be a chemical restraint.",93885,1,b. False,0
8253,Elearning-0000-1138,EMERGENCY DEPARTMENT:  MANAGEMENT OF THE PATIENT REQUIRING RESTRAINTS OR SECLUSION,n6234,30645,3,"True or False?  ALL restraint orders in the ED are good for 4 hours, after which time they must be renewed.",93886,0,a. True,0
8253,Elearning-0000-1138,EMERGENCY DEPARTMENT:  MANAGEMENT OF THE PATIENT REQUIRING RESTRAINTS OR SECLUSION,n6234,30645,3,"True or False?  ALL restraint orders in the ED are good for 4 hours, after which time they must be renewed.",93887,1,b. False,1
8253,Elearning-0000-1138,EMERGENCY DEPARTMENT:  MANAGEMENT OF THE PATIENT REQUIRING RESTRAINTS OR SECLUSION,n6234,30646,4,How often must a behavioral assessment be documented for the patient in violent restraints?,93888,0,a. Every 15 minutes,1
8253,Elearning-0000-1138,EMERGENCY DEPARTMENT:  MANAGEMENT OF THE PATIENT REQUIRING RESTRAINTS OR SECLUSION,n6234,30646,4,How often must a behavioral assessment be documented for the patient in violent restraints?,93889,1,b. Every 1 hour,0
8253,Elearning-0000-1138,EMERGENCY DEPARTMENT:  MANAGEMENT OF THE PATIENT REQUIRING RESTRAINTS OR SECLUSION,n6234,30646,4,How often must a behavioral assessment be documented for the patient in violent restraints?,93890,2,c. Every 2 hours,0
8253,Elearning-0000-1138,EMERGENCY DEPARTMENT:  MANAGEMENT OF THE PATIENT REQUIRING RESTRAINTS OR SECLUSION,n6234,30646,4,How often must a behavioral assessment be documented for the patient in violent restraints?,93891,3,d. Every 4 hours,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30667,0,1) Policy Numbers and Group Numbers must be entered on the STAR Insurance Form     without punctuation and spacing.,93953,0,TRUE,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30667,0,1) Policy Numbers and Group Numbers must be entered on the STAR Insurance Form     without punctuation and spacing.,93954,1,FALSE,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30668,1,"2) If there is no Group Number on the insurance card or in the RevRunner response,      then enter six nines in the Group number field.     (999999).",93955,0,TRUE,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30668,1,"2) If there is no Group Number on the insurance card or in the RevRunner response,      then enter six nines in the Group number field.     (999999).",93956,1,FALSE,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30669,2,"3) A patient's name is listed on his photo ID as Jeffrey Aaron Smith. His insurance card      lists his name as Jeff A Smith. In the Insured Name field of the STAR Insurance        Form, his name must be entered as:",93957,0,"A) Smith, Jeffrey Aaron",0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30669,2,"3) A patient's name is listed on his photo ID as Jeffrey Aaron Smith. His insurance card      lists his name as Jeff A Smith. In the Insured Name field of the STAR Insurance        Form, his name must be entered as:",93958,1,"B) Smith,Jeffrey",0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30669,2,"3) A patient's name is listed on his photo ID as Jeffrey Aaron Smith. His insurance card      lists his name as Jeff A Smith. In the Insured Name field of the STAR Insurance        Form, his name must be entered as:",93959,2,"C) Smith,Jeff A",1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30670,3,4)  Which of the following is the process for using plan code 301800 Commercial Other?,93960,0,A)  Use this code when the plan is not listed on the STAR Insurance Plan Codes          table and there are no Medicare Managed Care plan identifiers on the        insurance card.,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30670,3,4)  Which of the following is the process for using plan code 301800 Commercial Other?,93961,1,"B)	The insurance plan name shown on the card will need to be entered in the STAR Insurance Plan Name field.",0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30670,3,4)  Which of the following is the process for using plan code 301800 Commercial Other?,93962,2,C) All of the above,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30671,4,5) RevRunner should be utilized for all insurance eligibility requests.,93963,0,TRUE,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30671,4,5) RevRunner should be utilized for all insurance eligibility requests.,93964,1,FALSE,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30672,5,6) How would the Group Number be entered in STAR for this Insurance Card?,93965,0,A)  11111101400001,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30672,5,6) How would the Group Number be entered in STAR for this Insurance Card?,93966,1,B)  99999,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30672,5,6) How would the Group Number be entered in STAR for this Insurance Card?,93967,2,C)  111111-014-00001,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30673,6,7) How should the policy number for Jill Q Sample be entered in STAR?,93968,0,A)  W123456789,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30673,6,7) How should the policy number for Jill Q Sample be entered in STAR?,93969,1,B)  W1234 56789 03,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30673,6,7) How should the policy number for Jill Q Sample be entered in STAR?,93970,2,C)  W12345678903,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30674,7,8) What is the correct STAR Insurance plan code for this card?,93971,0,A) 400560,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30674,7,8) What is the correct STAR Insurance plan code for this card?,93972,1,B) 558011,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30674,7,8) What is the correct STAR Insurance plan code for this card?,93973,2,C) 558040,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30675,8,9) What is the correct STAR Insurance plan code for this card?,93974,0,A)  201955,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30675,8,9) What is the correct STAR Insurance plan code for this card?,93975,1,B)  204000,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30675,8,9) What is the correct STAR Insurance plan code for this card?,93976,2,C)  301800,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30676,9,"10) What needs to be entered in the ""Mail To Company"" field in the STAR Insurance        Form?",93977,0,"A)	378",0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30676,9,"10) What needs to be entered in the ""Mail To Company"" field in the STAR Insurance        Form?",93978,1,"B)	PA",1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30676,9,"10) What needs to be entered in the ""Mail To Company"" field in the STAR Insurance        Form?",93979,2,"C)	BCBS",0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30677,10,"11)  For Blue Cross Blue Shield Federal Employee Program plans, enter the Enrollment        Code in the STAR Insurance Group Number field.",93980,0,TRUE,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30677,10,"11)  For Blue Cross Blue Shield Federal Employee Program plans, enter the Enrollment        Code in the STAR Insurance Group Number field.",93981,1,FALSE,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30678,11,"12) For Aetna, BCBS, Cigna, Humana, and UHC cards not displaying any PPO, HMO,        POS, or Medicare Managed Care indicators, code the insurance plan as:",93982,0,A)  301800,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30678,11,"12) For Aetna, BCBS, Cigna, Humana, and UHC cards not displaying any PPO, HMO,        POS, or Medicare Managed Care indicators, code the insurance plan as:",93983,1,B) The payer's indemnity plan code,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30678,11,"12) For Aetna, BCBS, Cigna, Humana, and UHC cards not displaying any PPO, HMO,        POS, or Medicare Managed Care indicators, code the insurance plan as:",93984,2,C)  Make Self-Pay,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30679,12,13) What is the correct Insurance plan for this card?,93985,0,A) 606000,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30679,12,13) What is the correct Insurance plan for this card?,93986,1,B) 606020,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30679,12,13) What is the correct Insurance plan for this card?,93987,2,C) 608000,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30680,13,14) Enter the Subscriber # as the policy number for this insurance to       submit RevRunner eligibility request.,93988,0,TRUE,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30680,13,14) Enter the Subscriber # as the policy number for this insurance to       submit RevRunner eligibility request.,93989,1,FALSE,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30681,14,15) Medicare is always primary to Tricare and Medicaid.,93990,0,TRUE,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30681,14,15) Medicare is always primary to Tricare and Medicaid.,93991,1,FALSE,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30682,15,16) What is the correct Insurance Plan code for this Card?,93992,0,A) 407120,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30682,15,16) What is the correct Insurance Plan code for this Card?,93993,1,B)  407110,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30682,15,16) What is the correct Insurance Plan code for this Card?,93994,2,C)  407260,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30683,16,17) What is the correct Insurance Plan for this Card?,93995,0,A)  802030,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30683,16,17) What is the correct Insurance Plan for this Card?,93996,1,B)  402520,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30683,16,17) What is the correct Insurance Plan for this Card?,93997,2,C)  402500,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30684,17,18) What is the Group Number for this Insurance Card?,93998,0,A)  80840,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30684,17,18) What is the Group Number for this Insurance Card?,93999,1,B) 999999,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30684,17,18) What is the Group Number for this Insurance Card?,94000,2,C)  1234567,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30685,18,19) What is the correct Insurance Plan for this Card?,94001,0,A)  402520,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30685,18,19) What is the correct Insurance Plan for this Card?,94002,1,B)  406165,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30685,18,19) What is the correct Insurance Plan for this Card?,94003,2,C)  306190,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30686,19,20) The 11-digit DBN on the back of the card should be entered in the         STAR ID Card/DBN field.,94004,0,TRUE,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30686,19,20) The 11-digit DBN on the back of the card should be entered in the         STAR ID Card/DBN field.,94005,1,FALSE,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30687,20,21) What is the correct Insurance Plan for this Card (Patient goes to Kaiser Gwinnett)?,94006,0,A)  505401,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30687,20,21) What is the correct Insurance Plan for this Card (Patient goes to Kaiser Gwinnett)?,94007,1,B)  556401,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30687,20,21) What is the correct Insurance Plan for this Card (Patient goes to Kaiser Gwinnett)?,94008,2,C)  507401,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30688,22,22) What is the Policy Number for this Insurance Card?,94009,0,A)  0000000,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30688,22,22) What is the Policy Number for this Insurance Card?,94010,1,B)  1234-100,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30688,22,22) What is the Policy Number for this Insurance Card?,94011,2,C)  The Patients SS#,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30689,23,23)  Kaiser Policy Numbers are displayed on the insurance card as:,94012,0,A)  Health Record Number,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30689,23,23)  Kaiser Policy Numbers are displayed on the insurance card as:,94013,1,B)  Medical Record Number,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30689,23,23)  Kaiser Policy Numbers are displayed on the insurance card as:,94014,2,C)  Both A and B,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30690,25,24)  The Kaiser COB form must be completed for all patients with Kaiser insurance at          every visit.,94015,0,TRUE,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30690,25,24)  The Kaiser COB form must be completed for all patients with Kaiser insurance at          every visit.,94016,1,FALSE,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30691,27,25) What is the correct Insurance Plan for this Card?,94017,0,A)  556200,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30691,27,25) What is the correct Insurance Plan for this Card?,94018,1,B)  556300,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30691,27,25) What is the correct Insurance Plan for this Card?,94019,2,C)  557000,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30692,28,"26) When the patient presents a Medicare Part A and B card, but RevRunner returns an Other or Additional Payer Notification to indicate a Medicare Managed Care Plan but the patient is unable to provide complete plan details, code the insurance plan as:",94020,0,A) Medicare Managed Care,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30692,28,"26) When the patient presents a Medicare Part A and B card, but RevRunner returns an Other or Additional Payer Notification to indicate a Medicare Managed Care Plan but the patient is unable to provide complete plan details, code the insurance plan as:",94021,1,B) Medicare Part A and B only,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30692,28,"26) When the patient presents a Medicare Part A and B card, but RevRunner returns an Other or Additional Payer Notification to indicate a Medicare Managed Care Plan but the patient is unable to provide complete plan details, code the insurance plan as:",94022,2,C) Self Pay,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30693,29,"27)  If a Medicare patient is admitted as an inpatient, has Part A coverage, does         not have Part B coverage, and has no secondary coverage, the account should be         coded as Self-Pay.",94023,0,TRUE,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30693,29,"27)  If a Medicare patient is admitted as an inpatient, has Part A coverage, does         not have Part B coverage, and has no secondary coverage, the account should be         coded as Self-Pay.",94024,1,FALSE,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30694,30,"28) In the RevRunner Eligibility Detail Viewer, review the Notification bar and in the Subscriber section, Plan Detail, and Payer sections for data discrepancies.",94025,0,TRUE,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30694,30,"28) In the RevRunner Eligibility Detail Viewer, review the Notification bar and in the Subscriber section, Plan Detail, and Payer sections for data discrepancies.",94026,1,FALSE,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30695,31,29) The EDI # should be entered in the Payor ID field in STAR.,94027,0,TRUE,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30695,31,29) The EDI # should be entered in the Payor ID field in STAR.,94028,1,FALSE,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30696,32,30) When a patient has a policy suffix:,94029,0,A) Patient is insured,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30696,32,30) When a patient has a policy suffix:,94030,1,B) Do not remove suffix or change insured to subscriber per RevRunner,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,30696,32,30) When a patient has a policy suffix:,94031,2,C) Both A & B,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,47103,24,23)  Which of the following is TRUE when coding a Medicare Managed Care plan:,177702,0,"A)	The MBI field in STAR on the Medicare Managed Care Insurance Processing form must                                                be completed with the Medicare MBI Number, ask the patient for their Medicare MBI number.  If unable to obtain the MBI, registrar should enter (0 + HICN + Alpha Character) in the MBI field.",1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,47103,24,23)  Which of the following is TRUE when coding a Medicare Managed Care plan:,177703,1,"B)	Leave the Medicare Number STAR field blank if RevRunner does not provide the              Medicare MBI.",0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,47103,24,23)  Which of the following is TRUE when coding a Medicare Managed Care plan:,177704,2,C)  Enter the Medicare Managed Care Member ID in the STAR MBI field.,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,65844,26,24. Peachstate Ambetter is In-Network for all Northside facilities and should be coded to 401200.,220110,0,TRUE,1
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,65844,26,24. Peachstate Ambetter is In-Network for all Northside facilities and should be coded to 401200.,220111,1,FALSE,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,66034,21,21) What is the correct Insurance Plan for this Card?,220813,0,A)  505401,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,66034,21,21) What is the correct Insurance Plan for this Card?,220814,1,B)  556401,0
9827,Questions-0000-120,RCT: INSURANCE UNIVERSITY TEST (CURRENT),n6241,66034,21,21) What is the correct Insurance Plan for this Card?,220815,2,C)  508590,1
8245,Elearning-0000-1130,"OBSTRUCTIVE SLEEP APNEA, MOVING PAST STOP-BANG",n6245,30718,0,I acknowledge that I have read and understand the presentation on Obstructive Sleep Apnea -Stop Bang in it's entirety.,94108,0,TRUE,1
8245,Elearning-0000-1130,"OBSTRUCTIVE SLEEP APNEA, MOVING PAST STOP-BANG",n6245,30718,0,I acknowledge that I have read and understand the presentation on Obstructive Sleep Apnea -Stop Bang in it's entirety.,94109,1,FALSE,0
8249,Elearning-0000-1134,IUSS ROSTER,n6283,31080,0,I have read and understand the contents of the IUSS Roster CBL.,95446,0,TRUE,1
8249,Elearning-0000-1134,IUSS ROSTER,n6283,31080,0,I have read and understand the contents of the IUSS Roster CBL.,95447,1,FALSE,0
9101,Elearning-0000-369,NSH1169 AMENDMENT 7 - SELVITA,n6286,31083,0,I acknowledge that I have read and understand in its entirety the NSH1169 AMENDMENT 7 - SELVITA content.,95452,0,TRUE,1
9101,Elearning-0000-369,NSH1169 AMENDMENT 7 - SELVITA,n6286,31083,0,I acknowledge that I have read and understand in its entirety the NSH1169 AMENDMENT 7 - SELVITA content.,95453,1,FALSE,0
8250,Elearning-0000-1135,FORMALIN AND HAZARDOUS MATERIALS SPILL IN PROCEDURAL LOCATIONS,n6288,31087,0,"I acknowledge that I have read and understand the ""Formalin and Hazardous Materials Spill in Procedural Locations"" CBL in its entirety.",95464,0,TRUE,1
8250,Elearning-0000-1135,FORMALIN AND HAZARDOUS MATERIALS SPILL IN PROCEDURAL LOCATIONS,n6288,31087,0,"I acknowledge that I have read and understand the ""Formalin and Hazardous Materials Spill in Procedural Locations"" CBL in its entirety.",95465,1,FALSE,0
9356,Elearning-0000-600,FLEXIBLE LARYNGOSCOPE PRE-CLEANING,n6299,31168,0,Where does the flexible laryngoscope live?,95801,0,"a.	The GI lab",1
9356,Elearning-0000-600,FLEXIBLE LARYNGOSCOPE PRE-CLEANING,n6299,31168,0,Where does the flexible laryngoscope live?,95802,1,"b.	ED basement",0
9356,Elearning-0000-600,FLEXIBLE LARYNGOSCOPE PRE-CLEANING,n6299,31168,0,Where does the flexible laryngoscope live?,95803,2,"c.	CT2 equipment supply room",0
9356,Elearning-0000-600,FLEXIBLE LARYNGOSCOPE PRE-CLEANING,n6299,31169,1,Whom do you call to get the flexible laryngoscope and to take it back?,95804,0,"a.	You can get it yourself",0
9356,Elearning-0000-600,FLEXIBLE LARYNGOSCOPE PRE-CLEANING,n6299,31169,1,Whom do you call to get the flexible laryngoscope and to take it back?,95805,1,"b.	The supervisor",1
9356,Elearning-0000-600,FLEXIBLE LARYNGOSCOPE PRE-CLEANING,n6299,31169,1,Whom do you call to get the flexible laryngoscope and to take it back?,95806,2,"c.	The secretary",0
9356,Elearning-0000-600,FLEXIBLE LARYNGOSCOPE PRE-CLEANING,n6299,31170,2,Where do you place the yellow post-procedure sticker once it filled out?,95807,0,"a.	The patient's chart",0
9356,Elearning-0000-600,FLEXIBLE LARYNGOSCOPE PRE-CLEANING,n6299,31170,2,Where do you place the yellow post-procedure sticker once it filled out?,95808,1,"b.	The outside of the gray bin",0
9356,Elearning-0000-600,FLEXIBLE LARYNGOSCOPE PRE-CLEANING,n6299,31170,2,Where do you place the yellow post-procedure sticker once it filled out?,95809,2,"c.	The outside of the green bag",1
9356,Elearning-0000-600,FLEXIBLE LARYNGOSCOPE PRE-CLEANING,n6299,31171,3,How many patient labels do you need to send to the GI lab?,95810,0,"a.	1",0
9356,Elearning-0000-600,FLEXIBLE LARYNGOSCOPE PRE-CLEANING,n6299,31171,3,How many patient labels do you need to send to the GI lab?,95811,1,"b.	None",0
9356,Elearning-0000-600,FLEXIBLE LARYNGOSCOPE PRE-CLEANING,n6299,31171,3,How many patient labels do you need to send to the GI lab?,95812,2,"c.	3",1
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31369,0,Please list the location for this activity.,96611,0,Atlanta,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31369,0,Please list the location for this activity.,96612,1,Forsyth,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31369,0,Please list the location for this activity.,96613,2,Cherokee,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31369,0,Please list the location for this activity.,96614,3,Other,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31370,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the relationship between the electrical and mechanical systems of the heart as they relate to dysrhythmias. </ol>",96615,0,Strongly Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31370,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the relationship between the electrical and mechanical systems of the heart as they relate to dysrhythmias. </ol>",96616,1,Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31370,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the relationship between the electrical and mechanical systems of the heart as they relate to dysrhythmias. </ol>",96617,2,No Opinion,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31370,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the relationship between the electrical and mechanical systems of the heart as they relate to dysrhythmias. </ol>",96618,3,Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31370,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the relationship between the electrical and mechanical systems of the heart as they relate to dysrhythmias. </ol>",96619,4,Strongly Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31371,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the electrode location and polarity for each of the following bedside EKG monitoring leads:  I, II, III, aVR, aVL, V1, and V6. </ol>",96620,0,Strongly Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31371,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the electrode location and polarity for each of the following bedside EKG monitoring leads:  I, II, III, aVR, aVL, V1, and V6. </ol>",96621,1,Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31371,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the electrode location and polarity for each of the following bedside EKG monitoring leads:  I, II, III, aVR, aVL, V1, and V6. </ol>",96622,2,No Opinion,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31371,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the electrode location and polarity for each of the following bedside EKG monitoring leads:  I, II, III, aVR, aVL, V1, and V6. </ol>",96623,3,Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31371,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the electrode location and polarity for each of the following bedside EKG monitoring leads:  I, II, III, aVR, aVL, V1, and V6. </ol>",96624,4,Strongly Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31372,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify strategies to employ when faced with difficult to interpret cardiac rhythms. </ol>",96625,0,Strongly Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31372,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify strategies to employ when faced with difficult to interpret cardiac rhythms. </ol>",96626,1,Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31372,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify strategies to employ when faced with difficult to interpret cardiac rhythms. </ol>",96627,2,No Opinion,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31372,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify strategies to employ when faced with difficult to interpret cardiac rhythms. </ol>",96628,3,Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31372,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify strategies to employ when faced with difficult to interpret cardiac rhythms. </ol>",96629,4,Strongly Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31373,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the differences between complex dysrhythmias. </ol>",96630,0,Strongly Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31373,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the differences between complex dysrhythmias. </ol>",96631,1,Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31373,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the differences between complex dysrhythmias. </ol>",96632,2,No Opinion,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31373,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the differences between complex dysrhythmias. </ol>",96633,3,Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31373,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the differences between complex dysrhythmias. </ol>",96634,4,Strongly Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31374,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review conduction system anomalies that cause re-entry mechanisms and the development of tachycardia. </ol>",96635,0,Strongly Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31374,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review conduction system anomalies that cause re-entry mechanisms and the development of tachycardia. </ol>",96636,1,Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31374,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review conduction system anomalies that cause re-entry mechanisms and the development of tachycardia. </ol>",96637,2,No Opinion,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31374,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review conduction system anomalies that cause re-entry mechanisms and the development of tachycardia. </ol>",96638,3,Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31374,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review conduction system anomalies that cause re-entry mechanisms and the development of tachycardia. </ol>",96639,4,Strongly Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31375,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize two major EKG characteristics seen with WPW syndrome. </ol>",96640,0,Strongly Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31375,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize two major EKG characteristics seen with WPW syndrome. </ol>",96641,1,Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31375,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize two major EKG characteristics seen with WPW syndrome. </ol>",96642,2,No Opinion,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31375,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize two major EKG characteristics seen with WPW syndrome. </ol>",96643,3,Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31375,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize two major EKG characteristics seen with WPW syndrome. </ol>",96644,4,Strongly Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31376,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common reasons for QTI prolongation including medications administered in the critical care areas. </ol>",96645,0,Strongly Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31376,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common reasons for QTI prolongation including medications administered in the critical care areas. </ol>",96646,1,Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31376,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common reasons for QTI prolongation including medications administered in the critical care areas. </ol>",96647,2,No Opinion,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31376,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common reasons for QTI prolongation including medications administered in the critical care areas. </ol>",96648,3,Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31376,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common reasons for QTI prolongation including medications administered in the critical care areas. </ol>",96649,4,Strongly Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31377,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to summarize the EKG changes that may be seen with alterations in blood levels of potassium and calcium. </ol>",96650,0,Strongly Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31377,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to summarize the EKG changes that may be seen with alterations in blood levels of potassium and calcium. </ol>",96651,1,Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31377,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to summarize the EKG changes that may be seen with alterations in blood levels of potassium and calcium. </ol>",96652,2,No Opinion,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31377,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to summarize the EKG changes that may be seen with alterations in blood levels of potassium and calcium. </ol>",96653,3,Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31377,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to summarize the EKG changes that may be seen with alterations in blood levels of potassium and calcium. </ol>",96654,4,Strongly Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31378,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss strategies for cardiac alarm management that may reduce alarm fatigue and improve patient safety. </ol>",96655,0,Strongly Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31378,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss strategies for cardiac alarm management that may reduce alarm fatigue and improve patient safety. </ol>",96656,1,Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31378,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss strategies for cardiac alarm management that may reduce alarm fatigue and improve patient safety. </ol>",96657,2,No Opinion,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31378,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss strategies for cardiac alarm management that may reduce alarm fatigue and improve patient safety. </ol>",96658,3,Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31378,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss strategies for cardiac alarm management that may reduce alarm fatigue and improve patient safety. </ol>",96659,4,Strongly Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31379,10,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,96660,0,Strongly Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31379,10,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,96661,1,Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31379,10,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,96662,2,No Opinion,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31379,10,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,96663,3,Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31379,10,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,96664,4,Strongly Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31380,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",96665,0,Strongly Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31380,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",96666,1,Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31380,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",96667,2,No Opinion,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31380,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",96668,3,Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31380,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",96669,4,Strongly Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31381,12,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias. <OL>,96670,0,Strongly Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31381,12,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias. <OL>,96671,1,Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31381,12,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias. <OL>,96672,2,No Opinion,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31381,12,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias. <OL>,96673,3,Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31381,12,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias. <OL>,96674,4,Strongly Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31382,14,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",96675,0,Excellent,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31382,14,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",96676,1,Very Good,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31382,14,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",96677,2,Good,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31382,14,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",96678,3,Fair,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31382,14,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",96679,4,Poor,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31383,13,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,96680,0,Strongly Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31383,13,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,96681,1,Agree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31383,13,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,96682,2,No Opinion,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31383,13,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,96683,3,Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31383,13,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,96684,4,Strongly Disagree,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31384,15,"Overall, this activity was:",96685,0,Excellent,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31384,15,"Overall, this activity was:",96686,1,Very Good,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31384,15,"Overall, this activity was:",96687,2,Good,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31384,15,"Overall, this activity was:",96688,3,Fair,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31384,15,"Overall, this activity was:",96689,4,Poor,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31385,16,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",96690,0,Yes,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31385,16,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",96691,1,No,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31385,16,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",96692,2,N/A,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31388,19,How would you improve this class?,96693,0,Reduce content covered in class,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31388,19,How would you improve this class?,96694,1,Increase content covered in class,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31388,19,How would you improve this class?,96695,2,Update content covered in class,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31388,19,How would you improve this class?,96696,3,Improve the instructional methods,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31388,19,How would you improve this class?,96697,4,Make course activities more stimulating,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31388,19,How would you improve this class?,96698,5,Slow the pace of the class,0
541,ILT-0000-1571,ADVANCED DYSRHYTHMIA RECOGNITION  NSF 3.5.18,n6324,31388,19,How would you improve this class?,96699,6,"No changes needed: (appropriate speaker, handouts, setting, etc.)",0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31584,0,"When cleaning the operating room between cases, when is the trash from the completed case removed?",97370,0,A) After anesthesia supplies are removed,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31584,0,"When cleaning the operating room between cases, when is the trash from the completed case removed?",97371,1,B) After linen and supplies used in the completed case are contained,1
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31584,0,"When cleaning the operating room between cases, when is the trash from the completed case removed?",97372,2,"C) Either A or B, depending upon when the team can get to it",0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31585,1,The linen and trash from the completed case have been collected and contained. Where do you place the trash while cleaning?,97373,0,A) In the OR hallway just outside the door,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31585,1,The linen and trash from the completed case have been collected and contained. Where do you place the trash while cleaning?,97374,1,B) In the OR being cleaned just inside the door,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31585,1,The linen and trash from the completed case have been collected and contained. Where do you place the trash while cleaning?,97375,2,C)  In the designated trash room,1
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31586,2,When can the OR staff or Anesthesia staff bring supplies for the next case in the room?,97376,0,"A) During the cleaning process, once the OR staff starts cleaning the floor",0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31586,2,When can the OR staff or Anesthesia staff bring supplies for the next case in the room?,97377,1,"B) During the cleaning process, once the anesthesia staff has cleaned their area",0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31586,2,When can the OR staff or Anesthesia staff bring supplies for the next case in the room?,97378,2,C) After cleaning of the surgical suite is completed,1
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31587,3,"After removing gloves used for cleaning, when must you perform hand hygiene?",97379,0,A) Only if your glove had a hole in it,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31587,3,"After removing gloves used for cleaning, when must you perform hand hygiene?",97380,1,B) The next time you eat,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31587,3,"After removing gloves used for cleaning, when must you perform hand hygiene?",97381,2,"C) Immediately after removing the used glove and prior to performing other duties, including applying clean linen .",1
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31588,4,What items are to be discarded in biohazard trash?,97382,0,A) Disposable items that are saturated with blood and tissue that they would produce dripping if squeezed.,1
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31588,4,What items are to be discarded in biohazard trash?,97383,1,B)  All disposable items that have blood or tissue on it.,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31588,4,What items are to be discarded in biohazard trash?,97384,2,C)  Reusable items that have blood on it,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31589,5,When is the turn over cleaning team expected to perform hand hygiene?,97385,0,A) When they have time,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31589,5,When is the turn over cleaning team expected to perform hand hygiene?,97386,1,B) When someone is monitoring for compliance,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31589,5,When is the turn over cleaning team expected to perform hand hygiene?,97387,2,C) When removing gloves after cleaning the suite,1
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31590,6,What direction is cleaning performed in?,97388,0,A) Out to In; Top to bottom; Clean to dirty,1
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31590,6,What direction is cleaning performed in?,97389,1,B) In to Out; Top to bottom; Dirty to Clean,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31590,6,What direction is cleaning performed in?,97390,2,C) Out to In; Bottom to Top;  Clean to dirty,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31591,7,Where can you locate the MSDS for the cleaning products you use to clean the surgical suite?,97391,0,A) In the Lucidoc under policy and procedure,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31591,7,Where can you locate the MSDS for the cleaning products you use to clean the surgical suite?,97392,1,B) On the Northside Intranet  under Information Sources,1
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31591,7,Where can you locate the MSDS for the cleaning products you use to clean the surgical suite?,97393,2,C) In Employee Health,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31591,7,Where can you locate the MSDS for the cleaning products you use to clean the surgical suite?,97394,3,D) In security,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31592,8,Which of the following are FALSE: How do you prepare disinfectant when you are required to mix it?,97395,0,A) Cleaning cloths can be dipped into disinfectant after being used,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31592,8,Which of the following are FALSE: How do you prepare disinfectant when you are required to mix it?,97396,1,B) Anesthesia equipment is cleaned between cases,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31592,8,Which of the following are FALSE: How do you prepare disinfectant when you are required to mix it?,97397,2,C) PPE is worn any tine you are cleaning the surgical suite,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31592,8,Which of the following are FALSE: How do you prepare disinfectant when you are required to mix it?,97398,3,D) Brooms are allowed for sweeping up large debris,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31592,8,Which of the following are FALSE: How do you prepare disinfectant when you are required to mix it?,97399,4,E) A and D,1
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31593,9,Which of the following are True:,97400,0,A) Team members are NOT required to adhere standard precaution,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31593,9,Which of the following are True:,97401,1,B Team members are NOT required to wear PPE when cleaning the operating room,0
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31593,9,Which of the following are True:,97402,2,C) Brooms are NOT allowed to be used in the operating room for cleaning,1
9400,Elearning-0000-640,CLEANING THE OPERATING ROOM FIRST CASE BETWEEN CASES AND WHEN TRANSFERRING EQUIPMENT,n6351,31593,9,Which of the following are True:,97403,3,D) Team members DO NOT have to perform hand hygiene upon entry into the surgical suite or after removing gloves.,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31646,0,Please list the location for this activity.,97633,0,Atlanta,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31646,0,Please list the location for this activity.,97634,1,Forsyth,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31646,0,Please list the location for this activity.,97635,2,Cherokee,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31646,0,Please list the location for this activity.,97636,3,Other,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31647,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",97637,0,Strongly Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31647,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",97638,1,Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31647,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",97639,2,No Opinion,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31647,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",97640,3,Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31647,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",97641,4,Strongly Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31648,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",97642,0,Strongly Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31648,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",97643,1,Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31648,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",97644,2,No Opinion,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31648,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",97645,3,Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31648,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",97646,4,Strongly Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31649,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",97647,0,Strongly Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31649,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",97648,1,Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31649,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",97649,2,No Opinion,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31649,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",97650,3,Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31649,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",97651,4,Strongly Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31650,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",97652,0,Strongly Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31650,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",97653,1,Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31650,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",97654,2,No Opinion,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31650,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",97655,3,Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31650,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",97656,4,Strongly Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31651,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",97657,0,Strongly Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31651,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",97658,1,Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31651,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",97659,2,No Opinion,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31651,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",97660,3,Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31651,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",97661,4,Strongly Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31652,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",97662,0,Strongly Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31652,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",97663,1,Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31652,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",97664,2,No Opinion,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31652,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",97665,3,Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31652,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",97666,4,Strongly Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31653,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",97667,0,Strongly Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31653,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",97668,1,Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31653,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",97669,2,No Opinion,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31653,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",97670,3,Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31653,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",97671,4,Strongly Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31654,8,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,97672,0,Strongly Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31654,8,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,97673,1,Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31654,8,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,97674,2,No Opinion,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31654,8,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,97675,3,Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31654,8,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,97676,4,Strongly Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31655,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,97677,0,Strongly Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31655,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,97678,1,Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31655,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,97679,2,No Opinion,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31655,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,97680,3,Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31655,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,97681,4,Strongly Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31656,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",97682,0,Strongly Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31656,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",97683,1,Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31656,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",97684,2,No Opinion,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31656,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",97685,3,Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31656,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",97686,4,Strongly Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31657,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",97687,0,Strongly Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31657,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",97688,1,Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31657,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",97689,2,No Opinion,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31657,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",97690,3,Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31657,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",97691,4,Strongly Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31658,12,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,97692,0,Strongly Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31658,12,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,97693,1,Agree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31658,12,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,97694,2,No Opinion,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31658,12,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,97695,3,Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31658,12,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,97696,4,Strongly Disagree,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31659,13,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN </ol>",97697,0,Excellent,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31659,13,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN </ol>",97698,1,Very Good,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31659,13,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN </ol>",97699,2,Good,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31659,13,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN </ol>",97700,3,Fair,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31659,13,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN </ol>",97701,4,Poor,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31660,14,"Overall, this activity was:",97702,0,Excellent,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31660,14,"Overall, this activity was:",97703,1,Very Good,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31660,14,"Overall, this activity was:",97704,2,Good,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31660,14,"Overall, this activity was:",97705,3,Fair,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31660,14,"Overall, this activity was:",97706,4,Poor,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31661,15,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",97707,0,Yes,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31661,15,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",97708,1,No,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31661,15,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",97709,2,N/A,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31664,18,How would you improve this class?,97710,0,Reduce content covered in class,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31664,18,How would you improve this class?,97711,1,Increase content covered in class,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31664,18,How would you improve this class?,97712,2,Update content covered in class,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31664,18,How would you improve this class?,97713,3,Improve the instructional methods,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31664,18,How would you improve this class?,97714,4,Make course activities more stimulating,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31664,18,How would you improve this class?,97715,5,Slow the pace of the class,0
3491,ILT-0000-15323,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING NSA (EVALUATION SURVEY)  4.13.18,n6363,31664,18,How would you improve this class?,97716,6,"Nothing: (appropriate content, speaker, setting, setting.)",0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31810,0,Bladder cancer is more often diagnosed in males than females,98309,0,TRUE,1
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31810,0,Bladder cancer is more often diagnosed in males than females,98310,1,FALSE,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31811,1,"More than 72,000 new cases of bladder cancer are diagnosed each year",98311,0,TRUE,1
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31811,1,"More than 72,000 new cases of bladder cancer are diagnosed each year",98312,1,FALSE,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31812,2,Early detection of bladder cancer can help reduce the need for,98321,0,1. intravesical immunotherapy,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31812,2,Early detection of bladder cancer can help reduce the need for,98322,1,2. chemotherapy,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31812,2,Early detection of bladder cancer can help reduce the need for,98323,2,3. radical surgical excision,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31812,2,Early detection of bladder cancer can help reduce the need for,98324,3,4. chemoradiation,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31812,2,Early detection of bladder cancer can help reduce the need for,98325,4,a.     1 and 2,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31812,2,Early detection of bladder cancer can help reduce the need for,98326,5,b. 3 and 4,1
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31812,2,Early detection of bladder cancer can help reduce the need for,98327,6,"c.     1, 2 and 3",0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31812,2,Early detection of bladder cancer can help reduce the need for,98328,7,"d. 1, 2, 3, and 4",0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31813,3,Hexaminolevulinate HCl (Cysview) is a optical imaging agent used in blue light cystoscopy to detect non-muscle invasive bladder cancer,98329,0,TRUE,1
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31813,3,Hexaminolevulinate HCl (Cysview) is a optical imaging agent used in blue light cystoscopy to detect non-muscle invasive bladder cancer,98330,1,FALSE,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31814,4,There is a 3 hour window for procedure once Cysview is instilled in the bladder,98331,0,TRUE,1
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31814,4,There is a 3 hour window for procedure once Cysview is instilled in the bladder,98332,1,FALSE,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31815,5,Hexaminolevulinate HCl works by entering the mucosal cells of the bladder wall and causing tumor tissue to appear pink or red while normal tissue appears blue,98333,0,TRUE,1
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31815,5,Hexaminolevulinate HCl works by entering the mucosal cells of the bladder wall and causing tumor tissue to appear pink or red while normal tissue appears blue,98334,1,FALSE,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31816,6,Patient pre op teaching should include,98335,0,1. Describing the process for instillation of Cysview using an intermittent catheter,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31816,6,Patient pre op teaching should include,98336,1,2. Describing potential adverse reactions,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31816,6,Patient pre op teaching should include,98337,2,3. Explaining rationale for retaining the hexaminolevulinate HCl for at least 1 hour,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31816,6,Patient pre op teaching should include,98338,3,4. Describing how hexaminolevulinate HCl works in the TURBT,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31816,6,Patient pre op teaching should include,98339,4,a. 1 and 2,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31816,6,Patient pre op teaching should include,98340,5,b. 3 and 4,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31816,6,Patient pre op teaching should include,98341,6,"c.    2, 3, and 4",0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31816,6,Patient pre op teaching should include,98342,7,"d. 1,2,3, and 4",1
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31817,7,Important considerations regarding instillation of Cysview include:,98343,0,1. Eliminating Cysview from the patient's bladder 30 minutes prior to cysto or at the initiation of the cysto procedure by the MD,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31817,7,Important considerations regarding instillation of Cysview include:,98344,1,2. Instructing the patient to hold the solution in their bladder for at least one hour and a maximum of 3 hours,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31817,7,Important considerations regarding instillation of Cysview include:,98345,2,3. Waiting to begin the blue light cysto after the Cysview has been in the patient's bladder for at least one hour,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31817,7,Important considerations regarding instillation of Cysview include:,98346,3,"4. Pharmacy at NSH reconstitutes the medication, labels, and brings to pre-op",0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31817,7,Important considerations regarding instillation of Cysview include:,98347,4,a. 1 and 2,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31817,7,Important considerations regarding instillation of Cysview include:,98348,5,b. 3 and 4,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31817,7,Important considerations regarding instillation of Cysview include:,98349,6,"c. 1, 2, and 3",0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31817,7,Important considerations regarding instillation of Cysview include:,98350,7,"d. 1, 2, 3, and 4",1
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31818,8,One of the contraindications for Cysview is gross hematuria,98351,0,TRUE,1
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31818,8,One of the contraindications for Cysview is gross hematuria,98352,1,FALSE,0
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31819,9,The most common patient complaints include bladder spasms and blood in the urine,98353,0,TRUE,1
9539,Elearning-0000-767,BLUE LIGHT CYSTOSCOPY,n6388,31819,9,The most common patient complaints include bladder spasms and blood in the urine,98354,1,FALSE,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31822,0,All breastfeeding mothers who have babies admitted to the NICU should start pumping within what time frame?,98359,0,Within 6 hours of delivery,1
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31822,0,All breastfeeding mothers who have babies admitted to the NICU should start pumping within what time frame?,98360,1,Within 6 hours of admission to FCC,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31822,0,All breastfeeding mothers who have babies admitted to the NICU should start pumping within what time frame?,98361,2,24 hours after delivery,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31822,0,All breastfeeding mothers who have babies admitted to the NICU should start pumping within what time frame?,98362,3,Any time before discharge,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31823,1,Who is responsible for ensuring the breast pump and kit are in the room for a mother on FCC whose baby is transferred to the NICU at 28 hours of life?,98363,0,The PCT who sets up the room,1
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31823,1,Who is responsible for ensuring the breast pump and kit are in the room for a mother on FCC whose baby is transferred to the NICU at 28 hours of life?,98364,1,The nurse caring for the mother,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31823,1,Who is responsible for ensuring the breast pump and kit are in the room for a mother on FCC whose baby is transferred to the NICU at 28 hours of life?,98365,2,The anchor nurse,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31823,1,Who is responsible for ensuring the breast pump and kit are in the room for a mother on FCC whose baby is transferred to the NICU at 28 hours of life?,98366,3,This mother does not need to pump,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31824,2,How many times should a mother whose baby is in NICU pump during a 24 hour period?,98367,0,5 times for 15-20 minutes,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31824,2,How many times should a mother whose baby is in NICU pump during a 24 hour period?,98368,1,At least 8 times for 15 minutes,1
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31824,2,How many times should a mother whose baby is in NICU pump during a 24 hour period?,98369,2,Every 4 hours,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31824,2,How many times should a mother whose baby is in NICU pump during a 24 hour period?,98370,3,As many times as she can,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31825,3,Which of the following lists the 3 step communication process?,98371,0,"Open-ended concerns, validate, educate",0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31825,3,Which of the following lists the 3 step communication process?,98372,1,"Open-ended questions, validation/affirmation, share information",1
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31825,3,Which of the following lists the 3 step communication process?,98373,2,"Ask questions, confirm mom's fears, educate all of the family",0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31825,3,Which of the following lists the 3 step communication process?,98374,3,Any of the above,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31826,4,When educating parents you should remember:,98375,0,Adults learn more with small amounts of information in repeated conversations,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31826,4,When educating parents you should remember:,98376,1,Adults are more interested in solutions than rules or policies,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31826,4,When educating parents you should remember:,98377,2,Adults respect information they are interested in,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31826,4,When educating parents you should remember:,98378,3,All of the above,1
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31827,5,Which of the statements are true?,98379,0,Rooming in is not available at Northside Hospital,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31827,5,Which of the statements are true?,98380,1,Parents should be encouraged to keep their infant in the nursery at night so they can rest,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31827,5,Which of the statements are true?,98381,2,Rooming-in is available 24/7 and should be encouraged for all breastfeeding couplets,1
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31827,5,Which of the statements are true?,98382,3,Rooming-in is only for breastfeeding couplets,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31828,6,A formula feeding mother asks when she should discard a formula bottle after opening. What is the correct response?,98383,0,1 hour after opening,1
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31828,6,A formula feeding mother asks when she should discard a formula bottle after opening. What is the correct response?,98384,1,6 hours after opening,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31828,6,A formula feeding mother asks when she should discard a formula bottle after opening. What is the correct response?,98385,2,You should feed the entire bottle to your newborn,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31828,6,A formula feeding mother asks when she should discard a formula bottle after opening. What is the correct response?,98386,3,15-20 minutes after opening,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31829,7,While obtaining vital signs of a newborn you notice her respiratory rate is 77. What is the appropriate action regarding feeding this newborn?,98387,0,Hold feedings and notify the nurse caring for the newborn,1
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31829,7,While obtaining vital signs of a newborn you notice her respiratory rate is 77. What is the appropriate action regarding feeding this newborn?,98388,1,Feed the baby anyway.,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31829,7,While obtaining vital signs of a newborn you notice her respiratory rate is 77. What is the appropriate action regarding feeding this newborn?,98389,2,Nothing. This is a normal respiratory rate.,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31829,7,While obtaining vital signs of a newborn you notice her respiratory rate is 77. What is the appropriate action regarding feeding this newborn?,98390,3,B and C,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31830,8,A new father tells you he is concerned his son is not getting enough to eat because he has only had 2 wet diapers. The infant is 36 hours old. What is the appropriate response?,98391,0,That is concerning. Let me call the nurse.,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31830,8,A new father tells you he is concerned his son is not getting enough to eat because he has only had 2 wet diapers. The infant is 36 hours old. What is the appropriate response?,98392,1,A lot of new parents worry their infant isn't getting enough. 2 wet diapers by 48 hours of life is normal. Let me get your nurse so you can discuss this with her.,1
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31830,8,A new father tells you he is concerned his son is not getting enough to eat because he has only had 2 wet diapers. The infant is 36 hours old. What is the appropriate response?,98393,2,You're being silly. You shouldn't worry about things like that.,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31830,8,A new father tells you he is concerned his son is not getting enough to eat because he has only had 2 wet diapers. The infant is 36 hours old. What is the appropriate response?,98394,3,You should probably feed the baby more frequently to increase his output,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31831,9,A formula feeding mother asks how much she should feed her 1 day old infant. What is the appropriate response?,98395,0,As much as he will eat.,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31831,9,A formula feeding mother asks how much she should feed her 1 day old infant. What is the appropriate response?,98396,1,No more than an ounce per feeding,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31831,9,A formula feeding mother asks how much she should feed her 1 day old infant. What is the appropriate response?,98397,2,About a teaspoon is all he needs,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31831,9,A formula feeding mother asks how much she should feed her 1 day old infant. What is the appropriate response?,98398,3,No more than 15 ml at a time but watch for signs of fullness. Many newborns require as little as teaspoon per feeding in the first day of life.,1
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31832,10,You are assisting a mother with breastfeeding her 6 hour old infant. The infant is sleepy and not showing interest in feeding. Select the best response below.,98399,0,You should give your baby formula and you can try to breastfeed later.,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31832,10,You are assisting a mother with breastfeeding her 6 hour old infant. The infant is sleepy and not showing interest in feeding. Select the best response below.,98400,1,It is normal for babies to be sleepy the first day. Let me help you with hand expression and skin to skin.,1
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31832,10,You are assisting a mother with breastfeeding her 6 hour old infant. The infant is sleepy and not showing interest in feeding. Select the best response below.,98401,2,This is extremely abnormal. Let me get your nurse.,0
9140,Elearning-0000-404,FCC NEWBORN NUTRITION PCT ONLY,n6391,31832,10,You are assisting a mother with breastfeeding her 6 hour old infant. The infant is sleepy and not showing interest in feeding. Select the best response below.,98402,3,You probably need a breast pump. I will go get you one.,0
148,SCORM-0000-23,CREDENTIALING PROCESS - OVERVIEW,n6433,32079,0,I have read and understood the content within the Credentialing Process - Overview CBL.,99289,0,TRUE,1
148,SCORM-0000-23,CREDENTIALING PROCESS - OVERVIEW,n6433,32079,0,I have read and understood the content within the Credentialing Process - Overview CBL.,99290,1,FALSE,0
8237,Elearning-0000-1123,RCT: MEDICARE BENEFICIARY IDENTIFIER (MBI) CBL,n6437,32095,0,I acknowledge that I have  read and understand in its entirety the RCT: Medicare Beneficiary Identifier (MBI) CBL.,99338,0,TRUE,1
8237,Elearning-0000-1123,RCT: MEDICARE BENEFICIARY IDENTIFIER (MBI) CBL,n6437,32095,0,I acknowledge that I have  read and understand in its entirety the RCT: Medicare Beneficiary Identifier (MBI) CBL.,99339,1,FALSE,0
8236,Elearning-0000-1122,RCT: FAMILY MEDICAL LEAVE ACT (FMLA) AND AMERICANS WITH DISABILITIES ACT (ADA) INFORMATION FOR STAFF MEMBERS,n6447,32117,0,I acknowledge that I have read and understand in its entirety the Family Medical Leave Act (FMLA) and Americans With Disabilities (ADA) Information for Staff CBL.,99398,0,TRUE,1
8236,Elearning-0000-1122,RCT: FAMILY MEDICAL LEAVE ACT (FMLA) AND AMERICANS WITH DISABILITIES ACT (ADA) INFORMATION FOR STAFF MEMBERS,n6447,32117,0,I acknowledge that I have read and understand in its entirety the Family Medical Leave Act (FMLA) and Americans With Disabilities (ADA) Information for Staff CBL.,99399,1,FALSE,0
8387,Elearning-0000-1259,GREENWAY CLINICAL NOTE DOCUMENTATION SESSION 1,n6480,32372,0,I have read and understand Greenway Clinical Note Documentation Session 1,100372,0,TRUE,1
8387,Elearning-0000-1259,GREENWAY CLINICAL NOTE DOCUMENTATION SESSION 1,n6480,32372,0,I have read and understand Greenway Clinical Note Documentation Session 1,100373,1,FALSE,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32292,0,What are the three products used in the SpaceCare QL System?,100031,0,a. High Mileage Floor Finish,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32292,0,What are the three products used in the SpaceCare QL System?,100032,1,b. Ecolab Oxycide or Virex II 256,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32292,0,What are the three products used in the SpaceCare QL System?,100033,2,c. Pro Strip HD,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32292,0,What are the three products used in the SpaceCare QL System?,100034,3,d. Stride,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32292,0,What are the three products used in the SpaceCare QL System?,100035,4,e. Glance,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32292,0,What are the three products used in the SpaceCare QL System?,100036,5,"f. B, D and E",1
8908,Elearning-0000-193,SPACECARE QL,n6474,32293,1,Glance can be used to clean ___________________.,100037,0,a. Glass,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32293,1,Glance can be used to clean ___________________.,100038,1,b. Metal,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32293,1,Glance can be used to clean ___________________.,100039,2,c. Ceramic,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32293,1,Glance can be used to clean ___________________.,100040,3,d. Laminate and painted surfaces,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32293,1,Glance can be used to clean ___________________.,100041,4,e. All of the above,1
8908,Elearning-0000-193,SPACECARE QL,n6474,32294,2,Ecolab Oxycide or Virex II 256 are the disinfectant product for use in sanitizing and cleaning in the SpaceCare QL System.,100042,0,TRUE,1
8908,Elearning-0000-193,SPACECARE QL,n6474,32294,2,Ecolab Oxycide or Virex II 256 are the disinfectant product for use in sanitizing and cleaning in the SpaceCare QL System.,100043,1,FALSE,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32295,3,Which safety equipment should be worn when mixing RTU solution with the Dispensers?,100044,0,a. Gloves and goggles,1
8908,Elearning-0000-193,SPACECARE QL,n6474,32295,3,Which safety equipment should be worn when mixing RTU solution with the Dispensers?,100045,1,b. Goggles and apron,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32295,3,Which safety equipment should be worn when mixing RTU solution with the Dispensers?,100046,2,c. Wet Floor Sign,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32295,3,Which safety equipment should be worn when mixing RTU solution with the Dispensers?,100047,3,"d. Gloves, goggles and Wet Floor sign",0
8908,Elearning-0000-193,SPACECARE QL,n6474,32295,3,Which safety equipment should be worn when mixing RTU solution with the Dispensers?,100048,4,e. None of the above,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32296,4,The eductor is a device inside the dispenser that mixes concentrated product and water together to make a RTU solution.,100049,0,TRUE,1
8908,Elearning-0000-193,SPACECARE QL,n6474,32296,4,The eductor is a device inside the dispenser that mixes concentrated product and water together to make a RTU solution.,100050,1,FALSE,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32297,5,Which of the following is NOT one of the five daily steps for patient room cleaning?,100051,0,a. Restock & Pull Trash,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32297,5,Which of the following is NOT one of the five daily steps for patient room cleaning?,100052,1,b. Sanitize horizontal surfaces,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32297,5,Which of the following is NOT one of the five daily steps for patient room cleaning?,100053,2,c. Dust the ceiling vents,1
8908,Elearning-0000-193,SPACECARE QL,n6474,32297,5,Which of the following is NOT one of the five daily steps for patient room cleaning?,100054,3,d. Clean fixtures,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32297,5,Which of the following is NOT one of the five daily steps for patient room cleaning?,100055,4,e. Microfiber Mop the floors,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32297,5,Which of the following is NOT one of the five daily steps for patient room cleaning?,100056,5,f. Final Inspection,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32298,7,Floor cleaning with the microfiber mop uses the ____________________ motion to catch dirt and debris.,100057,0,a. Zigzag,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32298,7,Floor cleaning with the microfiber mop uses the ____________________ motion to catch dirt and debris.,100058,1,b. Back and forth,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32298,7,Floor cleaning with the microfiber mop uses the ____________________ motion to catch dirt and debris.,100059,2,c. S-stroke,1
8908,Elearning-0000-193,SPACECARE QL,n6474,32298,7,Floor cleaning with the microfiber mop uses the ____________________ motion to catch dirt and debris.,100060,3,d. The Corbomite maneuver,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32299,8,Start cleaning the floor with the microfiber mop and pad at the point furthest from _______________.,100061,0,a. The patient bed,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32299,8,Start cleaning the floor with the microfiber mop and pad at the point furthest from _______________.,100062,1,b. The patient room door,1
8908,Elearning-0000-193,SPACECARE QL,n6474,32299,8,Start cleaning the floor with the microfiber mop and pad at the point furthest from _______________.,100063,2,c. The bathroom,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32299,8,Start cleaning the floor with the microfiber mop and pad at the point furthest from _______________.,100064,3,d. The nurse's station,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32300,9,"When performing patient room cleaning, the microfiber pad should be changed every three to four rooms, or when soiled.",100065,0,TRUE,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32300,9,"When performing patient room cleaning, the microfiber pad should be changed every three to four rooms, or when soiled.",100066,1,FALSE,1
8908,Elearning-0000-193,SPACECARE QL,n6474,32301,10,The microfiber pad should be _________________________ thoroughly before reuse.,100067,0,a. Laundered,1
8908,Elearning-0000-193,SPACECARE QL,n6474,32301,10,The microfiber pad should be _________________________ thoroughly before reuse.,100068,1,b. Rung out,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32301,10,The microfiber pad should be _________________________ thoroughly before reuse.,100069,2,c. Shaken,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32301,10,The microfiber pad should be _________________________ thoroughly before reuse.,100070,3,d. Dried,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32302,11,"When cleaning a restroom, all surfaces are cleaned with _______________ and sanitized with _______________.",100071,0,a. Stride & Oxycide or Virex II 256,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32302,11,"When cleaning a restroom, all surfaces are cleaned with _______________ and sanitized with _______________.",100072,1,b. Glance & Crew,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32302,11,"When cleaning a restroom, all surfaces are cleaned with _______________ and sanitized with _______________.",100073,2,c. Pro Strip HD and Glance,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32302,11,"When cleaning a restroom, all surfaces are cleaned with _______________ and sanitized with _______________.",100074,3,d. Glance and Oxycide or Virex II 256,1
8908,Elearning-0000-193,SPACECARE QL,n6474,32303,12,The final step in the space cleaning steps is to _______________________.,100075,0,a. Report the completed room to your supervisor,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32303,12,The final step in the space cleaning steps is to _______________________.,100076,1,b. Adjust the blinds,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32303,12,The final step in the space cleaning steps is to _______________________.,100077,2,c. Do a final Inspection,1
8908,Elearning-0000-193,SPACECARE QL,n6474,32303,12,The final step in the space cleaning steps is to _______________________.,100078,3,d. Ask the patient if the room looks alright,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32304,13,Crew should be used daily to clean toilets and urinals.,100079,0,TRUE,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32304,13,Crew should be used daily to clean toilets and urinals.,100080,1,FALSE,1
8908,Elearning-0000-193,SPACECARE QL,n6474,32305,14,Stride is _____________________________in color.,100081,0,a. Green,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32305,14,Stride is _____________________________in color.,100082,1,b. Yellow,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32305,14,Stride is _____________________________in color.,100083,2,c. Orange,1
8908,Elearning-0000-193,SPACECARE QL,n6474,32305,14,Stride is _____________________________in color.,100084,3,d. Red,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32306,15,"In the SpaceCare QL system, Emerel should be used daily.",100085,0,TRUE,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32306,15,"In the SpaceCare QL system, Emerel should be used daily.",100086,1,FALSE,1
8908,Elearning-0000-193,SPACECARE QL,n6474,32307,16,Which of the following is not considered a high touch surface?,100087,0,a. Light switch,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32307,16,Which of the following is not considered a high touch surface?,100088,1,b. Call button,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32307,16,Which of the following is not considered a high touch surface?,100089,2,c. Door handle,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32307,16,Which of the following is not considered a high touch surface?,100090,3,d. Trash can,1
8908,Elearning-0000-193,SPACECARE QL,n6474,32308,17,Non daily SpaceCare QL cleaning products should be stored on which shelf on the cleaning cart?,100091,0,a. Second,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32308,17,Non daily SpaceCare QL cleaning products should be stored on which shelf on the cleaning cart?,100092,1,b. Third,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32308,17,Non daily SpaceCare QL cleaning products should be stored on which shelf on the cleaning cart?,100093,2,c. Bottom,1
8908,Elearning-0000-193,SPACECARE QL,n6474,32308,17,Non daily SpaceCare QL cleaning products should be stored on which shelf on the cleaning cart?,100094,3,d. Top,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32308,17,Non daily SpaceCare QL cleaning products should be stored on which shelf on the cleaning cart?,100095,4,e. Front Shelf,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32309,18,Personal items should be stored on which shelf on the cleaning cart?,100096,0,a. Second,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32309,18,Personal items should be stored on which shelf on the cleaning cart?,100097,1,b. Third,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32309,18,Personal items should be stored on which shelf on the cleaning cart?,100098,2,c. Bottom,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32309,18,Personal items should be stored on which shelf on the cleaning cart?,100099,3,d. Top,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32309,18,Personal items should be stored on which shelf on the cleaning cart?,100100,4,e. None of the above,1
8908,Elearning-0000-193,SPACECARE QL,n6474,32411,6,"List, in order, the proper sequence for preparing the microfiber mop for use:",100535,0,A. ___ Place a microfiber pad on holder by pressing the pad holder to the pad,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32411,6,"List, in order, the proper sequence for preparing the microfiber mop for use:",100536,1,"B.	 ___ Pre-moisten the pads with RTU solution and secure the container cover",0
8908,Elearning-0000-193,SPACECARE QL,n6474,32411,6,"List, in order, the proper sequence for preparing the microfiber mop for use:",100537,2,"C. ___  Place microfiber pads in their container,  Fill a one-gallon jug with RTU solution,  Pre-moisten the pads with pads with RTU solution and secure the container cover,  Remove the cover from the microfiber container, Place a microfiber pad on holder by pressing the pad holder to the pad,  Secure the cover on the pad container after securing a pad.",1
8908,Elearning-0000-193,SPACECARE QL,n6474,32411,6,"List, in order, the proper sequence for preparing the microfiber mop for use:",100538,3,D. ___ Fill a one-gallon jug with RTU solution,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32411,6,"List, in order, the proper sequence for preparing the microfiber mop for use:",103245,4,E. ___ Secure the cover on the pad container after securing a pad,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32411,6,"List, in order, the proper sequence for preparing the microfiber mop for use:",103246,5,F.  ___ Remove the cover from the microfiber container,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32412,19,List the key words used in daily patient room cleaning in the correct order.,103247,0,A. __ Thank the patient and ask what else can be done,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32412,19,List the key words used in daily patient room cleaning in the correct order.,103248,1,"B. __  Knock on the door and wait for acknowledgement,  Introduce yourself, Tell the patient how long you will be in the room  Explain what and how you are cleaning their room and restroom, Thank the patient and ask what else can be done.",1
8908,Elearning-0000-193,SPACECARE QL,n6474,32412,19,List the key words used in daily patient room cleaning in the correct order.,103249,2,C. __ Introduce yourself,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32412,19,List the key words used in daily patient room cleaning in the correct order.,103250,3,D. __ Tell the patient how long you will be in the room,0
8908,Elearning-0000-193,SPACECARE QL,n6474,32412,19,List the key words used in daily patient room cleaning in the correct order.,103251,4,E. __ Explain what and how you are cleaning their room and restroom.,0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32310,0,Diprivan is an anesthetic agent used for continuous sedation while intubated.,100101,0,A. True,1
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32310,0,Diprivan is an anesthetic agent used for continuous sedation while intubated.,100102,1,B. False,0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32311,1,Which scale is used to evaluate the effectiveness of sedation while on a Diprivan drip?,100103,0,A. Payen,0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32311,1,Which scale is used to evaluate the effectiveness of sedation while on a Diprivan drip?,100104,1,B. Non- verbal scale 0-10,0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32311,1,Which scale is used to evaluate the effectiveness of sedation while on a Diprivan drip?,100105,2,C. RASS,1
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32311,1,Which scale is used to evaluate the effectiveness of sedation while on a Diprivan drip?,100106,3,D. Verbal scale 0-10,0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32312,2,Choose below the information that applies to Diprivan that is necessary for you to provide safe patient care.,100107,0,"A. Must be extubated and breathing on own, an amnesic and slows brain & nervous system activity, no reversal agent",0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32312,2,Choose below the information that applies to Diprivan that is necessary for you to provide safe patient care.,100108,1,"B. An amnesic and slows brain & nervous system activity, no reversal agent, may cause hypotension & respiratory depression",0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32312,2,Choose below the information that applies to Diprivan that is necessary for you to provide safe patient care.,100109,2,C. Rapid onset and offset,0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32312,2,Choose below the information that applies to Diprivan that is necessary for you to provide safe patient care.,100110,3,D. Tapering of dose to determine lowest effective dose is done to avoid accumulation and prolonged sedation,0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32312,2,Choose below the information that applies to Diprivan that is necessary for you to provide safe patient care.,100111,4,E. Must be intubated,0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32312,2,Choose below the information that applies to Diprivan that is necessary for you to provide safe patient care.,100112,5,"F. B, C, D, E",1
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32312,2,Choose below the information that applies to Diprivan that is necessary for you to provide safe patient care.,100113,6,"G. A, C, D",0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32313,3,Medications that are titrated to provide a specific effect must consist of:,100114,0,A. Initial rate of infusion,0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32313,3,Medications that are titrated to provide a specific effect must consist of:,100115,1,B. Goal of titration,0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32313,3,Medications that are titrated to provide a specific effect must consist of:,100116,2,C. Increments of titration to obtain goal,0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32313,3,Medications that are titrated to provide a specific effect must consist of:,100117,3,D. Max rate or dose,0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32313,3,Medications that are titrated to provide a specific effect must consist of:,100118,4,E. If increments of dose titrated needs to be adjust at a different rate an order must be write,0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32313,3,Medications that are titrated to provide a specific effect must consist of:,100119,5,F. All of above,1
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32313,3,Medications that are titrated to provide a specific effect must consist of:,100120,6,"G. A, B, C, D",0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32314,4,A Fentanyl drip is evaluated by the RASS Scale.,100121,0,A. True,0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32314,4,A Fentanyl drip is evaluated by the RASS Scale.,100122,1,B. False,1
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32315,5,A Fentanyl drip is evaluated by the Payen Scale.,100123,0,A. True,1
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32315,5,A Fentanyl drip is evaluated by the Payen Scale.,100124,1,B. False,0
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32316,6,Payen & RASS score documentation if completed in the flowsheet under their specific tab.,100125,0,A. True,1
8903,Elearning-0000-189,SEDATION AND PAIN MANAGEMENT FOR INTUBATED POST-PROCEDURE PATIENT IN PACU,n6476,32316,6,Payen & RASS score documentation if completed in the flowsheet under their specific tab.,100126,1,B. False,0
8384,Elearning-0000-1256,GREENWAY DESKTOP NAVIGATION SESSION 1,n6479,32371,0,I have read and understand the Greenway Desktop Navigation Session 1,100370,0,TRUE,1
8384,Elearning-0000-1256,GREENWAY DESKTOP NAVIGATION SESSION 1,n6479,32371,0,I have read and understand the Greenway Desktop Navigation Session 1,100371,1,FALSE,0
9577,Elearning-0000-801,AGE-SPECIFIC COMPETENCIES FOR ICU/PTCU STAFF,n6497,32590,0,I have read and understand the contents of the AGE-SPECIFIC COMPETENCIES FOR ICU/PTCU STAFF CBL.,101276,0,TRUE,1
9577,Elearning-0000-801,AGE-SPECIFIC COMPETENCIES FOR ICU/PTCU STAFF,n6497,32590,0,I have read and understand the contents of the AGE-SPECIFIC COMPETENCIES FOR ICU/PTCU STAFF CBL.,101277,1,FALSE,0
9554,Elearning-0000-780,ISENSIX FOR STAFF,n6504,32601,0,"I acknowledge that I have read and understand the ""Isensix for Staff"" CBL in its entirety.",101308,0,TRUE,1
9554,Elearning-0000-780,ISENSIX FOR STAFF,n6504,32601,0,"I acknowledge that I have read and understand the ""Isensix for Staff"" CBL in its entirety.",101309,1,FALSE,0
8256,Elearning-0000-1140,ATTESTATION FOR NURSING CONSIDERATION: THE ADOLESCENT PATIENT,n6511,32606,0,I have read and understood the education Nursing Consideration: The Adolescent Patient.,101318,0,TRUE,1
8256,Elearning-0000-1140,ATTESTATION FOR NURSING CONSIDERATION: THE ADOLESCENT PATIENT,n6511,32606,0,I have read and understood the education Nursing Consideration: The Adolescent Patient.,101319,1,FALSE,0
9016,Elearning-0000-291,PALLIATIVE AND END OF LIFE CARE,n6531,32667,0,I have read and i understand the contents of the PALLIATIVE AND END OF LIFE CARE CBL.,101522,0,TRUE,1
9016,Elearning-0000-291,PALLIATIVE AND END OF LIFE CARE,n6531,32667,0,I have read and i understand the contents of the PALLIATIVE AND END OF LIFE CARE CBL.,101523,1,FALSE,0
9063,Elearning-0000-334,NSH1164 AMENDMENT 6: XENCOR,n6540,32697,0,I have read and understand the contents of the NSH1164 AMENDMENT 6: XENCOR CBL.,101655,0,TRUE,1
9063,Elearning-0000-334,NSH1164 AMENDMENT 6: XENCOR,n6540,32697,0,I have read and understand the contents of the NSH1164 AMENDMENT 6: XENCOR CBL.,101656,1,FALSE,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32732,0,Cord blood is an acceptable sample for testing with the Accu-Chek Inform II.,101832,0,TRUE,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32732,0,Cord blood is an acceptable sample for testing with the Accu-Chek Inform II.,101833,1,FALSE,1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32733,1,Quality Control (QC) failures do not require a comment.,101834,0,TRUE,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32733,1,Quality Control (QC) failures do not require a comment.,101835,1,FALSE,1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32734,2,QC vials must be labeled with the date opened and a 3-month expiration date.,101836,0,TRUE,1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32734,2,QC vials must be labeled with the date opened and a 3-month expiration date.,101837,1,FALSE,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32735,3,The meter must be kept in a horizontal position during any testing.,101838,0,TRUE,1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32735,3,The meter must be kept in a horizontal position during any testing.,101839,1,FALSE,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32736,4,"If the comment icon is flashing, you must add a comment.",101840,0,TRUE,1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32736,4,"If the comment icon is flashing, you must add a comment.",101841,1,FALSE,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32737,5,"After cleaning the meter with bleach, the meter surfaces should be dried thoroughly with a soft cloth or gauze.",101842,0,TRUE,1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32737,5,"After cleaning the meter with bleach, the meter surfaces should be dried thoroughly with a soft cloth or gauze.",101843,1,FALSE,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32738,6,"For both newborn and pediatric patients, treatment per Hypoglycemic Newborn policy should be followed.  For adult patients, treatment per Glucose Monitoring: Accu-chek Inform II Meter - Patient Care Procedure policy should be followed.",101844,0,TRUE,1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32738,6,"For both newborn and pediatric patients, treatment per Hypoglycemic Newborn policy should be followed.  For adult patients, treatment per Glucose Monitoring: Accu-chek Inform II Meter - Patient Care Procedure policy should be followed.",101845,1,FALSE,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32739,7,Any issues with glucometer need to be immediately reported to:,101846,0,a. the hospital Environmental Services team.,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32739,7,Any issues with glucometer need to be immediately reported to:,101847,1,b. the POCT Coordinator or Specialist for your campus.,1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32739,7,Any issues with glucometer need to be immediately reported to:,101848,2,c. Biomedical Engineering.,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32739,7,Any issues with glucometer need to be immediately reported to:,101849,3,d. the patient.,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32740,8,Quality control material must be tested every 24 hours.,101850,0,TRUE,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32740,8,Quality control material must be tested every 24 hours.,101851,1,FALSE,1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32741,9,"If wireless connectivity for your meter goes down, data transfer and updates are still possible for you:",101852,0,a. wait for the next shift change and let a colleague deal with it.,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32741,9,"If wireless connectivity for your meter goes down, data transfer and updates are still possible for you:",101853,1,b. call the Help Desk at ext. 8883 and complain about it.,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32741,9,"If wireless connectivity for your meter goes down, data transfer and updates are still possible for you:",101854,2,c. send the meter to your campus POCT department for troubleshooting.,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32741,9,"If wireless connectivity for your meter goes down, data transfer and updates are still possible for you:",101855,3,"d. dock the meter in its charging base for ""wired"" connectivity and communication.",1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32742,10,QC vials should be discarded if:,101856,0,a. There is no date,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32742,10,QC vials should be discarded if:,101857,1,b. The date of expiration is not legible,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32742,10,QC vials should be discarded if:,101858,2,c. The QC is expired,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32742,10,QC vials should be discarded if:,101859,3,d. There is more than one set on the floor,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32742,10,QC vials should be discarded if:,101860,4,e. a & b,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32742,10,QC vials should be discarded if:,101861,5,f. b & d,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32742,10,QC vials should be discarded if:,101862,6,"g. a, b & c",1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32743,11,QC vials should be inverted 5 times prior to performing Quality Control testing.,101863,0,TRUE,1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32743,11,QC vials should be inverted 5 times prior to performing Quality Control testing.,101864,1,FALSE,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32744,12,All critical results (low & high) should be repeated immediately or within 15 minutes.,101865,0,TRUE,1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32744,12,All critical results (low & high) should be repeated immediately or within 15 minutes.,101866,1,FALSE,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32745,13,Wiping the base unit between each patient is necessary.,101867,0,TRUE,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32745,13,Wiping the base unit between each patient is necessary.,101868,1,FALSE,1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32746,14,Select the answer that is False.  When the Accu-Chek does not give a Name & DOB:,101869,0,"a.	This means the account number does not exist",0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32746,14,Select the answer that is False.  When the Accu-Chek does not give a Name & DOB:,101870,1,"b.	The meter is experiencing a glitch",1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32746,14,Select the answer that is False.  When the Accu-Chek does not give a Name & DOB:,101871,2,"c.	Proceeding puts operator at risk for a Red-Rule Violation",0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32746,14,Select the answer that is False.  When the Accu-Chek does not give a Name & DOB:,101872,3,"d.	Operator should verify information on the patient's armband",0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32747,15,Things that can result in Red-Rule Violations:,101873,0,"a.	Confirming an invalid/incorrect account number.",0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32747,15,Things that can result in Red-Rule Violations:,101874,1,"b.	Using adult meters to perform glucose testing on infants and vice versa.",0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32747,15,Things that can result in Red-Rule Violations:,101876,2,"c.	Self-testing.",0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32747,15,Things that can result in Red-Rule Violations:,101877,3,"d.	All of the above",1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32748,16,"Entering made-up or false account numbers, even for experimental or training purposes is a violation.",101878,0,TRUE,1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32748,16,"Entering made-up or false account numbers, even for experimental or training purposes is a violation.",101879,1,FALSE,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32749,17,Meter should be stored in Accessory Kit case when not in use.,101880,0,TRUE,0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32749,17,Meter should be stored in Accessory Kit case when not in use.,101881,1,FALSE,1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32750,18,Excessive use of bleach wipes to clean or disinfect the meter and/or base unit can result in:,101882,0,"a.	Damaged display screens",0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32750,18,Excessive use of bleach wipes to clean or disinfect the meter and/or base unit can result in:,101883,1,"b.	Corroded contacts on the meter",0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32750,18,Excessive use of bleach wipes to clean or disinfect the meter and/or base unit can result in:,101884,2,"c.	Corroded contacts on the base unit",0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32750,18,Excessive use of bleach wipes to clean or disinfect the meter and/or base unit can result in:,101885,3,"d.	Charging issues",0
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32750,18,Excessive use of bleach wipes to clean or disinfect the meter and/or base unit can result in:,101886,4,e. All of the above,1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32751,19,Bleach wipes should only be used after testing a patient with C. difficile.,101887,0,TRUE,1
9145,Elearning-0000-409,ACCU-CHEK INFORM II GLUCOSE METER,n6547,32751,19,Bleach wipes should only be used after testing a patient with C. difficile.,101888,1,FALSE,0
9418,Elearning-0000-657,NEUROLOGICAL DRAINS PCT NURSE EXTERN,n6548,32752,0,How often should drains be emptied:,101895,0,a. 6am,0
9418,Elearning-0000-657,NEUROLOGICAL DRAINS PCT NURSE EXTERN,n6548,32752,0,How often should drains be emptied:,101896,1,b. 2pm,0
9418,Elearning-0000-657,NEUROLOGICAL DRAINS PCT NURSE EXTERN,n6548,32752,0,How often should drains be emptied:,101897,2,c. 10pm,0
9418,Elearning-0000-657,NEUROLOGICAL DRAINS PCT NURSE EXTERN,n6548,32752,0,How often should drains be emptied:,101898,3,e. All of the Above,1
9418,Elearning-0000-657,NEUROLOGICAL DRAINS PCT NURSE EXTERN,n6548,32753,1,"Who can empty JP, Hemovac and Foley Catheter drains?",101899,0,a. Nurses,0
9418,Elearning-0000-657,NEUROLOGICAL DRAINS PCT NURSE EXTERN,n6548,32753,1,"Who can empty JP, Hemovac and Foley Catheter drains?",101900,1,b. Techs,0
9418,Elearning-0000-657,NEUROLOGICAL DRAINS PCT NURSE EXTERN,n6548,32753,1,"Who can empty JP, Hemovac and Foley Catheter drains?",101901,2,c. All of the Above,1
9266,Elearning-0000-519,INFECTION PREVENTION COMMUNICATION AND MANAGEMENT,n6552,32775,0,You need a Physicians order to implement Isolation Precautions.,101975,0,TRUE,0
9266,Elearning-0000-519,INFECTION PREVENTION COMMUNICATION AND MANAGEMENT,n6552,32775,0,You need a Physicians order to implement Isolation Precautions.,101976,1,FALSE,1
9266,Elearning-0000-519,INFECTION PREVENTION COMMUNICATION AND MANAGEMENT,n6552,32776,1,A MDRO is a Significant Value.,101977,0,TRUE,1
9266,Elearning-0000-519,INFECTION PREVENTION COMMUNICATION AND MANAGEMENT,n6552,32776,1,A MDRO is a Significant Value.,101978,1,FALSE,0
9266,Elearning-0000-519,INFECTION PREVENTION COMMUNICATION AND MANAGEMENT,n6552,32777,2,Lab has just notified you of an MDRO on your patient. What steps do you complete?,101979,0,a.  Implement contact precautions,0
9266,Elearning-0000-519,INFECTION PREVENTION COMMUNICATION AND MANAGEMENT,n6552,32777,2,Lab has just notified you of an MDRO on your patient. What steps do you complete?,101980,1,b. Educate the patient and family members,0
9266,Elearning-0000-519,INFECTION PREVENTION COMMUNICATION AND MANAGEMENT,n6552,32777,2,Lab has just notified you of an MDRO on your patient. What steps do you complete?,101981,2,c. Notify the MD per policy,0
9266,Elearning-0000-519,INFECTION PREVENTION COMMUNICATION AND MANAGEMENT,n6552,32777,2,Lab has just notified you of an MDRO on your patient. What steps do you complete?,101982,3,d. All of the above,1
9266,Elearning-0000-519,INFECTION PREVENTION COMMUNICATION AND MANAGEMENT,n6552,32778,3,How do you document education for your patient and family member regarding Isolation?,101983,0,a. In a nurses note,0
9266,Elearning-0000-519,INFECTION PREVENTION COMMUNICATION AND MANAGEMENT,n6552,32778,3,How do you document education for your patient and family member regarding Isolation?,101984,1,"b. Under the Education tab in McKesson, under Isolation, ""handout"" should be charted as the teaching method used.",1
9266,Elearning-0000-519,INFECTION PREVENTION COMMUNICATION AND MANAGEMENT,n6552,32778,3,How do you document education for your patient and family member regarding Isolation?,101985,2,c. On the patients white board.,0
9266,Elearning-0000-519,INFECTION PREVENTION COMMUNICATION AND MANAGEMENT,n6552,32778,3,How do you document education for your patient and family member regarding Isolation?,101986,3,d. On a progress note.,0
9266,Elearning-0000-519,INFECTION PREVENTION COMMUNICATION AND MANAGEMENT,n6552,32779,4,Who do you notify or educate of a MDRO?,101987,0,a. Staff members that are interacting with the patient for tests or procedures,0
9266,Elearning-0000-519,INFECTION PREVENTION COMMUNICATION AND MANAGEMENT,n6552,32779,4,Who do you notify or educate of a MDRO?,101988,1,b. The Physician if it's a new result,0
9266,Elearning-0000-519,INFECTION PREVENTION COMMUNICATION AND MANAGEMENT,n6552,32779,4,Who do you notify or educate of a MDRO?,101989,2,c. The patient,0
9266,Elearning-0000-519,INFECTION PREVENTION COMMUNICATION AND MANAGEMENT,n6552,32779,4,Who do you notify or educate of a MDRO?,101990,3,d. The family members or visitors for PPE purposes,0
9266,Elearning-0000-519,INFECTION PREVENTION COMMUNICATION AND MANAGEMENT,n6552,32779,4,Who do you notify or educate of a MDRO?,101991,4,e. All of the above,1
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32787,0,Mrs. G arrives to L&D with complaints of vaginal leaking at 37 wks'.  She is writhing in the bed and complains of backpain.  Contractions are evident when EFM is initiated with contractions every 5 to 7 minutes.  <b>Which of the following is the correct response by the RN?</b>,102006,0,A. Amnisure,0
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32787,0,Mrs. G arrives to L&D with complaints of vaginal leaking at 37 wks'.  She is writhing in the bed and complains of backpain.  Contractions are evident when EFM is initiated with contractions every 5 to 7 minutes.  <b>Which of the following is the correct response by the RN?</b>,102007,1,B. Amniotest,0
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32787,0,Mrs. G arrives to L&D with complaints of vaginal leaking at 37 wks'.  She is writhing in the bed and complains of backpain.  Contractions are evident when EFM is initiated with contractions every 5 to 7 minutes.  <b>Which of the following is the correct response by the RN?</b>,102008,2,C. Vaginal exam,1
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32787,0,Mrs. G arrives to L&D with complaints of vaginal leaking at 37 wks'.  She is writhing in the bed and complains of backpain.  Contractions are evident when EFM is initiated with contractions every 5 to 7 minutes.  <b>Which of the following is the correct response by the RN?</b>,102009,3,D. All of the above,0
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32788,1,Ms. H is a G3 P1 at 29 weeks' gestation who presents with complaints of vaginal leaking.  She denies any cramping or back pain.  <b>Which of the following is the most appropriate initial response by the RN?</b>,102010,0,"A. Amniotest, then notify the provider.",0
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32788,1,Ms. H is a G3 P1 at 29 weeks' gestation who presents with complaints of vaginal leaking.  She denies any cramping or back pain.  <b>Which of the following is the most appropriate initial response by the RN?</b>,102011,1,B. Digital vaginal exam to check dilatation.,0
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32788,1,Ms. H is a G3 P1 at 29 weeks' gestation who presents with complaints of vaginal leaking.  She denies any cramping or back pain.  <b>Which of the following is the most appropriate initial response by the RN?</b>,102012,2,"C. Fetal fibronectin swab, then amniotest.",1
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32788,1,Ms. H is a G3 P1 at 29 weeks' gestation who presents with complaints of vaginal leaking.  She denies any cramping or back pain.  <b>Which of the following is the most appropriate initial response by the RN?</b>,102013,3,D. Any of the above.,0
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32789,2,Which of the following is an accurate statement about regarding the policy and procedure on amnisure at Northside Hospital?,102014,0,"A. It cannot be performed if a fetal <span class=""bold red""> fibronectin</span> specimen was collected.",0
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32789,2,Which of the following is an accurate statement about regarding the policy and procedure on amnisure at Northside Hospital?,102015,1,B.  It may be collected in patients less than 34 weeks who are in labor.,0
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32789,2,Which of the following is an accurate statement about regarding the policy and procedure on amnisure at Northside Hospital?,102016,2,"C.  It is only performed if the amniotest is <span class=""bold red"">negative</span>.",1
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32789,2,Which of the following is an accurate statement about regarding the policy and procedure on amnisure at Northside Hospital?,102017,3,D.  All of the above,0
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32790,3,Ms. A is a G1P0 at 35 weeks who is admitted to rule out rupture of membranes.  The RN does an amniotest and the color of the swab turns olive-green.  Which of the following is the most appropriate initial response by the RN?,102018,0,A. Collect a specimen for fetal fibronectin if the patient is not bleeding.,0
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32790,3,Ms. A is a G1P0 at 35 weeks who is admitted to rule out rupture of membranes.  The RN does an amniotest and the color of the swab turns olive-green.  Which of the following is the most appropriate initial response by the RN?,102019,1,B. Proceed with Amnisure and notify the provider of results.,1
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32790,3,Ms. A is a G1P0 at 35 weeks who is admitted to rule out rupture of membranes.  The RN does an amniotest and the color of the swab turns olive-green.  Which of the following is the most appropriate initial response by the RN?,102020,2,C. Report negative Amniotest to provider and discharge per order.,0
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32790,3,Ms. A is a G1P0 at 35 weeks who is admitted to rule out rupture of membranes.  The RN does an amniotest and the color of the swab turns olive-green.  Which of the following is the most appropriate initial response by the RN?,102021,3,D. All of the above,0
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32791,4,Ms. C is a G3P2 at 37 weeks who is admitted to rule out rupture of membranes.  The RN does an amniotest and the color of the swab turns blue-green.  Which of the following is the most appropriate initial response by the RN?,102022,0,A. Proceed with Amnisure and notify the provider of results.,0
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32791,4,Ms. C is a G3P2 at 37 weeks who is admitted to rule out rupture of membranes.  The RN does an amniotest and the color of the swab turns blue-green.  Which of the following is the most appropriate initial response by the RN?,102023,1,B. Report negative Amniotest to provider and discharge per order.,0
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32791,4,Ms. C is a G3P2 at 37 weeks who is admitted to rule out rupture of membranes.  The RN does an amniotest and the color of the swab turns blue-green.  Which of the following is the most appropriate initial response by the RN?,102024,2,C. Report positive Amniotest and inform CNM of positive ROM.,1
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32791,4,Ms. C is a G3P2 at 37 weeks who is admitted to rule out rupture of membranes.  The RN does an amniotest and the color of the swab turns blue-green.  Which of the following is the most appropriate initial response by the RN?,102025,3,D. Require CNM to present to bedside to further evaluate the patient.,0
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32792,5,Ms. L. is G2P0 at 33 weeks who is admitted to rule out ruptured membranes.  The RN does an Amniotest.  More than 50%; of the swab is noted to have bright red blood covering it.  What should the RN do?,102026,0,A. Proceed with the Amnisure and await results before notifying the provider,0
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32792,5,Ms. L. is G2P0 at 33 weeks who is admitted to rule out ruptured membranes.  The RN does an Amniotest.  More than 50%; of the swab is noted to have bright red blood covering it.  What should the RN do?,102027,1,B. Notify the provider of blood on the swab and the potential for inaccurate results,1
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32792,5,Ms. L. is G2P0 at 33 weeks who is admitted to rule out ruptured membranes.  The RN does an Amniotest.  More than 50%; of the swab is noted to have bright red blood covering it.  What should the RN do?,102028,2,C. Notify the provider of Amniotest results without including a report about blood covering the majority of the swab,0
8239,Elearning-0000-1125,ROM ASSESSMENT,n6560,32792,5,Ms. L. is G2P0 at 33 weeks who is admitted to rule out ruptured membranes.  The RN does an Amniotest.  More than 50%; of the swab is noted to have bright red blood covering it.  What should the RN do?,102029,3,D. All of the above,0
9041,Elearning-0000-314,NURSING CONSIDERATIONS: THE ADOLESCENT PATIENT,n6588,33099,0,"I acknowledge that I have read and understand the ""Nursing Considerations: The Adolescent Patient"" CBL in its entirety.",103225,0,TRUE,1
9041,Elearning-0000-314,NURSING CONSIDERATIONS: THE ADOLESCENT PATIENT,n6588,33099,0,"I acknowledge that I have read and understand the ""Nursing Considerations: The Adolescent Patient"" CBL in its entirety.",103226,1,FALSE,0
181,SCORM-0000-26,CREDENTIALING PROCESS - SUICIDE SCREENING,n6633,33384,0,I have read and understood the content within the Credentialing Process - Suicide Screening CBL.,104274,0,TRUE,1
181,SCORM-0000-26,CREDENTIALING PROCESS - SUICIDE SCREENING,n6633,33384,0,I have read and understood the content within the Credentialing Process - Suicide Screening CBL.,104275,1,FALSE,0
1692,ILT-0000-7259,FCC,n6634,33385,0,What is CROPS?,104276,0,"A)	Caring, Respect, Opportunity, Process",0
1692,ILT-0000-7259,FCC,n6634,33385,0,What is CROPS?,104277,1,"B)	Compassion, Respect, Ownership, Professionalism",1
1692,ILT-0000-7259,FCC,n6634,33385,0,What is CROPS?,104278,2,"C)	Communication, Responsibility, Observation, Professionalism",0
1692,ILT-0000-7259,FCC,n6634,33385,0,What is CROPS?,104279,3,"D)	Cooperation, Resolution, Opportunity, Perception",0
1692,ILT-0000-7259,FCC,n6634,33386,1,Which is NOT a good verbal cue?,104280,0,"A)	Lowers voice volume with infant sleeping.",0
1692,ILT-0000-7259,FCC,n6634,33386,1,Which is NOT a good verbal cue?,104281,1,"B)	Says please and thank you.",0
1692,ILT-0000-7259,FCC,n6634,33386,1,Which is NOT a good verbal cue?,104282,2,"C)	Chuckles when patient makes a joke about traffic.",0
1692,ILT-0000-7259,FCC,n6634,33386,1,Which is NOT a good verbal cue?,104283,3,"D)	Patient asks you to repeat yourself two times.",1
1692,ILT-0000-7259,FCC,n6634,33387,2,"Who has the responsibility of keeping the unit clean, organized, and secure?",104284,0,"A)	Patient Care Tech",0
1692,ILT-0000-7259,FCC,n6634,33387,2,"Who has the responsibility of keeping the unit clean, organized, and secure?",104285,1,"B)	EVS",0
1692,ILT-0000-7259,FCC,n6634,33387,2,"Who has the responsibility of keeping the unit clean, organized, and secure?",104286,2,"C)	Supervisor",0
1692,ILT-0000-7259,FCC,n6634,33387,2,"Who has the responsibility of keeping the unit clean, organized, and secure?",104287,3,"D)	Unit Secretary",0
1692,ILT-0000-7259,FCC,n6634,33387,2,"Who has the responsibility of keeping the unit clean, organized, and secure?",104288,4,"E)	All of the Above",1
1692,ILT-0000-7259,FCC,n6634,33388,3,"The patient in 171 calls out for help with breastfeeding. The Unit Secretary reaches out to the nurse, who has floated from 5th floor and is a newly graduated Resident. The nurse goes to the room to help with breastfeeding, but is encountering difficulty getting the baby latched. The PCT had reached out to her at the beginning of the shift to say let me know if you need any help. The nurse calls the PCT and the PCT comes to the room to help with patient/nurse with latch.   What CROP's do you see displayed in this scenario?",104289,0,"A)	Compassion, Ownership, Professionalism",1
1692,ILT-0000-7259,FCC,n6634,33388,3,"The patient in 171 calls out for help with breastfeeding. The Unit Secretary reaches out to the nurse, who has floated from 5th floor and is a newly graduated Resident. The nurse goes to the room to help with breastfeeding, but is encountering difficulty getting the baby latched. The PCT had reached out to her at the beginning of the shift to say let me know if you need any help. The nurse calls the PCT and the PCT comes to the room to help with patient/nurse with latch.   What CROP's do you see displayed in this scenario?",104290,1,"B)	Professionalism, Communication, Resolution",0
1692,ILT-0000-7259,FCC,n6634,33388,3,"The patient in 171 calls out for help with breastfeeding. The Unit Secretary reaches out to the nurse, who has floated from 5th floor and is a newly graduated Resident. The nurse goes to the room to help with breastfeeding, but is encountering difficulty getting the baby latched. The PCT had reached out to her at the beginning of the shift to say let me know if you need any help. The nurse calls the PCT and the PCT comes to the room to help with patient/nurse with latch.   What CROP's do you see displayed in this scenario?",104291,2,"C)	Observation, Compassion, Respect",0
1692,ILT-0000-7259,FCC,n6634,33388,3,"The patient in 171 calls out for help with breastfeeding. The Unit Secretary reaches out to the nurse, who has floated from 5th floor and is a newly graduated Resident. The nurse goes to the room to help with breastfeeding, but is encountering difficulty getting the baby latched. The PCT had reached out to her at the beginning of the shift to say let me know if you need any help. The nurse calls the PCT and the PCT comes to the room to help with patient/nurse with latch.   What CROP's do you see displayed in this scenario?",104292,3,"D)	No CROP's displayed",0
1692,ILT-0000-7259,FCC,n6634,33389,4,"While sitting at the desk, a patient calls out for pain meds. The assigned nurse is at lunch in the breakroom and the secretary asks if anyone can assist. Two nurses don't respond. One is speaking with a doctor and the other is charting her assessments. A third nurse suggests calling the assigned nurse to come back from lunch to administer. Ten minutes later the assigned nurse comes to administer the meds. She states to patient, ""Apparently no one could assist me, so I ended my lunch early because I didn't want you to be in pain.""   Who, in this scenario, displayed a component of CROP's?",104293,0,"A)	Nurse who suggested calling the assigned nurse as a resolution.",0
1692,ILT-0000-7259,FCC,n6634,33389,4,"While sitting at the desk, a patient calls out for pain meds. The assigned nurse is at lunch in the breakroom and the secretary asks if anyone can assist. Two nurses don't respond. One is speaking with a doctor and the other is charting her assessments. A third nurse suggests calling the assigned nurse to come back from lunch to administer. Ten minutes later the assigned nurse comes to administer the meds. She states to patient, ""Apparently no one could assist me, so I ended my lunch early because I didn't want you to be in pain.""   Who, in this scenario, displayed a component of CROP's?",104294,1,"B)	Assigned nurse who ended her break early to care for her patient.",0
1692,ILT-0000-7259,FCC,n6634,33389,4,"While sitting at the desk, a patient calls out for pain meds. The assigned nurse is at lunch in the breakroom and the secretary asks if anyone can assist. Two nurses don't respond. One is speaking with a doctor and the other is charting her assessments. A third nurse suggests calling the assigned nurse to come back from lunch to administer. Ten minutes later the assigned nurse comes to administer the meds. She states to patient, ""Apparently no one could assist me, so I ended my lunch early because I didn't want you to be in pain.""   Who, in this scenario, displayed a component of CROP's?",104295,2,"C)	Unit Secretary who took ownership of the situation to find help.",1
1692,ILT-0000-7259,FCC,n6634,33389,4,"While sitting at the desk, a patient calls out for pain meds. The assigned nurse is at lunch in the breakroom and the secretary asks if anyone can assist. Two nurses don't respond. One is speaking with a doctor and the other is charting her assessments. A third nurse suggests calling the assigned nurse to come back from lunch to administer. Ten minutes later the assigned nurse comes to administer the meds. She states to patient, ""Apparently no one could assist me, so I ended my lunch early because I didn't want you to be in pain.""   Who, in this scenario, displayed a component of CROP's?",104296,3,"D)	The nurse who was making sure to do real-time charting.",0
1692,ILT-0000-7259,FCC,n6634,33390,5,I have read and understood the content of this module.,104297,0,TRUE,1
1692,ILT-0000-7259,FCC,n6634,33390,5,I have read and understood the content of this module.,104298,1,FALSE,0
8240,Elearning-0000-1126,RECOGNITION OF THE HIGH-RISK SUICIDAL PATIENT,n6657,33595,0,"A 32 year old woman is admitted to a medical surgical unit due to her unstable diabetes. She has a history of substance abuse and she is a veteran who served two tours of duty in Afghanistan.  After 24 hours, her blood glucose is stabilized.  She is scheduled to be discharged tomorrow. Her family has been present throughout her stay and in support of her treatment plan.  Her breakfast tray is delivered and the patient calls the Nurse and reports that there are bugs in her food. The nurse finds the patient pacing and very agitated. The Nurse evaluates the food and does not see any evidence of bugs.  The patient is talking very fast and is not making sense.<br><br>   <b>What assessment findings should be reported?</b>",105049,0,a.) Blood sugar is normal,0
8240,Elearning-0000-1126,RECOGNITION OF THE HIGH-RISK SUICIDAL PATIENT,n6657,33595,0,"A 32 year old woman is admitted to a medical surgical unit due to her unstable diabetes. She has a history of substance abuse and she is a veteran who served two tours of duty in Afghanistan.  After 24 hours, her blood glucose is stabilized.  She is scheduled to be discharged tomorrow. Her family has been present throughout her stay and in support of her treatment plan.  Her breakfast tray is delivered and the patient calls the Nurse and reports that there are bugs in her food. The nurse finds the patient pacing and very agitated. The Nurse evaluates the food and does not see any evidence of bugs.  The patient is talking very fast and is not making sense.<br><br>   <b>What assessment findings should be reported?</b>",105050,1,b.) There's nothing to report,0
8240,Elearning-0000-1126,RECOGNITION OF THE HIGH-RISK SUICIDAL PATIENT,n6657,33595,0,"A 32 year old woman is admitted to a medical surgical unit due to her unstable diabetes. She has a history of substance abuse and she is a veteran who served two tours of duty in Afghanistan.  After 24 hours, her blood glucose is stabilized.  She is scheduled to be discharged tomorrow. Her family has been present throughout her stay and in support of her treatment plan.  Her breakfast tray is delivered and the patient calls the Nurse and reports that there are bugs in her food. The nurse finds the patient pacing and very agitated. The Nurse evaluates the food and does not see any evidence of bugs.  The patient is talking very fast and is not making sense.<br><br>   <b>What assessment findings should be reported?</b>",105051,2,c.) Change in behaviors,1
8240,Elearning-0000-1126,RECOGNITION OF THE HIGH-RISK SUICIDAL PATIENT,n6657,33595,0,"A 32 year old woman is admitted to a medical surgical unit due to her unstable diabetes. She has a history of substance abuse and she is a veteran who served two tours of duty in Afghanistan.  After 24 hours, her blood glucose is stabilized.  She is scheduled to be discharged tomorrow. Her family has been present throughout her stay and in support of her treatment plan.  Her breakfast tray is delivered and the patient calls the Nurse and reports that there are bugs in her food. The nurse finds the patient pacing and very agitated. The Nurse evaluates the food and does not see any evidence of bugs.  The patient is talking very fast and is not making sense.<br><br>   <b>What assessment findings should be reported?</b>",105052,3,c.) She's unhappy with her food,0
8240,Elearning-0000-1126,RECOGNITION OF THE HIGH-RISK SUICIDAL PATIENT,n6657,33596,1,"A 32 year old woman is admitted to a medical surgical unit due to her unstable diabetes. She has a history of substance abuse and she is a veteran who served two tours of duty in Afghanistan.  After 24 hours, her blood glucose is stabilized.  She is scheduled to be discharged tomorrow. Her family has been present throughout her stay and in support of her treatment plan.  Her breakfast tray is delivered and the patient calls the Nurse and reports that there are bugs in her food. The nurse finds the patient pacing and very agitated. The Nurse evaluates the food and does not see any evidence of bugs.  The patient is talking very fast and is not making sense.<br><br>  <b>What behaviors should be documented?</b>",105053,0,a.) Hallucinations,0
8240,Elearning-0000-1126,RECOGNITION OF THE HIGH-RISK SUICIDAL PATIENT,n6657,33596,1,"A 32 year old woman is admitted to a medical surgical unit due to her unstable diabetes. She has a history of substance abuse and she is a veteran who served two tours of duty in Afghanistan.  After 24 hours, her blood glucose is stabilized.  She is scheduled to be discharged tomorrow. Her family has been present throughout her stay and in support of her treatment plan.  Her breakfast tray is delivered and the patient calls the Nurse and reports that there are bugs in her food. The nurse finds the patient pacing and very agitated. The Nurse evaluates the food and does not see any evidence of bugs.  The patient is talking very fast and is not making sense.<br><br>  <b>What behaviors should be documented?</b>",105054,1,b.) Agitation,0
8240,Elearning-0000-1126,RECOGNITION OF THE HIGH-RISK SUICIDAL PATIENT,n6657,33596,1,"A 32 year old woman is admitted to a medical surgical unit due to her unstable diabetes. She has a history of substance abuse and she is a veteran who served two tours of duty in Afghanistan.  After 24 hours, her blood glucose is stabilized.  She is scheduled to be discharged tomorrow. Her family has been present throughout her stay and in support of her treatment plan.  Her breakfast tray is delivered and the patient calls the Nurse and reports that there are bugs in her food. The nurse finds the patient pacing and very agitated. The Nurse evaluates the food and does not see any evidence of bugs.  The patient is talking very fast and is not making sense.<br><br>  <b>What behaviors should be documented?</b>",105055,2,c.) Rapid speech,0
8240,Elearning-0000-1126,RECOGNITION OF THE HIGH-RISK SUICIDAL PATIENT,n6657,33596,1,"A 32 year old woman is admitted to a medical surgical unit due to her unstable diabetes. She has a history of substance abuse and she is a veteran who served two tours of duty in Afghanistan.  After 24 hours, her blood glucose is stabilized.  She is scheduled to be discharged tomorrow. Her family has been present throughout her stay and in support of her treatment plan.  Her breakfast tray is delivered and the patient calls the Nurse and reports that there are bugs in her food. The nurse finds the patient pacing and very agitated. The Nurse evaluates the food and does not see any evidence of bugs.  The patient is talking very fast and is not making sense.<br><br>  <b>What behaviors should be documented?</b>",105056,3,d.) All of the above,1
8240,Elearning-0000-1126,RECOGNITION OF THE HIGH-RISK SUICIDAL PATIENT,n6657,33597,2,"A 32 year old woman is admitted to a medical surgical unit due to her unstable diabetes. She has a history of substance abuse and she is a veteran who served two tours of duty in Afghanistan.  After 24 hours, her blood glucose is stabilized.  She is scheduled to be discharged tomorrow. Her family has been present throughout her stay and in support of her treatment plan.  Her breakfast tray is delivered and the patient calls the Nurse and reports that there are bugs in her food. The nurse finds the patient pacing and very agitated. The Nurse evaluates the food and does not see any evidence of bugs.  The patient is talking very fast and is not making sense.<br><br>  <b>Based on the signs and symptoms described in the case study, the care of the patient should be escalated.</b>",105057,0,a.) True,1
8240,Elearning-0000-1126,RECOGNITION OF THE HIGH-RISK SUICIDAL PATIENT,n6657,33597,2,"A 32 year old woman is admitted to a medical surgical unit due to her unstable diabetes. She has a history of substance abuse and she is a veteran who served two tours of duty in Afghanistan.  After 24 hours, her blood glucose is stabilized.  She is scheduled to be discharged tomorrow. Her family has been present throughout her stay and in support of her treatment plan.  Her breakfast tray is delivered and the patient calls the Nurse and reports that there are bugs in her food. The nurse finds the patient pacing and very agitated. The Nurse evaluates the food and does not see any evidence of bugs.  The patient is talking very fast and is not making sense.<br><br>  <b>Based on the signs and symptoms described in the case study, the care of the patient should be escalated.</b>",105058,1,b.) False,0
8240,Elearning-0000-1126,RECOGNITION OF THE HIGH-RISK SUICIDAL PATIENT,n6657,33598,3,"A 32 year old woman is admitted to a medical surgical unit due to her unstable diabetes. She has a history of substance abuse and she is a veteran who served two tours of duty in Afghanistan.  After 24 hours, her blood glucose is stabilized.  She is scheduled to be discharged tomorrow. Her family has been present throughout her stay and in support of her treatment plan.  Her breakfast tray is delivered and the patient calls the Nurse and reports that there are bugs in her food. The nurse finds the patient pacing and very agitated. The Nurse evaluates the food and does not see any evidence of bugs.  The patient is talking very fast and is not making sense.<br><br>  <b>Who should be notified of the change in the patient's condition?</b>",105059,0,"a.) Dietary, Security, Physician, Diabetes Education",0
8240,Elearning-0000-1126,RECOGNITION OF THE HIGH-RISK SUICIDAL PATIENT,n6657,33598,3,"A 32 year old woman is admitted to a medical surgical unit due to her unstable diabetes. She has a history of substance abuse and she is a veteran who served two tours of duty in Afghanistan.  After 24 hours, her blood glucose is stabilized.  She is scheduled to be discharged tomorrow. Her family has been present throughout her stay and in support of her treatment plan.  Her breakfast tray is delivered and the patient calls the Nurse and reports that there are bugs in her food. The nurse finds the patient pacing and very agitated. The Nurse evaluates the food and does not see any evidence of bugs.  The patient is talking very fast and is not making sense.<br><br>  <b>Who should be notified of the change in the patient's condition?</b>",105060,1,"b.) Clinical Supervisor, Physician, Security, Behavioral Health",1
8240,Elearning-0000-1126,RECOGNITION OF THE HIGH-RISK SUICIDAL PATIENT,n6657,33598,3,"A 32 year old woman is admitted to a medical surgical unit due to her unstable diabetes. She has a history of substance abuse and she is a veteran who served two tours of duty in Afghanistan.  After 24 hours, her blood glucose is stabilized.  She is scheduled to be discharged tomorrow. Her family has been present throughout her stay and in support of her treatment plan.  Her breakfast tray is delivered and the patient calls the Nurse and reports that there are bugs in her food. The nurse finds the patient pacing and very agitated. The Nurse evaluates the food and does not see any evidence of bugs.  The patient is talking very fast and is not making sense.<br><br>  <b>Who should be notified of the change in the patient's condition?</b>",105061,2,"c.) Patient Relations, Dietary, Physician, Security",0
8240,Elearning-0000-1126,RECOGNITION OF THE HIGH-RISK SUICIDAL PATIENT,n6657,33598,3,"A 32 year old woman is admitted to a medical surgical unit due to her unstable diabetes. She has a history of substance abuse and she is a veteran who served two tours of duty in Afghanistan.  After 24 hours, her blood glucose is stabilized.  She is scheduled to be discharged tomorrow. Her family has been present throughout her stay and in support of her treatment plan.  Her breakfast tray is delivered and the patient calls the Nurse and reports that there are bugs in her food. The nurse finds the patient pacing and very agitated. The Nurse evaluates the food and does not see any evidence of bugs.  The patient is talking very fast and is not making sense.<br><br>  <b>Who should be notified of the change in the patient's condition?</b>",105062,3,"d.) Security, Physician, Respiratory Care, Clinical Supervisor",0
9149,Elearning-0000-412,"NEUROLOGICAL DRAINS, RN",n6665,33697,1,How often should drains be emptied?,105460,0,"10:00, 2:00, 6:00 (every four hours) unless ordered otherwise",1
9149,Elearning-0000-412,"NEUROLOGICAL DRAINS, RN",n6665,33697,1,How often should drains be emptied?,105461,1,When full,0
9149,Elearning-0000-412,"NEUROLOGICAL DRAINS, RN",n6665,33697,1,How often should drains be emptied?,105462,2,Once a shift,0
9149,Elearning-0000-412,"NEUROLOGICAL DRAINS, RN",n6665,33698,0,"Who can empty JP, Hemovac and Foley Catheter drains?",105463,0,Only nurses can empty these drains.,0
9149,Elearning-0000-412,"NEUROLOGICAL DRAINS, RN",n6665,33698,0,"Who can empty JP, Hemovac and Foley Catheter drains?",105464,1,Nurses and Techs once they have been signed off.,1
9149,Elearning-0000-412,"NEUROLOGICAL DRAINS, RN",n6665,33698,0,"Who can empty JP, Hemovac and Foley Catheter drains?",105465,2,Only techs can empty these drains.,0
9149,Elearning-0000-412,"NEUROLOGICAL DRAINS, RN",n6665,33699,2,"The patient accidentally pulls out the drain, what are next steps?",105466,0,Apply sterile dressing and notify treatment team.,1
9149,Elearning-0000-412,"NEUROLOGICAL DRAINS, RN",n6665,33699,2,"The patient accidentally pulls out the drain, what are next steps?",105467,1,Apply a paper towel on the site to stop the bleeding.,0
9149,Elearning-0000-412,"NEUROLOGICAL DRAINS, RN",n6665,33699,2,"The patient accidentally pulls out the drain, what are next steps?",105468,2,Attempt to reinsert the drain.,0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34006,0,We spend _____ of our waking time communicating.,106708,0,A. 100%;,0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34006,0,We spend _____ of our waking time communicating.,106709,1,B. 70%;,1
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34006,0,We spend _____ of our waking time communicating.,106710,2,C. 60%;,0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34006,0,We spend _____ of our waking time communicating.,106711,3,D. 90%;,0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34007,1,"The term professional communication refers to the various forms of speaking, listening, writing, and responding carried out both in and out of work.",106712,0,A. True,1
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34007,1,"The term professional communication refers to the various forms of speaking, listening, writing, and responding carried out both in and out of work.",106713,1,B. False,0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34008,2,"Assertive Communication is based on mutual respect, it's an effective and diplomatic communication style. Being assertive shows that you respect yourself because you're willing to stand up for your interests and express your thoughts and feelings. It also demonstrates that you're aware of the rights of others and are willing to work on resolving conflicts",106714,0,A. True,1
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34008,2,"Assertive Communication is based on mutual respect, it's an effective and diplomatic communication style. Being assertive shows that you respect yourself because you're willing to stand up for your interests and express your thoughts and feelings. It also demonstrates that you're aware of the rights of others and are willing to work on resolving conflicts",106715,1,B. False,0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34009,3,Aggressive Behavior ______________________________________________________.,106716,0,"A. Undercuts trust and mutual respect. Your co-workers may come to resent you, leading them to avoid or oppose you.",1
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34009,3,Aggressive Behavior ______________________________________________________.,106717,1,B. Will show your co-workers who is boss and gain respect from them.,0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34009,3,Aggressive Behavior ______________________________________________________.,106718,2,C. Will gain respect from your co-workers,0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34009,3,Aggressive Behavior ______________________________________________________.,106719,3,D. Will show you are superior,0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34010,4,Emotional Intelligence shows<br><br> A. Understanding of your own emotions or self awareness<br> B. Self Management<br> C. Understanding of how other people feel <br> D. Empathy<br> E. How your emotions influence other people's emotions<br>,106720,0,"1) A, B, C",0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34010,4,Emotional Intelligence shows<br><br> A. Understanding of your own emotions or self awareness<br> B. Self Management<br> C. Understanding of how other people feel <br> D. Empathy<br> E. How your emotions influence other people's emotions<br>,106721,1,"2) C, D, E",0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34010,4,Emotional Intelligence shows<br><br> A. Understanding of your own emotions or self awareness<br> B. Self Management<br> C. Understanding of how other people feel <br> D. Empathy<br> E. How your emotions influence other people's emotions<br>,106722,2,"3) A, B, C, D",0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34010,4,Emotional Intelligence shows<br><br> A. Understanding of your own emotions or self awareness<br> B. Self Management<br> C. Understanding of how other people feel <br> D. Empathy<br> E. How your emotions influence other people's emotions<br>,106723,3,"4) A, B, C, D, E",1
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34011,5,"When communicating with someone who is angry<br><br> A.  Encourage communication in regards to what has caused the anger and don't interrupt until the situation has been fully explained. <br> B. Use Active listening skills-When others are speaking, focus on what they're saying, and don't get distracted by formulating your response before they've finished. When they're done speaking, show that you listened by reflecting back what they have just said<br> C. When it's your turn to talk, speak slowly and calmly, lower your vocal tone, and use non-threatening body language. This will often encourage others to calm down<br> D. Walk away, nothing is going to work",106724,0,1. D,0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34011,5,"When communicating with someone who is angry<br><br> A.  Encourage communication in regards to what has caused the anger and don't interrupt until the situation has been fully explained. <br> B. Use Active listening skills-When others are speaking, focus on what they're saying, and don't get distracted by formulating your response before they've finished. When they're done speaking, show that you listened by reflecting back what they have just said<br> C. When it's your turn to talk, speak slowly and calmly, lower your vocal tone, and use non-threatening body language. This will often encourage others to calm down<br> D. Walk away, nothing is going to work",106725,1,"2. A, B",0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34011,5,"When communicating with someone who is angry<br><br> A.  Encourage communication in regards to what has caused the anger and don't interrupt until the situation has been fully explained. <br> B. Use Active listening skills-When others are speaking, focus on what they're saying, and don't get distracted by formulating your response before they've finished. When they're done speaking, show that you listened by reflecting back what they have just said<br> C. When it's your turn to talk, speak slowly and calmly, lower your vocal tone, and use non-threatening body language. This will often encourage others to calm down<br> D. Walk away, nothing is going to work",106726,2,"3. B, C",0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34011,5,"When communicating with someone who is angry<br><br> A.  Encourage communication in regards to what has caused the anger and don't interrupt until the situation has been fully explained. <br> B. Use Active listening skills-When others are speaking, focus on what they're saying, and don't get distracted by formulating your response before they've finished. When they're done speaking, show that you listened by reflecting back what they have just said<br> C. When it's your turn to talk, speak slowly and calmly, lower your vocal tone, and use non-threatening body language. This will often encourage others to calm down<br> D. Walk away, nothing is going to work",106727,3,"4. A, B, C",1
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34012,6,"Anger is a natural response to perceived threats. However, anger becomes a problem when you don't manage it in a healthy way.",106728,0,A. True,1
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34012,6,"Anger is a natural response to perceived threats. However, anger becomes a problem when you don't manage it in a healthy way.",106729,1,B. False,0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34013,7,2014 survey from the Centers for Disease Control (CDC) found that only _____of U.S. citizens are trained medical professionals.,106730,0,A. 10%;,0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34013,7,2014 survey from the Centers for Disease Control (CDC) found that only _____of U.S. citizens are trained medical professionals.,106731,1,B. 20%;,0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34013,7,2014 survey from the Centers for Disease Control (CDC) found that only _____of U.S. citizens are trained medical professionals.,106732,2,C. 4%;,1
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34013,7,2014 survey from the Centers for Disease Control (CDC) found that only _____of U.S. citizens are trained medical professionals.,106733,3,D. 8%;,0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34014,8,2017-2018 Service Standards address communication in regards to staff and patients as well as co-workers.,106734,0,A. True,1
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34014,8,2017-2018 Service Standards address communication in regards to staff and patients as well as co-workers.,106735,1,B. False,0
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34015,9,"Passive-Aggressive behavior damages relationships and undercuts mutual respect, thus making it difficult for you to get your goals and needs met.",106736,0,A. True,1
9456,Elearning-0000-691,COMMUNICATION AND EMOTIONAL INTELLIGENCE,n6694,34015,9,"Passive-Aggressive behavior damages relationships and undercuts mutual respect, thus making it difficult for you to get your goals and needs met.",106737,1,B. False,0
8252,Elearning-0000-1137,ED STROKE KIT IMPLEMENTATION (2018),n6700,34027,0,"I acknowledge that I have read and understand the ""ED Stroke Kit Implementation (2018)"" CBL in its entirety.",106773,0,TRUE,1
8252,Elearning-0000-1137,ED STROKE KIT IMPLEMENTATION (2018),n6700,34027,0,"I acknowledge that I have read and understand the ""ED Stroke Kit Implementation (2018)"" CBL in its entirety.",106774,1,FALSE,0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34083,0,The person who developed the APGAR scoring system was:,106970,0,a. Virginia Apgar an anesthesiologist,1
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34083,0,The person who developed the APGAR scoring system was:,107212,1,b. A NICU nurse,0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34083,0,The person who developed the APGAR scoring system was:,107213,2,c. An OB,0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34083,0,The person who developed the APGAR scoring system was:,107214,3,d. Hospital Committee formed to look at improving Infant Mortality at birth,0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34084,1,The APGAR tool should be used for:,107215,0,a. determining the need for initial resuscitation,0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34084,1,The APGAR tool should be used for:,107216,1,b. which resuscitation steps are necessary,0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34084,1,The APGAR tool should be used for:,107217,2,c. determining when resuscitation should be used,0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34084,1,The APGAR tool should be used for:,106971,3,d. conveying information about the newborn's overall status       and response to resuscitation.,1
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34085,2,Infants with a score of less than ____ at 5 mins will go to the SCN for continued observation.,106972,0,a.7,1
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34085,2,Infants with a score of less than ____ at 5 mins will go to the SCN for continued observation.,107218,1,b.5,0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34085,2,Infants with a score of less than ____ at 5 mins will go to the SCN for continued observation.,107219,2,c.6,0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34085,2,Infants with a score of less than ____ at 5 mins will go to the SCN for continued observation.,107220,3,d.4,0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34086,3,The 5 areas that are assessed at birth for an infant known as the APGAR score are:,107221,0,"a. Appearance, Pallor, Grimace, Tone and Heartrate",0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34086,3,The 5 areas that are assessed at birth for an infant known as the APGAR score are:,107222,1,"b. Apical Pulse, Pallor, Gestation, Activity and Respiratory Effort",0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34086,3,The 5 areas that are assessed at birth for an infant known as the APGAR score are:,106973,2,"c. Appearance, Pulse, Grimace, Activity and Respiratory Effort",1
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34086,3,The 5 areas that are assessed at birth for an infant known as the APGAR score are:,107223,3,"d.Color, Heart Rate, Gestation, Tone and Breathing",0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34087,5,The area of assessment least effected by gestational age is:,107224,0,a.Color,0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34087,5,The area of assessment least effected by gestational age is:,106974,1,"b.	Heart rate",1
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34087,5,The area of assessment least effected by gestational age is:,107225,2,c. Tone,0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34087,5,The area of assessment least effected by gestational age is:,107226,3,d. Breathing,0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34088,6,True or False:  A term infant will less flexion when first born.,106975,0,TRUE,0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34088,6,True or False:  A term infant will less flexion when first born.,106976,1,FALSE,1
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34089,7,"Read the scenario and assign the APGAR score to the infant.<br> At 1 min of age the infant presents with the following:<br><br>  A  Infant - acrocyanosis (hands & feet blue)<br> P  Heart Rate is 95<br> G  No Grimace; does not respond to pain or stimuli<br> A  Extremities are slightly flexed; poor tone<br> R  Breathing -weak cry, retracting<br>",107227,0,"a.	 5",0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34089,7,"Read the scenario and assign the APGAR score to the infant.<br> At 1 min of age the infant presents with the following:<br><br>  A  Infant - acrocyanosis (hands & feet blue)<br> P  Heart Rate is 95<br> G  No Grimace; does not respond to pain or stimuli<br> A  Extremities are slightly flexed; poor tone<br> R  Breathing -weak cry, retracting<br>",107228,1,"b.	 4",1
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34089,7,"Read the scenario and assign the APGAR score to the infant.<br> At 1 min of age the infant presents with the following:<br><br>  A  Infant - acrocyanosis (hands & feet blue)<br> P  Heart Rate is 95<br> G  No Grimace; does not respond to pain or stimuli<br> A  Extremities are slightly flexed; poor tone<br> R  Breathing -weak cry, retracting<br>",107229,2,"c.	 6",0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34089,7,"Read the scenario and assign the APGAR score to the infant.<br> At 1 min of age the infant presents with the following:<br><br>  A  Infant - acrocyanosis (hands & feet blue)<br> P  Heart Rate is 95<br> G  No Grimace; does not respond to pain or stimuli<br> A  Extremities are slightly flexed; poor tone<br> R  Breathing -weak cry, retracting<br>",107230,3,"d.	 2",0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34090,8,The infant from the previous slide would could continue to receive APGARS for:,107231,0,"a.	3 more times",0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34090,8,The infant from the previous slide would could continue to receive APGARS for:,107232,1,"b.	At 5mins and  at 10 mins",0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34090,8,The infant from the previous slide would could continue to receive APGARS for:,107233,2,c. Until a score of 7 or more is reached,0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34090,8,The infant from the previous slide would could continue to receive APGARS for:,106978,3,"d.	At 5 mins  & every 5mins  until a score of 7 is reached up to 20",1
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34091,9,True or False: the APGAR score should not be used to predict possible individual infant's adverse neurologic outcomes or  treatment needed for the infant.,106979,0,TRUE,1
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34091,9,True or False: the APGAR score should not be used to predict possible individual infant's adverse neurologic outcomes or  treatment needed for the infant.,106980,1,FALSE,0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34092,4,Acrocyanosis is present in _________%; of all infants born.,107234,0,"a.	75%;",0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34092,4,Acrocyanosis is present in _________%; of all infants born.,107235,1,"b.	50%;",0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34092,4,Acrocyanosis is present in _________%; of all infants born.,107236,2,"c.	80%;",0
9563,Elearning-0000-789,ASSIGNING APGAR'S,n6712,34092,4,Acrocyanosis is present in _________%; of all infants born.,106981,3,"d.	85%;",1
9098,Elearning-0000-366,NSH1205 GSK,n6723,34153,0,Your patient has arrived to the unit and the blood draw for CBC and CMET is complete. You anticipate about 30 minutes are left until the drug is ready. What do you complete next?,107241,0,"a.	Verify that the patient has rested at least 10 minutes and begin the first EKG.",1
9098,Elearning-0000-366,NSH1205 GSK,n6723,34153,0,Your patient has arrived to the unit and the blood draw for CBC and CMET is complete. You anticipate about 30 minutes are left until the drug is ready. What do you complete next?,107242,1,"b.	Have the patient complete the Research questionnaire.",0
9098,Elearning-0000-366,NSH1205 GSK,n6723,34153,0,Your patient has arrived to the unit and the blood draw for CBC and CMET is complete. You anticipate about 30 minutes are left until the drug is ready. What do you complete next?,107243,2,"c.	Draw the pre-dose PK sample.",0
9098,Elearning-0000-366,NSH1205 GSK,n6723,34153,0,Your patient has arrived to the unit and the blood draw for CBC and CMET is complete. You anticipate about 30 minutes are left until the drug is ready. What do you complete next?,107244,3,"d.	Nothing. Wait for the drug to arrive.",0
9098,Elearning-0000-366,NSH1205 GSK,n6723,34154,1,"If there is a question about the timing of the PK draws and ECGs, you should reference the worksheets provided by Research.",107245,0,TRUE,1
9098,Elearning-0000-366,NSH1205 GSK,n6723,34154,1,"If there is a question about the timing of the PK draws and ECGs, you should reference the worksheets provided by Research.",107246,1,FALSE,0
9098,Elearning-0000-366,NSH1205 GSK,n6723,34155,2,What type of supportive care will these patients receive while on study?,107247,0,"a.	Insomnia medications.",0
9098,Elearning-0000-366,NSH1205 GSK,n6723,34155,2,What type of supportive care will these patients receive while on study?,107248,1,"b.	Corneal supportive care.",1
9098,Elearning-0000-366,NSH1205 GSK,n6723,34155,2,What type of supportive care will these patients receive while on study?,107249,2,"c.	None.",0
9429,Elearning-0000-667,DATA ENTRY AT THE ABL90 ANALYZER,n6725,34156,0,I acknowledge that I have read and understand in its entirety the DATA ENTRY AT THE ABL90 ANALYZER content.,107250,0,TRUE,1
9429,Elearning-0000-667,DATA ENTRY AT THE ABL90 ANALYZER,n6725,34156,0,I acknowledge that I have read and understand in its entirety the DATA ENTRY AT THE ABL90 ANALYZER content.,107251,1,FALSE,0
9096,Elearning-0000-364,NSH1208 JAZZ CPX-501,n6726,34157,0,The Primary Objective of the study is to evaluate the potential impact of moderate and severe cardiac impairment on th       pharmacokinetics (PK) of CPX-351,107253,0,TRUE,0
9096,Elearning-0000-364,NSH1208 JAZZ CPX-501,n6726,34157,0,The Primary Objective of the study is to evaluate the potential impact of moderate and severe cardiac impairment on th       pharmacokinetics (PK) of CPX-351,107254,1,FALSE,1
9096,Elearning-0000-364,NSH1208 JAZZ CPX-501,n6726,34158,1,CPX351 is administered in pill form.,107255,0,TRUE,0
9096,Elearning-0000-364,NSH1208 JAZZ CPX-501,n6726,34158,1,CPX351 is administered in pill form.,107256,1,FALSE,1
9096,Elearning-0000-364,NSH1208 JAZZ CPX-501,n6726,34159,2,There are no Research samples required for this study.,107257,0,TRUE,0
9096,Elearning-0000-364,NSH1208 JAZZ CPX-501,n6726,34159,2,There are no Research samples required for this study.,107258,1,FALSE,1
9652,Elearning-0000-87,PHARMACY ELECTRIC PALLET JACK TRAINING FY2018,n6727,34160,0,"It's the law, you must be trained and certified to operate the Crown WP 3000 Series.",107259,0,TRUE,1
9652,Elearning-0000-87,PHARMACY ELECTRIC PALLET JACK TRAINING FY2018,n6727,34160,0,"It's the law, you must be trained and certified to operate the Crown WP 3000 Series.",107260,1,FALSE,0
9652,Elearning-0000-87,PHARMACY ELECTRIC PALLET JACK TRAINING FY2018,n6727,34161,1,Keep __________ of the truck while traveling power unit first. Make certain the truck won't hit the back of your leg or foot.,107261,0,"a.	To the side",1
9652,Elearning-0000-87,PHARMACY ELECTRIC PALLET JACK TRAINING FY2018,n6727,34161,1,Keep __________ of the truck while traveling power unit first. Make certain the truck won't hit the back of your leg or foot.,107262,1,"b.	Directly in front of",0
9652,Elearning-0000-87,PHARMACY ELECTRIC PALLET JACK TRAINING FY2018,n6727,34161,1,Keep __________ of the truck while traveling power unit first. Make certain the truck won't hit the back of your leg or foot.,107263,2,"c.	Directly behind",0
9652,Elearning-0000-87,PHARMACY ELECTRIC PALLET JACK TRAINING FY2018,n6727,34162,2,"Battery maintenance: What the lights mean -- Which of the following items are true?  I.  A steady yellow light means there is power to the charger. If the light does not come on, or goes      out, make sure the AC outlet is working and the extension cord is OK.   II. A flashing yellow light means something is wrong with a battery or the charger. Notify your supervisor.   III. A flashing green light means the charger is working.   IV. A steady green light means charging is finished.",107264,0,"a.	I & II",0
9652,Elearning-0000-87,PHARMACY ELECTRIC PALLET JACK TRAINING FY2018,n6727,34162,2,"Battery maintenance: What the lights mean -- Which of the following items are true?  I.  A steady yellow light means there is power to the charger. If the light does not come on, or goes      out, make sure the AC outlet is working and the extension cord is OK.   II. A flashing yellow light means something is wrong with a battery or the charger. Notify your supervisor.   III. A flashing green light means the charger is working.   IV. A steady green light means charging is finished.",107265,1,"b.	III & IV",0
9652,Elearning-0000-87,PHARMACY ELECTRIC PALLET JACK TRAINING FY2018,n6727,34162,2,"Battery maintenance: What the lights mean -- Which of the following items are true?  I.  A steady yellow light means there is power to the charger. If the light does not come on, or goes      out, make sure the AC outlet is working and the extension cord is OK.   II. A flashing yellow light means something is wrong with a battery or the charger. Notify your supervisor.   III. A flashing green light means the charger is working.   IV. A steady green light means charging is finished.",107266,2,"c.	I, II & III",0
9652,Elearning-0000-87,PHARMACY ELECTRIC PALLET JACK TRAINING FY2018,n6727,34162,2,"Battery maintenance: What the lights mean -- Which of the following items are true?  I.  A steady yellow light means there is power to the charger. If the light does not come on, or goes      out, make sure the AC outlet is working and the extension cord is OK.   II. A flashing yellow light means something is wrong with a battery or the charger. Notify your supervisor.   III. A flashing green light means the charger is working.   IV. A steady green light means charging is finished.",107267,3,"d.	I, II, III & IV",1
9652,Elearning-0000-87,PHARMACY ELECTRIC PALLET JACK TRAINING FY2018,n6727,34163,3,"Key Switch: When leaving the truck, always turn the key to OFF (red dot).",107268,0,TRUE,1
9652,Elearning-0000-87,PHARMACY ELECTRIC PALLET JACK TRAINING FY2018,n6727,34163,3,"Key Switch: When leaving the truck, always turn the key to OFF (red dot).",107269,1,FALSE,0
9652,Elearning-0000-87,PHARMACY ELECTRIC PALLET JACK TRAINING FY2018,n6727,34164,4,Braking: Move the control handle ________ to apply the brake.,107270,0,"a.	All the way down",0
9652,Elearning-0000-87,PHARMACY ELECTRIC PALLET JACK TRAINING FY2018,n6727,34164,4,Braking: Move the control handle ________ to apply the brake.,107271,1,"b.	All the way up",0
9652,Elearning-0000-87,PHARMACY ELECTRIC PALLET JACK TRAINING FY2018,n6727,34164,4,Braking: Move the control handle ________ to apply the brake.,107272,2,"c.	All the way down or all the way up",1
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34384,0,"The ICD-10-CM coding system is a method of translating medical terminology into alpha-numeric coded for consistent reporting, tracking and trending?",108134,0,TRUE,1
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34384,0,"The ICD-10-CM coding system is a method of translating medical terminology into alpha-numeric coded for consistent reporting, tracking and trending?",108135,1,FALSE,0
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34385,1,"CPT codes are 5-digit numeric codes that are used to describe medical, surgical, radiology, laboratory and anesthesiology services performed by medical professionals?",108136,0,TRUE,1
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34385,1,"CPT codes are 5-digit numeric codes that are used to describe medical, surgical, radiology, laboratory and anesthesiology services performed by medical professionals?",108137,1,FALSE,0
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34386,2,"CPT/ICD-10 codes do not change from year to year, so it is appropriate to use a job aid that someone created for years without updating?",108138,0,TRUE,0
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34386,2,"CPT/ICD-10 codes do not change from year to year, so it is appropriate to use a job aid that someone created for years without updating?",108139,1,FALSE,1
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34387,3,The use of routine or blanket ABN's is acceptable for Medicare patients?,108140,0,TRUE,0
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34387,3,The use of routine or blanket ABN's is acceptable for Medicare patients?,108141,1,FALSE,1
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34388,4,Modifiers are 2-digit indicators attached to a 5-digit CPT/HCPCS code - which are a communication tool used to alert the payer that services provided need special attention,108142,0,TRUE,1
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34388,4,Modifiers are 2-digit indicators attached to a 5-digit CPT/HCPCS code - which are a communication tool used to alert the payer that services provided need special attention,108143,1,FALSE,0
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34389,5,Modifier-25 indicates that a procedure or service was distinct or independent from another service performed on the same day?,108144,0,TRUE,0
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34389,5,Modifier-25 indicates that a procedure or service was distinct or independent from another service performed on the same day?,108145,1,FALSE,1
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34390,6,The _________ modifier is noted on the claim when a provider/supplier believes a services or item will be denied for lack of medical necessity and a signed ABN is on file?,108146,0,A) GY Modifier,0
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34390,6,The _________ modifier is noted on the claim when a provider/supplier believes a services or item will be denied for lack of medical necessity and a signed ABN is on file?,108147,1,B) GZ Modifier,0
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34390,6,The _________ modifier is noted on the claim when a provider/supplier believes a services or item will be denied for lack of medical necessity and a signed ABN is on file?,108148,2,C) GA Modifier,1
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34391,7,"Is a patient who was seen by the same provider in the same practice, within the last 2 years considered a new patient?",108149,0,TRUE,0
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34391,7,"Is a patient who was seen by the same provider in the same practice, within the last 2 years considered a new patient?",108150,1,FALSE,1
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34392,8,Northside Hospital's Chief Compliance Officer is?,108152,0,Jorge Hernandez,1
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34392,8,Northside Hospital's Chief Compliance Officer is?,108154,1,JORGE HERNANDEZ,1
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34393,9,Charges for non-covered services are <b><u>never</u> </b>paid by Medicare?,108155,0,TRUE,1
9261,Elearning-0000-514,INTRO TO PHYSICIAN CODING AND BILLING,n6747,34393,9,Charges for non-covered services are <b><u>never</u> </b>paid by Medicare?,108156,1,FALSE,0
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34447,0,Which of the following is NOT a reason for a sharp decrease in breastfeeding during the first few days?,108321,0,Perception of insufficient milk production,0
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34447,0,Which of the following is NOT a reason for a sharp decrease in breastfeeding during the first few days?,108322,1,Difficulty with latch-on,0
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34447,0,Which of the following is NOT a reason for a sharp decrease in breastfeeding during the first few days?,108323,2,Lack of confidence,0
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34447,0,Which of the following is NOT a reason for a sharp decrease in breastfeeding during the first few days?,108324,3,Inability to get the newborn on a feeding schedule,1
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34448,1,"Because nursing staff document a LATCH score once per shift for all breastfeeding mothers, it is no longer necessary to document breastfeedings on the I&O record.",108325,0,TRUE,0
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34448,1,"Because nursing staff document a LATCH score once per shift for all breastfeeding mothers, it is no longer necessary to document breastfeedings on the I&O record.",108326,1,FALSE,1
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34449,2,"If a mother requires assistance to place her baby in the appropriate hold to facilitate latch-on, in which category should you document a ""0""?",108327,0,Readiness,0
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34449,2,"If a mother requires assistance to place her baby in the appropriate hold to facilitate latch-on, in which category should you document a ""0""?",108328,1,Position,1
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34449,2,"If a mother requires assistance to place her baby in the appropriate hold to facilitate latch-on, in which category should you document a ""0""?",108329,2,Latch-on,0
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34449,2,"If a mother requires assistance to place her baby in the appropriate hold to facilitate latch-on, in which category should you document a ""0""?",108330,3,Milk Transfer,0
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34450,3,How are open-ended questions useful?,108331,0,Allows the staff to assess patient's knowledge deficits,0
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34450,3,How are open-ended questions useful?,108332,1,Helps the patient realize there is a need for education,0
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34450,3,How are open-ended questions useful?,108333,2,Elicits a wide-range of answers and information,0
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34450,3,How are open-ended questions useful?,108334,3,All of the above,1
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34451,4,What are the steps to 3-step Communication Technique?,108335,0,"1) Share information, 2) ask open-ended questions, 3) Affirm/Validate feelings",0
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34451,4,What are the steps to 3-step Communication Technique?,108336,1,"1) Ask Open-ended question, Affirm/Validate feelings, Share Information",1
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34451,4,What are the steps to 3-step Communication Technique?,108337,2,"1) Consider your approach, 2) Consider your Audience, 3) Only provide relevant details",0
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34451,4,What are the steps to 3-step Communication Technique?,108338,3,"1) Ask Open-ended questions, 2) Assess non-verbal cues, 3) Share information",0
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34452,5,Adults learn best when small quantities of information are provided during repeated interactions.,108339,0,TRUE,1
1700,ILT-0000-7287,FCC PCT QUARTERLY BUNDLE FY18 Q4,n6761,34452,5,Adults learn best when small quantities of information are provided during repeated interactions.,108340,1,FALSE,0
8251,Elearning-0000-1136,FCC - NEWBORN IDENTIFICATION,n6773,34482,0,"I acknowledge that I have read and understand the ""FCC - Newborn Identification"" CBL in its entirety.",108431,0,TRUE,1
8251,Elearning-0000-1136,FCC - NEWBORN IDENTIFICATION,n6773,34482,0,"I acknowledge that I have read and understand the ""FCC - Newborn Identification"" CBL in its entirety.",108432,1,FALSE,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34498,0,Kymriah (tisagenlecleucel) is indicated for the treatment of,108473,0,A- Patients up to 25 years of age newly diagnosed B-cell acute lymphoblastic leukemia (ALL),0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34498,0,Kymriah (tisagenlecleucel) is indicated for the treatment of,108474,1,B- Patients up to 25 years of age with B-cell precursor ALL that is refractory or in 2nd or later relapse,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34498,0,Kymriah (tisagenlecleucel) is indicated for the treatment of,108475,2,C- Adult patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL),0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34498,0,Kymriah (tisagenlecleucel) is indicated for the treatment of,108476,3,"D- Adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy including DLBCL not otherwise specified, high grade B-cell lymphoma and DLBCL arising from follicular lymphoma",0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34498,0,Kymriah (tisagenlecleucel) is indicated for the treatment of,108477,4,E- Both B and D,1
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34499,1,"Delay Kymriah infusion if the patient has any of the following, except:",108478,0,A- Active uncontrolled infection,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34499,1,"Delay Kymriah infusion if the patient has any of the following, except:",108479,1,B- Worsening of leukemia burden following lymphodepleting chemotherapy,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34499,1,"Delay Kymriah infusion if the patient has any of the following, except:",108480,2,C- Severe neutropenia and thrombocytopenia following lymphodepleting chemotherapy,1
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34499,1,"Delay Kymriah infusion if the patient has any of the following, except:",108481,3,D- Active graft versus host disease,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34499,1,"Delay Kymriah infusion if the patient has any of the following, except:",108482,4,E- Unresolved serious adverse reactions from preceding chemotherapies,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34500,2,"Clinically, patients with CRS can manifest with the following signs and symptom except:",108483,0,A- High grade fever,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34500,2,"Clinically, patients with CRS can manifest with the following signs and symptom except:",108484,1,B- Hypotension,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34500,2,"Clinically, patients with CRS can manifest with the following signs and symptom except:",108485,2,C- Hair loss,1
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34500,2,"Clinically, patients with CRS can manifest with the following signs and symptom except:",108486,3,D- Respiratory distress,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34500,2,"Clinically, patients with CRS can manifest with the following signs and symptom except:",108487,4,E- Hypofibrinogenemia,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34501,3,Which one of the following is true regarding the time to onset of CRS? It typically occurs:,108488,0,"A- 7-14 days following Kymriah infusion, with a median time to onset of 10 days",0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34501,3,Which one of the following is true regarding the time to onset of CRS? It typically occurs:,108489,1,"B- 7-21 days following Kymriah infusion, with a median time to onset of 10 days",0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34501,3,Which one of the following is true regarding the time to onset of CRS? It typically occurs:,108490,2,C- Median time to onset is 3 days following Kymriah infusion,1
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34501,3,Which one of the following is true regarding the time to onset of CRS? It typically occurs:,108491,3,D- Rarely starts during the first week following Kymriah infusion,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34502,4,"As a part of planning for Kymriah infusion, it is required to have two doses of tocilizumab on site for each patient prior to dispensing and administering Kymriah to patients:",108492,0,A- True,1
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34502,4,"As a part of planning for Kymriah infusion, it is required to have two doses of tocilizumab on site for each patient prior to dispensing and administering Kymriah to patients:",108493,1,B- False,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34503,5,"As a part of the patient and caregiver education for Kymriah, advise the patient to refrain from driving and engaging in hazardous occupations or activities (operating heavy or potentially dangerous machinery) for at least 8 weeks after receiving Kymriah:",108494,0,A- True,1
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34503,5,"As a part of the patient and caregiver education for Kymriah, advise the patient to refrain from driving and engaging in hazardous occupations or activities (operating heavy or potentially dangerous machinery) for at least 8 weeks after receiving Kymriah:",108495,1,B- False,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34504,6,"A 5-year-old male with relapsed ALL following an allogeneic transplantation was treated with Kymriah. One day following infusion, he developed high grade fever (40-41 degrees C) with neutropenia and was hospitalized. On day 2, he developed hypotension, which improved with fluid resuscitation. He was transferred to the PICU for close observation, and later developed recurrent hypotension, mild tachypnea and hypoxia (O<sub>2</sub> saturation 91%;). He was started on norepinephrine at a low dose and O<sub>2</sub> supplement via nasal cannula. All of the following are correct, except:",108496,0,A- The patient has symptoms consistent with cytokine release syndrome and should be managed according to the CRS management algorithm,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34504,6,"A 5-year-old male with relapsed ALL following an allogeneic transplantation was treated with Kymriah. One day following infusion, he developed high grade fever (40-41 degrees C) with neutropenia and was hospitalized. On day 2, he developed hypotension, which improved with fluid resuscitation. He was transferred to the PICU for close observation, and later developed recurrent hypotension, mild tachypnea and hypoxia (O<sub>2</sub> saturation 91%;). He was started on norepinephrine at a low dose and O<sub>2</sub> supplement via nasal cannula. All of the following are correct, except:",108497,1,B- Sepsis should be considered and treated adequately with broad spectrum antibiotics,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34504,6,"A 5-year-old male with relapsed ALL following an allogeneic transplantation was treated with Kymriah. One day following infusion, he developed high grade fever (40-41 degrees C) with neutropenia and was hospitalized. On day 2, he developed hypotension, which improved with fluid resuscitation. He was transferred to the PICU for close observation, and later developed recurrent hypotension, mild tachypnea and hypoxia (O<sub>2</sub> saturation 91%;). He was started on norepinephrine at a low dose and O<sub>2</sub> supplement via nasal cannula. All of the following are correct, except:",108498,2,C- Start myeloid growth factor to expedite neutrophil recovery,1
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34504,6,"A 5-year-old male with relapsed ALL following an allogeneic transplantation was treated with Kymriah. One day following infusion, he developed high grade fever (40-41 degrees C) with neutropenia and was hospitalized. On day 2, he developed hypotension, which improved with fluid resuscitation. He was transferred to the PICU for close observation, and later developed recurrent hypotension, mild tachypnea and hypoxia (O<sub>2</sub> saturation 91%;). He was started on norepinephrine at a low dose and O<sub>2</sub> supplement via nasal cannula. All of the following are correct, except:",108499,3,"D- Continue supportive care and close monitoring of hemodynamic, respiratory and neurological status",0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34505,7,"Neurological toxicities were observed with Kymriah, and the patient and the caregiver should be informed about this risk. All of the following are correct, except:",108500,0,"A- May occur in the context of CRS, following the resolution of CRS or without CRS",0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34505,7,"Neurological toxicities were observed with Kymriah, and the patient and the caregiver should be informed about this risk. All of the following are correct, except:",108501,1,B- Symptoms range from headache and confusion to encephalopathy and seizures,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34505,7,"Neurological toxicities were observed with Kymriah, and the patient and the caregiver should be informed about this risk. All of the following are correct, except:",108502,2,C- The majority of events were transient and self-limiting,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34505,7,"Neurological toxicities were observed with Kymriah, and the patient and the caregiver should be informed about this risk. All of the following are correct, except:",108503,3,D- Can be prevented with the administration of tocilizumab,1
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34506,8,Which one of the following about neurological toxicities as a result of Kymriah is correct?,108504,0,A- Perform neurological work-up as appropriate to exclude other etiologies of neurological symptoms,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34506,8,Which one of the following about neurological toxicities as a result of Kymriah is correct?,108505,1,B- Management includes supportive care,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34506,8,Which one of the following about neurological toxicities as a result of Kymriah is correct?,108506,2,C- Majority occurred within 8 weeks following Kymriah infusion,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34506,8,Which one of the following about neurological toxicities as a result of Kymriah is correct?,108507,3,D- All of the above,1
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34507,9,A 30-year-old female with multiply relapsed DLBCL treated with Kymriah as an outpatient 2 days after completion of lymphodepleting chemotherapy. The patient and her caregiver should be advised about the following:,108508,0,A- The risk of CRS and neurological toxicities and to contact the healthcare provider if experiencing signs and symptoms associated with CRS and neurological toxicities,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34507,9,A 30-year-old female with multiply relapsed DLBCL treated with Kymriah as an outpatient 2 days after completion of lymphodepleting chemotherapy. The patient and her caregiver should be advised about the following:,108509,1,B- The patient should plan to stay within 2 hours of the treatment site for at least 4 weeks after receiving Kymriah,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34507,9,A 30-year-old female with multiply relapsed DLBCL treated with Kymriah as an outpatient 2 days after completion of lymphodepleting chemotherapy. The patient and her caregiver should be advised about the following:,108510,2,C- The patient should carry the Kymriah patient wallet card to remind them of the signs and symptoms of CRS and neurological toxicities that require immediate attention,0
8220,Elearning-0000-1108,KYMRIAH REMS TRAINING,n6779,34507,9,A 30-year-old female with multiply relapsed DLBCL treated with Kymriah as an outpatient 2 days after completion of lymphodepleting chemotherapy. The patient and her caregiver should be advised about the following:,108511,3,D- All of the above,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,1983,46,When you smell smoke you should dial,1908,0,8384 and report it.,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,1983,46,When you smell smoke you should dial,1909,1,8911 and report it.,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,1983,46,When you smell smoke you should dial,1910,2,8797 and report it.,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,1983,46,When you smell smoke you should dial,1911,3,either b or c.,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,1984,47,Anyone may turn off the oxygen zone valves.,1912,0,TRUE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,1984,47,Anyone may turn off the oxygen zone valves.,1913,1,FALSE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,1985,48,The code word for a fire emergency is,1914,0,Code Green,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,1985,48,The code word for a fire emergency is,1915,1,Code Pink,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,1985,48,The code word for a fire emergency is,1916,2,Code Red,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,1985,48,The code word for a fire emergency is,1917,3,Code Blue,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,2058,49,The following persons may authorize the oxygen valves to be shut off.,2050,0,Fire Response Team Leader or Fire Chief,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,2058,49,The following persons may authorize the oxygen valves to be shut off.,2051,1,Safety Officer or Facility Services Director,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,2058,49,The following persons may authorize the oxygen valves to be shut off.,2052,2,Respiratory Therapy Director/Supervisor,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,2058,49,The following persons may authorize the oxygen valves to be shut off.,2053,3,House Co-ordinator,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,2058,49,The following persons may authorize the oxygen valves to be shut off.,2054,4,Any of the above,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,252,0,"There are three elements in every fire.  If one element is missing, there can be no fire.",298,0,TRUE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,252,0,"There are three elements in every fire.  If one element is missing, there can be no fire.",299,1,FALSE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,253,1,Building design is not part of the fire safety program.,300,0,TRUE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,253,1,Building design is not part of the fire safety program.,301,1,FALSE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,254,2,Patient rooms are within smoke compartments.,302,0,TRUE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,254,2,Patient rooms are within smoke compartments.,303,1,FALSE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,255,3,The door to a patient room protects from smoke and fire for about twenty hours.,304,0,TRUE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,255,3,The door to a patient room protects from smoke and fire for about twenty hours.,305,1,FALSE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,256,4,Zone shutoff valves for oxygen lines are provided in patient areas.,306,0,TRUE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,256,4,Zone shutoff valves for oxygen lines are provided in patient areas.,307,1,FALSE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,257,5,You should always use elevators during an alarm situation.,308,0,TRUE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,257,5,You should always use elevators during an alarm situation.,309,1,FALSE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,258,6,"The fire alarm system contains pull stations, smoke detectors, duct detectors, sprinklers, and flow switches.",310,0,TRUE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,258,6,"The fire alarm system contains pull stations, smoke detectors, duct detectors, sprinklers, and flow switches.",311,1,FALSE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,259,7,The alarm system is not connected to an automatic warning system.,312,0,TRUE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,259,7,The alarm system is not connected to an automatic warning system.,313,1,FALSE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,260,8,Cigarettes can start fires if they are not snuffed out completely in an appropriate container.,314,0,TRUE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,260,8,Cigarettes can start fires if they are not snuffed out completely in an appropriate container.,315,1,FALSE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,261,9,Cigarettes and oxygen are not a deadly combination.,316,0,TRUE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,261,9,Cigarettes and oxygen are not a deadly combination.,317,1,FALSE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,262,10,You should not overload electric sockets or extension cords.,318,0,TRUE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,262,10,You should not overload electric sockets or extension cords.,319,1,FALSE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,263,11,Special precautions are not necessary when working with flammable materials.,320,0,TRUE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,263,11,Special precautions are not necessary when working with flammable materials.,321,1,FALSE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,264,12,Class B fires are related to flammable liquids and gases such as gasoline.,322,0,TRUE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,264,12,Class B fires are related to flammable liquids and gases such as gasoline.,323,1,FALSE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,265,13,Class D fires involve combustible metals and are not normally found in a hospital environment.,324,0,TRUE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,265,13,Class D fires involve combustible metals and are not normally found in a hospital environment.,325,1,FALSE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,266,14,"Appliances and equipment can cause Class C fires, which are electrical, energized, or ""plugged in.""",326,0,TRUE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,266,14,"Appliances and equipment can cause Class C fires, which are electrical, energized, or ""plugged in.""",327,1,FALSE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,267,15,Good general housekeeping is not part of the fire safety program.,328,0,TRUE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,267,15,Good general housekeeping is not part of the fire safety program.,329,1,FALSE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,268,16,Trash cans should be emptied frequently.,330,0,TRUE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,268,16,Trash cans should be emptied frequently.,331,1,FALSE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,269,17,"You should promptly clean up wet spills, especially in the presence of electrical equipment.",332,0,TRUE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,269,17,"You should promptly clean up wet spills, especially in the presence of electrical equipment.",333,1,FALSE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,270,18,Empty containers cannot build up gases and cause a fire.,334,0,TRUE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,270,18,Empty containers cannot build up gases and cause a fire.,335,1,FALSE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,271,19,"RACE stands for:  Read the fire manual, Ask patients what to do, Call your family and Eat a snack.",336,0,TRUE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,271,19,"RACE stands for:  Read the fire manual, Ask patients what to do, Call your family and Eat a snack.",337,1,FALSE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,272,20,The first step to take in the event of a fire is to rescue all persons from immediate danger.,338,0,TRUE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,272,20,The first step to take in the event of a fire is to rescue all persons from immediate danger.,339,1,FALSE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,273,21,"In the event of a fire, the second step is to pull the alarm and warn others of the potential danger.",340,0,TRUE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,273,21,"In the event of a fire, the second step is to pull the alarm and warn others of the potential danger.",341,1,FALSE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,274,22,You should not consider yourself to be in a fire situation each time the alarm sounds.,342,0,TRUE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,274,22,You should not consider yourself to be in a fire situation each time the alarm sounds.,343,1,FALSE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,275,23,"In the event of a fire, you should not separate people from smoke and fire.",344,0,TRUE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,275,23,"In the event of a fire, you should not separate people from smoke and fire.",345,1,FALSE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,276,24,"All fire extinguishers are alike, so you may use any extinguisher on any fire.",346,0,TRUE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,276,24,"All fire extinguishers are alike, so you may use any extinguisher on any fire.",347,1,FALSE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,277,25,"PASS stands for:  Pull the pin, Aim at the base of the fire, Squeeze the handle, Sweep from side to side.",348,0,TRUE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,277,25,"PASS stands for:  Pull the pin, Aim at the base of the fire, Squeeze the handle, Sweep from side to side.",349,1,FALSE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,278,26,"Once you put out the fire, you should walk into the fire area and look around.",350,0,TRUE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,278,26,"Once you put out the fire, you should walk into the fire area and look around.",351,1,FALSE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,279,27,The three elements present in every fire are,352,0,"oxygen, heat, and fuel",1
1729,ILT-0000-7431,FIRE SAFETY,n1087,279,27,The three elements present in every fire are,353,1,"oxygen, flame, and wood",0
1729,ILT-0000-7431,FIRE SAFETY,n1087,279,27,The three elements present in every fire are,354,2,"heat, gas, and paper",0
1729,ILT-0000-7431,FIRE SAFETY,n1087,279,27,The three elements present in every fire are,355,3,all of the above,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,280,28,Which statement is true of smoke compartments?,356,0,Firewalls separate buildings into smoke compartments.,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,280,28,Which statement is true of smoke compartments?,357,1,Each stairwell is a separate smoke compartment.,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,280,28,Which statement is true of smoke compartments?,358,2,Both A and B are true.,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,280,28,Which statement is true of smoke compartments?,359,3,None of the above statements are true.,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,281,29,Fire prevention guidelines include which of the following?,360,0,using extension cords that are not approved,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,281,29,Fire prevention guidelines include which of the following?,361,1,"enforcing ""No Smoking"" rules",1
1729,ILT-0000-7431,FIRE SAFETY,n1087,281,29,Fire prevention guidelines include which of the following?,362,2,placing flammable materials near ignition sources,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,281,29,Fire prevention guidelines include which of the following?,363,3,all of the above,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,282,30,Which of the following is not a fire prevention guideline?,364,0,enforce policies about unauthorized appliances and equipment,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,282,30,Which of the following is not a fire prevention guideline?,365,1,keep general housekeeping in order,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,282,30,Which of the following is not a fire prevention guideline?,366,2,ignore any fire hazards,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,282,30,Which of the following is not a fire prevention guideline?,367,3,none of the above are fire prevention guidelines.,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,283,31,Which of the following is not a smoking policy?,368,0,restrict smoking to designated areas,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,283,31,Which of the following is not a smoking policy?,369,1,allow smoking near oxygen or other oxidizers,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,283,31,Which of the following is not a smoking policy?,370,2,completely extinguish cigarette butts in fireproof ash containers,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,283,31,Which of the following is not a smoking policy?,371,3,none of the above are smoking policies,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,284,32,Which statement is true of Class A fires?,372,0,Class A fires involve normal combustibles such as wood and paper.,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,284,32,Which statement is true of Class A fires?,373,1,Class A fires are related to flammable liquids and gases such as gasoline.,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,284,32,Which statement is true of Class A fires?,374,2,Class A fires involve combustible metals not normally found in a hospital.,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,284,32,Which statement is true of Class A fires?,375,3,None of the above.,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,285,33,Which of the following is an unauthorized appliances and equipment guideline?,376,0,Encourage patients to bring personal appliances into the facility,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,285,33,Which of the following is an unauthorized appliances and equipment guideline?,377,1,Always use the correct equipment for the environment,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,285,33,Which of the following is an unauthorized appliances and equipment guideline?,378,2,There are no policies about unauthorized appliances and equipment,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,286,34,"Which of the following is a ""good housekeeping"" guideline?",379,0,allow piles of soiled rags and linens to accumulate,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,286,34,"Which of the following is a ""good housekeeping"" guideline?",380,1,save all boxes and papers,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,286,34,"Which of the following is a ""good housekeeping"" guideline?",381,2,keep exits and corridors clear for evacuation,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,286,34,"Which of the following is a ""good housekeeping"" guideline?",382,3,"all of the above are ""good housekeeping"" guidelines",0
1729,ILT-0000-7431,FIRE SAFETY,n1087,287,35,Which statement is true of fire hazards?,383,0,You should report or correct any fire hazards.,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,287,35,Which statement is true of fire hazards?,384,1,"Damaged electrical wires, plugs, lights, or equipment are not fire hazards",0
1729,ILT-0000-7431,FIRE SAFETY,n1087,287,35,Which statement is true of fire hazards?,385,2,You do not need to strictly control chemical storage,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,287,35,Which statement is true of fire hazards?,386,3,All of the above statements are true of fire hazards,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,288,36,What should you do in the event of a fire?,387,0,RACE,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,288,36,What should you do in the event of a fire?,388,1,PACE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,288,36,What should you do in the event of a fire?,389,2,LACE,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,288,36,What should you do in the event of a fire?,390,3,all of the above,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,289,37,RACE stands for which of the following?,391,0,rescue persons near the fire,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,289,37,RACE stands for which of the following?,392,1,alarm those who need to respond to the fire,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,289,37,RACE stands for which of the following?,393,2,contain the fire,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,289,37,RACE stands for which of the following?,394,3,extinguish the fire,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,289,37,RACE stands for which of the following?,395,4,all of the above,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,290,38,What should you do in the event of a fire?,396,0,"warn people by running down the hall yelling ""fire""",0
1729,ILT-0000-7431,FIRE SAFETY,n1087,290,38,What should you do in the event of a fire?,397,1,ignore a fire alarm until you smell smoke,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,290,38,What should you do in the event of a fire?,398,2,"smell for smoke, look for fire, and close all doors",1
1729,ILT-0000-7431,FIRE SAFETY,n1087,290,38,What should you do in the event of a fire?,399,3,all of the above,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,291,39,"If the alarm does not sound  when you pull it, what should you do?",400,0,pull the alarm located closest to the fire area,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,291,39,"If the alarm does not sound  when you pull it, what should you do?",401,1,notify the hospital operator of a fire by phone or messenger if the alarm system fails to operate in a fire situation,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,291,39,"If the alarm does not sound  when you pull it, what should you do?",402,2,both A and B,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,292,40,Which action helps contain a fire?,403,0,Open all doors and windows to the area where the fire is located.,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,292,40,Which action helps contain a fire?,404,1,"Check all rooms for smoke and fire, then close the door when you exit the room.",1
1729,ILT-0000-7431,FIRE SAFETY,n1087,292,40,Which action helps contain a fire?,405,2,Allow visitors and patients to fill the corridors.,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,292,40,Which action helps contain a fire?,406,3,All of the above.,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,293,41,Which of the following is true of fire extinguishers?,407,0,You should not know the location and type of fire extinguishers in your area.,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,293,41,Which of the following is true of fire extinguishers?,408,1,Evacuate the area and get help if one fire extinguisher does not put a fire out.,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,293,41,Which of the following is true of fire extinguishers?,409,2,"None of the extinguishers in this facility are rated for fire classes A, B, and C",0
1729,ILT-0000-7431,FIRE SAFETY,n1087,294,42,What should you do in the event of a fire?,410,0,try to fight only small fires in their initial stages.,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,294,42,What should you do in the event of a fire?,411,1,become hysterical.,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,294,42,What should you do in the event of a fire?,412,2,endanger yourself,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,294,42,What should you do in the event of a fire?,413,3,all of the above,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,295,43,Which of the following is a good guideline for fire extinguisher use?,414,0,Never throw water on electrical fire or on flammable liquids.,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,295,43,Which of the following is a good guideline for fire extinguisher use?,415,1,"After a fire extinguisher is used, remove it from service and have it recharged.",0
1729,ILT-0000-7431,FIRE SAFETY,n1087,295,43,Which of the following is a good guideline for fire extinguisher use?,416,2,Use water extinguishers in construction areas as needed.,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,295,43,Which of the following is a good guideline for fire extinguisher use?,417,3,All of the above.,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,296,44,PASS stands for which of the following?,418,0,Pull the pin. Aim at the base. Squeeze the handle. Sweep from side to side,1
1729,ILT-0000-7431,FIRE SAFETY,n1087,296,44,PASS stands for which of the following?,419,1,"Position the extinguisher. Ask for help. Squirt the fire. Say ""Oh no!""",0
1729,ILT-0000-7431,FIRE SAFETY,n1087,296,44,PASS stands for which of the following?,420,2,both A and B,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,296,44,PASS stands for which of the following?,421,3,none of the above,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,297,45,What should you do after putting out a fire?,422,0,call the news media,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,297,45,What should you do after putting out a fire?,423,1,"go from room to room saying ""I did it!""",0
1729,ILT-0000-7431,FIRE SAFETY,n1087,297,45,What should you do after putting out a fire?,424,2,take a vacation,0
1729,ILT-0000-7431,FIRE SAFETY,n1087,297,45,What should you do after putting out a fire?,425,3,back away from the fire area,1
9587,Elearning-0000-810,ACTS OF KINDNESS TOOLKIT,n7569,34616,0,I acknowledge that I have read and understand in its entirety the ACTS OF KINDNESS TOOLKIT CBL.,108924,0,TRUE,1
9587,Elearning-0000-810,ACTS OF KINDNESS TOOLKIT,n7569,34616,0,I acknowledge that I have read and understand in its entirety the ACTS OF KINDNESS TOOLKIT CBL.,108925,1,FALSE,0
8235,Elearning-0000-1121,RCT: ADVANCE DIRECTIVES CBL,n7574,34618,0,I acknowledge that I have read and understand in its entirety the RCT: Advance Directives CBL.,108930,0,TRUE,1
10264,Elearning-0000-2035,RCT: ADVANCE DIRECTIVES CBL,n7574,34618,0,I acknowledge that I have read and understand in its entirety the RCT: Advance Directives CBL.,108930,0,TRUE,1
8235,Elearning-0000-1121,RCT: ADVANCE DIRECTIVES CBL,n7574,34618,0,I acknowledge that I have read and understand in its entirety the RCT: Advance Directives CBL.,108931,1,FALSE,0
10264,Elearning-0000-2035,RCT: ADVANCE DIRECTIVES CBL,n7574,34618,0,I acknowledge that I have read and understand in its entirety the RCT: Advance Directives CBL.,108931,1,FALSE,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34988,0,Radiation Oncology price estimates consist of what two types of estimates?,110323,0,Profee and Technical,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34988,0,Radiation Oncology price estimates consist of what two types of estimates?,110324,1,Technical only,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34988,0,Radiation Oncology price estimates consist of what two types of estimates?,110325,2,Profee only,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34989,1,The Financial Counselor should create a _____________ and ______________ estimate for employed physicians.,110326,0,Professional and Contracted,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34989,1,The Financial Counselor should create a _____________ and ______________ estimate for employed physicians.,110327,1,Professional and Technical,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34989,1,The Financial Counselor should create a _____________ and ______________ estimate for employed physicians.,110328,2,Technical and Commercial,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34990,2,The Financial Counselor should create a _____________ ________ only for contracted physicians.,110329,0,Technical estimate,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34990,2,The Financial Counselor should create a _____________ ________ only for contracted physicians.,110330,1,Insurance estimate,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34990,2,The Financial Counselor should create a _____________ ________ only for contracted physicians.,110331,2,Contracted estimate,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34991,3,"If the patient has a profee and a technical estimate, which should be generated first?",110332,0,Either one - it does not matter which order they are created in,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34991,3,"If the patient has a profee and a technical estimate, which should be generated first?",110333,1,Technical,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34991,3,"If the patient has a profee and a technical estimate, which should be generated first?",110334,2,Profee,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34992,4,The Financial Counselor should review previous accounts for outstanding balances and bad debt. This should be included in the FET as it is the total patient financial responsibility.,110335,0,TRUE,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34992,4,The Financial Counselor should review previous accounts for outstanding balances and bad debt. This should be included in the FET as it is the total patient financial responsibility.,110336,1,FALSE,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34993,5,"When creating the technical estimate, it is not necessary to deduct the profee estimate from the remaining insurance benefits.",110337,0,TRUE,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34993,5,"When creating the technical estimate, it is not necessary to deduct the profee estimate from the remaining insurance benefits.",110338,1,FALSE,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34994,6,What is the first step in preparation for creating a Radiation Oncology price estimate?,110339,0,Access OneContent queue and locate Modality Treatment Plan,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34994,6,What is the first step in preparation for creating a Radiation Oncology price estimate?,110340,1,Access STAR to obtain insurance benefits,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34994,6,What is the first step in preparation for creating a Radiation Oncology price estimate?,110341,2,Log into the FET Tool,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34995,7,What is the name of the task list used by the Financial Counselor to locate the treatment plans in One Content?,110342,0,PFS: FIN COUN RAD ONC,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34995,7,What is the name of the task list used by the Financial Counselor to locate the treatment plans in One Content?,110343,1,PFS: RADIOLOGY PATIENTS,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34995,7,What is the name of the task list used by the Financial Counselor to locate the treatment plans in One Content?,110344,2,PFS: IDK,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34996,8,A standard note code must be added to each account to notate the financial outcome.,110345,0,TRUE,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34996,8,A standard note code must be added to each account to notate the financial outcome.,110346,1,FALSE,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34997,9,A financial clearance/ non-clearance email will be sent to the appropriate email distribution list after the Financial Counselor works each account.,110347,0,TRUE,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34997,9,A financial clearance/ non-clearance email will be sent to the appropriate email distribution list after the Financial Counselor works each account.,110348,1,FALSE,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34998,10,The Modality Treatment plan specifies the quantities of CPT codes and differentiates which codes are profee versus technical.,110349,0,TRUE,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34998,10,The Modality Treatment plan specifies the quantities of CPT codes and differentiates which codes are profee versus technical.,110350,1,FALSE,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34999,11,"When creating the technical estimate, the Financial Counselor will refer to the standard processes and procedures via the Financial Estimation Tool.",110351,0,TRUE,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,34999,11,"When creating the technical estimate, the Financial Counselor will refer to the standard processes and procedures via the Financial Estimation Tool.",110352,1,FALSE,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35000,12,Each treatment plan has either 3 days or 5 days listed at the top. What does the Financial Counselor use this for?,110353,0,This does not indicate anything,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35000,12,Each treatment plan has either 3 days or 5 days listed at the top. What does the Financial Counselor use this for?,110354,1,The number of treatments,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35000,12,Each treatment plan has either 3 days or 5 days listed at the top. What does the Financial Counselor use this for?,110355,2,The number of business days to financially clear the patient,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35001,13,"If an ABN is located in one content, the Financial Counselor should create a self-pay estimate for the applicable non-covered CPT codes?",110356,0,TRUE,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35001,13,"If an ABN is located in one content, the Financial Counselor should create a self-pay estimate for the applicable non-covered CPT codes?",110357,1,FALSE,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35002,14,"Once the Financial Counselor completes the ABN, the completed document should be scanned into what ILE folder?",110358,0,PFS: Primary Insurance,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35002,14,"Once the Financial Counselor completes the ABN, the completed document should be scanned into what ILE folder?",110359,1,PFS: Insurance Information,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35002,14,"Once the Financial Counselor completes the ABN, the completed document should be scanned into what ILE folder?",110360,2,PFS: ABN,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35003,15,The Intake team will write ________________ across the top of the treatment plan when a patient's care must begin immediately.,110361,0,Hurry Up,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35003,15,The Intake team will write ________________ across the top of the treatment plan when a patient's care must begin immediately.,110362,1,Emergency,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35003,15,The Intake team will write ________________ across the top of the treatment plan when a patient's care must begin immediately.,110363,2,ASAP,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35004,16,"If an emergency patient is unable to make a suitable payment arrangement or qualify for financial assistance, their appointment ______ _______ be postponed.",110364,0,Will,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35004,16,"If an emergency patient is unable to make a suitable payment arrangement or qualify for financial assistance, their appointment ______ _______ be postponed.",110365,1,Will not,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35004,16,"If an emergency patient is unable to make a suitable payment arrangement or qualify for financial assistance, their appointment ______ _______ be postponed.",110366,2,May be,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35005,17,The Financial Counselor fills out the Patient Tracker on each patient worked.,110367,0,TRUE,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35005,17,The Financial Counselor fills out the Patient Tracker on each patient worked.,110368,1,FALSE,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35006,18,"If a non-emergency patient cannot make a suitable payment arrangement or qualify for financial assistance, the treatment is  ____________________.",110369,0,Postponed/rescheduled,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35006,18,"If a non-emergency patient cannot make a suitable payment arrangement or qualify for financial assistance, the treatment is  ____________________.",110370,1,Continued,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35006,18,"If a non-emergency patient cannot make a suitable payment arrangement or qualify for financial assistance, the treatment is  ____________________.",110371,2,Cancelled,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35007,19,Generic Treatment Plans will be created for patients that do not have an estimated amount due for radiation oncology treatment but may have _______________.,110372,0,Outstanding balances and/or bad debt,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35007,19,Generic Treatment Plans will be created for patients that do not have an estimated amount due for radiation oncology treatment but may have _______________.,110373,1,A regularly scheduled appointment,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35007,19,Generic Treatment Plans will be created for patients that do not have an estimated amount due for radiation oncology treatment but may have _______________.,110374,2,Paperwork that needs to be updated,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35008,20,The Profee Calculator is located in what folder?,110375,0,Patient Access All - Radiation Oncology Estimator Worksheet,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35008,20,The Profee Calculator is located in what folder?,110376,1,Patient Access All - Rad Onc Profee Worksheet,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35008,20,The Profee Calculator is located in what folder?,110377,2,Patient Access All - Profee Workbook,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35009,21,"When saving an estimate letter in the Profee Calculator Workbook, the following process is followed:",110378,0,"While on the letter tab, hit the save button",0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35009,21,"When saving an estimate letter in the Profee Calculator Workbook, the following process is followed:",110379,1,"While on the letter tab, do ""file, save as"" and save letter to desktop",0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35009,21,"When saving an estimate letter in the Profee Calculator Workbook, the following process is followed:",110380,2,Return to the patient tab and hit the gray save button at the top,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35010,22,"By selecting the gray SAVE button on the Patient Form tab of the Profee Calculator Workbook, the estimate letter is:",110381,0,Automatically saved to the Galen folder,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35010,22,"By selecting the gray SAVE button on the Patient Form tab of the Profee Calculator Workbook, the estimate letter is:",110382,1,Automatically saved to the desktop,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35010,22,"By selecting the gray SAVE button on the Patient Form tab of the Profee Calculator Workbook, the estimate letter is:",110383,2,Automatically sent to the patient,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35011,23,"Once the Profee estimate letter is saved on the Galen drive, the Financial Counselor should access the Galen drive and",110384,0,"Open the excel workbook, access the estimate letter and change to a PDF format.",1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35011,23,"Once the Profee estimate letter is saved on the Galen drive, the Financial Counselor should access the Galen drive and",110385,1,Open the excel workbook and delete the estimate letter.,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35011,23,"Once the Profee estimate letter is saved on the Galen drive, the Financial Counselor should access the Galen drive and",110386,2,Do nothing.  Galen does not need the letter.,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35012,24,Profee and technical payments are applied to the same outlet in Wells Fargo.,110387,0,TRUE,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35012,24,Profee and technical payments are applied to the same outlet in Wells Fargo.,110388,1,FALSE,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35013,25,What two steps have to be done in order to create the profee estimate letter once the Financial Counselor accesses the Profee Calculator?,110389,0,Fill in the insurance benefits on the Patient Form and review the Detailed Bill Estimate tab,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35013,25,What two steps have to be done in order to create the profee estimate letter once the Financial Counselor accesses the Profee Calculator?,110390,1,Fill in the insurance benefits on the Patient Form tab and save to the desktop,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35013,25,What two steps have to be done in order to create the profee estimate letter once the Financial Counselor accesses the Profee Calculator?,110391,2,Fill in the insurance benefits on the Patient Form tab and compare the Treatment Plan CPT Codes and Quantities to the ones listed on the Template List tab and update as needed,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35014,26,"If a Financial Counselor is unable to reach a patient to provide an estimate prior to treatment, the patient is considered financially cleared.",110392,0,TRUE,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35014,26,"If a Financial Counselor is unable to reach a patient to provide an estimate prior to treatment, the patient is considered financially cleared.",110393,1,FALSE,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35015,27,When should the Financial Counselor run eligibility through RevRunner (if applicable) to see if the patient has met more of their deductible or out of pocket prior to creating the estimate letter?,110394,0,Only if benefits were verified by the Intake Team within the past two weeks,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35015,27,When should the Financial Counselor run eligibility through RevRunner (if applicable) to see if the patient has met more of their deductible or out of pocket prior to creating the estimate letter?,110395,1,Only if benefits were verified by the Intake Team within the past week.,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35015,27,When should the Financial Counselor run eligibility through RevRunner (if applicable) to see if the patient has met more of their deductible or out of pocket prior to creating the estimate letter?,110396,2,Prior to every estimate.,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35016,28,The Financial Counselor should scan both the profee and technical estimate letters to what folder in ILE?,110397,0,PFS:  POS COLLECTIONS DOCUMENTS,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35016,28,The Financial Counselor should scan both the profee and technical estimate letters to what folder in ILE?,110398,1,PFS:  PRICE ESTIMATE LETTERS,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35016,28,The Financial Counselor should scan both the profee and technical estimate letters to what folder in ILE?,110399,2,PFS:  COLLECTIONS LETTERS,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35017,29,"If a patient pays more than the required 1/3 down deposit or has a copay only benefit, the Financial Counselor should use what form located on the Revenue Cycle Website?",110400,0,Generic FET Letter,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35017,29,"If a patient pays more than the required 1/3 down deposit or has a copay only benefit, the Financial Counselor should use what form located on the Revenue Cycle Website?",110401,1,Copay FET Letter,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,35017,29,"If a patient pays more than the required 1/3 down deposit or has a copay only benefit, the Financial Counselor should use what form located on the Revenue Cycle Website?",110402,2,1/3 Down/Copay Only FET Letter,0
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,36389,30,The Modality Treatment plan specifies the quantities of CPT codes and differentiates which codes are profee versus technical.,115687,0,TRUE,1
8358,Elearning-0000-1232,RCI: RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES CBL,n7596,36389,30,The Modality Treatment plan specifies the quantities of CPT codes and differentiates which codes are profee versus technical.,115688,1,FALSE,0
8248,Elearning-0000-1133,MEDICATION RECONCILIATION,n7616,35180,0,"I acknowledge that I have read and understand the ""Medication Reconciliation"" CBL in its entirety.",111026,0,TRUE,1
8248,Elearning-0000-1133,MEDICATION RECONCILIATION,n7616,35180,0,"I acknowledge that I have read and understand the ""Medication Reconciliation"" CBL in its entirety.",111027,1,FALSE,0
9486,Elearning-0000-719,LASER SAFETY OFFICER TRAINING REGISTRATION,n7630,35415,0,"I have read and understand the ""Laser Safety Officer Training Registration""  CBL.",112024,0,TRUE,1
9486,Elearning-0000-719,LASER SAFETY OFFICER TRAINING REGISTRATION,n7630,35415,0,"I have read and understand the ""Laser Safety Officer Training Registration""  CBL.",112025,1,FALSE,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35474,0,Identify an effective communication technique FCC PCTs can utilize when talking to patients:,112251,0,Active Listening,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35474,0,Identify an effective communication technique FCC PCTs can utilize when talking to patients:,112252,1,Restating,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35474,0,Identify an effective communication technique FCC PCTs can utilize when talking to patients:,112253,2,Silence - Passive Involvement,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35474,0,Identify an effective communication technique FCC PCTs can utilize when talking to patients:,112254,3,All of the above,1
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35475,1,Indicators for Maternal Sepsis include which of the following:,112255,0,Increasing pain that is not what you would expect for the patient's type of delivery and how long since they had their baby,1
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35475,1,Indicators for Maternal Sepsis include which of the following:,112256,1,Bradycardia (low heart rate),0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35475,1,Indicators for Maternal Sepsis include which of the following:,112257,2,Normal temperature,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35475,1,Indicators for Maternal Sepsis include which of the following:,112258,3,Complaint of spots before eyes,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35476,2,"According to the Northside Early Warning Triggers for Obstetrics - NEWT-OB, if the patient's MAP is the only positive trigger:",112259,0,All vital signs should be obtained every hour for the next 24 hours,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35476,2,"According to the Northside Early Warning Triggers for Obstetrics - NEWT-OB, if the patient's MAP is the only positive trigger:",112260,1,No change in vital signs frequency is needed,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35476,2,"According to the Northside Early Warning Triggers for Obstetrics - NEWT-OB, if the patient's MAP is the only positive trigger:",112261,2,A full set of vital signs should be obtained in 30 minutes,1
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35476,2,"According to the Northside Early Warning Triggers for Obstetrics - NEWT-OB, if the patient's MAP is the only positive trigger:",112262,3,Patient should be transferred to ICU immediately,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35477,3,The role of a PCT for Sepsis protocol includes which of the following:,112263,0,Notify the nurse immediately if vital signs are abnormal,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35477,3,The role of a PCT for Sepsis protocol includes which of the following:,112264,1,Complete and document vital signs in timely manner,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35477,3,The role of a PCT for Sepsis protocol includes which of the following:,112265,2,Notify the nurse immediately if you notice a Sepsis Alert on the patient's computer record,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35477,3,The role of a PCT for Sepsis protocol includes which of the following:,112266,3,All of the above,1
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35478,4,What are some possible interventions that a nurse might instruct you to perform for a postpartum patient to decrease the likelihood of urinary complications?,112267,0,Measure the first three voids after delivery or after foley removal,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35478,4,What are some possible interventions that a nurse might instruct you to perform for a postpartum patient to decrease the likelihood of urinary complications?,112268,1,Encourage the patient to eat foods high in protein,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35478,4,What are some possible interventions that a nurse might instruct you to perform for a postpartum patient to decrease the likelihood of urinary complications?,112269,2,Demonstrate to the patient how to perform pericare and hand hygiene,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35478,4,What are some possible interventions that a nurse might instruct you to perform for a postpartum patient to decrease the likelihood of urinary complications?,112270,3,Both A & C,1
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35479,5,"When getting a patient up for the first time, what interventions should be considered to prevent a fall?",112271,0,It is okay to assist a patient out of bed for the first time by yourself if a nurse approves it.,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35479,5,"When getting a patient up for the first time, what interventions should be considered to prevent a fall?",112272,1,A nurse must complete a fall risk assessment before attempting to get the patient up for the first time.,1
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35479,5,"When getting a patient up for the first time, what interventions should be considered to prevent a fall?",112273,2,Make sure the patient has not been medicated for at least 4 hours before getting out of bed.,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35479,5,"When getting a patient up for the first time, what interventions should be considered to prevent a fall?",112274,3,You may ask family member to assist you with getting the patient up.,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35480,6,Which of the following statements are true regarding vital sign routines for a postpartum mother?,112275,0,"For a vaginal delivery mom, vital signs should be performed: on admission to FCC, every 4 hours for the first 12 hours, then every shift until discharge",1
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35480,6,Which of the following statements are true regarding vital sign routines for a postpartum mother?,112276,1,Pulse Oximetry should only be performed on a C-Section mom for her initial set of vital signs upon admission,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35480,6,Which of the following statements are true regarding vital sign routines for a postpartum mother?,112277,2,There is no difference in the routine for a vaginal delivery and a C-Section delivery,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35480,6,Which of the following statements are true regarding vital sign routines for a postpartum mother?,112278,3,All temperatures for postpartum moms should be axillary,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35481,7,"When taking vital signs for a postpartum mom, which of the following should be done to ensure vital sign accuracy:",112279,0,Blood pressure cuff should be 1.5 times the upper arm circumference and the cuff should encircle the arm by 80% or greater,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35481,7,"When taking vital signs for a postpartum mom, which of the following should be done to ensure vital sign accuracy:",112280,1,Make sure the patient is not in pain,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35481,7,"When taking vital signs for a postpartum mom, which of the following should be done to ensure vital sign accuracy:",112281,2,Ensure that the patient has not been drinking a hot or cold beverage immediately before vital signs,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35481,7,"When taking vital signs for a postpartum mom, which of the following should be done to ensure vital sign accuracy:",112282,3,All of the above,1
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35482,8,What action below is false regarding a PCT's actions if a vital sign is abnormal?,112283,0,Notify supervisor immediately,1
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35482,8,What action below is false regarding a PCT's actions if a vital sign is abnormal?,112284,1,Repeat vital sign as instructed by the nurse,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35482,8,What action below is false regarding a PCT's actions if a vital sign is abnormal?,112285,2,Document the name of the staff member that was notified,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35482,8,What action below is false regarding a PCT's actions if a vital sign is abnormal?,112286,3,Make sure all vital signs are documented (both abnormal and repeats),0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35483,9,"For a Low Birth Weight or premature newborn, what is accurate regarding the vital signs routine?",112287,0,The first 24 hour vital sign routine is exactly as for a normal newborn,1
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35483,9,"For a Low Birth Weight or premature newborn, what is accurate regarding the vital signs routine?",112288,1,"After the first 24 hours, all vital signs should be assessed every 4 hours until discharge",0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35483,9,"For a Low Birth Weight or premature newborn, what is accurate regarding the vital signs routine?",112289,2,Obtain blood pressures on all 4 extremities upon admission,0
8234,Elearning-0000-1120,FCC PCT RESIDENCY WELCOME CLASS I,n7640,35483,9,"For a Low Birth Weight or premature newborn, what is accurate regarding the vital signs routine?",112290,3,"If the temperature is low, you do not need to notify the nurse",0
8399,Elearning-0000-127,NSF TELESTROKE COMPETENCY FOR RRT NSF,n7648,35527,0,I acknowledge that I have read and understand in its entirety the NSF TELESTROKE COMPETENCY FOR RRT NSF content.,112368,0,TRUE,1
8399,Elearning-0000-127,NSF TELESTROKE COMPETENCY FOR RRT NSF,n7648,35527,0,I acknowledge that I have read and understand in its entirety the NSF TELESTROKE COMPETENCY FOR RRT NSF content.,112369,1,FALSE,0
9548,Elearning-0000-775,BED PLACEMENT & TELEPHONE REPORTING,n7668,35665,0,I acknowledge that I have read and understand in its entirety the BED PLACEMENT & TELEPHONE REPORTING content.,112855,0,TRUE,1
9548,Elearning-0000-775,BED PLACEMENT & TELEPHONE REPORTING,n7668,35665,0,I acknowledge that I have read and understand in its entirety the BED PLACEMENT & TELEPHONE REPORTING content.,112856,1,FALSE,0
8410,Elearning-0000-128,NSF TELESTROKE COMPETENCY FOR ED STAFF,n7669,35666,0,I acknowledge that I have read and understand in its entirety the NSF TELESTROKE COMPETENCY FOR ED STAFF content.,112857,0,TRUE,1
8410,Elearning-0000-128,NSF TELESTROKE COMPETENCY FOR ED STAFF,n7669,35666,0,I acknowledge that I have read and understand in its entirety the NSF TELESTROKE COMPETENCY FOR ED STAFF content.,112858,1,FALSE,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36315,0,"An antineoplastic agent capable of producing pain at the IV site and along the vein, with or without an inflammatory response is considered a:",115418,0,"a.	Vesicant",0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36315,0,"An antineoplastic agent capable of producing pain at the IV site and along the vein, with or without an inflammatory response is considered a:",115419,1,"b.	Irritant",1
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36315,0,"An antineoplastic agent capable of producing pain at the IV site and along the vein, with or without an inflammatory response is considered a:",115420,2,"c.	Neither",0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36316,1,Which pharmacologic agents are available to treat chemotherapy extravasation?,115421,0,"a.	DMSO",0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36316,1,Which pharmacologic agents are available to treat chemotherapy extravasation?,115422,1,"b.	Hyaluronidase",0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36316,1,Which pharmacologic agents are available to treat chemotherapy extravasation?,115423,2,"c.	Sodium Thiosulfate",0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36316,1,Which pharmacologic agents are available to treat chemotherapy extravasation?,115424,3,"d.	Dexrazoxane",0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36316,1,Which pharmacologic agents are available to treat chemotherapy extravasation?,115425,4,"e.	B and D",1
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36317,2,Which is NOT a delayed manifestation of a vesicant extravasation?,115426,0,"a.	Increased redness",0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36317,2,Which is NOT a delayed manifestation of a vesicant extravasation?,115427,1,"b.	Increased pain",0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36317,2,Which is NOT a delayed manifestation of a vesicant extravasation?,115428,2,"c.	Loss of blood return",1
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36317,2,Which is NOT a delayed manifestation of a vesicant extravasation?,115429,3,"d.	Ulceration",0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36317,2,Which is NOT a delayed manifestation of a vesicant extravasation?,115430,4,"e.	Increased swelling",0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36318,3,Immediate blotches or streaks along the veins which usually subsides within a few minutes is a typical flare reaction.,115431,0,TRUE,1
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36318,3,Immediate blotches or streaks along the veins which usually subsides within a few minutes is a typical flare reaction.,115432,1,FALSE,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36319,4,"What is correct sequence of events at first suspicion of an extravasation? 1.	Remove IV device or needle 2.	Stop infusion 3.	Aspirate residual drug from IV device 4.	Disconnect IV tubing from IV device",115433,0,"a.	2, 3, 1, 4",0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36319,4,"What is correct sequence of events at first suspicion of an extravasation? 1.	Remove IV device or needle 2.	Stop infusion 3.	Aspirate residual drug from IV device 4.	Disconnect IV tubing from IV device",115434,1,"b.	2, 1, 3, 4",0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36319,4,"What is correct sequence of events at first suspicion of an extravasation? 1.	Remove IV device or needle 2.	Stop infusion 3.	Aspirate residual drug from IV device 4.	Disconnect IV tubing from IV device",115435,2,"c.	2, 4, 3, 1",1
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36319,4,"What is correct sequence of events at first suspicion of an extravasation? 1.	Remove IV device or needle 2.	Stop infusion 3.	Aspirate residual drug from IV device 4.	Disconnect IV tubing from IV device",115436,3,"d.	1, 2, 3, 4",0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36320,5,Which of the following is INCORRECT about Zinecard (dexrazoxane)?,115437,0,a. Reduce dose by 40% in patients with CrCL less than 50ml/min.,1
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36320,5,Which of the following is INCORRECT about Zinecard (dexrazoxane)?,115438,1,b. Should be mixed in Ringers Lactate.,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36320,5,Which of the following is INCORRECT about Zinecard (dexrazoxane)?,115439,2,"c. Should be administered on Days 1, 2, and 3.",0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36320,5,Which of the following is INCORRECT about Zinecard (dexrazoxane)?,115440,3,d. Should be initiated within 6 hours.,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36321,6,Which is the only medication requiring warm compresses but no pharmaceutical antidote?,115441,0,a. Etoposide,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36321,6,Which is the only medication requiring warm compresses but no pharmaceutical antidote?,115442,1,b. Oxaliplatin,1
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36321,6,Which is the only medication requiring warm compresses but no pharmaceutical antidote?,115443,2,c. Irinotecan,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36321,6,Which is the only medication requiring warm compresses but no pharmaceutical antidote?,115444,3,d. Vincristine,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36322,7,"If a medication infiltrates and it is not listed on your reference chart as a vesicant or irritant, what should you do?",115445,0,a. Advise patient to apply cold compress for 15 min every 6 hours x 24 hours,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36322,7,"If a medication infiltrates and it is not listed on your reference chart as a vesicant or irritant, what should you do?",115446,1,b. Advise patient to apply warm compress for 15 min every 6 hours x 24 hours,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36322,7,"If a medication infiltrates and it is not listed on your reference chart as a vesicant or irritant, what should you do?",115447,2,"c. Advise patient to avoid pressure and report signs of redness, pain, skin breakdown.",0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36322,7,"If a medication infiltrates and it is not listed on your reference chart as a vesicant or irritant, what should you do?",115448,3,d. A and C,1
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36323,8,Hyaluronidase should be administered:,115449,0,a. In a series of 0.2ml injections in a clockwise fashion,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36323,8,Hyaluronidase should be administered:,115450,1,b. Using a new 25 g or smaller needle for each injection,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36323,8,Hyaluronidase should be administered:,115451,2,c. As a total dose of 1ml dose subcutaneously,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36323,8,Hyaluronidase should be administered:,115452,3,d. All of the above,1
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36324,9,Dexrazoxane should be used to treat an extravasation of all of the following EXCEPT:,115453,0,a. Epirubicin,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36324,9,Dexrazoxane should be used to treat an extravasation of all of the following EXCEPT:,115454,1,b. Mitomycin,1
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36324,9,Dexrazoxane should be used to treat an extravasation of all of the following EXCEPT:,115455,2,c. Doxorubicin,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36324,9,Dexrazoxane should be used to treat an extravasation of all of the following EXCEPT:,115456,3,d. Idarubicin,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36325,10,Hyaluronidase is used to treat extravasation of which of the following medications?,115457,0,a. Etoposide,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36325,10,Hyaluronidase is used to treat extravasation of which of the following medications?,115458,1,b. Vincristine,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36325,10,Hyaluronidase is used to treat extravasation of which of the following medications?,115459,2,c. Vinblastine,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36325,10,Hyaluronidase is used to treat extravasation of which of the following medications?,115460,3,d. Vinorelbine,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36325,10,Hyaluronidase is used to treat extravasation of which of the following medications?,115461,4,e. All of the above,1
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36326,11,Which of the following is considered an irritant medication?,115462,0,a. Trabectidin,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36326,11,Which of the following is considered an irritant medication?,115463,1,b. Bendamustine,0
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36326,11,Which of the following is considered an irritant medication?,115464,2,c. Gemcitabine,1
9026,Elearning-0000-300,2018 ONCOLOGIC EMERGENCY - EXTRAVASATION,n7710,36326,11,Which of the following is considered an irritant medication?,115465,3,d. Mitoxantrone,0
9053,Elearning-0000-325,NSH1207 JCAR017,n7725,36460,0,All subjects will undergo leukapheresis,115972,0,TRUE,1
9053,Elearning-0000-325,NSH1207 JCAR017,n7725,36460,0,All subjects will undergo leukapheresis,115973,1,FALSE,0
9053,Elearning-0000-325,NSH1207 JCAR017,n7725,36461,1,Cytokine release syndrome is not a side effect of JCAR017,115974,0,TRUE,0
9053,Elearning-0000-325,NSH1207 JCAR017,n7725,36461,1,Cytokine release syndrome is not a side effect of JCAR017,115975,1,FALSE,1
9053,Elearning-0000-325,NSH1207 JCAR017,n7725,36462,2,An indolent NHL can transform into DLBCL,115976,0,TRUE,1
9053,Elearning-0000-325,NSH1207 JCAR017,n7725,36462,2,An indolent NHL can transform into DLBCL,115977,1,FALSE,0
140,SCORM-0000-22,CREDENTIALING PROCESS - ORIENTATION MATERIALS,n7736,36565,0,I have read and understood the content within the Credentialing Process - Orientation Materials CBL.,116391,0,TRUE,1
140,SCORM-0000-22,CREDENTIALING PROCESS - ORIENTATION MATERIALS,n7736,36565,0,I have read and understood the content within the Credentialing Process - Orientation Materials CBL.,116392,1,FALSE,0
8246,Elearning-0000-1131,GUIDELINES FOR NIPPLE SHIELD USE 2018,n7751,36717,0,"I acknowledge that I have read and understand the ""Guidelines for Nipple Shield Use 2018"" CBL in its entirety.",116980,0,TRUE,1
8246,Elearning-0000-1131,GUIDELINES FOR NIPPLE SHIELD USE 2018,n7751,36717,0,"I acknowledge that I have read and understand the ""Guidelines for Nipple Shield Use 2018"" CBL in its entirety.",116981,1,FALSE,0
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36873,0,Which type of infection can cause sepsis?,117444,0,"a.	Bacterial",0
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36873,0,Which type of infection can cause sepsis?,117445,1,"b.	Viral",0
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36873,0,Which type of infection can cause sepsis?,117446,2,"c.	Fungal",0
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36873,0,Which type of infection can cause sepsis?,117447,3,"d.	All of the above",1
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36874,1,Which of the following conditions should be treated as a MEDICAL EMERGENCY?,117448,0,"a.	Nausea & vomiting",0
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36874,1,Which of the following conditions should be treated as a MEDICAL EMERGENCY?,117449,1,"b.	Burning or tingling sensation in fingers or toes",0
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36874,1,Which of the following conditions should be treated as a MEDICAL EMERGENCY?,117450,2,"c.	Febrile neutropenia",1
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36874,1,Which of the following conditions should be treated as a MEDICAL EMERGENCY?,117451,3,"d.	New onset alopecia",0
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36875,2,Which of the following is NOT a required part of the sepsis bundle?,117452,0,"a.	Lactate",0
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36875,2,Which of the following is NOT a required part of the sepsis bundle?,117453,1,"b.	CBC",1
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36875,2,Which of the following is NOT a required part of the sepsis bundle?,117454,2,"c.	Blood cultures before antibiotics",0
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36875,2,Which of the following is NOT a required part of the sepsis bundle?,117455,3,"d.	Broad spectrum antibiotics",0
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36876,3,A lactate level must be repeated if the initial lactate level is:,117456,0,"a.	Greater than or equal to 2",1
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36876,3,A lactate level must be repeated if the initial lactate level is:,117457,1,"b.	Greater than or equal to 4",0
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36876,3,A lactate level must be repeated if the initial lactate level is:,117458,2,"c.	Less than 4",0
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36876,3,A lactate level must be repeated if the initial lactate level is:,117459,3,"d.	The lactate level never needs to be repeated",0
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36877,4,"A patient was admitted to your inpatient unit from the outpatient infusion center for febrile neutropenia.  Blood cultures and a lactate level were drawn in the infusion center, and the patient received a dose of IV antibiotics there.  What documentation MUST be included on the inpatient chart?",117460,0,"a.	Documentation from the infusion center indicating the time lactate and blood cultures were drawn.",0
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36877,4,"A patient was admitted to your inpatient unit from the outpatient infusion center for febrile neutropenia.  Blood cultures and a lactate level were drawn in the infusion center, and the patient received a dose of IV antibiotics there.  What documentation MUST be included on the inpatient chart?",117461,1,"b.	The lactate result, if known.",0
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36877,4,"A patient was admitted to your inpatient unit from the outpatient infusion center for febrile neutropenia.  Blood cultures and a lactate level were drawn in the infusion center, and the patient received a dose of IV antibiotics there.  What documentation MUST be included on the inpatient chart?",117462,2,"c.	Documentation from the infusion center indicating the name, dose, route, and administration time of the antibiotic given.",0
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36877,4,"A patient was admitted to your inpatient unit from the outpatient infusion center for febrile neutropenia.  Blood cultures and a lactate level were drawn in the infusion center, and the patient received a dose of IV antibiotics there.  What documentation MUST be included on the inpatient chart?",117463,3,"d.	All of the above.",1
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36878,5,Your patient is being treated for febrile neutropenia and pneumonia.  They are tachycardic and their respiratory rate has been in the low 20's.  The blood pressure drops to 88/42.  What should you do?,117464,0,"a.	Increase their IV fluid rate to see if that brings the blood pressure up.",0
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36878,5,Your patient is being treated for febrile neutropenia and pneumonia.  They are tachycardic and their respiratory rate has been in the low 20's.  The blood pressure drops to 88/42.  What should you do?,117465,1,"b.	Wait an hour and re-check the blood pressure.",0
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36878,5,Your patient is being treated for febrile neutropenia and pneumonia.  They are tachycardic and their respiratory rate has been in the low 20's.  The blood pressure drops to 88/42.  What should you do?,117466,2,"c.	Activate the Rapid Response Team and notify the physician of possible severe sepsis.",1
8900,Elearning-0000-186,SEPSIS FOR ONCOLOGY NURSES,n7769,36878,5,Your patient is being treated for febrile neutropenia and pneumonia.  They are tachycardic and their respiratory rate has been in the low 20's.  The blood pressure drops to 88/42.  What should you do?,117467,3,"d.	Nothing.  A low blood pressure is normal with febrile neutropenia.",0
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36880,0,Proper disposal of pharmaceutical waste is a legal and regulatory compliance issue. The following entities work together to ensure compliance.<br><br> EPA<br> NIOSH<br> CDC<br> The Joint Commission<br> CMS<br> State of Georgia<br>,117470,0,a. True,1
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36880,0,Proper disposal of pharmaceutical waste is a legal and regulatory compliance issue. The following entities work together to ensure compliance.<br><br> EPA<br> NIOSH<br> CDC<br> The Joint Commission<br> CMS<br> State of Georgia<br>,117471,1,b. False,0
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36881,1,Which of the following items should be placed in regular trash,117472,0,a. Empty medication packaging,0
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36881,1,Which of the following items should be placed in regular trash,117473,1,b. Plain IV fluids,0
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36881,1,Which of the following items should be placed in regular trash,117474,2,c. Plain IV fluids w/KCl or Bicarb,0
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36881,1,Which of the following items should be placed in regular trash,117475,3,d. IV contrast,0
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36881,1,Which of the following items should be placed in regular trash,117476,4,e. All of the above,0
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36881,1,Which of the following items should be placed in regular trash,117477,5,"f. A, B, and C only",1
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36881,1,Which of the following items should be placed in regular trash,117478,6,g. A and B only,0
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36882,2,Medications must be placed in a plastic bag before discarding into the black bin.,117479,0,a. True,1
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36882,2,Medications must be placed in a plastic bag before discarding into the black bin.,117480,1,b. False,0
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36883,3,Partial doses of which medications should be placed in the black bin?,117481,0,a. Benadryl,0
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36883,3,Partial doses of which medications should be placed in the black bin?,117482,1,b. Inhalers,0
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36883,3,Partial doses of which medications should be placed in the black bin?,117483,2,c. Lidocaine,0
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36883,3,Partial doses of which medications should be placed in the black bin?,117484,3,d. Oral and IV Contrast Media,0
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36883,3,Partial doses of which medications should be placed in the black bin?,117485,4,e. All of the above,0
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36883,3,Partial doses of which medications should be placed in the black bin?,117486,5,"f. A, B, and D only",0
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36883,3,Partial doses of which medications should be placed in the black bin?,117487,6,"g. A, and B only",1
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36883,3,Partial doses of which medications should be placed in the black bin?,117488,7,h. None of the above,0
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36884,4,Who checks and removes pharmacy waste bins from patient care areas?,117489,0,a. Environmental Services (EVS),0
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36884,4,Who checks and removes pharmacy waste bins from patient care areas?,117490,1,b. Pharmacy Waste Vendor,1
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36884,4,Who checks and removes pharmacy waste bins from patient care areas?,117491,2,c. Anyone can take out the trash.,0
8242,Elearning-0000-1128,PHARMACEUTICAL WASTE PROGRAM FOR OFFSITE RADIOLOGY FY2019,n7771,36884,4,Who checks and removes pharmacy waste bins from patient care areas?,117492,3,d. A and B only,0
65,SCORM-0000-15,COMPASSION FATIGUE,n7783,36982,0,I have read and understood the content within the Compassion Fatigue CBL.,117900,0,TRUE,1
1156,ILT-0000-4611,COMPASSION FATIGUE,n7783,36982,0,I have read and understood the content within the Compassion Fatigue CBL.,117900,0,TRUE,1
65,SCORM-0000-15,COMPASSION FATIGUE,n7783,36982,0,I have read and understood the content within the Compassion Fatigue CBL.,117901,1,FALSE,0
1156,ILT-0000-4611,COMPASSION FATIGUE,n7783,36982,0,I have read and understood the content within the Compassion Fatigue CBL.,117901,1,FALSE,0
8217,Elearning-0000-1105,MASSIVE TRANSFUSION PROTOCOL ENHANCEMENTS - OCTOBER 2018,n7814,37179,0,True or False - the primary runner between the department and the blood bank is to stay in the department after delivering blood and wait for the blood bank to call to say that there is more to pick up,118609,0,TRUE,0
8217,Elearning-0000-1105,MASSIVE TRANSFUSION PROTOCOL ENHANCEMENTS - OCTOBER 2018,n7814,37179,0,True or False - the primary runner between the department and the blood bank is to stay in the department after delivering blood and wait for the blood bank to call to say that there is more to pick up,118610,1,FALSE,1
8217,Elearning-0000-1105,MASSIVE TRANSFUSION PROTOCOL ENHANCEMENTS - OCTOBER 2018,n7814,37180,1,"MTP events are to be treated with the same level of seriousness and attention that resuscitation (Code Blue) are.  As such, a designated recorder role has been developed to ensure the following",118611,0,a. Documentation of the time and product number that each blood product unit is administered,0
8217,Elearning-0000-1105,MASSIVE TRANSFUSION PROTOCOL ENHANCEMENTS - OCTOBER 2018,n7814,37180,1,"MTP events are to be treated with the same level of seriousness and attention that resuscitation (Code Blue) are.  As such, a designated recorder role has been developed to ensure the following",118612,1,"b.	Blood bank is called regularly to check on the status of blood products",0
8217,Elearning-0000-1105,MASSIVE TRANSFUSION PROTOCOL ENHANCEMENTS - OCTOBER 2018,n7814,37180,1,"MTP events are to be treated with the same level of seriousness and attention that resuscitation (Code Blue) are.  As such, a designated recorder role has been developed to ensure the following",118613,2,"c.	Notification to the physician leader of the packed red blood cell to fresh frozen ratio",0
8217,Elearning-0000-1105,MASSIVE TRANSFUSION PROTOCOL ENHANCEMENTS - OCTOBER 2018,n7814,37180,1,"MTP events are to be treated with the same level of seriousness and attention that resuscitation (Code Blue) are.  As such, a designated recorder role has been developed to ensure the following",118614,3,"d.	Both a & b",0
8217,Elearning-0000-1105,MASSIVE TRANSFUSION PROTOCOL ENHANCEMENTS - OCTOBER 2018,n7814,37180,1,"MTP events are to be treated with the same level of seriousness and attention that resuscitation (Code Blue) are.  As such, a designated recorder role has been developed to ensure the following",118615,4,"e.	Both a & c",1
8217,Elearning-0000-1105,MASSIVE TRANSFUSION PROTOCOL ENHANCEMENTS - OCTOBER 2018,n7814,37180,1,"MTP events are to be treated with the same level of seriousness and attention that resuscitation (Code Blue) are.  As such, a designated recorder role has been developed to ensure the following",118616,5,"f.	Both b & c",0
8217,Elearning-0000-1105,MASSIVE TRANSFUSION PROTOCOL ENHANCEMENTS - OCTOBER 2018,n7814,37180,1,"MTP events are to be treated with the same level of seriousness and attention that resuscitation (Code Blue) are.  As such, a designated recorder role has been developed to ensure the following",118617,6,"g.	All of the above",0
8217,Elearning-0000-1105,MASSIVE TRANSFUSION PROTOCOL ENHANCEMENTS - OCTOBER 2018,n7814,37181,2,A short debriefing event is to occur following each MTP event.  Which of the following is NOT a characteristic of a debriefing.,118618,0,"a.	To be done standing up",0
8217,Elearning-0000-1105,MASSIVE TRANSFUSION PROTOCOL ENHANCEMENTS - OCTOBER 2018,n7814,37181,2,A short debriefing event is to occur following each MTP event.  Which of the following is NOT a characteristic of a debriefing.,118619,1,"b.	Completed as soon as possible as to completion of the event",0
8217,Elearning-0000-1105,MASSIVE TRANSFUSION PROTOCOL ENHANCEMENTS - OCTOBER 2018,n7814,37181,2,A short debriefing event is to occur following each MTP event.  Which of the following is NOT a characteristic of a debriefing.,118620,2,"c.	To be completed by all departments involved in the  event",0
8217,Elearning-0000-1105,MASSIVE TRANSFUSION PROTOCOL ENHANCEMENTS - OCTOBER 2018,n7814,37181,2,A short debriefing event is to occur following each MTP event.  Which of the following is NOT a characteristic of a debriefing.,118621,3,"d.	Optional to do",1
8217,Elearning-0000-1105,MASSIVE TRANSFUSION PROTOCOL ENHANCEMENTS - OCTOBER 2018,n7814,37181,2,A short debriefing event is to occur following each MTP event.  Which of the following is NOT a characteristic of a debriefing.,118622,4,"e.	Needs to include all of the participants involved in the MTP event, including the blood bank",0
8217,Elearning-0000-1105,MASSIVE TRANSFUSION PROTOCOL ENHANCEMENTS - OCTOBER 2018,n7814,37181,2,A short debriefing event is to occur following each MTP event.  Which of the following is NOT a characteristic of a debriefing.,118623,5,"f.	Is an opportunity to provide positive aspects of care as well as opportunities to improve",0
9288,Elearning-0000-539,HBI CHARGE RECONCILIATION,n7830,37328,0,I acknowledge that I have read and understand in its entirety the HBI CHARGE RECONCILIATION content.,119212,0,TRUE,1
9288,Elearning-0000-539,HBI CHARGE RECONCILIATION,n7830,37328,0,I acknowledge that I have read and understand in its entirety the HBI CHARGE RECONCILIATION content.,119213,1,FALSE,0
8918,Elearning-0000-202,SCN ALARM LIMITS 2019,n7840,37350,0,I acknowledge that I have read and understand in its entirety the SCN ALARM LIMITS 2019 content.,119235,0,TRUE,1
8918,Elearning-0000-202,SCN ALARM LIMITS 2019,n7840,37350,0,I acknowledge that I have read and understand in its entirety the SCN ALARM LIMITS 2019 content.,119236,1,FALSE,0
8911,Elearning-0000-196,SCN THERMOREGULATION 2019,n7842,37352,0,I acknowledge that I have read and understand in its entirety the SCN Thermoregulation 2019 content.,119239,0,TRUE,1
8911,Elearning-0000-196,SCN THERMOREGULATION 2019,n7842,37352,0,I acknowledge that I have read and understand in its entirety the SCN Thermoregulation 2019 content.,119240,1,FALSE,0
9420,Elearning-0000-659,DOCUMENTATION IN THE MEDICAL RECORD REMINDERS,n7848,37375,0,"When documenting an additional note in the medical record, do all of the following EXCEPT",119323,0,A. Be objective,0
9420,Elearning-0000-659,DOCUMENTATION IN THE MEDICAL RECORD REMINDERS,n7848,37375,0,"When documenting an additional note in the medical record, do all of the following EXCEPT",119324,1,B. Be specific,0
9420,Elearning-0000-659,DOCUMENTATION IN THE MEDICAL RECORD REMINDERS,n7848,37375,0,"When documenting an additional note in the medical record, do all of the following EXCEPT",119325,2,C. Only state positive events,1
9420,Elearning-0000-659,DOCUMENTATION IN THE MEDICAL RECORD REMINDERS,n7848,37375,0,"When documenting an additional note in the medical record, do all of the following EXCEPT",119326,3,D. Remain Neutral,0
9420,Elearning-0000-659,DOCUMENTATION IN THE MEDICAL RECORD REMINDERS,n7848,37376,1,"When something happens to the patient that was not part of the planned care of the patient (i.e. procedure complication, change in LOS, etc), which of the following items should you NOT do.",119327,0,"A.	Document specifically what happened",0
9420,Elearning-0000-659,DOCUMENTATION IN THE MEDICAL RECORD REMINDERS,n7848,37376,1,"When something happens to the patient that was not part of the planned care of the patient (i.e. procedure complication, change in LOS, etc), which of the following items should you NOT do.",119328,1,"B.	Include direct observations and actions taken",0
9420,Elearning-0000-659,DOCUMENTATION IN THE MEDICAL RECORD REMINDERS,n7848,37376,1,"When something happens to the patient that was not part of the planned care of the patient (i.e. procedure complication, change in LOS, etc), which of the following items should you NOT do.",119329,2,"C.	Identify sources of information and use direct quotes",0
9420,Elearning-0000-659,DOCUMENTATION IN THE MEDICAL RECORD REMINDERS,n7848,37376,1,"When something happens to the patient that was not part of the planned care of the patient (i.e. procedure complication, change in LOS, etc), which of the following items should you NOT do.",119330,3,"D.	Complete and include a reassessment of condition",0
9420,Elearning-0000-659,DOCUMENTATION IN THE MEDICAL RECORD REMINDERS,n7848,37376,1,"When something happens to the patient that was not part of the planned care of the patient (i.e. procedure complication, change in LOS, etc), which of the following items should you NOT do.",119331,4,"E.	Then fill out incident report through the Intranet",0
9420,Elearning-0000-659,DOCUMENTATION IN THE MEDICAL RECORD REMINDERS,n7848,37376,1,"When something happens to the patient that was not part of the planned care of the patient (i.e. procedure complication, change in LOS, etc), which of the following items should you NOT do.",119332,5,"F.	Reference or indicate existence of an incident report in the patients chart.",1
9420,Elearning-0000-659,DOCUMENTATION IN THE MEDICAL RECORD REMINDERS,n7848,37377,2,"I acknowledge that I have read and understand the ""Documentation in the Medical Record Reminders"" CBL in its entirety.",119333,0,TRUE,1
9420,Elearning-0000-659,DOCUMENTATION IN THE MEDICAL RECORD REMINDERS,n7848,37377,2,"I acknowledge that I have read and understand the ""Documentation in the Medical Record Reminders"" CBL in its entirety.",119334,1,FALSE,0
278,SCORM-0000-88,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 1,n7852,37394,0,"I acknowledge that I have read and understood the ""Patient Access Solutions/PatientCo Training - Part 1"" CBL in its entirety.",119390,0,TRUE,1
278,SCORM-0000-88,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 1,n7852,37394,0,"I acknowledge that I have read and understood the ""Patient Access Solutions/PatientCo Training - Part 1"" CBL in its entirety.",119391,1,FALSE,0
279,SCORM-0000-89,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 2,n7853,37393,0,"I acknowledge that I have read and understood the ""Patient Access Solutions/PatientCo Training - Part 2"" CBL in its entirety.",119388,0,TRUE,1
279,SCORM-0000-89,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 2,n7853,37393,0,"I acknowledge that I have read and understood the ""Patient Access Solutions/PatientCo Training - Part 2"" CBL in its entirety.",119389,1,FALSE,0
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37385,0,Can a user cancel a payment transaction?,119357,0,"a. Yes, before 6:00pm on the day payment was collected",0
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37385,0,Can a user cancel a payment transaction?,119358,1,"b. Yes, before ending a shift and before 8:00pm on the day payment was collected",1
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37385,0,Can a user cancel a payment transaction?,119359,2,"c. No, Galen must cancel a transaction",0
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37385,0,Can a user cancel a payment transaction?,119360,3,"d. No, a transaction may not be canceled",0
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37386,1,Which payment types need to be reconciled by the user at the end of the work day?,119361,0,a. Cash and e-checks,0
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37386,1,Which payment types need to be reconciled by the user at the end of the work day?,119362,1,b. Cash only,1
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37386,1,Which payment types need to be reconciled by the user at the end of the work day?,119363,2,"c. Cash, e-checks and credit card transactions",0
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37386,1,Which payment types need to be reconciled by the user at the end of the work day?,119364,3,d. Payments do not need to be reconciled,0
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37387,2,Which payment types automatically reconcile at the end of the work day?,119365,0,"a. Electronic payments, including e-checks & credit card transactions",1
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37387,2,Which payment types automatically reconcile at the end of the work day?,119366,1,b. Credit card transactions only,0
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37387,2,Which payment types automatically reconcile at the end of the work day?,119367,2,c. Cash and e-checks,0
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37387,2,Which payment types automatically reconcile at the end of the work day?,119368,3,d. Cash,0
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37388,3,When should a user close their shift?,119369,0,a. Every day,1
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37388,3,When should a user close their shift?,119370,1,b. Once a week,0
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37388,3,When should a user close their shift?,119371,2,c. Once a month,0
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37388,3,When should a user close their shift?,119372,3,d. Never,0
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37389,4,Can a user refund a payment?,119373,0,a. Yes,0
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37389,4,Can a user refund a payment?,119374,1,"b. No, only the practice manager can refund a payment",0
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37389,4,Can a user refund a payment?,119375,2,"c. No, only Galen can refund a payment",1
280,SCORM-0000-90,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 3,n7854,37389,4,Can a user refund a payment?,119376,3,d. None of the above,0
281,SCORM-0000-91,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 4,n7855,37390,0,When does the deposit slip process need to be completed?,119377,0,a. On the same day cash is collected,1
281,SCORM-0000-91,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 4,n7855,37390,0,When does the deposit slip process need to be completed?,119378,1,b. When it's convenient,0
281,SCORM-0000-91,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 4,n7855,37390,0,When does the deposit slip process need to be completed?,119379,2,c. Within 2 weeks of collecting cash,0
281,SCORM-0000-91,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 4,n7855,37390,0,When does the deposit slip process need to be completed?,119380,3,d.  Within 3 business days of collecting cash,0
281,SCORM-0000-91,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 4,n7855,37391,1,When should a user close their shift?,119384,0,a. Every day,1
281,SCORM-0000-91,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 4,n7855,37391,1,When should a user close their shift?,119381,1,b. Once a week,0
281,SCORM-0000-91,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 4,n7855,37391,1,When should a user close their shift?,119382,2,c. Once a month,0
281,SCORM-0000-91,PATIENT ACCESS SOLUTIONS/PATIENTCO TRAINING - PART 4,n7855,37391,1,When should a user close their shift?,119383,3,d. Never,0
9100,Elearning-0000-368,NSH1205 GSK - AMENDMENT 2,n7874,37434,0,I acknowledge that I have read and understand in its entirety the NSH1205 GSK - AMENDMENT 2 content.,119514,0,TRUE,1
9100,Elearning-0000-368,NSH1205 GSK - AMENDMENT 2,n7874,37434,0,I acknowledge that I have read and understand in its entirety the NSH1205 GSK - AMENDMENT 2 content.,119515,1,FALSE,0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37557,0,Interpret this order: Zofran 2mg IV every 6-8 hours prn nausea,119934,0,"a.	Zofran 2mg IV every 8 hours prn nausea",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37557,0,Interpret this order: Zofran 2mg IV every 6-8 hours prn nausea,119935,1,"b.	Zofran 2mg IV every 6-8 hours",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37557,0,Interpret this order: Zofran 2mg IV every 6-8 hours prn nausea,119936,2,"c.	Zofran 2mg IV every 6 hours prn nausea",1
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37557,0,Interpret this order: Zofran 2mg IV every 6-8 hours prn nausea,119937,3,"d.	Zofran 2mg IV every 6 hours",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37558,1,Interpret this order: Morphine 1-5mg IV no more than every 3 hours prn pain,119938,0,"a.	Morphine 1-5mg IV every 3 hours prn pain",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37558,1,Interpret this order: Morphine 1-5mg IV no more than every 3 hours prn pain,119939,1,"b.	Morphine 1mg IV every 3 hours prn pain.  May repeat x 1 dose after 30 min for uncontrolled pain",1
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37558,1,Interpret this order: Morphine 1-5mg IV no more than every 3 hours prn pain,119940,2,"c.	Morphine 1mg IV every 3 hours prn pain.  May repeat 4mg once after 30 min for uncontrolled pain",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37558,1,Interpret this order: Morphine 1-5mg IV no more than every 3 hours prn pain,119941,3,"d.	Morphine 5mg IV every 3 hours prn pain",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37559,2,Interpret this order: Dilaudid 2-4mg IV every 4-6 hours prn pain,119942,0,"a.	Dilaudid 0.5-4mg IV every 4 hours prn pain",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37559,2,Interpret this order: Dilaudid 2-4mg IV every 4-6 hours prn pain,119943,1,"b.	Dilaudid 0.5-2mg IV every 6 hours prn pain",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37559,2,Interpret this order: Dilaudid 2-4mg IV every 4-6 hours prn pain,119944,2,"c.	Dilaudid 2-4mg IV every 6 hours prn pain",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37559,2,Interpret this order: Dilaudid 2-4mg IV every 4-6 hours prn pain,119945,3,"d.	Dilaudid 0.5 IV every 4 hours prn pain. May repeat x1 after 30 min for uncontrolled pain",1
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37560,3,Interpret this order: Dilaudid 2mg IV every 4 hours prn pain,119946,0,"a.	Dilaudid 0.5-2mg IV every 4 hours prn pain",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37560,3,Interpret this order: Dilaudid 2mg IV every 4 hours prn pain,119947,1,"b.	Dilaudid 0.5mg IV every 4 hours prn pain. May repeat x1 after 30 min prn uncontrolled pain.",1
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37560,3,Interpret this order: Dilaudid 2mg IV every 4 hours prn pain,119948,2,"c.	Dilaudid 2mg IV every 6 hours prn pain",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37560,3,Interpret this order: Dilaudid 2mg IV every 4 hours prn pain,119949,3,"d.	Dilaudid 2mg IV every 4 hours prn pain",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37561,4,Interpret this order: Demerol 50-100mg IV every 6-8 hours prn pain,119950,0,"a.	Demerol 50-200mg IV every 6 hours prn pain",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37561,4,Interpret this order: Demerol 50-100mg IV every 6-8 hours prn pain,119951,1,"b.	Demerol 50-100mg IV every 6 hours prn pain",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37561,4,Interpret this order: Demerol 50-100mg IV every 6-8 hours prn pain,119952,2,"c.	Demerol 50mg IV every 6 hours prn pain.  May repeat x1 after 30 min for uncontrolled pain",1
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37561,4,Interpret this order: Demerol 50-100mg IV every 6-8 hours prn pain,119953,3,"d.	Demerol 50 IV every 8 hours prn pain. May repeat x1 after 30 min for uncontrolled pain",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37562,5,"With the below medication order, which is correct concerning the order of preferred routes? Ativan 1mg PO/IV/PR Q6H prn anxiety",119954,0,"a.	PR, followed by PO then IV",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37562,5,"With the below medication order, which is correct concerning the order of preferred routes? Ativan 1mg PO/IV/PR Q6H prn anxiety",119955,1,"b.	IV (if patient has access), followed by PO then PR",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37562,5,"With the below medication order, which is correct concerning the order of preferred routes? Ativan 1mg PO/IV/PR Q6H prn anxiety",119956,2,"c.	PO, followed by PR then IV",1
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37563,6,When can the next dose of medication be administered? Morphine 1mg IV every 6 hours prn pain. May repeat x 1 dose after 30 mins prn unrelieved pain.  Morphine 1mg IV dose administered at 1330. When can morphine 1mg be given again?,119957,0,"a.	1030",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37563,6,When can the next dose of medication be administered? Morphine 1mg IV every 6 hours prn pain. May repeat x 1 dose after 30 mins prn unrelieved pain.  Morphine 1mg IV dose administered at 1330. When can morphine 1mg be given again?,119958,1,"b.	1400",1
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37563,6,When can the next dose of medication be administered? Morphine 1mg IV every 6 hours prn pain. May repeat x 1 dose after 30 mins prn unrelieved pain.  Morphine 1mg IV dose administered at 1330. When can morphine 1mg be given again?,119959,2,"c.	2030",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,37563,6,When can the next dose of medication be administered? Morphine 1mg IV every 6 hours prn pain. May repeat x 1 dose after 30 mins prn unrelieved pain.  Morphine 1mg IV dose administered at 1330. When can morphine 1mg be given again?,119960,3,"d.	2230",0
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,40356,7,"I acknowledge that I have read and understand the ""Range Orders: How to Interpret Range Orders FY2019"" CBL in its entirety",129370,0,TRUE,1
8945,Elearning-0000-227,RANGE ORDERS: HOW TO INTERPRET RANGE ORDERS FY2019,n7878,40356,7,"I acknowledge that I have read and understand the ""Range Orders: How to Interpret Range Orders FY2019"" CBL in its entirety",129371,1,FALSE,0
9022,Elearning-0000-297,NURSE-DRIVE VACCINE SCREENING FY2019,n7879,37564,0,Which pneumococcal vaccine(s) can be ordered from Northside's nurse-drive vaccination protocol?,119961,0,"a.	Pneumovax 23 and Prevnar 7",0
9022,Elearning-0000-297,NURSE-DRIVE VACCINE SCREENING FY2019,n7879,37564,0,Which pneumococcal vaccine(s) can be ordered from Northside's nurse-drive vaccination protocol?,119962,1,"b.	Pneumovax 23 only",0
9022,Elearning-0000-297,NURSE-DRIVE VACCINE SCREENING FY2019,n7879,37564,0,Which pneumococcal vaccine(s) can be ordered from Northside's nurse-drive vaccination protocol?,119963,2,"c.	Pneumovax 23 and Prevnar 13",1
9022,Elearning-0000-297,NURSE-DRIVE VACCINE SCREENING FY2019,n7879,37564,0,Which pneumococcal vaccine(s) can be ordered from Northside's nurse-drive vaccination protocol?,119964,3,"d.	Prevnar 13 only",0
9022,Elearning-0000-297,NURSE-DRIVE VACCINE SCREENING FY2019,n7879,37565,1,"To be eligible for pneumococcal vaccination, patients 65 and older MUST have a chronic condition.",119965,0,TRUE,0
9022,Elearning-0000-297,NURSE-DRIVE VACCINE SCREENING FY2019,n7879,37565,1,"To be eligible for pneumococcal vaccination, patients 65 and older MUST have a chronic condition.",119966,1,FALSE,1
9022,Elearning-0000-297,NURSE-DRIVE VACCINE SCREENING FY2019,n7879,37566,2,Which of the following are chronic conditions that may make patients aged 19-64 eligible for pneumococcal vaccination?,119967,0,"a.	Hypertension",0
9022,Elearning-0000-297,NURSE-DRIVE VACCINE SCREENING FY2019,n7879,37566,2,Which of the following are chronic conditions that may make patients aged 19-64 eligible for pneumococcal vaccination?,119968,1,"b.	Long-term Oral Steroid",0
9022,Elearning-0000-297,NURSE-DRIVE VACCINE SCREENING FY2019,n7879,37566,2,Which of the following are chronic conditions that may make patients aged 19-64 eligible for pneumococcal vaccination?,119969,2,"c.	Cigarette Smoking",0
9022,Elearning-0000-297,NURSE-DRIVE VACCINE SCREENING FY2019,n7879,37566,2,Which of the following are chronic conditions that may make patients aged 19-64 eligible for pneumococcal vaccination?,119970,3,"d.	Heart Failure",0
9022,Elearning-0000-297,NURSE-DRIVE VACCINE SCREENING FY2019,n7879,37566,2,Which of the following are chronic conditions that may make patients aged 19-64 eligible for pneumococcal vaccination?,119971,4,"e.	Asthma",0
9022,Elearning-0000-297,NURSE-DRIVE VACCINE SCREENING FY2019,n7879,37566,2,Which of the following are chronic conditions that may make patients aged 19-64 eligible for pneumococcal vaccination?,119972,5,"f.	B, C, D , E only",1
9022,Elearning-0000-297,NURSE-DRIVE VACCINE SCREENING FY2019,n7879,37566,2,Which of the following are chronic conditions that may make patients aged 19-64 eligible for pneumococcal vaccination?,119973,6,"g.	All of the above",0
9022,Elearning-0000-297,NURSE-DRIVE VACCINE SCREENING FY2019,n7879,37567,3,During which months are patients screened for the influenza vaccine?,119974,0,"a.	April - September",0
9022,Elearning-0000-297,NURSE-DRIVE VACCINE SCREENING FY2019,n7879,37567,3,During which months are patients screened for the influenza vaccine?,119975,1,"b.	October - March",1
9022,Elearning-0000-297,NURSE-DRIVE VACCINE SCREENING FY2019,n7879,37567,3,During which months are patients screened for the influenza vaccine?,119976,2,"c.	September - April",0
9022,Elearning-0000-297,NURSE-DRIVE VACCINE SCREENING FY2019,n7879,37567,3,During which months are patients screened for the influenza vaccine?,119977,3,"d.	Year-round",0
8934,Elearning-0000-217,REGULATORY READINESS -A PRACTICE REVIEW 2018,n7889,37678,0,"I have read and understand the content Regulatory Readiness CBL. I will seek any needed clarification from my supervisor, CDS, Clinician, Chain of Command",120438,0,TRUE,1
8934,Elearning-0000-217,REGULATORY READINESS -A PRACTICE REVIEW 2018,n7889,37678,0,"I have read and understand the content Regulatory Readiness CBL. I will seek any needed clarification from my supervisor, CDS, Clinician, Chain of Command",120439,1,FALSE,0
8934,Elearning-0000-217,REGULATORY READINESS -A PRACTICE REVIEW 2018,n7889,37679,1,"I Have Read And Understand The Content On Fire Risk Assessment Cbl. I Will Seek Any Needed Clarification From My Supervisor, Cds, Clinician, Chain Of Command",120440,0,TRUE,1
8934,Elearning-0000-217,REGULATORY READINESS -A PRACTICE REVIEW 2018,n7889,37679,1,"I Have Read And Understand The Content On Fire Risk Assessment Cbl. I Will Seek Any Needed Clarification From My Supervisor, Cds, Clinician, Chain Of Command",120441,1,FALSE,0
8204,Elearning-0000-1094,2019 SAFE PATIENT HANDLING PRACTICES IN RADIOLOGY INPATIENT SETTING,n8144,38229,0,I acknowledge that I have read and understand in its entirety the 2019 SAFE PATIENT HANDLING PRACTICES IN RADIOLOGY INPATIENT SETTING content.,122265,0,TRUE,1
8204,Elearning-0000-1094,2019 SAFE PATIENT HANDLING PRACTICES IN RADIOLOGY INPATIENT SETTING,n8144,38229,0,I acknowledge that I have read and understand in its entirety the 2019 SAFE PATIENT HANDLING PRACTICES IN RADIOLOGY INPATIENT SETTING content.,122266,1,FALSE,0
8396,Elearning-0000-1267,THE PATIENT EXPERIENCE,n8146,38237,0,I have watched The Patient Experience video in its entirety and I understand my role in ensuring an excellent patient experience.,122286,0,TRUE,1
8396,Elearning-0000-1267,THE PATIENT EXPERIENCE,n8146,38237,0,I have watched The Patient Experience video in its entirety and I understand my role in ensuring an excellent patient experience.,122287,1,FALSE,0
9249,Elearning-0000-503,KEY POINTS TO REMEMBER IN INSTRUMENT TRANSPORT,n8148,38258,0,"During transport, dirty instruments are identified with either a RED BIOHAZARD bag or Tag",122363,0,TRUE,1
9249,Elearning-0000-503,KEY POINTS TO REMEMBER IN INSTRUMENT TRANSPORT,n8148,38258,0,"During transport, dirty instruments are identified with either a RED BIOHAZARD bag or Tag",122364,1,FALSE,0
9249,Elearning-0000-503,KEY POINTS TO REMEMBER IN INSTRUMENT TRANSPORT,n8148,38259,1,"If the outside of the Genesis Pan becomes contaminated, what is the proper procedure?",122365,0,A). Wipe Down the outside of the pan using a PDI wipe,1
9249,Elearning-0000-503,KEY POINTS TO REMEMBER IN INSTRUMENT TRANSPORT,n8148,38259,1,"If the outside of the Genesis Pan becomes contaminated, what is the proper procedure?",122366,1,"B).  Since gloves will be used during transport, no other action is needed",0
9249,Elearning-0000-503,KEY POINTS TO REMEMBER IN INSTRUMENT TRANSPORT,n8148,38259,1,"If the outside of the Genesis Pan becomes contaminated, what is the proper procedure?",122367,2,C). Cover the pan with a RED BAG,0
9249,Elearning-0000-503,KEY POINTS TO REMEMBER IN INSTRUMENT TRANSPORT,n8148,38259,1,"If the outside of the Genesis Pan becomes contaminated, what is the proper procedure?",122368,3,D). None of the above,0
9249,Elearning-0000-503,KEY POINTS TO REMEMBER IN INSTRUMENT TRANSPORT,n8148,38260,2,What are the options for transporting instruments ?,122369,0,A). Rigid Container/Genesis Pan with BIOHAZARD TAG,0
9249,Elearning-0000-503,KEY POINTS TO REMEMBER IN INSTRUMENT TRANSPORT,n8148,38260,2,What are the options for transporting instruments ?,122370,1,B). Transport Container (Red Bin),0
9249,Elearning-0000-503,KEY POINTS TO REMEMBER IN INSTRUMENT TRANSPORT,n8148,38260,2,What are the options for transporting instruments ?,122371,2,C). Case Carts,0
9249,Elearning-0000-503,KEY POINTS TO REMEMBER IN INSTRUMENT TRANSPORT,n8148,38260,2,What are the options for transporting instruments ?,122372,3,D). Clean Transport Table,0
9249,Elearning-0000-503,KEY POINTS TO REMEMBER IN INSTRUMENT TRANSPORT,n8148,38260,2,What are the options for transporting instruments ?,122373,4,E). All the above,1
9249,Elearning-0000-503,KEY POINTS TO REMEMBER IN INSTRUMENT TRANSPORT,n8148,38261,3,"Once the dirty instruments have been taken to decontam, the transport table must be cleaned/wiped down prior to taking it back across the red line to be used again for transport.",122374,0,TRUE,1
9249,Elearning-0000-503,KEY POINTS TO REMEMBER IN INSTRUMENT TRANSPORT,n8148,38261,3,"Once the dirty instruments have been taken to decontam, the transport table must be cleaned/wiped down prior to taking it back across the red line to be used again for transport.",122375,1,FALSE,0
9249,Elearning-0000-503,KEY POINTS TO REMEMBER IN INSTRUMENT TRANSPORT,n8148,38262,4,The scrub tech has just placed their dirty instruments into the genesis pan. What is the next correct sequence of events?,122423,0,"A).   1. Spray the Point of Use Processing Gel on the instruments 	2. Remove gloves  	3. Perform hand hygiene  	4. Secure and lock the lid  	5. Verify the pan is tagged with a biohazard tag",0
9249,Elearning-0000-503,KEY POINTS TO REMEMBER IN INSTRUMENT TRANSPORT,n8148,38262,4,The scrub tech has just placed their dirty instruments into the genesis pan. What is the next correct sequence of events?,122424,1,"B).   1. Remove gloves  	2. Perform hand hygiene         3. Spray instruments with the Point of Use Processing Gel  	4. Secure and lock the lid 	5. Verify the pan is labeled with a biohazard tag",1
9249,Elearning-0000-503,KEY POINTS TO REMEMBER IN INSTRUMENT TRANSPORT,n8148,38262,4,The scrub tech has just placed their dirty instruments into the genesis pan. What is the next correct sequence of events?,122425,2,"C).   1. Spray the Point of Use Processing Gel on the instruments  	2. Cover the dirty instruments with the lid  	3. Secure and lock the lid  	4. Remove gloves, perform hand hygiene 	5. Verify the pan is labeled with a biohazard tag",0
9263,Elearning-0000-516,INSTRUMENT TRANSPORT,n8153,38300,0,I verify that I have read and understand the content on this CBL on Instrument Transport.,122537,0,TRUE,1
9263,Elearning-0000-516,INSTRUMENT TRANSPORT,n8153,38300,0,I verify that I have read and understand the content on this CBL on Instrument Transport.,122538,1,FALSE,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38424,0,"LL is a 75 year old female admitted to the ICU. Based on LL's microbiology results, what is your recommendation for antifungal therapy?   DATE: 1/1/18 SOURCE: BLOOD ORGANISM ID BY PCR: CANDIDA ALBICANS GRAM STAIN: BUDDING YEAST (AEROBIC BOTTLE)",122829,0,"A. 	Fluconazole",0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38424,0,"LL is a 75 year old female admitted to the ICU. Based on LL's microbiology results, what is your recommendation for antifungal therapy?   DATE: 1/1/18 SOURCE: BLOOD ORGANISM ID BY PCR: CANDIDA ALBICANS GRAM STAIN: BUDDING YEAST (AEROBIC BOTTLE)",122830,1,"B. 	Amphotericin B",0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38424,0,"LL is a 75 year old female admitted to the ICU. Based on LL's microbiology results, what is your recommendation for antifungal therapy?   DATE: 1/1/18 SOURCE: BLOOD ORGANISM ID BY PCR: CANDIDA ALBICANS GRAM STAIN: BUDDING YEAST (AEROBIC BOTTLE)",122831,2,"C.	Micafungin",1
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38424,0,"LL is a 75 year old female admitted to the ICU. Based on LL's microbiology results, what is your recommendation for antifungal therapy?   DATE: 1/1/18 SOURCE: BLOOD ORGANISM ID BY PCR: CANDIDA ALBICANS GRAM STAIN: BUDDING YEAST (AEROBIC BOTTLE)",122832,3,"D. 	Posaconazole",0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38425,1,"After calling the prescriber to discuss LL's blood culture results, you receive an order for micafungin 50 mg IV Q24H. What should you do?",122833,0,A. Enter micafungin 50 mg IV Q24H,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38425,1,"After calling the prescriber to discuss LL's blood culture results, you receive an order for micafungin 50 mg IV Q24H. What should you do?",122834,1,B. Recommend discontinuing micagunfin,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38425,1,"After calling the prescriber to discuss LL's blood culture results, you receive an order for micafungin 50 mg IV Q24H. What should you do?",122835,2,C. Recommend switching LL to fluconazole,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38425,1,"After calling the prescriber to discuss LL's blood culture results, you receive an order for micafungin 50 mg IV Q24H. What should you do?",122836,3,"D. Enter order for micafungin 100 mg IV Q24H ""per P&T therapeutic interchange policy""",1
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38426,2,"Four days later, LL's blood culture results are final and state the following. What is your recommendation?  DATE: 1/7/18 STATUS:  FINAL  ORGANISM: CANDIDA ALBICANS METHOD: MIC FLUCONAZOLE                <=1  SUSCEPTIBLE VORICONAZOLE               <=0.12  SUSCEPTIBLE",122837,0,A. Continue micafungin,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38426,2,"Four days later, LL's blood culture results are final and state the following. What is your recommendation?  DATE: 1/7/18 STATUS:  FINAL  ORGANISM: CANDIDA ALBICANS METHOD: MIC FLUCONAZOLE                <=1  SUSCEPTIBLE VORICONAZOLE               <=0.12  SUSCEPTIBLE",122838,1,B. Recommend discontinuing micagunfin,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38426,2,"Four days later, LL's blood culture results are final and state the following. What is your recommendation?  DATE: 1/7/18 STATUS:  FINAL  ORGANISM: CANDIDA ALBICANS METHOD: MIC FLUCONAZOLE                <=1  SUSCEPTIBLE VORICONAZOLE               <=0.12  SUSCEPTIBLE",122839,2,C. Recommend de-escalating LL to fluconazole,1
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38426,2,"Four days later, LL's blood culture results are final and state the following. What is your recommendation?  DATE: 1/7/18 STATUS:  FINAL  ORGANISM: CANDIDA ALBICANS METHOD: MIC FLUCONAZOLE                <=1  SUSCEPTIBLE VORICONAZOLE               <=0.12  SUSCEPTIBLE",122840,3,D. Recommend switching patient to Ambisome,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38427,3,SS is a 79 year old female admitted to the pulmonary unit for COPD exacerbation. The ETT aspirate and BAL are positive for C. albicans. What is your recommendation for treatment?,122841,0,"A. Treat the patient, the patient is at risk for respiratory complications",0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38427,3,SS is a 79 year old female admitted to the pulmonary unit for COPD exacerbation. The ETT aspirate and BAL are positive for C. albicans. What is your recommendation for treatment?,122842,1,"B. Treat the patient, C. albicans should not be present in respiratory secretions",0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38427,3,SS is a 79 year old female admitted to the pulmonary unit for COPD exacerbation. The ETT aspirate and BAL are positive for C. albicans. What is your recommendation for treatment?,122843,2,"C. Do not recommend treatment, candida species commonly colonize the respiratory tract and rarely cause infection",1
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38427,3,SS is a 79 year old female admitted to the pulmonary unit for COPD exacerbation. The ETT aspirate and BAL are positive for C. albicans. What is your recommendation for treatment?,122844,3,D. Wait for culture and susceptibility results,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38428,4,Amphotericin B is incompatible with normal saline,122845,0,TRUE,1
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38428,4,Amphotericin B is incompatible with normal saline,122846,1,FALSE,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38429,5,Candida krusei is intrinsically resistant to fluconazole,122847,0,TRUE,1
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38429,5,Candida krusei is intrinsically resistant to fluconazole,122848,1,FALSE,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38430,6,LL is a 75 year old female with (C. albicans) candidemia. LL was initiated on micafungin and de-escalated to fluconazole based on susceptibility results. She has now transferred from the ICU to IMS with no documented evidence of candidemia complications. Today you see her repeat blood cultures have come back as final with no growth. What should you recommend?,122849,0,A. Discontinue fluconazole now,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38430,6,LL is a 75 year old female with (C. albicans) candidemia. LL was initiated on micafungin and de-escalated to fluconazole based on susceptibility results. She has now transferred from the ICU to IMS with no documented evidence of candidemia complications. Today you see her repeat blood cultures have come back as final with no growth. What should you recommend?,122850,1,B. Recommend fluconazole treatment duration for 14 days after negative blood culture,1
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38430,6,LL is a 75 year old female with (C. albicans) candidemia. LL was initiated on micafungin and de-escalated to fluconazole based on susceptibility results. She has now transferred from the ICU to IMS with no documented evidence of candidemia complications. Today you see her repeat blood cultures have come back as final with no growth. What should you recommend?,122851,2,"C. Recommend a total antifungal treatment duration of 14 days, including the 5 days of micafungin received initially",0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38430,6,LL is a 75 year old female with (C. albicans) candidemia. LL was initiated on micafungin and de-escalated to fluconazole based on susceptibility results. She has now transferred from the ICU to IMS with no documented evidence of candidemia complications. Today you see her repeat blood cultures have come back as final with no growth. What should you recommend?,122852,3,D. None of the above,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38431,7,In which of the following infections would an echinocandin be the least optimal antifungal of choice?,122853,0,A. Ocular infections,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38431,7,In which of the following infections would an echinocandin be the least optimal antifungal of choice?,122854,1,B. Central Nervous System infections,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38431,7,In which of the following infections would an echinocandin be the least optimal antifungal of choice?,122855,2,C. Urinary Tract infections,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38431,7,In which of the following infections would an echinocandin be the least optimal antifungal of choice?,122856,3,D. All of the above,1
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38432,8,1. Which of the following is true,122857,0,A. There are multiple formulations of amphotericin,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38432,8,1. Which of the following is true,122858,1,B.  Medication errors due to confusion between lipid-based forms of amphotericin and conventional amphotericin B have resulted in death,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38432,8,1. Which of the following is true,122859,2,C. Doses exceeding 1.5 mg/kg/day of the conventional formulation of amphotericin may result in cardiopulmonary arrest,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38432,8,1. Which of the following is true,122860,3,D. It is important to verify the product name and dosage prior to dispensing to prevent fatal adverse events,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38432,8,1. Which of the following is true,122861,4,E. All of the above,1
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38433,9,2. Which of the following is true,122862,0,A. Flucytosine is active against all fungi,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38433,9,2. Which of the following is true,122863,1,B. Flucytosine does not achieve therapeutic concentrations in the eyes and CNS,0
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38433,9,2. Which of the following is true,122864,2,C. Flucytosine is usually given in combination with another agent due to high rates of resistance during monotherapy,1
9566,Elearning-0000-791,PHARMACY ANTIFUNGAL COMPETENCY FY2019,n8177,38433,9,2. Which of the following is true,122865,3,D. All of the above,0
9097,Elearning-0000-365,NSH1208 - AMENDMENT 1,n8182,38522,0,I acknowledge that I have read and understand the NSH1208 - Amendment 1 CBL in its entirety.,123240,0,TRUE,1
9097,Elearning-0000-365,NSH1208 - AMENDMENT 1,n8182,38522,0,I acknowledge that I have read and understand the NSH1208 - Amendment 1 CBL in its entirety.,123241,1,FALSE,0
8277,Elearning-0000-116,CARE OF THE UNSTABLE PATIENT,n8205,38697,0,I acknowledge that I have participated in a group discussion regarding an Unstable Patient.,123714,0,TRUE,1
8277,Elearning-0000-116,CARE OF THE UNSTABLE PATIENT,n8205,38697,0,I acknowledge that I have participated in a group discussion regarding an Unstable Patient.,123715,1,FALSE,0
9017,Elearning-0000-292,PAIN MANAGEMENT: PAIN ASSESSMENT AND REASSESSMENT IN THE PERIANESTHESIA PHASES OF CARE,n8231,38758,0,I acknowledge that I have read and understand in its entirety the PAIN MANAGEMENT: PAIN ASSESSMENT AND REASSESSMENT IN THE PERIANESTHESIA PHASES OF CARE content.,123927,0,TRUE,1
9017,Elearning-0000-292,PAIN MANAGEMENT: PAIN ASSESSMENT AND REASSESSMENT IN THE PERIANESTHESIA PHASES OF CARE,n8231,38758,0,I acknowledge that I have read and understand in its entirety the PAIN MANAGEMENT: PAIN ASSESSMENT AND REASSESSMENT IN THE PERIANESTHESIA PHASES OF CARE content.,123928,1,FALSE,0
9468,Elearning-0000-702,CLEANING DURING OR TURNOVER-ANESTHESIA UPDATE,n8283,39118,0,"Anesthesia staff may begin set-up for next case, after room is cleaned.",125061,0,TRUE,1
9468,Elearning-0000-702,CLEANING DURING OR TURNOVER-ANESTHESIA UPDATE,n8283,39118,0,"Anesthesia staff may begin set-up for next case, after room is cleaned.",125062,1,FALSE,0
9468,Elearning-0000-702,CLEANING DURING OR TURNOVER-ANESTHESIA UPDATE,n8283,39119,1,"BEFORE touching clean supplies / linen, REMOVE any gloves and perform Hand Hygiene.",125063,0,TRUE,1
9468,Elearning-0000-702,CLEANING DURING OR TURNOVER-ANESTHESIA UPDATE,n8283,39119,1,"BEFORE touching clean supplies / linen, REMOVE any gloves and perform Hand Hygiene.",125064,1,FALSE,0
9468,Elearning-0000-702,CLEANING DURING OR TURNOVER-ANESTHESIA UPDATE,n8283,39120,2,Gloves used for cleaning are NOT worn outside of the suite being cleaned.,125065,0,TRUE,1
9468,Elearning-0000-702,CLEANING DURING OR TURNOVER-ANESTHESIA UPDATE,n8283,39120,2,Gloves used for cleaning are NOT worn outside of the suite being cleaned.,125066,1,FALSE,0
9359,Elearning-0000-603,FIRE EDUCATION FOR ANESTHESIA TECHS,n8286,39123,0,To Use a Fire Extinguisher,125071,0,"a)	Pull the pin, Aim at the base of the fire, Squeeze the trigger, Sweep up and down",0
9359,Elearning-0000-603,FIRE EDUCATION FOR ANESTHESIA TECHS,n8286,39123,0,To Use a Fire Extinguisher,125072,1,"b)	Pull the pin, Aim at the top of the fire, Squeeze the trigger, Sweep side to side",0
9359,Elearning-0000-603,FIRE EDUCATION FOR ANESTHESIA TECHS,n8286,39123,0,To Use a Fire Extinguisher,125073,2,"c)	Pull the pin, Aim at the base of the fire, Squeeze the trigger, Sweep side to side",1
9359,Elearning-0000-603,FIRE EDUCATION FOR ANESTHESIA TECHS,n8286,39124,1,The closest person to the medical gas shut off values should turn them off as soon as a code red is announced.,125074,0,TRUE,0
9359,Elearning-0000-603,FIRE EDUCATION FOR ANESTHESIA TECHS,n8286,39124,1,The closest person to the medical gas shut off values should turn them off as soon as a code red is announced.,125075,1,FALSE,1
9359,Elearning-0000-603,FIRE EDUCATION FOR ANESTHESIA TECHS,n8286,39125,2,Possible containment measures that can be used to reduce exposure to smoke include:,125076,0,"a)	Close doors",0
9359,Elearning-0000-603,FIRE EDUCATION FOR ANESTHESIA TECHS,n8286,39125,2,Possible containment measures that can be used to reduce exposure to smoke include:,125077,1,"b)	Place wet blankets or towels under doors to prevent smoke infiltration",0
9359,Elearning-0000-603,FIRE EDUCATION FOR ANESTHESIA TECHS,n8286,39125,2,Possible containment measures that can be used to reduce exposure to smoke include:,125078,2,"c)	Keep OR doors open to ensure airflow",0
9359,Elearning-0000-603,FIRE EDUCATION FOR ANESTHESIA TECHS,n8286,39125,2,Possible containment measures that can be used to reduce exposure to smoke include:,125079,3,"d)	All of the above",0
9359,Elearning-0000-603,FIRE EDUCATION FOR ANESTHESIA TECHS,n8286,39125,2,Possible containment measures that can be used to reduce exposure to smoke include:,125080,4,"e)	Both A & B",1
9359,Elearning-0000-603,FIRE EDUCATION FOR ANESTHESIA TECHS,n8286,39125,2,Possible containment measures that can be used to reduce exposure to smoke include:,125081,5,"f)	Both B & C",0
9359,Elearning-0000-603,FIRE EDUCATION FOR ANESTHESIA TECHS,n8286,39126,3,"I have read and understand the Code Red in Surgical Services # 12562 Policy, and the Fire (Code Red) # 20222 Policy.",125082,0,TRUE,1
9359,Elearning-0000-603,FIRE EDUCATION FOR ANESTHESIA TECHS,n8286,39126,3,"I have read and understand the Code Red in Surgical Services # 12562 Policy, and the Fire (Code Red) # 20222 Policy.",125083,1,FALSE,0
9293,Elearning-0000-543,HAND HYGEINE,n8288,39130,0,Perform hand hygiene (sanitizer or soap & water):,125098,0,"a)	Before contact with patient or pt. environment (entering patient space)",0
9293,Elearning-0000-543,HAND HYGEINE,n8288,39130,0,Perform hand hygiene (sanitizer or soap & water):,125099,1,"b)	After contact with patient or pt. environment (leaving patient space)",0
9293,Elearning-0000-543,HAND HYGEINE,n8288,39130,0,Perform hand hygiene (sanitizer or soap & water):,125100,2,"c)	Before and after gloves",0
9293,Elearning-0000-543,HAND HYGEINE,n8288,39130,0,Perform hand hygiene (sanitizer or soap & water):,125101,3,"d)	After contact with blood or body fluids",0
9293,Elearning-0000-543,HAND HYGEINE,n8288,39130,0,Perform hand hygiene (sanitizer or soap & water):,125102,4,"e)	Before Entering a clean storage room",0
9293,Elearning-0000-543,HAND HYGEINE,n8288,39130,0,Perform hand hygiene (sanitizer or soap & water):,125103,5,"f)	Exiting a soiled utility room",0
9293,Elearning-0000-543,HAND HYGEINE,n8288,39130,0,Perform hand hygiene (sanitizer or soap & water):,125104,6,"g)	All of the above",1
9293,Elearning-0000-543,HAND HYGEINE,n8288,39131,1,Wash hands with soap and water when:,125105,0,"a)	Hands are visibly soiled",0
9293,Elearning-0000-543,HAND HYGEINE,n8288,39131,1,Wash hands with soap and water when:,125106,1,"b)	After using the restroom",0
9293,Elearning-0000-543,HAND HYGEINE,n8288,39131,1,Wash hands with soap and water when:,125107,2,"c)	Before eating",0
9293,Elearning-0000-543,HAND HYGEINE,n8288,39131,1,Wash hands with soap and water when:,125108,3,"d)	Caring for a patient with c. difficile or norovirus",0
9293,Elearning-0000-543,HAND HYGEINE,n8288,39131,1,Wash hands with soap and water when:,125109,4,"e)	All of the above",1
9293,Elearning-0000-543,HAND HYGEINE,n8288,39132,2,Hand hygiene is the best way to prevent the spread of infections.,125110,0,TRUE,1
9293,Elearning-0000-543,HAND HYGEINE,n8288,39132,2,Hand hygiene is the best way to prevent the spread of infections.,125111,1,FALSE,0
9206,Elearning-0000-464,LOW-LEVEL DISINFECTION ANESETHSIA TECH,n8290,39136,0,_____________ is ideal for low-level disinfection of ultrasound probes and other equipment requiring a low-alcohol content or alcohol free disinfectant within Surgical Services.,125118,0,"a)	PDI Super Sani-Cloth",0
9206,Elearning-0000-464,LOW-LEVEL DISINFECTION ANESETHSIA TECH,n8290,39136,0,_____________ is ideal for low-level disinfection of ultrasound probes and other equipment requiring a low-alcohol content or alcohol free disinfectant within Surgical Services.,125119,1,"b)	PDI Super Sani-Cloth with Bleach",0
9206,Elearning-0000-464,LOW-LEVEL DISINFECTION ANESETHSIA TECH,n8290,39136,0,_____________ is ideal for low-level disinfection of ultrasound probes and other equipment requiring a low-alcohol content or alcohol free disinfectant within Surgical Services.,125120,2,"c)	SONO wipes",1
9206,Elearning-0000-464,LOW-LEVEL DISINFECTION ANESETHSIA TECH,n8290,39137,1,PDI Super Sani-Cloth __________contact time,125121,0,"a)	2 minutes",1
9206,Elearning-0000-464,LOW-LEVEL DISINFECTION ANESETHSIA TECH,n8290,39137,1,PDI Super Sani-Cloth __________contact time,125122,1,"b)	3 minutes",0
9206,Elearning-0000-464,LOW-LEVEL DISINFECTION ANESETHSIA TECH,n8290,39137,1,PDI Super Sani-Cloth __________contact time,125123,2,"c)	4 minutes",0
9206,Elearning-0000-464,LOW-LEVEL DISINFECTION ANESETHSIA TECH,n8290,39138,2,PDI Super Sani-Cloth with Bleach _____________contact time,125124,0,"a)	2 minutes",0
9206,Elearning-0000-464,LOW-LEVEL DISINFECTION ANESETHSIA TECH,n8290,39138,2,PDI Super Sani-Cloth with Bleach _____________contact time,125125,1,"b)	3 minutes",0
9206,Elearning-0000-464,LOW-LEVEL DISINFECTION ANESETHSIA TECH,n8290,39138,2,PDI Super Sani-Cloth with Bleach _____________contact time,125126,2,"c)	4 minutes",1
9206,Elearning-0000-464,LOW-LEVEL DISINFECTION ANESETHSIA TECH,n8290,39139,3,_____________ is ideal for disinfecting high risk areas endemic with Clostridium difficile spores and Norovirus.,125127,0,"a)	PDI Super Sani-Cloth",0
9206,Elearning-0000-464,LOW-LEVEL DISINFECTION ANESETHSIA TECH,n8290,39139,3,_____________ is ideal for disinfecting high risk areas endemic with Clostridium difficile spores and Norovirus.,125128,1,"b)	PDI Super Sani-Cloth with Bleach",1
9206,Elearning-0000-464,LOW-LEVEL DISINFECTION ANESETHSIA TECH,n8290,39139,3,_____________ is ideal for disinfecting high risk areas endemic with Clostridium difficile spores and Norovirus.,125129,2,"c)	SONO wipes",0
9206,Elearning-0000-464,LOW-LEVEL DISINFECTION ANESETHSIA TECH,n8290,39140,4,SONO Disinfecting Wipes _______________contact time,125130,0,"a)	2 minutes",0
9206,Elearning-0000-464,LOW-LEVEL DISINFECTION ANESETHSIA TECH,n8290,39140,4,SONO Disinfecting Wipes _______________contact time,125131,1,"b)	3 minutes",0
9206,Elearning-0000-464,LOW-LEVEL DISINFECTION ANESETHSIA TECH,n8290,39140,4,SONO Disinfecting Wipes _______________contact time,125132,2,"c)	4 minutes",1
8225,Elearning-0000-1112,ENHANCED RECOVERY CESAREAN SOAP 2019,n8292,39145,0,I have read and reviewed the Education on Enhanced Recovery Cesarean located on P Drive<br> P:\Surgical Services Education\Staff Meeting GFS TFS BCC\2018,125143,0,TRUE,1
8225,Elearning-0000-1112,ENHANCED RECOVERY CESAREAN SOAP 2019,n8292,39145,0,I have read and reviewed the Education on Enhanced Recovery Cesarean located on P Drive<br> P:\Surgical Services Education\Staff Meeting GFS TFS BCC\2018,125144,1,FALSE,0
9499,Elearning-0000-730,CARE OF TRANSGENDER PATIENTS PERIOPERATIVE SETTING,n8294,39147,0,"For compliance with federal regulations, a transgender patient's sex as assigned at birth should be indicated on the medical record.",125147,0,TRUE,1
9499,Elearning-0000-730,CARE OF TRANSGENDER PATIENTS PERIOPERATIVE SETTING,n8294,39147,0,"For compliance with federal regulations, a transgender patient's sex as assigned at birth should be indicated on the medical record.",125148,1,FALSE,0
8622,Elearning-0000-149,"STORAGE OF STERILE, CLEAN AND OFFICE SUPPLIES",n8300,39177,0,Office supplies may be stored with sterile supplies.,125221,0,TRUE,0
8622,Elearning-0000-149,"STORAGE OF STERILE, CLEAN AND OFFICE SUPPLIES",n8300,39177,0,Office supplies may be stored with sterile supplies.,125222,1,FALSE,1
8622,Elearning-0000-149,"STORAGE OF STERILE, CLEAN AND OFFICE SUPPLIES",n8300,39178,1,"Sterile supplies should be rotated first in, first out to prevent items from expiring.",125223,0,TRUE,1
8622,Elearning-0000-149,"STORAGE OF STERILE, CLEAN AND OFFICE SUPPLIES",n8300,39178,1,"Sterile supplies should be rotated first in, first out to prevent items from expiring.",125224,1,FALSE,0
8622,Elearning-0000-149,"STORAGE OF STERILE, CLEAN AND OFFICE SUPPLIES",n8300,39179,2,Sterile and Clean supplies may be stored together and do not require that they be stored separately.,125225,0,TRUE,0
8622,Elearning-0000-149,"STORAGE OF STERILE, CLEAN AND OFFICE SUPPLIES",n8300,39179,2,Sterile and Clean supplies may be stored together and do not require that they be stored separately.,125226,1,FALSE,1
8622,Elearning-0000-149,"STORAGE OF STERILE, CLEAN AND OFFICE SUPPLIES",n8300,39180,3,Acceptable temperature range for storage of supplies is 72 F - 78 F and acceptable Humidity Range is a maximum of 60%.,125227,0,TRUE,1
8622,Elearning-0000-149,"STORAGE OF STERILE, CLEAN AND OFFICE SUPPLIES",n8300,39180,3,Acceptable temperature range for storage of supplies is 72 F - 78 F and acceptable Humidity Range is a maximum of 60%.,125228,1,FALSE,0
8622,Elearning-0000-149,"STORAGE OF STERILE, CLEAN AND OFFICE SUPPLIES",n8300,39181,4,"External corrugated cardboard boxes and original shipping packages are not allowed in storage areas as these items could contain dust, bacteria and insects.",125229,0,TRUE,1
8622,Elearning-0000-149,"STORAGE OF STERILE, CLEAN AND OFFICE SUPPLIES",n8300,39181,4,"External corrugated cardboard boxes and original shipping packages are not allowed in storage areas as these items could contain dust, bacteria and insects.",125230,1,FALSE,0
8199,Elearning-0000-109,VAPOR CLEAN,n8301,39182,0,I have read and understand the content of the CBL Vapor Clean.,125231,0,TRUE,1
8199,Elearning-0000-109,VAPOR CLEAN,n8301,39182,0,I have read and understand the content of the CBL Vapor Clean.,125232,1,FALSE,0
8219,Elearning-0000-1107,MACROPHAGE ACTIVATION SYNDROME,n8323,39327,0,Macrophage activation syndrome is caused by:,125636,0,"a.	Immunosuppression",0
8219,Elearning-0000-1107,MACROPHAGE ACTIVATION SYNDROME,n8323,39327,0,Macrophage activation syndrome is caused by:,125637,1,"b.	Chemotherapy effects",0
8219,Elearning-0000-1107,MACROPHAGE ACTIVATION SYNDROME,n8323,39327,0,Macrophage activation syndrome is caused by:,125638,2,"c.	Uncontrolled activation and proliferation of T lymphocytes and Macrophages",1
8219,Elearning-0000-1107,MACROPHAGE ACTIVATION SYNDROME,n8323,39328,1,MAS is a very common occurrence in CAR-T cell therapy,125639,0,"a.	True",0
8219,Elearning-0000-1107,MACROPHAGE ACTIVATION SYNDROME,n8323,39328,1,MAS is a very common occurrence in CAR-T cell therapy,125640,1,"b.	False",1
8219,Elearning-0000-1107,MACROPHAGE ACTIVATION SYNDROME,n8323,39329,2,What diagnostic feature is NOT associated with MAS?,125641,0,"a.	Low fibrinogen",0
8219,Elearning-0000-1107,MACROPHAGE ACTIVATION SYNDROME,n8323,39329,2,What diagnostic feature is NOT associated with MAS?,125642,1,"b.	Fever of 38oC r higher",0
8219,Elearning-0000-1107,MACROPHAGE ACTIVATION SYNDROME,n8323,39329,2,What diagnostic feature is NOT associated with MAS?,125643,2,"c.	Low ferritin",1
8219,Elearning-0000-1107,MACROPHAGE ACTIVATION SYNDROME,n8323,39329,2,What diagnostic feature is NOT associated with MAS?,125644,3,"d.	CNS disturbances",0
8219,Elearning-0000-1107,MACROPHAGE ACTIVATION SYNDROME,n8323,39330,3,MAS is a life threatening condition that may require more aggressive treatment.,125645,0,"a.	True",1
8219,Elearning-0000-1107,MACROPHAGE ACTIVATION SYNDROME,n8323,39330,3,MAS is a life threatening condition that may require more aggressive treatment.,125646,1,"b.	False",0
8219,Elearning-0000-1107,MACROPHAGE ACTIVATION SYNDROME,n8323,39331,4,MAS is initially treated as CRS,125647,0,"a.	True",1
8219,Elearning-0000-1107,MACROPHAGE ACTIVATION SYNDROME,n8323,39331,4,MAS is initially treated as CRS,125648,1,"b.	False",0
8219,Elearning-0000-1107,MACROPHAGE ACTIVATION SYNDROME,n8323,39332,5,"If a patient does not respond to initial treatment after ________, more aggressive treatment may be required.",125649,0,"a.	24 hours",0
8219,Elearning-0000-1107,MACROPHAGE ACTIVATION SYNDROME,n8323,39332,5,"If a patient does not respond to initial treatment after ________, more aggressive treatment may be required.",125650,1,"b.	1 week",0
8219,Elearning-0000-1107,MACROPHAGE ACTIVATION SYNDROME,n8323,39332,5,"If a patient does not respond to initial treatment after ________, more aggressive treatment may be required.",125651,2,"c.	3 days",0
8219,Elearning-0000-1107,MACROPHAGE ACTIVATION SYNDROME,n8323,39332,5,"If a patient does not respond to initial treatment after ________, more aggressive treatment may be required.",125652,3,"d.	48 hours",1
8196,Elearning-0000-1087,RCT: CONCIERGE SCHEDULER - PREPARING PATIENT ESTIMATES CBL,n8324,39333,0,I acknowledge that I have read and understand in its entirety the RCT: Concierge Scheduler - Preparing Patient Estimates CBL.,125653,0,TRUE,1
8196,Elearning-0000-1087,RCT: CONCIERGE SCHEDULER - PREPARING PATIENT ESTIMATES CBL,n8324,39333,0,I acknowledge that I have read and understand in its entirety the RCT: Concierge Scheduler - Preparing Patient Estimates CBL.,125654,1,FALSE,0
9579,Elearning-0000-803,AGE SPECIFIC COMPETENCY FOR UNLICENSED ASSISTIVE PERSONNEL(PCT),n8335,39426,0,It is important to treat both pediatric and geriatric patients the same when providing care because all patients are the same regardless of age or stage of development.,126014,0,TRUE,0
9579,Elearning-0000-803,AGE SPECIFIC COMPETENCY FOR UNLICENSED ASSISTIVE PERSONNEL(PCT),n8335,39426,0,It is important to treat both pediatric and geriatric patients the same when providing care because all patients are the same regardless of age or stage of development.,126015,1,FALSE,1
9579,Elearning-0000-803,AGE SPECIFIC COMPETENCY FOR UNLICENSED ASSISTIVE PERSONNEL(PCT),n8335,39427,1,"If you suspect either child abuse or elder abuse, you must:",126016,0,a. tell the doctor immediately,0
9579,Elearning-0000-803,AGE SPECIFIC COMPETENCY FOR UNLICENSED ASSISTIVE PERSONNEL(PCT),n8335,39427,1,"If you suspect either child abuse or elder abuse, you must:",126017,1,b. remove all family and visitors from the room,0
9579,Elearning-0000-803,AGE SPECIFIC COMPETENCY FOR UNLICENSED ASSISTIVE PERSONNEL(PCT),n8335,39427,1,"If you suspect either child abuse or elder abuse, you must:",126018,2,c. report to the nurse and if she is not available use your chain of command,1
9579,Elearning-0000-803,AGE SPECIFIC COMPETENCY FOR UNLICENSED ASSISTIVE PERSONNEL(PCT),n8335,39428,2,"A 85 year old female patient has hearing aids, glasses and dentures. She tells you her husband has never seen her without her teeth. Her husband is with her today and has stated he wants to sit with her while she waits to go back to surgery. What would be the best thing to do?",126019,0,a. leave the husband in the waiting room until the patient goes to surgery,0
9579,Elearning-0000-803,AGE SPECIFIC COMPETENCY FOR UNLICENSED ASSISTIVE PERSONNEL(PCT),n8335,39428,2,"A 85 year old female patient has hearing aids, glasses and dentures. She tells you her husband has never seen her without her teeth. Her husband is with her today and has stated he wants to sit with her while she waits to go back to surgery. What would be the best thing to do?",126020,1,b. tell the patient that her teeth glasses and hearing aids must be locked up by security for safe keeping.,0
9579,Elearning-0000-803,AGE SPECIFIC COMPETENCY FOR UNLICENSED ASSISTIVE PERSONNEL(PCT),n8335,39428,2,"A 85 year old female patient has hearing aids, glasses and dentures. She tells you her husband has never seen her without her teeth. Her husband is with her today and has stated he wants to sit with her while she waits to go back to surgery. What would be the best thing to do?",126021,2,"c. tell the patient you will have her husband say good bye before she goes to surgery and take him to the waiting room. Have the OR nurse take the teeth at handoff and give to PACU so patient can have them in 	her mouth before the husband sees her for discharge.",1
9579,Elearning-0000-803,AGE SPECIFIC COMPETENCY FOR UNLICENSED ASSISTIVE PERSONNEL(PCT),n8335,39429,3,"A 6 year old boy is having his tonsils removed. When you ask him to sit in the wheelchair to take him to his father's car, the boy says he feels sick to his stomach and he vomits bright red blood. You would:",126022,0,a. Clean it up and take him to the car.,0
9579,Elearning-0000-803,AGE SPECIFIC COMPETENCY FOR UNLICENSED ASSISTIVE PERSONNEL(PCT),n8335,39429,3,"A 6 year old boy is having his tonsils removed. When you ask him to sit in the wheelchair to take him to his father's car, the boy says he feels sick to his stomach and he vomits bright red blood. You would:",126023,1,b. Have the father clean up the child,0
9579,Elearning-0000-803,AGE SPECIFIC COMPETENCY FOR UNLICENSED ASSISTIVE PERSONNEL(PCT),n8335,39429,3,"A 6 year old boy is having his tonsils removed. When you ask him to sit in the wheelchair to take him to his father's car, the boy says he feels sick to his stomach and he vomits bright red blood. You would:",126024,2,c. Call the doctor,0
9579,Elearning-0000-803,AGE SPECIFIC COMPETENCY FOR UNLICENSED ASSISTIVE PERSONNEL(PCT),n8335,39429,3,"A 6 year old boy is having his tonsils removed. When you ask him to sit in the wheelchair to take him to his father's car, the boy says he feels sick to his stomach and he vomits bright red blood. You would:",126025,3,d. Call the nurse for assistance,1
9579,Elearning-0000-803,AGE SPECIFIC COMPETENCY FOR UNLICENSED ASSISTIVE PERSONNEL(PCT),n8335,39430,4,An elderly nursing home patient is admitted for surgery and stays overnight in the ERU. The nurse asks you          to remove the IV. While removing the tape the patient's skin tears: You should:,126026,0,a. apply pressure then antibiotic ointment and then a dry clean dressing,0
9579,Elearning-0000-803,AGE SPECIFIC COMPETENCY FOR UNLICENSED ASSISTIVE PERSONNEL(PCT),n8335,39430,4,An elderly nursing home patient is admitted for surgery and stays overnight in the ERU. The nurse asks you          to remove the IV. While removing the tape the patient's skin tears: You should:,126027,1,b. stop what you are doing and run for help,0
9579,Elearning-0000-803,AGE SPECIFIC COMPETENCY FOR UNLICENSED ASSISTIVE PERSONNEL(PCT),n8335,39430,4,An elderly nursing home patient is admitted for surgery and stays overnight in the ERU. The nurse asks you          to remove the IV. While removing the tape the patient's skin tears: You should:,126028,2,c. call the doctor,0
9579,Elearning-0000-803,AGE SPECIFIC COMPETENCY FOR UNLICENSED ASSISTIVE PERSONNEL(PCT),n8335,39430,4,An elderly nursing home patient is admitted for surgery and stays overnight in the ERU. The nurse asks you          to remove the IV. While removing the tape the patient's skin tears: You should:,126029,3,d. call for immediate assistance from the nurse and tell her what happened.,1
9580,Elearning-0000-804,ADVERSE MEDICATION REACTIONS FOR ED STAFF 2019,n8340,39462,0,I have read and understand the contents of the CBL ADVERSE MEDICATION REACTIONS FOR ED STAFF 2019.,126155,0,TRUE,1
9580,Elearning-0000-804,ADVERSE MEDICATION REACTIONS FOR ED STAFF 2019,n8340,39462,0,I have read and understand the contents of the CBL ADVERSE MEDICATION REACTIONS FOR ED STAFF 2019.,126156,1,FALSE,0
8451,Elearning-0000-133,TARGETED TEMERAPTURE MANAGEMENT 2019,n8343,39465,0,I acknowledge that I have read and understand the CBL Targeted Temperature Management.,126161,0,TRUE,1
8451,Elearning-0000-133,TARGETED TEMERAPTURE MANAGEMENT 2019,n8343,39465,0,I acknowledge that I have read and understand the CBL Targeted Temperature Management.,126162,1,FALSE,0
9470,Elearning-0000-704,CIWA SCORING FOR ED NURSES 2019,n8342,39464,0,I acknowledge that I have read and understand the CIWA Scoring for ED Nurses 2019.,126159,0,TRUE,1
9470,Elearning-0000-704,CIWA SCORING FOR ED NURSES 2019,n8342,39464,0,I acknowledge that I have read and understand the CIWA Scoring for ED Nurses 2019.,126160,1,FALSE,0
9590,Elearning-0000-813,ACS SIGNS SYMPTOMS FOR ED TECHS 2019,n8352,39492,0,I have read and understand the CBL ACS SIGNS SYMPTOMS FOR ED TECHS 2019.,126243,0,TRUE,1
9590,Elearning-0000-813,ACS SIGNS SYMPTOMS FOR ED TECHS 2019,n8352,39492,0,I have read and understand the CBL ACS SIGNS SYMPTOMS FOR ED TECHS 2019.,126244,1,FALSE,0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39493,0,Which of the following is more likely to be a symptom of sepsis?,126245,0,"a.	Headache",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39493,0,Which of the following is more likely to be a symptom of sepsis?,126246,1,"b.	Hypothermia",1
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39493,0,Which of the following is more likely to be a symptom of sepsis?,126247,2,"c.	Chest Pain",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39493,0,Which of the following is more likely to be a symptom of sepsis?,126248,3,"d.	Vomiting",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39494,1,Which of the following patients is at the GREATEST risk for sepsis?,126249,0,"a.	A 12 year old otherwise healthy child complaining of a sore throat",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39494,1,Which of the following patients is at the GREATEST risk for sepsis?,126250,1,"b.	A 28 year old, 16-week pregnant female complaining of urinary frequency",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39494,1,Which of the following patients is at the GREATEST risk for sepsis?,126251,2,"c.	A 72 year old diabetic complaining of cough & fever",1
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39494,1,Which of the following patients is at the GREATEST risk for sepsis?,126252,3,"d.	A 37 year old male complaining of abdominal pain & diarrhea after traveling to Mexico",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39495,2,Which POC (Point of Care) test should be run on all suspected sepsis patients?,126253,0,"a.	Troponin",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39495,2,Which POC (Point of Care) test should be run on all suspected sepsis patients?,126254,1,"b.	Electrolytes (BMET)",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39495,2,Which POC (Point of Care) test should be run on all suspected sepsis patients?,126255,2,"c.	Urine Pregnancy",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39495,2,Which POC (Point of Care) test should be run on all suspected sepsis patients?,126256,3,"d.	Lactate",1
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39496,3,Which of the following statements is INCORRECT regarding blood cultures & antibiotics?,126257,0,"a.	It is OK to draw the first blood culture from an EMS IV, as long as the second set is drawn from another peripheral site.",1
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39496,3,Which of the following statements is INCORRECT regarding blood cultures & antibiotics?,126258,1,"b.	Blood cultures must be drawn before antibiotic administration.",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39496,3,Which of the following statements is INCORRECT regarding blood cultures & antibiotics?,126259,2,"c.	Antibiotics must be started within 3 hours of when the patient presents with severe sepsis",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39496,3,Which of the following statements is INCORRECT regarding blood cultures & antibiotics?,126260,3,"d.	When drawing two sets of blood cultures, it is preferred to have at least one set drawn from a peripheral site.",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39497,4,A patient enters triage complaining of fever & a productive cough.  There are no beds available in the ED.  What should the triage nurse do?,126261,0,"a.	Call the ED Clinical Supervisor or Charge Nurse and ask them what to do",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39497,4,A patient enters triage complaining of fever & a productive cough.  There are no beds available in the ED.  What should the triage nurse do?,126262,1,"b.	Place the patient in a chair in the ED hallway",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39497,4,A patient enters triage complaining of fever & a productive cough.  There are no beds available in the ED.  What should the triage nurse do?,126263,2,"c.	Order a chest x-ray per the Nurse-Initiated Guidelines",1
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39497,4,A patient enters triage complaining of fever & a productive cough.  There are no beds available in the ED.  What should the triage nurse do?,126264,3,"d.	Tell the patient that all of our beds are full, so it might be a while.",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39498,5,What is the best way to prevent CAUTI (Catheter Associated Urinary Tract Infection)?,126265,0,"a.	Place an indwelling catheter in all incontinent patients to avoid frequent bedpan use.",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39498,5,What is the best way to prevent CAUTI (Catheter Associated Urinary Tract Infection)?,126266,1,"b.	Limit the use of indwelling catheters.",1
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39498,5,What is the best way to prevent CAUTI (Catheter Associated Urinary Tract Infection)?,126267,2,"c.	Leave a urinary catheter in for as long as possible to avoid having to reinsert it.",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39498,5,What is the best way to prevent CAUTI (Catheter Associated Urinary Tract Infection)?,126268,3,"d.	Rest the urinary drainage bag on the mattress with the patient.",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39499,6,You have just inserted a Foley catheter using strict aseptic technique.  What else should you do?,126269,0,"a.	Secure the catheter to the patient with a STAT-lock device",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39499,6,You have just inserted a Foley catheter using strict aseptic technique.  What else should you do?,126270,1,"b.	Attach the drainage bag to the side of the bed, below the level of the patient's bladder",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39499,6,You have just inserted a Foley catheter using strict aseptic technique.  What else should you do?,126271,2,"c.	Ensure that a closed drainage system is maintained",0
8898,Elearning-0000-184,"SEPSIS, PNEUMONIA, CAUTI FOR ED STAFF",n8353,39499,6,You have just inserted a Foley catheter using strict aseptic technique.  What else should you do?,126272,3,"d.	All of the above",1
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39511,0,Please list the location for this activity.,126305,0,Atlanta,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39511,0,Please list the location for this activity.,126306,1,Cherokee,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39511,0,Please list the location for this activity.,126307,2,Forsyth,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39511,0,Please list the location for this activity.,126308,3,Other,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39512,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the major impact of heart failure diagnoses on the US population.</ol>",126309,0,Strongly Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39512,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the major impact of heart failure diagnoses on the US population.</ol>",126310,1,Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39512,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the major impact of heart failure diagnoses on the US population.</ol>",126311,2,No Opinion,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39512,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the major impact of heart failure diagnoses on the US population.</ol>",126312,3,Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39512,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the major impact of heart failure diagnoses on the US population.</ol>",126313,4,Strongly Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39513,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the syndrome of heart failure and identify two symptoms of worsening heart failure.</ol>",126314,0,Strongly Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39513,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the syndrome of heart failure and identify two symptoms of worsening heart failure.</ol>",126315,1,Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39513,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the syndrome of heart failure and identify two symptoms of worsening heart failure.</ol>",126316,2,No Opinion,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39513,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the syndrome of heart failure and identify two symptoms of worsening heart failure.</ol>",126317,3,Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39513,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the syndrome of heart failure and identify two symptoms of worsening heart failure.</ol>",126318,4,Strongly Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39514,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to name at least 2 medications commonly used in the treatment of heart failure.</ol>",126319,0,Strongly Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39514,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to name at least 2 medications commonly used in the treatment of heart failure.</ol>",126320,1,Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39514,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to name at least 2 medications commonly used in the treatment of heart failure.</ol>",126321,2,No Opinion,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39514,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to name at least 2 medications commonly used in the treatment of heart failure.</ol>",126322,3,Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39514,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to name at least 2 medications commonly used in the treatment of heart failure.</ol>",126323,4,Strongly Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39515,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list at least 2 self-care practices for the heart failure patient and describe at least one benefit of a Heart Failure Management Team.</ol>",126324,0,Strongly Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39515,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list at least 2 self-care practices for the heart failure patient and describe at least one benefit of a Heart Failure Management Team.</ol>",126325,1,Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39515,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list at least 2 self-care practices for the heart failure patient and describe at least one benefit of a Heart Failure Management Team.</ol>",126326,2,No Opinion,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39515,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list at least 2 self-care practices for the heart failure patient and describe at least one benefit of a Heart Failure Management Team.</ol>",126327,3,Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39515,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list at least 2 self-care practices for the heart failure patient and describe at least one benefit of a Heart Failure Management Team.</ol>",126328,4,Strongly Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39516,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe heart failure symptoms.</ol>",126329,0,Strongly Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39516,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe heart failure symptoms.</ol>",126330,1,Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39516,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe heart failure symptoms.</ol>",126331,2,No Opinion,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39516,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe heart failure symptoms.</ol>",126332,3,Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39516,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe heart failure symptoms.</ol>",126333,4,Strongly Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39517,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the rationale and basic care of the patient treated with a wearable defibrillator device.</ol>",126334,0,Strongly Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39517,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the rationale and basic care of the patient treated with a wearable defibrillator device.</ol>",126335,1,Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39517,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the rationale and basic care of the patient treated with a wearable defibrillator device.</ol>",126336,2,No Opinion,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39517,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the rationale and basic care of the patient treated with a wearable defibrillator device.</ol>",126337,3,Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39517,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the rationale and basic care of the patient treated with a wearable defibrillator device.</ol>",126338,4,Strongly Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39518,7,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,126339,0,Strongly Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39518,7,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,126340,1,Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39518,7,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,126341,2,No Opinion,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39518,7,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,126342,3,Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39518,7,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,126343,4,Strongly Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39519,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of ways to educate heart failure patients on their disease process and treatment regimens.OL>,126344,0,Strongly Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39519,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of ways to educate heart failure patients on their disease process and treatment regimens.OL>,126345,1,Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39519,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of ways to educate heart failure patients on their disease process and treatment regimens.OL>,126346,2,No Opinion,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39519,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of ways to educate heart failure patients on their disease process and treatment regimens.OL>,126347,3,Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39519,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of ways to educate heart failure patients on their disease process and treatment regimens.OL>,126348,4,Strongly Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39520,8,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to recognize the signs and symptoms of worsening heart failure and respond appropriately.</OL>,126349,0,Strongly Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39520,8,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to recognize the signs and symptoms of worsening heart failure and respond appropriately.</OL>,126350,1,Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39520,8,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to recognize the signs and symptoms of worsening heart failure and respond appropriately.</OL>,126351,2,No Opinion,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39520,8,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to recognize the signs and symptoms of worsening heart failure and respond appropriately.</OL>,126352,3,Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39520,8,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to recognize the signs and symptoms of worsening heart failure and respond appropriately.</OL>,126353,4,Strongly Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39521,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.<OL>",126354,0,Strongly Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39521,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.<OL>",126355,1,Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39521,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.<OL>",126356,2,No Opinion,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39521,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.<OL>",126357,3,Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39521,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.<OL>",126358,4,Strongly Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39522,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",126359,0,Strongly Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39522,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",126360,1,Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39522,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",126361,2,No Opinion,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39522,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",126362,3,Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39522,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",126363,4,Strongly Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39523,12,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</OL>,126364,0,Strongly Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39523,12,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</OL>,126365,1,Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39523,12,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</OL>,126366,2,No Opinion,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39523,12,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</OL>,126367,3,Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39523,12,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</OL>,126368,4,Strongly Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39524,13,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,126369,0,Strongly Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39524,13,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,126370,1,Agree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39524,13,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,126371,2,No Opinion,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39524,13,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,126372,3,Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39524,13,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,126373,4,Strongly Disagree,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39525,14,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Linda Kelly, MSN, ANP- BC</ol>",126374,0,Excellent,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39525,14,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Linda Kelly, MSN, ANP- BC</ol>",126375,1,Very Good,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39525,14,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Linda Kelly, MSN, ANP- BC</ol>",126376,2,Good,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39525,14,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Linda Kelly, MSN, ANP- BC</ol>",126377,3,Fair,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39525,14,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Linda Kelly, MSN, ANP- BC</ol>",126378,4,Poor,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39526,15,"Overall, this activity was:",126379,0,Excellent,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39526,15,"Overall, this activity was:",126380,1,Very Good,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39526,15,"Overall, this activity was:",126381,2,Good,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39526,15,"Overall, this activity was:",126382,3,Fair,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39526,15,"Overall, this activity was:",126383,4,Poor,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39527,16,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",126384,0,Yes,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39527,16,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",126385,1,No,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39527,16,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",126386,2,N/A,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39530,19,How would you improve this class?,126387,0,Reduce content covered in class,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39530,19,How would you improve this class?,126388,1,Increase content covered in class,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39530,19,How would you improve this class?,126389,2,Update content covered in class,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39530,19,How would you improve this class?,126390,3,Improve the instructional methods,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39530,19,How would you improve this class?,126391,4,Make course activities more stimulating,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39530,19,How would you improve this class?,126392,5,Slow the pace of the class,0
777,ILT-0000-2786,BEST PRACTICES FOR HEART FAILURE MANAGEMENT (EVALUATION SURVEY) NSA  2.13.19,n8357,39530,19,How would you improve this class?,126393,6,"Nothing: (appropriate speakers, content, facility, etc.)",0
123,SCORM-0000-203,UMANO BED TRAINING VIDEO,n8359,39534,0,I have read and understood the content within the Umano Bed Training Video.,126396,0,TRUE,1
123,SCORM-0000-203,UMANO BED TRAINING VIDEO,n8359,39534,0,I have read and understood the content within the Umano Bed Training Video.,126397,1,FALSE,0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39536,0,Diversion means any criminal act involving a prescription drug,126400,0,A.) True,1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39536,0,Diversion means any criminal act involving a prescription drug,126401,1,B.) False,0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39537,1,The most common drugs diverted from the health care facility settings are,126402,0,"A.	Athletic performance enhancing drugs",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39537,1,The most common drugs diverted from the health care facility settings are,126403,1,"B.	Psychotropic drugs",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39537,1,The most common drugs diverted from the health care facility settings are,126404,2,"C.	Opioids",1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39537,1,The most common drugs diverted from the health care facility settings are,126405,3,"D.	Hydrocodone",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39537,1,The most common drugs diverted from the health care facility settings are,126406,4,"E.	Fentanyl",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39538,2,Hospital systems that have no vulnerability to diversion are ones with robust pharmacy surveillance systems.,126407,0,A. True,0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39538,2,Hospital systems that have no vulnerability to diversion are ones with robust pharmacy surveillance systems.,126408,1,B. False,1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39539,3,Diversion risk is primarily borne by the diverting care giver and results in profound morbidity and mortality.,126409,0,A. True,0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39539,3,Diversion risk is primarily borne by the diverting care giver and results in profound morbidity and mortality.,126410,1,B. False,1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39540,4,The care giver who commits drug diversion is generally characterized as:,126411,0,"A.	Secretive",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39540,4,The care giver who commits drug diversion is generally characterized as:,126412,1,"B.	Persuasive",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39540,4,The care giver who commits drug diversion is generally characterized as:,126413,2,"C.	Prefers autonomy",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39540,4,The care giver who commits drug diversion is generally characterized as:,126414,3,"D.	Seeks extra shifts, frequently arrives early and stays late",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39540,4,The care giver who commits drug diversion is generally characterized as:,126415,4,"E.	All of the above",1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39541,5,Patients who are harmed by diversion may suffer all of the following except:,126416,0,"A.	Substandard Care",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39541,5,Patients who are harmed by diversion may suffer all of the following except:,126417,1,"B.	Pathogen Transfer",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39541,5,Patients who are harmed by diversion may suffer all of the following except:,126418,2,"C.	Allergic Reaction",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39541,5,Patients who are harmed by diversion may suffer all of the following except:,126419,3,"D.	Sepsis and Death",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39541,5,Patients who are harmed by diversion may suffer all of the following except:,126420,4,"E.	Negligence",1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39542,6,The Care Team may be harmed by diversion when an altered dose exposure injury occurs.,126421,0,A. True,1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39542,6,The Care Team may be harmed by diversion when an altered dose exposure injury occurs.,126422,1,B. False,0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39543,7,The Hospital may be harmed by diversion most profoundly when one of the following occurs:,126423,0,"A.	Regulatory Scrutiny",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39543,7,The Hospital may be harmed by diversion most profoundly when one of the following occurs:,126424,1,"B.	Class Action Lawsuits",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39543,7,The Hospital may be harmed by diversion most profoundly when one of the following occurs:,126425,2,"C.	Medicare / Medicaid Reimbursement",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39543,7,The Hospital may be harmed by diversion most profoundly when one of the following occurs:,126426,3,"D.	Charges of Negligence",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39543,7,The Hospital may be harmed by diversion most profoundly when one of the following occurs:,126427,4,"E.	All of the above",1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39544,8,Each care team employee is at risk for diversion as an occupational hazard,126428,0,A. True,1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39544,8,Each care team employee is at risk for diversion as an occupational hazard,126429,1,B. False,0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39545,9,Substandard care from a diverting health care worker can occur with all of the following except:,126430,0,"A.	Insufficient rescue from excruciating pain",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39545,9,Substandard care from a diverting health care worker can occur with all of the following except:,126431,1,"B.	Insufficient sedation during a procedure",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39545,9,Substandard care from a diverting health care worker can occur with all of the following except:,126432,2,"C.	Tampering",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39545,9,Substandard care from a diverting health care worker can occur with all of the following except:,126433,3,"D.	Discharged patient diversion",1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39545,9,Substandard care from a diverting health care worker can occur with all of the following except:,126434,4,"E.	All of the above will cause substandard care",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39546,10,Drug diversion publicity potential labels the healthcare facility as one that provides poor patient safety,126435,0,A. True,1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39546,10,Drug diversion publicity potential labels the healthcare facility as one that provides poor patient safety,126436,1,B. False,0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39547,11,"Charting that a controlled substance dose was given to cover diversion has no harm impact to patient, care team, or hospital.",126437,0,A. True,0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39547,11,"Charting that a controlled substance dose was given to cover diversion has no harm impact to patient, care team, or hospital.",126438,1,B. False,1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39549,12,Diversion during a waste transaction occurs when the witness conditionally cooperates during the ADM system waste sign-on.,126441,0,"A.	True",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39549,12,Diversion during a waste transaction occurs when the witness conditionally cooperates during the ADM system waste sign-on.,126442,1,"B.	False",1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39550,13,"According to NSH policy, ADM narcotic counts (whole machine) are to occur for each machine how often?",126443,0,"A.	Counts are not needed because each user counts under blind count each time the pocket is accessed",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39550,13,"According to NSH policy, ADM narcotic counts (whole machine) are to occur for each machine how often?",126444,1,"B.	Monthly",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39550,13,"According to NSH policy, ADM narcotic counts (whole machine) are to occur for each machine how often?",126445,2,"C.	Bi-Weekly",1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39550,13,"According to NSH policy, ADM narcotic counts (whole machine) are to occur for each machine how often?",126446,3,"D.	Weekly",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39551,14,"According to NSH policy, ADM count discrepancies must be investigated and resolved",126447,0,"A.	By Nursing, prior to the end of the shift",1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39551,14,"According to NSH policy, ADM count discrepancies must be investigated and resolved",126448,1,"B.	By Nursing, immediately upon discovery",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39551,14,"According to NSH policy, ADM count discrepancies must be investigated and resolved",126449,2,"C.	By Pharmacy, as part of their daily surveillance",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39551,14,"According to NSH policy, ADM count discrepancies must be investigated and resolved",126450,3,"D.	By Nursing Leadership, as part of their weekly review of operations",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39552,15,Patient safety is achieved by all of the following except:,126451,0,"A.	Understanding NSH compliance policies",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39552,15,Patient safety is achieved by all of the following except:,126452,1,"B.	Preventing harm from diversion",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39552,15,Patient safety is achieved by all of the following except:,126453,2,"C.	Reporting policy compliance and policy concerns",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39552,15,Patient safety is achieved by all of the following except:,126454,3,"D.	Perform according to professional standards",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39552,15,Patient safety is achieved by all of the following except:,126455,4,"E.	Document administration at the end of the shift",1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39553,16,"After your policy study and review is completed, which of the following scenarios are true? <br><br> I.	A full vial of versed drawn up in a syringe may be wasted if not used. <br> II.	0.5mg of a 1mg dilaudid syringe may be wasted after patient administration of 0.5mg.<br> III.	A whole Percocet 5mg/325mg tablet that fell on the floor may be wasted.<br>",126456,0,"A.	I only",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39553,16,"After your policy study and review is completed, which of the following scenarios are true? <br><br> I.	A full vial of versed drawn up in a syringe may be wasted if not used. <br> II.	0.5mg of a 1mg dilaudid syringe may be wasted after patient administration of 0.5mg.<br> III.	A whole Percocet 5mg/325mg tablet that fell on the floor may be wasted.<br>",126457,1,"B.	II only",1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39553,16,"After your policy study and review is completed, which of the following scenarios are true? <br><br> I.	A full vial of versed drawn up in a syringe may be wasted if not used. <br> II.	0.5mg of a 1mg dilaudid syringe may be wasted after patient administration of 0.5mg.<br> III.	A whole Percocet 5mg/325mg tablet that fell on the floor may be wasted.<br>",126458,2,"C.	I and III",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39553,16,"After your policy study and review is completed, which of the following scenarios are true? <br><br> I.	A full vial of versed drawn up in a syringe may be wasted if not used. <br> II.	0.5mg of a 1mg dilaudid syringe may be wasted after patient administration of 0.5mg.<br> III.	A whole Percocet 5mg/325mg tablet that fell on the floor may be wasted.<br>",126459,3,"D.	I, II, and III",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39554,17,A patient is administered 1mg of morphine from a 2mg prefilled syringe. Which of the following is true?,126460,0,"A.	1mg should be wasted in AcuDose prior to administration",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39554,17,A patient is administered 1mg of morphine from a 2mg prefilled syringe. Which of the following is true?,126461,1,"B.	An individual who didn't dispense the syringe can log in to the AcuDose cabinet for a colleague to witness the waste",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39554,17,A patient is administered 1mg of morphine from a 2mg prefilled syringe. Which of the following is true?,126462,2,"C.	A waste witness needs to only be told the name of drug and quantity before they complete the ADM waste",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39554,17,A patient is administered 1mg of morphine from a 2mg prefilled syringe. Which of the following is true?,126463,3,"D.	Upon ADM waste completion, the partial dose should be expelled from the syringe into the blue and white waste bin",1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39555,18,"Diazepam 5mg tablets are not stocked in the AcuDose cabinet, so a dose is dispensed from main pharmacy. The patient refuses the dose, so the tablet should be placed in the patient credit bin.",126464,0,"A.	True",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39555,18,"Diazepam 5mg tablets are not stocked in the AcuDose cabinet, so a dose is dispensed from main pharmacy. The patient refuses the dose, so the tablet should be placed in the patient credit bin.",126465,1,"B.	False",1
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39556,19,A trusted colleague requests you to witness a narcotic waste in the ADM. Which of the following is compliant with hospital policy?,126466,0,"A.	Whole dose waste",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39556,19,A trusted colleague requests you to witness a narcotic waste in the ADM. Which of the following is compliant with hospital policy?,126467,1,"B.	Partial dose in an unlabeled syringe",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39556,19,A trusted colleague requests you to witness a narcotic waste in the ADM. Which of the following is compliant with hospital policy?,126468,2,"C.	Charge nurse's and the colleague's statement that the waste occurred in the patient's room",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39556,19,A trusted colleague requests you to witness a narcotic waste in the ADM. Which of the following is compliant with hospital policy?,126469,3,"D.	Needle box disposal of labeled narcotic syringe",0
8226,Elearning-0000-1113,ED DRUG DIVERSION AND NARCOTIC COMPLIANCE,n8361,39556,19,A trusted colleague requests you to witness a narcotic waste in the ADM. Which of the following is compliant with hospital policy?,126470,4,"E.	None of the above",1
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39557,0,"If your patient has a blood glucose value greater than or equal to 450, what are the next actions per policy to take?",126471,0,Call MD immediately for further orders,0
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39557,0,"If your patient has a blood glucose value greater than or equal to 450, what are the next actions per policy to take?",126472,1,Repeat finger stick immediately then call MD,0
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39557,0,"If your patient has a blood glucose value greater than or equal to 450, what are the next actions per policy to take?",126473,2,"Repeat finger stick immediately, if repeat is still greater than or equal to 450, enter order for stat lab draw, call MD with lab result",1
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39558,1,When is the recommended time to register for mock code?,126474,0,Anytime before July 31st,0
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39558,1,When is the recommended time to register for mock code?,126475,1,Month of hire,1
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39558,1,When is the recommended time to register for mock code?,126476,2,anytime I want,0
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39559,2,CBI intake and output documentation is now completely electronic.,126477,0,TRUE,1
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39559,2,CBI intake and output documentation is now completely electronic.,126478,1,FALSE,0
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39560,3,What should you do if you have a hip fracture admission that is made NPO?,126479,0,Keep patient NPO,0
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39560,3,What should you do if you have a hip fracture admission that is made NPO?,126480,1,Call Ortho MD to see if hip fracture clear liquids is appropriate and get new NPO restart time,1
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39561,4,Cauti bundle and catheter site cleansing should be documented at least every ___ .,126481,0,12 hours,1
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39561,4,Cauti bundle and catheter site cleansing should be documented at least every ___ .,126482,1,day,0
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39561,4,Cauti bundle and catheter site cleansing should be documented at least every ___ .,126483,2,night,0
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39562,5,For every patient with a Foley catheter:  'Risk for Infection' must be added to the POC  Education with the 'Cauti FAQs' hand out given to patient is documented under Infection Prevention ->Educational Materials Provided,126484,0,TRUE,1
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39562,5,For every patient with a Foley catheter:  'Risk for Infection' must be added to the POC  Education with the 'Cauti FAQs' hand out given to patient is documented under Infection Prevention ->Educational Materials Provided,126485,1,FALSE,0
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39563,6,"After insertion of Foley Catheter, both of the following steps must be completed: 1)Start 'Urinary Catheter' Dynamic Group 2)Complete fields appropriate for insertion (activity, sterile field, balloon inflation, pt response, etc.)",126486,0,TRUE,1
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39563,6,"After insertion of Foley Catheter, both of the following steps must be completed: 1)Start 'Urinary Catheter' Dynamic Group 2)Complete fields appropriate for insertion (activity, sterile field, balloon inflation, pt response, etc.)",126487,1,FALSE,0
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39564,7,After removal of Foley Catheter the following steps must be documented:  1)Document activity as discontinued and removal reason along with patient response 2) Inactive dynamic group,126488,0,TRUE,1
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39564,7,After removal of Foley Catheter the following steps must be documented:  1)Document activity as discontinued and removal reason along with patient response 2) Inactive dynamic group,126489,1,FALSE,0
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39565,8,If any hazardous chemical gets into your eyes you must hold eyes open and flush them at the eye wash station for ___ minutes.,126490,0,15,1
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39565,8,If any hazardous chemical gets into your eyes you must hold eyes open and flush them at the eye wash station for ___ minutes.,126491,1,5,0
389,ILT-0000-946,8 EAST STAFF MEETING JAN 2019,n8362,39565,8,If any hazardous chemical gets into your eyes you must hold eyes open and flush them at the eye wash station for ___ minutes.,126492,2,60,0
8232,Elearning-0000-1119,FY2019 COPD DISEASE SPECIFIC CERTIFICATION PROGRAM,n8371,39622,0,"I acknowledge that I have read and understand the ""FY2019 COPD Disease Specific Certification' CBL in its entirety.",126707,0,TRUE,1
8232,Elearning-0000-1119,FY2019 COPD DISEASE SPECIFIC CERTIFICATION PROGRAM,n8371,39622,0,"I acknowledge that I have read and understand the ""FY2019 COPD Disease Specific Certification' CBL in its entirety.",126708,1,FALSE,0
9778,Elearning-0000-984,FY2019 LINE RECONCILIATION FOR TRI-CAMPUS NURSES,n8372,39623,0,"Line Reconciliation is an Always Event. Every patient, every time?",126709,0,a. True,1
9778,Elearning-0000-984,FY2019 LINE RECONCILIATION FOR TRI-CAMPUS NURSES,n8372,39623,0,"Line Reconciliation is an Always Event. Every patient, every time?",126710,1,b. False,0
9778,Elearning-0000-984,FY2019 LINE RECONCILIATION FOR TRI-CAMPUS NURSES,n8372,39624,1,Lines to be traced in the line reconciliation process include,126711,0,"a.	Tube feedings",0
9778,Elearning-0000-984,FY2019 LINE RECONCILIATION FOR TRI-CAMPUS NURSES,n8372,39624,1,Lines to be traced in the line reconciliation process include,126712,1,"b.	IV drips",0
9778,Elearning-0000-984,FY2019 LINE RECONCILIATION FOR TRI-CAMPUS NURSES,n8372,39624,1,Lines to be traced in the line reconciliation process include,126713,2,"c.	Epidurals",0
9778,Elearning-0000-984,FY2019 LINE RECONCILIATION FOR TRI-CAMPUS NURSES,n8372,39624,1,Lines to be traced in the line reconciliation process include,126714,3,"d.	All the above",1
9778,Elearning-0000-984,FY2019 LINE RECONCILIATION FOR TRI-CAMPUS NURSES,n8372,39625,2,Line reconciliation will be performed at the following times:,126715,0,"a.	Not at all",0
9778,Elearning-0000-984,FY2019 LINE RECONCILIATION FOR TRI-CAMPUS NURSES,n8372,39625,2,Line reconciliation will be performed at the following times:,126716,1,"b.	During hand-off communication",0
9778,Elearning-0000-984,FY2019 LINE RECONCILIATION FOR TRI-CAMPUS NURSES,n8372,39625,2,Line reconciliation will be performed at the following times:,126717,2,"c.	Prior to initiating new infusion or connection into a tube",0
9778,Elearning-0000-984,FY2019 LINE RECONCILIATION FOR TRI-CAMPUS NURSES,n8372,39625,2,Line reconciliation will be performed at the following times:,126718,3,"d.	B and C",1
9778,Elearning-0000-984,FY2019 LINE RECONCILIATION FOR TRI-CAMPUS NURSES,n8372,39626,3,"In the IV line reconciliation process, it is not necessary to verify pump settings",126719,0,"a.	True",0
9778,Elearning-0000-984,FY2019 LINE RECONCILIATION FOR TRI-CAMPUS NURSES,n8372,39626,3,"In the IV line reconciliation process, it is not necessary to verify pump settings",126720,1,"b.	False",1
8506,Elearning-0000-138,AGE SPECIFIC EDUCATION UNLICENSED SUPPORT TEAM MEMBER,n8381,39701,0,I acknowledge that I have read and understand in its entirety the AGE SPECIFIC EDUCATION UNLICENSED SUPPORT TEAM MEMBER content.,126989,0,TRUE,1
8506,Elearning-0000-138,AGE SPECIFIC EDUCATION UNLICENSED SUPPORT TEAM MEMBER,n8381,39701,0,I acknowledge that I have read and understand in its entirety the AGE SPECIFIC EDUCATION UNLICENSED SUPPORT TEAM MEMBER content.,126990,1,FALSE,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39813,0,Signs and symptoms of NAS may not be exhibited for how many hours after birth?,127415,0,Up to 24 hours,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39813,0,Signs and symptoms of NAS may not be exhibited for how many hours after birth?,127416,1,Up to 48 hours,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39813,0,Signs and symptoms of NAS may not be exhibited for how many hours after birth?,127417,2,Up to 72 hours,1
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39813,0,Signs and symptoms of NAS may not be exhibited for how many hours after birth?,127418,3,Up to 120 hours,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39814,1,Therapeutic handling of the NAS infant includes all of the following except:,127419,0,Swaddling,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39814,1,Therapeutic handling of the NAS infant includes all of the following except:,127420,1,Quiet environment,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39814,1,Therapeutic handling of the NAS infant includes all of the following except:,127421,2,Rocking back and forth,1
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39814,1,Therapeutic handling of the NAS infant includes all of the following except:,127422,3,Keeping babies with their moms when possible,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39815,2,You discover that a mother used Percocet 5mg daily throughout her pregnancy for chronic back pain. What is the appropriate nursing action?,127423,0,Nothing since it is a prescribed medication,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39815,2,You discover that a mother used Percocet 5mg daily throughout her pregnancy for chronic back pain. What is the appropriate nursing action?,127424,1,Notify the pediatrician and begin NAS scoring every 4 hours,1
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39815,2,You discover that a mother used Percocet 5mg daily throughout her pregnancy for chronic back pain. What is the appropriate nursing action?,127425,2,Instruct the mother not to breastfeed,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39815,2,You discover that a mother used Percocet 5mg daily throughout her pregnancy for chronic back pain. What is the appropriate nursing action?,127426,3,All of the above,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39816,3,What two bacteria are the most common cause of newborn sepsis?,127427,0,E. coli and Group A Strep,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39816,3,What two bacteria are the most common cause of newborn sepsis?,127428,1,E. coli and Group B strep,1
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39816,3,What two bacteria are the most common cause of newborn sepsis?,127429,2,Staphylococcus aureus and Listeria,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39816,3,What two bacteria are the most common cause of newborn sepsis?,127430,3,Treponema pallidum and Group B Strep,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39817,4,What is the best treatment for suspected/confirmed newborn infection?,127431,0,Ampicillin and Gentamycin,1
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39817,4,What is the best treatment for suspected/confirmed newborn infection?,127432,1,Clindamycin and Augmentin,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39817,4,What is the best treatment for suspected/confirmed newborn infection?,127433,2,Rocephin and Gentamycin,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39817,4,What is the best treatment for suspected/confirmed newborn infection?,127434,3,Ampicillin and Cephazolin,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39818,5,Which of the following is an I/T ration that indicates sepsis/infection?,127435,0,>1,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39818,5,Which of the following is an I/T ration that indicates sepsis/infection?,127436,1,<13,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39818,5,Which of the following is an I/T ration that indicates sepsis/infection?,127437,2,>0.2,1
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39818,5,Which of the following is an I/T ration that indicates sepsis/infection?,127438,3,>0.5,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39819,6,"If someone is Rh positive, this means they have a D antigen on their red blood cell.",127439,0,TRUE,1
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39819,6,"If someone is Rh positive, this means they have a D antigen on their red blood cell.",127440,1,FALSE,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39820,7,Rh sensitization occurs when an Rh negative mother comes in contact with Rh positive blood.,127441,0,TRUE,1
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39820,7,Rh sensitization occurs when an Rh negative mother comes in contact with Rh positive blood.,127442,1,FALSE,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39821,8,Newborn consequences of maternal newborn blood incompatibility include which of the following:,127443,0,Anemia,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39821,8,Newborn consequences of maternal newborn blood incompatibility include which of the following:,127444,1,Jaundice,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39821,8,Newborn consequences of maternal newborn blood incompatibility include which of the following:,127445,2,Hydrops fetalis,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39821,8,Newborn consequences of maternal newborn blood incompatibility include which of the following:,127446,3,All of the above,1
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39822,9,Which of the following describes indirect/unconjugated bilirubin?,127447,0,Fat soluble,1
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39822,9,Which of the following describes indirect/unconjugated bilirubin?,127448,1,Non-toxic,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39822,9,Which of the following describes indirect/unconjugated bilirubin?,127449,2,Water soluble,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39822,9,Which of the following describes indirect/unconjugated bilirubin?,127450,3,Excreted in urine and stool,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39823,10,"If you see jaundice before the infant is 24 hours of age, it is pathological jaundice.",127451,0,TRUE,1
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39823,10,"If you see jaundice before the infant is 24 hours of age, it is pathological jaundice.",127452,1,FALSE,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39824,11,Physiological jaundice is the result of which of the following?,127453,0,Increased red blood cell destruction,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39824,11,Physiological jaundice is the result of which of the following?,127454,1,Immature liver function in the newborn,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39824,11,Physiological jaundice is the result of which of the following?,127455,2,Another disease process,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39824,11,Physiological jaundice is the result of which of the following?,127456,3,A and B only,1
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39825,12,What assessments are performed if the newborn is exhibiting signs of respiratory distress?,127457,0,"Respiratory rate, pulse oximetry, breath sounds, work of breathing, color",1
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39825,12,What assessments are performed if the newborn is exhibiting signs of respiratory distress?,127458,1,"Heart rate, blood sugar, temperature, capillary refill",0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39825,12,What assessments are performed if the newborn is exhibiting signs of respiratory distress?,127459,2,"Weight, feeding status, amount of time between feedings, regurgitation",0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39825,12,What assessments are performed if the newborn is exhibiting signs of respiratory distress?,127460,3,"Temperature, sweating, maternal labs, method of delivery",0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39826,13,Pallor is more concerning than cyanosis in an infant,127461,0,TRUE,1
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39826,13,Pallor is more concerning than cyanosis in an infant,127462,1,FALSE,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39827,14,How do we call a code for a baby that is in distress?,127463,0,Dial 8911,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39827,14,How do we call a code for a baby that is in distress?,127464,1,Call 911,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39827,14,How do we call a code for a baby that is in distress?,127465,2,Obtain help from your supervisor,0
9395,Elearning-0000-636,FCC EXPERIENCED NURSE CLASS NEWBORN CBL,n8396,39827,14,How do we call a code for a baby that is in distress?,127466,3,Call the Resus team by the white phone or 7323,1
11,SCORM-0000-100,RADIOACTIVE SEED LOCALIZATION,n8397,39828,0,I have read and understood the content within the Radioactive Seed Localization Video.,127467,0,TRUE,1
11,SCORM-0000-100,RADIOACTIVE SEED LOCALIZATION,n8397,39828,0,I have read and understood the content within the Radioactive Seed Localization Video.,127468,1,FALSE,0
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39873,0,Which program began to help prevent patient falls?,127606,0,a. Falls Prevention Program,1
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39873,0,Which program began to help prevent patient falls?,127607,1,b. Safety Assessment,0
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39873,0,Which program began to help prevent patient falls?,127608,2,c. Slip and Fall Prevention,0
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39874,1,Which situations below can invoke chain of command?,127609,0,a. The patient's condition requires immediate attention,0
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39874,1,Which situations below can invoke chain of command?,127610,1,b. Patients are upset or angry,0
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39874,1,Which situations below can invoke chain of command?,127611,2,c. Orders are believed to be inappropriate for the clinical situation,0
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39874,1,Which situations below can invoke chain of command?,127612,3,d. All the above,1
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39875,2,Which items listed below are effective methods of communication when invoking chain of command situations?,127613,0,a. SBAR,0
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39875,2,Which items listed below are effective methods of communication when invoking chain of command situations?,127614,1,b. Advocate and Assertion,0
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39875,2,Which items listed below are effective methods of communication when invoking chain of command situations?,127615,2,c. Two-challenge rule,0
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39875,2,Which items listed below are effective methods of communication when invoking chain of command situations?,127616,3,d. All the above,1
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39876,3,It takes all employees to prevent errors  from happening and staff should be empowered and feel comfortable expressing concerns with the ultimate goal of patient safety never being sacrificed.,127617,0,TRUE,1
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39876,3,It takes all employees to prevent errors  from happening and staff should be empowered and feel comfortable expressing concerns with the ultimate goal of patient safety never being sacrificed.,127618,1,FALSE,0
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39877,4,"You are unable to obtain vein access after 2 attempts and your co-worker has also tried once, what is your next step?",127619,0,a. Try for a fourth attempt,0
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39877,4,"You are unable to obtain vein access after 2 attempts and your co-worker has also tried once, what is your next step?",127620,1,b. Call or get your supervisor and/or Radiologist to find out the next steps,1
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39877,4,"You are unable to obtain vein access after 2 attempts and your co-worker has also tried once, what is your next step?",127621,2,c. Perform the exam without contrast,0
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39877,4,"You are unable to obtain vein access after 2 attempts and your co-worker has also tried once, what is your next step?",127622,3,d. Reschedule the patient to return,0
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39878,5,Patient arrives at the center with no order and we do not have it on file in any of our systems. The patient is very angry because they may not be seen. The situation occurs in the evening and the referring office is closed.,127623,0,a. Patient is rescheduled until a proper order is obtained,0
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39878,5,Patient arrives at the center with no order and we do not have it on file in any of our systems. The patient is very angry because they may not be seen. The situation occurs in the evening and the referring office is closed.,127624,1,b. Escalate to the Supervisor,1
9013,Elearning-0000-289,PATIENT SAFETY AND CHAIN OF COMMAND-RADIOLOGY,n8412,39878,5,Patient arrives at the center with no order and we do not have it on file in any of our systems. The patient is very angry because they may not be seen. The situation occurs in the evening and the referring office is closed.,127625,2,c. Perform the exam without an order,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39913,0,Severe maternal morbidity during the postpartum period has started to decrease over the last decade due to advancement in medicine.,127725,0,TRUE,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39913,0,Severe maternal morbidity during the postpartum period has started to decrease over the last decade due to advancement in medicine.,127726,1,FALSE,1
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39914,1,Which of the following is a common preventable nursing error that results in maternal death?,127727,0,Failure to adequately control blood pressure in hypertensive women,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39914,1,Which of the following is a common preventable nursing error that results in maternal death?,127728,1,Failure to pay attention to vital signs after a cesarean delivery,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39914,1,Which of the following is a common preventable nursing error that results in maternal death?,127729,2,Poor communication among the clinical care team,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39914,1,Which of the following is a common preventable nursing error that results in maternal death?,127730,3,Both A and B,1
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39915,2,Your patient has a positive NEWT-OB trigger for a HR of 122. The provider has been notified and does not feel this is due to sepsis so they will come to the bedside. How should you monitor this patient's vital signs?,127731,0,Continue to monitor CS every 30 minutes until the parameter is no longer considered a positive trigger,1
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39915,2,Your patient has a positive NEWT-OB trigger for a HR of 122. The provider has been notified and does not feel this is due to sepsis so they will come to the bedside. How should you monitor this patient's vital signs?,127732,1,Monitor VS every 4 hours,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39915,2,Your patient has a positive NEWT-OB trigger for a HR of 122. The provider has been notified and does not feel this is due to sepsis so they will come to the bedside. How should you monitor this patient's vital signs?,127733,2,Monitor VS every hour,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39915,2,Your patient has a positive NEWT-OB trigger for a HR of 122. The provider has been notified and does not feel this is due to sepsis so they will come to the bedside. How should you monitor this patient's vital signs?,127734,3,I do not increase VS frequency because the provider is coming to the bedside,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39916,3,"Your patient has a positive NEWT-OB trigger for a HR of 122. The provider has been notified and does not feel this is due to sepsis so they will come to the bedside. After the patient has stabilized and the parameter is no longer considered positive, how should you monitor her vital signs?",127735,0,Monitor VS every 4 hours,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39916,3,"Your patient has a positive NEWT-OB trigger for a HR of 122. The provider has been notified and does not feel this is due to sepsis so they will come to the bedside. After the patient has stabilized and the parameter is no longer considered positive, how should you monitor her vital signs?",127736,1,Monitor VS every shift,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39916,3,"Your patient has a positive NEWT-OB trigger for a HR of 122. The provider has been notified and does not feel this is due to sepsis so they will come to the bedside. After the patient has stabilized and the parameter is no longer considered positive, how should you monitor her vital signs?",127737,2,Monitor VS every hour for the remainder of the shift,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39916,3,"Your patient has a positive NEWT-OB trigger for a HR of 122. The provider has been notified and does not feel this is due to sepsis so they will come to the bedside. After the patient has stabilized and the parameter is no longer considered positive, how should you monitor her vital signs?",127738,3,Monitor VS every 30 minutes for 2 hours,1
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39917,4,"A G4L3 was induced and had a NSVD of a 9lb 2oz baby girl. Here delivery was rapid and uncomplicated. Upon transfer to FCC she has a large gush of bleeding. The blood soaks her peripad, mesh panties, and her chux pad. Her QBL at delivery was 225 mL. Do you restart QBL at this time?",127739,0,Yes,1
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39917,4,"A G4L3 was induced and had a NSVD of a 9lb 2oz baby girl. Here delivery was rapid and uncomplicated. Upon transfer to FCC she has a large gush of bleeding. The blood soaks her peripad, mesh panties, and her chux pad. Her QBL at delivery was 225 mL. Do you restart QBL at this time?",127740,1,No,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39918,5,Her QBL from the current blood soaked items is 310 mL. Is she experiencing a PPH now? DO you need to increase VS monitoring?,127741,0,No; Continue routine monitoring,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39918,5,Her QBL from the current blood soaked items is 310 mL. Is she experiencing a PPH now? DO you need to increase VS monitoring?,127742,1,No; Check VS in 30 minutes just to be precautious,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39918,5,Her QBL from the current blood soaked items is 310 mL. Is she experiencing a PPH now? DO you need to increase VS monitoring?,127743,2,Yes; Monitor VS every 30 minutes during PPH,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39918,5,Her QBL from the current blood soaked items is 310 mL. Is she experiencing a PPH now? DO you need to increase VS monitoring?,127744,3,Yes; Monitor VS every 5 minutes during the PPH,1
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39919,6,Risk factors for sepsis in the post-partum population include which of the following:,127745,0,Diabetes,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39919,6,Risk factors for sepsis in the post-partum population include which of the following:,127746,1,Hypertension,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39919,6,Risk factors for sepsis in the post-partum population include which of the following:,127747,2,Obesity,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39919,6,Risk factors for sepsis in the post-partum population include which of the following:,127748,3,Use of anitbiotics within 2 weeks prior to delivery,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39919,6,Risk factors for sepsis in the post-partum population include which of the following:,127749,4,All of the above,1
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39920,7,A serum lactate was drawn on your patient for suspected sepsis and it is 3. What is the appropriate nursing action?,127750,0,Notify MD and the clinical supervisor,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39920,7,A serum lactate was drawn on your patient for suspected sepsis and it is 3. What is the appropriate nursing action?,127751,1,"Nothing, a serum lactate of 3 is normal",0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39920,7,A serum lactate was drawn on your patient for suspected sepsis and it is 3. What is the appropriate nursing action?,127752,2,"Notify MD, get orders for blood cultures, broad spectrum antibiotics, and a repeat lactate in 2 hours",1
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39920,7,A serum lactate was drawn on your patient for suspected sepsis and it is 3. What is the appropriate nursing action?,127753,3,Notify rapid response,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39921,8,What does HELLP stand for?,127754,0,"Hemolysis, Elevated Liver Enzymes, Low Platelets",1
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39921,8,What does HELLP stand for?,127755,1,"Hemoglobin, Eosinophils, Lung Sounds, Liver Enzymes, Proteinuria",0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39921,8,What does HELLP stand for?,127756,2,"Hematocrit, Elevated BP, Low Liver Enzymes, Platelets",0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39921,8,What does HELLP stand for?,127757,3,"Headache, Elevated BP, Liver Enzymes, Low Platelets",0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39922,9,How is Acute Hypertensive Emergency defined?,127758,0,BP greater than or equal to 185/110,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39922,9,How is Acute Hypertensive Emergency defined?,127759,1,Systolic BP greater than or equal to 140 or Diastolic BP greater than or equal to 90,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39922,9,How is Acute Hypertensive Emergency defined?,127760,2,Systolic BP greater than or equal to 160 or Diastolic BP greater than or equal to 110,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39922,9,How is Acute Hypertensive Emergency defined?,127761,3,"Systolic BP greater than or equal to 160 or Diastolic BP greater than or equal to 110, sustained for 15 minutes",1
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39923,10,Your patient is experiencing signs of hypoglycemia. You decide to check her blood glucose and it is 55. Identify your next action:,127762,0,Provide the patient with orange juice and crackers and check back later to see if she is feeling better,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39923,10,Your patient is experiencing signs of hypoglycemia. You decide to check her blood glucose and it is 55. Identify your next action:,127763,1,Immediately recheck the BG and if it is still below 60 then you need to treat the patient for hypoglycemia per the hypoglycemia treatment order,1
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39923,10,Your patient is experiencing signs of hypoglycemia. You decide to check her blood glucose and it is 55. Identify your next action:,127764,2,The patient states she feels fine so you don't worry about it right now,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39923,10,Your patient is experiencing signs of hypoglycemia. You decide to check her blood glucose and it is 55. Identify your next action:,127765,3,Place the baby skin to skin with mom to increase her blood sugar,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39924,11,A patient with gestational diabetes is at an increased risk for developing type II diabetes. The nurse should screen her on admission for the pneumococcal vaccine and offer the patient the vaccine if she has not already received it in her adult life.,127766,0,TRUE,1
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39924,11,A patient with gestational diabetes is at an increased risk for developing type II diabetes. The nurse should screen her on admission for the pneumococcal vaccine and offer the patient the vaccine if she has not already received it in her adult life.,127767,1,FALSE,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39925,12,How frequently must vital signs be assessed after administering a PCA clinician bolus?,127768,0,Q 2 hours X 4,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39925,12,How frequently must vital signs be assessed after administering a PCA clinician bolus?,127769,1,Q 5 minutes X 5,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39925,12,How frequently must vital signs be assessed after administering a PCA clinician bolus?,127770,2,Q 15 minutes X 2,1
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39925,12,How frequently must vital signs be assessed after administering a PCA clinician bolus?,127771,3,Q 1 hour X 2,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39926,13,What 2 criteria must a patient meet prior to weaning from an epidural or PCA?,127772,0,Greater than 24 hours post-delivery with no reports of numbness,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39926,13,What 2 criteria must a patient meet prior to weaning from an epidural or PCA?,127773,1,Able to tolerate solid food and pain should be under control per patient pain goal,1
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39926,13,What 2 criteria must a patient meet prior to weaning from an epidural or PCA?,127774,2,Normal EKG and pain under control per patient goal,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39926,13,What 2 criteria must a patient meet prior to weaning from an epidural or PCA?,127775,3,Vital signs stable and patient able to tolerate solid food,0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39927,14,"What physical signs and symptoms might a PPH patient exhibit that would make you suspicious of internal blood loss, even if there is no obvious external bleeding?",127776,0,"Low BP, high MAP, fatigue, low H&H",0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39927,14,"What physical signs and symptoms might a PPH patient exhibit that would make you suspicious of internal blood loss, even if there is no obvious external bleeding?",127777,1,"Low BP, high HR, low MAP, Pain",1
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39927,14,"What physical signs and symptoms might a PPH patient exhibit that would make you suspicious of internal blood loss, even if there is no obvious external bleeding?",127778,2,"Low BP, high HR, high MAP, pain",0
9396,Elearning-0000-637,FCC EXPERIENCED NURSE MATERNAL CBL,n8425,39927,14,"What physical signs and symptoms might a PPH patient exhibit that would make you suspicious of internal blood loss, even if there is no obvious external bleeding?",127779,3,"Low BP, low HR, low MAP, decreased output",0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39929,0,Claims requiring additional intervention by AUDIT or Coding are placed on hold in SSI.,127782,0,TRUE,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39929,0,Claims requiring additional intervention by AUDIT or Coding are placed on hold in SSI.,127783,1,FALSE,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39930,1,AUDIT issues are handled via the Coding Work list.,127784,0,TRUE,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39930,1,AUDIT issues are handled via the Coding Work list.,127785,1,FALSE,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39931,2,What is the Source of Payer code specific to Medicare and Medicare HMO?,127786,0,D,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39931,2,What is the Source of Payer code specific to Medicare and Medicare HMO?,127787,1,C,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39931,2,What is the Source of Payer code specific to Medicare and Medicare HMO?,127788,2,None of the above,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39932,3,The Medicare HMO INPATIENT claims:,127789,0,Have Room and Board Charges and their Type of Bill are 11X,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39932,3,The Medicare HMO INPATIENT claims:,127790,1,Should not have any dates in any charge line,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39932,3,The Medicare HMO INPATIENT claims:,127791,2,All of the above,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39933,4,All Edits errors must be worked before working  the Audit Report and Late Charges accounts.,127792,0,TRUE,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39933,4,All Edits errors must be worked before working  the Audit Report and Late Charges accounts.,127793,1,FALSE,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39934,5,"In SSI, a green smiley face represents:",127794,0,Error claim,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39934,5,"In SSI, a green smiley face represents:",127795,1,Hold claim,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39934,5,"In SSI, a green smiley face represents:",140280,2,Validated claim,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39935,6,"When placing claims on hold in SSI, the biller MUST add a reason why on Custom Field 1.",127797,0,TRUE,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39935,6,"When placing claims on hold in SSI, the biller MUST add a reason why on Custom Field 1.",127798,1,FALSE,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39936,7,"In SSI, a red sad face represents:",127799,0,The claim is on HOLD in SSI,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39936,7,"In SSI, a red sad face represents:",127800,1,The claim in in ERROR status and needs to be worked,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39936,7,"In SSI, a red sad face represents:",127801,2,The claim is validated,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39937,8,"In SSI, claim destination X demonstrates:",127802,0,A paper claim,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39937,8,"In SSI, claim destination X demonstrates:",127803,1,An Electronic claim,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39937,8,"In SSI, claim destination X demonstrates:",127804,2,A and B,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39938,9,"In SSI, what tab allows the biller to place the claim on hold?",127805,0,Green checkmark,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39938,9,"In SSI, what tab allows the biller to place the claim on hold?",127806,1,Claim,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39938,9,"In SSI, what tab allows the biller to place the claim on hold?",127807,2,Charges,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39939,10,"In line 40 of the UB-04, what does Value Code 80 represent?",127808,0,The coinsurance amount,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39939,10,"In line 40 of the UB-04, what does Value Code 80 represent?",127809,1,The number of times the patient has visited the hospital,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39939,10,"In line 40 of the UB-04, what does Value Code 80 represent?",127810,2,The number of days the patient stays in the hospital,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39940,11,Coding Issues are entered via STAR.,127811,0,TRUE,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39940,11,Coding Issues are entered via STAR.,127812,1,FALSE,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39941,12,Referrals made to CCI includes issues such as:,127813,0,Issues where charges fail medical necessity,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39941,12,Referrals made to CCI includes issues such as:,127814,1,Conflict among two HCPCS Codes performed the same day,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39941,12,Referrals made to CCI includes issues such as:,127815,2,Missing Diagnosis Code (s),0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39941,12,Referrals made to CCI includes issues such as:,127816,3,POA Indicator,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39942,13,"If line item 76 Attending NPI number is missing, what should the biller do?",127817,0,Go to STAR; retrieve the Doctor's name and use the NPI registry to get the respective NPI number.,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39942,13,"If line item 76 Attending NPI number is missing, what should the biller do?",127818,1,Bypass the edit as the physician name and NPI is not important,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39942,13,"If line item 76 Attending NPI number is missing, what should the biller do?",127819,2,Ask the Supervisor for the Doctor's name and NPI,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39943,14,"When billing Secondary claims, the PR adjustment code stands for:",127820,0,The payment,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39943,14,"When billing Secondary claims, the PR adjustment code stands for:",127821,1,The Date of the Remit,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39943,14,"When billing Secondary claims, the PR adjustment code stands for:",127822,2,Any coinsurance or deductibles,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39944,15,The purpose of the Coding Work list is to:,127823,0,View all codes on all accounts,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39944,15,The purpose of the Coding Work list is to:,127824,1,Retrieve coding issues in order to code the accounts in STAR accordingly,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39944,15,The purpose of the Coding Work list is to:,127825,2,Request coding review on certain issues to assure correct billing,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39945,16,"In order to access the Coding Worklist, the biller must select the following tab:",140281,0,M,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39945,16,"In order to access the Coding Worklist, the biller must select the following tab:",140282,1,ATB,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39945,16,"In order to access the Coding Worklist, the biller must select the following tab:",140283,2,AIA,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39945,16,"In order to access the Coding Worklist, the biller must select the following tab:",140284,3,CW,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39946,17,Medicare Billers are responsible to work RADCERT accounts in the Coding Work List.,127830,0,TRUE,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39946,17,Medicare Billers are responsible to work RADCERT accounts in the Coding Work List.,127831,1,FALSE,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39947,18,Audit referrals are managed via:,127832,0,SSI,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39947,18,Audit referrals are managed via:,127833,1,STAR,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39947,18,Audit referrals are managed via:,127834,2,Coding Work List,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39948,19,What is the Standard Note Code used to send accounts to AUDIT?,127835,0,Standard Note Code 25,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39948,19,What is the Standard Note Code used to send accounts to AUDIT?,127836,1,Standard Note Code 221,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39948,19,What is the Standard Note Code used to send accounts to AUDIT?,127837,2,Standard Note Code 1724,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39949,20,Accounts that carry a RED Font on the AUDIT report:,127838,0,Represent a new account,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39949,20,Accounts that carry a RED Font on the AUDIT report:,127839,1,There are no RED accounts in the AUDIT report,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39949,20,Accounts that carry a RED Font on the AUDIT report:,127840,2,Represents an unworked account from the previous day,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39950,21,What is the importance of adding a Free Note form in STAR when sending accounts to AUDIT?,127841,0,It tells the coders to review our account,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39950,21,What is the importance of adding a Free Note form in STAR when sending accounts to AUDIT?,127842,1,It tells the AUDIT department why we need them to review the claim,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39950,21,What is the importance of adding a Free Note form in STAR when sending accounts to AUDIT?,127843,2,A and B,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39951,22,Standard Note Code 1724 will create the following note in STAR:,127844,0,REF TO AUDIT FROM BILLING,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39951,22,Standard Note Code 1724 will create the following note in STAR:,127845,1,AUDIT COMPLTD BILLING REFERAL,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39951,22,Standard Note Code 1724 will create the following note in STAR:,127846,2,Valid Claim Billed,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39952,23,What Standard Note Code is used to close the AUDIT referral after taken the necessary action?,127847,0,Standard Note Code 1724,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39952,23,What Standard Note Code is used to close the AUDIT referral after taken the necessary action?,127848,1,Standard Note Code 25,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39952,23,What Standard Note Code is used to close the AUDIT referral after taken the necessary action?,127849,2,Standard Note Code 2452,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39952,23,What Standard Note Code is used to close the AUDIT referral after taken the necessary action?,127850,3,None of the above,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39953,24,Late Charges always drop under the Patient.,127851,0,TRUE,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39953,24,Late Charges always drop under the Patient.,127852,1,FALSE,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39954,25,"Late Charges for Inpatient Claims, the billing threshold to adjust a claim depending on the charges is:",127853,0,Less than $200,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39954,25,"Late Charges for Inpatient Claims, the billing threshold to adjust a claim depending on the charges is:",127854,1,Less than $2000,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39954,25,"Late Charges for Inpatient Claims, the billing threshold to adjust a claim depending on the charges is:",127855,2,Less than $1000,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39955,26,What is the correct Standard Note Code used while working the late charge report?,127856,0,Standard Note Code 25,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39955,26,What is the correct Standard Note Code used while working the late charge report?,127857,1,Standard Note Code 200,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39955,26,What is the correct Standard Note Code used while working the late charge report?,127858,2,Standard Note Code 82,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39956,27,How often the biller does Editor Clean up?,127859,0,Once a month,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39956,27,How often the biller does Editor Clean up?,127860,1,At least once a week,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39956,27,How often the biller does Editor Clean up?,127861,2,This duty is performed by the respective Team Lead.,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39957,28,What is the correct definition of LMRP?,127862,0,No definition,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39957,28,What is the correct definition of LMRP?,127863,1,Local Modern Room Process,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39957,28,What is the correct definition of LMRP?,127864,2,Local Medical Review Policy,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39958,29,What is the definition of CCI?,127865,0,Cope Cake Industry,0
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39958,29,What is the definition of CCI?,127866,1,Corrective Coding Initiative,1
9833,Questions-0000-126,RCT: MEDICARE HMO BILLING UNIVERSITY TEST (CURRENT),n8427,39958,29,What is the definition of CCI?,127867,2,None of the above,0
130,SCORM-0000-21,CREDENTIALING PROCESS - NATIONAL PATIENT SAFETY GOALS,n8484,40409,0,I have read and understood the content within the Credentialing Process - National Patient Safety Goals CBL.,129498,0,TRUE,1
130,SCORM-0000-21,CREDENTIALING PROCESS - NATIONAL PATIENT SAFETY GOALS,n8484,40409,0,I have read and understood the content within the Credentialing Process - National Patient Safety Goals CBL.,129499,1,FALSE,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40630,0,"In STAR, what is the MENU on which changes can be made such as adding Insurance, Resequence Financial Class, Balance Transfer, etc?",130284,0,Account Inquiry,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40630,0,"In STAR, what is the MENU on which changes can be made such as adding Insurance, Resequence Financial Class, Balance Transfer, etc?",130285,1,Demand Bill,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40630,0,"In STAR, what is the MENU on which changes can be made such as adding Insurance, Resequence Financial Class, Balance Transfer, etc?",130286,2,Account Revision,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40630,0,"In STAR, what is the MENU on which changes can be made such as adding Insurance, Resequence Financial Class, Balance Transfer, etc?",130287,3,Clinicals,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40631,1,On which operating system the collector can verify the active HIC number?,130288,0,STAR,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40631,1,On which operating system the collector can verify the active HIC number?,130289,1,SSI,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40631,1,On which operating system the collector can verify the active HIC number?,130290,2,FSSO,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40631,1,On which operating system the collector can verify the active HIC number?,130291,3,ATB,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40632,2,"In Account Revision, after opening the account and pressing ENTER what option will be used to change the Financial Class?",130292,0,Admission Information,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40632,2,"In Account Revision, after opening the account and pressing ENTER what option will be used to change the Financial Class?",130293,1,Financial Information,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40633,3,What is the Plan Code for Medicare Part A and B?,130294,0,556300,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40633,3,What is the Plan Code for Medicare Part A and B?,130295,1,557700,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40633,3,What is the Plan Code for Medicare Part A and B?,130296,2,556200,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40633,3,What is the Plan Code for Medicare Part A and B?,130297,3,305020,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40634,4,What is the complete definition of CCSM?,130298,0,Correct Coding System Manual,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40634,4,What is the complete definition of CCSM?,130299,1,Click On Claim Status Module,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40634,4,What is the complete definition of CCSM?,130300,2,Correct Claim Status Module,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40634,4,What is the complete definition of CCSM?,130301,3,Click On Coding System Manual,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40635,5,What information is used to calculate the Collector's productivity?,130302,0,"Medicare Billing, Pending and CCI",0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40635,5,What information is used to calculate the Collector's productivity?,130303,1,"LMRP, Audit, Late Charge",0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40635,5,What information is used to calculate the Collector's productivity?,130304,2,ATB and HPF,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40635,5,What information is used to calculate the Collector's productivity?,130305,3,All of the above,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40636,6,"In the Tool, under ""My Goal"" - Do you know when the Cash Goals are established to each Collector?",130306,0,At the Beginning of the Month,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40636,6,"In the Tool, under ""My Goal"" - Do you know when the Cash Goals are established to each Collector?",130307,1,Every other Month,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40636,6,"In the Tool, under ""My Goal"" - Do you know when the Cash Goals are established to each Collector?",130308,2,Every 15th of the Month,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40636,6,"In the Tool, under ""My Goal"" - Do you know when the Cash Goals are established to each Collector?",130309,3,At the End of the Month,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40637,7,What is the purpose of the ATB report?,130310,0,"The collector is able to review the total number of accounts a total dollar amount within the assigned section. The ATB is worked as follows: Greater than 30 days, working the Z's, High Dollar Accounts, and Warnings.",0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40637,7,What is the purpose of the ATB report?,130311,1,To increase the opportunities of bringing Revenue.,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40637,7,What is the purpose of the ATB report?,130312,2,To maintain my claims up to date in terms of follow ups.,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40637,7,What is the purpose of the ATB report?,130313,3,All of the Above,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40638,8,"The ""Not Found"" or ""N"" Status are those claims that were billed to Medicare with the incorrect Medicare Number.",130314,0,TRUE,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40638,8,"The ""Not Found"" or ""N"" Status are those claims that were billed to Medicare with the incorrect Medicare Number.",130315,1,FALSE,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40642,9,How often does a Collector have to report the Daily Productivity Volume Calculator Report?,130408,0,Once a week,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40642,9,How often does a Collector have to report the Daily Productivity Volume Calculator Report?,130409,1,Everyday,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40642,9,How often does a Collector have to report the Daily Productivity Volume Calculator Report?,130410,2,Once a month,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40642,9,How often does a Collector have to report the Daily Productivity Volume Calculator Report?,130411,3,Never,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40643,10,"Status ""Z"" accounts in the ATB are:",130330,0,New accounts,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40643,10,"Status ""Z"" accounts in the ATB are:",130331,1,Take backs,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40643,10,"Status ""Z"" accounts in the ATB are:",130332,2,MSP claims that need to be billed,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40643,10,"Status ""Z"" accounts in the ATB are:",130333,3,All of the above,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40644,11,High dollar accounts should be worked last when working the ATB.,130334,0,TRUE,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40644,11,High dollar accounts should be worked last when working the ATB.,130335,1,FALSE,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40645,12,Rejections are claims billed to Medicare but Medicare rejected them due to billed incorrectly.,130336,0,TRUE,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40645,12,Rejections are claims billed to Medicare but Medicare rejected them due to billed incorrectly.,130337,1,FALSE,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40646,13,What is the appropriate CODE used by Collectors to document Medicare accounts in the ATB?,130338,0,1724,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40646,13,What is the appropriate CODE used by Collectors to document Medicare accounts in the ATB?,130339,1,9021,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40646,13,What is the appropriate CODE used by Collectors to document Medicare accounts in the ATB?,130340,2,1512,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40647,14,"What happens after the Collector selects ""Update Follow up""?",130341,0,The account will purge.,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40647,14,"What happens after the Collector selects ""Update Follow up""?",130342,1,The account follow up date will be updated to today's date.,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40647,14,"What happens after the Collector selects ""Update Follow up""?",130343,2,Neither A or B,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40648,15,How do you access CCSM?,130344,0,ATB,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40648,15,How do you access CCSM?,130345,1,STAR,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40648,15,How do you access CCSM?,130346,2,SSI,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40648,15,How do you access CCSM?,130347,3,One Content,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40649,16,"While working the ATB, what is STATUS ""Billed w/in 15 days""?",130348,0,Accounts that have been processed.,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40649,16,"While working the ATB, what is STATUS ""Billed w/in 15 days""?",130349,1,Billed w/in 15 days are accounts recently billed,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40649,16,"While working the ATB, what is STATUS ""Billed w/in 15 days""?",130350,2,Accounts that will reject shortly.,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40649,16,"While working the ATB, what is STATUS ""Billed w/in 15 days""?",130351,3,Accounts needing immediate attention.,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40650,17,"When documenting any account in the ATB, the Collector MUST add a note by pressing ""add note"".",130352,0,TRUE,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40650,17,"When documenting any account in the ATB, the Collector MUST add a note by pressing ""add note"".",130353,1,FALSE,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40651,18,What is RTP's or Return to Provider?,130354,0,"""T"" claims that were billed to Medicare but instead of rejecting or denying the claim, Medicare allows to correct the claims and send them back for processing.",0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40651,18,What is RTP's or Return to Provider?,130355,1,Can be corrected via the CCSM system.,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40651,18,What is RTP's or Return to Provider?,130356,2,There might be some situation where the claim cannot be corrected due to COB issues where the incorrect insurance was added and the charges will need to be suppressed.,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40651,18,What is RTP's or Return to Provider?,130357,3,All of the above.,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40652,19,Not Found claims are claims that were billed with the incorrect Medicare number.,130358,0,TRUE,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40652,19,Not Found claims are claims that were billed with the incorrect Medicare number.,130359,1,FALSE,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40653,20,How do you remove a Not found from CCSM?,130360,0,Not founds cannot be removed,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40653,20,How do you remove a Not found from CCSM?,130361,1,Right Click on the account and select Remove,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40653,20,How do you remove a Not found from CCSM?,130362,2,Right Click on the account and select Re status,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40654,21,"What kind of information does the column ""Error Code"" represent?",130363,0,The Medicare Number.,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40654,21,"What kind of information does the column ""Error Code"" represent?",130364,1,The Status of the Claim.,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40654,21,"What kind of information does the column ""Error Code"" represent?",130365,2,"An assigned code containing a brief explanation as why the claim rejected, RTP's or Denied.",1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40654,21,"What kind of information does the column ""Error Code"" represent?",130366,3,The EFT Check number.,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40655,22,"What does ""ATB"" stands for?",130367,0,Account Trial Balance,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40655,22,"What does ""ATB"" stands for?",130368,1,Account Transaction Balance,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40655,22,"What does ""ATB"" stands for?",130369,2,Account Test Balance,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40655,22,"What does ""ATB"" stands for?",130370,3,Account Trial Bill,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40656,23,Denied claims cannot be corrected. Denied claims will need to be removed from CCSM by pressing right click on the account and selecting the option to Remove.,130371,0,TRUE,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40656,23,Denied claims cannot be corrected. Denied claims will need to be removed from CCSM by pressing right click on the account and selecting the option to Remove.,130372,1,FALSE,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40657,24,Can claims under location T B9900 as indicated below be corrected in CCSM?,130373,0,Only claims with B9997 location can be corrected.,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40657,24,Can claims under location T B9900 as indicated below be corrected in CCSM?,130374,1,B9900 is a location that can be corrected through CCSM.,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40657,24,Can claims under location T B9900 as indicated below be corrected in CCSM?,130375,2,It depends of the total charges.,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40657,24,Can claims under location T B9900 as indicated below be corrected in CCSM?,130376,3,Both B9997 and B9900 can be corrected.,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40658,25,"Based on the screen listed below, when is the Medicare Effective Date for this Patient?",130377,0,Patient does not have Medicare,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40658,25,"Based on the screen listed below, when is the Medicare Effective Date for this Patient?",130378,1,10/1/2001,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40658,25,"Based on the screen listed below, when is the Medicare Effective Date for this Patient?",130379,2,1/1/2017,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40658,25,"Based on the screen listed below, when is the Medicare Effective Date for this Patient?",130380,3,10/10/2001,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40659,26,What Operating Systems do you need to work as a collector?,130381,0,"STAR, and the Tool",0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40659,26,What Operating Systems do you need to work as a collector?,130382,1,SSI and FSS0,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40659,26,What Operating Systems do you need to work as a collector?,130383,2,One Content and STAR,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40659,26,What Operating Systems do you need to work as a collector?,130384,3,"STAR, The Tool, One Content, SSI and Excel Daily Productivity Volume Report",1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40661,27,"Based on the below screenshot, how many FULL Inpatient days does this Patient have?",130389,0,30 Full days,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40661,27,"Based on the below screenshot, how many FULL Inpatient days does this Patient have?",130390,1,80 Full days,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40661,27,"Based on the below screenshot, how many FULL Inpatient days does this Patient have?",130391,2,57 Full Hospital Days,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40661,27,"Based on the below screenshot, how many FULL Inpatient days does this Patient have?",130392,3,20 Full Days,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40662,29,Once the Full Days and Co-Insurance Days are used:,130393,0,The Patient has exhausted all the Inpatient Benefits.,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40662,29,Once the Full Days and Co-Insurance Days are used:,130394,1,The Patient cannot be an Inpatient anywhere.,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40662,29,Once the Full Days and Co-Insurance Days are used:,130395,2,The Patient will decide if the LTR days can be used.,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40662,29,Once the Full Days and Co-Insurance Days are used:,130396,3,The Patient will go to an SNF.,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40663,28,How many LTR days are assigned to Patients in Life Time?,130397,0,30,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40663,28,How many LTR days are assigned to Patients in Life Time?,130398,1,50,0
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40663,28,How many LTR days are assigned to Patients in Life Time?,130399,2,60,1
9836,Questions-0000-129,RCT: MEDICARE TRADITIONAL COLLECTIONS UNIVERITY TEST (CURRENT),n8532,40663,28,How many LTR days are assigned to Patients in Life Time?,130400,3,90,0
8212,Elearning-0000-1100,POC INR - CHEROKEE,n8579,40882,0,"I acknowledge that I have read and understand the ""POC INR - Cherokee"" CBL in its entirety.",131081,0,TRUE,1
8212,Elearning-0000-1100,POC INR - CHEROKEE,n8579,40882,0,"I acknowledge that I have read and understand the ""POC INR - Cherokee"" CBL in its entirety.",131082,1,FALSE,0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40883,0,"The Mission Statement for the Blood and Marrow Transplant Program at Northside Hospital is: <br> <I>The Blood and Marrow Transplant Program at Northside Hospital is committed to excellence and strives to be the premier transplant program in Georgia and the Southeast, providing outstanding state-of-the-art care for patients undergoing hematopoietic and immune effector cellular therapies</I>",131083,0,TRUE,1
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40883,0,"The Mission Statement for the Blood and Marrow Transplant Program at Northside Hospital is: <br> <I>The Blood and Marrow Transplant Program at Northside Hospital is committed to excellence and strives to be the premier transplant program in Georgia and the Southeast, providing outstanding state-of-the-art care for patients undergoing hematopoietic and immune effector cellular therapies</I>",131084,1,FALSE,0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40884,1,The National Accreditations & Recognitions include:,131085,0,"a.	FACT",0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40884,1,The National Accreditations & Recognitions include:,131086,1,"b.	NMDP",0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40884,1,The National Accreditations & Recognitions include:,131087,2,"c.	AABB",0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40884,1,The National Accreditations & Recognitions include:,131088,3,"d.	FDA",0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40884,1,The National Accreditations & Recognitions include:,131089,4,"e.	CLIA",0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40884,1,The National Accreditations & Recognitions include:,131090,5,"f.	JCAHO",0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40884,1,The National Accreditations & Recognitions include:,131091,6,"g.	NCI NCORP",0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40884,1,The National Accreditations & Recognitions include:,131092,7,"g.	NCI NCORP",0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40884,1,The National Accreditations & Recognitions include:,131093,8,"h.	All of the above",1
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40885,2,Donor  Evaluation Testing includes:,131094,0,"a.	Health and Physical",0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40885,2,Donor  Evaluation Testing includes:,131095,1,"b.	Health History Quetionnaire per FDA guidelines",0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40885,2,Donor  Evaluation Testing includes:,131096,2,"c.	Labs",0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40885,2,Donor  Evaluation Testing includes:,131097,3,"d.	Infectious Disease Markers",0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40885,2,Donor  Evaluation Testing includes:,131098,4,"e.	EKG",0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40885,2,Donor  Evaluation Testing includes:,131099,5,"f.	Chest x-ray",0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40885,2,Donor  Evaluation Testing includes:,131100,6,"g.	Further testing or clearances based on results as applicable",0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40885,2,Donor  Evaluation Testing includes:,131101,7,"h.	All of the above",1
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40886,3,"Key Point to remember for Pre-Op is:<br> Ensure CBC w/diff is drawn the day of the harvest both prior to and after the harvest, This is a requirement for all bone marrow donors. We are required to draw a pre and post collection CBC",131102,0,TRUE,1
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40886,3,"Key Point to remember for Pre-Op is:<br> Ensure CBC w/diff is drawn the day of the harvest both prior to and after the harvest, This is a requirement for all bone marrow donors. We are required to draw a pre and post collection CBC",131103,1,FALSE,0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40887,4,Key Point to remember for OR is :<br> Ensure appropriate kits are available. List of items available on MD preference cards.,131104,0,TRUE,1
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40887,4,Key Point to remember for OR is :<br> Ensure appropriate kits are available. List of items available on MD preference cards.,131105,1,FALSE,0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40888,5,Key Point to remember for PACU:<br> a. Donor may receive autologous units. BMT MD is usually the one to discharge donor home.<br> b. Donor will return to the BMT outpatient clinic the next day for labs and assessment<br> c. Most donors have minimal recovery time and side effects<br>,131106,0,"1)  a,b",0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40888,5,Key Point to remember for PACU:<br> a. Donor may receive autologous units. BMT MD is usually the one to discharge donor home.<br> b. Donor will return to the BMT outpatient clinic the next day for labs and assessment<br> c. Most donors have minimal recovery time and side effects<br>,131107,1,"2)  b,c",0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40888,5,Key Point to remember for PACU:<br> a. Donor may receive autologous units. BMT MD is usually the one to discharge donor home.<br> b. Donor will return to the BMT outpatient clinic the next day for labs and assessment<br> c. Most donors have minimal recovery time and side effects<br>,131108,2,"3)  a,b,c",1
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40888,5,Key Point to remember for PACU:<br> a. Donor may receive autologous units. BMT MD is usually the one to discharge donor home.<br> b. Donor will return to the BMT outpatient clinic the next day for labs and assessment<br> c. Most donors have minimal recovery time and side effects<br>,131109,3,4)  b only,0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40889,6,The BMT Program at Northside has exceeded survival predictions for allogeneic transplant for the past 9 reporting cycles,131110,0,TRUE,1
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40889,6,The BMT Program at Northside has exceeded survival predictions for allogeneic transplant for the past 9 reporting cycles,131111,1,FALSE,0
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40890,7,The collaborative effort between NSH Cancer Institute and The Blood and Marrow Transplant Group of Georgia (BMTGA) was established in 1997,131112,0,TRUE,1
8228,Elearning-0000-1115,THE BLOOD & MARROW TRANSPLANT AND IMMUNE EFFECTOR CELLULAR THERAPY PROGRAM AT NORTHSIDE HOSPITAL,n8580,40890,7,The collaborative effort between NSH Cancer Institute and The Blood and Marrow Transplant Group of Georgia (BMTGA) was established in 1997,131113,1,FALSE,0
8208,Elearning-0000-1098,PRE VERIFICATION IN PRE OP,n8625,41322,0,I have read and understand the content contained in this CBL and in the Procedural Counts policy.,132835,0,TRUE,1
8208,Elearning-0000-1098,PRE VERIFICATION IN PRE OP,n8625,41322,0,I have read and understand the content contained in this CBL and in the Procedural Counts policy.,132836,1,FALSE,0
8207,Elearning-0000-1097,PRE VERIFICATION IN OR EVOR UNIVERSAL PROTOCOL,n8626,41323,0,I have read and understand the content contained in this CBL and in the Procedural Counts policy.,132837,0,TRUE,1
8207,Elearning-0000-1097,PRE VERIFICATION IN OR EVOR UNIVERSAL PROTOCOL,n8626,41323,0,I have read and understand the content contained in this CBL and in the Procedural Counts policy.,132838,1,FALSE,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41381,0,Within what timeframe should all patients be assessed?,133051,0,By 9:00,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41381,0,Within what timeframe should all patients be assessed?,133052,1,By 8:00,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41381,0,Within what timeframe should all patients be assessed?,133053,2,Within 2 hours after first contact with the patient,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41381,0,Within what timeframe should all patients be assessed?,133054,3,By 10:00,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41382,1,Documentation for any assessment/intervention/procedure should be completed within how many hours after the actual action?,133055,0,Within 2 hours,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41382,1,Documentation for any assessment/intervention/procedure should be completed within how many hours after the actual action?,133056,1,Within 1 hour,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41382,1,Documentation for any assessment/intervention/procedure should be completed within how many hours after the actual action?,133057,2,Always immediately,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41382,1,Documentation for any assessment/intervention/procedure should be completed within how many hours after the actual action?,133058,3,Within 4 hours,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41383,2,It is ok to leave the pain goal blank in your documentation if the patient's pain score is below their pain goal.,133059,0,TRUE,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41383,2,It is ok to leave the pain goal blank in your documentation if the patient's pain score is below their pain goal.,133060,1,FALSE,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41384,3,"If a patient reports a pain score > 0, pain character and location must be included in your documentation.",133061,0,TRUE,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41384,3,"If a patient reports a pain score > 0, pain character and location must be included in your documentation.",133062,1,FALSE,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41385,4,"Within what timeframe should the NSH OB Screening: Vaccinations, Consults Referrals be completed in the EMR for all admissions?",133063,0,By the end of your shift,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41385,4,"Within what timeframe should the NSH OB Screening: Vaccinations, Consults Referrals be completed in the EMR for all admissions?",133064,1,By discharge,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41385,4,"Within what timeframe should the NSH OB Screening: Vaccinations, Consults Referrals be completed in the EMR for all admissions?",133065,2,Within 30 minutes of arrival to the unit,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41385,4,"Within what timeframe should the NSH OB Screening: Vaccinations, Consults Referrals be completed in the EMR for all admissions?",133066,3,Within 2 hours of arrival to the unit,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41386,5,Who is responsible for reviewing and reconciling the Medication Reconciliation after transfer from L&D or HRP?,133067,0,The secretary,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41386,5,Who is responsible for reviewing and reconciling the Medication Reconciliation after transfer from L&D or HRP?,133068,1,The admission nurse,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41386,5,Who is responsible for reviewing and reconciling the Medication Reconciliation after transfer from L&D or HRP?,133069,2,All nurses,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41386,5,Who is responsible for reviewing and reconciling the Medication Reconciliation after transfer from L&D or HRP?,133070,3,The discharging nurse,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41387,6,What information must be included when documenting a critical lab value in the medical record?,133071,0,The critical lab result,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41387,6,What information must be included when documenting a critical lab value in the medical record?,133072,1,The date and time the provider is notified,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41387,6,What information must be included when documenting a critical lab value in the medical record?,133073,2,All orders received,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41387,6,What information must be included when documenting a critical lab value in the medical record?,133074,3,All of the above,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41388,7,Within what time frame should all PRN pain interventions be re-assessed?,133075,0,Within 3 hours,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41388,7,Within what time frame should all PRN pain interventions be re-assessed?,133076,1,Within 2 hours,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41388,7,Within what time frame should all PRN pain interventions be re-assessed?,133077,2,Within 1 hour,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41388,7,Within what time frame should all PRN pain interventions be re-assessed?,133078,3,Within 30 min,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41389,8,A new resident asks you what FCC's stance is on sucrose use with our newborns.  Where will you obtain this information?,133079,0,Google,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41389,8,A new resident asks you what FCC's stance is on sucrose use with our newborns.  Where will you obtain this information?,133080,1,Your experience,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41389,8,A new resident asks you what FCC's stance is on sucrose use with our newborns.  Where will you obtain this information?,133081,2,Lucidoc,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41389,8,A new resident asks you what FCC's stance is on sucrose use with our newborns.  Where will you obtain this information?,133082,3,By asking other coworkers,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41390,9,What is the User Name and Password for Forms on Demand?,133083,0,nsaforms/northside,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41390,9,What is the User Name and Password for Forms on Demand?,133084,1,northside/welcome,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41390,9,What is the User Name and Password for Forms on Demand?,133085,2,FCC forms/welcome,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41390,9,What is the User Name and Password for Forms on Demand?,133086,3,Northsideforms/northside,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41391,10,A patient is taking a medication you are unfamiliar with.  Where can you locate information regarding side effects and indications for this medication?,133087,0,Google,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41391,10,A patient is taking a medication you are unfamiliar with.  Where can you locate information regarding side effects and indications for this medication?,133088,1,Micromedex,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41391,10,A patient is taking a medication you are unfamiliar with.  Where can you locate information regarding side effects and indications for this medication?,133089,2,Ask your supervisor,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41391,10,A patient is taking a medication you are unfamiliar with.  Where can you locate information regarding side effects and indications for this medication?,133090,3,Call the provider,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41392,11,A mother is taking a medication and you are unsure of its breastfeeding compatibility.  Where will you locate this information?,133091,0,Place Lactation referral,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41392,11,A mother is taking a medication and you are unsure of its breastfeeding compatibility.  Where will you locate this information?,133092,1,Call/Ask a lactation nurse,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41392,11,A mother is taking a medication and you are unsure of its breastfeeding compatibility.  Where will you locate this information?,133093,2,Call Pharmacy,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41392,11,A mother is taking a medication and you are unsure of its breastfeeding compatibility.  Where will you locate this information?,133094,3,Medications and Mother's Milk on the Intranet,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41393,12,Within what time frame should a Plan of Care be initiated after being admitted to FCC?,133095,0,Within 12 hours of admission to FCC,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41393,12,Within what time frame should a Plan of Care be initiated after being admitted to FCC?,133096,1,Within 2 hours of admission to FCC,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41393,12,Within what time frame should a Plan of Care be initiated after being admitted to FCC?,133097,2,By the end of the next shift,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41393,12,Within what time frame should a Plan of Care be initiated after being admitted to FCC?,133098,3,Within 24 hours of admission to FCC,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41394,13,How often should the plan of care be evaluated?,133099,0,At least once before discharge,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41394,13,How often should the plan of care be evaluated?,133100,1,Only if there are updates needed,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41394,13,How often should the plan of care be evaluated?,133101,2,"At least once a shift, but preferably more",1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41394,13,How often should the plan of care be evaluated?,133102,3,Every 8 hours,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41395,14,Which of the following statements is true of the Northside Pain Scale?,133103,0,1-4 = Mild Pain,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41395,14,Which of the following statements is true of the Northside Pain Scale?,133104,1,5-7 = Moderate Pain,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41395,14,Which of the following statements is true of the Northside Pain Scale?,133105,2,7-10 = Severe Pain,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41395,14,Which of the following statements is true of the Northside Pain Scale?,133106,3,6-10 = Severe Pain,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41396,15,You are the RN providing for coverage for an LPN. Which of the following require your oversight?,133107,0,Plan of Care,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41396,15,You are the RN providing for coverage for an LPN. Which of the following require your oversight?,133108,1,Discharge Education,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41396,15,You are the RN providing for coverage for an LPN. Which of the following require your oversight?,133109,2,Changing the rate of an epidural,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41396,15,You are the RN providing for coverage for an LPN. Which of the following require your oversight?,133110,3,Both A and C,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41396,15,You are the RN providing for coverage for an LPN. Which of the following require your oversight?,133111,4,All of the above,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41397,16,Your patient went down for a CT scan of the abdomen. Where would you read the finalized report for this?,133112,0,Under the Task List,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41397,16,Your patient went down for a CT scan of the abdomen. Where would you read the finalized report for this?,133113,1,Under the Postpartum Iview Band,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41397,16,Your patient went down for a CT scan of the abdomen. Where would you read the finalized report for this?,133114,2,Document Viewing,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41397,16,Your patient went down for a CT scan of the abdomen. Where would you read the finalized report for this?,133115,3,Results Review,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41397,16,Your patient went down for a CT scan of the abdomen. Where would you read the finalized report for this?,133116,4,Form Browser,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41397,16,Your patient went down for a CT scan of the abdomen. Where would you read the finalized report for this?,133117,5,C&D,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41398,17,A provider places a communication order stating to start moderate phototherapy if the serum bilirubin is = 12. The serum bilirubin came back 12.6. What are your next actions?,133118,0,Place order set for phototherapy,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41398,17,A provider places a communication order stating to start moderate phototherapy if the serum bilirubin is = 12. The serum bilirubin came back 12.6. What are your next actions?,133119,1,Place IPOC for phototherapy,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41398,17,A provider places a communication order stating to start moderate phototherapy if the serum bilirubin is = 12. The serum bilirubin came back 12.6. What are your next actions?,133120,2,Radiometer equipment,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41398,17,A provider places a communication order stating to start moderate phototherapy if the serum bilirubin is = 12. The serum bilirubin came back 12.6. What are your next actions?,133121,3,Both B&C,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41398,17,A provider places a communication order stating to start moderate phototherapy if the serum bilirubin is = 12. The serum bilirubin came back 12.6. What are your next actions?,133122,4,All the above,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41399,18,"When initiating day of discharge order, what commonly prevents staff members from getting the green check mark?",133123,0,Specific order stating discharge patient is missing,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41399,18,"When initiating day of discharge order, what commonly prevents staff members from getting the green check mark?",133124,1,Discharge Med reconciliation not completed,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41399,18,"When initiating day of discharge order, what commonly prevents staff members from getting the green check mark?",133125,2,No PSO order,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41399,18,"When initiating day of discharge order, what commonly prevents staff members from getting the green check mark?",133126,3,None of the above,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41399,18,"When initiating day of discharge order, what commonly prevents staff members from getting the green check mark?",133127,4,All of the above,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41400,19,A staff member comes up to you and states that only diaper count is populating on the newborn I&O band. How do you fix this for them?,133128,0,Tell them to call the help desk,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41400,19,A staff member comes up to you and states that only diaper count is populating on the newborn I&O band. How do you fix this for them?,133129,1,Tell them they do not have access to that screen,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41400,19,A staff member comes up to you and states that only diaper count is populating on the newborn I&O band. How do you fix this for them?,133130,2,Pull band down from customized view,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41400,19,A staff member comes up to you and states that only diaper count is populating on the newborn I&O band. How do you fix this for them?,133131,3,Instruct them to document in this field only,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41401,20,"During a Go Live of additional changes in the OneChart system, you are pulled out of staffing. What would your scheduled day look like?",133132,0,Sit in the break room until a staff member asks for assistance,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41401,20,"During a Go Live of additional changes in the OneChart system, you are pulled out of staffing. What would your scheduled day look like?",133133,1,Assist in patient care for the floor staff,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41401,20,"During a Go Live of additional changes in the OneChart system, you are pulled out of staffing. What would your scheduled day look like?",133134,2,"Round on each side of the floor assigned, asking staff if they need assistance",1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41401,20,"During a Go Live of additional changes in the OneChart system, you are pulled out of staffing. What would your scheduled day look like?",133135,3,Go to your home floor to assist the staff there rather than your assigned floor,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41402,21,You have a staff member that comes to you quite often for the same charting issues. What is the best action to assist this staff member?,133136,0,Tell them you have assisted with them in the past on this issue and they should review the information given to them previously,0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41402,21,You have a staff member that comes to you quite often for the same charting issues. What is the best action to assist this staff member?,133137,1,"Give them a quick, basic answer and move on to your patient care",0
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41402,21,You have a staff member that comes to you quite often for the same charting issues. What is the best action to assist this staff member?,133138,2,Assist them by walking them through the documentation while they document the needed                     information,1
8567,Elearning-0000-144,FCC CERNER SUPERUSER PRE-ASSESSMENT,n8634,41402,21,You have a staff member that comes to you quite often for the same charting issues. What is the best action to assist this staff member?,133139,3,Have them log in and complete the documentation for them. You will show them later,0
1125,ILT-0000-4431,CODE BLUE IN SURGICAL SERVICES,n8637,41405,0,I have read and understand the information reviewed.    If I have any questions I will contact my supervisor or Clinical Development Specialist (CDS) with any questions I may have.,133144,0,TRUE,1
8227,Elearning-0000-1114,CODE BLUE IN SURGICAL SERVICES,n8637,41405,0,I have read and understand the information reviewed.    If I have any questions I will contact my supervisor or Clinical Development Specialist (CDS) with any questions I may have.,133144,0,TRUE,1
1125,ILT-0000-4431,CODE BLUE IN SURGICAL SERVICES,n8637,41405,0,I have read and understand the information reviewed.    If I have any questions I will contact my supervisor or Clinical Development Specialist (CDS) with any questions I may have.,133145,1,FALSE,0
8227,Elearning-0000-1114,CODE BLUE IN SURGICAL SERVICES,n8637,41405,0,I have read and understand the information reviewed.    If I have any questions I will contact my supervisor or Clinical Development Specialist (CDS) with any questions I may have.,133145,1,FALSE,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41500,0,Please list the location for this activity.,133531,0,Atlanta,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41500,0,Please list the location for this activity.,133532,1,Forsyth,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41500,0,Please list the location for this activity.,133533,2,Cherokee,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41500,0,Please list the location for this activity.,133534,3,Other,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41501,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to apply at least one recommendation from the 2018 cholesterol management guideline updates to clinical practice.</ol>",133535,0,Strongly Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41501,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to apply at least one recommendation from the 2018 cholesterol management guideline updates to clinical practice.</ol>",133536,1,Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41501,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to apply at least one recommendation from the 2018 cholesterol management guideline updates to clinical practice.</ol>",133537,2,No Opinion,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41501,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to apply at least one recommendation from the 2018 cholesterol management guideline updates to clinical practice.</ol>",133538,3,Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41501,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to apply at least one recommendation from the 2018 cholesterol management guideline updates to clinical practice.</ol>",133539,4,Strongly Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41502,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe at least one difference in heart disease in women compared to men. </ol>",133540,0,Strongly Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41502,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe at least one difference in heart disease in women compared to men. </ol>",133541,1,Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41502,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe at least one difference in heart disease in women compared to men. </ol>",133542,2,No Opinion,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41502,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe at least one difference in heart disease in women compared to men. </ol>",133543,3,Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41502,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe at least one difference in heart disease in women compared to men. </ol>",133544,4,Strongly Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41503,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the current screening recommendation for asymptomatic carotid stenosis.</ol>",133545,0,Strongly Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41503,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the current screening recommendation for asymptomatic carotid stenosis.</ol>",133546,1,Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41503,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the current screening recommendation for asymptomatic carotid stenosis.</ol>",133547,2,No Opinion,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41503,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the current screening recommendation for asymptomatic carotid stenosis.</ol>",133548,3,Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41503,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the current screening recommendation for asymptomatic carotid stenosis.</ol>",133549,4,Strongly Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41504,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify one characteristic of ischemic heart disease on an EKG.</ol>",133550,0,Strongly Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41504,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify one characteristic of ischemic heart disease on an EKG.</ol>",133551,1,Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41504,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify one characteristic of ischemic heart disease on an EKG.</ol>",133552,2,No Opinion,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41504,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify one characteristic of ischemic heart disease on an EKG.</ol>",133553,3,Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41504,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify one characteristic of ischemic heart disease on an EKG.</ol>",133554,4,Strongly Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41505,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe when a patient should be referred for stress testing prior to non-cardiac surgery.</ol>",133555,0,Strongly Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41505,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe when a patient should be referred for stress testing prior to non-cardiac surgery.</ol>",133556,1,Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41505,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe when a patient should be referred for stress testing prior to non-cardiac surgery.</ol>",133557,2,No Opinion,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41505,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe when a patient should be referred for stress testing prior to non-cardiac surgery.</ol>",133558,3,Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41505,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe when a patient should be referred for stress testing prior to non-cardiac surgery.</ol>",133559,4,Strongly Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41506,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the role and indication for anticoagulation in atrial fibrillation.</ol>",133560,0,Strongly Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41506,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the role and indication for anticoagulation in atrial fibrillation.</ol>",133561,1,Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41506,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the role and indication for anticoagulation in atrial fibrillation.</ol>",133562,2,No Opinion,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41506,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the role and indication for anticoagulation in atrial fibrillation.</ol>",133563,3,Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41506,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the role and indication for anticoagulation in atrial fibrillation.</ol>",133564,4,Strongly Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41507,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define general treatment strategies for venous disease.<ol>",133565,0,Strongly Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41507,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define general treatment strategies for venous disease.<ol>",133566,1,Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41507,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define general treatment strategies for venous disease.<ol>",133567,2,No Opinion,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41507,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define general treatment strategies for venous disease.<ol>",133568,3,Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41507,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define general treatment strategies for venous disease.<ol>",133569,4,Strongly Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41508,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to name at least one benefit of meditation in the cardiovascular population. </ol>",133570,0,Strongly Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41508,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to name at least one benefit of meditation in the cardiovascular population. </ol>",133571,1,Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41508,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to name at least one benefit of meditation in the cardiovascular population. </ol>",133572,2,No Opinion,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41508,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to name at least one benefit of meditation in the cardiovascular population. </ol>",133573,3,Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41508,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to name at least one benefit of meditation in the cardiovascular population. </ol>",133574,4,Strongly Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41509,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,133575,0,Strongly Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41509,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,133576,1,Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41509,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,133577,2,No Opinion,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41509,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,133578,3,Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41509,9,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,133579,4,Strongly Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41510,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",133580,0,Strongly Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41510,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",133581,1,Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41510,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",133582,2,No Opinion,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41510,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",133583,3,Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41510,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",133584,4,Strongly Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41511,11,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the skills needed for EKG interpretation in the outpatient primary care setting.<OL>,133585,0,Strongly Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41511,11,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the skills needed for EKG interpretation in the outpatient primary care setting.<OL>,133586,1,Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41511,11,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the skills needed for EKG interpretation in the outpatient primary care setting.<OL>,133587,2,No Opinion,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41511,11,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the skills needed for EKG interpretation in the outpatient primary care setting.<OL>,133588,3,Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41511,11,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the skills needed for EKG interpretation in the outpatient primary care setting.<OL>,133589,4,Strongly Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41512,12,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to changes in lipid guidelines and indications for the newest medications.</OL>,133590,0,Strongly Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41512,12,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to changes in lipid guidelines and indications for the newest medications.</OL>,133591,1,Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41512,12,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to changes in lipid guidelines and indications for the newest medications.</OL>,133592,2,No Opinion,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41512,12,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to changes in lipid guidelines and indications for the newest medications.</OL>,133593,3,Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41512,12,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to changes in lipid guidelines and indications for the newest medications.</OL>,133594,4,Strongly Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41513,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of incorporating meditation into practice as a way to holistically treat patients.</OL>,133595,0,Strongly Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41513,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of incorporating meditation into practice as a way to holistically treat patients.</OL>,133596,1,Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41513,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of incorporating meditation into practice as a way to holistically treat patients.</OL>,133597,2,No Opinion,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41513,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of incorporating meditation into practice as a way to holistically treat patients.</OL>,133598,3,Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41513,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of incorporating meditation into practice as a way to holistically treat patients.</OL>,133599,4,Strongly Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41514,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge regarding management and evaluation of patients with or at risk for cardiovascular disease.</OL>,133600,0,Strongly Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41514,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge regarding management and evaluation of patients with or at risk for cardiovascular disease.</OL>,133601,1,Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41514,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge regarding management and evaluation of patients with or at risk for cardiovascular disease.</OL>,133602,2,No Opinion,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41514,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge regarding management and evaluation of patients with or at risk for cardiovascular disease.</OL>,133603,3,Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41514,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge regarding management and evaluation of patients with or at risk for cardiovascular disease.</OL>,133604,4,Strongly Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41515,15,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",133605,0,Strongly Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41515,15,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",133606,1,Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41515,15,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",133607,2,No Opinion,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41515,15,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",133608,3,Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41515,15,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",133609,4,Strongly Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41516,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</ol>,133610,0,Strongly Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41516,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</ol>,133611,1,Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41516,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</ol>,133612,2,No Opinion,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41516,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</ol>,133613,3,Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41516,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</ol>,133614,4,Strongly Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41517,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,133615,0,Strongly Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41517,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,133616,1,Agree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41517,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,133617,2,No Opinion,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41517,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,133618,3,Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41517,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,133619,4,Strongly Disagree,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41518,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Marcus Brown, MD</ol>",133620,0,Excellent,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41518,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Marcus Brown, MD</ol>",133621,1,Very Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41518,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Marcus Brown, MD</ol>",133622,2,Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41518,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Marcus Brown, MD</ol>",133623,3,Fair,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41518,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Marcus Brown, MD</ol>",133624,4,Poor,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41519,19,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Aman Kakkar, MD</ol>",133625,0,Excellent,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41519,19,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Aman Kakkar, MD</ol>",133626,1,Very Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41519,19,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Aman Kakkar, MD</ol>",133627,2,Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41519,19,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Aman Kakkar, MD</ol>",133628,3,Fair,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41519,19,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Aman Kakkar, MD</ol>",133629,4,Poor,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41520,20,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kimberly Champney, MD</ol>",133630,0,Excellent,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41520,20,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kimberly Champney, MD</ol>",133631,1,Very Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41520,20,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kimberly Champney, MD</ol>",133632,2,Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41520,20,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kimberly Champney, MD</ol>",133633,3,Fair,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41520,20,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kimberly Champney, MD</ol>",133634,4,Poor,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41521,21,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Siddarth Patel, MD</ol>",133635,0,Excellent,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41521,21,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Siddarth Patel, MD</ol>",133636,1,Very Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41521,21,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Siddarth Patel, MD</ol>",133637,2,Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41521,21,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Siddarth Patel, MD</ol>",133638,3,Fair,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41521,21,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Siddarth Patel, MD</ol>",133639,4,Poor,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41522,22,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Adam Buntaine, MD</ol>",133640,0,Excellent,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41522,22,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Adam Buntaine, MD</ol>",133641,1,Very Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41522,22,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Adam Buntaine, MD</ol>",133642,2,Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41522,22,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Adam Buntaine, MD</ol>",133643,3,Fair,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41522,22,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Adam Buntaine, MD</ol>",133644,4,Poor,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41523,23,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of John Cherian, MD</ol>",133645,0,Excellent,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41523,23,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of John Cherian, MD</ol>",133646,1,Very Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41523,23,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of John Cherian, MD</ol>",133647,2,Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41523,23,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of John Cherian, MD</ol>",133648,3,Fair,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41523,23,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of John Cherian, MD</ol>",133649,4,Poor,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41524,24,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Scott Beach, MD</ol>",133650,0,Excellent,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41524,24,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Scott Beach, MD</ol>",133651,1,Very Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41524,24,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Scott Beach, MD</ol>",133652,2,Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41524,24,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Scott Beach, MD</ol>",133653,3,Fair,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41524,24,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Scott Beach, MD</ol>",133654,4,Poor,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41525,25,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ramal Weragoda, MD</ol>",133655,0,Excellent,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41525,25,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ramal Weragoda, MD</ol>",133656,1,Very Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41525,25,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ramal Weragoda, MD</ol>",133657,2,Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41525,25,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ramal Weragoda, MD</ol>",133658,3,Fair,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41525,25,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ramal Weragoda, MD</ol>",133659,4,Poor,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41526,26,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Marc Cohen, PhD</ol>",133660,0,Excellent,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41526,26,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Marc Cohen, PhD</ol>",133661,1,Very Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41526,26,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Marc Cohen, PhD</ol>",133662,2,Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41526,26,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Marc Cohen, PhD</ol>",133663,3,Fair,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41526,26,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Marc Cohen, PhD</ol>",133664,4,Poor,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41527,27,"Overall, this activity was:",133665,0,Excellent,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41527,27,"Overall, this activity was:",133666,1,Very Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41527,27,"Overall, this activity was:",133667,2,Good,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41527,27,"Overall, this activity was:",133668,3,Fair,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41527,27,"Overall, this activity was:",133669,4,Poor,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41528,28,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",133670,0,Yes,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41528,28,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",133671,1,No,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41528,28,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",133672,2,N/A,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41531,31,How would you improve this class?,133673,0,Reduce content covered in class,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41531,31,How would you improve this class?,133674,1,Increase content covered in class,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41531,31,How would you improve this class?,133675,2,Update content covered in class,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41531,31,How would you improve this class?,133676,3,Improve the instructional methods,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41531,31,How would you improve this class?,133677,4,Make course activities more stimulating,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41531,31,How would you improve this class?,133678,5,Slow the pace of the class,0
939,ILT-0000-3399,CARDIOVASCULAR SUMMIT 2019  (EVALUATION SURVEY) 4.13.19 (ALPHARETTA),n8647,41531,31,How would you improve this class?,133679,6,"Nothing: (appropriate speakers, content, facility, etc.)",0
8951,Elearning-0000-232,RADIATION THERAPY PATIENT GUIDE: STAFF EDUCATION,n8653,41540,0,Information about Fertility Preservation can be found under the section entitled:,133700,0,"a.	Day to Day Concerns",1
8951,Elearning-0000-232,RADIATION THERAPY PATIENT GUIDE: STAFF EDUCATION,n8653,41540,0,Information about Fertility Preservation can be found under the section entitled:,133701,1,"b.	Managing Your Side Effects",0
8951,Elearning-0000-232,RADIATION THERAPY PATIENT GUIDE: STAFF EDUCATION,n8653,41540,0,Information about Fertility Preservation can be found under the section entitled:,133702,2,"c.	Starting Radiation Therapy Treatment",0
8951,Elearning-0000-232,RADIATION THERAPY PATIENT GUIDE: STAFF EDUCATION,n8653,41540,0,Information about Fertility Preservation can be found under the section entitled:,133703,3,"d.	Resources",0
8951,Elearning-0000-232,RADIATION THERAPY PATIENT GUIDE: STAFF EDUCATION,n8653,41541,1,Tobacco and Alcohol use recommendations are found in Part 4: Managing Your Side Effects.,133704,0,TRUE,0
8951,Elearning-0000-232,RADIATION THERAPY PATIENT GUIDE: STAFF EDUCATION,n8653,41541,1,Tobacco and Alcohol use recommendations are found in Part 4: Managing Your Side Effects.,133705,1,FALSE,1
8951,Elearning-0000-232,RADIATION THERAPY PATIENT GUIDE: STAFF EDUCATION,n8653,41542,2,The Radiation Therapy Patient Guide was designed to be given to:,133706,0,"a.	All patients receiving radiation therapy",0
8951,Elearning-0000-232,RADIATION THERAPY PATIENT GUIDE: STAFF EDUCATION,n8653,41542,2,The Radiation Therapy Patient Guide was designed to be given to:,133707,1,"b.	Only patients receiving Palliative radiation therapy",0
8951,Elearning-0000-232,RADIATION THERAPY PATIENT GUIDE: STAFF EDUCATION,n8653,41542,2,The Radiation Therapy Patient Guide was designed to be given to:,133708,2,"c.	Only patients receiving Curative Intent radiation therapy",1
8951,Elearning-0000-232,RADIATION THERAPY PATIENT GUIDE: STAFF EDUCATION,n8653,41543,3,The following information can be found under Part 5: Resources,133709,0,"a.	American Cancer Society",0
8951,Elearning-0000-232,RADIATION THERAPY PATIENT GUIDE: STAFF EDUCATION,n8653,41543,3,The following information can be found under Part 5: Resources,133710,1,"b.	Behavioral Health and Psych-Oncology Services",0
8951,Elearning-0000-232,RADIATION THERAPY PATIENT GUIDE: STAFF EDUCATION,n8653,41543,3,The following information can be found under Part 5: Resources,133711,2,"c.	Northside Hospital Cancer Institute Call Center",0
8951,Elearning-0000-232,RADIATION THERAPY PATIENT GUIDE: STAFF EDUCATION,n8653,41543,3,The following information can be found under Part 5: Resources,133712,3,"d.	All of the above",1
8951,Elearning-0000-232,RADIATION THERAPY PATIENT GUIDE: STAFF EDUCATION,n8653,41544,4,The Operations Coordinator for each clinic will be responsible for ordering the Radiation Therapy Patient Guides.,133713,0,TRUE,0
8951,Elearning-0000-232,RADIATION THERAPY PATIENT GUIDE: STAFF EDUCATION,n8653,41544,4,The Operations Coordinator for each clinic will be responsible for ordering the Radiation Therapy Patient Guides.,133714,1,FALSE,1
8213,Elearning-0000-1101,FY2019 PNEUMONIA DSC EDUCATION: PATIENT CARE ATLANTA AND FORSYTH,n8681,41683,0,"I acknowledge that I have read and understand the ""FY2019 Pneumonia DSC Education: Patient Care Atlanta and Forsyth"" CBL in its entirety.",134210,0,TRUE,1
8213,Elearning-0000-1101,FY2019 PNEUMONIA DSC EDUCATION: PATIENT CARE ATLANTA AND FORSYTH,n8681,41683,0,"I acknowledge that I have read and understand the ""FY2019 Pneumonia DSC Education: Patient Care Atlanta and Forsyth"" CBL in its entirety.",134211,1,FALSE,0
9089,Elearning-0000-358,NSH1226 JCAR017 CLL/SLL,n8743,42070,0,NSH1226 includes patients with _____________ .,135710,0,"a.	Relapsed/Refractory Acute Myelogenous Leukemia",0
9089,Elearning-0000-358,NSH1226 JCAR017 CLL/SLL,n8743,42070,0,NSH1226 includes patients with _____________ .,135711,1,"b.	Relapsed/Refractory Multiple Myeloma",0
9089,Elearning-0000-358,NSH1226 JCAR017 CLL/SLL,n8743,42070,0,NSH1226 includes patients with _____________ .,135712,2,"c.	Relapsed/Refractory Chronic Lymphocytic Leukemia",1
9089,Elearning-0000-358,NSH1226 JCAR017 CLL/SLL,n8743,42070,0,NSH1226 includes patients with _____________ .,135713,3,"d.	Relapsed/Refractory Non-Hodgkin's Lymphoma",0
9089,Elearning-0000-358,NSH1226 JCAR017 CLL/SLL,n8743,42071,1,A combination cohort of JCAR01 and ibrutinib will initiate at the discretion of the Sponsor.,135714,0,TRUE,1
9089,Elearning-0000-358,NSH1226 JCAR017 CLL/SLL,n8743,42071,1,A combination cohort of JCAR01 and ibrutinib will initiate at the discretion of the Sponsor.,135715,1,FALSE,0
9089,Elearning-0000-358,NSH1226 JCAR017 CLL/SLL,n8743,42072,2,Potential side effects of JCAR017 include all of the following EXCEPT:,135716,0,"a.	GVHD",0
9089,Elearning-0000-358,NSH1226 JCAR017 CLL/SLL,n8743,42072,2,Potential side effects of JCAR017 include all of the following EXCEPT:,135717,1,"b.	CRS",0
9089,Elearning-0000-358,NSH1226 JCAR017 CLL/SLL,n8743,42072,2,Potential side effects of JCAR017 include all of the following EXCEPT:,135718,2,"c.	TLS",0
9089,Elearning-0000-358,NSH1226 JCAR017 CLL/SLL,n8743,42072,2,Potential side effects of JCAR017 include all of the following EXCEPT:,135719,3,"d.	Cytopenias",0
9089,Elearning-0000-358,NSH1226 JCAR017 CLL/SLL,n8743,42072,2,Potential side effects of JCAR017 include all of the following EXCEPT:,135720,4,"e.	None of the above",1
8201,Elearning-0000-1091,SS EVOR: CAROTID ARTERY STENOSIS -ETIOLOGY-DIAGNOSIS AND TREATMENT-REVISED APRIL 2019,n8744,42073,0,There are generally 3 aortic arch types.,135721,0,TRUE,1
8201,Elearning-0000-1091,SS EVOR: CAROTID ARTERY STENOSIS -ETIOLOGY-DIAGNOSIS AND TREATMENT-REVISED APRIL 2019,n8744,42073,0,There are generally 3 aortic arch types.,135722,1,FALSE,0
8201,Elearning-0000-1091,SS EVOR: CAROTID ARTERY STENOSIS -ETIOLOGY-DIAGNOSIS AND TREATMENT-REVISED APRIL 2019,n8744,42074,1,The internal carotid artery supplies blood supply to the face and neck.,135723,0,TRUE,0
8201,Elearning-0000-1091,SS EVOR: CAROTID ARTERY STENOSIS -ETIOLOGY-DIAGNOSIS AND TREATMENT-REVISED APRIL 2019,n8744,42074,1,The internal carotid artery supplies blood supply to the face and neck.,135724,1,FALSE,1
8201,Elearning-0000-1091,SS EVOR: CAROTID ARTERY STENOSIS -ETIOLOGY-DIAGNOSIS AND TREATMENT-REVISED APRIL 2019,n8744,42075,2,Atherosclerosis looks like hard paste inside the artery.,135725,0,TRUE,1
8201,Elearning-0000-1091,SS EVOR: CAROTID ARTERY STENOSIS -ETIOLOGY-DIAGNOSIS AND TREATMENT-REVISED APRIL 2019,n8744,42075,2,Atherosclerosis looks like hard paste inside the artery.,135726,1,FALSE,0
8201,Elearning-0000-1091,SS EVOR: CAROTID ARTERY STENOSIS -ETIOLOGY-DIAGNOSIS AND TREATMENT-REVISED APRIL 2019,n8744,42076,3,Aortic arch angiography assists in determining difficulties with carotid stenting procedures.,135727,0,TRUE,1
8201,Elearning-0000-1091,SS EVOR: CAROTID ARTERY STENOSIS -ETIOLOGY-DIAGNOSIS AND TREATMENT-REVISED APRIL 2019,n8744,42076,3,Aortic arch angiography assists in determining difficulties with carotid stenting procedures.,135728,1,FALSE,0
8201,Elearning-0000-1091,SS EVOR: CAROTID ARTERY STENOSIS -ETIOLOGY-DIAGNOSIS AND TREATMENT-REVISED APRIL 2019,n8744,42077,4,The three treatment interventions for carotid stenosis include:<br><br> a. Carotid stenting<br> b. carotid endarterectomy<br> c. carotid bifurcation reduction<br> d. trans carotid artery revascularization (TCAR)<br>,135729,0,"1. a, b, and c",0
8201,Elearning-0000-1091,SS EVOR: CAROTID ARTERY STENOSIS -ETIOLOGY-DIAGNOSIS AND TREATMENT-REVISED APRIL 2019,n8744,42077,4,The three treatment interventions for carotid stenosis include:<br><br> a. Carotid stenting<br> b. carotid endarterectomy<br> c. carotid bifurcation reduction<br> d. trans carotid artery revascularization (TCAR)<br>,135730,1,"2. a, c, and d",0
8201,Elearning-0000-1091,SS EVOR: CAROTID ARTERY STENOSIS -ETIOLOGY-DIAGNOSIS AND TREATMENT-REVISED APRIL 2019,n8744,42077,4,The three treatment interventions for carotid stenosis include:<br><br> a. Carotid stenting<br> b. carotid endarterectomy<br> c. carotid bifurcation reduction<br> d. trans carotid artery revascularization (TCAR)<br>,135731,2,"3. a, b, and d",1
8201,Elearning-0000-1091,SS EVOR: CAROTID ARTERY STENOSIS -ETIOLOGY-DIAGNOSIS AND TREATMENT-REVISED APRIL 2019,n8744,42077,4,The three treatment interventions for carotid stenosis include:<br><br> a. Carotid stenting<br> b. carotid endarterectomy<br> c. carotid bifurcation reduction<br> d. trans carotid artery revascularization (TCAR)<br>,135732,3,4. All of the above,0
8201,Elearning-0000-1091,SS EVOR: CAROTID ARTERY STENOSIS -ETIOLOGY-DIAGNOSIS AND TREATMENT-REVISED APRIL 2019,n8744,42078,5,"Carotid endarterectomy remains the ""gold standard"" for non-invasive treatment of carotid stenosis.",135733,0,TRUE,0
8201,Elearning-0000-1091,SS EVOR: CAROTID ARTERY STENOSIS -ETIOLOGY-DIAGNOSIS AND TREATMENT-REVISED APRIL 2019,n8744,42078,5,"Carotid endarterectomy remains the ""gold standard"" for non-invasive treatment of carotid stenosis.",135734,1,FALSE,1
8201,Elearning-0000-1091,SS EVOR: CAROTID ARTERY STENOSIS -ETIOLOGY-DIAGNOSIS AND TREATMENT-REVISED APRIL 2019,n8744,42079,6,TCAR is a procedure that...<br><br> a. accesses the carotid artery from an incision made above the collar bone<br> b. ultimately replaces carotid stenting procedures<br> c. helps prevent emboli from reaching the brain<br> d. temporarily reverses the blood flow from the carotid artery,135735,0,"1. a, b, and c",0
8201,Elearning-0000-1091,SS EVOR: CAROTID ARTERY STENOSIS -ETIOLOGY-DIAGNOSIS AND TREATMENT-REVISED APRIL 2019,n8744,42079,6,TCAR is a procedure that...<br><br> a. accesses the carotid artery from an incision made above the collar bone<br> b. ultimately replaces carotid stenting procedures<br> c. helps prevent emboli from reaching the brain<br> d. temporarily reverses the blood flow from the carotid artery,135736,1,"2. a, c, and d",1
8201,Elearning-0000-1091,SS EVOR: CAROTID ARTERY STENOSIS -ETIOLOGY-DIAGNOSIS AND TREATMENT-REVISED APRIL 2019,n8744,42079,6,TCAR is a procedure that...<br><br> a. accesses the carotid artery from an incision made above the collar bone<br> b. ultimately replaces carotid stenting procedures<br> c. helps prevent emboli from reaching the brain<br> d. temporarily reverses the blood flow from the carotid artery,135737,2,"3. b, c, and d",0
8201,Elearning-0000-1091,SS EVOR: CAROTID ARTERY STENOSIS -ETIOLOGY-DIAGNOSIS AND TREATMENT-REVISED APRIL 2019,n8744,42079,6,TCAR is a procedure that...<br><br> a. accesses the carotid artery from an incision made above the collar bone<br> b. ultimately replaces carotid stenting procedures<br> c. helps prevent emboli from reaching the brain<br> d. temporarily reverses the blood flow from the carotid artery,135738,3,4. All of the above,0
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42080,0,Which of these are NOT appropriate uses of CO2?,135739,0,a. Cerebral vasculature,0
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42080,0,Which of these are NOT appropriate uses of CO2?,135740,1,b. Thoracic aorta,0
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42080,0,Which of these are NOT appropriate uses of CO2?,135741,2,c. Abdominal aorta in a prone patient,0
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42080,0,Which of these are NOT appropriate uses of CO2?,135742,3,d. A patient receiving nitrous oxide,0
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42080,0,Which of these are NOT appropriate uses of CO2?,135743,4,e. All of the above,1
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42081,1,"Check BP before the first injection of CO2 and every minute after for at least""",135744,0,a. 2 minutes,0
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42081,1,"Check BP before the first injection of CO2 and every minute after for at least""",135745,1,b. 3 minutes,1
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42081,1,"Check BP before the first injection of CO2 and every minute after for at least""",135746,2,c. 5 minutes,0
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42081,1,"Check BP before the first injection of CO2 and every minute after for at least""",135747,3,d. 10 minutes,0
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42082,2,A patient's systolic blood pressure drops 40 mmHg after administration of CO2.  What is the appropriate response?,135748,0,a. They probably just received a lot of sedation so it's fine,0
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42082,2,A patient's systolic blood pressure drops 40 mmHg after administration of CO2.  What is the appropriate response?,135749,1,b. Use fluoroscopy to check for persistent air bubbles,0
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42082,2,A patient's systolic blood pressure drops 40 mmHg after administration of CO2.  What is the appropriate response?,135750,2,c. Check the CO2 delivery system for leaks,0
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42082,2,A patient's systolic blood pressure drops 40 mmHg after administration of CO2.  What is the appropriate response?,135751,3,d. B and C,1
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42083,3,"To allow CO2 bubbles to dissolve, space injections by at least""",135752,0,a. 1 minute,0
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42083,3,"To allow CO2 bubbles to dissolve, space injections by at least""",135753,1,b. 2-3 minutes,1
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42083,3,"To allow CO2 bubbles to dissolve, space injections by at least""",135754,2,c. 5 minutes,0
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42083,3,"To allow CO2 bubbles to dissolve, space injections by at least""",135755,3,d. 10 minutes,0
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42084,4,"If used correctly, CO2 is a safe and effective contrast option.",135756,0,TRUE,1
8678,Elearning-0000-154,SS EVOR:  CARBON DIOXIDE (CO2) GAS AS CONTRAST AGENT-REVISED APRIL 2019,n8745,42084,4,"If used correctly, CO2 is a safe and effective contrast option.",135757,1,FALSE,0
261,SCORM-0000-71,NORTHSIDE HOSPITAL - DRESS CODE POLICY,n8764,42256,0,I have read and understood the content within the Northside Hospital Dress Code Policy CBL.,136440,0,TRUE,1
261,SCORM-0000-71,NORTHSIDE HOSPITAL - DRESS CODE POLICY,n8764,42256,0,I have read and understood the content within the Northside Hospital Dress Code Policy CBL.,136441,1,FALSE,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42271,0,Which of the following measures <b>does not</b> adhere to the fundamental principles of radiation protection?,136542,0,a. minimize exposure times.,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42271,0,Which of the following measures <b>does not</b> adhere to the fundamental principles of radiation protection?,136543,1,b. minimize distance from the x-ray source.,1
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42271,0,Which of the following measures <b>does not</b> adhere to the fundamental principles of radiation protection?,136544,2,c. maximize shielding,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42288,1,"To limit radiation dose, most fluoroscopic procedures are performed using  ____ mA and ____ kVp settings.",136545,0,a. low; high,1
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42288,1,"To limit radiation dose, most fluoroscopic procedures are performed using  ____ mA and ____ kVp settings.",136546,1,b. low; low,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42288,1,"To limit radiation dose, most fluoroscopic procedures are performed using  ____ mA and ____ kVp settings.",136547,2,c. high; low,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42289,2,The FDA limits the maximum entrance skin exposure to ____ per minute when using normal automatic exposure rate control modes.,136548,0,a. 0.1 R,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42289,2,The FDA limits the maximum entrance skin exposure to ____ per minute when using normal automatic exposure rate control modes.,136549,1,b. 1 R,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42289,2,The FDA limits the maximum entrance skin exposure to ____ per minute when using normal automatic exposure rate control modes.,136550,2,c. 10 R,1
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42290,3,Which of the following is not a technique to reduce radiation exposure during fluoroscopy procedures?,136551,0,a. Stop exposures when not viewing the monitor.,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42290,3,Which of the following is not a technique to reduce radiation exposure during fluoroscopy procedures?,136552,1,b. Use continuous fluoroscopy modes.,1
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42290,3,Which of the following is not a technique to reduce radiation exposure during fluoroscopy procedures?,136553,2,c. Minimize redundant views.,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42291,4,____ is an equipment feature that retains the last image of a fluoroscopy sequence on the monitor after the fluoroscopic pedal is released.,136554,0,a. LIH,1
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42291,4,____ is an equipment feature that retains the last image of a fluoroscopy sequence on the monitor after the fluoroscopic pedal is released.,136555,1,b. SSD,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42291,4,____ is an equipment feature that retains the last image of a fluoroscopy sequence on the monitor after the fluoroscopic pedal is released.,136556,2,c. DAP,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42292,5,"All of the following are techniques to minimize patient dose, <b><I>except</I></b> for:",136557,0,a. removing the grid during pediatric exams.,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42292,5,"All of the following are techniques to minimize patient dose, <b><I>except</I></b> for:",136558,1,b. positioning over the area of interest before depressing the fluoroscopy pedal.,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42292,5,"All of the following are techniques to minimize patient dose, <b><I>except</I></b> for:",136559,2,c. using the highest pulse rate possible.,1
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42293,6,Fluoroscopic systems are equipped with an audible signal to alert operators of the cumulative exposure time at _____ intervals.,136560,0,a. 3-minute,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42293,6,Fluoroscopic systems are equipped with an audible signal to alert operators of the cumulative exposure time at _____ intervals.,136561,1,b. 5-minute,1
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42293,6,Fluoroscopic systems are equipped with an audible signal to alert operators of the cumulative exposure time at _____ intervals.,136562,2,c. 7-minute,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42294,7,"To minimize patient dose, fluoroscopy operators should <b><I>avoid</I></b> the use of _______ when possible.",136563,0,a. collimation,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42294,7,"To minimize patient dose, fluoroscopy operators should <b><I>avoid</I></b> the use of _______ when possible.",136564,1,b. pulsed fluoroscopy modes,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42294,7,"To minimize patient dose, fluoroscopy operators should <b><I>avoid</I></b> the use of _______ when possible.",136565,2,c. magnification modes,1
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42295,8,"According to recommendations from the National Council on Radiation Protection and Measurements, the annual occupational effective dose limit for the <b><I>whole body</I></b> is:",136566,0,a. 50 mSv.,1
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42295,8,"According to recommendations from the National Council on Radiation Protection and Measurements, the annual occupational effective dose limit for the <b><I>whole body</I></b> is:",136567,1,b. 100 mSv.,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42295,8,"According to recommendations from the National Council on Radiation Protection and Measurements, the annual occupational effective dose limit for the <b><I>whole body</I></b> is:",136568,2,c. 500 mSv.,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42296,9,"According to recommendations from the National Council on Radiation Protection and Measurements, the annual occupational equivalent dose limit for the extremities is:",136569,0,a. 50 mSv.,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42296,9,"According to recommendations from the National Council on Radiation Protection and Measurements, the annual occupational equivalent dose limit for the extremities is:",136570,1,b. 100 mSv.,0
9421,Elearning-0000-66,SAFE FLUOROSCOPY PRACTICES 2019,n8767,42296,9,"According to recommendations from the National Council on Radiation Protection and Measurements, the annual occupational equivalent dose limit for the extremities is:",136571,2,c. 500 mSv.,1
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42297,0,Documentation of the tourniquet on the Intraoperative Record must include:,136572,0,"A. The unit used, person who applied the cuff and indicators used to verify sterile instrumentation",0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42297,0,Documentation of the tourniquet on the Intraoperative Record must include:,136573,1,"B. Time of inflation/deflation, cuff tubing placement and pressure",0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42297,0,Documentation of the tourniquet on the Intraoperative Record must include:,136574,2,"C. Skin integrity, cuff location, unit used, time of inflation/deflation",1
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42298,1,Choose the best statement:,136575,0,A. Multiple layers of padding under the tourniquet is necessary to protect the patient from wrinkled skin,0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42298,1,Choose the best statement:,136576,1,"B. Apply low lint, wrinkle-free, soft padding or 2 layers of stockinette using manufacturer's instructions",1
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42298,1,Choose the best statement:,136577,2,C. Additional padding is applied to allow for the least amount of moisture from the surgical field,0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42299,2,When do you inform the surgeon of the tourniquet inflation time?,136578,0,"A. 30 minutes, 60 minutes and 90 minutes",0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42299,2,When do you inform the surgeon of the tourniquet inflation time?,136579,1,"B. 60 minutes, 90 minutes",0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42299,2,When do you inform the surgeon of the tourniquet inflation time?,136580,2,"C. 60 minutes, 120 minutes",0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42299,2,When do you inform the surgeon of the tourniquet inflation time?,136581,3,"D. 60 minutes,  90 minutes, 120 minutes",1
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42300,3,"Per NSH Policy OR-25: ""Tourniquet Guidelines"", How long should a period of  reperfusion last before the tourniquet can be re-inflated?",136582,0,A. This time period will be determined by the surgeon only,0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42300,3,"Per NSH Policy OR-25: ""Tourniquet Guidelines"", How long should a period of  reperfusion last before the tourniquet can be re-inflated?",136583,1,B. 10-15 minutes or more,1
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42300,3,"Per NSH Policy OR-25: ""Tourniquet Guidelines"", How long should a period of  reperfusion last before the tourniquet can be re-inflated?",136584,2,C. At least 5 minutes,0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42301,4,Disposable Tourniquets <b>(choose the best response)</b>,136585,0,A. Shall be properly cleaned and disinfected and stored in their designated location after use F. All of the above,0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42301,4,Disposable Tourniquets <b>(choose the best response)</b>,136586,1,B. Come in multiple sizes,0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42301,4,Disposable Tourniquets <b>(choose the best response)</b>,136587,2,C. Maybe sterile or unsterile,0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42301,4,Disposable Tourniquets <b>(choose the best response)</b>,136588,3,D. Are discarded after use,0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42301,4,Disposable Tourniquets <b>(choose the best response)</b>,136589,4,"E. Answers B, C, and D",1
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42301,4,Disposable Tourniquets <b>(choose the best response)</b>,136590,5,F. All of the above,0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42302,5,After using the tourniquet,136591,0,"A. The unit and all its accessories should be cleaned and disinfected per 	manufacturer's written instructions.",0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42302,5,After using the tourniquet,136592,1,B. Hoses are wrapped for proper storage,0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42302,5,After using the tourniquet,136593,2,C. Unit is turned off,0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42302,5,After using the tourniquet,136594,3,D. Unit is plugged into a wall outlet to maintain battery charge,0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42302,5,After using the tourniquet,136595,4,"E. A,B and D",0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42302,5,After using the tourniquet,136596,5,F. All the above,1
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42303,6,What are ways to prevent patient injury in the use of a tourniquet during surgery?,136597,0,"A. Take in account the patient's age, anatomy and medical condition when selecting and placing the tourniquet cuff",0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42303,6,What are ways to prevent patient injury in the use of a tourniquet during surgery?,136598,1,B. Adjusting the tourniquet once inflated,0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42303,6,What are ways to prevent patient injury in the use of a tourniquet during surgery?,136599,2,C. Positioning the cuff so that underlying skin and tissues are protected,0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42303,6,What are ways to prevent patient injury in the use of a tourniquet during surgery?,136600,3,D. Monitoring inflation time and pressure,0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42303,6,What are ways to prevent patient injury in the use of a tourniquet during surgery?,136601,4,"E. Answers A, C, and D",1
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42303,6,What are ways to prevent patient injury in the use of a tourniquet during surgery?,136602,5,F. All the above,0
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42304,7,"After 120 min,  the surgeon and/or anesthesiologist should establish a plan for tourniquet cuff deflation and reperfusion.",136603,0,TRUE,1
8197,Elearning-0000-1088,PNUEMATIC TOURNIQUET USE IN SURGERY,n8771,42304,7,"After 120 min,  the surgeon and/or anesthesiologist should establish a plan for tourniquet cuff deflation and reperfusion.",136604,1,FALSE,0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42430,0,"1.	The initiation of resuscitation efforts are started based on the 1 minute apgar score.",137131,0,TRUE,0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42430,0,"1.	The initiation of resuscitation efforts are started based on the 1 minute apgar score.",137132,1,FALSE,1
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42431,1,"2.	If the infant has a 5 minute Apgar score of 5. Where is the appropriate action for this baby?",137133,0,"a.	The baby should be transferred to TCN for observation",1
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42431,1,"2.	If the infant has a 5 minute Apgar score of 5. Where is the appropriate action for this baby?",137134,1,"b.	The baby should admitted by the admission team as usual",0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42431,1,"2.	If the infant has a 5 minute Apgar score of 5. Where is the appropriate action for this baby?",137135,2,"c.	The baby should be transferred to the FCC nursery for observation",0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42431,1,"2.	If the infant has a 5 minute Apgar score of 5. Where is the appropriate action for this baby?",137136,3,"d.	The baby should be left with the mother in SSC to stabilize the infant",0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42432,2,"3.	What does Apgar stand for?",137137,0,"a.	It is just the name of the assessment we perform",0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42432,2,"3.	What does Apgar stand for?",137138,1,"b.	A-Appearance, P-Pulse, G-Grimace, A-Activity, R-Respiration",1
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42432,2,"3.	What does Apgar stand for?",137139,2,"c.	A-Activity, P-pink, G-grabbing reflex, A- apnea, R- return to spontaneous breathing",0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42432,2,"3.	What does Apgar stand for?",137140,3,"d.	None of the above",0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42433,3,"4.	The degree of flexion when assessing the Apgar score is based on the maturity of the infant. A preterm infant will have less flexion due to the gestational age.",137141,0,TRUE,1
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42433,3,"4.	The degree of flexion when assessing the Apgar score is based on the maturity of the infant. A preterm infant will have less flexion due to the gestational age.",137142,1,FALSE,0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42434,4,"5.	If a newborn is apneic at birth, it should be resuscitated as if it is in secondary apnea.",137143,0,TRUE,1
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42434,4,"5.	If a newborn is apneic at birth, it should be resuscitated as if it is in secondary apnea.",137144,1,FALSE,0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42435,5,"6.	What is the best way to assess the heart rate after birth?",137145,0,"a.	Palpating the umbilical cord",0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42435,5,"6.	What is the best way to assess the heart rate after birth?",137146,1,"b.	Assessing the apical pulse with a stethoscope",1
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42435,5,"6.	What is the best way to assess the heart rate after birth?",137147,2,"c.	Feeling the brachial pulse",0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42435,5,"6.	What is the best way to assess the heart rate after birth?",137148,3,"d.	Manually feeling the pulse on the chest with your hand",0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42436,6,"7.	You are attending a delivery of a 38 week old baby. Based on your assessment below, score the one minute apgar score: The baby's body is pink but the baby is showing signs of acrocyanosis Heart Rate is 110 When stimulating the baby you notice the baby has a grimacing facial expression The baby is actively moving all extremities The baby has a weak cry",137149,0,"a.	9",0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42436,6,"7.	You are attending a delivery of a 38 week old baby. Based on your assessment below, score the one minute apgar score: The baby's body is pink but the baby is showing signs of acrocyanosis Heart Rate is 110 When stimulating the baby you notice the baby has a grimacing facial expression The baby is actively moving all extremities The baby has a weak cry",137150,1,"b.	6",0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42436,6,"7.	You are attending a delivery of a 38 week old baby. Based on your assessment below, score the one minute apgar score: The baby's body is pink but the baby is showing signs of acrocyanosis Heart Rate is 110 When stimulating the baby you notice the baby has a grimacing facial expression The baby is actively moving all extremities The baby has a weak cry",137151,2,"c.	7",1
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42436,6,"7.	You are attending a delivery of a 38 week old baby. Based on your assessment below, score the one minute apgar score: The baby's body is pink but the baby is showing signs of acrocyanosis Heart Rate is 110 When stimulating the baby you notice the baby has a grimacing facial expression The baby is actively moving all extremities The baby has a weak cry",137152,3,"d.	5",0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42437,7,"8.	A baby is born, the 1 minute Apgar score was 7, the baby is now presenting with this assessment. What is the 5 minute Apgar score? The baby's body is pink but the hands and feet are blue The heart rate is 150 The baby is actively crying and moving round",137153,0,"a.	10",0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42437,7,"8.	A baby is born, the 1 minute Apgar score was 7, the baby is now presenting with this assessment. What is the 5 minute Apgar score? The baby's body is pink but the hands and feet are blue The heart rate is 150 The baby is actively crying and moving round",137154,1,"b.	8",0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42437,7,"8.	A baby is born, the 1 minute Apgar score was 7, the baby is now presenting with this assessment. What is the 5 minute Apgar score? The baby's body is pink but the hands and feet are blue The heart rate is 150 The baby is actively crying and moving round",137155,2,"c.	7",0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42437,7,"8.	A baby is born, the 1 minute Apgar score was 7, the baby is now presenting with this assessment. What is the 5 minute Apgar score? The baby's body is pink but the hands and feet are blue The heart rate is 150 The baby is actively crying and moving round",137156,3,"d.	9",1
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42438,8,"9.	A baby is born and is placed on the mothers chest, as you are drying off the baby you are looking at them and see that the infant is pale, is not crying, just staring, the heart rate is 99. What should your next action be?",137157,0,"a.	Take the baby and place on the warmer for further interventions",1
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42438,8,"9.	A baby is born and is placed on the mothers chest, as you are drying off the baby you are looking at them and see that the infant is pale, is not crying, just staring, the heart rate is 99. What should your next action be?",137158,1,"b.	Leave the baby with the mother to stabilize",0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42438,8,"9.	A baby is born and is placed on the mothers chest, as you are drying off the baby you are looking at them and see that the infant is pale, is not crying, just staring, the heart rate is 99. What should your next action be?",137159,2,"c.	Watch the baby for 5 minutes more to see what happens",0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42438,8,"9.	A baby is born and is placed on the mothers chest, as you are drying off the baby you are looking at them and see that the infant is pale, is not crying, just staring, the heart rate is 99. What should your next action be?",137160,3,"d.	Wait until the full 1 minute mark to provide any interventions",0
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42439,9,"10.	If there is a significant concern about the infant at any point in the admission process, the NET team can be contacted to intervene and assist the baby's emergent needs.",137161,0,TRUE,1
9562,Elearning-0000-788,FCC NSA ASSIGNING APGARS,n8779,42439,9,"10.	If there is a significant concern about the infant at any point in the admission process, the NET team can be contacted to intervene and assist the baby's emergent needs.",137162,1,FALSE,0
9361,Elearning-0000-605,FY2019 PNEUMONIA DSC EDUCATION: PATIENT CARE CHEROKEE,n8803,42603,0,I have read and understand the CBL FY2019 Pneumonia DSC Education: Patient Care Cherokee.,137731,0,TRUE,1
9361,Elearning-0000-605,FY2019 PNEUMONIA DSC EDUCATION: PATIENT CARE CHEROKEE,n8803,42603,0,I have read and understand the CBL FY2019 Pneumonia DSC Education: Patient Care Cherokee.,137732,1,FALSE,0
8218,Elearning-0000-1106,PHARMACY NST MALNUTRITION EDUCATION FY2019,n8804,42604,0,"JL,  76 year old female with colon cancer admitted with 3 day history of severe abdominal pain, n/v and no po intake.  Current weight is 60kg and on her previous admission 2 months ago she was 65kg.   Clinical nutrition assesses her on day one of admission and determines that she does not meet criteria for malnutrition.  Do you agree?",137733,0,"a.	Yes, based on information available this patient only presents with weight loss.",1
8218,Elearning-0000-1106,PHARMACY NST MALNUTRITION EDUCATION FY2019,n8804,42604,0,"JL,  76 year old female with colon cancer admitted with 3 day history of severe abdominal pain, n/v and no po intake.  Current weight is 60kg and on her previous admission 2 months ago she was 65kg.   Clinical nutrition assesses her on day one of admission and determines that she does not meet criteria for malnutrition.  Do you agree?",137734,1,"b.	No, any amount of weight loss represents malnutrition",0
8218,Elearning-0000-1106,PHARMACY NST MALNUTRITION EDUCATION FY2019,n8804,42605,1,"Nutrition support team members are to only assess for weight loss and po intake and should never assess for fat loss, muscle loss, grip strength and fluid accumulation.",137735,0,TRUE,0
8218,Elearning-0000-1106,PHARMACY NST MALNUTRITION EDUCATION FY2019,n8804,42605,1,"Nutrition support team members are to only assess for weight loss and po intake and should never assess for fat loss, muscle loss, grip strength and fluid accumulation.",137736,1,FALSE,1
8218,Elearning-0000-1106,PHARMACY NST MALNUTRITION EDUCATION FY2019,n8804,42606,2,JP has been on the keto diet for 4 weeks and has intentionally lost 10% of her usual body weight.  She was admitted for SBO and is expected to be NPO for less than 5 days and her surgeon would like supplemental PPN during this time period.  This is appropriate because JP meets criteria for malnutrition.,137737,0,TRUE,0
8218,Elearning-0000-1106,PHARMACY NST MALNUTRITION EDUCATION FY2019,n8804,42606,2,JP has been on the keto diet for 4 weeks and has intentionally lost 10% of her usual body weight.  She was admitted for SBO and is expected to be NPO for less than 5 days and her surgeon would like supplemental PPN during this time period.  This is appropriate because JP meets criteria for malnutrition.,137738,1,FALSE,1
8218,Elearning-0000-1106,PHARMACY NST MALNUTRITION EDUCATION FY2019,n8804,42607,3,Which of the following is not used as criteria to assess  for malnutrition,137739,0,"a.	Unintentional weight loss",0
8218,Elearning-0000-1106,PHARMACY NST MALNUTRITION EDUCATION FY2019,n8804,42607,3,Which of the following is not used as criteria to assess  for malnutrition,137740,1,"b.	Insufficient energy intake",0
8218,Elearning-0000-1106,PHARMACY NST MALNUTRITION EDUCATION FY2019,n8804,42607,3,Which of the following is not used as criteria to assess  for malnutrition,137741,2,"c.	Fat and muscle loss",0
8218,Elearning-0000-1106,PHARMACY NST MALNUTRITION EDUCATION FY2019,n8804,42607,3,Which of the following is not used as criteria to assess  for malnutrition,137742,3,"d.	Low prealbumin",1
8218,Elearning-0000-1106,PHARMACY NST MALNUTRITION EDUCATION FY2019,n8804,42608,4,"If a patient does not meet criteria for malnutrition, NST should document ""Does not meet malnutrition criteria"" in the Nutrition Support Initial Assessment Note.",137743,0,TRUE,0
8218,Elearning-0000-1106,PHARMACY NST MALNUTRITION EDUCATION FY2019,n8804,42608,4,"If a patient does not meet criteria for malnutrition, NST should document ""Does not meet malnutrition criteria"" in the Nutrition Support Initial Assessment Note.",137744,1,FALSE,1
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42670,0,What system is used during the registration process in order to establish auto draft/ auto debit payment plans?,137941,0,Wells Fargo,1
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42670,0,What system is used during the registration process in order to establish auto draft/ auto debit payment plans?,137942,1,AHIQA,0
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42670,0,What system is used during the registration process in order to establish auto draft/ auto debit payment plans?,137943,2,STAR,0
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42671,1,The payment plan has an initial deposit. Which outlet will the initial deposit be applied to?,137944,0,"A. Other, C. Other, or F.Other",0
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42671,1,The payment plan has an initial deposit. Which outlet will the initial deposit be applied to?,137945,1,Pre-Registration Outlet,0
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42671,1,The payment plan has an initial deposit. Which outlet will the initial deposit be applied to?,137964,2,POS Outlet where services will be rendered,1
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42672,2,"The second transaction (scheduled auto payments) will post to A.Other, C.Other, or F.Other.",137946,0,TRUE,1
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42672,2,"The second transaction (scheduled auto payments) will post to A.Other, C.Other, or F.Other.",137947,1,FALSE,0
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42673,3,Outstanding Balances should not be included in the payment plan for the current visit's estimated amount.,137948,0,TRUE,1
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42673,3,Outstanding Balances should not be included in the payment plan for the current visit's estimated amount.,137949,1,FALSE,0
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42674,4,SNC 2050- DEPOSIT PAID/PMT PLAN SETUP is used for patients who elect auto draft payments.,137950,0,TRUE,1
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42674,4,SNC 2050- DEPOSIT PAID/PMT PLAN SETUP is used for patients who elect auto draft payments.,137951,1,FALSE,0
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42675,5,Which standard note code should be used when a patient elects a payment plan but does not want to participate in scheduled auto draft payments?,137952,0,SNC 2050,0
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42675,5,Which standard note code should be used when a patient elects a payment plan but does not want to participate in scheduled auto draft payments?,137953,1,SNC 2055,1
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42675,5,Which standard note code should be used when a patient elects a payment plan but does not want to participate in scheduled auto draft payments?,137954,2,Both responses are correct,0
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42676,6,Self-Pay Department will take calls from patients to correct any payment plans that are higher or lower than the estimate or incorrect established payment plans.,137955,0,TRUE,1
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42676,6,Self-Pay Department will take calls from patients to correct any payment plans that are higher or lower than the estimate or incorrect established payment plans.,137956,1,FALSE,0
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42677,7,"A patient is presenting for a current visit. Their financial responsibility for the service is $400, and there is a collectable OSB in the amount of $700. The payment plan should include the OSB.",137957,0,TRUE,0
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42677,7,"A patient is presenting for a current visit. Their financial responsibility for the service is $400, and there is a collectable OSB in the amount of $700. The payment plan should include the OSB.",137958,1,FALSE,1
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42678,8,Patient must sign their initials acknowledging that the payment plan will be auto drafted from their bank account or debited from their credit card.,137959,0,TRUE,1
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42678,8,Patient must sign their initials acknowledging that the payment plan will be auto drafted from their bank account or debited from their credit card.,137960,1,FALSE,0
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42679,9,Which of the following dates are payments drafted from patient accounts?,137961,0,1st,0
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42679,9,Which of the following dates are payments drafted from patient accounts?,137962,1,15th,0
8194,Elearning-0000-1085,RCT: PATIENT PAYMENT PLAN CBL,n8825,42679,9,Which of the following dates are payments drafted from patient accounts?,137963,2,25th,1
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42718,0,Inspect light cables prior to use for fiberoptic breakage and replace as needed.,138078,0,TRUE,1
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42718,0,Inspect light cables prior to use for fiberoptic breakage and replace as needed.,138079,1,FALSE,0
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42719,1,Light source should be set to the _____________________________________.,138080,0,"a.	Middle intensity of the light source and never make adjustments.",0
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42719,1,Light source should be set to the _____________________________________.,138081,1,"b.	Lowest level of Intensity and still adequately illuminate the surgical site",1
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42719,1,Light source should be set to the _____________________________________.,138082,2,"c.	Highest setting available to ensure adequate illumination.",0
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42720,2,A verbal and visual confirmation that the light cable and scope / instrument are connected and that the tip of the scope / instrument is in a safe position on the sterile field should occur before activation of the light cable.,138083,0,TRUE,1
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42720,2,A verbal and visual confirmation that the light cable and scope / instrument are connected and that the tip of the scope / instrument is in a safe position on the sterile field should occur before activation of the light cable.,138084,1,FALSE,0
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42721,3,The circulator should announce the intensity setting of the light source _________________.,138085,0,"a.	When turning on the unit",1
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42721,3,The circulator should announce the intensity setting of the light source _________________.,138086,1,"b.	At the end of the procedure",0
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42721,3,The circulator should announce the intensity setting of the light source _________________.,138087,2,"c.	When the surgeon request the information",0
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42722,4,Do not place light source on standby or shut-off when not in use because it may cause an increase in the procedure time.,138088,0,TRUE,0
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42722,4,Do not place light source on standby or shut-off when not in use because it may cause an increase in the procedure time.,138089,1,FALSE,1
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42723,5,To ensure fiberoptic cables are appropriately sized or compatible for the instrument and light source.,138090,0,"a.	Staff should refer to IFU or contact light source and light cable manufacturers for compatibility information.",0
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42723,5,To ensure fiberoptic cables are appropriately sized or compatible for the instrument and light source.,138091,1,"b.	Visually compare instrument and light cable bundles (e.g., endoscope, lighted retractor). If the cable bundle is noticeably larger in diameter than the instrument bundle, replace it with a light cable that matches the instrument's bundle size.",0
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42723,5,To ensure fiberoptic cables are appropriately sized or compatible for the instrument and light source.,138092,2,"c.	Depend on Sterile Processing Department to include the correct size light cord in the tray.",0
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42723,5,To ensure fiberoptic cables are appropriately sized or compatible for the instrument and light source.,138093,3,"d.	A and B only",1
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42723,5,To ensure fiberoptic cables are appropriately sized or compatible for the instrument and light source.,138094,4,"e.	B and C only",0
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42723,5,To ensure fiberoptic cables are appropriately sized or compatible for the instrument and light source.,138095,5,"f.	All of the Above",0
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42724,6,There is no increased risk of excessive heat that could cause burns or fire when light cables and scopes are placed directly on the patient or sterile drapes.,138096,0,TRUE,0
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42724,6,There is no increased risk of excessive heat that could cause burns or fire when light cables and scopes are placed directly on the patient or sterile drapes.,138097,1,FALSE,1
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42725,7,"When multiple light cords are used, the light cord should be added to the surgical field ________________.",138098,0,"a.	at the beginning of the procedure.",0
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42725,7,"When multiple light cords are used, the light cord should be added to the surgical field ________________.",138099,1,"b.	immediately prior to use.",1
9213,Elearning-0000-470,FY2019 - SURGICAL LIGHT SOURCE SAFETY GUIDELINES,n8836,42725,7,"When multiple light cords are used, the light cord should be added to the surgical field ________________.",138100,2,"c.	at the end of the procedure.",0
8967,Elearning-0000-247,PRETERM LABOR: CARE COORDINATION DEPARTMENT EDUCATION FY19,n8843,42756,0,I have read and understand CBL PRETERM LABOR: CARE COORDINATION DEPARTMENT EDUCATION .,138205,0,TRUE,1
8967,Elearning-0000-247,PRETERM LABOR: CARE COORDINATION DEPARTMENT EDUCATION FY19,n8843,42756,0,I have read and understand CBL PRETERM LABOR: CARE COORDINATION DEPARTMENT EDUCATION .,138206,1,FALSE,0
8897,Elearning-0000-183,SERVICE ANIMALS,n8849,42852,0,I have read and understand CBL Service Animals.,138595,0,TRUE,1
8897,Elearning-0000-183,SERVICE ANIMALS,n8849,42852,0,I have read and understand CBL Service Animals.,138596,1,FALSE,0
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42898,0,"As part of the HAP/VAP guidelines, oral care should be performed every 3-4 hours and should be documented in McKesson under the ventilator tab.",138727,0,TRUE,1
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42898,0,"As part of the HAP/VAP guidelines, oral care should be performed every 3-4 hours and should be documented in McKesson under the ventilator tab.",138728,1,FALSE,0
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42899,1,"Regarding oral/nasal/ETT suctioning, it is a given that this includes oral care and that there is not a need to document oral care separately in the patient's record.",138729,0,TRUE,0
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42899,1,"Regarding oral/nasal/ETT suctioning, it is a given that this includes oral care and that there is not a need to document oral care separately in the patient's record.",138730,1,FALSE,1
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42900,2,"At a minimum, gloves should be put on after performing hand hygiene, when performing respiratory care or handling respiratory circuits.",138731,0,TRUE,1
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42900,2,"At a minimum, gloves should be put on after performing hand hygiene, when performing respiratory care or handling respiratory circuits.",138732,1,FALSE,0
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42901,3,It is acceptable to disconnect the respiratory in-line suction tubing or respiratory tubing to reposition an infant to prevent accidental extubations.,138733,0,TRUE,0
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42901,3,It is acceptable to disconnect the respiratory in-line suction tubing or respiratory tubing to reposition an infant to prevent accidental extubations.,138734,1,FALSE,1
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42902,4,Elevating the head of the baby's bed ensures that the head of the baby is also elevated.,138735,0,TRUE,0
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42902,4,Elevating the head of the baby's bed ensures that the head of the baby is also elevated.,138736,1,FALSE,1
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42903,5,"Oral care can be done with sterile normal saline, sterile water, or colostrum",138737,0,TRUE,1
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42903,5,"Oral care can be done with sterile normal saline, sterile water, or colostrum",138738,1,FALSE,0
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42904,6,2-Person repositioning is mandatory when changing the head and trunk position of an intubated infant.,138739,0,TRUE,1
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42904,6,2-Person repositioning is mandatory when changing the head and trunk position of an intubated infant.,138740,1,FALSE,0
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42905,7,"Oral suctioning should always be performed before suctioning the ETT, but oral care and nasal suctioning should be performed after ETT suctioning.",138741,0,TRUE,1
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42905,7,"Oral suctioning should always be performed before suctioning the ETT, but oral care and nasal suctioning should be performed after ETT suctioning.",138742,1,FALSE,0
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42906,8,"Saline can wash bacteria from the ETT into the airway, therefore it is preferred  that saline not be instilled into the ETT when suctioning.",138743,0,TRUE,1
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42906,8,"Saline can wash bacteria from the ETT into the airway, therefore it is preferred  that saline not be instilled into the ETT when suctioning.",138744,1,FALSE,0
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42907,9,Oral care and respiratory suctioning are done prior to repositioning an infant on respiratory support devices.,138745,0,TRUE,1
8203,Elearning-0000-1093,2019 HAP/VAP CBL RESPIRATORY,n8861,42907,9,Oral care and respiratory suctioning are done prior to repositioning an infant on respiratory support devices.,138746,1,FALSE,0
8223,Elearning-0000-1110,FY2019 ICU TELEMETRY AND ST ALARMS,n8907,43123,0,"I acknowledge that I have read and understand the ""FY2019 ICU Telemetry and ST Alarms"" CBL in its entirety.",139482,0,TRUE,1
8223,Elearning-0000-1110,FY2019 ICU TELEMETRY AND ST ALARMS,n8907,43123,0,"I acknowledge that I have read and understand the ""FY2019 ICU Telemetry and ST Alarms"" CBL in its entirety.",139483,1,FALSE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43182,0,What Operating Systems do you need to work Medicaid CMO Collection Accounts?,139639,0,"SSI, STAR, Tool, and One Content",1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43182,0,What Operating Systems do you need to work Medicaid CMO Collection Accounts?,139640,1,SSI and STAR,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43182,0,What Operating Systems do you need to work Medicaid CMO Collection Accounts?,139641,2,"SSI, Tool, and One Content",0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43182,0,What Operating Systems do you need to work Medicaid CMO Collection Accounts?,139642,3,SSI and One Content,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43183,1,"When working the Account Trial Balance ""ATB"" what Collection Environment should you choose?",139643,0,Commercial,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43183,1,"When working the Account Trial Balance ""ATB"" what Collection Environment should you choose?",139644,1,Medicaid,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43183,1,"When working the Account Trial Balance ""ATB"" what Collection Environment should you choose?",139645,2,Medicare,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43183,1,"When working the Account Trial Balance ""ATB"" what Collection Environment should you choose?",139646,3,Denial Management,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43184,2,In the ATB the collector is able to review the total number of accounts and dollar amount within the assigned Alpha Split.,139647,0,TRUE,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43184,2,In the ATB the collector is able to review the total number of accounts and dollar amount within the assigned Alpha Split.,139648,1,FALSE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43185,3,What type of accounts does the Collector work in the ATB?,139649,0,Low Dollar Accounts and Bad Debt Accounts,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43185,3,What type of accounts does the Collector work in the ATB?,139650,1,Greater than 30 days and High Dollar Accounts,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43185,3,What type of accounts does the Collector work in the ATB?,139651,2,Final Bill Accounts,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43185,3,What type of accounts does the Collector work in the ATB?,139652,3,Audit Accounts,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43186,4,What is the purpose of working the ATB Daily?,139653,0,Assign a new follow up date upon reviewing the each account.,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43186,4,What is the purpose of working the ATB Daily?,139654,1,Have better control of the High Dollar Account Inventory.,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43186,4,What is the purpose of working the ATB Daily?,139655,2,Maintain Inventory as High Dollar Accounts Hold Revenue.,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43186,4,What is the purpose of working the ATB Daily?,139656,3,All of the above,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43187,5,"When requesting Medical Records, what status should be displayed in the ATB?",139657,0,Pending Payer EOB.,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43187,5,"When requesting Medical Records, what status should be displayed in the ATB?",139658,1,Pending Patient Info.,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43187,5,"When requesting Medical Records, what status should be displayed in the ATB?",139659,2,Pending Medical Records.,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43187,5,"When requesting Medical Records, what status should be displayed in the ATB?",139660,3,Pending Final Bill.,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43188,6,To Work the DRG Conversion the collector will:,139661,0,Print a copy of the letter.,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43188,6,To Work the DRG Conversion the collector will:,139662,1,Scan the Letter to yourself.,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43188,6,To Work the DRG Conversion the collector will:,139663,2,E-mail HIS Coding.,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43188,6,To Work the DRG Conversion the collector will:,139664,3,All of the Above.,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43189,7,The CMO Outlier Process for PeachState and Amerigroup is submitted via:,139665,0,Fax.,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43189,7,The CMO Outlier Process for PeachState and Amerigroup is submitted via:,139666,1,E-mail.,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43189,7,The CMO Outlier Process for PeachState and Amerigroup is submitted via:,139667,2,Certified Mail.,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43189,7,The CMO Outlier Process for PeachState and Amerigroup is submitted via:,139668,3,UPS.,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43190,8,The CMO Outlier Process for Wellcare is sent via FEDEX.,139669,0,TRUE,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43190,8,The CMO Outlier Process for Wellcare is sent via FEDEX.,139670,1,FALSE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43191,9,What is the process to work CareSource 30 Days for Reconsideration no Exceptions?,139671,0,Submit an E-mail to the Provider.,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43191,9,What is the process to work CareSource 30 Days for Reconsideration no Exceptions?,139672,1,"Check GAMMIS and CareSource Portal. If eligible on CareSource, but not GAMMIS, update information on CareSource Portal.",1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43191,9,What is the process to work CareSource 30 Days for Reconsideration no Exceptions?,139673,2,"Nothing, it will work itself out.",0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43192,10,Which are the Workqueues accessed by the CMO Collectors?,139674,0,PFS: BILL CMO CORR REFERRAL QUEUE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43192,10,Which are the Workqueues accessed by the CMO Collectors?,139675,1,PFS: BILL CMO REFERRAL QUEUE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43192,10,Which are the Workqueues accessed by the CMO Collectors?,139676,2,PFS: BILL BILLING LEAD QUEUE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43192,10,Which are the Workqueues accessed by the CMO Collectors?,139677,3,PFS: BILL MCAID LEAD QUEUE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43192,10,Which are the Workqueues accessed by the CMO Collectors?,139678,4,A & B,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43193,11,When Re-Assigning accounts in One Content the Collector should:,139679,0,Create and Assignment.,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43193,11,When Re-Assigning accounts in One Content the Collector should:,139680,1,Go to the Patient Tab.,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43193,11,When Re-Assigning accounts in One Content the Collector should:,139681,2,Select the account and click Process.,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43193,11,When Re-Assigning accounts in One Content the Collector should:,139682,3,"Go to the Task List, double-click to open the account and click REASSIGN.",1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43194,12,What is the purpose of the Account Research Request Form?,139683,0,Research Missing Payment,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43194,12,What is the purpose of the Account Research Request Form?,139684,1,Offset Remits,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43194,12,What is the purpose of the Account Research Request Form?,139685,2,Transfer Bucket Balance,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43194,12,What is the purpose of the Account Research Request Form?,139686,3,All of the Above,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43195,13,"With the Outpatient CMO Observation Policy, During the initial Billing Collectors are to review Revenue Code 762 for Observation Hours greater than 24.",139687,0,TRUE,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43195,13,"With the Outpatient CMO Observation Policy, During the initial Billing Collectors are to review Revenue Code 762 for Observation Hours greater than 24.",139688,1,FALSE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43196,14,"If Observation Hours are greater than 24, the Collector needs to add what Standard Note Code?",139689,0,"25 ""VALID CLAIM BILLED""",0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43196,14,"If Observation Hours are greater than 24, the Collector needs to add what Standard Note Code?",139690,1,"1724 to AUDIT ""REFERRED TO AUDIT FROM BILLING""",1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43196,14,"If Observation Hours are greater than 24, the Collector needs to add what Standard Note Code?",139691,2,"2452 ""COMPLETED AUDIT""",0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43196,14,"If Observation Hours are greater than 24, the Collector needs to add what Standard Note Code?",139692,3,"2605 ""EDITOR HOLD (SSI)""",0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43197,15,To calculate the Observation Hours divide the Room and Board minutes by 60 minutes for total Observation Hours.,139693,0,TRUE,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43197,15,To calculate the Observation Hours divide the Room and Board minutes by 60 minutes for total Observation Hours.,139694,1,FALSE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43198,16,The Daily Production Volume Calculator Medicaid is completed once a week.,139695,0,TRUE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43198,16,The Daily Production Volume Calculator Medicaid is completed once a week.,139696,1,FALSE,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43199,17,The Goal per Hour column anticipates the number of accounts a collector is supposed to work.,139697,0,TRUE,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43199,17,The Goal per Hour column anticipates the number of accounts a collector is supposed to work.,139698,1,FALSE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43200,18,What does CCI stands for?,139699,0,Coding Corrective Issue,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43200,18,What does CCI stands for?,139700,1,Correct Coding Initiative,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43200,18,What does CCI stands for?,139701,2,Correct Code Issue,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43200,18,What does CCI stands for?,139702,3,None of the above,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43201,19,Local Medical review Policy is also known as LMRP.,139703,0,TRUE,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43201,19,Local Medical review Policy is also known as LMRP.,139704,1,FALSE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43202,20,The Late Charge report is supposed to be worked once a week.,139705,0,TRUE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43202,20,The Late Charge report is supposed to be worked once a week.,139706,1,FALSE,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43203,21,"To Calculate the Goal Per Hours add the number obtained from the ""Goal Hours Total"" plus the ""Total Hours Worked.",139707,0,TRUE,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43203,21,"To Calculate the Goal Per Hours add the number obtained from the ""Goal Hours Total"" plus the ""Total Hours Worked.",139708,1,FALSE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43204,22,How many hours should the Collector work daily?,139709,0,9,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43204,22,How many hours should the Collector work daily?,139710,1,7.5,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43204,22,How many hours should the Collector work daily?,139711,2,8,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43204,22,How many hours should the Collector work daily?,139712,3,7,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43205,23,To Complete the Productivity Report the Collector should print the Summary of accounts worked from the ATB at the end of each Business Day.,139713,0,TRUE,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43205,23,To Complete the Productivity Report the Collector should print the Summary of accounts worked from the ATB at the end of each Business Day.,139714,1,FALSE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43206,24,"One Content is used to create Assignment, Re-Assign Accounts, Complete Accounts and View Scanned Images.",139715,0,TRUE,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43206,24,"One Content is used to create Assignment, Re-Assign Accounts, Complete Accounts and View Scanned Images.",139716,1,FALSE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43207,25,The ATB can be accessed through STAR.,139717,0,TRUE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43207,25,The ATB can be accessed through STAR.,139718,1,FALSE,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43208,26,"In Account Revision, changes can be made to the account, but not in Account Inquiry.",139719,0,TRUE,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43208,26,"In Account Revision, changes can be made to the account, but not in Account Inquiry.",139720,1,FALSE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43209,27,The Collector is supposed to create 5 Batches in the Adjustment Processor.,139721,0,TRUE,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43209,27,The Collector is supposed to create 5 Batches in the Adjustment Processor.,139722,1,FALSE,0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43210,28,What is the Dollar Amount for the 5 Batches the Collector should create in the Adjustment Processor?,139723,0,"$0 - $499, $500 - $999, $1000 - $2999, $3000 - $4999 and > $5K",1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43210,28,What is the Dollar Amount for the 5 Batches the Collector should create in the Adjustment Processor?,139724,1,"$1- $5,999, $6K - $10K, and $11K and up",0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43210,28,What is the Dollar Amount for the 5 Batches the Collector should create in the Adjustment Processor?,139725,2,"$1 - $6,999, $7K - $10K, and $11K and up",0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43210,28,What is the Dollar Amount for the 5 Batches the Collector should create in the Adjustment Processor?,139726,3,"$1 - 10K, $11K - $15K, and $16 and up",0
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43211,29,Did you review the entire Medicaid CMO Collections Reference Guide?,139727,0,TRUE,1
9830,Questions-0000-123,RCT: MEDICAID CMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8917,43211,29,Did you review the entire Medicaid CMO Collections Reference Guide?,139728,1,FALSE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43212,0,What Operating Systems do you need to work Medicaid Traditional Collection Accounts?,139729,0,"a. SSI, STAR, Tool, and One Content",1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43212,0,What Operating Systems do you need to work Medicaid Traditional Collection Accounts?,139730,1,b. SSI and STAR,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43212,0,What Operating Systems do you need to work Medicaid Traditional Collection Accounts?,139731,2,"c. SSI, Tool, and One Content",0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43212,0,What Operating Systems do you need to work Medicaid Traditional Collection Accounts?,139732,3,"d. SSI, and One Content",0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43213,1,"When working the Account Trial Balance ""ATB"" what Collection Environment should you choose?",139733,0,a. Commercial,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43213,1,"When working the Account Trial Balance ""ATB"" what Collection Environment should you choose?",139734,1,b. Medicaid,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43213,1,"When working the Account Trial Balance ""ATB"" what Collection Environment should you choose?",139735,2,c. Medicare,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43213,1,"When working the Account Trial Balance ""ATB"" what Collection Environment should you choose?",139736,3,d. Denial Management,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43214,2,In the ATB the collector is able to review the total number of accounts and dollar amount within the assigned Alpha Split.,139737,0,TRUE,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43214,2,In the ATB the collector is able to review the total number of accounts and dollar amount within the assigned Alpha Split.,139738,1,FALSE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43215,3,What type of accounts does the Collector work in the ATB?,139739,0,a. Low Dollar Accounts and Bad Debt Accounts,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43215,3,What type of accounts does the Collector work in the ATB?,139740,1,b. Greater than 30 days and High Dollar Accounts.,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43215,3,What type of accounts does the Collector work in the ATB?,139741,2,c. Final Bill Accounts,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43215,3,What type of accounts does the Collector work in the ATB?,139742,3,d. Audit Accounts,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43216,4,What is the purpose of working the ATB Daily?,139743,0,a. Assign a new follow up date upon reviewing the each account.,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43216,4,What is the purpose of working the ATB Daily?,139744,1,b. Have better control of the High Dollar Account Inventory.,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43216,4,What is the purpose of working the ATB Daily?,139745,2,c. Maintain Inventory as High Dollar Accounts Hold Revenue.,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43216,4,What is the purpose of working the ATB Daily?,139746,3,d. All of the above,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43217,5,The CEA Issue List is also known as Change Healthcare.,139747,0,TRUE,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43217,5,The CEA Issue List is also known as Change Healthcare.,139748,1,FALSE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43218,6,To check the Status of a Pending Authorization the Collector should:,139749,0,a. Google it,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43218,6,To check the Status of a Pending Authorization the Collector should:,139750,1,b. Look in SSI,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43218,6,To check the Status of a Pending Authorization the Collector should:,139751,2,c. E-mail the Lead or Supervisor,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43218,6,To check the Status of a Pending Authorization the Collector should:,139752,3,d. GAMMIS > Prior Authorization > Search Prior Authorization,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43219,7,When the Collector identifies issues such as the Expected Reimbursement is less than the actual Balance tracking the Collector should:,139753,0,a. Notify the Lead or Supervisor,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43219,7,When the Collector identifies issues such as the Expected Reimbursement is less than the actual Balance tracking the Collector should:,139754,1,b. Fax a request to GAMMIS,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43219,7,When the Collector identifies issues such as the Expected Reimbursement is less than the actual Balance tracking the Collector should:,139755,2,c. Refer the Account to Government Reimbursement Workqueue via One Content: PFS: REIM: REF GOVT REIMB QUEUE,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43219,7,When the Collector identifies issues such as the Expected Reimbursement is less than the actual Balance tracking the Collector should:,139756,3,d. Simply wait until the account resolves itself,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43220,8,"Anytime an update and/or follow up is given to an account, the collector should update the ATB and STAR.",139757,0,TRUE,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43220,8,"Anytime an update and/or follow up is given to an account, the collector should update the ATB and STAR.",139758,1,FALSE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43221,9,"In the ATB, what is the status for CEA Issues?",139759,0,a. Pending Medical Records,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43221,9,"In the ATB, what is the status for CEA Issues?",139760,1,b. Pending CEA,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43221,9,"In the ATB, what is the status for CEA Issues?",139761,2,c. To be Paid,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43221,9,"In the ATB, what is the status for CEA Issues?",139762,3,d. Pending Lead/Supervisor,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43222,10,Identify the Work queue accessed by the Medicaid Traditional Collectors?,139763,0,a. PFS: BILL MCAID REF QUEUE,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43222,10,Identify the Work queue accessed by the Medicaid Traditional Collectors?,139764,1,b. PFS: BILL CMO REFERRAL QUEUE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43222,10,Identify the Work queue accessed by the Medicaid Traditional Collectors?,139765,2,c. PFS: BILL BILLING LEAD QUEUE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43222,10,Identify the Work queue accessed by the Medicaid Traditional Collectors?,139766,3,d. PFS: BILL MCAID LEAD QUEUE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43223,11,When Re-Assigning accounts in One Content the Collector should:,139767,0,a. Create and Assignment.,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43223,11,When Re-Assigning accounts in One Content the Collector should:,139768,1,b. Go to the Patient Tab.,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43223,11,When Re-Assigning accounts in One Content the Collector should:,139769,2,c. Select the account and click Process.,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43223,11,When Re-Assigning accounts in One Content the Collector should:,139770,3,"d. Go to the Task List, double-click to open the account and click REASSIGN.",1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43224,12,What is the purpose of the Account Research Request Form?,139771,0,a. Research Missing Payment,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43224,12,What is the purpose of the Account Research Request Form?,139772,1,b. Offset Remits,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43224,12,What is the purpose of the Account Research Request Form?,139773,2,c. Transfer Bucket Balance,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43224,12,What is the purpose of the Account Research Request Form?,139774,3,d. All of the Above,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43225,13,"With the Outpatient Medicaid Traditional Observation Policy, during the initial billing Collectors are to review Revenue Code 762 for Observation Hours greater than 24.",139775,0,TRUE,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43225,13,"With the Outpatient Medicaid Traditional Observation Policy, during the initial billing Collectors are to review Revenue Code 762 for Observation Hours greater than 24.",139776,1,FALSE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43226,14,"If Observation Hours are greater than 24, the Collector needs to add what Standard Note Code?",139777,0,"a. 25 ""VALID CLAIM BILLED""",0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43226,14,"If Observation Hours are greater than 24, the Collector needs to add what Standard Note Code?",139778,1,"b. 1724 to AUDIT ""REFERRED TO AUDIT FROM BILLING""",1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43226,14,"If Observation Hours are greater than 24, the Collector needs to add what Standard Note Code?",139779,2,"c. 2452 ""COMPLETED AUDIT""",0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43226,14,"If Observation Hours are greater than 24, the Collector needs to add what Standard Note Code?",139780,3,"d. 2605 ""EDITOR HOLD (SSI)""",0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43227,15,To calculate the Observation Hours divide the Room and Board minutes by 60 minutes for total Observation hours.,139781,0,TRUE,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43227,15,To calculate the Observation Hours divide the Room and Board minutes by 60 minutes for total Observation hours.,139782,1,FALSE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43228,16,The Daily Production Volume Calculator Medicaid is completed once a week.,139783,0,TRUE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43228,16,The Daily Production Volume Calculator Medicaid is completed once a week.,139784,1,FALSE,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43229,17,The Goal per Hour column anticipates the number of accounts a collector is supposed to work.,139785,0,TRUE,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43229,17,The Goal per Hour column anticipates the number of accounts a collector is supposed to work.,139786,1,FALSE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43230,18,What does CCI stands for?,139787,0,a. Coding Corrective Issue,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43230,18,What does CCI stands for?,139788,1,b. Correct Coding Initiative,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43230,18,What does CCI stands for?,139789,2,c. Correct Code Issue,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43230,18,What does CCI stands for?,139790,3,d. None of the above,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43231,19,Local Medical review Policy is also known as LMRP.,139791,0,TRUE,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43231,19,Local Medical review Policy is also known as LMRP.,139792,1,FALSE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43235,20,The Late Charge report is supposed to be worked once a week.,139802,0,TRUE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43235,20,The Late Charge report is supposed to be worked once a week.,139803,1,FALSE,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43236,21,"To calculate the Goal Per Hours, add the number obtained from the ""Goal Hours Total"" plus the ""Total Hours Worked"".",139804,0,TRUE,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43236,21,"To calculate the Goal Per Hours, add the number obtained from the ""Goal Hours Total"" plus the ""Total Hours Worked"".",139805,1,FALSE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43237,22,How many hours the Collector should work daily?,139806,0,9,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43237,22,How many hours the Collector should work daily?,139807,1,7.5,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43237,22,How many hours the Collector should work daily?,139808,2,8,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43237,22,How many hours the Collector should work daily?,139809,3,7,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43238,23,"To complete the Productivity Report, the Collector should print the Summary of accounts worked from the ATB at the end of each Business Day.",139810,0,TRUE,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43238,23,"To complete the Productivity Report, the Collector should print the Summary of accounts worked from the ATB at the end of each Business Day.",139811,1,FALSE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43239,24,"One Content is used to create assignments, re-Assign accounts, complete Accounts and view Scanned Images.",139812,0,TRUE,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43239,24,"One Content is used to create assignments, re-Assign accounts, complete Accounts and view Scanned Images.",139813,1,FALSE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43240,25,The ATB can be accessed through STAR.,139814,0,TRUE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43240,25,The ATB can be accessed through STAR.,139815,1,FALSE,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43241,26,"In Account Revision, changes can be made to the account, but not in Account Inquiry.",139816,0,TRUE,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43241,26,"In Account Revision, changes can be made to the account, but not in Account Inquiry.",139817,1,FALSE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43242,27,The Collector is supposed to create 5 batches in the Adjustment Processor.,139818,0,TRUE,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43242,27,The Collector is supposed to create 5 batches in the Adjustment Processor.,139819,1,FALSE,0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43243,28,What is the Dollar Amount for the 5 Batches the Collector should create in the Adjustment Processor?,139820,0,"a.$0 - $499, $500 - $999, $1000 - $2999, $3000 - $4999, and > $4999K",1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43243,28,What is the Dollar Amount for the 5 Batches the Collector should create in the Adjustment Processor?,139821,1,"b. $1- $5,999, $6K - $10K, and $11K and up",0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43243,28,What is the Dollar Amount for the 5 Batches the Collector should create in the Adjustment Processor?,139822,2,"c. $1 - $6,999, $7K - $10K, and $11K and up",0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43243,28,What is the Dollar Amount for the 5 Batches the Collector should create in the Adjustment Processor?,139823,3,"d. $1 - 10K, $11K - $15K, and $16 and up",0
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43244,29,Did you (the student) review the entire Medicaid Traditional Collections Reference Guide?,139824,0,TRUE,1
9832,Questions-0000-125,RCT: MEDICAID TRADITIONAL COLLECTIONS UNIVERSITY TEST (CURRENT),n8918,43244,29,Did you (the student) review the entire Medicaid Traditional Collections Reference Guide?,139825,1,FALSE,0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43245,0,What is the eGFR for a 43 year old African American Male with a Creatinine result of 1.2 mg/dL ?,139827,0,"a.	85",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43245,0,What is the eGFR for a 43 year old African American Male with a Creatinine result of 1.2 mg/dL ?,139828,1,"b.	80",1
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43245,0,What is the eGFR for a 43 year old African American Male with a Creatinine result of 1.2 mg/dL ?,139829,2,"c.	78",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43245,0,What is the eGFR for a 43 year old African American Male with a Creatinine result of 1.2 mg/dL ?,139830,3,"d.	83",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43246,1,What medication may cause errors in iSTAT Creatinine results?,139831,0,"a.	Hydrea",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43246,1,What medication may cause errors in iSTAT Creatinine results?,139832,1,"b.	Droxia",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43246,1,What medication may cause errors in iSTAT Creatinine results?,139833,2,"c.	Hydroxyurea",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43246,1,What medication may cause errors in iSTAT Creatinine results?,139834,3,"d.	All of the Above",1
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43247,2,What Radiology policy contains screening guidelines using eGFR?,139835,0,"a.	Administration of Gadolinium Contrast",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43247,2,What Radiology policy contains screening guidelines using eGFR?,139836,1,"b.	Iodinated IV Contrast Administration",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43247,2,What Radiology policy contains screening guidelines using eGFR?,139837,2,"c.	Administration of Iodinated Contrast and Metformin",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43247,2,What Radiology policy contains screening guidelines using eGFR?,139838,3,"d.	All of the Above",1
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43248,3,Traceable to IDMS should be checked Yes for all calculations:,139839,0,"a.	Yes",1
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43248,3,Traceable to IDMS should be checked Yes for all calculations:,139840,1,"b.	No",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43249,4,Which Equation do we use:,139841,0,"a.	CKD-EIP CREATININE (2009)",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43249,4,Which Equation do we use:,139842,1,"b.	CKD-EPI CYSTATIN C (2012)",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43249,4,Which Equation do we use:,139843,2,"c.	CKD-EPI CREATININE-CYSTATIN C (2012)",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43249,4,Which Equation do we use:,139844,3,"d.	MDRD STUDY EQUATION",1
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43250,5,What is the eGFR for a 77 year old White Female with a Creatinine result of .7 mg/dL ?,139845,0,"a.	84",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43250,5,What is the eGFR for a 77 year old White Female with a Creatinine result of .7 mg/dL ?,139846,1,"b.	81",1
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43250,5,What is the eGFR for a 77 year old White Female with a Creatinine result of .7 mg/dL ?,139847,2,"c.	91",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43250,5,What is the eGFR for a 77 year old White Female with a Creatinine result of .7 mg/dL ?,139848,3,"d.	109",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43251,6,What is the eGFR for a 65 year old Hispanic Male with a creatinine of 2.2?,139849,0,"a.	35",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43251,6,What is the eGFR for a 65 year old Hispanic Male with a creatinine of 2.2?,139850,1,"b.	37",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43251,6,What is the eGFR for a 65 year old Hispanic Male with a creatinine of 2.2?,139851,2,"c.	30",1
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43251,6,What is the eGFR for a 65 year old Hispanic Male with a creatinine of 2.2?,139852,3,"d.	22",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43252,7,What is the Northside Hospital approved website to calculate eGFR?,140180,0,"a.	www.kidney.org",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43252,7,What is the Northside Hospital approved website to calculate eGFR?,140181,1,"b.	www.mdcalc.com",0
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43252,7,What is the Northside Hospital approved website to calculate eGFR?,140182,2,"c.	www.MDRD.com",1
9296,Elearning-0000-546,GFR CALCULATION IN RADIOLOGY,n8920,43252,7,What is the Northside Hospital approved website to calculate eGFR?,140183,3,"d.	All of the above",0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43253,0,"In STAR, what is the MENU on which changes can be made such as adding Insurance, Resequence Financial Class, Balance Transfer, etc?",139857,0,Account Inquiry,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43253,0,"In STAR, what is the MENU on which changes can be made such as adding Insurance, Resequence Financial Class, Balance Transfer, etc?",139858,1,Demand Bill,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43253,0,"In STAR, what is the MENU on which changes can be made such as adding Insurance, Resequence Financial Class, Balance Transfer, etc?",139859,2,Account Revision,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43253,0,"In STAR, what is the MENU on which changes can be made such as adding Insurance, Resequence Financial Class, Balance Transfer, etc?",139860,3,Clinicals,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43254,1,What is the Financial Class identifying Medicare HMO Accounts in SSI?,139861,0,H,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43254,1,What is the Financial Class identifying Medicare HMO Accounts in SSI?,139862,1,F,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43254,1,What is the Financial Class identifying Medicare HMO Accounts in SSI?,139863,2,C,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43254,1,What is the Financial Class identifying Medicare HMO Accounts in SSI?,139864,3,G,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43255,2,"In Account Revision, after opening the account and pressing ENTER what option will be used to change the Financial Class?",139865,0,Admission Information,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43255,2,"In Account Revision, after opening the account and pressing ENTER what option will be used to change the Financial Class?",139866,1,Financial Information,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43256,3,For Medicare Advantage the DME charges replace the Revenue Code 292 to 274 in the UB-04.,139867,0,TRUE,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43256,3,For Medicare Advantage the DME charges replace the Revenue Code 292 to 274 in the UB-04.,139868,1,FALSE,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43257,4,What is the complete definition of CCSM?,139869,0,Correct Coding System Manual,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43257,4,What is the complete definition of CCSM?,139870,1,Click On Claim Status Module,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43257,4,What is the complete definition of CCSM?,139871,2,Correct Claim Status Module,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43257,4,What is the complete definition of CCSM?,139872,3,Click On Coding System Manual,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43258,5,What information is used to calculate the Collector's Productivity?,139873,0,"Medicare Billing, Pending and CCI",0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43258,5,What information is used to calculate the Collector's Productivity?,139874,1,"LMRP, Audit, Late Charge",0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43258,5,What information is used to calculate the Collector's Productivity?,139875,2,ATB and HPF,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43258,5,What information is used to calculate the Collector's Productivity?,139876,3,All of the above,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43259,6,"In the Tool, under ""My Goal"" - Do you know when the Cash Goals are established to each Collector?",139877,0,At the Beginning of the Month,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43259,6,"In the Tool, under ""My Goal"" - Do you know when the Cash Goals are established to each Collector?",139878,1,Every other Month,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43259,6,"In the Tool, under ""My Goal"" - Do you know when the Cash Goals are established to each Collector?",139879,2,Every 15th of the Month,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43259,6,"In the Tool, under ""My Goal"" - Do you know when the Cash Goals are established to each Collector?",139880,3,At the End of the Month,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43260,7,What is the purpose of the ATB report?,139881,0,"The collector is able to review the total number of accounts a total dollar amount within the assigned section. The ATB is worked as follows: Greater than 30 days, working the Z's, High Dollar Accounts, and Warnings.",0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43260,7,What is the purpose of the ATB report?,139882,1,To increase the opportunities of bringing Revenue.,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43260,7,What is the purpose of the ATB report?,139883,2,To maintain my claims up to date in terms of follow ups.,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43260,7,What is the purpose of the ATB report?,139884,3,All of the Above,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43261,8,"The ""Not Found"" or ""N"" Status are those claims that were billed to Medicare with the incorrect Medicare Number.",139885,0,TRUE,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43261,8,"The ""Not Found"" or ""N"" Status are those claims that were billed to Medicare with the incorrect Medicare Number.",139886,1,FALSE,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43262,9,"Status ""Z"" accounts in the ATB are:",139887,0,New accounts,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43262,9,"Status ""Z"" accounts in the ATB are:",139888,1,Take backs,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43262,9,"Status ""Z"" accounts in the ATB are:",139889,2,MSP claims that need to be billed,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43262,9,"Status ""Z"" accounts in the ATB are:",139890,3,All of the above,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43343,10,High dollar accounts should be worked last when working the ATB.,140212,0,TRUE,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43343,10,High dollar accounts should be worked last when working the ATB.,140213,1,FALSE,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43344,11,Does Overlaps go to AUDIT?,140214,0,TRUE,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43344,11,Does Overlaps go to AUDIT?,140215,1,FALSE,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43345,12,What is the appropriate CODE use by Collectors to document Medicare accounts in the ATB?,140216,0,1724,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43345,12,What is the appropriate CODE use by Collectors to document Medicare accounts in the ATB?,140217,1,9021,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43345,12,What is the appropriate CODE use by Collectors to document Medicare accounts in the ATB?,140218,2,1512,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43346,13,"What happens after the Collector selects ""Update Follow up ""?",140219,0,The account will purge.,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43346,13,"What happens after the Collector selects ""Update Follow up ""?",140220,1,The account follow up date will be updated to today's date.,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43346,13,"What happens after the Collector selects ""Update Follow up ""?",140221,2,Neither A or B,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43347,14,How do you access the ATB?,140222,0,Revenue Cycle Website,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43347,14,How do you access the ATB?,140223,1,STAR,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43347,14,How do you access the ATB?,140224,2,The Tool,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43347,14,How do you access the ATB?,140225,3,One Content,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43348,15,"While working the ATB, What is STATUS ""Billed w/in 15 days""?",140226,0,Accounts that have been processed.,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43348,15,"While working the ATB, What is STATUS ""Billed w/in 15 days""?",140227,1,Billed w/in 15 days are accounts recently billed.,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43348,15,"While working the ATB, What is STATUS ""Billed w/in 15 days""?",140228,2,Accounts that will reject shortly.,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43348,15,"While working the ATB, What is STATUS ""Billed w/in 15 days""?",140229,3,Accounts needing immediate attention.,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43349,16,"When documenting any account in the ATB, the Collector MUST add a note by pressing ""add note"".",140230,0,TRUE,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43349,16,"When documenting any account in the ATB, the Collector MUST add a note by pressing ""add note"".",140231,1,FALSE,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43350,17,An Inpatient claim is represented by Type of Bill 131.,140232,0,TRUE,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43350,17,An Inpatient claim is represented by Type of Bill 131.,140233,1,FALSE,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43351,18,Not Found claims are claims that were billed with the incorrect Medicare number.,140234,0,TRUE,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43351,18,Not Found claims are claims that were billed with the incorrect Medicare number.,140235,1,FALSE,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43352,19,An Outpatient Claim is represented by Type of Bill 131.,140236,0,TRUE,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43352,19,An Outpatient Claim is represented by Type of Bill 131.,140237,1,FALSE,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43353,20,What are the steps to view the details of the Late Charges?,140238,0,Financial Information,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43353,20,What are the steps to view the details of the Late Charges?,140239,1,Admission Information,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43353,20,What are the steps to view the details of the Late Charges?,140240,2,"Type ""B"" on the flashcard > ""S"" for Pro Summaries > Select All Charges > View the Details",1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43353,20,What are the steps to view the details of the Late Charges?,140241,3,Patient Demographics,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43354,21,"What does ""ATB"" stands for?",140242,0,Account Trial Balance,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43354,21,"What does ""ATB"" stands for?",140243,1,Account Transaction Balance,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43354,21,"What does ""ATB"" stands for?",140244,2,Account Test Balance,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43354,21,"What does ""ATB"" stands for?",140245,3,Account Trial Bill,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43355,22,What date of the month the Collectors work the SPA accounts?,140246,0,The 9th of every month,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43355,22,What date of the month the Collectors work the SPA accounts?,140247,1,The 15th of every month,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43355,22,What date of the month the Collectors work the SPA accounts?,140248,2,The 1st of the Month,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43355,22,What date of the month the Collectors work the SPA accounts?,140249,3,Never,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43356,23,At the end of each Business day the collector should print the Summary of Accounts worked from the ATB.,140250,0,TRUE,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43356,23,At the end of each Business day the collector should print the Summary of Accounts worked from the ATB.,140251,1,FALSE,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43357,24,My ATB tab is worked by Greater than 30 days and High Dollar Accounts.,140252,0,TRUE,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43357,24,My ATB tab is worked by Greater than 30 days and High Dollar Accounts.,140253,1,FALSE,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43358,25,What Systems do you need to work as a collector?,140254,0,"STAR, and the Tool",0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43358,25,What Systems do you need to work as a collector?,140255,1,SSI and FSS0,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43358,25,What Systems do you need to work as a collector?,140256,2,One Content and STAR,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43358,25,What Systems do you need to work as a collector?,140257,3,"STAR, The Tool, One Content, SSI and Excel Daily Productivity Volume Report",1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43359,26,How often a Collector have to report the Daily Productivity Volume Calculator Report?,140258,0,Once a week,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43359,26,How often a Collector have to report the Daily Productivity Volume Calculator Report?,140259,1,Everyday,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43359,26,How often a Collector have to report the Daily Productivity Volume Calculator Report?,140260,2,Once a Month,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43359,26,How often a Collector have to report the Daily Productivity Volume Calculator Report?,140261,3,Never,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43360,27,"When submitting a request for a Medical Records, what Status should be displayed in the ATB?",140262,0,Pending Lead/Supervisor,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43360,27,"When submitting a request for a Medical Records, what Status should be displayed in the ATB?",140263,1,Requested Medical Records,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43360,27,"When submitting a request for a Medical Records, what Status should be displayed in the ATB?",140264,2,Pending Medical Records,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43360,27,"When submitting a request for a Medical Records, what Status should be displayed in the ATB?",140265,3,Pending Final Bill,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43361,28,In One Content the Medicare Collections queues are PFS: COLL: DELAYS MH and PFS: COLL: REF MC QUEUE.,140266,0,TRUE,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43361,28,In One Content the Medicare Collections queues are PFS: COLL: DELAYS MH and PFS: COLL: REF MC QUEUE.,140267,1,FALSE,0
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43362,29,"In One Content the Collector can Create an Assignment, Re-Assign and Complete Requests under the Task List tab.",140268,0,TRUE,1
9834,Questions-0000-127,RCT: MEDICARE HMO COLLECTIONS UNIVERSITY TEST (CURRENT),n8921,43362,29,"In One Content the Collector can Create an Assignment, Re-Assign and Complete Requests under the Task List tab.",140269,1,FALSE,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43368,0,What operating systems do you use to work as a Biller?,140285,0,"SSI, STAR Navigator, The Tool, and One Content",1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43368,0,What operating systems do you use to work as a Biller?,140286,1,SSI and STAR,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43368,0,What operating systems do you use to work as a Biller?,140287,2,The Tool and SSI,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43368,0,What operating systems do you use to work as a Biller?,140288,3,One Content and STAR,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43369,1,The Web portal to review Medicaid Claims is known as GAMMIS.,140289,0,TRUE,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43369,1,The Web portal to review Medicaid Claims is known as GAMMIS.,140290,1,FALSE,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43370,2,The Source of Payer Code specific to Medicaid Billing is:,140291,0,C,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43370,2,The Source of Payer Code specific to Medicaid Billing is:,140292,1,B,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43370,2,The Source of Payer Code specific to Medicaid Billing is:,140293,2,D,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43370,2,The Source of Payer Code specific to Medicaid Billing is:,140294,3,A,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43371,3,"In SSI , what is Custom Field 1 use for:",140295,0,To add the biller's initials,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43371,3,"In SSI , what is Custom Field 1 use for:",140296,1,"To describe the reason why the claim was placed on HOLD, PEND, AUDIT, MGMT",1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43371,3,"In SSI , what is Custom Field 1 use for:",140297,2,To add a Payer,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43371,3,"In SSI , what is Custom Field 1 use for:",140298,3,To send the account to Audit,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43372,4,"In the UB-04, INPATIENT claims :",140299,0,Have Room and Board charges and their type of bill is 11X,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43372,4,"In the UB-04, INPATIENT claims :",140300,1,Should have NO dates on any charge,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43372,4,"In the UB-04, INPATIENT claims :",140301,2,Authorization is obtained from the Payer's website,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43372,4,"In the UB-04, INPATIENT claims :",140302,3,All of the above,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43373,5,"When billing Medicaid as Secondary Insurance, the biller must:",140303,0,Make sure the Primary Remit Exist and have a copy of the Primary Remit Prior to Billing Secondary Insurance.,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43373,5,"When billing Medicaid as Secondary Insurance, the biller must:",140304,1,Request Medical Records,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43373,5,"When billing Medicaid as Secondary Insurance, the biller must:",140305,2,Adjust off the remaining of the Bill,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43373,5,"When billing Medicaid as Secondary Insurance, the biller must:",140306,3,Send the Account to Audit,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43374,6,Outpatient claims are identified by the Bill type:,140307,0,13X,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43374,6,Outpatient claims are identified by the Bill type:,140308,1,11X,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43374,6,Outpatient claims are identified by the Bill type:,140309,2,112,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43375,7,The Coding Worklist is used:,140310,0,To Print the Remits,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43375,7,The Coding Worklist is used:,140311,1,To Place Claims on HOLD,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43375,7,The Coding Worklist is used:,140312,2,To Add Referrals that require Coding Review,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43375,7,The Coding Worklist is used:,140313,3,To Close the Account,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43376,8,The correct Standard Note Code used to send an account to Audit is:,140314,0,222 - Claim is on HOLD,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43376,8,The correct Standard Note Code used to send an account to Audit is:,140315,1,2452 - Completed Audit,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43376,8,The correct Standard Note Code used to send an account to Audit is:,140316,2,1724 - Referred to Audit from Billing,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43376,8,The correct Standard Note Code used to send an account to Audit is:,140317,3,1954 - Billing Review Completed,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43377,9,Claim Destination X represents :,140318,0,A paper Claim,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43377,9,Claim Destination X represents :,140319,1,An Electronic claim,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43377,9,Claim Destination X represents :,140320,2,A Duplicate Claim,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43378,10,"In SSI, to place a Claim on HOLD go to:",140321,0,Charges,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43378,10,"In SSI, to place a Claim on HOLD go to:",140322,1,Remit,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43378,10,"In SSI, to place a Claim on HOLD go to:",140323,2,Claim,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43378,10,"In SSI, to place a Claim on HOLD go to:",140324,3,Forms,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43379,11,"On INPATIENT claims, Value Code 80 represents:",140325,0,Coinsurance Amount,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43379,11,"On INPATIENT claims, Value Code 80 represents:",140326,1,Diagnosis Code,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43379,11,"On INPATIENT claims, Value Code 80 represents:",140327,2,Number of times the patient has visited the Hospital,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43379,11,"On INPATIENT claims, Value Code 80 represents:",140328,3,Number of days the Patient stayed in the Hospital,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43380,12,"In OUTPATIENT Claims, Revenue Codes 302 & 305 gets changed to Revenue Code 300.",140329,0,TRUE,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43380,12,"In OUTPATIENT Claims, Revenue Codes 302 & 305 gets changed to Revenue Code 300.",140330,1,FALSE,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43381,13,Revenue Code 360 always change the Units to 1.,140331,0,TRUE,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43381,13,Revenue Code 360 always change the Units to 1.,140332,1,FALSE,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43382,14,Medicaid authorizations can be retrieved from the GAMMIS Webportal.,140333,0,TRUE,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43382,14,Medicaid authorizations can be retrieved from the GAMMIS Webportal.,140334,1,FALSE,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43383,15,The Appeal process for Medicaid Traditional is completed in .GAMMIS,140335,0,TRUE,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43383,15,The Appeal process for Medicaid Traditional is completed in .GAMMIS,140336,1,FALSE,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43384,16,The Timely Filing for Medicaid on New Claims is 90 Days.,140337,0,TRUE,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43384,16,The Timely Filing for Medicaid on New Claims is 90 Days.,140338,1,FALSE,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43385,17,EDIT # 171 - No Diagnosis on Claim. How would you work this Edit?,140339,0,Diagnosis Code issues need to go to Coding via the Coding Worklist,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43385,17,EDIT # 171 - No Diagnosis on Claim. How would you work this Edit?,140340,1,"In SSI, place the Claim on HOLD",0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43385,17,EDIT # 171 - No Diagnosis on Claim. How would you work this Edit?,140341,2,The biller will add a request in the Coding Worklist under PENDING - Diagnosis,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43385,17,EDIT # 171 - No Diagnosis on Claim. How would you work this Edit?,140342,3,All of the Above,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43386,18,"If line item 76 Attending NPI number is missing, what should the biller do?",140343,0,Bypass the edit and bill the claim without the NPI,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43386,18,"If line item 76 Attending NPI number is missing, what should the biller do?",140344,1,Look for the NPI number in STAR and/or search in the NPI Registry,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43386,18,"If line item 76 Attending NPI number is missing, what should the biller do?",140345,2,Skip the Edit and move to the Next Edit,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43387,19,"In order to bill Medicaid Secondary, there has to be a Deductible or Coinsurance.",140347,0,TRUE,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43387,19,"In order to bill Medicaid Secondary, there has to be a Deductible or Coinsurance.",140348,1,FALSE,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43388,20,When there is issues with Two HCPCS Codes Procedures the biller will:,140349,0,Send the account to PENDING,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43388,20,When there is issues with Two HCPCS Codes Procedures the biller will:,140350,1,Send the account to CCI,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43388,20,When there is issues with Two HCPCS Codes Procedures the biller will:,140351,2,Send the account to LMRP,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43388,20,When there is issues with Two HCPCS Codes Procedures the biller will:,140352,3,Send the account to RADCERT,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43389,21,What Transaction Code is used to work Late Charges?,140353,0,Code 582,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43389,21,What Transaction Code is used to work Late Charges?,140354,1,Code 81,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43389,21,What Transaction Code is used to work Late Charges?,140355,2,Code 1724,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43389,21,What Transaction Code is used to work Late Charges?,140356,3,Code 222,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43390,22,The AUDIT report is worked once a month.,140357,0,TRUE,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43390,22,The AUDIT report is worked once a month.,140358,1,FALSE,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43391,23,The AUDIT report is distributed to the Medicaid Staff via email and/or Printed by the Manager.,140359,0,TRUE,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43391,23,The AUDIT report is distributed to the Medicaid Staff via email and/or Printed by the Manager.,140360,1,FALSE,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43392,24,What Standard Note Code is used when working the Late Charge Report?,140361,0,Standard Note Code 25,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43392,24,What Standard Note Code is used when working the Late Charge Report?,140362,1,Standard Note Code 200,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43392,24,What Standard Note Code is used when working the Late Charge Report?,140363,2,Standard Note Code 1724,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43392,24,What Standard Note Code is used when working the Late Charge Report?,140364,3,Standard Note Code 82,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43393,25,72 hour Overlaps are referred to:,140365,0,The Coding Department,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43393,25,72 hour Overlaps are referred to:,140366,1,The AUDIT Department,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43393,25,72 hour Overlaps are referred to:,140367,2,Management works them,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43393,25,72 hour Overlaps are referred to:,140368,3,The Reimbursement Department,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43394,26,Once the AUDIT referral is worked by the Medicaid representative:,140369,0,The referral MUST be closed by using Standard Note Code 2452,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43394,26,Once the AUDIT referral is worked by the Medicaid representative:,140370,1,No action taken by the Medicaid Representative,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43394,26,Once the AUDIT referral is worked by the Medicaid representative:,140371,2,The referral MUST stay opened,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43394,26,Once the AUDIT referral is worked by the Medicaid representative:,140372,3,Ignore and move to the next Audit,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43395,27,The Standard Note Code for Completed Audit is 2452.,140373,0,TRUE,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43395,27,The Standard Note Code for Completed Audit is 2452.,140374,1,FALSE,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43396,28,What is the Financial Class for Medicaid Traditional?,140375,0,WM,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43396,28,What is the Financial Class for Medicaid Traditional?,140376,1,W2,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43396,28,What is the Financial Class for Medicaid Traditional?,140377,2,W,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43396,28,What is the Financial Class for Medicaid Traditional?,140378,3,W3,0
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43397,29,"In ONE CONTENT the biller is able to verified the Patient's Insurance Information, Medical Records, UB04, and Workqueues.",140379,0,TRUE,1
9831,Questions-0000-124,RCT: MEDICAID TRADITIONAL BILLING UNIVERSITY TEST (CURRENT),n8931,43397,29,"In ONE CONTENT the biller is able to verified the Patient's Insurance Information, Medical Records, UB04, and Workqueues.",140380,1,FALSE,0
8200,Elearning-0000-1090,STANDARD PRECAUTIONS AND SURGICAL SERVICES,n8944,43560,0,"I acknowledge that I have read and understand the ""Standard Precautions and Surgical Services"" CBL in its entirety.",141014,0,TRUE,1
8200,Elearning-0000-1090,STANDARD PRECAUTIONS AND SURGICAL SERVICES,n8944,43560,0,"I acknowledge that I have read and understand the ""Standard Precautions and Surgical Services"" CBL in its entirety.",141015,1,FALSE,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43561,0,"Marking of a pulse will be made with an ""X"" for palpable pulse and ""O"" for a pulse that can only be found with a Doppler.",141016,0,TRUE,1
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43561,0,"Marking of a pulse will be made with an ""X"" for palpable pulse and ""O"" for a pulse that can only be found with a Doppler.",141017,1,FALSE,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43562,1,A bounding pulse may be due to,141018,0,a. Fever,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43562,1,A bounding pulse may be due to,141019,1,b. Increased cardiac output,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43562,1,A bounding pulse may be due to,141020,2,c. Atherosclerosis,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43562,1,A bounding pulse may be due to,141021,3,d. All of the above,1
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43563,2,A 1+ on the Pulse Scale =,141022,0,a. Weak,1
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43563,2,A 1+ on the Pulse Scale =,141023,1,b. Normal,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43563,2,A 1+ on the Pulse Scale =,141024,2,c. Bounding,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43563,2,A 1+ on the Pulse Scale =,141025,3,d. No Pulse,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43564,3,A 2+ on the Pulse Scale=,141026,0,a. Weak,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43564,3,A 2+ on the Pulse Scale=,141027,1,b. Normal,1
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43564,3,A 2+ on the Pulse Scale=,141028,2,c. Bounding,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43564,3,A 2+ on the Pulse Scale=,141029,3,d. No Pulse,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43565,4,A 3+ on the Pulse Scale=,141030,0,a. Weak,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43565,4,A 3+ on the Pulse Scale=,141031,1,b. Normal,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43565,4,A 3+ on the Pulse Scale=,141032,2,c. Bounding,1
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43565,4,A 3+ on the Pulse Scale=,141033,3,d. No Pulse,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43566,5,"A ""D"" on the Pulse Scale=",141034,0,a. Palpable,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43566,5,"A ""D"" on the Pulse Scale=",141035,1,b. No pulse,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43566,5,"A ""D"" on the Pulse Scale=",141036,2,c. Doppler,1
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43567,6,"A ""0"" on the Pulse Scale=",141037,0,a. Palpable,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43567,6,"A ""0"" on the Pulse Scale=",141038,1,b. No pulse,1
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43567,6,"A ""0"" on the Pulse Scale=",141039,2,c. Doppler,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43568,7,The Radial Pulse rate is always equal to the Apical heart rate,141040,0,TRUE,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43568,7,The Radial Pulse rate is always equal to the Apical heart rate,141041,1,FALSE,1
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43569,8,You should always be able to feel the Dorsalis Pedis in a young healthy adult,141042,0,TRUE,0
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43569,8,You should always be able to feel the Dorsalis Pedis in a young healthy adult,141043,1,FALSE,1
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43570,9,You can palpate your own Posterior Tibialis Pulse if you allow the Femoral artery to open,141044,0,TRUE,1
8205,Elearning-0000-1095,PULSES AND THE BEAT GOES ON,n8945,43570,9,You can palpate your own Posterior Tibialis Pulse if you allow the Femoral artery to open,141045,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43576,0,The Government Post Payment Review is Responsible to Process Insurance and Patient Refunds.,141059,0,TRUE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43576,0,The Government Post Payment Review is Responsible to Process Insurance and Patient Refunds.,141059,0,TRUE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43576,0,The Government Post Payment Review is Responsible to Process Insurance and Patient Refunds.,141060,1,FALSE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43576,0,The Government Post Payment Review is Responsible to Process Insurance and Patient Refunds.,141060,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43577,1,What Operating Systems are used to complete the Reimbursement Process?,141062,0,STAR Navigator,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43577,1,What Operating Systems are used to complete the Reimbursement Process?,141062,0,STAR Navigator,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43577,1,What Operating Systems are used to complete the Reimbursement Process?,216937,1,Med-Metrix,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43577,1,What Operating Systems are used to complete the Reimbursement Process?,216937,1,Med-Metrix,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43577,1,What Operating Systems are used to complete the Reimbursement Process?,141064,2,One Content,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43577,1,What Operating Systems are used to complete the Reimbursement Process?,141064,2,One Content,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43577,1,What Operating Systems are used to complete the Reimbursement Process?,141066,3,All of the above,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43577,1,What Operating Systems are used to complete the Reimbursement Process?,141066,3,All of the above,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43578,2,The Government Post Payment Review Analyst is responsible to work the following Payers:,141067,0,"Medicare Traditional and Medicare Advantage, Medicaid Traditional and Medicaid CMO",1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43578,2,The Government Post Payment Review Analyst is responsible to work the following Payers:,141067,0,"Medicare Traditional and Medicare Advantage, Medicaid Traditional and Medicaid CMO",1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43578,2,The Government Post Payment Review Analyst is responsible to work the following Payers:,141068,1,All Commercial Payers,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43578,2,The Government Post Payment Review Analyst is responsible to work the following Payers:,141068,1,All Commercial Payers,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43578,2,The Government Post Payment Review Analyst is responsible to work the following Payers:,141069,2,"State Farm, Allstate, Workers Compensation, Miscellaneous",0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43578,2,The Government Post Payment Review Analyst is responsible to work the following Payers:,141069,2,"State Farm, Allstate, Workers Compensation, Miscellaneous",0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43579,3,The Government Reimbursement Analyst Responsibilities includes:,141070,0,Work all the Government Remits,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43579,3,The Government Reimbursement Analyst Responsibilities includes:,141070,0,Work all the Government Remits,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43579,3,The Government Reimbursement Analyst Responsibilities includes:,141071,1,One Content - Work all Credit Balances Referrals,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43579,3,The Government Reimbursement Analyst Responsibilities includes:,141071,1,One Content - Work all Credit Balances Referrals,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43579,3,The Government Reimbursement Analyst Responsibilities includes:,141072,2,The Tool Productivity,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43579,3,The Government Reimbursement Analyst Responsibilities includes:,141072,2,The Tool Productivity,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43579,3,The Government Reimbursement Analyst Responsibilities includes:,141073,3,Respond to Emails,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43579,3,The Government Reimbursement Analyst Responsibilities includes:,141073,3,Respond to Emails,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43579,3,The Government Reimbursement Analyst Responsibilities includes:,141074,4,All of the above,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43579,3,The Government Reimbursement Analyst Responsibilities includes:,141074,4,All of the above,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43580,4,The Government Refund Analyst Responsibilities includes:,141075,0,Complete Daily Review of Credit Balances for Government Payers,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43580,4,The Government Refund Analyst Responsibilities includes:,141075,0,Complete Daily Review of Credit Balances for Government Payers,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43580,4,The Government Refund Analyst Responsibilities includes:,141076,1,One Content - Work all Credit Balances Referrals,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43580,4,The Government Refund Analyst Responsibilities includes:,141076,1,One Content - Work all Credit Balances Referrals,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43580,4,The Government Refund Analyst Responsibilities includes:,141077,2,Process Refunds,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43580,4,The Government Refund Analyst Responsibilities includes:,141077,2,Process Refunds,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43580,4,The Government Refund Analyst Responsibilities includes:,141078,3,The Tool Productivity,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43580,4,The Government Refund Analyst Responsibilities includes:,141078,3,The Tool Productivity,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43580,4,The Government Refund Analyst Responsibilities includes:,141079,4,Respond to Emails,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43580,4,The Government Refund Analyst Responsibilities includes:,141079,4,Respond to Emails,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43580,4,The Government Refund Analyst Responsibilities includes:,141080,5,All of the above,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43580,4,The Government Refund Analyst Responsibilities includes:,141080,5,All of the above,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43581,5,Which option should be accessed in The Tool by for Reimbursement?,141081,0,ATB,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43581,5,Which option should be accessed in The Tool by for Reimbursement?,141081,0,ATB,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43581,5,Which option should be accessed in The Tool by for Reimbursement?,141082,1,CW,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43581,5,Which option should be accessed in The Tool by for Reimbursement?,141082,1,CW,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43581,5,Which option should be accessed in The Tool by for Reimbursement?,141083,2,R,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43581,5,Which option should be accessed in The Tool by for Reimbursement?,141083,2,R,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43581,5,Which option should be accessed in The Tool by for Reimbursement?,141084,3,CB,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43581,5,Which option should be accessed in The Tool by for Reimbursement?,141084,3,CB,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43582,6,Which option should be accessed in The Tool for Credit Balance?,141085,0,ATB,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43582,6,Which option should be accessed in The Tool for Credit Balance?,141085,0,ATB,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43582,6,Which option should be accessed in The Tool for Credit Balance?,141086,1,CW,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43582,6,Which option should be accessed in The Tool for Credit Balance?,141086,1,CW,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43582,6,Which option should be accessed in The Tool for Credit Balance?,141087,2,R,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43582,6,Which option should be accessed in The Tool for Credit Balance?,141087,2,R,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43582,6,Which option should be accessed in The Tool for Credit Balance?,141088,3,CB,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43582,6,Which option should be accessed in The Tool for Credit Balance?,141088,3,CB,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43583,7,The Government Post Payment Review Analysts should access which Environment while working in The Tool?,141089,0,Government,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43583,7,The Government Post Payment Review Analysts should access which Environment while working in The Tool?,141089,0,Government,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43583,7,The Government Post Payment Review Analysts should access which Environment while working in The Tool?,141090,1,Commercial,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43583,7,The Government Post Payment Review Analysts should access which Environment while working in The Tool?,141090,1,Commercial,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43583,7,The Government Post Payment Review Analysts should access which Environment while working in The Tool?,141091,2,Medicaid,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43583,7,The Government Post Payment Review Analysts should access which Environment while working in The Tool?,141091,2,Medicaid,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43583,7,The Government Post Payment Review Analysts should access which Environment while working in The Tool?,141092,3,None of the Above,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43583,7,The Government Post Payment Review Analysts should access which Environment while working in The Tool?,141092,3,None of the Above,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43584,8,"In The Tool, the ""WORK"" tab is where the Reimbursement Analyst will proceed to review and complete the accounts assigned by the Supervisor.",141093,0,TRUE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43584,8,"In The Tool, the ""WORK"" tab is where the Reimbursement Analyst will proceed to review and complete the accounts assigned by the Supervisor.",141093,0,TRUE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43584,8,"In The Tool, the ""WORK"" tab is where the Reimbursement Analyst will proceed to review and complete the accounts assigned by the Supervisor.",141094,1,FALSE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43584,8,"In The Tool, the ""WORK"" tab is where the Reimbursement Analyst will proceed to review and complete the accounts assigned by the Supervisor.",141094,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43585,9,"The Financial Class ""5"" denotes a ""Payment Arrangement Account.",141095,0,TRUE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43585,9,"The Financial Class ""5"" denotes a ""Payment Arrangement Account.",141095,0,TRUE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43585,9,"The Financial Class ""5"" denotes a ""Payment Arrangement Account.",141096,1,FALSE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43585,9,"The Financial Class ""5"" denotes a ""Payment Arrangement Account.",141096,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43586,10,"What Code is an indication of an Outlier when reviewing the ""REMIT""?",141097,0,Code 7074,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43586,10,"What Code is an indication of an Outlier when reviewing the ""REMIT""?",141097,0,Code 7074,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43586,10,"What Code is an indication of an Outlier when reviewing the ""REMIT""?",141098,1,Code 4337,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43586,10,"What Code is an indication of an Outlier when reviewing the ""REMIT""?",141098,1,Code 4337,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43586,10,"What Code is an indication of an Outlier when reviewing the ""REMIT""?",141099,2,Code 1574,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43586,10,"What Code is an indication of an Outlier when reviewing the ""REMIT""?",141099,2,Code 1574,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43586,10,"What Code is an indication of an Outlier when reviewing the ""REMIT""?",141100,3,None of the above,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43586,10,"What Code is an indication of an Outlier when reviewing the ""REMIT""?",141100,3,None of the above,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43587,11,What is your job as a Government Reimbursement Analyst?,141101,0,Make sure each account is in great standing with debits and Credits Applied.,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43587,11,What is your job as a Government Reimbursement Analyst?,141101,0,Make sure each account is in great standing with debits and Credits Applied.,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43587,11,What is your job as a Government Reimbursement Analyst?,141102,1,Make sure the Contractual Adjustment is applied according to the Contracted Rate.,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43587,11,What is your job as a Government Reimbursement Analyst?,141102,1,Make sure the Contractual Adjustment is applied according to the Contracted Rate.,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43587,11,What is your job as a Government Reimbursement Analyst?,141103,2,Be sure to review the Transaction History in case some of the adjustments needs to be reverse such as Small Balance Write Off.,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43587,11,What is your job as a Government Reimbursement Analyst?,141103,2,Be sure to review the Transaction History in case some of the adjustments needs to be reverse such as Small Balance Write Off.,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43587,11,What is your job as a Government Reimbursement Analyst?,141104,3,All of the Above,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43587,11,What is your job as a Government Reimbursement Analyst?,141104,3,All of the Above,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43588,12,What is the purpose of using STAR Clinicals?,141105,0,Apply Credit and Debit Adjustments.,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43588,12,What is the purpose of using STAR Clinicals?,141105,0,Apply Credit and Debit Adjustments.,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43588,12,What is the purpose of using STAR Clinicals?,141106,1,"Make sure the ""Adjustments"" are under ""Contractual"" not under the Patient's Bucket.",0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43588,12,What is the purpose of using STAR Clinicals?,141106,1,"Make sure the ""Adjustments"" are under ""Contractual"" not under the Patient's Bucket.",0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43588,12,What is the purpose of using STAR Clinicals?,141107,2,Open Batches and Balance them.,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43588,12,What is the purpose of using STAR Clinicals?,141107,2,Open Batches and Balance them.,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43588,12,What is the purpose of using STAR Clinicals?,141108,3,All of the above,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43588,12,What is the purpose of using STAR Clinicals?,141108,3,All of the above,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43589,13,When creating a Batch in STAR Clinicals the Analyst cannot add multiple transactions to an open Batch.,141109,0,TRUE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43589,13,When creating a Batch in STAR Clinicals the Analyst cannot add multiple transactions to an open Batch.,141109,0,TRUE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43589,13,When creating a Batch in STAR Clinicals the Analyst cannot add multiple transactions to an open Batch.,141110,1,FALSE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43589,13,When creating a Batch in STAR Clinicals the Analyst cannot add multiple transactions to an open Batch.,141110,1,FALSE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43590,14,"When adding Adjustment Transactions to an open Batch, the transaction has to be for the same Facility.",141111,0,TRUE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43590,14,"When adding Adjustment Transactions to an open Batch, the transaction has to be for the same Facility.",141111,0,TRUE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43590,14,"When adding Adjustment Transactions to an open Batch, the transaction has to be for the same Facility.",141112,1,FALSE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43590,14,"When adding Adjustment Transactions to an open Batch, the transaction has to be for the same Facility.",141112,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43591,15,When Posting Adjustment Transactions is necessary to use the same Transaction Code to apply the necessary Credit or Debit adjustment.,141113,0,TRUE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43591,15,When Posting Adjustment Transactions is necessary to use the same Transaction Code to apply the necessary Credit or Debit adjustment.,141113,0,TRUE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43591,15,When Posting Adjustment Transactions is necessary to use the same Transaction Code to apply the necessary Credit or Debit adjustment.,141114,1,FALSE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43591,15,When Posting Adjustment Transactions is necessary to use the same Transaction Code to apply the necessary Credit or Debit adjustment.,141114,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43592,16,Which Operating Systems are used to verify the Patient's Payment History are?,216938,0,STAR Navigator,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43592,16,Which Operating Systems are used to verify the Patient's Payment History are?,216938,0,STAR Navigator,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43592,16,Which Operating Systems are used to verify the Patient's Payment History are?,216939,1,Med-Metrix,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43592,16,Which Operating Systems are used to verify the Patient's Payment History are?,216939,1,Med-Metrix,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43592,16,Which Operating Systems are used to verify the Patient's Payment History are?,216940,2,OneContent,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43592,16,Which Operating Systems are used to verify the Patient's Payment History are?,216940,2,OneContent,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43592,16,Which Operating Systems are used to verify the Patient's Payment History are?,216941,3,All of the above,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43592,16,Which Operating Systems are used to verify the Patient's Payment History are?,216941,3,All of the above,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43593,17,The Wells Fargo Lockbox is used to research Payments.,141119,0,TRUE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43593,17,The Wells Fargo Lockbox is used to research Payments.,141119,0,TRUE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43593,17,The Wells Fargo Lockbox is used to research Payments.,141120,1,FALSE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43593,17,The Wells Fargo Lockbox is used to research Payments.,141120,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43594,18,"In One Content Task List, what referral queues are worked by the Government Post Payment Review Analyst?",141121,0,PFS:REIMB:REF GOVT REFUND QUEUE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43594,18,"In One Content Task List, what referral queues are worked by the Government Post Payment Review Analyst?",141121,0,PFS:REIMB:REF GOVT REFUND QUEUE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43594,18,"In One Content Task List, what referral queues are worked by the Government Post Payment Review Analyst?",141122,1,PFS:REIMB:REF GOVT REIMB QUEUE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43594,18,"In One Content Task List, what referral queues are worked by the Government Post Payment Review Analyst?",141122,1,PFS:REIMB:REF GOVT REIMB QUEUE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43594,18,"In One Content Task List, what referral queues are worked by the Government Post Payment Review Analyst?",141123,2,PFS: REIMB:CMO CORR REFERRAL QUEUE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43594,18,"In One Content Task List, what referral queues are worked by the Government Post Payment Review Analyst?",141123,2,PFS: REIMB:CMO CORR REFERRAL QUEUE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43594,18,"In One Content Task List, what referral queues are worked by the Government Post Payment Review Analyst?",141124,3,PFS: REIMB: ADJUSTMENT QUEUE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43594,18,"In One Content Task List, what referral queues are worked by the Government Post Payment Review Analyst?",141124,3,PFS: REIMB: ADJUSTMENT QUEUE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43594,18,"In One Content Task List, what referral queues are worked by the Government Post Payment Review Analyst?",141125,4,A & B,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43594,18,"In One Content Task List, what referral queues are worked by the Government Post Payment Review Analyst?",141125,4,A & B,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43595,19,In One Content the Analysts is responsible to route (Reassign) accounts to the correct department so the accounts can be worked accordingly.,141126,0,TRUE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43595,19,In One Content the Analysts is responsible to route (Reassign) accounts to the correct department so the accounts can be worked accordingly.,141126,0,TRUE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43595,19,In One Content the Analysts is responsible to route (Reassign) accounts to the correct department so the accounts can be worked accordingly.,141127,1,FALSE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43595,19,In One Content the Analysts is responsible to route (Reassign) accounts to the correct department so the accounts can be worked accordingly.,141127,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43596,20,The Government Refund spreadsheet keeps a log of the accounts and its details set up to generate a word-formatted document used to create Refund Letters.,141128,0,TRUE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43596,20,The Government Refund spreadsheet keeps a log of the accounts and its details set up to generate a word-formatted document used to create Refund Letters.,141128,0,TRUE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43596,20,The Government Refund spreadsheet keeps a log of the accounts and its details set up to generate a word-formatted document used to create Refund Letters.,141129,1,FALSE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43596,20,The Government Refund spreadsheet keeps a log of the accounts and its details set up to generate a word-formatted document used to create Refund Letters.,141129,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43597,21,How many hours the Analyst should work daily?,141130,0,9 Hours,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43597,21,How many hours the Analyst should work daily?,141130,0,9 Hours,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43597,21,How many hours the Analyst should work daily?,141131,1,6 Hours,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43597,21,How many hours the Analyst should work daily?,141131,1,6 Hours,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43597,21,How many hours the Analyst should work daily?,141132,2,7.5 Hours,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43597,21,How many hours the Analyst should work daily?,141132,2,7.5 Hours,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43597,21,How many hours the Analyst should work daily?,141133,3,8 Hours,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43597,21,How many hours the Analyst should work daily?,141133,3,8 Hours,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43598,22,How is the Overall Production Score obtained?,141134,0,"Add the ""Goal Hours Total"" plus the ""Total Hours Worked""",0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43598,22,How is the Overall Production Score obtained?,141134,0,"Add the ""Goal Hours Total"" plus the ""Total Hours Worked""",0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43598,22,How is the Overall Production Score obtained?,141135,1,"Dividing the ""Goal Hours"" by the ""Actual Hours""",1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43598,22,How is the Overall Production Score obtained?,141135,1,"Dividing the ""Goal Hours"" by the ""Actual Hours""",1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43598,22,How is the Overall Production Score obtained?,141136,2,"Dividing the ""Goal Hours Total"" by the ""Actual Hours Worked""",0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43598,22,How is the Overall Production Score obtained?,141136,2,"Dividing the ""Goal Hours Total"" by the ""Actual Hours Worked""",0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43598,22,How is the Overall Production Score obtained?,141137,3,None of the above,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43598,22,How is the Overall Production Score obtained?,141137,3,None of the above,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43599,23,What is the Goal Per Hour of Medicare EOB Accounts for the Analyst to Review?,141138,0,13,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43599,23,What is the Goal Per Hour of Medicare EOB Accounts for the Analyst to Review?,141138,0,13,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43599,23,What is the Goal Per Hour of Medicare EOB Accounts for the Analyst to Review?,141139,1,17,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43599,23,What is the Goal Per Hour of Medicare EOB Accounts for the Analyst to Review?,141139,1,17,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43599,23,What is the Goal Per Hour of Medicare EOB Accounts for the Analyst to Review?,141140,2,8,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43599,23,What is the Goal Per Hour of Medicare EOB Accounts for the Analyst to Review?,141140,2,8,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43599,23,What is the Goal Per Hour of Medicare EOB Accounts for the Analyst to Review?,141141,3,10,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43599,23,What is the Goal Per Hour of Medicare EOB Accounts for the Analyst to Review?,141141,3,10,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43600,24,What is the Goal Per Hour of Medicaid EOB Accounts for the Analyst to Review?,141142,0,17,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43600,24,What is the Goal Per Hour of Medicaid EOB Accounts for the Analyst to Review?,141142,0,17,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43600,24,What is the Goal Per Hour of Medicaid EOB Accounts for the Analyst to Review?,141143,1,13,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43600,24,What is the Goal Per Hour of Medicaid EOB Accounts for the Analyst to Review?,141143,1,13,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43600,24,What is the Goal Per Hour of Medicaid EOB Accounts for the Analyst to Review?,141144,2,8,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43600,24,What is the Goal Per Hour of Medicaid EOB Accounts for the Analyst to Review?,141144,2,8,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43600,24,What is the Goal Per Hour of Medicaid EOB Accounts for the Analyst to Review?,141145,3,10,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43600,24,What is the Goal Per Hour of Medicaid EOB Accounts for the Analyst to Review?,141145,3,10,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43601,25,The Contractual Adjustments made by the Government Post Payment Review Analysts via STAR post automatically.,141146,0,TRUE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43601,25,The Contractual Adjustments made by the Government Post Payment Review Analysts via STAR post automatically.,141146,0,TRUE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43601,25,The Contractual Adjustments made by the Government Post Payment Review Analysts via STAR post automatically.,141147,1,FALSE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43601,25,The Contractual Adjustments made by the Government Post Payment Review Analysts via STAR post automatically.,141147,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43602,26,"To post Credit and/or Debit Adjustments in STAR, the Analyst will perform this process in STAR Financials.",141148,0,TRUE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43602,26,"To post Credit and/or Debit Adjustments in STAR, the Analyst will perform this process in STAR Financials.",141148,0,TRUE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43602,26,"To post Credit and/or Debit Adjustments in STAR, the Analyst will perform this process in STAR Financials.",141149,1,FALSE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43602,26,"To post Credit and/or Debit Adjustments in STAR, the Analyst will perform this process in STAR Financials.",141149,1,FALSE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43603,27,Which of the following are to be verified on the Wells Fargo receipt prior to refunding?,180321,0,Patient's/Card Holder's Name/Information,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43603,27,Which of the following are to be verified on the Wells Fargo receipt prior to refunding?,180321,0,Patient's/Card Holder's Name/Information,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43603,27,Which of the following are to be verified on the Wells Fargo receipt prior to refunding?,180322,1,The Card Payment Amount,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43603,27,Which of the following are to be verified on the Wells Fargo receipt prior to refunding?,180322,1,The Card Payment Amount,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43603,27,Which of the following are to be verified on the Wells Fargo receipt prior to refunding?,180323,2,Patient Account Number,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43603,27,Which of the following are to be verified on the Wells Fargo receipt prior to refunding?,180323,2,Patient Account Number,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43603,27,Which of the following are to be verified on the Wells Fargo receipt prior to refunding?,180324,3,All the Above (Correct),1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43603,27,Which of the following are to be verified on the Wells Fargo receipt prior to refunding?,180324,3,All the Above (Correct),1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43604,28,"When a credit balance is found on a patient's account, the credit payment can only be transferred for up to 5 years.",180325,0,TRUE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43604,28,"When a credit balance is found on a patient's account, the credit payment can only be transferred for up to 5 years.",180325,0,TRUE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43604,28,"When a credit balance is found on a patient's account, the credit payment can only be transferred for up to 5 years.",180326,1,FALSE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43604,28,"When a credit balance is found on a patient's account, the credit payment can only be transferred for up to 5 years.",180326,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43605,29,The Tool is the main system used to work exception accounts by the Government Reimbursement Analysts.,141154,0,TRUE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43605,29,The Tool is the main system used to work exception accounts by the Government Reimbursement Analysts.,141154,0,TRUE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43605,29,The Tool is the main system used to work exception accounts by the Government Reimbursement Analysts.,141155,1,FALSE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,43605,29,The Tool is the main system used to work exception accounts by the Government Reimbursement Analysts.,141155,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64922,30,Actions for Government Post Payment Review are located in which folder in Med-Metrix?,216942,0,Post Payment ONLY,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64922,30,Actions for Government Post Payment Review are located in which folder in Med-Metrix?,216942,0,Post Payment ONLY,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64922,30,Actions for Government Post Payment Review are located in which folder in Med-Metrix?,216943,1,Billing ONLY,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64922,30,Actions for Government Post Payment Review are located in which folder in Med-Metrix?,216943,1,Billing ONLY,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64922,30,Actions for Government Post Payment Review are located in which folder in Med-Metrix?,216944,2,CCA ONLY,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64922,30,Actions for Government Post Payment Review are located in which folder in Med-Metrix?,216944,2,CCA ONLY,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64923,31,"Which option in STAR allows you to view such things as patient demographics, review and enter account notes, medical information and diagnosis codes?",216945,0,Patient Information,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64923,31,"Which option in STAR allows you to view such things as patient demographics, review and enter account notes, medical information and diagnosis codes?",216945,0,Patient Information,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64923,31,"Which option in STAR allows you to view such things as patient demographics, review and enter account notes, medical information and diagnosis codes?",216946,1,Account Revision,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64923,31,"Which option in STAR allows you to view such things as patient demographics, review and enter account notes, medical information and diagnosis codes?",216946,1,Account Revision,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64923,31,"Which option in STAR allows you to view such things as patient demographics, review and enter account notes, medical information and diagnosis codes?",216947,2,Notes,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64923,31,"Which option in STAR allows you to view such things as patient demographics, review and enter account notes, medical information and diagnosis codes?",216947,2,Notes,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64923,31,"Which option in STAR allows you to view such things as patient demographics, review and enter account notes, medical information and diagnosis codes?",216948,3,Account Inquiry,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64923,31,"Which option in STAR allows you to view such things as patient demographics, review and enter account notes, medical information and diagnosis codes?",216948,3,Account Inquiry,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64924,32,It is important to review your notes before saving in Med-Metrix as they cannot be changed/updated once completed.,216949,0,TRUE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64924,32,It is important to review your notes before saving in Med-Metrix as they cannot be changed/updated once completed.,216949,0,TRUE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64924,32,It is important to review your notes before saving in Med-Metrix as they cannot be changed/updated once completed.,216950,1,FALSE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64924,32,It is important to review your notes before saving in Med-Metrix as they cannot be changed/updated once completed.,216950,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64925,33,"Once SmartFeeds-Accounting is launched in Med-Metrix, an account is automatically served in your Shopping Cart.",216951,0,TRUE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64925,33,"Once SmartFeeds-Accounting is launched in Med-Metrix, an account is automatically served in your Shopping Cart.",216951,0,TRUE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64925,33,"Once SmartFeeds-Accounting is launched in Med-Metrix, an account is automatically served in your Shopping Cart.",216952,1,FALSE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64925,33,"Once SmartFeeds-Accounting is launched in Med-Metrix, an account is automatically served in your Shopping Cart.",216952,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64926,34,"There are 2 OneContent environments, one for Atlanta, Cherokee & Forsyth and one for Duluth & Gwinnett.",216953,0,TRUE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64926,34,"There are 2 OneContent environments, one for Atlanta, Cherokee & Forsyth and one for Duluth & Gwinnett.",216953,0,TRUE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64926,34,"There are 2 OneContent environments, one for Atlanta, Cherokee & Forsyth and one for Duluth & Gwinnett.",216954,1,FALSE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64926,34,"There are 2 OneContent environments, one for Atlanta, Cherokee & Forsyth and one for Duluth & Gwinnett.",216954,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64927,35,"From the Flashcard, what is typed to view the Balance Summary?",216955,0,M,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64927,35,"From the Flashcard, what is typed to view the Balance Summary?",216955,0,M,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64927,35,"From the Flashcard, what is typed to view the Balance Summary?",216956,1,K,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64927,35,"From the Flashcard, what is typed to view the Balance Summary?",216956,1,K,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64927,35,"From the Flashcard, what is typed to view the Balance Summary?",216957,2,H,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64927,35,"From the Flashcard, what is typed to view the Balance Summary?",216957,2,H,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64927,35,"From the Flashcard, what is typed to view the Balance Summary?",216958,3,B,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64927,35,"From the Flashcard, what is typed to view the Balance Summary?",216958,3,B,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64928,36,Which option in STAR is selected to view the Expected Reimbursement?,216959,0,3- Financial Information,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64928,36,Which option in STAR is selected to view the Expected Reimbursement?,216959,0,3- Financial Information,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64928,36,Which option in STAR is selected to view the Expected Reimbursement?,216960,1,Flashcard,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64928,36,Which option in STAR is selected to view the Expected Reimbursement?,216960,1,Flashcard,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64928,36,Which option in STAR is selected to view the Expected Reimbursement?,216961,2,15- User Defined Fields,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64928,36,Which option in STAR is selected to view the Expected Reimbursement?,216961,2,15- User Defined Fields,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64928,36,Which option in STAR is selected to view the Expected Reimbursement?,216962,3,1- Contractual Adjustments,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64928,36,Which option in STAR is selected to view the Expected Reimbursement?,216962,3,1- Contractual Adjustments,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64929,37,You can view your productivity by clicking on the How Am I doing accordion in Med-Metrix,216963,0,TRUE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64929,37,You can view your productivity by clicking on the How Am I doing accordion in Med-Metrix,216963,0,TRUE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64929,37,You can view your productivity by clicking on the How Am I doing accordion in Med-Metrix,216964,1,FALSE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64929,37,You can view your productivity by clicking on the How Am I doing accordion in Med-Metrix,216964,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64930,38,"In OneContent, the Patient tab allows the user to review a specific account by entering the Encounter number.",216965,0,TRUE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64930,38,"In OneContent, the Patient tab allows the user to review a specific account by entering the Encounter number.",216965,0,TRUE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64930,38,"In OneContent, the Patient tab allows the user to review a specific account by entering the Encounter number.",216966,1,FALSE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64930,38,"In OneContent, the Patient tab allows the user to review a specific account by entering the Encounter number.",216966,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64931,39,"What screen in STAR is the Admission Type, Service and Admitting Diagnosis viewed on?",216967,0,Location Information,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64931,39,"What screen in STAR is the Admission Type, Service and Admitting Diagnosis viewed on?",216967,0,Location Information,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64931,39,"What screen in STAR is the Admission Type, Service and Admitting Diagnosis viewed on?",216968,1,Physician Information,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64931,39,"What screen in STAR is the Admission Type, Service and Admitting Diagnosis viewed on?",216968,1,Physician Information,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64931,39,"What screen in STAR is the Admission Type, Service and Admitting Diagnosis viewed on?",216969,2,Diagnosis Information,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64931,39,"What screen in STAR is the Admission Type, Service and Admitting Diagnosis viewed on?",216969,2,Diagnosis Information,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64931,39,"What screen in STAR is the Admission Type, Service and Admitting Diagnosis viewed on?",216970,3,Medical Information,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64931,39,"What screen in STAR is the Admission Type, Service and Admitting Diagnosis viewed on?",216970,3,Medical Information,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64932,40,You cannot skip an account in your SmartFeed in Med-Metrix.,216971,0,TRUE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64932,40,You cannot skip an account in your SmartFeed in Med-Metrix.,216971,0,TRUE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64932,40,You cannot skip an account in your SmartFeed in Med-Metrix.,216972,1,FALSE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64932,40,You cannot skip an account in your SmartFeed in Med-Metrix.,216972,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64933,41,Med-Metrix gives you the highest priority account from your highest priority _________________.,216973,0,Action,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64933,41,Med-Metrix gives you the highest priority account from your highest priority _________________.,216973,0,Action,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64933,41,Med-Metrix gives you the highest priority account from your highest priority _________________.,216974,1,SmartFeed,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64933,41,Med-Metrix gives you the highest priority account from your highest priority _________________.,216974,1,SmartFeed,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64933,41,Med-Metrix gives you the highest priority account from your highest priority _________________.,216975,2,Event Trigger,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64933,41,Med-Metrix gives you the highest priority account from your highest priority _________________.,216975,2,Event Trigger,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64934,42,A Credit:,216976,0,Increases the Balance,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64934,42,A Credit:,216976,0,Increases the Balance,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64934,42,A Credit:,216977,1,Decreases the Balance,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64934,42,A Credit:,216977,1,Decreases the Balance,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64934,42,A Credit:,216978,2,Does not affect the Balance,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64934,42,A Credit:,216978,2,Does not affect the Balance,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64935,43,Escalations to leadership should take place in Med-Metrix by following the appropriate Action workflow.,216979,0,TRUE,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64935,43,Escalations to leadership should take place in Med-Metrix by following the appropriate Action workflow.,216979,0,TRUE,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64935,43,Escalations to leadership should take place in Med-Metrix by following the appropriate Action workflow.,216980,1,FALSE,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64935,43,Escalations to leadership should take place in Med-Metrix by following the appropriate Action workflow.,216980,1,FALSE,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64936,44,Med-Metrix works fastest in:,216981,0,Chrome,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64936,44,Med-Metrix works fastest in:,216981,0,Chrome,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64936,44,Med-Metrix works fastest in:,216982,1,Internet Explorer,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64936,44,Med-Metrix works fastest in:,216982,1,Internet Explorer,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64936,44,Med-Metrix works fastest in:,216983,2,Northside Intranet,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64936,44,Med-Metrix works fastest in:,216983,2,Northside Intranet,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64937,45,________ indicate a separate concurrent process an account is included in.,216984,0,Actions,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64937,45,________ indicate a separate concurrent process an account is included in.,216984,0,Actions,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64937,45,________ indicate a separate concurrent process an account is included in.,216985,1,SmartFeeds,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64937,45,________ indicate a separate concurrent process an account is included in.,216985,1,SmartFeeds,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64937,45,________ indicate a separate concurrent process an account is included in.,216986,2,Flags,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64937,45,________ indicate a separate concurrent process an account is included in.,216986,2,Flags,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64938,46,"In Med-Metrix, Actions are used to note:",216987,0,Incoming Calls,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64938,46,"In Med-Metrix, Actions are used to note:",216987,0,Incoming Calls,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64938,46,"In Med-Metrix, Actions are used to note:",216988,1,Emails Received,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64938,46,"In Med-Metrix, Actions are used to note:",216988,1,Emails Received,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64938,46,"In Med-Metrix, Actions are used to note:",216989,2,The work that was performed on an account,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64938,46,"In Med-Metrix, Actions are used to note:",216989,2,The work that was performed on an account,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64939,47,The two most visited options in STAR on the Main tab are:,216990,0,Account Inquiry and Account Revision,1
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64939,47,The two most visited options in STAR on the Main tab are:,216990,0,Account Inquiry and Account Revision,1
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64939,47,The two most visited options in STAR on the Main tab are:,216991,1,MPI Inquiry and Account Revision,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64939,47,The two most visited options in STAR on the Main tab are:,216991,1,MPI Inquiry and Account Revision,0
4073,ILT-0000-18056,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64939,47,The two most visited options in STAR on the Main tab are:,216992,2,Account Revision and Notes,0
9825,Questions-0000-119,RCT: GOVERNMENT POST PAYMENT REVIEW UNIVERSITY TEST 2020,n8946,64939,47,The two most visited options in STAR on the Main tab are:,216992,2,Account Revision and Notes,0
9523,Elearning-0000-752,C-373: DONOR SELECTION,n8952,43624,0,C-373 includes patients with _____________ .,141208,0,"a.	Any age.",0
9523,Elearning-0000-752,C-373: DONOR SELECTION,n8952,43624,0,C-373 includes patients with _____________ .,141209,1,"b.	Any conditioning regimen.",0
9523,Elearning-0000-752,C-373: DONOR SELECTION,n8952,43624,0,C-373 includes patients with _____________ .,141210,2,"c.	Any GVHD prophylaxis",0
9523,Elearning-0000-752,C-373: DONOR SELECTION,n8952,43624,0,C-373 includes patients with _____________ .,141211,3,"d.	All of the above.",1
9523,Elearning-0000-752,C-373: DONOR SELECTION,n8952,43625,1,C-373 is an observational study only to look at donor selection alternatives.,141212,0,TRUE,1
9523,Elearning-0000-752,C-373: DONOR SELECTION,n8952,43625,1,C-373 is an observational study only to look at donor selection alternatives.,141213,1,FALSE,0
9523,Elearning-0000-752,C-373: DONOR SELECTION,n8952,43626,2,The QOL Substudy is only for patients with AML and early stage MDS.,141214,0,TRUE,1
9523,Elearning-0000-752,C-373: DONOR SELECTION,n8952,43626,2,The QOL Substudy is only for patients with AML and early stage MDS.,141215,1,FALSE,0
9526,Elearning-0000-755,C-369: BMTCTN 1703/180,n8954,43643,0,"1)	In order to be eligible for this study, the patient is allowed to have had a prior transplant.",141280,0,TRUE,0
9526,Elearning-0000-755,C-369: BMTCTN 1703/180,n8954,43643,0,"1)	In order to be eligible for this study, the patient is allowed to have had a prior transplant.",141281,1,FALSE,1
9526,Elearning-0000-755,C-369: BMTCTN 1703/180,n8954,43644,1,"In order to be on the 1703 study, the patient/donor does NOT have to be on the 1801 companion study.",141282,0,TRUE,1
9526,Elearning-0000-755,C-369: BMTCTN 1703/180,n8954,43644,1,"In order to be on the 1703 study, the patient/donor does NOT have to be on the 1801 companion study.",141283,1,FALSE,0
9526,Elearning-0000-755,C-369: BMTCTN 1703/180,n8954,43645,2,"The 1801 study will collect stool, urine and blood biospecimens.",141284,0,TRUE,1
9526,Elearning-0000-755,C-369: BMTCTN 1703/180,n8954,43645,2,"The 1801 study will collect stool, urine and blood biospecimens.",141285,1,FALSE,0
9518,Elearning-0000-748,C-378: ETCTN 9924,n8955,43646,0,The primary objective is to determine the maximum tolerated dose (MTD) of Lenalidomide when given in combination with Blinatumomab.,141286,0,TRUE,1
9518,Elearning-0000-748,C-378: ETCTN 9924,n8955,43646,0,The primary objective is to determine the maximum tolerated dose (MTD) of Lenalidomide when given in combination with Blinatumomab.,141287,1,FALSE,0
9518,Elearning-0000-748,C-378: ETCTN 9924,n8955,43647,1,HIV infected patients are not eligible for this study.,141288,0,TRUE,0
9518,Elearning-0000-748,C-378: ETCTN 9924,n8955,43647,1,HIV infected patients are not eligible for this study.,141289,1,FALSE,1
9518,Elearning-0000-748,C-378: ETCTN 9924,n8955,43648,2,"If Lenalidomide is taken during pregnancy, it may cause birth defects or death to any unborn baby.",141290,0,TRUE,1
9518,Elearning-0000-748,C-378: ETCTN 9924,n8955,43648,2,"If Lenalidomide is taken during pregnancy, it may cause birth defects or death to any unborn baby.",141291,1,FALSE,0
8980,Elearning-0000-259,FY2019 ICU PNEUMONIA DSC EDUCATION: PATIENT CARE,n8971,43827,0,I have read and understand the contents of the CBL FY2019 ICU Pneumonia DSC Education: Patient Care .,142000,0,TRUE,1
8980,Elearning-0000-259,FY2019 ICU PNEUMONIA DSC EDUCATION: PATIENT CARE,n8971,43827,0,I have read and understand the contents of the CBL FY2019 ICU Pneumonia DSC Education: Patient Care .,142001,1,FALSE,0
9220,Elearning-0000-477,LD SURGICOUNT UPDATE JUNE 2019,n8973,43833,0,I acknowledge that I have read and understood the contents of this CBL course.,142017,0,Yes,1
9220,Elearning-0000-477,LD SURGICOUNT UPDATE JUNE 2019,n8973,43833,0,I acknowledge that I have read and understood the contents of this CBL course.,142016,1,No,0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43834,0,The most common use for an NGT following surgery is for ____________________________,142018,0,"a.	Medication administration",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43834,0,The most common use for an NGT following surgery is for ____________________________,142019,1,"b.	Enteral nutrition feeding",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43834,0,The most common use for an NGT following surgery is for ____________________________,142020,2,"c.	Stomach Lavage",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43834,0,The most common use for an NGT following surgery is for ____________________________,142021,3,"d.	Stomach decompression",1
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43835,1,Confirmation that the tube is in proper position in PACU can be done radiology or by physician confirmation.,142022,0,a. True,1
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43835,1,Confirmation that the tube is in proper position in PACU can be done radiology or by physician confirmation.,142023,1,b. False,0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43836,2,NGT placement confirmation by the Surgeon under direct visualization:,142024,0,"a.	is appropriate for confirming initial placement.",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43836,2,NGT placement confirmation by the Surgeon under direct visualization:,142025,1,"b.	can be used to administer medication",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43836,2,NGT placement confirmation by the Surgeon under direct visualization:,142026,2,"c.	may be used for decompression ONLY in the absence of respiratory difficulties or complaints",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43836,2,NGT placement confirmation by the Surgeon under direct visualization:,142027,3,"d.	All of the above",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43836,2,NGT placement confirmation by the Surgeon under direct visualization:,142028,4,"e.	Both B and C",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43836,2,NGT placement confirmation by the Surgeon under direct visualization:,142029,5,"f.	Both A and C",1
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43837,3,Taping or securing tube properly decreases:,142030,0,"a.	Risk of alar necrosis",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43837,3,Taping or securing tube properly decreases:,142031,1,"b.	Damage of nares",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43837,3,Taping or securing tube properly decreases:,142032,2,"c.	Inadvertent dislodgement of tube",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43837,3,Taping or securing tube properly decreases:,142033,3,"d.	All of the above",1
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43838,4,NG tubes should be assessed upon arrival and discharge of the patient in the PACU and should include:,142034,0,"a.	Type of suction",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43838,4,NG tubes should be assessed upon arrival and discharge of the patient in the PACU and should include:,142035,1,"b.	Patency",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43838,4,NG tubes should be assessed upon arrival and discharge of the patient in the PACU and should include:,142036,2,"c.	Amount and color of drainage is not assessed",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43838,4,NG tubes should be assessed upon arrival and discharge of the patient in the PACU and should include:,142037,3,"d.	Tube site and mark the tube at the place it exits the patient's nare.",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43838,4,NG tubes should be assessed upon arrival and discharge of the patient in the PACU and should include:,142038,4,"e.	Assess for signs of respiratory distress",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43838,4,NG tubes should be assessed upon arrival and discharge of the patient in the PACU and should include:,142039,5,"f.	All of the above",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43838,4,NG tubes should be assessed upon arrival and discharge of the patient in the PACU and should include:,142040,6,"g.	All but C",1
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43838,4,NG tubes should be assessed upon arrival and discharge of the patient in the PACU and should include:,142041,7,"h.	Only A, B, and C",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43839,5,Do not irrigate or manipulate the NG tube unless ordered by the surgeon.,142042,0,a. True,1
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43839,5,Do not irrigate or manipulate the NG tube unless ordered by the surgeon.,142043,1,b. False,0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43840,6,Signs of respiratory distress due to misplacement of NGT in pulmonary tree include:,142044,0,"a.	Sneezing",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43840,6,Signs of respiratory distress due to misplacement of NGT in pulmonary tree include:,142045,1,"b.	Tachypnea",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43840,6,Signs of respiratory distress due to misplacement of NGT in pulmonary tree include:,142046,2,"c.	Dyspnea",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43840,6,Signs of respiratory distress due to misplacement of NGT in pulmonary tree include:,142047,3,"d.	Increase in O2",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43840,6,Signs of respiratory distress due to misplacement of NGT in pulmonary tree include:,142048,4,"e.	No Change in skin color",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43840,6,Signs of respiratory distress due to misplacement of NGT in pulmonary tree include:,142049,5,"f.	Periods of apnea",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43840,6,Signs of respiratory distress due to misplacement of NGT in pulmonary tree include:,142050,6,"g.	All of the above",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43840,6,Signs of respiratory distress due to misplacement of NGT in pulmonary tree include:,142051,7,"h.	Only A, B and C",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43840,6,Signs of respiratory distress due to misplacement of NGT in pulmonary tree include:,142052,8,"i.	Only B, C and F",1
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43840,6,Signs of respiratory distress due to misplacement of NGT in pulmonary tree include:,142053,9,"j.	Only B, C and D",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43841,7,Placement of an NGT is not associated with perforation of pulmonary structures or the gastrointestinal tract.,142054,0,a. True,0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43841,7,Placement of an NGT is not associated with perforation of pulmonary structures or the gastrointestinal tract.,142055,1,b. False,1
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43842,8,NGT Information that should be included in Handoff communication includes:,142056,0,"a.	Securement device",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43842,8,NGT Information that should be included in Handoff communication includes:,142057,1,"b.	How placement was verified",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43842,8,NGT Information that should be included in Handoff communication includes:,142058,2,"c.	Specific orders related to NGT use",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43842,8,NGT Information that should be included in Handoff communication includes:,142059,3,"d.	Type of tube",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43842,8,NGT Information that should be included in Handoff communication includes:,142060,4,"e.	All of the above",1
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43842,8,NGT Information that should be included in Handoff communication includes:,142061,5,"f.	Only A and C",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43842,8,NGT Information that should be included in Handoff communication includes:,142062,6,"g.	Only A and E",0
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43843,9,Improperly securing the tube placement of too large of a tube in an unconscious patient that cannot verbalize their discomfort can lead to ulcers and even necrosis,142063,0,a. True,1
8209,Elearning-0000-1099,FY2019 POST-OPERATIVE CARE OF THE NASOGASTRIC TUBE IN PACU,n8974,43843,9,Improperly securing the tube placement of too large of a tube in an unconscious patient that cannot verbalize their discomfort can lead to ulcers and even necrosis,142064,1,b. False,0
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43900,0,"When a wound vacuum dressing is placed in the operating room, the following must be documented:",142255,0,"a.	Type of Sponge",0
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43900,0,"When a wound vacuum dressing is placed in the operating room, the following must be documented:",142256,1,"b.	Number of sponges",0
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43900,0,"When a wound vacuum dressing is placed in the operating room, the following must be documented:",142257,2,"c.	Pressure Setting",0
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43900,0,"When a wound vacuum dressing is placed in the operating room, the following must be documented:",142258,3,"d.	Site, including laterality if applicable",0
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43900,0,"When a wound vacuum dressing is placed in the operating room, the following must be documented:",142259,4,"e.	All of the Above",1
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43901,1,What types of sponges are available to be used with wound vacuum dressing?,142260,0,"a.	Black",0
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43901,1,What types of sponges are available to be used with wound vacuum dressing?,142261,1,"b.	White",0
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43901,1,What types of sponges are available to be used with wound vacuum dressing?,142262,2,"c.	Red",0
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43901,1,What types of sponges are available to be used with wound vacuum dressing?,142263,3,"d.	Silver",0
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43901,1,What types of sponges are available to be used with wound vacuum dressing?,142264,4,"e.	All of the above",0
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43901,1,What types of sponges are available to be used with wound vacuum dressing?,142265,5,"f.	Only A, C and D",0
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43901,1,What types of sponges are available to be used with wound vacuum dressing?,142266,6,"g.	Only A, B and D",1
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43901,1,What types of sponges are available to be used with wound vacuum dressing?,142267,7,"h.	Only B and C",0
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43902,2,The information related to the wound vacuum dressing placed in the operating room does not have to be included in handoff communication.,142268,0,TRUE,0
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43902,2,The information related to the wound vacuum dressing placed in the operating room does not have to be included in handoff communication.,142269,1,FALSE,1
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43903,3,"In the OR, ______________ is responsible for placing the wound vacuum dressing and including details in their immediate post-operative note.",142270,0,"a.	RN",0
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43903,3,"In the OR, ______________ is responsible for placing the wound vacuum dressing and including details in their immediate post-operative note.",142271,1,"b.	Tech",0
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43903,3,"In the OR, ______________ is responsible for placing the wound vacuum dressing and including details in their immediate post-operative note.",142272,2,"c.	First Assist",0
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43903,3,"In the OR, ______________ is responsible for placing the wound vacuum dressing and including details in their immediate post-operative note.",142273,3,"d.	Physician",1
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43904,4,The RN can choose the pressure setting for a wound vacuum dressing once placed.,142274,0,TRUE,0
9340,Elearning-0000-586,FY2019 REQUIRED INTRA-OPERATIVE CERNER DOCUMENTATION FOR WOUND VACUUM DRESSING,n8982,43904,4,The RN can choose the pressure setting for a wound vacuum dressing once placed.,142275,1,FALSE,1
8905,Elearning-0000-190,"FY19 ANALGESIC, SEDATON, AND NMBA ASSESSMENT",n8985,43907,0,How often are you assessing and documenting RASS for a non-vented patient on Precedex drip?,142280,0,A. Every 2 hours,0
8905,Elearning-0000-190,"FY19 ANALGESIC, SEDATON, AND NMBA ASSESSMENT",n8985,43907,0,How often are you assessing and documenting RASS for a non-vented patient on Precedex drip?,142281,1,B. Every 4 hours,0
8905,Elearning-0000-190,"FY19 ANALGESIC, SEDATON, AND NMBA ASSESSMENT",n8985,43907,0,How often are you assessing and documenting RASS for a non-vented patient on Precedex drip?,142282,2,C. Only as needed,0
8905,Elearning-0000-190,"FY19 ANALGESIC, SEDATON, AND NMBA ASSESSMENT",n8985,43907,0,How often are you assessing and documenting RASS for a non-vented patient on Precedex drip?,142283,3,"D. Every 2 hours, as well as with any boluses and/or drip titrations.",1
8905,Elearning-0000-190,"FY19 ANALGESIC, SEDATON, AND NMBA ASSESSMENT",n8985,43908,1,How often are you to assess PAYEN for a non-vented patient?,142284,0,A. Every 2 hours,0
8905,Elearning-0000-190,"FY19 ANALGESIC, SEDATON, AND NMBA ASSESSMENT",n8985,43908,1,How often are you to assess PAYEN for a non-vented patient?,142285,1,B. Not required,1
8905,Elearning-0000-190,"FY19 ANALGESIC, SEDATON, AND NMBA ASSESSMENT",n8985,43908,1,How often are you to assess PAYEN for a non-vented patient?,142286,2,C. Every 4 hours,0
8905,Elearning-0000-190,"FY19 ANALGESIC, SEDATON, AND NMBA ASSESSMENT",n8985,43908,1,How often are you to assess PAYEN for a non-vented patient?,142287,3,"D. Every 2 hours, as well as with any boluses and/or drip titrations.",0
8905,Elearning-0000-190,"FY19 ANALGESIC, SEDATON, AND NMBA ASSESSMENT",n8985,43909,2,How often are you to assess RASS for a vented patient on a versed drip?,142288,0,A. Every 2 hours,0
8905,Elearning-0000-190,"FY19 ANALGESIC, SEDATON, AND NMBA ASSESSMENT",n8985,43909,2,How often are you to assess RASS for a vented patient on a versed drip?,142289,1,"B. Every 2 hours, as well as with any boluses and/or drip titrations.",1
8905,Elearning-0000-190,"FY19 ANALGESIC, SEDATON, AND NMBA ASSESSMENT",n8985,43909,2,How often are you to assess RASS for a vented patient on a versed drip?,142290,2,C. Only as needed,0
8905,Elearning-0000-190,"FY19 ANALGESIC, SEDATON, AND NMBA ASSESSMENT",n8985,43909,2,How often are you to assess RASS for a vented patient on a versed drip?,142291,3,D. Not required.,0
9343,Elearning-0000-589,FY19 SURGICOUNT TABLET OVERVIEW,n8989,43936,0,I have read and understand the contents of this CBL and will complete return demonstration on my unit.,142391,0,TRUE,1
9343,Elearning-0000-589,FY19 SURGICOUNT TABLET OVERVIEW,n8989,43936,0,I have read and understand the contents of this CBL and will complete return demonstration on my unit.,142392,1,FALSE,0
8202,Elearning-0000-1092,SKIN INTEGRITY FOR THE HEMODYNAMICALLY COMPROMISED PATIENT UPDATED,n9003,44127,0,"Mr. H was admitted 2 days ago. He has been oxygen dependent for the last 3 months. Today, you notice a wound on the left ear from his oxygen tubing. Cartilage can be seen in the wound base. What do you do?",143057,0,"A. Suspect this is a pressure injury because of location and patient history. Document, offload area, consult WOCN.",1
8202,Elearning-0000-1092,SKIN INTEGRITY FOR THE HEMODYNAMICALLY COMPROMISED PATIENT UPDATED,n9003,44127,0,"Mr. H was admitted 2 days ago. He has been oxygen dependent for the last 3 months. Today, you notice a wound on the left ear from his oxygen tubing. Cartilage can be seen in the wound base. What do you do?",143058,1,B. Nothing. It wasn't documented in the computer and looks existing.,0
8202,Elearning-0000-1092,SKIN INTEGRITY FOR THE HEMODYNAMICALLY COMPROMISED PATIENT UPDATED,n9003,44128,1,What should the admitting RN do with dressings found on admission?,143059,0,A. Leave in place until WOCN assesses the patient.,0
8202,Elearning-0000-1092,SKIN INTEGRITY FOR THE HEMODYNAMICALLY COMPROMISED PATIENT UPDATED,n9003,44128,1,What should the admitting RN do with dressings found on admission?,143060,1,B. Notify MD of dressing. Get wound treatment orders or WOCN consult.,0
8202,Elearning-0000-1092,SKIN INTEGRITY FOR THE HEMODYNAMICALLY COMPROMISED PATIENT UPDATED,n9003,44128,1,What should the admitting RN do with dressings found on admission?,143061,2,C. Reinforce as needed. Wait for admitting MD to provide orders when she rounds.,0
8202,Elearning-0000-1092,SKIN INTEGRITY FOR THE HEMODYNAMICALLY COMPROMISED PATIENT UPDATED,n9003,44128,1,What should the admitting RN do with dressings found on admission?,143062,3,"D. Remove dressings, start a wound in Cerner, document location and wound description. Notify attending MD and request wound treatment orders or WOCN consult.",1
8202,Elearning-0000-1092,SKIN INTEGRITY FOR THE HEMODYNAMICALLY COMPROMISED PATIENT UPDATED,n9003,44129,2,"An 84 year old female was admitted to your unit for confusion. She is bedbound and is oriented to self but requires reorientation of time and place.<br> She follows commands, is continent of urine and stool, has no dietary restrictions but has been refusing meals. <br> She is able to reposition herself in bed without assist but occasionally slides down in the bed.<br> What is her Braden score? (use chart to calculate)",143063,0,A. 16,1
8202,Elearning-0000-1092,SKIN INTEGRITY FOR THE HEMODYNAMICALLY COMPROMISED PATIENT UPDATED,n9003,44129,2,"An 84 year old female was admitted to your unit for confusion. She is bedbound and is oriented to self but requires reorientation of time and place.<br> She follows commands, is continent of urine and stool, has no dietary restrictions but has been refusing meals. <br> She is able to reposition herself in bed without assist but occasionally slides down in the bed.<br> What is her Braden score? (use chart to calculate)",143064,1,B. 10,0
8202,Elearning-0000-1092,SKIN INTEGRITY FOR THE HEMODYNAMICALLY COMPROMISED PATIENT UPDATED,n9003,44129,2,"An 84 year old female was admitted to your unit for confusion. She is bedbound and is oriented to self but requires reorientation of time and place.<br> She follows commands, is continent of urine and stool, has no dietary restrictions but has been refusing meals. <br> She is able to reposition herself in bed without assist but occasionally slides down in the bed.<br> What is her Braden score? (use chart to calculate)",143065,2,C. 23,0
8202,Elearning-0000-1092,SKIN INTEGRITY FOR THE HEMODYNAMICALLY COMPROMISED PATIENT UPDATED,n9003,44130,3,"Based on her Braden Score, what interventions would you initiate as her primary nurse?",143066,0,"A. 	Consult WOCN, await orders",0
8202,Elearning-0000-1092,SKIN INTEGRITY FOR THE HEMODYNAMICALLY COMPROMISED PATIENT UPDATED,n9003,44130,3,"Based on her Braden Score, what interventions would you initiate as her primary nurse?",143067,1,"B. Consult WOCN, initiate skin integrity guidelines",0
8202,Elearning-0000-1092,SKIN INTEGRITY FOR THE HEMODYNAMICALLY COMPROMISED PATIENT UPDATED,n9003,44130,3,"Based on her Braden Score, what interventions would you initiate as her primary nurse?",143068,2,"C. Initiate skin integrity guidelines, 	order a waffle overlay for pressure redistribution, discuss dietary 	preference with patient to encourage PO intake",1
8202,Elearning-0000-1092,SKIN INTEGRITY FOR THE HEMODYNAMICALLY COMPROMISED PATIENT UPDATED,n9003,44130,3,"Based on her Braden Score, what interventions would you initiate as her primary nurse?",143069,3,D. All of the above,0
2528,ILT-0000-11829,LABOR AND DELIVERY,n9035,44351,0,I have read and understood the content of this module.,143866,0,TRUE,1
2528,ILT-0000-11829,LABOR AND DELIVERY,n9035,44351,0,I have read and understood the content of this module.,143867,1,FALSE,0
9048,Elearning-0000-320,NSH1230 TRANSCEND,n9036,44352,0,Patients must be eligible for a transplant to participate in this study,143868,0,TRUE,0
9048,Elearning-0000-320,NSH1230 TRANSCEND,n9036,44352,0,Patients must be eligible for a transplant to participate in this study,143869,1,FALSE,1
9048,Elearning-0000-320,NSH1230 TRANSCEND,n9036,44353,1,The washout period for steroids is 7 days prior to leukapheresis and 72 hours to JCAR,143870,0,TRUE,1
9048,Elearning-0000-320,NSH1230 TRANSCEND,n9036,44353,1,The washout period for steroids is 7 days prior to leukapheresis and 72 hours to JCAR,143871,1,FALSE,0
9048,Elearning-0000-320,NSH1230 TRANSCEND,n9036,44354,2,Patients can have prior CD19 therapy,143872,0,TRUE,0
9048,Elearning-0000-320,NSH1230 TRANSCEND,n9036,44354,2,Patients can have prior CD19 therapy,143873,1,FALSE,1
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44436,0,"_____________________ are responsible for entering the order for any ABG that is run under the Oxygen, Rapid Response or Ventilator protocol.",144205,0,"a)	The Nurse",0
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44436,0,"_____________________ are responsible for entering the order for any ABG that is run under the Oxygen, Rapid Response or Ventilator protocol.",144206,1,"b)	You",1
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44437,1,You must have an ABG in order to wean.,144207,0,TRUE,0
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44437,1,You must have an ABG in order to wean.,144208,1,FALSE,1
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44438,2,"Before performing an ABG, the patient identity needs to be verified using:",144209,0,"a)	Name",0
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44438,2,"Before performing an ABG, the patient identity needs to be verified using:",144210,1,"b)	Birthdate",0
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44438,2,"Before performing an ABG, the patient identity needs to be verified using:",144211,2,"c)	MRN from patient's armband",0
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44438,2,"Before performing an ABG, the patient identity needs to be verified using:",144212,3,"d)	Any 2 identifiers listed above",1
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44439,3,"During an Allen's test, you release pressure on the ____________ artery.",144213,0,"a.	Ulnar",1
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44439,3,"During an Allen's test, you release pressure on the ____________ artery.",144214,1,"b.	Femoral",0
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44439,3,"During an Allen's test, you release pressure on the ____________ artery.",144215,2,"c.	Radial",0
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44440,4,If a sample is more than 1 hour old and on ice or 30 minutes without ice you should:,144216,0,"a.	Run the sample anyway",0
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44440,4,If a sample is more than 1 hour old and on ice or 30 minutes without ice you should:,144217,1,"b.	Discard the sample and enter a no charge panel for the test.",1
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44441,5,Mandatory Fields include:,144218,0,"a.	Draw Time",0
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44441,5,Mandatory Fields include:,144219,1,"b.	Ordered by",0
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44441,5,Mandatory Fields include:,144220,2,"c.	Sample type",0
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44441,5,Mandatory Fields include:,144221,3,"d.	Sample site",0
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44441,5,Mandatory Fields include:,144222,4,"e.	All of the above",1
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44442,6,All Critical results must be reported to a credential medical professional within ___________minutes.,144223,0,"a.	10",0
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44442,6,All Critical results must be reported to a credential medical professional within ___________minutes.,144224,1,"b.	30",1
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44442,6,All Critical results must be reported to a credential medical professional within ___________minutes.,144225,2,"c.	60",0
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44443,7,You must enter both an AdHoc and Therapist time when performing an ABG.,144226,0,TRUE,1
8230,Elearning-0000-1117,2019 ANNUAL ABG CBL,n9044,44443,7,You must enter both an AdHoc and Therapist time when performing an ABG.,144227,1,FALSE,0
9093,Elearning-0000-361,NSH1219: RITUXAN + IBRUTINIB,n9053,44492,0,The combination of Ibrutinib and Rituximab will be used in the proposed protocol for the treatment of AML?,144381,0,TRUE,0
9093,Elearning-0000-361,NSH1219: RITUXAN + IBRUTINIB,n9053,44492,0,The combination of Ibrutinib and Rituximab will be used in the proposed protocol for the treatment of AML?,144382,1,FALSE,1
9093,Elearning-0000-361,NSH1219: RITUXAN + IBRUTINIB,n9053,44493,1,The use of CYP3A inhibitors poses no risk when used concomitantly in this treatment regimen?,144383,0,TRUE,0
9093,Elearning-0000-361,NSH1219: RITUXAN + IBRUTINIB,n9053,44493,1,The use of CYP3A inhibitors poses no risk when used concomitantly in this treatment regimen?,144384,1,FALSE,1
9093,Elearning-0000-361,NSH1219: RITUXAN + IBRUTINIB,n9053,44494,2,Dose modifications guidance for patients with impaired hepatic function is based on Bilirubin level.,144385,0,TRUE,1
9093,Elearning-0000-361,NSH1219: RITUXAN + IBRUTINIB,n9053,44494,2,Dose modifications guidance for patients with impaired hepatic function is based on Bilirubin level.,144386,1,FALSE,0
9093,Elearning-0000-361,NSH1219: RITUXAN + IBRUTINIB,n9053,44495,3,Growth factor usage is not allowed per protocol.,144387,0,TRUE,0
9093,Elearning-0000-361,NSH1219: RITUXAN + IBRUTINIB,n9053,44495,3,Growth factor usage is not allowed per protocol.,144388,1,FALSE,1
9093,Elearning-0000-361,NSH1219: RITUXAN + IBRUTINIB,n9053,44496,4,Patients may remain on study for 12 months of treatment,144389,0,TRUE,1
9093,Elearning-0000-361,NSH1219: RITUXAN + IBRUTINIB,n9053,44496,4,Patients may remain on study for 12 months of treatment,144390,1,FALSE,0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44472,0,Pre-Team Verifiers will call the payer to get the actual authorizations.,144329,0,TRUE,0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44472,0,Pre-Team Verifiers will call the payer to get the actual authorizations.,144330,1,FALSE,1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44473,1,"What application is used to determine if the visit is for OP or IP, to view if there are any discrepancies with the DOS, and to confirm the account number for the scheduled visit?",144331,0,"a.	OneContent",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44473,1,"What application is used to determine if the visit is for OP or IP, to view if there are any discrepancies with the DOS, and to confirm the account number for the scheduled visit?",144332,1,"b.	Cerner Schapptbook",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44473,1,"What application is used to determine if the visit is for OP or IP, to view if there are any discrepancies with the DOS, and to confirm the account number for the scheduled visit?",144333,2,"c.	RevRunner",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44474,2,Pre-Team Verifiers work is received via the:,144334,0,"a.	OneContent queues",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44474,2,Pre-Team Verifiers work is received via the:,144335,1,"b.	Med-Metrix",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44474,2,Pre-Team Verifiers work is received via the:,144336,2,"c.	STAR",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44475,5,When is the Perioperative Procedure Crosswalk used?,144337,0,"a.	If the actual CPT code is not listed in the Worklist Tool",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44475,5,When is the Perioperative Procedure Crosswalk used?,144338,1,"b.	STAR is down",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44475,5,When is the Perioperative Procedure Crosswalk used?,144339,2,"c.	The appointment cannot be found in Cerner",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44476,3,All insurance eligibility should be obtained directly from Availity?,144340,0,TRUE,0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44476,3,All insurance eligibility should be obtained directly from Availity?,144341,1,FALSE,1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44477,4,Availity will return insurance eligibility for most payors except for:,144342,0,"a.	Medicaid, UHC, and Blue Cross",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44477,4,Availity will return insurance eligibility for most payors except for:,144343,1,"b.	UHC, Kaiser, and Tricare",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44477,4,Availity will return insurance eligibility for most payors except for:,144344,2,"c.	UHC, Kaiser, and Medicaid",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44478,8,"Under the Pre-Registration menu within the tool, Pre Team selects ""My Verif Worklist"" to view accounts that have been assigned by your lead and/or Supervisor.",144345,0,TRUE,1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44478,8,"Under the Pre-Registration menu within the tool, Pre Team selects ""My Verif Worklist"" to view accounts that have been assigned by your lead and/or Supervisor.",144346,1,FALSE,0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44479,6,"Without an authorization from the payer, what will the financial class be listed for the visit?",144347,0,"a.	S- Self-pay",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44479,6,"Without an authorization from the payer, what will the financial class be listed for the visit?",144348,1,"b.	I- Commercial",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44479,6,"Without an authorization from the payer, what will the financial class be listed for the visit?",144349,2,"c.	G- Employee account",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44480,7,"Contacting the Payer, what is one item NSH will not request   _________________.",144350,0,"a.	Effective date of coverage",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44480,7,"Contacting the Payer, what is one item NSH will not request   _________________.",144351,1,"b.	Diagnosis code",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44480,7,"Contacting the Payer, what is one item NSH will not request   _________________.",144352,2,"c.	Deductible",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44481,9,The following steps are followed for accounts with no verifiable insurance information:,144353,0,"a.	Call the physician's office to see if they have updated information",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44481,9,The following steps are followed for accounts with no verifiable insurance information:,144354,1,"b.	Call the patient to see if they have updated information",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44481,9,The following steps are followed for accounts with no verifiable insurance information:,144355,2,"c.	Both A & B",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44483,10,Accounts that do not have an authorization for a procedure that requires authorization should be escalated if that service is to be performed within three days.,144358,0,TRUE,1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44483,10,Accounts that do not have an authorization for a procedure that requires authorization should be escalated if that service is to be performed within three days.,144359,1,FALSE,0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44484,11,"In the Tool, what will be the status of an unworked account?",144360,0,"a.	 ""Z' status",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44484,11,"In the Tool, what will be the status of an unworked account?",144361,1,"b.	Wrong Phone Number status",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44484,11,"In the Tool, what will be the status of an unworked account?",144362,2,"c.	Appointment canceled status",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44485,12,"On the Worklist Tool, what items need to be addressed in order to complete the account?",144363,0,"a.	Pre-Cert Status, FET Status, Account Number",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44485,12,"On the Worklist Tool, what items need to be addressed in order to complete the account?",144364,1,"b.	Pre-Cert Status, Verification Status, Account Number",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44485,12,"On the Worklist Tool, what items need to be addressed in order to complete the account?",144365,2,"c.	Verification Status, Contact Status, Amount Collected",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44486,13,Name items that would need to be obtained from the Payer.,144366,0,"a.	Insurance benefit information Met/Remaining",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44486,13,Name items that would need to be obtained from the Payer.,144367,1,"b.	Name of Representative",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44486,13,Name items that would need to be obtained from the Payer.,144368,2,"c.	All of the above",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44487,14,Pre-Team Reps will never have a reason to contact a patient.,144369,0,TRUE,0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44487,14,Pre-Team Reps will never have a reason to contact a patient.,144370,1,FALSE,1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44488,15,This site is used for Medicaid Eligibility and/or Precert information for a specific CPT code.,144371,0,"a.	Gammis",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44488,15,This site is used for Medicaid Eligibility and/or Precert information for a specific CPT code.,144372,1,"b.	Availity",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44488,15,This site is used for Medicaid Eligibility and/or Precert information for a specific CPT code.,144373,2,"c.	Revrunner",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44489,16,MCA (McKesson Compliance Advisor) is the system that NSH uses to confirm medical necessity prior to a patient receiving services.  We check for medical necessity for Medicare and Medicare Managed Care patients.,144374,0,TRUE,1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44489,16,MCA (McKesson Compliance Advisor) is the system that NSH uses to confirm medical necessity prior to a patient receiving services.  We check for medical necessity for Medicare and Medicare Managed Care patients.,144375,1,FALSE,0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44490,17,What information is obtained when contacting the physician's office and precert has been completed?,144376,0,"a.	CPT codes(s) listed on the precert/authorization",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44490,17,What information is obtained when contacting the physician's office and precert has been completed?,144377,1,"b.	Start and end date of precert/authorization",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44490,17,What information is obtained when contacting the physician's office and precert has been completed?,144378,2,"c.	Both A & B",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44491,18,To ensure correct reimbursement NSH need to assure that there is a pre-certification (authorization) on the patients file.,144379,0,TRUE,1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,44491,18,To ensure correct reimbursement NSH need to assure that there is a pre-certification (authorization) on the patients file.,144380,1,FALSE,0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64093,19,We would call the Physician office if the CPT code & procedure description are unknown.,213934,0,TRUE,1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64093,19,We would call the Physician office if the CPT code & procedure description are unknown.,213935,1,FALSE,0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64094,20,What Standard Note Code is used to express Verification Completed?,213936,0,"a.	SNC 1999",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64094,20,What Standard Note Code is used to express Verification Completed?,213937,1,"b.	SNC 1965",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64094,20,What Standard Note Code is used to express Verification Completed?,213938,2,"c.	SNC 1950",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64095,21,What Standard Note Code is used to express Pre-Certification Completed?,213939,0,"a.	SNC 1966",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64095,21,What Standard Note Code is used to express Pre-Certification Completed?,213940,1,"b.	SNC 1965",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64095,21,What Standard Note Code is used to express Pre-Certification Completed?,213941,2,"c.	SNC 1903",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64096,22,What Standard Note Code is used to express Acct Reviewed?,213942,0,"a.	SNC 1965",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64096,22,What Standard Note Code is used to express Acct Reviewed?,213943,1,"b.	SNC 1966",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64096,22,What Standard Note Code is used to express Acct Reviewed?,213944,2,"c.	SNC 1964",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64097,23,What Standard Note Code is used to express Acct Completed Pre-Cert Not Required?,213945,0,"a.	SNC 1966",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64097,23,What Standard Note Code is used to express Acct Completed Pre-Cert Not Required?,213946,1,"b.	SNC 1964",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64097,23,What Standard Note Code is used to express Acct Completed Pre-Cert Not Required?,213947,2,"c.	SNC 33",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64098,24,What page in STAR is used to load the Pre-Certification information?,213948,0,"a.	Insurance Process Processor page",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64098,24,What page in STAR is used to load the Pre-Certification information?,213949,1,"b.	Patient Page",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64098,24,What page in STAR is used to load the Pre-Certification information?,213950,2,"c.	Insurance Follow-up Processor",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64099,25,"On the Insurance Process Processor Screen, what would need to be entered into the STAR field 18 Approval #?",213951,0,"a.	Patient ID",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64099,25,"On the Insurance Process Processor Screen, what would need to be entered into the STAR field 18 Approval #?",213952,1,"b.	Inpatient authorization number",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64099,25,"On the Insurance Process Processor Screen, what would need to be entered into the STAR field 18 Approval #?",213953,2,"c.	Pre-Team Rep's name",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64100,26,"On the Insurance Process Processor Screen, what would need to be entered into the STAR field 20 -Appr LOS?",213954,0,"a.	""0"" Inpatient ""00"" Outpatient",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64100,26,"On the Insurance Process Processor Screen, what would need to be entered into the STAR field 20 -Appr LOS?",213955,1,"b.	Name of insurance Agency",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64100,26,"On the Insurance Process Processor Screen, what would need to be entered into the STAR field 20 -Appr LOS?",213956,2,"c.	Patients ID number",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64101,27,MCA (McKesson Compliance Advisor) can be accessed directly from the Northside Intranet under Applications.,213957,0,TRUE,1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64101,27,MCA (McKesson Compliance Advisor) can be accessed directly from the Northside Intranet under Applications.,213958,1,FALSE,0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64102,28,While working in MCA what Data source should be selected?,213959,0,"a.	MCAGOTO Meet",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64102,28,While working in MCA what Data source should be selected?,213960,1,"b.	MCA Test",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64102,28,While working in MCA what Data source should be selected?,213961,2,"c.	MCAPROD",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64103,29,What response will a Rep receive if the medical diagnosis code meets the criteria for medical necessity in MCA?,213962,0,"a.	""All Procedures are covered. Save this patient transaction?""",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64103,29,What response will a Rep receive if the medical diagnosis code meets the criteria for medical necessity in MCA?,213963,1,"b.	""All Procedures are Medicare approved. Delete this transaction?""",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64103,29,What response will a Rep receive if the medical diagnosis code meets the criteria for medical necessity in MCA?,213964,2,"c.	""All Procedures are clear. Began billing?""",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64104,30,Copy the Med-Metrix hyperlink and paste in:,213965,0,"a.	Internet Explorer",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64104,30,Copy the Med-Metrix hyperlink and paste in:,213966,1,"b.	Google Chrome",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64104,30,Copy the Med-Metrix hyperlink and paste in:,213967,2,"c.	Northside Intranet",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64105,31,"If a patient has a verified insurance that Northside does not accept, ______________ those accounts as soon as you identify them for an estimate.",213968,0,"a.	Work",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64105,31,"If a patient has a verified insurance that Northside does not accept, ______________ those accounts as soon as you identify them for an estimate.",213969,1,"b.	Escalate",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64105,31,"If a patient has a verified insurance that Northside does not accept, ______________ those accounts as soon as you identify them for an estimate.",213970,2,"c.	Review",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64106,32,"In GAMMIS, under Eligibility Verification Request, which of the following is NOT entered:",213971,0,"a.	Member ID",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64106,32,"In GAMMIS, under Eligibility Verification Request, which of the following is NOT entered:",213972,1,"b.	SSN",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64106,32,"In GAMMIS, under Eligibility Verification Request, which of the following is NOT entered:",213973,2,"c.	Date of Service",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64107,33,"When the patients call the department inquiring about pre-certs or insurance benefits, Pre-Team is to transfer the call to the:",213974,0,"a.	Physician's Office",0
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64107,33,"When the patients call the department inquiring about pre-certs or insurance benefits, Pre-Team is to transfer the call to the:",213975,1,"b.	Lead or Supervisor",1
9839,Questions-0000-131,RCT: PRE-REGISTRATION PRE TEAM UNIVERSITY TEST FY19,n9051,64107,33,"When the patients call the department inquiring about pre-certs or insurance benefits, Pre-Team is to transfer the call to the:",213976,2,"c.	Customer Service",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44532,0,CSM stands for:,144529,0,"a.	Controlled Substance Manager",1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44532,0,CSM stands for:,144530,1,"b.	Compounding System Management",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44532,0,CSM stands for:,144531,2,"c.	Compounded Syringe Medications",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44532,0,CSM stands for:,144532,3,"d.	None of the above",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44533,1,Which of the following terms and definitions are mismatched?,144533,0,"a.	Restock Route: a group of ADMs set to be polled and restocked together.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44533,1,Which of the following terms and definitions are mismatched?,144534,1,"b.	Par value: the minimum stock level of a drug in a pocket.",1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44533,1,Which of the following terms and definitions are mismatched?,144535,2,"c.	Manual Waste: process to waste an item from CSM inventory.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44533,1,Which of the following terms and definitions are mismatched?,144536,3,"d.	None of the above.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44534,2,CSMs can be built with 2 different storage models - Hardware CSM and Software Only CSM.,144537,0,TRUE,1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44534,2,CSMs can be built with 2 different storage models - Hardware CSM and Software Only CSM.,144538,1,FALSE,0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44535,3,Which of the following statements is/are TRUE regarding how to select an item from an on-screen list?,144539,0,"a.	Start typing the first few letters/numbers on any screen with a search box in the top right.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44535,3,Which of the following statements is/are TRUE regarding how to select an item from an on-screen list?,144540,1,"b.	Use the single arrows to scroll down the list and find the item or patient.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44535,3,Which of the following statements is/are TRUE regarding how to select an item from an on-screen list?,144541,2,"c.	Toggle between Brand and Generic names using the radio buttons at the top of a drug list.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44535,3,Which of the following statements is/are TRUE regarding how to select an item from an on-screen list?,144542,3,"d.	Use the double arrows to scroll all the way to the top or bottom of a list.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44535,3,Which of the following statements is/are TRUE regarding how to select an item from an on-screen list?,144543,4,"e.	All of the above are true.",1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44536,4,Which patient identifier is BEST PRACTICE to search by?,144544,0,"a.	Name",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44536,4,Which patient identifier is BEST PRACTICE to search by?,144545,1,"b.	Room number",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44536,4,Which patient identifier is BEST PRACTICE to search by?,144546,2,"c.	Patient ID aka FIN",1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44536,4,Which patient identifier is BEST PRACTICE to search by?,144547,3,"d.	Admission Date",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44536,4,Which patient identifier is BEST PRACTICE to search by?,144548,4,"e.	None of the above",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44537,5,The CSM scanner has a keypad which can be used to type quantities during Cycle Counts.,144549,0,TRUE,1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44537,5,The CSM scanner has a keypad which can be used to type quantities during Cycle Counts.,144550,1,FALSE,0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44538,6,How are Stock-Outs alerted in CSM?,144551,0,"a.	A pop-up window appears on-screen any time an ADM pocket stocks out.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44538,6,How are Stock-Outs alerted in CSM?,144552,1,"b.	A red badge appears above the Stock-Out icon on the Dispense/Return menu.",1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44538,6,How are Stock-Outs alerted in CSM?,144553,2,"c.	A chime sounds on the machine each time, whether someone is logged in or not.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44538,6,How are Stock-Outs alerted in CSM?,144554,3,"d.	A piece of paper prints on the CSM printer.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44538,6,How are Stock-Outs alerted in CSM?,144555,4,"e.	None of the above.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44539,7,All controlled substances dispensed from CSM must be verified through the Pick Verification process.,144556,0,TRUE,1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44539,7,All controlled substances dispensed from CSM must be verified through the Pick Verification process.,144557,1,FALSE,0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44540,8,"To DELETE an item from a dispense, return, expire, or waste process:",144558,0,"a.	Click the alert",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44540,8,"To DELETE an item from a dispense, return, expire, or waste process:",144559,1,"b.	Logout",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44540,8,"To DELETE an item from a dispense, return, expire, or waste process:",144560,2,"c.	Return to the Home screen",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44540,8,"To DELETE an item from a dispense, return, expire, or waste process:",144561,3,"d.	Click the wastebasket icon on the line item",1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44541,9,What's the difference between the Dispense option and the Dispense to Patient option?,144562,0,"a.	Use Dispense to Patient to dispense to an ADM",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44541,9,What's the difference between the Dispense option and the Dispense to Patient option?,144563,1,"b.	Use Dispense to Patient to dispense to an Area",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44541,9,What's the difference between the Dispense option and the Dispense to Patient option?,144564,2,"c.	Use Dispense to send a med to a patient.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44541,9,What's the difference between the Dispense option and the Dispense to Patient option?,144565,3,"d.	Use Dispense to send a med to an ADM or Area without polling all inventory.",1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44542,10,You emptied the return bin on an ADM and found a morphine tablet that was open and a note from the nurse saying it had been dropped. How do you handle it?,144566,0,"a.	Restock it to the ADM pocket.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44542,10,You emptied the return bin on an ADM and found a morphine tablet that was open and a note from the nurse saying it had been dropped. How do you handle it?,144567,1,"b.	Return it to the narc vault using the Manual Return option, waste it using Manual Waste, and then enter the waste amount and waste reason with a witness.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44542,10,You emptied the return bin on an ADM and found a morphine tablet that was open and a note from the nurse saying it had been dropped. How do you handle it?,144568,2,"c.	Return it to the narc vault using the Queued Returns option, find the item on the list as a return from the ADM, then enter the waste amount and waste reason with a witness.",1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44542,10,You emptied the return bin on an ADM and found a morphine tablet that was open and a note from the nurse saying it had been dropped. How do you handle it?,144569,3,"d.	Waste it using Manual Waste.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44542,10,You emptied the return bin on an ADM and found a morphine tablet that was open and a note from the nurse saying it had been dropped. How do you handle it?,144570,4,"e.	B or C.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44543,11,Which option is NOT part of the Patient-Specific compounding process? Such as to compound an item that is not premixed.,144571,0,"a.	Dispense the ingredient to the IV Room.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44543,11,Which option is NOT part of the Patient-Specific compounding process? Such as to compound an item that is not premixed.,144572,1,"b.	Return the compound as a Manual Return.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44543,11,Which option is NOT part of the Patient-Specific compounding process? Such as to compound an item that is not premixed.,144573,2,"c.	Dispense the compound to the patient using Dispense to Patient.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44543,11,Which option is NOT part of the Patient-Specific compounding process? Such as to compound an item that is not premixed.,144574,3,"d.	Use the AcuDose machine in main pharmacy to dispense the ingredient, if available.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44543,11,Which option is NOT part of the Patient-Specific compounding process? Such as to compound an item that is not premixed.,144575,4,"e.	All of the above options are acceptable.",1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44544,12,Which of the following is NOT an option for Cycle Counts?,144576,0,"a.	By Item",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44544,12,Which of the following is NOT an option for Cycle Counts?,144577,1,"b.	By Control Level",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44544,12,Which of the following is NOT an option for Cycle Counts?,144578,2,"c.	By Last Touched Date",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44544,12,Which of the following is NOT an option for Cycle Counts?,144579,3,"d.	By Dispense",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44544,12,Which of the following is NOT an option for Cycle Counts?,144580,4,"e.	By Color",1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44545,13,The Inventory Disposal menu is used to expire items returned from ADMs.,144581,0,TRUE,0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44545,13,The Inventory Disposal menu is used to expire items returned from ADMs.,144582,1,FALSE,1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44546,14,Which of the following is TRUE?,144583,0,"a.	In CSM, orders from venders are received in 3 steps.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44546,14,Which of the following is TRUE?,144584,1,"b.	It is best practice for a different pharmacist to stock received items than the one who entered the invoice into CSM.",1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44546,14,Which of the following is TRUE?,144585,2,"c.	A temporary vender cannot be added in CSM.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44546,14,Which of the following is TRUE?,144586,3,"d.	None of the above are true.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44547,15,The Prepack Menu can be used for which of the following?,144587,0,"a.	Picking bulk items to prepack into unit dose.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44547,15,The Prepack Menu can be used for which of the following?,144588,1,"b.	Stocking unit-dose items into CSM after prepacking.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44547,15,The Prepack Menu can be used for which of the following?,144589,2,"c.	Batch IV compounding, if the templates are built.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44547,15,The Prepack Menu can be used for which of the following?,144590,3,"d.	The Prepack menu can be used for all of the above.",1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44548,16,How is are CSM discrepancies indicated?,144591,0,"a.	A red badge appears above the Resolve Discrepancies icon on the Reports and Tracking menu.",1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44548,16,How is are CSM discrepancies indicated?,144592,1,"b.	A pop-up window appears on-screen when you log into CSM.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44548,16,How is are CSM discrepancies indicated?,144593,2,"c.	A chime sounds on the machine each time, whether someone is logged in or not.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44548,16,How is are CSM discrepancies indicated?,144594,3,"d.	A piece of paper prints on the CSM printer.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44548,16,How is are CSM discrepancies indicated?,144595,4,"e.	None of the above.",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44549,17,Which of the following processes do NOT require a witness?,144596,0,"a.	Cabinet Restock",1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44549,17,Which of the following processes do NOT require a witness?,144597,1,"b.	Guided Expire",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44549,17,Which of the following processes do NOT require a witness?,144598,2,"c.	Manual Expire",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44549,17,Which of the following processes do NOT require a witness?,144599,3,"d.	Manual Waste",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44549,17,Which of the following processes do NOT require a witness?,144600,4,"e.	Wasting/Expiring from a Queued Return",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44550,18,Which menu would you choose to close the CSM program and restart the CSM machine?,144601,0,"a.	Dispense/Return",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44550,18,Which menu would you choose to close the CSM program and restart the CSM machine?,144602,1,"b.	System Administration",1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44550,18,Which menu would you choose to close the CSM program and restart the CSM machine?,144603,2,"c.	Inventory Management",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44550,18,Which menu would you choose to close the CSM program and restart the CSM machine?,144604,3,"d.	Reports and Tracking",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44551,19,Which product(s) require you to call the Omnicell Help Desk (1-800-910-2220) rather than the Aesynt legacy line to enter a ticket?,144605,0,"a.	Acudose",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44551,19,Which product(s) require you to call the Omnicell Help Desk (1-800-910-2220) rather than the Aesynt legacy line to enter a ticket?,144606,1,"b.	NarcStation",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44551,19,Which product(s) require you to call the Omnicell Help Desk (1-800-910-2220) rather than the Aesynt legacy line to enter a ticket?,144607,2,"c.	CSM",1
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44551,19,Which product(s) require you to call the Omnicell Help Desk (1-800-910-2220) rather than the Aesynt legacy line to enter a ticket?,144608,3,"d.	MedCarousel",0
9434,Elearning-0000-671,PHARMACY CONTROLLED SUBSTANCE MANAGER EDUCATION FY2019,n9056,44551,19,Which product(s) require you to call the Omnicell Help Desk (1-800-910-2220) rather than the Aesynt legacy line to enter a ticket?,144609,4,"e.	All of the above",0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44612,0,The magnetic field of a MRI scanner is only on when an exam is being performed so the door does not have to be closed between procedures when the technologist is not present:,144865,0,"a.	True",0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44612,0,The magnetic field of a MRI scanner is only on when an exam is being performed so the door does not have to be closed between procedures when the technologist is not present:,144866,1,"b.	False ""Magnet is Always On""",1
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44613,1,Prior to entering the MRI Scan room the patient must:,144867,0,"a.	Be screened twice",0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44613,1,Prior to entering the MRI Scan room the patient must:,144868,1,"b.	Complete the MRI Screening Form",0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44613,1,Prior to entering the MRI Scan room the patient must:,144869,2,"c.	Remove jewelry and any other objects that are not suited for entry into the magnetic field, and change into hospital provided MRI Safe gowns or scrubs.",0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44613,1,Prior to entering the MRI Scan room the patient must:,144870,3,"d.	All of the above",1
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44614,2,Activation of the Quench Button is reserved only for life threatening situations.,144871,0,TRUE,1
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44614,2,Activation of the Quench Button is reserved only for life threatening situations.,144872,1,FALSE,0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44615,3,The following are strategies for calming or responding to the anxious or distressed patient:,144873,0,"a.	Place a towel over the patients eyes",0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44615,3,The following are strategies for calming or responding to the anxious or distressed patient:,144874,1,"b.	Offer soothing music",0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44615,3,The following are strategies for calming or responding to the anxious or distressed patient:,144875,2,"c.	Allow a family member to remain in the scan room with the patient",0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44615,3,The following are strategies for calming or responding to the anxious or distressed patient:,144876,3,"d.	All of the above",1
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44616,4,Only Level I MR Personnel are allowed to escort patients into Zone III.,144877,0,"a.	True",0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44616,4,Only Level I MR Personnel are allowed to escort patients into Zone III.,144878,1,"b.	False ""Level I and Level II MR Personnel",1
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44617,5,All implants and non-detachable medical devices  will be checked to determine MRI compatibility by:,144879,0,"a.	Reviewing the product labeling",0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44617,5,All implants and non-detachable medical devices  will be checked to determine MRI compatibility by:,144880,1,"b.	Checking  manufacturer literature or peer-reviewed publications regarding the specific device",0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44617,5,All implants and non-detachable medical devices  will be checked to determine MRI compatibility by:,144881,2,"c.	Verifying On-line verification via www.mrisafety.com (""THE LIST')",0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44617,5,All implants and non-detachable medical devices  will be checked to determine MRI compatibility by:,144882,3,"d.	All of the above",1
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44618,6,"In the event of a suspected magnet quench, the following step must be taken:",144883,0,"a.	Technologist will evacuate all patients and visitors from MRI area",1
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44618,6,"In the event of a suspected magnet quench, the following step must be taken:",144884,1,"b.	Leave the scan room door open to allow for release of super cooled cryogens",0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44618,6,"In the event of a suspected magnet quench, the following step must be taken:",144885,2,"c.	Both a and b",0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44618,6,"In the event of a suspected magnet quench, the following step must be taken:",144886,3,"d.	None of the above",0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44619,7,Staff should call Biomed/GE at 800-437-1171 for non-emergent incidents involving the magnetic field.,144887,0,TRUE,1
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44619,7,Staff should call Biomed/GE at 800-437-1171 for non-emergent incidents involving the magnetic field.,144888,1,FALSE,0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44620,8,Only MRI Safe and MRI Conditional objects will be allowed in the MRI Scan room. This includes:,144889,0,"a.	IV poles",0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44620,8,Only MRI Safe and MRI Conditional objects will be allowed in the MRI Scan room. This includes:,144890,1,"b.	Wheelchairs and Stretchers",0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44620,8,Only MRI Safe and MRI Conditional objects will be allowed in the MRI Scan room. This includes:,144891,2,"c.	Oxygen Tanks",0
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44620,8,Only MRI Safe and MRI Conditional objects will be allowed in the MRI Scan room. This includes:,144892,3,"d.	All of the above",1
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44621,9,Patients who require urgent or emergent medical care (CODE BLUE) are immediately withdrawn from the MRI table and scanner room to allow access to life saving devices.,144893,0,TRUE,1
9163,Elearning-0000-425,MRI SAFETY CBL,n9060,44621,9,Patients who require urgent or emergent medical care (CODE BLUE) are immediately withdrawn from the MRI table and scanner room to allow access to life saving devices.,144894,1,FALSE,0
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44636,0,"Specimen Management in the Operating Room is divided into 7 steps that include: Plan of Care, Confirm the Specimen Site, Brief, Collection, Handling, Transfer, and Debrief.",144940,0,TRUE,1
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44636,0,"Specimen Management in the Operating Room is divided into 7 steps that include: Plan of Care, Confirm the Specimen Site, Brief, Collection, Handling, Transfer, and Debrief.",144941,1,FALSE,0
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44637,1,The Perioperative RN will incorporate specimen management needs into the patient's plan of care by reviewing:,144942,0,"a.	Type of specimen container needed",0
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44637,1,The Perioperative RN will incorporate specimen management needs into the patient's plan of care by reviewing:,144943,1,"b.	Need for special specimen retrieval devices",0
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44637,1,The Perioperative RN will incorporate specimen management needs into the patient's plan of care by reviewing:,144944,2,"c.	Special consents or requisition forms",0
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44637,1,The Perioperative RN will incorporate specimen management needs into the patient's plan of care by reviewing:,144945,3,"d.	Only A and C",0
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44637,1,The Perioperative RN will incorporate specimen management needs into the patient's plan of care by reviewing:,144946,4,"e.	All of the above",1
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44638,2,The Brief should include discussion concerning any anticipated specimens and method of submission.,144947,0,TRUE,1
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44638,2,The Brief should include discussion concerning any anticipated specimens and method of submission.,144948,1,FALSE,0
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44639,3,"The nurse and surgical scrub are required to review specimen information with staff giving break, lunch, or handoff for shift.",144949,0,TRUE,1
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44639,3,"The nurse and surgical scrub are required to review specimen information with staff giving break, lunch, or handoff for shift.",144950,1,FALSE,0
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44640,4,"Specimens should be transferred from the sterile field using _______________ and _____________________.   1.	A one handed technique 2.	Standard precautions 3.	Contact precautions 4.	Sterile technique",144951,0,"a.	1 only",0
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44640,4,"Specimens should be transferred from the sterile field using _______________ and _____________________.   1.	A one handed technique 2.	Standard precautions 3.	Contact precautions 4.	Sterile technique",144952,1,"b.	2 and 4",1
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44640,4,"Specimens should be transferred from the sterile field using _______________ and _____________________.   1.	A one handed technique 2.	Standard precautions 3.	Contact precautions 4.	Sterile technique",144953,2,"c.	2 and 3",0
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44640,4,"Specimens should be transferred from the sterile field using _______________ and _____________________.   1.	A one handed technique 2.	Standard precautions 3.	Contact precautions 4.	Sterile technique",144954,3,"d.	All of the above",0
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44641,5,"Any specimen remaining on the sterile field:   1.	Will be sequestered in a specific location on the back table or mayo. 2.	The location of the specimen is communicated to the entire procedural team. 3.	Identified by the surgeon and the RN using a ""write/type down, read back"" technique.  4.	Does not have to be identified on the table by the scrub tech. 5.	The specimen identifier and location will be written on the communication white board.",144955,0,"a.	1,2,3,5",1
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44641,5,"Any specimen remaining on the sterile field:   1.	Will be sequestered in a specific location on the back table or mayo. 2.	The location of the specimen is communicated to the entire procedural team. 3.	Identified by the surgeon and the RN using a ""write/type down, read back"" technique.  4.	Does not have to be identified on the table by the scrub tech. 5.	The specimen identifier and location will be written on the communication white board.",144956,1,"b.	1,2,3,4",0
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44641,5,"Any specimen remaining on the sterile field:   1.	Will be sequestered in a specific location on the back table or mayo. 2.	The location of the specimen is communicated to the entire procedural team. 3.	Identified by the surgeon and the RN using a ""write/type down, read back"" technique.  4.	Does not have to be identified on the table by the scrub tech. 5.	The specimen identifier and location will be written on the communication white board.",144957,2,"c.	2,3,4,5",0
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44641,5,"Any specimen remaining on the sterile field:   1.	Will be sequestered in a specific location on the back table or mayo. 2.	The location of the specimen is communicated to the entire procedural team. 3.	Identified by the surgeon and the RN using a ""write/type down, read back"" technique.  4.	Does not have to be identified on the table by the scrub tech. 5.	The specimen identifier and location will be written on the communication white board.",144958,3,"d.	1,3,4,5",0
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44641,5,"Any specimen remaining on the sterile field:   1.	Will be sequestered in a specific location on the back table or mayo. 2.	The location of the specimen is communicated to the entire procedural team. 3.	Identified by the surgeon and the RN using a ""write/type down, read back"" technique.  4.	Does not have to be identified on the table by the scrub tech. 5.	The specimen identifier and location will be written on the communication white board.",144959,4,"e.	All of the above",0
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44642,6,"Before any or all procedural team members leave the OR (e.g. Breaks, Lunch relief, end of the procedure) and before room turn over begins a Debrief will occur. This includes:   1.	A recap the number of specimens collected 2.	Confirmation that each specimen is labeled and accurately identified 3.	Review specimen collection/pathology form for completeness and accuracy (including the patient's clinical history) 4.	Patient is in the correct position.",144960,0,"a.	1,2,4",0
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44642,6,"Before any or all procedural team members leave the OR (e.g. Breaks, Lunch relief, end of the procedure) and before room turn over begins a Debrief will occur. This includes:   1.	A recap the number of specimens collected 2.	Confirmation that each specimen is labeled and accurately identified 3.	Review specimen collection/pathology form for completeness and accuracy (including the patient's clinical history) 4.	Patient is in the correct position.",144961,1,"b.	1,2,3",1
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44642,6,"Before any or all procedural team members leave the OR (e.g. Breaks, Lunch relief, end of the procedure) and before room turn over begins a Debrief will occur. This includes:   1.	A recap the number of specimens collected 2.	Confirmation that each specimen is labeled and accurately identified 3.	Review specimen collection/pathology form for completeness and accuracy (including the patient's clinical history) 4.	Patient is in the correct position.",144962,2,"c.	2 and 3",0
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44642,6,"Before any or all procedural team members leave the OR (e.g. Breaks, Lunch relief, end of the procedure) and before room turn over begins a Debrief will occur. This includes:   1.	A recap the number of specimens collected 2.	Confirmation that each specimen is labeled and accurately identified 3.	Review specimen collection/pathology form for completeness and accuracy (including the patient's clinical history) 4.	Patient is in the correct position.",144963,3,"d.	1 and 4",0
9341,Elearning-0000-587,FY2019 SPECIMEN MANAGEMENT IN SURGICAL SERVICES,n9066,44642,6,"Before any or all procedural team members leave the OR (e.g. Breaks, Lunch relief, end of the procedure) and before room turn over begins a Debrief will occur. This includes:   1.	A recap the number of specimens collected 2.	Confirmation that each specimen is labeled and accurately identified 3.	Review specimen collection/pathology form for completeness and accuracy (including the patient's clinical history) 4.	Patient is in the correct position.",144964,4,"e.	All of the above",0
8224,Elearning-0000-1111,GLEOLAN CARE OF THE PATIENT RECEIVING GLEOLAN,n9067,44643,0,Gleolan<sup>TM</sup> minolevulinic acid hydrochloride (ALA HCI) is an optical imaging agent indicated in patients with glioma (suspected World Health Organization Grades III or IV on preoperative imaging) as an adjunct for the visualization of malignant tissue during surgery,144965,0,TRUE,1
8224,Elearning-0000-1111,GLEOLAN CARE OF THE PATIENT RECEIVING GLEOLAN,n9067,44643,0,Gleolan<sup>TM</sup> minolevulinic acid hydrochloride (ALA HCI) is an optical imaging agent indicated in patients with glioma (suspected World Health Organization Grades III or IV on preoperative imaging) as an adjunct for the visualization of malignant tissue during surgery,144966,1,FALSE,0
8224,Elearning-0000-1111,GLEOLAN CARE OF THE PATIENT RECEIVING GLEOLAN,n9067,44644,1,Gleolan<sup>TM</sup> helps to improve the visualization of suspected Glioma tumors by turning the tumor ________ color under blue light.,144967,0,a. Yellow,0
8224,Elearning-0000-1111,GLEOLAN CARE OF THE PATIENT RECEIVING GLEOLAN,n9067,44644,1,Gleolan<sup>TM</sup> helps to improve the visualization of suspected Glioma tumors by turning the tumor ________ color under blue light.,144968,1,b. Purple,0
8224,Elearning-0000-1111,GLEOLAN CARE OF THE PATIENT RECEIVING GLEOLAN,n9067,44644,1,Gleolan<sup>TM</sup> helps to improve the visualization of suspected Glioma tumors by turning the tumor ________ color under blue light.,144969,2,c. Red-violet,1
8224,Elearning-0000-1111,GLEOLAN CARE OF THE PATIENT RECEIVING GLEOLAN,n9067,44644,1,Gleolan<sup>TM</sup> helps to improve the visualization of suspected Glioma tumors by turning the tumor ________ color under blue light.,144970,3,d. Cool Blue,0
8224,Elearning-0000-1111,GLEOLAN CARE OF THE PATIENT RECEIVING GLEOLAN,n9067,44645,2,Gleolan<sup>TM</sup> is administered ___ hours with a range of _______ hours prior to anesthesia.,144971,0,a. 2  hours and range 2-4 hours,0
8224,Elearning-0000-1111,GLEOLAN CARE OF THE PATIENT RECEIVING GLEOLAN,n9067,44645,2,Gleolan<sup>TM</sup> is administered ___ hours with a range of _______ hours prior to anesthesia.,144972,1,b. 1 hour and range 1 to 1.5 hours,0
8224,Elearning-0000-1111,GLEOLAN CARE OF THE PATIENT RECEIVING GLEOLAN,n9067,44645,2,Gleolan<sup>TM</sup> is administered ___ hours with a range of _______ hours prior to anesthesia.,144973,2,c. 4 hours and range 3-5 hours,0
8224,Elearning-0000-1111,GLEOLAN CARE OF THE PATIENT RECEIVING GLEOLAN,n9067,44645,2,Gleolan<sup>TM</sup> is administered ___ hours with a range of _______ hours prior to anesthesia.,144974,3,d. 3 hours and range 2-4 hours,1
8224,Elearning-0000-1111,GLEOLAN CARE OF THE PATIENT RECEIVING GLEOLAN,n9067,44646,3,Gleolan<sup>TM</sup> patients do not need to avoid any type of medications prior to the administration of Gleolan<sup>TM</sup>. Gleolan<sup>TM</sup> is compatible with all medications.,144975,0,TRUE,0
8224,Elearning-0000-1111,GLEOLAN CARE OF THE PATIENT RECEIVING GLEOLAN,n9067,44646,3,Gleolan<sup>TM</sup> patients do not need to avoid any type of medications prior to the administration of Gleolan<sup>TM</sup>. Gleolan<sup>TM</sup> is compatible with all medications.,144976,1,FALSE,1
8224,Elearning-0000-1111,GLEOLAN CARE OF THE PATIENT RECEIVING GLEOLAN,n9067,44647,4,Nursing staff can play a major role in protecting the patient receiving Gleolan<sup>TM</sup> from Photosensitizing reactions by,144977,0,a. Reducing exposure to sunlight and room light for 48 hours after dosing,0
8224,Elearning-0000-1111,GLEOLAN CARE OF THE PATIENT RECEIVING GLEOLAN,n9067,44647,4,Nursing staff can play a major role in protecting the patient receiving Gleolan<sup>TM</sup> from Photosensitizing reactions by,144978,1,b. Applying appropriate draping precautions when transporting patient,0
8224,Elearning-0000-1111,GLEOLAN CARE OF THE PATIENT RECEIVING GLEOLAN,n9067,44647,4,Nursing staff can play a major role in protecting the patient receiving Gleolan<sup>TM</sup> from Photosensitizing reactions by,144979,2,c. Educating patient to hold phototoxic medications 24 hours prior to surgery,0
8224,Elearning-0000-1111,GLEOLAN CARE OF THE PATIENT RECEIVING GLEOLAN,n9067,44647,4,Nursing staff can play a major role in protecting the patient receiving Gleolan<sup>TM</sup> from Photosensitizing reactions by,144980,3,d. Placing wristband on patient and placing door signage on door,0
8224,Elearning-0000-1111,GLEOLAN CARE OF THE PATIENT RECEIVING GLEOLAN,n9067,44647,4,Nursing staff can play a major role in protecting the patient receiving Gleolan<sup>TM</sup> from Photosensitizing reactions by,144981,4,"e. Monitor for adverse reactions including anaphylaxis, hypotension, pyrexia, nausea and vomiting after administration of Gleolan<sup>TM</sup>",0
8224,Elearning-0000-1111,GLEOLAN CARE OF THE PATIENT RECEIVING GLEOLAN,n9067,44647,4,Nursing staff can play a major role in protecting the patient receiving Gleolan<sup>TM</sup> from Photosensitizing reactions by,144982,5,f. All of the above,1
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44652,0,Therapy documentation must contain data relevant to all document consumers.,144991,0,TRUE,1
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44652,0,Therapy documentation must contain data relevant to all document consumers.,144992,1,FALSE,0
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44653,1,Therapy notes are legal documents.,144993,0,TRUE,1
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44653,1,Therapy notes are legal documents.,144994,1,FALSE,0
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44654,2,The use of flowsheets in therapy documentation is prohibited.,144995,0,TRUE,0
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44654,2,The use of flowsheets in therapy documentation is prohibited.,144996,1,FALSE,1
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44655,3,All document consumers have the same level of understanding of therapy interventions as the treating therapist.,144997,0,TRUE,0
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44655,3,All document consumers have the same level of understanding of therapy interventions as the treating therapist.,144998,1,FALSE,1
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44656,4,"Relevant data for a successful therapy document begins with the ""Intervention""?",144999,0,TRUE,0
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44656,4,"Relevant data for a successful therapy document begins with the ""Intervention""?",145000,1,FALSE,1
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44657,5,Which of the following terms best describes problems that an individual may experience in involvement in age appropriate life situations?,145001,0,A. Impairment in Body Function/Structure,0
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44657,5,Which of the following terms best describes problems that an individual may experience in involvement in age appropriate life situations?,145002,1,B. Activity Limitation,0
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44657,5,Which of the following terms best describes problems that an individual may experience in involvement in age appropriate life situations?,145003,2,C. Participation Restriction,1
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44658,6,What is considered Significant Progress and Reasonable Amount of Time is defined specifically by Medicare for each patient based on diagnosis.,145004,0,TRUE,0
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44658,6,What is considered Significant Progress and Reasonable Amount of Time is defined specifically by Medicare for each patient based on diagnosis.,145005,1,FALSE,1
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44659,7,"When measuring data, measurements can be both Quantitative and/or Qualitative.",145006,0,TRUE,1
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44659,7,"When measuring data, measurements can be both Quantitative and/or Qualitative.",145007,1,FALSE,0
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44660,8,All problems being addressed by therapy must have a documented goal.,145008,0,TRUE,1
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44660,8,All problems being addressed by therapy must have a documented goal.,145009,1,FALSE,0
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44661,9,"Once a goal is met, a therapist is allowed to work above the stated goal without revising the goal.",145010,0,TRUE,0
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44661,9,"Once a goal is met, a therapist is allowed to work above the stated goal without revising the goal.",145011,1,FALSE,1
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44662,10,Which type of documentation data provides evidence of the PATIENT'S perception of the problems and/or goals?,145012,0,A. Subjective,1
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44662,10,Which type of documentation data provides evidence of the PATIENT'S perception of the problems and/or goals?,145013,1,B. Objective,0
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44662,10,Which type of documentation data provides evidence of the PATIENT'S perception of the problems and/or goals?,145014,2,C. Assessment,0
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44662,10,Which type of documentation data provides evidence of the PATIENT'S perception of the problems and/or goals?,145015,3,D. Plan,0
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44663,11,"Therapy documentation must demonstrate Necessity, Skill, Value, and Justification.",145016,0,TRUE,1
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44663,11,"Therapy documentation must demonstrate Necessity, Skill, Value, and Justification.",145017,1,FALSE,0
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44664,12,The skill of a therapist is their clinical decision making and problem solving process.,145018,0,TRUE,1
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44664,12,The skill of a therapist is their clinical decision making and problem solving process.,145019,1,FALSE,0
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44665,13,"If a patient is unable to speak, then subjective data can and should be omitted from the therapy document.",145020,0,TRUE,0
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44665,13,"If a patient is unable to speak, then subjective data can and should be omitted from the therapy document.",145021,1,FALSE,1
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44666,14,Use of an Electronic Medical Record will prevent denials.,145022,0,TRUE,0
8405,Elearning-0000-1275,ADDING VALUE TO YOUR CLINICAL DOCUMENTATION (WEBINAR),n9072,44666,14,Use of an Electronic Medical Record will prevent denials.,145023,1,FALSE,1
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45074,0,Pressure injury by wound care: Hannah Cleveland,146590,0,"1.	Excellent",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45074,0,Pressure injury by wound care: Hannah Cleveland,146591,1,"2.	Good",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45074,0,Pressure injury by wound care: Hannah Cleveland,146592,2,"3.	Fair",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45074,0,Pressure injury by wound care: Hannah Cleveland,146593,3,"4.	Poor",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45075,1,Hypothermia: Regan Pruitt,146594,0,"1.	Excellent",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45075,1,Hypothermia: Regan Pruitt,146595,1,"2.	Good",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45075,1,Hypothermia: Regan Pruitt,146596,2,"3.	Fair",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45075,1,Hypothermia: Regan Pruitt,146597,3,"4.	Poor",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45076,2,Accu-check / glucometer: Regan,146598,0,"1.	Excellent",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45076,2,Accu-check / glucometer: Regan,146599,1,"2.	Good",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45076,2,Accu-check / glucometer: Regan,146600,2,"3.	Fair",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45076,2,Accu-check / glucometer: Regan,146601,3,"4.	Poor",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45077,3,TPN/Lipids refresher: Mona Winey,146602,0,"1.	Excellent",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45077,3,TPN/Lipids refresher: Mona Winey,146603,1,"2.	Good",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45077,3,TPN/Lipids refresher: Mona Winey,146604,2,"3.	Fair",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45077,3,TPN/Lipids refresher: Mona Winey,146605,3,"4.	Poor",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45078,4,PCA: Mona Winey,146606,0,"1.	Excellent",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45078,4,PCA: Mona Winey,146607,1,"2.	Good",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45078,4,PCA: Mona Winey,146608,2,"3.	Fair",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45078,4,PCA: Mona Winey,146609,3,"4.	Poor",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45079,5,Chest Tubes: Karen Ideker,146610,0,"1.	Excellent",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45079,5,Chest Tubes: Karen Ideker,146611,1,"2.	Good",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45079,5,Chest Tubes: Karen Ideker,146612,2,"3.	Fair",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45079,5,Chest Tubes: Karen Ideker,146613,3,"4.	Poor",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45080,6,CIWA/1013/2013: Beverlie Garner,146614,0,"1.	Excellent",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45080,6,CIWA/1013/2013: Beverlie Garner,146615,1,"2.	Good",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45080,6,CIWA/1013/2013: Beverlie Garner,146616,2,"3.	Fair",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45080,6,CIWA/1013/2013: Beverlie Garner,146617,3,"4.	Poor",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45081,7,Mock Code: Mona Winey,146618,0,"1.	Excellent",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45081,7,Mock Code: Mona Winey,146619,1,"2.	Good",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45081,7,Mock Code: Mona Winey,146620,2,"3.	Fair",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45081,7,Mock Code: Mona Winey,146621,3,"4.	Poor",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45082,8,Heparin Gtt: Karen Ideker,146622,0,"1.	Excellent",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45082,8,Heparin Gtt: Karen Ideker,146623,1,"2.	Good",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45082,8,Heparin Gtt: Karen Ideker,146624,2,"3.	Fair",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45082,8,Heparin Gtt: Karen Ideker,146625,3,"4.	Poor",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45083,9,Foley Care and Documentation: Beverlie Garner,146626,0,"1.	Excellent",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45083,9,Foley Care and Documentation: Beverlie Garner,146627,1,"2.	Good",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45083,9,Foley Care and Documentation: Beverlie Garner,146628,2,"3.	Fair",0
375,ILT-0000-893,5C SKILLS NURSES SKILLS DAY EVALUATION,n9137,45083,9,Foley Care and Documentation: Beverlie Garner,146629,3,"4.	Poor",0
9522,Elearning-0000-751,C-374: GLYCOMIMETICS,n9140,45116,0,C-374 includes patients with _____________ .,146740,0,"a.	AML",1
9522,Elearning-0000-751,C-374: GLYCOMIMETICS,n9140,45116,0,C-374 includes patients with _____________ .,146741,1,"b.	MDS",0
9522,Elearning-0000-751,C-374: GLYCOMIMETICS,n9140,45116,0,C-374 includes patients with _____________ .,146742,2,"c.	MM",0
9522,Elearning-0000-751,C-374: GLYCOMIMETICS,n9140,45116,0,C-374 includes patients with _____________ .,146743,3,"d.	NHL",0
9522,Elearning-0000-751,C-374: GLYCOMIMETICS,n9140,45117,1,Uproleselan/placebo will be administered 24 hours after the first dose of chemotherapy.,146744,0,TRUE,0
9522,Elearning-0000-751,C-374: GLYCOMIMETICS,n9140,45117,1,Uproleselan/placebo will be administered 24 hours after the first dose of chemotherapy.,146745,1,FALSE,1
9522,Elearning-0000-751,C-374: GLYCOMIMETICS,n9140,45118,2,"Day -1 should be scheduled on Tuesday, Wednesday, or Thursday to accommodate Research availability for PK days.",146746,0,TRUE,1
9522,Elearning-0000-751,C-374: GLYCOMIMETICS,n9140,45118,2,"Day -1 should be scheduled on Tuesday, Wednesday, or Thursday to accommodate Research availability for PK days.",146747,1,FALSE,0
8172,Elearning-0000-1065,2019.08.01- POLICY AND PROCEDURE DEVELOPMENT AND MAINTENANCE,n9147,45124,0,I have read and fully understand this SOP.,146758,0,TRUE,1
8172,Elearning-0000-1065,2019.08.01- POLICY AND PROCEDURE DEVELOPMENT AND MAINTENANCE,n9147,45124,0,I have read and fully understand this SOP.,146759,1,FALSE,0
8192,Elearning-0000-1083,2019.08.01- COLLECTION AND COMPLETION OF SOURCE DOCUMENTATION,n9148,45125,0,I have read and fully understand this SOP.,146760,0,TRUE,1
8192,Elearning-0000-1083,2019.08.01- COLLECTION AND COMPLETION OF SOURCE DOCUMENTATION,n9148,45125,0,I have read and fully understand this SOP.,146761,1,FALSE,0
8191,Elearning-0000-1082,2019.08.01- INFORMED CONSENT PROCESS FOR CLINICAL TRIALS,n9149,45126,0,I have read and fully understand this SOP.,146762,0,TRUE,1
10225,Elearning-0000-1996,2019.08.01- INFORMED CONSENT PROCESS FOR CLINICAL TRIALS,n9149,45126,0,I have read and fully understand this SOP.,146762,0,TRUE,1
8191,Elearning-0000-1082,2019.08.01- INFORMED CONSENT PROCESS FOR CLINICAL TRIALS,n9149,45126,0,I have read and fully understand this SOP.,146763,1,FALSE,0
10225,Elearning-0000-1996,2019.08.01- INFORMED CONSENT PROCESS FOR CLINICAL TRIALS,n9149,45126,0,I have read and fully understand this SOP.,146763,1,FALSE,0
8190,Elearning-0000-1081,2019.08.01- MONITORING VISIT MANAGEMENT,n9150,45127,0,I have read and fully understand this SOP.,146764,0,TRUE,1
8190,Elearning-0000-1081,2019.08.01- MONITORING VISIT MANAGEMENT,n9150,45127,0,I have read and fully understand this SOP.,146765,1,FALSE,0
8189,Elearning-0000-1080,2019.08.01- REPORTING OF ADVERSE EVENTS AND SERIOUS ADVERSE EVENTS,n9151,45128,0,I have read and fully understand this SOP.,146766,0,TRUE,1
8189,Elearning-0000-1080,2019.08.01- REPORTING OF ADVERSE EVENTS AND SERIOUS ADVERSE EVENTS,n9151,45128,0,I have read and fully understand this SOP.,146767,1,FALSE,0
8187,Elearning-0000-1079,2019.08.01- SUBJECT SCREENING AND ELIGIBILITY,n9152,45129,0,I have read and fully understand this SOP.,146768,0,TRUE,1
8187,Elearning-0000-1079,2019.08.01- SUBJECT SCREENING AND ELIGIBILITY,n9152,45129,0,I have read and fully understand this SOP.,146769,1,FALSE,0
8186,Elearning-0000-1078,2019.08.01- GUIDELINES FOR NOTIFYING PATIENTS OF AVAILABLE CLINICAL TRIALS,n9153,45130,0,I have read and fully understand this SOP.,146770,0,TRUE,1
8186,Elearning-0000-1078,2019.08.01- GUIDELINES FOR NOTIFYING PATIENTS OF AVAILABLE CLINICAL TRIALS,n9153,45130,0,I have read and fully understand this SOP.,146771,1,FALSE,0
8185,Elearning-0000-1077,2019.08.01- CLOSE OUT VISITS,n9154,45131,0,I have read and fully understand this SOP.,146772,0,TRUE,1
8185,Elearning-0000-1077,2019.08.01- CLOSE OUT VISITS,n9154,45131,0,I have read and fully understand this SOP.,146773,1,FALSE,0
8184,Elearning-0000-1076,2019.08.01-STUDY INITIATION VISITS,n9155,45132,0,I have read and fully understand this SOP.,146774,0,TRUE,1
8184,Elearning-0000-1076,2019.08.01-STUDY INITIATION VISITS,n9155,45132,0,I have read and fully understand this SOP.,146775,1,FALSE,0
8183,Elearning-0000-1075,2019.08.01-TRAINING PLAN FOR CLINICAL RESEARCH STAFF,n9156,45133,0,I have read and fully understand this SOP.,146776,0,TRUE,1
8183,Elearning-0000-1075,2019.08.01-TRAINING PLAN FOR CLINICAL RESEARCH STAFF,n9156,45133,0,I have read and fully understand this SOP.,146777,1,FALSE,0
8182,Elearning-0000-1074,2019.08.01-INVESTIGATOR TRAINING AND COMPLIANCE,n9157,45134,0,I have read and fully understand this SOP.,146778,0,TRUE,1
8182,Elearning-0000-1074,2019.08.01-INVESTIGATOR TRAINING AND COMPLIANCE,n9157,45134,0,I have read and fully understand this SOP.,146779,1,FALSE,0
8181,Elearning-0000-1073,2019.08.01-PRIMARY INVESTIGATOR OVERSIGHT,n9158,45135,0,I have read and fully understand this SOP.,146780,0,TRUE,1
8181,Elearning-0000-1073,2019.08.01-PRIMARY INVESTIGATOR OVERSIGHT,n9158,45135,0,I have read and fully understand this SOP.,146781,1,FALSE,0
8180,Elearning-0000-1072,2019.08.01-RESEARCH CONFLICT OF INTEREST PROCEDURE,n9159,45136,0,I have read and fully understand this SOP.,146782,0,TRUE,1
8180,Elearning-0000-1072,2019.08.01-RESEARCH CONFLICT OF INTEREST PROCEDURE,n9159,45136,0,I have read and fully understand this SOP.,146783,1,FALSE,0
8178,Elearning-0000-1070,2019.08.01-REGULATORY ESSENTIAL DOCUMENTATION,n9162,45143,0,I have read and fully understand this SOP.,146804,0,TRUE,1
8178,Elearning-0000-1070,2019.08.01-REGULATORY ESSENTIAL DOCUMENTATION,n9162,45143,0,I have read and fully understand this SOP.,146805,1,FALSE,0
8176,Elearning-0000-1069,2019.08.01- CURRICULUM VITAE,n9163,45144,0,I have read and fully understand this SOP.,146806,0,TRUE,1
8176,Elearning-0000-1069,2019.08.01- CURRICULUM VITAE,n9163,45144,0,I have read and fully understand this SOP.,146807,1,FALSE,0
8175,Elearning-0000-1068,2019.08.01- DELEGATION OF AUTHORITY,n9164,45145,0,I have read and fully read and understand this SOP.,146808,0,TRUE,1
8175,Elearning-0000-1068,2019.08.01- DELEGATION OF AUTHORITY,n9164,45145,0,I have read and fully read and understand this SOP.,146809,1,FALSE,0
229,SCORM-0000-35,FY2019 BBRAUN ONGUARD CLOSED SYSTEM TRANSFER DEVICE (CSTD)-NURSING,n9166,45147,0,"I acknowledge that I have read and understand the ""FY2019 BBRAUN ONGUARD CLOSED SYSTEM TRANSFER DEVICE (CSTD)-NURSING"" CBL in its entirety.",146812,0,TRUE,1
229,SCORM-0000-35,FY2019 BBRAUN ONGUARD CLOSED SYSTEM TRANSFER DEVICE (CSTD)-NURSING,n9166,45147,0,"I acknowledge that I have read and understand the ""FY2019 BBRAUN ONGUARD CLOSED SYSTEM TRANSFER DEVICE (CSTD)-NURSING"" CBL in its entirety.",146813,1,FALSE,0
9247,Elearning-0000-501,LARYNGECTOMY INFORMATION,n9170,45178,0,I have read and understand the CBL LARYNGECTOMY INFORMATION.,146926,0,TRUE,1
9247,Elearning-0000-501,LARYNGECTOMY INFORMATION,n9170,45178,0,I have read and understand the CBL LARYNGECTOMY INFORMATION.,146927,1,FALSE,0
9740,Elearning-0000-95,WHY AIR FLOW AND TEMP & HUMIDITY MATTER,n9184,45272,0,I acknowledge that I have read and understand in its entirety the WHY AIR FLOW AND TEMP & HUMIDITY MATTER CBL.,147303,0,TRUE,1
9740,Elearning-0000-95,WHY AIR FLOW AND TEMP & HUMIDITY MATTER,n9184,45272,0,I acknowledge that I have read and understand in its entirety the WHY AIR FLOW AND TEMP & HUMIDITY MATTER CBL.,147304,1,FALSE,0
9545,Elearning-0000-772,BEHAVIORAL HEALTH VISITATION,n9187,45353,0,I have read and understood the contents of this module.,147629,0,TRUE,1
9545,Elearning-0000-772,BEHAVIORAL HEALTH VISITATION,n9187,45353,0,I have read and understood the contents of this module.,147630,1,FALSE,0
9540,Elearning-0000-768,TOURNIQUETS: STOP THE BLEED,n9190,45369,0,Where should you apply a tourniquet in relation to a wound?,147676,0,"a.	2-3"" above a wound",1
9540,Elearning-0000-768,TOURNIQUETS: STOP THE BLEED,n9190,45369,0,Where should you apply a tourniquet in relation to a wound?,147677,1,"b.	2-3"" below a wound",0
9540,Elearning-0000-768,TOURNIQUETS: STOP THE BLEED,n9190,45369,0,Where should you apply a tourniquet in relation to a wound?,147678,2,"c.	directly on the wound",0
9540,Elearning-0000-768,TOURNIQUETS: STOP THE BLEED,n9190,45369,0,Where should you apply a tourniquet in relation to a wound?,147679,3,"d.	over the closest joint",0
9540,Elearning-0000-768,TOURNIQUETS: STOP THE BLEED,n9190,45370,1,What is the correct action if the patient with a tourniquet in place complains of pain,147680,0,"a.	Loosen the tourniquet, because the patient may be at risk for nerve injury",0
9540,Elearning-0000-768,TOURNIQUETS: STOP THE BLEED,n9190,45370,1,What is the correct action if the patient with a tourniquet in place complains of pain,147681,1,"b.	Leave tourniquet in place. Severe pain with tourniquet use is expected.",1
9540,Elearning-0000-768,TOURNIQUETS: STOP THE BLEED,n9190,45370,1,What is the correct action if the patient with a tourniquet in place complains of pain,147682,2,"c.	Loosen the tourniquet for 2 minutes then retighten tourniquet to prevent tissue ischemia",0
9540,Elearning-0000-768,TOURNIQUETS: STOP THE BLEED,n9190,45371,2,"Packing a wound can help control bleeding, especially with deep wounds",147683,0,TRUE,1
9540,Elearning-0000-768,TOURNIQUETS: STOP THE BLEED,n9190,45371,2,"Packing a wound can help control bleeding, especially with deep wounds",147684,1,FALSE,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45632,0,"An antineoplastic agent capable of producing pain at the IV site and along the vein, with or without an inflammatory response is considered a:",148713,0,"a.	Vesicant",0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45632,0,"An antineoplastic agent capable of producing pain at the IV site and along the vein, with or without an inflammatory response is considered a:",148714,1,"b.	Irritant",1
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45632,0,"An antineoplastic agent capable of producing pain at the IV site and along the vein, with or without an inflammatory response is considered a:",148715,2,"c.	Neither",0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45633,1,Which pharmacologic agents are available to treat chemotherapy extravasation?,148716,0,"a.	DMSO",0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45633,1,Which pharmacologic agents are available to treat chemotherapy extravasation?,148717,1,"b.	Hyaluronidase",0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45633,1,Which pharmacologic agents are available to treat chemotherapy extravasation?,148718,2,"c.	Sodium Thiosulfate",0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45633,1,Which pharmacologic agents are available to treat chemotherapy extravasation?,148719,3,"d.	Dexrazoxane",0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45633,1,Which pharmacologic agents are available to treat chemotherapy extravasation?,148720,4,"e.	B and D",1
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45634,2,Which is NOT a delayed manifestation of a vesicant extravasation?,148721,0,"a.	Increased redness",0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45634,2,Which is NOT a delayed manifestation of a vesicant extravasation?,148722,1,"b.	Increased pain",0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45634,2,Which is NOT a delayed manifestation of a vesicant extravasation?,148723,2,"c.	Loss of blood return",1
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45634,2,Which is NOT a delayed manifestation of a vesicant extravasation?,148724,3,"d.	Ulceration",0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45634,2,Which is NOT a delayed manifestation of a vesicant extravasation?,148725,4,"e.	Increased swelling",0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45635,3,Immediate blotches or streaks along the veins which usually subsides within a few minutes is a typical flare reaction.,148726,0,TRUE,1
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45635,3,Immediate blotches or streaks along the veins which usually subsides within a few minutes is a typical flare reaction.,148727,1,FALSE,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45636,4,"5.	What is correct sequence of events at first suspicion of an extravasation? 1.	Remove IV device or needle 2.	Stop infusion 3.	Aspirate residual drug from IV device 4.	Disconnect IV tubing from IV device",148728,0,"a.	2, 3, 1, 4",0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45636,4,"5.	What is correct sequence of events at first suspicion of an extravasation? 1.	Remove IV device or needle 2.	Stop infusion 3.	Aspirate residual drug from IV device 4.	Disconnect IV tubing from IV device",148729,1,"b.	2, 1, 3, 4",0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45636,4,"5.	What is correct sequence of events at first suspicion of an extravasation? 1.	Remove IV device or needle 2.	Stop infusion 3.	Aspirate residual drug from IV device 4.	Disconnect IV tubing from IV device",148730,2,"c.	2, 4, 3, 1",1
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45636,4,"5.	What is correct sequence of events at first suspicion of an extravasation? 1.	Remove IV device or needle 2.	Stop infusion 3.	Aspirate residual drug from IV device 4.	Disconnect IV tubing from IV device",148731,3,"d.	1, 2, 3, 4",0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45637,5,Which of the following is INCORRECT about Zinecard (dexrazoxane)?,148732,0,a. Reduce dose by 40% in patients with CrCL less than 50ml/min.,1
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45637,5,Which of the following is INCORRECT about Zinecard (dexrazoxane)?,148733,1,b. Should be mixed in Ringers Lactate.,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45637,5,Which of the following is INCORRECT about Zinecard (dexrazoxane)?,148734,2,"c. Should be administered on Days 1, 2, and 3.",0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45637,5,Which of the following is INCORRECT about Zinecard (dexrazoxane)?,148735,3,d. Should be initiated within 6 hours.,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45638,6,Which is the only medication requiring warm compresses but no pharmaceutical antidote?,148736,0,a. Etoposide,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45638,6,Which is the only medication requiring warm compresses but no pharmaceutical antidote?,148737,1,b. Oxaliplatin,1
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45638,6,Which is the only medication requiring warm compresses but no pharmaceutical antidote?,148738,2,c. Irinotecan,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45638,6,Which is the only medication requiring warm compresses but no pharmaceutical antidote?,148739,3,d. Vincristine,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45639,7,"If a medication infiltrates and it is not listed on your reference chart as a vesicant or irritant, what should you do?",148740,0,a. Advise patient to apply cold compress for 15 min every 6 hours x 24 hours,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45639,7,"If a medication infiltrates and it is not listed on your reference chart as a vesicant or irritant, what should you do?",148741,1,b. Advise patient to apply warm compress for 15 min every 6 hours x 24 hours,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45639,7,"If a medication infiltrates and it is not listed on your reference chart as a vesicant or irritant, what should you do?",148742,2,"c. Advise patient to avoid pressure and report signs of redness, pain, skin breakdown.",0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45639,7,"If a medication infiltrates and it is not listed on your reference chart as a vesicant or irritant, what should you do?",148743,3,d. A and C,1
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45640,8,Hyaluronidase should be administered:,148744,0,a. In a series of 0.2ml injections in a clockwise fashion,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45640,8,Hyaluronidase should be administered:,148745,1,b. Using a new 25 g or smaller needle for each injection,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45640,8,Hyaluronidase should be administered:,148746,2,c. As a total dose of 1ml dose subcutaneously,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45640,8,Hyaluronidase should be administered:,148747,3,d. All of the above,1
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45641,9,Dexrazoxane should be used to treat an extravasation of all of the following EXCEPT:,148748,0,a. Epirubicin,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45641,9,Dexrazoxane should be used to treat an extravasation of all of the following EXCEPT:,148749,1,b. Mitomycin,1
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45641,9,Dexrazoxane should be used to treat an extravasation of all of the following EXCEPT:,148750,2,c. Doxorubicin,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45641,9,Dexrazoxane should be used to treat an extravasation of all of the following EXCEPT:,148751,3,d. Idarubicin,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45642,10,Hyaluronidase is used to treat extravasation of which of the following medications?,148752,0,a. Etoposide,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45642,10,Hyaluronidase is used to treat extravasation of which of the following medications?,148753,1,b. Vincristine,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45642,10,Hyaluronidase is used to treat extravasation of which of the following medications?,148754,2,c. Vinblastine,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45642,10,Hyaluronidase is used to treat extravasation of which of the following medications?,148755,3,d. Vinorelbine,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45642,10,Hyaluronidase is used to treat extravasation of which of the following medications?,148756,4,e. All of the above,1
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45643,11,Which of the following is considered an irritant medication?,148757,0,a. Trabectidin,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45643,11,Which of the following is considered an irritant medication?,148758,1,b. Bendamustine,0
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45643,11,Which of the following is considered an irritant medication?,148759,2,c. Gemcitabine,1
9024,Elearning-0000-299,ONCOLOGIC EMERGENCY - EXTRAVASATION 2019,n9208,45643,11,Which of the following is considered an irritant medication?,148760,3,d. Mitoxantrone,0
9517,Elearning-0000-747,C-389 S1803,n9216,45732,0,C-389 includes patients _____________ .,149091,0,"a.	With relapsed/refractory Acute Myelogenous Leukemia.",0
9517,Elearning-0000-747,C-389 S1803,n9216,45732,0,C-389 includes patients _____________ .,149092,1,"b.	Undergoing auto transplant for Multiple Myeloma.",1
9517,Elearning-0000-747,C-389 S1803,n9216,45732,0,C-389 includes patients _____________ .,149093,2,"c.	With newly diagnosed Acute Myelogenous Leukemia.",0
9517,Elearning-0000-747,C-389 S1803,n9216,45732,0,C-389 includes patients _____________ .,149094,3,"d.	Undergoing allo transplant for Multiple Myeloma.",0
9517,Elearning-0000-747,C-389 S1803,n9216,45733,1,Patients will be randomized before transplant to receive lenalidomide alone or lenalidomide plus daratumumab.,149095,0,TRUE,0
9517,Elearning-0000-747,C-389 S1803,n9216,45733,1,Patients will be randomized before transplant to receive lenalidomide alone or lenalidomide plus daratumumab.,149096,1,FALSE,1
9517,Elearning-0000-747,C-389 S1803,n9216,45734,2,Daratumumab is given subcutaneously.,149097,0,TRUE,1
9517,Elearning-0000-747,C-389 S1803,n9216,45734,2,Daratumumab is given subcutaneously.,149098,1,FALSE,0
9517,Elearning-0000-747,C-389 S1803,n9216,45735,3,Patients will continue maintenance therapy for:,149099,0,"a.	24 cycles.",0
9517,Elearning-0000-747,C-389 S1803,n9216,45735,3,Patients will continue maintenance therapy for:,149100,1,"b.	Up to 7 years if they are randomized to continue maintenance treatment after 2 years.",0
9517,Elearning-0000-747,C-389 S1803,n9216,45735,3,Patients will continue maintenance therapy for:,149101,2,"c.	Indefinitely.",0
9517,Elearning-0000-747,C-389 S1803,n9216,45735,3,Patients will continue maintenance therapy for:,149102,3,"d.	Both A and B.",1
9517,Elearning-0000-747,C-389 S1803,n9216,45735,3,Patients will continue maintenance therapy for:,149103,4,"e.	None of the above",0
8229,Elearning-0000-1116,BB2121: PRODUCT ADMINISTRATION AND SAFETY MONITORING,n9223,45777,0,"I acknowledge that I have read and understand the ""bb2121: PRODUCT ADMINISTRATION AND SAFETY MONITORING"" CBL in its entirety.",149244,0,TRUE,1
8229,Elearning-0000-1116,BB2121: PRODUCT ADMINISTRATION AND SAFETY MONITORING,n9223,45777,0,"I acknowledge that I have read and understand the ""bb2121: PRODUCT ADMINISTRATION AND SAFETY MONITORING"" CBL in its entirety.",149245,1,FALSE,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45779,0,"In case of anesthesia workstation machine failure, which of the following is true?",149248,0,A) Anesthesia providers can pull the red emergency release to access the drawers containing non-controlled medications and anesthesia supplies,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45779,0,"In case of anesthesia workstation machine failure, which of the following is true?",149249,1,B) Anesthesia provider should call pharmacy to notify of failure,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45779,0,"In case of anesthesia workstation machine failure, which of the following is true?",149250,2,C) They keys to access the narcotic drawers can be given to anesthesia to dispense narcotics,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45779,0,"In case of anesthesia workstation machine failure, which of the following is true?",149251,3,D) Both A & B are true,1
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45779,0,"In case of anesthesia workstation machine failure, which of the following is true?",149252,4,E) All of the above are true,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45780,1,If an anesthesia provider removes a medication from an anesthesia workstation where can they return/waste the medication?,149253,0,A) At any anesthesia workstation,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45780,1,If an anesthesia provider removes a medication from an anesthesia workstation where can they return/waste the medication?,149254,1,B) Only at the anesthesia workstation where the medication was removed,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45780,1,If an anesthesia provider removes a medication from an anesthesia workstation where can they return/waste the medication?,149255,2,"C) At the Omnicell XT cabinet in ground floor PACU, third floor surgery PACU or in the L&D anesthesia workroom.",0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45780,1,If an anesthesia provider removes a medication from an anesthesia workstation where can they return/waste the medication?,149256,3,D) Both A & C,1
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45780,1,If an anesthesia provider removes a medication from an anesthesia workstation where can they return/waste the medication?,149257,4,E) Both B & C,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45781,2,"If a preop RN removes a medication from the preop Acudose, where can it be returned?",149258,0,A) At the PreOp Acudose,1
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45781,2,"If a preop RN removes a medication from the preop Acudose, where can it be returned?",149259,1,B) At the PACU Omnicell XT,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45781,2,"If a preop RN removes a medication from the preop Acudose, where can it be returned?",149260,2,C) At any anesthesia workstation,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45781,2,"If a preop RN removes a medication from the preop Acudose, where can it be returned?",149261,3,D) Both A & B,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45781,2,"If a preop RN removes a medication from the preop Acudose, where can it be returned?",149262,4,E) All of the above,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45782,3,If an AWS machine needs to be moved to a different location in an OR room which of the following is true?,149263,0,A) AWS machines cannot be moved,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45782,3,If an AWS machine needs to be moved to a different location in an OR room which of the following is true?,149264,1,B) AWS machines have a battery backup so it is ok to unplug the machines for a long period of time,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45782,3,If an AWS machine needs to be moved to a different location in an OR room which of the following is true?,149265,2,C) AWS machines have a battery backup of 10mins so they can be moved but must be plugged in as soon as possible,1
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45782,3,If an AWS machine needs to be moved to a different location in an OR room which of the following is true?,149266,3,D) The Data port can be unplugged and moved to another port in the OR room,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45783,4,True or False: Omnicell Anesthesia workstations will be stocked with one controlled medication per bin,149267,0,TRUE,1
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45783,4,True or False: Omnicell Anesthesia workstations will be stocked with one controlled medication per bin,149268,1,FALSE,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45784,5,True or False: Anesthesia workstations are profiled units and providers can only remove medications once verified by pharmacy,149269,0,TRUE,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45784,5,True or False: Anesthesia workstations are profiled units and providers can only remove medications once verified by pharmacy,149270,1,FALSE,1
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45785,6,True or False: Anesthesia providers can remove non-controlled medications from the open matrix drawers by simply scanning the medication barcode.,149271,0,TRUE,1
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45785,6,True or False: Anesthesia providers can remove non-controlled medications from the open matrix drawers by simply scanning the medication barcode.,149272,1,FALSE,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45786,7,What system does pharmacy use to poll for anesthesia workstation restocking?,149273,0,A) Connect RX,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45786,7,What system does pharmacy use to poll for anesthesia workstation restocking?,149274,1,B) Omnicenter,1
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45786,7,What system does pharmacy use to poll for anesthesia workstation restocking?,149275,2,C) CSM,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45786,7,What system does pharmacy use to poll for anesthesia workstation restocking?,149276,3,D) Cerner,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45787,8,True or false: AWS does not require expiration date documentation to restock a medication.,149277,0,TRUE,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45787,8,True or false: AWS does not require expiration date documentation to restock a medication.,149278,1,FALSE,1
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45788,9,Which is false about discrepancy resolution,149279,0,A) A discrepancy receipt prints at the time the discrepancy is created,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45788,9,Which is false about discrepancy resolution,149280,1,B) Discrepancy resolution requires a witness,0
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45788,9,Which is false about discrepancy resolution,149281,2,C) To research a discrepancy you must inventory every pocket that contains that medication,1
8996,Elearning-0000-273,PHARMACY AWS EDUCATION FOR PHARMACISTS FY2019,n9225,45788,9,Which is false about discrepancy resolution,149282,3,"D) On the discrepancy resolution screen, there is a cycle count button that will allow you to only inventory the pocket where the discrepancy was created",0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45871,0,"In case of anesthesia workstation machine failure, which of the following is true?",149578,0,A) Anesthesia providers can pull the red emergency release to access the drawers containing non-controlled medications and anesthesia supplies,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45871,0,"In case of anesthesia workstation machine failure, which of the following is true?",149579,1,B) Anesthesia provider should call pharmacy to notify of failure,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45871,0,"In case of anesthesia workstation machine failure, which of the following is true?",149580,2,C) They keys to access the narcotic drawers can be given to anesthesia to dispense narcotics,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45871,0,"In case of anesthesia workstation machine failure, which of the following is true?",149581,3,D) Both A & B are true,1
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45871,0,"In case of anesthesia workstation machine failure, which of the following is true?",149582,4,E) All of the above are true,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45872,1,If an anesthesia provider removes a medication from an anesthesia workstation where can they return/waste the medication?,149583,0,A) At any anesthesia workstation,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45872,1,If an anesthesia provider removes a medication from an anesthesia workstation where can they return/waste the medication?,149584,1,B) Only at the anesthesia workstation where the medication was removed,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45872,1,If an anesthesia provider removes a medication from an anesthesia workstation where can they return/waste the medication?,149585,2,"C) At the Omnicell XT cabinet in ground floor PACU, third floor surgery PACU or in the L&D anesthesia workroom.",0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45872,1,If an anesthesia provider removes a medication from an anesthesia workstation where can they return/waste the medication?,149586,3,D) Both A & C,1
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45872,1,If an anesthesia provider removes a medication from an anesthesia workstation where can they return/waste the medication?,149587,4,E) Both B & C,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45873,2,"If a preop RN removes a medication from the preop Acudose, where can it be returned?",149588,0,A) At the PreOp Acudose,1
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45873,2,"If a preop RN removes a medication from the preop Acudose, where can it be returned?",149589,1,B) At the PACU Omnicell XT,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45873,2,"If a preop RN removes a medication from the preop Acudose, where can it be returned?",149590,2,C) At any anesthesia workstation,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45873,2,"If a preop RN removes a medication from the preop Acudose, where can it be returned?",149591,3,D) Both A & B,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45873,2,"If a preop RN removes a medication from the preop Acudose, where can it be returned?",149592,4,E) All of the above,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45874,3,If an AWS machine needs to be moved to a different location in an OR room which of the following is true?,149593,0,A) AWS machines cannot be moved,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45874,3,If an AWS machine needs to be moved to a different location in an OR room which of the following is true?,149594,1,B) AWS machines have a battery backup so it is ok to unplug the machines for a long period of time,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45874,3,If an AWS machine needs to be moved to a different location in an OR room which of the following is true?,149595,2,C) AWS machines have a battery backup of 10mins so they can be moved but must be plugged in as soon as possible,1
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45874,3,If an AWS machine needs to be moved to a different location in an OR room which of the following is true?,149596,3,D) The Data port can be unplugged and moved to another port in the OR room,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45875,4,True or False: Omnicell Anesthesia workstations will be stocked with one controlled medication per bin,149597,0,TRUE,1
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45875,4,True or False: Omnicell Anesthesia workstations will be stocked with one controlled medication per bin,149598,1,FALSE,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45876,5,What system does pharmacy use to poll for anesthesia workstation restocking?,149599,0,A) Connect RX,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45876,5,What system does pharmacy use to poll for anesthesia workstation restocking?,149600,1,B) Omnicenter,1
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45876,5,What system does pharmacy use to poll for anesthesia workstation restocking?,149601,2,C) CSM,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45876,5,What system does pharmacy use to poll for anesthesia workstation restocking?,149602,3,D) Cerner,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45877,6,True or false: AWS does not require expiration date documentation to restock a medication.,149603,0,TRUE,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45877,6,True or false: AWS does not require expiration date documentation to restock a medication.,149604,1,FALSE,1
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45878,7,Which of the following will need to be checked the AWS during restocking?,149605,0,A) Paper level in the receipt printer,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45878,7,Which of the following will need to be checked the AWS during restocking?,149606,1,B) Labels remaining in the label printer,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45878,7,Which of the following will need to be checked the AWS during restocking?,149607,2,C) Ink cartridge levels in the label printer,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45878,7,Which of the following will need to be checked the AWS during restocking?,149608,3,D) System message on the AWS screen,0
8995,Elearning-0000-272,PHARMACY AWS EDUCATION FOR TECHNICIANS FY2019,n9237,45878,7,Which of the following will need to be checked the AWS during restocking?,149609,4,E) All of the above,1
9557,Elearning-0000-783,ANESTHESIA WORKSTATIONS OR NURSING EDUCATION,n9243,45903,0,"In case of anesthesia workstation machine failure, which of the following is true?",149703,0,A) Anesthesia providers can pull the red emergency release to access the drawers containing non-controlled medications and anesthesia supplies,0
9557,Elearning-0000-783,ANESTHESIA WORKSTATIONS OR NURSING EDUCATION,n9243,45903,0,"In case of anesthesia workstation machine failure, which of the following is true?",149704,1,B) Anesthesia providers should call pharmacy to notify of failure,0
9557,Elearning-0000-783,ANESTHESIA WORKSTATIONS OR NURSING EDUCATION,n9243,45903,0,"In case of anesthesia workstation machine failure, which of the following is true?",149705,2,"C) Anesthesia providers should call another anesthesia providers, nursing, or pharmacy to get narcotic medications from another anesthesia workstation or PACU Omnicell XT",0
9557,Elearning-0000-783,ANESTHESIA WORKSTATIONS OR NURSING EDUCATION,n9243,45903,0,"In case of anesthesia workstation machine failure, which of the following is true?",149706,3,D) All of the above are true,1
9557,Elearning-0000-783,ANESTHESIA WORKSTATIONS OR NURSING EDUCATION,n9243,45904,1,"If an anesthesia provider removes a medication from an anesthesia workstation, where can they return/waste the medication?",149707,0,A) At any anesthesia workstation,0
9557,Elearning-0000-783,ANESTHESIA WORKSTATIONS OR NURSING EDUCATION,n9243,45904,1,"If an anesthesia provider removes a medication from an anesthesia workstation, where can they return/waste the medication?",149708,1,B) Only at the anesthesia workstation where the medication was removed,0
9557,Elearning-0000-783,ANESTHESIA WORKSTATIONS OR NURSING EDUCATION,n9243,45904,1,"If an anesthesia provider removes a medication from an anesthesia workstation, where can they return/waste the medication?",149709,2,"C) At the Omnicell XT cabinet in ground floor PACU, third floor surgery PACU or in the L&D anesthesia workroom.",0
9557,Elearning-0000-783,ANESTHESIA WORKSTATIONS OR NURSING EDUCATION,n9243,45904,1,"If an anesthesia provider removes a medication from an anesthesia workstation, where can they return/waste the medication?",149710,3,D) Both A & C,1
9557,Elearning-0000-783,ANESTHESIA WORKSTATIONS OR NURSING EDUCATION,n9243,45904,1,"If an anesthesia provider removes a medication from an anesthesia workstation, where can they return/waste the medication?",149711,4,E) Both B & C,0
9557,Elearning-0000-783,ANESTHESIA WORKSTATIONS OR NURSING EDUCATION,n9243,45905,2,If an AWS machine needs to be moved to a different location in an OR room which of the following is true?,149712,0,A) AWS machines cannot be moved,0
9557,Elearning-0000-783,ANESTHESIA WORKSTATIONS OR NURSING EDUCATION,n9243,45905,2,If an AWS machine needs to be moved to a different location in an OR room which of the following is true?,149713,1,B) AWS machines have a battery backup so it is ok to unplug the machines for a long period of time,0
9557,Elearning-0000-783,ANESTHESIA WORKSTATIONS OR NURSING EDUCATION,n9243,45905,2,If an AWS machine needs to be moved to a different location in an OR room which of the following is true?,149714,2,C) AWS machines have a battery backup of 10mins so they can be moved but must be plugged in as soon as possible,1
9557,Elearning-0000-783,ANESTHESIA WORKSTATIONS OR NURSING EDUCATION,n9243,45905,2,If an AWS machine needs to be moved to a different location in an OR room which of the following is true?,149715,3,D) The Data port can be unplugged and moved to another port in the OR room,0
8147,Elearning-0000-1042,CONSENT FOR DIALYSIS SERVICES,n9254,46027,0,I acknowledge that I have read and understand in its entirety the CONSENT FOR DIALYSIS SERVICES CBL content and the subsequent expectations.,150196,0,TRUE,1
8147,Elearning-0000-1042,CONSENT FOR DIALYSIS SERVICES,n9254,46027,0,I acknowledge that I have read and understand in its entirety the CONSENT FOR DIALYSIS SERVICES CBL content and the subsequent expectations.,150197,1,FALSE,0
8206,Elearning-0000-1096,PROCESSED & UNPROCESSED INTERNAL AND EXTERNAL CHEMICAL INDICATORS,n9261,46094,0,"For questions about these statements, contact your manager.<br><br> I have reviewed the PROCESSED & UNPROCESSED INTERNAL AND EXTERNAL CHEMICAL INDICATORS CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",150455,0,TRUE,1
8206,Elearning-0000-1096,PROCESSED & UNPROCESSED INTERNAL AND EXTERNAL CHEMICAL INDICATORS,n9261,46094,0,"For questions about these statements, contact your manager.<br><br> I have reviewed the PROCESSED & UNPROCESSED INTERNAL AND EXTERNAL CHEMICAL INDICATORS CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",150456,1,FALSE,0
8146,Elearning-0000-1041,LD AWS NURSING EDUCATION,n9268,46233,0,I have read and understood the content of this module.,151018,0,TRUE,1
8146,Elearning-0000-1041,LD AWS NURSING EDUCATION,n9268,46233,0,I have read and understood the content of this module.,151019,1,FALSE,0
9528,Elearning-0000-757,C-282 UPDATE #6,n9270,46235,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the C-282 UPDATE #6 CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",151022,0,TRUE,1
9528,Elearning-0000-757,C-282 UPDATE #6,n9270,46235,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the C-282 UPDATE #6 CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",151023,1,FALSE,0
8215,Elearning-0000-1103,MODIFIERS,n9272,46237,0,<b>True or False?</b>  A modifier is a 2 digit alpha-numeric indicator appended to a CPT.,151026,0,TRUE,0
8215,Elearning-0000-1103,MODIFIERS,n9272,46237,0,<b>True or False?</b>  A modifier is a 2 digit alpha-numeric indicator appended to a CPT.,151027,1,FALSE,1
8215,Elearning-0000-1103,MODIFIERS,n9272,46238,1,<b>True or False?</b> Modifiers are solely for informational purposes that affect the processing of a code.,151028,0,TRUE,0
8215,Elearning-0000-1103,MODIFIERS,n9272,46238,1,<b>True or False?</b> Modifiers are solely for informational purposes that affect the processing of a code.,151029,1,FALSE,1
8215,Elearning-0000-1103,MODIFIERS,n9272,46239,2,"<b>True or False?</b>  Because modifiers are ranked, payment modifiers are always listed first.",151030,0,TRUE,1
8215,Elearning-0000-1103,MODIFIERS,n9272,46239,2,"<b>True or False?</b>  Because modifiers are ranked, payment modifiers are always listed first.",151031,1,FALSE,0
8215,Elearning-0000-1103,MODIFIERS,n9272,46240,3,<b>True or False?</b> Modifier 53 can be used on E&M services.,151032,0,TRUE,0
8215,Elearning-0000-1103,MODIFIERS,n9272,46240,3,<b>True or False?</b> Modifier 53 can be used on E&M services.,151033,1,FALSE,1
8215,Elearning-0000-1103,MODIFIERS,n9272,46241,4,<b>True or False?<b>  Modifier GA is used when you issue a mandatory ABN for a service as required and it is on file.,151034,0,TRUE,1
8215,Elearning-0000-1103,MODIFIERS,n9272,46241,4,<b>True or False?<b>  Modifier GA is used when you issue a mandatory ABN for a service as required and it is on file.,151035,1,FALSE,0
8215,Elearning-0000-1103,MODIFIERS,n9272,46242,5,<b>True or False?</b> Modifier ML is applicable when a patient is seen by the MidLevel Provider and the Physician on the same day but the documentation does not support the face-to-face encounter with the Physician.,151036,0,TRUE,1
8215,Elearning-0000-1103,MODIFIERS,n9272,46242,5,<b>True or False?</b> Modifier ML is applicable when a patient is seen by the MidLevel Provider and the Physician on the same day but the documentation does not support the face-to-face encounter with the Physician.,151037,1,FALSE,0
8215,Elearning-0000-1103,MODIFIERS,n9272,46243,6,<b>True or False?</b>  Aetna developed HCPCS modifiers XE/XP/XS/XU to further define situations in which modifier 59 is used.,151038,0,TRUE,0
8215,Elearning-0000-1103,MODIFIERS,n9272,46243,6,<b>True or False?</b>  Aetna developed HCPCS modifiers XE/XP/XS/XU to further define situations in which modifier 59 is used.,151039,1,FALSE,1
8215,Elearning-0000-1103,MODIFIERS,n9272,46244,7,An Arthrocentesis of small joint was performed on the same day of a level 2 established visit.  The correct coding would be:,151040,0,"A) 99212-22, 20600",0
8215,Elearning-0000-1103,MODIFIERS,n9272,46244,7,An Arthrocentesis of small joint was performed on the same day of a level 2 established visit.  The correct coding would be:,151041,1,"B) 99202-25, 20600",0
8215,Elearning-0000-1103,MODIFIERS,n9272,46244,7,An Arthrocentesis of small joint was performed on the same day of a level 2 established visit.  The correct coding would be:,151042,2,"C) 99202-24, 20600",0
8215,Elearning-0000-1103,MODIFIERS,n9272,46244,7,An Arthrocentesis of small joint was performed on the same day of a level 2 established visit.  The correct coding would be:,151043,3,"D) 99212-25, 20600",1
8215,Elearning-0000-1103,MODIFIERS,n9272,46245,8,Modifiers are used to,151044,0,A) Assist in avoiding fraud and abuse compliance issues,0
8215,Elearning-0000-1103,MODIFIERS,n9272,46245,8,Modifiers are used to,151045,1,B) Demonstrate both professional and technical components,0
8215,Elearning-0000-1103,MODIFIERS,n9272,46245,8,Modifiers are used to,151046,2,C) Impact timely reimbursement,0
8215,Elearning-0000-1103,MODIFIERS,n9272,46245,8,Modifiers are used to,151047,3,D) Suggests something should be paid that might ordinarily be denied,0
8215,Elearning-0000-1103,MODIFIERS,n9272,46245,8,Modifiers are used to,151048,4,E) All of the above,1
8215,Elearning-0000-1103,MODIFIERS,n9272,46246,9,"<b>True or False?</b> Use of modifier 22 requires the documentation of extra work for the procedure, the reason(s), and support that services are more complex that the CPT definition.",151049,0,TRUE,1
8215,Elearning-0000-1103,MODIFIERS,n9272,46246,9,"<b>True or False?</b> Use of modifier 22 requires the documentation of extra work for the procedure, the reason(s), and support that services are more complex that the CPT definition.",151050,1,FALSE,0
8517,Elearning-0000-139,SURGICAL ATTIRE UPDATE FY20,n9273,46247,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Surgical Attire Update FY20 CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",151051,0,TRUE,1
8517,Elearning-0000-139,SURGICAL ATTIRE UPDATE FY20,n9273,46247,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Surgical Attire Update FY20 CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",151052,1,FALSE,0
250,SCORM-0000-60,KINDNESS THROUGH COMMUNICATION- COURTESY AND RESPECT,n9343,46750,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Kindness Through Communication-Courtesy and Respect CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",152864,0,TRUE,1
250,SCORM-0000-60,KINDNESS THROUGH COMMUNICATION- COURTESY AND RESPECT,n9343,46750,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Kindness Through Communication-Courtesy and Respect CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",152865,1,FALSE,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46450,0,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Care Coordination:,151872,0,No needs identified,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46450,0,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Care Coordination:,151873,1,Adolescent 17 years or younger,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46450,0,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Care Coordination:,151874,2,Identify need for community resources,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46450,0,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Care Coordination:,151875,3,Pt/neonate with possible alcohol/drug screen,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46450,0,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Care Coordination:,151876,4,Pt verbalizes drug use during pregnancy,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46450,0,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Care Coordination:,151877,5,"B, D, and E",1
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46450,0,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Care Coordination:,151878,6,All of the above,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46451,1,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Behavioral Health:,151879,0,No needs identified,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46451,1,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Behavioral Health:,151880,1,Substance abuse,1
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46451,1,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Behavioral Health:,151881,2,Displays disorientation inconsistent with diagnosis,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46451,1,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Behavioral Health:,151882,3,Displays delusional/ disorganized thinking,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46451,1,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Behavioral Health:,151883,4,Receiving outpatient Mental Health Services,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46451,1,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Behavioral Health:,151884,5,Active suicidal/ homicidal thoughts or plans,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46451,1,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Behavioral Health:,151885,6,Pt has experienced catastrophic diagnosis,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46451,1,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Behavioral Health:,151886,7,Depressed mood,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46451,1,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Behavioral Health:,151887,8,Prominent anxiety,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46452,2,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Physical Therapy:,151888,0,No needs identified,1
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46452,2,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Physical Therapy:,151889,1,"Decline in gait, transfer, balance, or mobility skills",0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46452,2,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Physical Therapy:,151890,2,"Decrease in strength, ROM, or endurance",0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46452,2,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Physical Therapy:,151891,3,Acute increase in musculoskeletal pain,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46453,3,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Occupational Therapy:,151892,0,No needs identified,1
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46453,3,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Occupational Therapy:,151893,1,Adaptive equipment,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46453,3,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Occupational Therapy:,151894,2,Diminishing self care,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46453,3,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Occupational Therapy:,151895,3,Impaired movement UE,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46453,3,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Occupational Therapy:,151896,4,Impaired movement LE,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46453,3,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Occupational Therapy:,151897,5,Unable to dress,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46453,3,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Occupational Therapy:,151898,6,Unable to feed,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46454,4,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Clinical Nutrition:,151899,0,No needs identified,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46454,4,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Clinical Nutrition:,151900,1,Multiple gestation,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46454,4,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Clinical Nutrition:,151901,2,Excessive weight gain,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46454,4,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Clinical Nutrition:,151902,3,Progressive weight loss,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46454,4,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Clinical Nutrition:,151903,4,Pregnant less than 17 years old,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46454,4,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Clinical Nutrition:,151904,5,B and E,1
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46454,4,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Clinical Nutrition:,151905,6,"B, D, and E",0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46455,5,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Diabetes Education:,151906,0,No needs identified,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46455,5,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Diabetes Education:,151907,1,Diabetic Ketoacidosis,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46455,5,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Diabetes Education:,151908,2,Gestational Diabetes Mellitus,1
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46455,5,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Diabetes Education:,151909,3,Pre-Diabetes,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46455,5,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Diabetes Education:,151910,4,PCOS,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46455,5,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Diabetes Education:,151911,5,Type 1 Diabetes Mellitus,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46455,5,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Diabetes Education:,151912,6,Type 2 Diabetes Mellitus,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46456,6,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Respiratory Therapy:,151913,0,No needs identified,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46456,6,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Respiratory Therapy:,151914,1,CPAP check,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46456,6,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Respiratory Therapy:,151915,2,CPAP order,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46456,6,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Respiratory Therapy:,151916,3,Smoking cessation,1
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46457,7,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Pastoral Care:,151917,0,No needs identified,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46457,7,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Pastoral Care:,151918,1,Perinatal loss,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46457,7,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Pastoral Care:,151919,2,Newborn with congenital anomaly,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46457,7,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Pastoral Care:,151920,3,Pt/ family request,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46457,7,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Pastoral Care:,151921,4,Pt/ family experiencing spiritual distress,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46457,7,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Pastoral Care:,151922,5,Pt/ family experiencing catastrophic diagnosis,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46457,7,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Pastoral Care:,151923,6,Newborn for adoption,1
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46458,8,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Lactation:,151924,0,No needs identified,1
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46458,8,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Lactation:,151925,1,History of breast surgery/ biopsy,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46459,9,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Pharmacy:,151926,0,No needs identified,1
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46459,9,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals. Select all that apply to Pharmacy:,151927,1,Medical education,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46460,10,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Tdap vaccine. Patricia states she received the Tdap vaccine at 30 weeks gestation in the office. You confirm this is true on her prenatal record. Make the appropriate selection for the screening.,151928,0,No history of receiving Tdap vaccine this pregnancy AND patient is pregnant between 27 and 0/7 weeks and 38 and 0/7 weeks,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46460,10,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Tdap vaccine. Patricia states she received the Tdap vaccine at 30 weeks gestation in the office. You confirm this is true on her prenatal record. Make the appropriate selection for the screening.,151929,1,Patient is currently pregnant at 26 and 6/7 weeks gestation or earlier,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46460,10,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Tdap vaccine. Patricia states she received the Tdap vaccine at 30 weeks gestation in the office. You confirm this is true on her prenatal record. Make the appropriate selection for the screening.,151930,2,Patient is currently pregnant at 38 and 1/7 weeks or greater,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46460,10,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Tdap vaccine. Patricia states she received the Tdap vaccine at 30 weeks gestation in the office. You confirm this is true on her prenatal record. Make the appropriate selection for the screening.,151931,3,Has received Tdap vaccine this pregnancy,1
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46460,10,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Tdap vaccine. Patricia states she received the Tdap vaccine at 30 weeks gestation in the office. You confirm this is true on her prenatal record. Make the appropriate selection for the screening.,151932,4,"History of previous serious reaction to tetanus, diphtheria, or pertussis vaccine",0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46460,10,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Tdap vaccine. Patricia states she received the Tdap vaccine at 30 weeks gestation in the office. You confirm this is true on her prenatal record. Make the appropriate selection for the screening.,151933,5,Patient educated but declines vaccine,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46461,11,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Influenza vaccine. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,151934,0,No history of immunization this flu season (October1-March 31),0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46461,11,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Influenza vaccine. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,151935,1,Patient uncertain of history of immunization unreliable this flu season (October 1- March 31),0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46461,11,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Influenza vaccine. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,151936,2,Not currently flu Season (April 1- September 30),1
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46461,11,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Influenza vaccine. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,151937,3,Previously immunized this flu season,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46461,11,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Influenza vaccine. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,151938,4,Anaphylactic reaction to eggs,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46461,11,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Influenza vaccine. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,151939,5,History of Guillain Barre Syndrome,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46461,11,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Influenza vaccine. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,151940,6,Bone marrow transplant within last 6 months,0
9226,Elearning-0000-482,LD FY 2020 COMPETENCY DSC CASE STUDY,n9295,46461,11,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Influenza vaccine. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,151941,7,Patient educated but declines vaccine,0
9225,Elearning-0000-481,LD FY 2020 COMPETENCY RN DOCUMENTS,n9299,46465,0,I acknowledge that I must print and complete these documents and turn them in to my supervisor as part of my annual competency.,151948,0,Yes,1
9225,Elearning-0000-481,LD FY 2020 COMPETENCY RN DOCUMENTS,n9299,46465,0,I acknowledge that I must print and complete these documents and turn them in to my supervisor as part of my annual competency.,151949,1,No,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46637,0,Please list the location for this activity.,152397,0,Atlanta,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46637,0,Please list the location for this activity.,152398,1,Forsyth,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46637,0,Please list the location for this activity.,152399,2,Cherokee,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46637,0,Please list the location for this activity.,152400,3,Other,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46638,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the management of cardiovascular (CV) disease utilizing Impella as a treatment for cardiogenic shock.<ol>",152401,0,Strongly Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46638,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the management of cardiovascular (CV) disease utilizing Impella as a treatment for cardiogenic shock.<ol>",152402,1,Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46638,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the management of cardiovascular (CV) disease utilizing Impella as a treatment for cardiogenic shock.<ol>",152403,2,No Opinion,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46638,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the management of cardiovascular (CV) disease utilizing Impella as a treatment for cardiogenic shock.<ol>",152404,3,Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46638,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the management of cardiovascular (CV) disease utilizing Impella as a treatment for cardiogenic shock.<ol>",152405,4,Strongly Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46639,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify advantages and disadvantages of cardiac catheterization using snuffbox access. </ol>",152406,0,Strongly Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46639,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify advantages and disadvantages of cardiac catheterization using snuffbox access. </ol>",152407,1,Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46639,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify advantages and disadvantages of cardiac catheterization using snuffbox access. </ol>",152408,2,No Opinion,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46639,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify advantages and disadvantages of cardiac catheterization using snuffbox access. </ol>",152409,3,Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46639,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify advantages and disadvantages of cardiac catheterization using snuffbox access. </ol>",152410,4,Strongly Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46640,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe ways that pregnancy helps to identify those at risk for cardiovascular morbidity and mortality.</ol>",152411,0,Strongly Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46640,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe ways that pregnancy helps to identify those at risk for cardiovascular morbidity and mortality.</ol>",152412,1,Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46640,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe ways that pregnancy helps to identify those at risk for cardiovascular morbidity and mortality.</ol>",152413,2,No Opinion,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46640,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe ways that pregnancy helps to identify those at risk for cardiovascular morbidity and mortality.</ol>",152414,3,Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46640,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe ways that pregnancy helps to identify those at risk for cardiovascular morbidity and mortality.</ol>",152415,4,Strongly Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46641,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify current recommendations for modification of risk factors for the purpose of reducing CV risk in asymptomatic adults.</ol>",152416,0,Strongly Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46641,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify current recommendations for modification of risk factors for the purpose of reducing CV risk in asymptomatic adults.</ol>",152417,1,Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46641,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify current recommendations for modification of risk factors for the purpose of reducing CV risk in asymptomatic adults.</ol>",152418,2,No Opinion,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46641,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify current recommendations for modification of risk factors for the purpose of reducing CV risk in asymptomatic adults.</ol>",152419,3,Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46641,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify current recommendations for modification of risk factors for the purpose of reducing CV risk in asymptomatic adults.</ol>",152420,4,Strongly Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46642,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define geriatric cardiology, describe CV issues in the elderly patient and identify treatment goals.</ol>",152421,0,Strongly Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46642,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define geriatric cardiology, describe CV issues in the elderly patient and identify treatment goals.</ol>",152422,1,Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46642,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define geriatric cardiology, describe CV issues in the elderly patient and identify treatment goals.</ol>",152423,2,No Opinion,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46642,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define geriatric cardiology, describe CV issues in the elderly patient and identify treatment goals.</ol>",152424,3,Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46642,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define geriatric cardiology, describe CV issues in the elderly patient and identify treatment goals.</ol>",152425,4,Strongly Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46643,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common EKG patterns and EKG patterns requiring prompt cardiovascular attention.</ol>",152426,0,Strongly Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46643,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common EKG patterns and EKG patterns requiring prompt cardiovascular attention.</ol>",152427,1,Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46643,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common EKG patterns and EKG patterns requiring prompt cardiovascular attention.</ol>",152428,2,No Opinion,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46643,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common EKG patterns and EKG patterns requiring prompt cardiovascular attention.</ol>",152429,3,Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46643,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common EKG patterns and EKG patterns requiring prompt cardiovascular attention.</ol>",152430,4,Strongly Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46644,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize risks and clinical implications for patients with Afib and describe steps for managing Afib.ol>",152431,0,Strongly Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46644,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize risks and clinical implications for patients with Afib and describe steps for managing Afib.ol>",152432,1,Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46644,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize risks and clinical implications for patients with Afib and describe steps for managing Afib.ol>",152433,2,No Opinion,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46644,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize risks and clinical implications for patients with Afib and describe steps for managing Afib.ol>",152434,3,Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46644,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize risks and clinical implications for patients with Afib and describe steps for managing Afib.ol>",152435,4,Strongly Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46645,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify risk factors associated with peripheral artery disease (PAD) and discuss the diagnostic algorithm utilized for suspected PAD.</ol>",152436,0,Strongly Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46645,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify risk factors associated with peripheral artery disease (PAD) and discuss the diagnostic algorithm utilized for suspected PAD.</ol>",152437,1,Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46645,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify risk factors associated with peripheral artery disease (PAD) and discuss the diagnostic algorithm utilized for suspected PAD.</ol>",152438,2,No Opinion,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46645,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify risk factors associated with peripheral artery disease (PAD) and discuss the diagnostic algorithm utilized for suspected PAD.</ol>",152439,3,Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46645,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify risk factors associated with peripheral artery disease (PAD) and discuss the diagnostic algorithm utilized for suspected PAD.</ol>",152440,4,Strongly Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46646,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe treatments for claudication vs critical limb ischemia.</ol>",152441,0,Strongly Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46646,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe treatments for claudication vs critical limb ischemia.</ol>",152442,1,Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46646,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe treatments for claudication vs critical limb ischemia.</ol>",152443,2,No Opinion,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46646,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe treatments for claudication vs critical limb ischemia.</ol>",152444,3,Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46646,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe treatments for claudication vs critical limb ischemia.</ol>",152445,4,Strongly Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46647,10,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,152446,0,Strongly Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46647,10,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,152447,1,Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46647,10,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,152448,2,No Opinion,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46647,10,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,152449,3,Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46647,10,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,152450,4,Strongly Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46648,12,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",152451,0,Strongly Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46648,12,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",152452,1,Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46648,12,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",152453,2,No Opinion,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46648,12,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",152454,3,Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46648,12,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",152455,4,Strongly Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46649,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of the most current, evidenced-based trends in cardiovascular care related to prevention and management of the adult population.<OL>",152456,0,Strongly Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46649,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of the most current, evidenced-based trends in cardiovascular care related to prevention and management of the adult population.<OL>",152457,1,Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46649,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of the most current, evidenced-based trends in cardiovascular care related to prevention and management of the adult population.<OL>",152458,2,No Opinion,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46649,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of the most current, evidenced-based trends in cardiovascular care related to prevention and management of the adult population.<OL>",152459,3,Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46649,11,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of the most current, evidenced-based trends in cardiovascular care related to prevention and management of the adult population.<OL>",152460,4,Strongly Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46650,13,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",152461,0,Strongly Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46650,13,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",152462,1,Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46650,13,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",152463,2,No Opinion,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46650,13,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",152464,3,Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46650,13,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",152465,4,Strongly Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46651,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</ol>,152466,0,Strongly Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46651,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</ol>,152467,1,Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46651,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</ol>,152468,2,No Opinion,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46651,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</ol>,152469,3,Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46651,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</ol>,152470,4,Strongly Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46652,15,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,152471,0,Strongly Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46652,15,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,152472,1,Agree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46652,15,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,152473,2,No Opinion,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46652,15,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,152474,3,Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46652,15,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,152475,4,Strongly Disagree,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46653,16,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mehul Bhatt, MD</ol>",152476,0,Excellent,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46653,16,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mehul Bhatt, MD</ol>",152477,1,Very Good,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46653,16,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mehul Bhatt, MD</ol>",152478,2,Good,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46653,16,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mehul Bhatt, MD</ol>",152479,3,Fair,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46653,16,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mehul Bhatt, MD</ol>",152480,4,Poor,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46654,17,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lee Padove, MD</ol>",152481,0,Excellent,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46654,17,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lee Padove, MD</ol>",152482,1,Very Good,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46654,17,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lee Padove, MD</ol>",152483,2,Good,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46654,17,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lee Padove, MD</ol>",152484,3,Fair,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46654,17,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lee Padove, MD</ol>",152485,4,Poor,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46655,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Anjan Deka, MD</ol>",152486,0,Excellent,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46655,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Anjan Deka, MD</ol>",152487,1,Very Good,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46655,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Anjan Deka, MD</ol>",152488,2,Good,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46655,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Anjan Deka, MD</ol>",152489,3,Fair,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46655,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Anjan Deka, MD</ol>",152490,4,Poor,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46656,19,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Parham Eshtehardi, MD</ol>",152491,0,Excellent,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46656,19,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Parham Eshtehardi, MD</ol>",152492,1,Very Good,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46656,19,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Parham Eshtehardi, MD</ol>",152493,2,Good,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46656,19,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Parham Eshtehardi, MD</ol>",152494,3,Fair,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46656,19,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Parham Eshtehardi, MD</ol>",152495,4,Poor,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46657,20,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Adam Buntaine, MD</ol>",152496,0,Excellent,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46657,20,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Adam Buntaine, MD</ol>",152497,1,Very Good,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46657,20,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Adam Buntaine, MD</ol>",152498,2,Good,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46657,20,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Adam Buntaine, MD</ol>",152499,3,Fair,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46657,20,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Adam Buntaine, MD</ol>",152500,4,Poor,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46658,21,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Apurva Shah, MD</ol>",152501,0,Excellent,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46658,21,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Apurva Shah, MD</ol>",152502,1,Very Good,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46658,21,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Apurva Shah, MD</ol>",152503,2,Good,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46658,21,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Apurva Shah, MD</ol>",152504,3,Fair,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46658,21,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Apurva Shah, MD</ol>",152505,4,Poor,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46659,22,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Carlos Muller, MD</ol>",152506,0,Excellent,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46659,22,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Carlos Muller, MD</ol>",152507,1,Very Good,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46659,22,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Carlos Muller, MD</ol>",152508,2,Good,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46659,22,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Carlos Muller, MD</ol>",152509,3,Fair,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46659,22,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Carlos Muller, MD</ol>",152510,4,Poor,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46660,23,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cheney Wilson, MD</ol>",152511,0,Excellent,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46660,23,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cheney Wilson, MD</ol>",152512,1,Very Good,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46660,23,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cheney Wilson, MD</ol>",152513,2,Good,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46660,23,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cheney Wilson, MD</ol>",152514,3,Fair,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46660,23,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cheney Wilson, MD</ol>",152515,4,Poor,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46661,24,"Overall, this activity was:",152516,0,Excellent,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46661,24,"Overall, this activity was:",152517,1,Very Good,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46661,24,"Overall, this activity was:",152518,2,Good,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46661,24,"Overall, this activity was:",152519,3,Fair,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46661,24,"Overall, this activity was:",152520,4,Poor,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46662,25,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",152521,0,Yes,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46662,25,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",152522,1,No,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46662,25,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",152523,2,N/A,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46665,28,How would you improve this class?,152524,0,Reduce content covered in class,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46665,28,How would you improve this class?,152525,1,Increase content covered in class,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46665,28,How would you improve this class?,152526,2,Update content covered in class,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46665,28,How would you improve this class?,152527,3,Improve the instructional methods,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46665,28,How would you improve this class?,152528,4,Make course activities more stimulating,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46665,28,How would you improve this class?,152529,5,Slow the pace of the class,0
396,ILT-0000-968,8TH ANNUAL CHEROKEE CARDIOVASCULAR SUMMIT- YANMAR EVO CENTER (EVALUATION SURVEY) 10-5-19,n9336,46665,28,How would you improve this class?,152530,6,"Nothing: (appropriate speakers, content, facility, etc.)",0
8216,Elearning-0000-1104,NEUROSURGERY INITIAL COMPETENCY MODULES FOR MED-SURG,n9348,46798,0,I  have successfully completed the THREE  required Healthstream modules.,153047,0,TRUE,1
8216,Elearning-0000-1104,NEUROSURGERY INITIAL COMPETENCY MODULES FOR MED-SURG,n9348,46798,0,I  have successfully completed the THREE  required Healthstream modules.,153048,1,FALSE,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46823,0,"ATB is an abbreviation for ""Account Trial Balance"".",153121,0,TRUE,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46823,0,"ATB is an abbreviation for ""Account Trial Balance"".",153122,1,FALSE,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46824,1,Which of the following denials is NOT worked by denial management?,153123,0,a. Bundling,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46824,1,Which of the following denials is NOT worked by denial management?,153124,1,b. Level of Care,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46824,1,Which of the following denials is NOT worked by denial management?,153125,2,c. Coordination of Benefits,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46825,2,Denial Managements Northside financial class is 3.,153126,0,TRUE,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46825,2,Denial Managements Northside financial class is 3.,153127,1,FALSE,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46826,3,Which standard note code is used for bundling denial?,153128,0,a. 1040,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46826,3,Which standard note code is used for bundling denial?,153129,1,b. 1001,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46826,3,Which standard note code is used for bundling denial?,153130,2,c. 1041,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46827,4,The Tool can be accessed through which of the following sites?,153131,0,a. Northside Intranet,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46827,4,The Tool can be accessed through which of the following sites?,153132,1,b. OneContent,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46827,4,The Tool can be accessed through which of the following sites?,153133,2,c. Revenue Cycle Website,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46828,5,"Which of these is true about accounts with a ""Z Status""?",153134,0,a. Zero balance account,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46828,5,"Which of these is true about accounts with a ""Z Status""?",153135,1,b. New account,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46828,5,"Which of these is true about accounts with a ""Z Status""?",153136,2,c. Denied account,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46829,6,Which is the preferred search method to search for a patient in Cerner?,153137,0,a. Patient's Name,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46829,6,Which is the preferred search method to search for a patient in Cerner?,153138,1,b. Patient's MRN,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46829,6,Which is the preferred search method to search for a patient in Cerner?,153139,2,c. FIN (STAR Account Number),1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46830,7,Notes from The Tool automatically transfer to STAR.,153140,0,TRUE,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46830,7,Notes from The Tool automatically transfer to STAR.,153141,1,FALSE,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46831,8,PowerChart and Schapptbook are applications found in which system?,153142,0,a. Cerner,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46831,8,PowerChart and Schapptbook are applications found in which system?,153143,1,b. OneContent,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46831,8,PowerChart and Schapptbook are applications found in which system?,153144,2,c. The Tool,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46832,9,"Under contract details in The Tool, what does rate type 4DMO indicate?",153145,0,a. Box 7,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46832,9,"Under contract details in The Tool, what does rate type 4DMO indicate?",153146,1,b. Box 45,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46832,9,"Under contract details in The Tool, what does rate type 4DMO indicate?",153147,2,c. 4 Day Mother Only,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46833,10,Medical necessity denials occur when the payer has deemed the service(s) billed is non-covered because the diagnoses code billed is inconsistent with the service.,153148,0,TRUE,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46833,10,Medical necessity denials occur when the payer has deemed the service(s) billed is non-covered because the diagnoses code billed is inconsistent with the service.,153149,1,FALSE,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46834,11,"In Allscripts, task __________ are used to communicate with other departments.",153150,0,a. lists,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46834,11,"In Allscripts, task __________ are used to communicate with other departments.",153151,1,b. letter,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46834,11,"In Allscripts, task __________ are used to communicate with other departments.",153152,2,c. notes,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46835,12,Standard note code 1121 DM - Acct Review indicates___________________:,153153,0,a. The account requires follow-up,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46835,12,Standard note code 1121 DM - Acct Review indicates___________________:,153154,1,b. The account was worked by the DM Specialist,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46835,12,Standard note code 1121 DM - Acct Review indicates___________________:,153155,2,c. The account was referred to another department,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46836,13,How many copies of the appeal letter are specialist required to print?,153156,0,a. 2,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46836,13,How many copies of the appeal letter are specialist required to print?,153157,1,b. 3,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46836,13,How many copies of the appeal letter are specialist required to print?,153158,2,c. 4,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46837,14,Which of the following systems is not used by Denial Management?,153159,0,a. SSI,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46837,14,Which of the following systems is not used by Denial Management?,153160,1,b. The Tool,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46837,14,Which of the following systems is not used by Denial Management?,153161,2,c. OneContent,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46838,15,A copy of every appeal letter must be scanned into OneContent.,153162,0,TRUE,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46838,15,A copy of every appeal letter must be scanned into OneContent.,153163,1,FALSE,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46839,16,"When a task is sent to a department, it will appear in the ______________.",153164,0,a. Task Outbox,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46839,16,"When a task is sent to a department, it will appear in the ______________.",153165,1,b. Client Mailbox,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46839,16,"When a task is sent to a department, it will appear in the ______________.",153166,2,c. Task Inbox,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46840,17,Which request is submitted when all avenues available to obtain reimbursement have been exhausted?,153167,0,a. Write-off,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46840,17,Which request is submitted when all avenues available to obtain reimbursement have been exhausted?,153168,1,b. Balance Correction,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46840,17,Which request is submitted when all avenues available to obtain reimbursement have been exhausted?,153169,2,c. Appeal,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46841,18,STAR can be accessed from the Revenue Cycle Website.,153170,0,TRUE,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46841,18,STAR can be accessed from the Revenue Cycle Website.,153171,1,FALSE,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46842,19,Which system is used to request medical records?,153172,0,"a. OneContent ""Search""",0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46842,19,Which system is used to request medical records?,153173,1,"b. STAR ""Med Rec Request""",0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46842,19,Which system is used to request medical records?,153174,2,"c. The Tool ""Med Rec Request""",1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46843,20,Timely filing is the time limit set by insurance companies to submit initial claims for services rendered to its subscribers.,153175,0,TRUE,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46843,20,Timely filing is the time limit set by insurance companies to submit initial claims for services rendered to its subscribers.,153176,1,FALSE,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46844,21,"In The Tool, which collections environment should be accessed by non-government collectors?",153177,0,a. Medicaid,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46844,21,"In The Tool, which collections environment should be accessed by non-government collectors?",153178,1,b. Commercial,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46844,21,"In The Tool, which collections environment should be accessed by non-government collectors?",153179,2,c. Denial Management,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46845,22,"Which tab within the Contract tab displays the negotiated rates for the payor in question and is divided into three sections Inpatient, Outpatient, and MISC services?",153180,0,a. Notes,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46845,22,"Which tab within the Contract tab displays the negotiated rates for the payor in question and is divided into three sections Inpatient, Outpatient, and MISC services?",153181,1,b. Groupers,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46845,22,"Which tab within the Contract tab displays the negotiated rates for the payor in question and is divided into three sections Inpatient, Outpatient, and MISC services?",153182,2,c. Details,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46846,23,The Tool does not allow users to customize how column headers are displayed on the ATB display.,153183,0,TRUE,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46846,23,The Tool does not allow users to customize how column headers are displayed on the ATB display.,153184,1,FALSE,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46847,24,Which of the following is not an option for medical records requests:,153185,0,a. Fax records to patient,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46847,24,Which of the following is not an option for medical records requests:,153186,1,b. Forward record as noted below,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46847,24,Which of the following is not an option for medical records requests:,153187,2,c. Return records to Business Office,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46848,25,OneContent is used to calculate patient financial responsibility.,153188,0,TRUE,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46848,25,OneContent is used to calculate patient financial responsibility.,153189,1,FALSE,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46849,26,Which tab within the Contract tab is utilized to search for which surgical grouper a particular CPT code falls under?,153190,0,a. Details,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46849,26,Which tab within the Contract tab is utilized to search for which surgical grouper a particular CPT code falls under?,153191,1,b. Notes,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46849,26,Which tab within the Contract tab is utilized to search for which surgical grouper a particular CPT code falls under?,153192,2,c. Groupers,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46850,27,Denial Management standard note code 1055 is used to indicate contract issues.,153193,0,TRUE,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46850,27,Denial Management standard note code 1055 is used to indicate contract issues.,153194,1,FALSE,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46851,28,"Under contract details in The Tool, what does rate type 2DMO indicate?",153195,0,a. 2 Date Mother Only,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46851,28,"Under contract details in The Tool, what does rate type 2DMO indicate?",153196,1,b. 2 Day Mother Only,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46851,28,"Under contract details in The Tool, what does rate type 2DMO indicate?",153197,2,c. 2 Dad Month Only,0
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46852,29,An appeal is a request for Health Insurance Company's to review a decision that denies a benefit or payment.,153198,0,TRUE,1
9819,Questions-0000-113,RCT: DENIAL MANAGEMENT UNIVERSITY TEST,n9358,46852,29,An appeal is a request for Health Insurance Company's to review a decision that denies a benefit or payment.,153199,1,FALSE,0
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46883,0,The use of routine or blanket ABNs is acceptable for Medicare patients .True or False?,153279,0,TRUE,0
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46883,0,The use of routine or blanket ABNs is acceptable for Medicare patients .True or False?,153280,1,FALSE,1
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46884,1,An ABN must be delivered to the affected beneficiary or their representative(s) prior to providing the item or service. True or False?,153281,0,TRUE,1
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46884,1,An ABN must be delivered to the affected beneficiary or their representative(s) prior to providing the item or service. True or False?,153282,1,FALSE,0
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46885,2,Modifier GA is used when you issue a mandatory ABN for a service as required and it is on file. True or False?,153283,0,TRUE,1
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46885,2,Modifier GA is used when you issue a mandatory ABN for a service as required and it is on file. True or False?,153284,1,FALSE,0
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46886,3,A Medicare beneficiary (age 65+) presents for preventative visit with CPT code 99387 or 99397 which are not covered benefits.  Append the following modifier(s):,153285,0,A) GA,0
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46886,3,A Medicare beneficiary (age 65+) presents for preventative visit with CPT code 99387 or 99397 which are not covered benefits.  Append the following modifier(s):,153286,1,B) GA and GY,0
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46886,3,A Medicare beneficiary (age 65+) presents for preventative visit with CPT code 99387 or 99397 which are not covered benefits.  Append the following modifier(s):,153287,2,C) GZ,0
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46886,3,A Medicare beneficiary (age 65+) presents for preventative visit with CPT code 99387 or 99397 which are not covered benefits.  Append the following modifier(s):,153288,3,D) GX and GY,1
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46887,4,"If you believe and item or service may exceed frequency limits, you do not have to issue an ABN before furnishing item(s) or service(s) to the beneficiary.  True or False?",153289,0,TRUE,0
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46887,4,"If you believe and item or service may exceed frequency limits, you do not have to issue an ABN before furnishing item(s) or service(s) to the beneficiary.  True or False?",153290,1,FALSE,1
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46888,5,"A Medicare beneficiary presents to the clinic and requests a Tdap injection because her daughter just had a baby, and as a visitor, she needs to be up to date on all vaccinations.",153291,0,A) GA,1
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46888,5,"A Medicare beneficiary presents to the clinic and requests a Tdap injection because her daughter just had a baby, and as a visitor, she needs to be up to date on all vaccinations.",153292,1,B) GA and GY,0
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46888,5,"A Medicare beneficiary presents to the clinic and requests a Tdap injection because her daughter just had a baby, and as a visitor, she needs to be up to date on all vaccinations.",153293,2,C) GZ,0
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46888,5,"A Medicare beneficiary presents to the clinic and requests a Tdap injection because her daughter just had a baby, and as a visitor, she needs to be up to date on all vaccinations.",153294,3,D) GX and GY,0
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46889,6,Issue an ABN for a service when Medicare never covers because it is statutorily excluded or is not a Medicare benefit. True or False?,153295,0,TRUE,1
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46889,6,Issue an ABN for a service when Medicare never covers because it is statutorily excluded or is not a Medicare benefit. True or False?,153296,1,FALSE,0
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46890,7,"If the beneficiary does not get written notice when it is required, he or she may be held financially liable if Medicare denies payment. True or False?",153297,0,TRUE,0
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46890,7,"If the beneficiary does not get written notice when it is required, he or she may be held financially liable if Medicare denies payment. True or False?",153298,1,FALSE,1
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46891,8,"You must issue the ABN in the standardized notice format, and it cannot exceed one page in length. True or False?",153299,0,TRUE,1
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46891,8,"You must issue the ABN in the standardized notice format, and it cannot exceed one page in length. True or False?",153300,1,FALSE,0
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46892,9,The Northside Physician Policy and Procedure concerning the Advance Beneficiary Notice (ABN) can be found where in Lucidoc?,153301,0,A) PPM005,0
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46892,9,The Northside Physician Policy and Procedure concerning the Advance Beneficiary Notice (ABN) can be found where in Lucidoc?,153302,1,B) PPM001,1
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46892,9,The Northside Physician Policy and Procedure concerning the Advance Beneficiary Notice (ABN) can be found where in Lucidoc?,153303,2,C) PPM009,0
8231,Elearning-0000-1118,ADVANCE BENEFICIARY NOTICE OF NON-COVERAGE (ABN),n9360,46892,9,The Northside Physician Policy and Procedure concerning the Advance Beneficiary Notice (ABN) can be found where in Lucidoc?,153304,3,D) PPM003,0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46894,0,For which reason(s) are Point of Service collections important to patients?,153307,0,"A.	Patients deserve to be able to make informed financial decisions about their care.",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46894,0,For which reason(s) are Point of Service collections important to patients?,153308,1,"B.	Reduced stress for the patients knowing they've made a payment for their bills",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46894,0,For which reason(s) are Point of Service collections important to patients?,153309,2,"C.	Both A&B",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46895,1,For which reason(s) are Point of Service collections important to Northside Hospital?,153310,0,"A.	Northside buys advanced technology, uses the money collected to serve the patients and the community.",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46895,1,For which reason(s) are Point of Service collections important to Northside Hospital?,153311,1,B. Northside hires the best physicians and staff to serve the patients.,0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46895,1,For which reason(s) are Point of Service collections important to Northside Hospital?,153312,2,"C.	Both A & B",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46896,2,Collections are important to employees because it is a __________ specific standard.,153313,0,"A.	Per quota",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46896,2,Collections are important to employees because it is a __________ specific standard.,153314,1,"B.	Job",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46896,2,Collections are important to employees because it is a __________ specific standard.,153315,2,"C.	Collections is not important to employees",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46897,3,Grueling George is Insured Electing Self Pay and opts for 75% - Prompt Pay Discount. The representative should enter SNC 0154 and SNC 1354 on the account.,153316,0,TRUE,1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46897,3,Grueling George is Insured Electing Self Pay and opts for 75% - Prompt Pay Discount. The representative should enter SNC 0154 and SNC 1354 on the account.,153317,1,FALSE,0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46898,4,Northside Representatives will always ask for the Total Estimated Financial Responsibility first for insured patients then:,153318,0,"A.	75% discount",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46898,4,Northside Representatives will always ask for the Total Estimated Financial Responsibility first for insured patients then:,153319,1,"B.	Payment Plan 1/3 deposit",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46898,4,Northside Representatives will always ask for the Total Estimated Financial Responsibility first for insured patients then:,153320,2,"C.	Financial Assistance Survey",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46899,5,"When the patient opts for the payment plan, the agreed upon response will be used to ensure patient understands the monthly payments will be auto-drafted.",153321,0,TRUE,1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46899,5,"When the patient opts for the payment plan, the agreed upon response will be used to ensure patient understands the monthly payments will be auto-drafted.",153322,1,FALSE,0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46900,6,Northside representatives will reinforce conversations about amounts as _______________.,153323,0,"A.	Total responsibility",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46900,6,Northside representatives will reinforce conversations about amounts as _______________.,153324,1,"B.	Final charges",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46900,6,Northside representatives will reinforce conversations about amounts as _______________.,153325,2,"C.	Estimates",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46901,7,Which charges does the 75% disclaimer apply to on the FET Letter?,153326,0,"A.	There are no additional charges when patient agrees to the 75% prompt pay POS discount.",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46901,7,Which charges does the 75% disclaimer apply to on the FET Letter?,153327,1,"B.	Any billed amount that exceeds the estimated amount.",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46901,7,Which charges does the 75% disclaimer apply to on the FET Letter?,153328,2,"C.	Separate professional fees.",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46902,8,Which of the following is NOT true for an insured patient electing self-pay?,153329,0,"A.	We are unable to file insurance to the account at a later time.",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46902,8,Which of the following is NOT true for an insured patient electing self-pay?,153330,1,"B.	Registration must file the insurance when the insured patient elects self-pay.",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46902,8,Which of the following is NOT true for an insured patient electing self-pay?,153331,2,"C.	Monies paid will not affect or reduce out-of-pocket financial responsibility for future services as determined by the insurance company.",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46903,9,"If a patient presents with out of state Medicaid, follow which process below:",153332,0,"A. If the Medicaid is a traditional plan, from a Bordering State and is active, load the applicable STAR plan code. If it is a Non-Bordering State, scan the Medicaid card (if available), run eligibility via RevRunner to confirm active coverage. If active coverage is confirmed, patient automatically qualifies for Financial Assistance. Note account with SNC 1263.",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46903,9,"If a patient presents with out of state Medicaid, follow which process below:",153333,1,"B.	Northside does not accept out of state Medicaid.",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46903,9,"If a patient presents with out of state Medicaid, follow which process below:",153334,2,"C.	Refer the patient to the Business Office to check for approval.",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46904,10,Which criteria must be met in order for the Financial Assistance Survey (FA Survey) to be completed?,153335,0,"A.	All efforts to collect payment have been exhausted; collection of payments has been determined unlikely based on the patient's verbal statements, emotional expressions, or medical circumstances.",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46904,10,Which criteria must be met in order for the Financial Assistance Survey (FA Survey) to be completed?,153336,1,"B.	The patient's total financial responsibility (including all outstanding balances and current estimate) is less than $5000; state of residency is Georgia or bordering states, unless patient provides some sort of bill with their name and address listing Georgia or a bordering state of Georgia.",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46904,10,Which criteria must be met in order for the Financial Assistance Survey (FA Survey) to be completed?,153337,2,"C.	All of the above",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46905,11,"An Agreed Upon Response for the financial conversation when explaining the 75% prompt pay POS discount  - amount due in full today is $8,375.00. This is 25% of the estimated amount due, a cost savings of $25,125.00.",153338,0,TRUE,1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46905,11,"An Agreed Upon Response for the financial conversation when explaining the 75% prompt pay POS discount  - amount due in full today is $8,375.00. This is 25% of the estimated amount due, a cost savings of $25,125.00.",153339,1,FALSE,0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46908,12,"Perturbed Patty is uninsured/self-pay and unable to take advantage of the 75% Prompt Pay discount. According to the Framework for Financial Conversation, what is the next available option the representative can offer?",153344,0,A. 65% - 120 Day Payment Plan,1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46908,12,"Perturbed Patty is uninsured/self-pay and unable to take advantage of the 75% Prompt Pay discount. According to the Framework for Financial Conversation, what is the next available option the representative can offer?",153345,1,B. Financial Survey,0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46908,12,"Perturbed Patty is uninsured/self-pay and unable to take advantage of the 75% Prompt Pay discount. According to the Framework for Financial Conversation, what is the next available option the representative can offer?",153346,2,C. Patient can be billed for the service at a later date.,0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46909,13,The Payment Worksheet above requires a deposit of _______ to secure the payment plan.,153347,0,"A.	$68.68",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46909,13,The Payment Worksheet above requires a deposit of _______ to secure the payment plan.,153348,1,"B.	$824.20",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46909,13,The Payment Worksheet above requires a deposit of _______ to secure the payment plan.,153349,2,"C.	$274.73",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46910,14,"If patient agrees to the payment plan, the monthly payments of ______ will be auto-drafted starting the next month.",153350,0,"A.	$274.73",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46910,14,"If patient agrees to the payment plan, the monthly payments of ______ will be auto-drafted starting the next month.",153351,1,"B.	$68.68",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46910,14,"If patient agrees to the payment plan, the monthly payments of ______ will be auto-drafted starting the next month.",153352,2,"C.	Monthly payments are not auto-drafted",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46911,15,Which of the following statements should be utilized when registrars are collecting and/or asking for payment?,153353,0,"A.	""You need to pay this today.""",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46911,15,Which of the following statements should be utilized when registrars are collecting and/or asking for payment?,153354,1,"B.	""How would you like to take care of this today?""",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46911,15,Which of the following statements should be utilized when registrars are collecting and/or asking for payment?,153355,2,"C.	""Can you pay this today?""",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46912,16,"If patient has outstanding balances, then registrar will:",153356,0,"A.	Verbally inform the patient and collect the total amount; there is no documentation enter the outstanding balances.",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46912,16,"If patient has outstanding balances, then registrar will:",153357,1,"B.	Manually enter the Total Outstanding Balance on the FET and enter the amount the patient agrees to pay (full, 1/2, or 1/3) in the Pay Today line.",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46912,16,"If patient has outstanding balances, then registrar will:",153358,2,"C.	Inform the patient of the outstanding balance and direct patient to the About Your Billing brochure to call the billing department and arrange collections of the OSB.",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46913,17,"If RevRunner returns an incomplete response, unclear response, or the payer is a non-RevRunner payer, which steps should be taken:",153359,0,"A.	Call the payer and complete the Alternate Insurance Verification (AIV) Worksheet. Make free form note regarding the call reference number. Make a free form payment collection note and POS SNC. Scan the AIV to the POS Collections folder.",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46913,17,"If RevRunner returns an incomplete response, unclear response, or the payer is a non-RevRunner payer, which steps should be taken:",153360,1,"B.	Call the payer for verification and make a free form payment collection note.",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46913,17,"If RevRunner returns an incomplete response, unclear response, or the payer is a non-RevRunner payer, which steps should be taken:",153361,2,"C.	Only SNC 1218 and 8010 are necessary",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46914,18,The FA Survey is offered in the ED.,153362,0,TRUE,0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46914,18,The FA Survey is offered in the ED.,153363,1,FALSE,1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46915,19,The Framework for Financial Conversation should be utilized for consistency in the order when presenting the payment options to the patient.,153393,0,TRUE,1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46915,19,The Framework for Financial Conversation should be utilized for consistency in the order when presenting the payment options to the patient.,153394,1,FALSE,0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46916,21,"Burdensome Brandy is Self-Pay with a current visit in the amount of $3,897.00. She also has an outstanding balance (OSB) of $3,100. When presented with FET Options 75% Prompt-Pay and 65% 120 - Day Payment Plan, she is unable to accept either. She now qualifies for Financial Assistance.",153367,0,TRUE,0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46916,21,"Burdensome Brandy is Self-Pay with a current visit in the amount of $3,897.00. She also has an outstanding balance (OSB) of $3,100. When presented with FET Options 75% Prompt-Pay and 65% 120 - Day Payment Plan, she is unable to accept either. She now qualifies for Financial Assistance.",153368,1,FALSE,1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46917,22,"The SNC 2050 is entered in STAR when the insured patient agrees to the payment plan, pays the 1/3 deposit, and agrees to the monthly payment installment auto-draft.",153369,0,TRUE,1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46917,22,"The SNC 2050 is entered in STAR when the insured patient agrees to the payment plan, pays the 1/3 deposit, and agrees to the monthly payment installment auto-draft.",153370,1,FALSE,0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46918,23,The FET payment options should be offered before the Financial Assistance Survey.,153371,0,TRUE,1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46918,23,The FET payment options should be offered before the Financial Assistance Survey.,153372,1,FALSE,0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46919,24,The 75% and 65% discount are offered to:,153373,0,A. True Uninsured Self-Pay only,0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46919,24,The 75% and 65% discount are offered to:,153374,1,B. Uninsured Self-Pay and Insured Electing Self-Pay,1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46919,24,The 75% and 65% discount are offered to:,153375,2,C. Uninsured Self-Pay and Insured Patients,0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46920,25,The Financial Conversation should be conducted to include all of the following EXCEPT:,153376,0,"A.	The patient is presented with an estimate at the time of service",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46920,25,The Financial Conversation should be conducted to include all of the following EXCEPT:,153377,1,"B.	ALL of the financial options are explained to the patient who is not able to pay the full amount of the estimated financial responsibility and a payment arrangement of some kind is expected to be secured prior to service",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46920,25,The Financial Conversation should be conducted to include all of the following EXCEPT:,153378,2,"C.	NSH representatives should begin the financial conversation only after patients ask about what they owe.",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46921,26,NSH representatives should incorporate the NSH Service Excellence Standards when collecting from patients and during the Financial Conversation.,153379,0,TRUE,1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46921,26,NSH representatives should incorporate the NSH Service Excellence Standards when collecting from patients and during the Financial Conversation.,153380,1,FALSE,0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46922,27,The financial resources used to determine the total estimated financial responsibility are:,153381,0,"A.	Wells Fargo, STAR, FET",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46922,27,The financial resources used to determine the total estimated financial responsibility are:,153382,1,"B.	FET, STAR, RevRunner, Financial Assistance",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46922,27,The financial resources used to determine the total estimated financial responsibility are:,153383,2,"C.	FET RevRunner",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46923,28,Outstanding Balances should be reviewed in which location:,153384,0,"A.	E-STAR Account Management",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46923,28,Outstanding Balances should be reviewed in which location:,153385,1,"B.	G-STAR Outstanding Balance Report",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46923,28,Outstanding Balances should be reviewed in which location:,153386,2,"C.	All of the above",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46924,29,"When patient agrees to the insured payment plan and the monthly payments are auto-drafted, which SNC should be entered in STAR?",153387,0,"A.	2055",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46924,29,"When patient agrees to the insured payment plan and the monthly payments are auto-drafted, which SNC should be entered in STAR?",153388,1,"B.	2050",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46924,29,"When patient agrees to the insured payment plan and the monthly payments are auto-drafted, which SNC should be entered in STAR?",153389,2,"C.	2060",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46925,20,Key word to avoid when collecting include:,153390,0,"A. You owe, It's our policy, Bad debt, Can you",1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46925,20,Key word to avoid when collecting include:,153391,1,"B. It's Our Process, previous balance, your financial responsibility",0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,46925,20,Key word to avoid when collecting include:,153392,2,C. What form of payment would you like for us to use,0
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,66176,30,The Framework for Financial Conversations should be utilized in the order shown for consistency when presenting the payment options to the patient.,221290,0,TRUE,1
9817,Questions-0000-111,RCT: CONFIDENT COLLECTOR UNIVERSITY TEST,n9362,66176,30,The Framework for Financial Conversations should be utilized in the order shown for consistency when presenting the payment options to the patient.,221291,1,FALSE,0
8116,Elearning-0000-1014,NEUROSURGICAL POSTOP INITIAL COMPETENCY MODULES,n9365,46926,0,I have successfully completed BOTH of the required Healthstream modules.,153395,0,TRUE,1
8116,Elearning-0000-1014,NEUROSURGICAL POSTOP INITIAL COMPETENCY MODULES,n9365,46926,0,I have successfully completed BOTH of the required Healthstream modules.,153396,1,FALSE,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46958,0,STAR is a dialer system that allows Collectors to call patients with balances due.,153480,0,TRUE,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46958,0,STAR is a dialer system that allows Collectors to call patients with balances due.,153481,1,FALSE,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46959,1,Outstanding accounts are sent to collections if payment arrangements are not setup within ____ days?,153482,0,60,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46959,1,Outstanding accounts are sent to collections if payment arrangements are not setup within ____ days?,153483,1,90,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46959,1,Outstanding accounts are sent to collections if payment arrangements are not setup within ____ days?,153484,2,120,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46960,2,"In Artiva, Pools are groupings of specific calling queues that require Self-Pay Collectors to contact patients.",153485,0,TRUE,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46960,2,"In Artiva, Pools are groupings of specific calling queues that require Self-Pay Collectors to contact patients.",153486,1,FALSE,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46961,3,"Commonly referred to as the ___________, the Financial Assistance Survey is used for Northside Hospital patients with a total financial liability of $5,000.00 or less.",153487,0,short form,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46961,3,"Commonly referred to as the ___________, the Financial Assistance Survey is used for Northside Hospital patients with a total financial liability of $5,000.00 or less.",153488,1,long form,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46961,3,"Commonly referred to as the ___________, the Financial Assistance Survey is used for Northside Hospital patients with a total financial liability of $5,000.00 or less.",153489,2,access form,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46962,4,The Financial Assistance Survey can be accessed through which of the following sites?,153490,0,Northside Website,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46962,4,The Financial Assistance Survey can be accessed through which of the following sites?,153491,1,OneContent,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46962,4,The Financial Assistance Survey can be accessed through which of the following sites?,153492,2,Revenue Cycle Website,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46963,5,"In STAR a hyphen ""-"" allows users to ___________________?",153493,0,Exit a function or screen,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46963,5,"In STAR a hyphen ""-"" allows users to ___________________?",153494,1,Pull up a table of possible selections,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46963,5,"In STAR a hyphen ""-"" allows users to ___________________?",153495,2,Move to the next page,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46964,7,Self-Pay is the only department in the Business Office that uses Artiva.,153496,0,TRUE,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46964,7,Self-Pay is the only department in the Business Office that uses Artiva.,153497,1,FALSE,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46965,8,STAR can be accessed from the Revenue Cycle Website.,153498,0,TRUE,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46965,8,STAR can be accessed from the Revenue Cycle Website.,153499,1,FALSE,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46966,9,"Which business office system is used to view scanned patient documents (i.e. UB-04, insurance cards, denial letters, EOBs)?",153500,0,OneContent,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46966,9,"Which business office system is used to view scanned patient documents (i.e. UB-04, insurance cards, denial letters, EOBs)?",153501,1,STAR,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46966,9,"Which business office system is used to view scanned patient documents (i.e. UB-04, insurance cards, denial letters, EOBs)?",153502,2,The Tool,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46967,10,Artiva can be access from the Revenue Cycle Website.,153503,0,TRUE,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46967,10,Artiva can be access from the Revenue Cycle Website.,153504,1,FALSE,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46968,11,"In Artiva, Pool 460 is only worked when a patient has _____________.",153505,0,Broken their promise to pay,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46968,11,"In Artiva, Pool 460 is only worked when a patient has _____________.",153506,1,Broken down crying,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46968,11,"In Artiva, Pool 460 is only worked when a patient has _____________.",153507,2,Broken their phone,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46969,12,When speaking to a patient which of the following phrases should be avoided?,153508,0,"""As a courtesy""""",0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46969,12,When speaking to a patient which of the following phrases should be avoided?,153509,1,"""You need to""""",1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46969,12,When speaking to a patient which of the following phrases should be avoided?,153510,2,"""How would you like to take care of this?""",0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46970,13,Which of the following is not a qualifying question on the Financial Assistance Survey?,153511,0,Are you insured?,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46970,13,Which of the following is not a qualifying question on the Financial Assistance Survey?,153512,1,What is the name of your employer?,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46970,13,Which of the following is not a qualifying question on the Financial Assistance Survey?,153513,2,What is your gross household income?,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46971,14,Free Form notes are predefined notes that utilize a shortened numerical code to notate an action(s) on an account for quick insertion in STAR.,153514,0,TRUE,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46971,14,Free Form notes are predefined notes that utilize a shortened numerical code to notate an action(s) on an account for quick insertion in STAR.,153515,1,FALSE,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46972,15,"In Wells Fargo, the Account Status Type will always be BD for self-pay accounts.",153516,0,TRUE,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46972,15,"In Wells Fargo, the Account Status Type will always be BD for self-pay accounts.",153517,1,FALSE,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46973,16,"In Wells Fargo, Automatic Drafts are setup under which of the following tabs?",153518,0,Payment Plans,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46973,16,"In Wells Fargo, Automatic Drafts are setup under which of the following tabs?",153519,1,Patient Payments,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46973,16,"In Wells Fargo, Automatic Drafts are setup under which of the following tabs?",153520,2,Payment History,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46974,18,"In STAR, which button is selected to complete a manual financial class change?",153521,0,Account Inquiry,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46974,18,"In STAR, which button is selected to complete a manual financial class change?",153522,1,Account Revision,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46974,18,"In STAR, which button is selected to complete a manual financial class change?",153523,2,Accounts Receivables Workstation,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46975,19,Financial Class __ indicates payment plan monitoring.,153524,0,2,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46975,19,Financial Class __ indicates payment plan monitoring.,153525,1,S5,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46975,19,Financial Class __ indicates payment plan monitoring.,153526,2,5,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46976,20,Patient and guarantor demographic information is updated in which of the following systems?,153527,0,Artiva,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46976,20,Patient and guarantor demographic information is updated in which of the following systems?,153528,1,STAR,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46976,20,Patient and guarantor demographic information is updated in which of the following systems?,153529,2,OneContent,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46977,21,Financial Assistance is not used for ___________.,153530,0,Cosmetics,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46977,21,Financial Assistance is not used for ___________.,153531,1,Medically Necessary Services,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46977,21,Financial Assistance is not used for ___________.,153532,2,NS Outpatient Services,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46978,22,Standard Note Codes are notes manually entered by a user to document action taken on an account.,153533,0,TRUE,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46978,22,Standard Note Codes are notes manually entered by a user to document action taken on an account.,153534,1,FALSE,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46979,23,Anesthesia Services provided by Northside Anesthesia (Sentinel) or Northside Cherokee Anesthesia Associates are covered by the financial assistance program.,153535,0,TRUE,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46979,23,Anesthesia Services provided by Northside Anesthesia (Sentinel) or Northside Cherokee Anesthesia Associates are covered by the financial assistance program.,153536,1,FALSE,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46980,24,"A _________ patient is a patient who is uninsured, meaning the patient does not have any primary or secondary insurance.",153537,0,Insured,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46980,24,"A _________ patient is a patient who is uninsured, meaning the patient does not have any primary or secondary insurance.",153538,1,Employed,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46980,24,"A _________ patient is a patient who is uninsured, meaning the patient does not have any primary or secondary insurance.",153539,2,Self-Pay,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46981,25,Financial assistance may be available to patients who received emergency or ____________health care services at Northside.,153540,0,medically necessary,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46981,25,Financial assistance may be available to patients who received emergency or ____________health care services at Northside.,153541,1,cosmetic,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46981,25,Financial assistance may be available to patients who received emergency or ____________health care services at Northside.,153542,2,elective,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46982,26,"A __________ is a monetary amount owed that is unlikely to be paid, or a service provider is not willing to take action to collect the debt for various reasons, often due to the debtor's inability to pay.",153543,0,Bad Credit,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46982,26,"A __________ is a monetary amount owed that is unlikely to be paid, or a service provider is not willing to take action to collect the debt for various reasons, often due to the debtor's inability to pay.",153544,1,Bad Debt,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46982,26,"A __________ is a monetary amount owed that is unlikely to be paid, or a service provider is not willing to take action to collect the debt for various reasons, often due to the debtor's inability to pay.",153545,2,Loan,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46983,27,Accounts assigned to a _______ Agency will remain with that agency for a period of 120 days.,153546,0,Primary,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46983,27,Accounts assigned to a _______ Agency will remain with that agency for a period of 120 days.,153547,1,Secondary,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46983,27,Accounts assigned to a _______ Agency will remain with that agency for a period of 120 days.,153548,2,Tertiary,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46984,28,"Financial Assistance does not cover cosmetic, foreign visitors, and flat fee services.",153549,0,TRUE,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46984,28,"Financial Assistance does not cover cosmetic, foreign visitors, and flat fee services.",153550,1,FALSE,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46985,29,An ________________ often arrives via mail and provides details about medical insurance claims that have been processed and explains what portion was paid to the health provider and what portion of the payment if any is patient responsibility.,153551,0,electronic remittance advice,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46985,29,An ________________ often arrives via mail and provides details about medical insurance claims that have been processed and explains what portion was paid to the health provider and what portion of the payment if any is patient responsibility.,153552,1,invoice,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46985,29,An ________________ often arrives via mail and provides details about medical insurance claims that have been processed and explains what portion was paid to the health provider and what portion of the payment if any is patient responsibility.,153553,2,explanation of benefits,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46986,30,"In STAR, account notes can be accessed from the patient's flashcard by typing ""B"" and pressing Enter.",153554,0,TRUE,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46986,30,"In STAR, account notes can be accessed from the patient's flashcard by typing ""B"" and pressing Enter.",153555,1,FALSE,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46987,32,Referrals are sent to other departments in which of the following systems?,153556,0,OneContent,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46987,32,Referrals are sent to other departments in which of the following systems?,153557,1,Wells Fargo,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,46987,32,Referrals are sent to other departments in which of the following systems?,153558,2,STAR,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,52783,6,"The verbal signs of active listening are positive reinforcement, remembering, questioning, reflection, clarification, and ___________________?",173876,0,a. screening,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,52783,6,"The verbal signs of active listening are positive reinforcement, remembering, questioning, reflection, clarification, and ___________________?",173877,1,b. summarization,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,52783,6,"The verbal signs of active listening are positive reinforcement, remembering, questioning, reflection, clarification, and ___________________?",173878,2,c. summons,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,52784,31,"In STAR, what financial class indicates S/P After Insurance?",173879,0,a. 2M,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,52784,31,"In STAR, what financial class indicates S/P After Insurance?",173880,1,b. 2,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,52784,31,"In STAR, what financial class indicates S/P After Insurance?",173881,2,c. 5,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,52785,33,Referrals (Assignments) are sent to other departments in which of the following systems?,173882,0,a. MedMetrix,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,52785,33,Referrals (Assignments) are sent to other departments in which of the following systems?,173883,1,b. PatientCo,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,52785,33,Referrals (Assignments) are sent to other departments in which of the following systems?,173884,2,c. STAR,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,66168,17,"When initially logging into Patientco, Location should be the department where you are working/taking the payment.",221264,0,TRUE,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,66168,17,"When initially logging into Patientco, Location should be the department where you are working/taking the payment.",221265,1,FALSE,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,66169,34,Patients who are not comfortable providing credit/debit card information over the phone can utilize:,221266,0,Text to Pay,1
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,66169,34,Patients who are not comfortable providing credit/debit card information over the phone can utilize:,221267,1,Wells Fargo,0
9844,Questions-0000-136,RCT: SELF PAY UNIVERSITY TEST (CURRENT),n9368,66169,34,Patients who are not comfortable providing credit/debit card information over the phone can utilize:,221268,2,Artiva,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46988,0,The Radiology Flat Fee Calculator includes all of the following EXCEPT:,153559,0,A discounted rate option for Self-pay patients to access MRI and CT services at an affordable cost.,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46988,0,The Radiology Flat Fee Calculator includes all of the following EXCEPT:,153560,1,A discounted rate option for Self-pay patients to access PET scan services at an affordable cost.,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46988,0,The Radiology Flat Fee Calculator includes all of the following EXCEPT:,153561,2,A discounted rate option for Self-pay patient to access 3D Mammogram services at an affordable cost.,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46989,1,The FET Estimate Uninsured/Insured Payment Option Letters are scanned to ILE Folder_________.,153562,0,PFS Precertification,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46989,1,The FET Estimate Uninsured/Insured Payment Option Letters are scanned to ILE Folder_________.,153563,1,PFS Payroll Deduct Form,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46989,1,The FET Estimate Uninsured/Insured Payment Option Letters are scanned to ILE Folder_________.,153564,2,POS Collection Documents,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46990,2,"The insured required payment amount determined by the health insurance contract and generally required to be met within a calendar year.  These can be a per-visit deductible, a family deductible, or an inpatient stay deductible. Deductibles may be stated in RevRunner as per individual or as a family deductible",153565,0,Co-pay,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46990,2,"The insured required payment amount determined by the health insurance contract and generally required to be met within a calendar year.  These can be a per-visit deductible, a family deductible, or an inpatient stay deductible. Deductibles may be stated in RevRunner as per individual or as a family deductible",153566,1,Out-of-Pocket,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46990,2,"The insured required payment amount determined by the health insurance contract and generally required to be met within a calendar year.  These can be a per-visit deductible, a family deductible, or an inpatient stay deductible. Deductibles may be stated in RevRunner as per individual or as a family deductible",153567,2,Deductible,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46991,3,A health insurance cost-sharing requirement which states the insured will assume a portion or percentage of the costs of covered services.,153568,0,Out-of-Pocket,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46991,3,A health insurance cost-sharing requirement which states the insured will assume a portion or percentage of the costs of covered services.,153569,1,Co-pay,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46991,3,A health insurance cost-sharing requirement which states the insured will assume a portion or percentage of the costs of covered services.,153570,2,Co-insurance,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46992,4,Which answer below equals Total Estimated Financial Responsibility?,153571,0,Co-pay plus coinsurance,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46992,4,Which answer below equals Total Estimated Financial Responsibility?,153572,1,Current visit estimate due plus previous balances,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46992,4,Which answer below equals Total Estimated Financial Responsibility?,153573,2,Deductible plus co-pay,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46993,5,"To view previous balances in STAR, select which option in STAR?",153574,0,Admission,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46993,5,"To view previous balances in STAR, select which option in STAR?",153575,1,Revise Admission,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46993,5,"To view previous balances in STAR, select which option in STAR?",153576,2,Account Management,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46994,6,The following previous balance locations can be collected by registration:,153577,0,PA,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46994,6,The following previous balance locations can be collected by registration:,153578,1,"AR and BD, BD/BDE",1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46994,6,The following previous balance locations can be collected by registration:,153579,2,BD/BDE and BDI,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46995,7,POS Standard Note Code Outcomes should tell the story of the financial conversation along with a supporting free form note when necessary.,153580,0,TRUE,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46995,7,POS Standard Note Code Outcomes should tell the story of the financial conversation along with a supporting free form note when necessary.,153581,1,FALSE,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46996,8,The Payment Worksheet is used for the current visit.,153582,0,TRUE,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46996,8,The Payment Worksheet is used for the current visit.,153583,1,FALSE,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46997,9,This SNC is to be used when Insured Patients refuse to initial the second initials line on the FET letter option B.,153584,0,2050,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46997,9,This SNC is to be used when Insured Patients refuse to initial the second initials line on the FET letter option B.,153585,1,2055,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46997,9,This SNC is to be used when Insured Patients refuse to initial the second initials line on the FET letter option B.,153586,2,2060,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46998,10,This SNC is to be used for the 65% Self-Pay Discount 120 Day Payment Plan,153587,0,1265,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46998,10,This SNC is to be used for the 65% Self-Pay Discount 120 Day Payment Plan,153588,1,1354,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46998,10,This SNC is to be used for the 65% Self-Pay Discount 120 Day Payment Plan,153589,2,There is no Self-Pay Discount 120 Day Payment Plan,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46999,11,"When setting up a Wells Fargo payment plan, always select Installment in the Schedule section. Do not select Save on File.",153590,0,TRUE,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,46999,11,"When setting up a Wells Fargo payment plan, always select Installment in the Schedule section. Do not select Save on File.",153591,1,FALSE,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47000,12,"Per the Payment Worksheet below, what is the amount that representatives should always present first?",153592,0,Monthly payments of $74.07,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47000,12,"Per the Payment Worksheet below, what is the amount that representatives should always present first?",153593,1,Initial deposit of $333.33,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47000,12,"Per the Payment Worksheet below, what is the amount that representatives should always present first?",153594,2,Total estimated financial responsibility of $1000.00,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47001,13,Which of the following is NOT true for an insured patient electing self-pay?,153595,0,The patient is financially responsible for charges incurred.,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47001,13,Which of the following is NOT true for an insured patient electing self-pay?,153596,1,Payment will not affect or reduce any out-of-pocket financial responsibility for future services.,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47001,13,Which of the following is NOT true for an insured patient electing self-pay?,153597,2,The patient can change their mind after the services are rendered to file their insurance.,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47002,14,"For the Insured FET letter below, if the patient chooses the Payment Plan option and refuses to initial the second line under Option B, the registrar should take all of the following steps EXCEPT?",153598,0,"In STAR GUI account notes, enter Standard Note Code (SNC) 2055 - Deposit Paid/No Pmt Plan Setup.",0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47002,14,"For the Insured FET letter below, if the patient chooses the Payment Plan option and refuses to initial the second line under Option B, the registrar should take all of the following steps EXCEPT?",153599,1,The registrar will inform that they must initial the second line under Option B or they cannot proceed with services.,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47002,14,"For the Insured FET letter below, if the patient chooses the Payment Plan option and refuses to initial the second line under Option B, the registrar should take all of the following steps EXCEPT?",153600,2,The registrar will inform patient - a member of the Business Office will be reaching out to you regarding setting up your payment plan so that your account does not go to collections.,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47003,15,Which criteria must be met in order for the Financial Assistance Survey (FA Survey) to be completed?,153601,0,"All efforts to collect payment have been exhausted; collection of payments has been determined unlikely based on the patient's verbal statements, emotional expressions, or medical circumstances.",0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47003,15,Which criteria must be met in order for the Financial Assistance Survey (FA Survey) to be completed?,153602,1,"The patient's total financial responsibility (including all outstanding balances and current estimate) is less than $5000; state of residency is Georgia or bordering states, unless patient provides some sort of bill with their name and address listing Georgia or a bordering state of Georgia.",0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47003,15,Which criteria must be met in order for the Financial Assistance Survey (FA Survey) to be completed?,153603,2,All of the above,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47004,16,The disclaimer under the 75% prompt pay discount indicates the patient has up to 30 days after service date to receive the 75% discount. What charges does the disclaimer apply to?,153604,0,This only applies to any billed amount that exceeds the estimated amount.,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47004,16,The disclaimer under the 75% prompt pay discount indicates the patient has up to 30 days after service date to receive the 75% discount. What charges does the disclaimer apply to?,153605,1,This applies to current charges and charges for future services.,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47004,16,The disclaimer under the 75% prompt pay discount indicates the patient has up to 30 days after service date to receive the 75% discount. What charges does the disclaimer apply to?,153606,2,This applies to the 120 day Payment Plan after 65%.,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47005,17,How much interest would the patient pay if they elect the 65% discount payment plan?,153607,0,0%,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47005,17,How much interest would the patient pay if they elect the 65% discount payment plan?,153608,1,5%,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47005,17,How much interest would the patient pay if they elect the 65% discount payment plan?,153609,2,10%,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47006,18,"Based on the picture, the Payment Worksheet above requires a deposit of _______ to secure the payment plan.",153610,0,$750 ,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47006,18,"Based on the picture, the Payment Worksheet above requires a deposit of _______ to secure the payment plan.",153611,1,$71.42 ,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47006,18,"Based on the picture, the Payment Worksheet above requires a deposit of _______ to secure the payment plan.",153612,2,$250 ,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47007,19,"Based on the picture, the monthly payments of ______ will be due on the____ of each month.",153613,0,$750.00/25th,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47007,19,"Based on the picture, the monthly payments of ______ will be due on the____ of each month.",153614,1,$71.42/the calendar day of the month that the patient chooses,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47007,19,"Based on the picture, the monthly payments of ______ will be due on the____ of each month.",153615,2,$250.00/15th,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47008,20,"To complete the FA Survey, we must ask the patient for the _________  _household income.",153616,0,Monthly Gross,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47008,20,"To complete the FA Survey, we must ask the patient for the _________  _household income.",153617,1,Monthly Net,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47008,20,"To complete the FA Survey, we must ask the patient for the _________  _household income.",153618,2,Annual Net,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47009,21,Which report on the Revenue Cycle Website should staff use to access outstanding balances for the facilities Duluth and Lawrenceville in the Gwinnett Medical Center's G-STAR system?,153619,0,Existing Northside Hospital employees should use the G-STAR Outstanding Balances Report (Team members on the NSH Network),0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47009,21,Which report on the Revenue Cycle Website should staff use to access outstanding balances for the facilities Duluth and Lawrenceville in the Gwinnett Medical Center's G-STAR system?,153620,1,Employees on the GHS_NT1 Network should use the G-STAR Outstanding Balances Report (Team members on the GHS_NT1 Network),0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47009,21,Which report on the Revenue Cycle Website should staff use to access outstanding balances for the facilities Duluth and Lawrenceville in the Gwinnett Medical Center's G-STAR system?,153621,2,A & B are both correct dependent on the location of the employee,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47010,22,"If there is not a Financial Advocate on site and a patient is not approved for Financial Assistance Survey or if the patient's financial responsibility exceeds $5,000, they should be referred to the Business Office number in their About Your Billing brochure and provided the Long Form Financial Assistance Application.",153622,0,TRUE,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47010,22,"If there is not a Financial Advocate on site and a patient is not approved for Financial Assistance Survey or if the patient's financial responsibility exceeds $5,000, they should be referred to the Business Office number in their About Your Billing brochure and provided the Long Form Financial Assistance Application.",153623,1,FALSE,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47011,23,"For Cost Share patients who elect to OPT OUT of using their Cost Share program to take advantage of a 50% prompt pay in full discount, registrar should use which of the following POS SNC?",212453,0,A.1805,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47011,23,"For Cost Share patients who elect to OPT OUT of using their Cost Share program to take advantage of a 50% prompt pay in full discount, registrar should use which of the following POS SNC?",212454,1,B.1354,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47011,23,"For Cost Share patients who elect to OPT OUT of using their Cost Share program to take advantage of a 50% prompt pay in full discount, registrar should use which of the following POS SNC?",212455,2,C.Cost Share Patients cannot elect to OPT OUT of using their Cost Share program.,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47012,24,Outstanding balance payment options are:,153626,0,"Pay full amount, 50%, or 1/3",1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47012,24,Outstanding balance payment options are:,153627,1,Must pay full amount,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47012,24,Outstanding balance payment options are:,153628,2,Pay full amount or 1/4,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47013,25,"If patient has outstanding balances, then registrar will:",153629,0,Verbally inform the patient and collect the total amount; there is no documentation enter the outstanding balances.,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47013,25,"If patient has outstanding balances, then registrar will:",153630,1,"Write in the total OSB manually on the FET letter in the Outstanding Balance(s) Total Due area, then enter the Outstanding balance the patient agrees to pay in the Pay Today area and add that amount to the current estimate amount.",1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47013,25,"If patient has outstanding balances, then registrar will:",153631,2,Inform the patient of the outstanding balance and direct patient to the About Your Billing brochure to call the billing department and arrange collections of the OSB.,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47014,26,"If RevRunner returns an incomplete response, unclear response, or the payer is a non-RevRunner payer, which form should be utilized to obtain benefits and eligibility:",153632,0,Alternate Insurance Verification Worksheet,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47014,26,"If RevRunner returns an incomplete response, unclear response, or the payer is a non-RevRunner payer, which form should be utilized to obtain benefits and eligibility:",153633,1,POS Collections Document,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47014,26,"If RevRunner returns an incomplete response, unclear response, or the payer is a non-RevRunner payer, which form should be utilized to obtain benefits and eligibility:",153634,2,Only SNC 1218 and 8010 are necessary,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47015,27,Employee Payroll Deductions can be set up for as little as ______ per pay period.,153635,0,$25.00 ,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47015,27,Employee Payroll Deductions can be set up for as little as ______ per pay period.,153636,1,$12.50 ,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47015,27,Employee Payroll Deductions can be set up for as little as ______ per pay period.,153637,2,$10.00 ,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47016,28,If the individual deductible and/or out-of-pocket total amount contains a zero dollar amount.,153638,0,Use the applicable family remaining deductible and out-of-pocket amounts.,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47016,28,If the individual deductible and/or out-of-pocket total amount contains a zero dollar amount.,153639,1,Do not collect the family deductible or out-of-pocket.,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47016,28,If the individual deductible and/or out-of-pocket total amount contains a zero dollar amount.,153640,2,Use the Alternate Insurance Verification method because there should NOT be a zero dollar amount in the individual deductible and out-of-pocket totals.,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47017,29,"If the Family deductible has been met and there is a remaining individual deductible, we should collect the remaining individual deductible.",153641,0,TRUE,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,47017,29,"If the Family deductible has been met and there is a remaining individual deductible, we should collect the remaining individual deductible.",153642,1,FALSE,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,66114,30,Use the ______________   _______________  located in the top right corner in RevRunner to review the detailed message view of benefits.,221090,0,Expand Arrow,1
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,66114,30,Use the ______________   _______________  located in the top right corner in RevRunner to review the detailed message view of benefits.,221091,1,Dropdown List,0
9810,Questions-0000-105,RCT: ACCOUNT RESOLUTION UNIVERSITY TEST (CURRENT),n9369,66114,30,Use the ______________   _______________  located in the top right corner in RevRunner to review the detailed message view of benefits.,221092,2,Payer Down,0
9088,Elearning-0000-357,NSH1238 SEL120,n9379,47084,0,Patients must have relapsed/refractory AML or MDS. (T/F),153898,0,TRUE,1
9088,Elearning-0000-357,NSH1238 SEL120,n9379,47084,0,Patients must have relapsed/refractory AML or MDS. (T/F),153899,1,FALSE,0
9088,Elearning-0000-357,NSH1238 SEL120,n9379,47085,1,SEL120 is administered IV every other day for a total of 9 doses. (T/F),153900,0,TRUE,0
9088,Elearning-0000-357,NSH1238 SEL120,n9379,47085,1,SEL120 is administered IV every other day for a total of 9 doses. (T/F),153901,1,FALSE,1
9088,Elearning-0000-357,NSH1238 SEL120,n9379,47086,2,"Troponin levels are collected pre-dose every dosing day. If abnormal, the relationship to SEL120 must be addressed by a cardiologist and/or physician before proceeding with dosing. (T/F)",153902,0,TRUE,1
9088,Elearning-0000-357,NSH1238 SEL120,n9379,47086,2,"Troponin levels are collected pre-dose every dosing day. If abnormal, the relationship to SEL120 must be addressed by a cardiologist and/or physician before proceeding with dosing. (T/F)",153903,1,FALSE,0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47087,0,How many pictograms are there included in the new Global Harmonized System for Safety Data Sheets?,153904,0,A. 9,1
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47087,0,How many pictograms are there included in the new Global Harmonized System for Safety Data Sheets?,153905,1,B. 12,0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47087,0,How many pictograms are there included in the new Global Harmonized System for Safety Data Sheets?,153906,2,C. 15,0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47087,0,How many pictograms are there included in the new Global Harmonized System for Safety Data Sheets?,153907,3,D. 6,0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47088,1,What does the red diamond in the NFPA 704 placarding system represent?,153908,0,A. Reactivity,0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47088,1,What does the red diamond in the NFPA 704 placarding system represent?,153909,1,B. Specific Hazard,0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47088,1,What does the red diamond in the NFPA 704 placarding system represent?,153910,2,C. Health Hazard,0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47088,1,What does the red diamond in the NFPA 704 placarding system represent?,153911,3,D. Fire Hazard,1
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47089,2,"After a spill, where are hazardous materials stored for on-campus pick up?",153912,0,"A.	Kitchen",0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47089,2,"After a spill, where are hazardous materials stored for on-campus pick up?",153913,1,"B.	EVS Storage Room",0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47089,2,"After a spill, where are hazardous materials stored for on-campus pick up?",153914,2,"C.	Loading Dock",1
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47089,2,"After a spill, where are hazardous materials stored for on-campus pick up?",153915,3,"D.	Lab",0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47090,3,How many levels of Hazmat PPE are there?,153916,0,A. 5,0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47090,3,How many levels of Hazmat PPE are there?,153917,1,B. 4,0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47090,3,How many levels of Hazmat PPE are there?,153918,2,C. 3,1
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47090,3,How many levels of Hazmat PPE are there?,153919,3,D. 2,0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47091,4,Using the Internet and conducting a Google search for an SDS for a spilled material is acceptable.,153920,0,A. True,1
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47091,4,Using the Internet and conducting a Google search for an SDS for a spilled material is acceptable.,153921,1,B. False,0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47092,5,What is the main difference between PPE Levels B and C?,153922,0,"A.	The use of a PAPR",0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47092,5,What is the main difference between PPE Levels B and C?,153923,1,"B.	No hard hat required",0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47092,5,What is the main difference between PPE Levels B and C?,153924,2,"C.	The respiratory equipment (i.e., SCBA vs. a full face air purifying respirator)",1
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47092,5,What is the main difference between PPE Levels B and C?,153925,3,"D.	Boot size",0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47093,6,Which of the following are routes for hazardous material to enter the body?,153926,0,"A.	Inhalation",0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47093,6,Which of the following are routes for hazardous material to enter the body?,153927,1,"B.	Ingestion",0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47093,6,Which of the following are routes for hazardous material to enter the body?,153928,2,"C.	Absorption",0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47093,6,Which of the following are routes for hazardous material to enter the body?,153929,3,"D.	Injection",0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47093,6,Which of the following are routes for hazardous material to enter the body?,153930,4,"E.	All of the above",1
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47094,7,Which of the following is <b><u>not</u></b> a type of health hazard associated with hazardous materials?,153931,0,"A..	Carcinogenicity",0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47094,7,Which of the following is <b><u>not</u></b> a type of health hazard associated with hazardous materials?,153932,1,"B.	High-pressure system",1
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47094,7,Which of the following is <b><u>not</u></b> a type of health hazard associated with hazardous materials?,153933,2,"C.	Specific target organ toxicity",0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47094,7,Which of the following is <b><u>not</u></b> a type of health hazard associated with hazardous materials?,153934,3,"D.	Skin corrosion or irritation",0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47095,8,"Determine which of the following is the correct order of the Hierarchy of Controls (i.e., most effective to least effective)",153935,0,"A.	Substitution > Engineering Controls > PPE > Administrative Controls > Elimination",0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47095,8,"Determine which of the following is the correct order of the Hierarchy of Controls (i.e., most effective to least effective)",153936,1,"B.	PPE > Administrative Controls > Engineering Controls > Substitution > Elimination",0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47095,8,"Determine which of the following is the correct order of the Hierarchy of Controls (i.e., most effective to least effective)",153937,2,"C.	Engineering Controls > PPE > Elimination > Substitution > Administrative Controls",0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47095,8,"Determine which of the following is the correct order of the Hierarchy of Controls (i.e., most effective to least effective)",153938,3,"D.	Elimination > Substitution > Engineering Controls > Administrative Controls > PPE",1
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47096,9,Which of the following hazard controls is an example of an engineering control?,153939,0,"A.	Enclosing an operation to prevent contact with the hazardous material",1
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47096,9,Which of the following hazard controls is an example of an engineering control?,153940,1,"B.	Training employees on the proper handling and storage of a hazardous material",0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47096,9,Which of the following hazard controls is an example of an engineering control?,153941,2,"C.	Implementing a procedure for the proper use of a hazardous material",0
9291,Elearning-0000-541,HAZMAT AWARENESS,n9380,47096,9,Which of the following hazard controls is an example of an engineering control?,153942,3,"D.	Requiring personal protective equipment to be worn when working with a hazardous material",0
9789,Elearning-0000-994,"FY2020 TISSUE REQUISITION, TRANSPORT AND STORAGE",n9381,47097,0,Frozen and refrigerated tissue may be placed on top of the ice.,153943,0,a. True,0
9789,Elearning-0000-994,"FY2020 TISSUE REQUISITION, TRANSPORT AND STORAGE",n9381,47097,0,Frozen and refrigerated tissue may be placed on top of the ice.,153944,1,b. False,1
9789,Elearning-0000-994,"FY2020 TISSUE REQUISITION, TRANSPORT AND STORAGE",n9381,47098,1,"Before a tissue is returned to the Tissue Bank, the staff in the OR/OPSC must complete the __________________________ and verify that the tissue(s) was stored correctly while in the OR / OPSC.",153945,0,"a.	attestation statement box",1
9789,Elearning-0000-994,"FY2020 TISSUE REQUISITION, TRANSPORT AND STORAGE",n9381,47098,1,"Before a tissue is returned to the Tissue Bank, the staff in the OR/OPSC must complete the __________________________ and verify that the tissue(s) was stored correctly while in the OR / OPSC.",153946,1,"b.	the discard column",0
9789,Elearning-0000-994,"FY2020 TISSUE REQUISITION, TRANSPORT AND STORAGE",n9381,47098,1,"Before a tissue is returned to the Tissue Bank, the staff in the OR/OPSC must complete the __________________________ and verify that the tissue(s) was stored correctly while in the OR / OPSC.",153947,2,"c.	no documentation is needed",0
9789,Elearning-0000-994,"FY2020 TISSUE REQUISITION, TRANSPORT AND STORAGE",n9381,47099,2,"Tissues that are opened during a case but are not used, are to be discarded in the OR/OPSC and <u>NOT</u> returned to Tissue Bank.",153948,0,a. True,1
9789,Elearning-0000-994,"FY2020 TISSUE REQUISITION, TRANSPORT AND STORAGE",n9381,47099,2,"Tissues that are opened during a case but are not used, are to be discarded in the OR/OPSC and <u>NOT</u> returned to Tissue Bank.",153949,1,b. False,0
9789,Elearning-0000-994,"FY2020 TISSUE REQUISITION, TRANSPORT AND STORAGE",n9381,47100,3,The _________________ must returned to the Tissue Bank when returning or discarding tissue so that the inventory can be updated in UDI Tracker.,153950,0,"a.	Surgeon's order",0
9789,Elearning-0000-994,"FY2020 TISSUE REQUISITION, TRANSPORT AND STORAGE",n9381,47100,3,The _________________ must returned to the Tissue Bank when returning or discarding tissue so that the inventory can be updated in UDI Tracker.,153951,1,"b.	Tissue Requisition Form",1
9789,Elearning-0000-994,"FY2020 TISSUE REQUISITION, TRANSPORT AND STORAGE",n9381,47100,3,The _________________ must returned to the Tissue Bank when returning or discarding tissue so that the inventory can be updated in UDI Tracker.,153952,2,"c.	Empty tissue box",0
9789,Elearning-0000-994,"FY2020 TISSUE REQUISITION, TRANSPORT AND STORAGE",n9381,47101,4,Tissues that must be stored at <b>-75  C or below cannot be returned</b> to the Tissue Bank and must be discarded.  Complete the Tissue Requisition form and indicate that the tissue was discarded.,153953,0,a. True,1
9789,Elearning-0000-994,"FY2020 TISSUE REQUISITION, TRANSPORT AND STORAGE",n9381,47101,4,Tissues that must be stored at <b>-75  C or below cannot be returned</b> to the Tissue Bank and must be discarded.  Complete the Tissue Requisition form and indicate that the tissue was discarded.,153954,1,b. False,0
9789,Elearning-0000-994,"FY2020 TISSUE REQUISITION, TRANSPORT AND STORAGE",n9381,47102,5,"If a patient is scheduled for surgery on one unit and then has to be transferred to another unit for their procedure, tissue issued to the original unit for that patient must be ____________ to the Tissue Bank and the receiving unit where the patient is being transferred will need to ___________ the needed tissue from the tissue bank so that the tissue can be re-issued to that location.",153955,0,"a.	Request / returned",0
9789,Elearning-0000-994,"FY2020 TISSUE REQUISITION, TRANSPORT AND STORAGE",n9381,47102,5,"If a patient is scheduled for surgery on one unit and then has to be transferred to another unit for their procedure, tissue issued to the original unit for that patient must be ____________ to the Tissue Bank and the receiving unit where the patient is being transferred will need to ___________ the needed tissue from the tissue bank so that the tissue can be re-issued to that location.",153956,1,"b.	Returned / request",1
9789,Elearning-0000-994,"FY2020 TISSUE REQUISITION, TRANSPORT AND STORAGE",n9381,47102,5,"If a patient is scheduled for surgery on one unit and then has to be transferred to another unit for their procedure, tissue issued to the original unit for that patient must be ____________ to the Tissue Bank and the receiving unit where the patient is being transferred will need to ___________ the needed tissue from the tissue bank so that the tissue can be re-issued to that location.",153957,2,"c.	Discarded and not returned / request",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47183,0,"If it is at least 2 weeks before the delivery date, POB Collectors can send the patient a POB estimation letter.",154290,0,TRUE,1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47183,0,"If it is at least 2 weeks before the delivery date, POB Collectors can send the patient a POB estimation letter.",154291,1,FALSE,0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47184,1,"POB Collectors should review the diagnosis, facility, physician, and date of service (i.e., Admit Date) in the STAR MPI to determine if visit is for the current service before creating and/or converting an account.",154292,0,TRUE,1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47184,1,"POB Collectors should review the diagnosis, facility, physician, and date of service (i.e., Admit Date) in the STAR MPI to determine if visit is for the current service before creating and/or converting an account.",154293,1,FALSE,0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47185,2,POB Collectors work the PFS: VERF: MATERNITY QUEUE in One Content to generate patient estimates and register the patient's account.,154294,0,TRUE,1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47185,2,POB Collectors work the PFS: VERF: MATERNITY QUEUE in One Content to generate patient estimates and register the patient's account.,154295,1,FALSE,0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47186,3,What SNC is placed on the patient's account when the account is reviewed?,154296,0,"a.	1004",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47186,3,What SNC is placed on the patient's account when the account is reviewed?,154297,1,"b.	104",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47186,3,What SNC is placed on the patient's account when the account is reviewed?,154298,2,"c.	8076",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47187,4,POB Collectors can view a patient's eligibility and benefits through_____________.,154299,0,"a.	RevRunner",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47187,4,POB Collectors can view a patient's eligibility and benefits through_____________.,154300,1,"b.	Payor Websites",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47187,4,POB Collectors can view a patient's eligibility and benefits through_____________.,154301,2,"c.	Both A & B",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47188,5,"To complete the insurance portion of the FET, the Rep will use information from which system(s)?",154302,0,"a.	One Content/Artiva",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47188,5,"To complete the insurance portion of the FET, the Rep will use information from which system(s)?",154303,1,"b.	RevRunner/Payor's web sites",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47188,5,"To complete the insurance portion of the FET, the Rep will use information from which system(s)?",154304,2,"c.	SSI",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47189,6,What is the interest rate that a patient is required to pay on a POS-Pont Of Service Payment Plan?,154305,0,"a.	75%",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47189,6,What is the interest rate that a patient is required to pay on a POS-Pont Of Service Payment Plan?,154306,1,"b.	9%",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47189,6,What is the interest rate that a patient is required to pay on a POS-Pont Of Service Payment Plan?,154307,2,"c.	0%",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47190,7,Why is it important to select the correct location facility while taking payment in PatientCo?,154308,0,"a.	To ensure that money is applied to the location of the rendered services.",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47190,7,Why is it important to select the correct location facility while taking payment in PatientCo?,154309,1,"b.	To ensure that that facility A has the same amount of payments as Facility C.",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47190,7,Why is it important to select the correct location facility while taking payment in PatientCo?,154310,2,"c.	 To ensure that those facilities can compete with each other.",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47191,8,When Pre-registering a patient and no insurance is available S financial class will indicate what?,154311,0,"a.	Silent insurance",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47191,8,When Pre-registering a patient and no insurance is available S financial class will indicate what?,154312,1,"b.	Self-Pay",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47191,8,When Pre-registering a patient and no insurance is available S financial class will indicate what?,154313,2,"c.	Significant other",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47192,9,What system is used to provide a patient's estimated liability?,154314,0,"a.	PHS pathway Healthcare Scheduling",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47192,9,What system is used to provide a patient's estimated liability?,154315,1,"b.	STAR",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47192,9,What system is used to provide a patient's estimated liability?,154316,2,"c.	FET",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47245,10,"When generating patient estimates, the Type of Service should be_____________.",154522,0,"a.	OP",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47245,10,"When generating patient estimates, the Type of Service should be_____________.",154523,1,"b.	OB",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47245,10,"When generating patient estimates, the Type of Service should be_____________.",154524,2,"c.	OBS",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47246,11,Patient estimates are created in the Financial Evaluation Tool.,154525,0,TRUE,0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47246,11,Patient estimates are created in the Financial Evaluation Tool.,154526,1,FALSE,1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47247,12,When the POB team prepares an estimate in the FET what type of service is selected?,154527,0,"a.	OP estimation",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47247,12,When the POB team prepares an estimate in the FET what type of service is selected?,154528,1,"b.	OB estimation",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47247,12,When the POB team prepares an estimate in the FET what type of service is selected?,154529,2,"c.	IP estimation",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47248,13,When advising a patient of their financial responsibility it is important to remind them that this is only an estimate.,154530,0,TRUE,1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47248,13,When advising a patient of their financial responsibility it is important to remind them that this is only an estimate.,154531,1,FALSE,0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47249,14,Patients are expected to pay all or at least ____  of their estimate amount due.,154532,0,"a.	1/3",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47249,14,Patients are expected to pay all or at least ____  of their estimate amount due.,154533,1,"b.	1/2",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47249,14,Patients are expected to pay all or at least ____  of their estimate amount due.,154534,2,"c.	5/17",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47250,15,"In STAR during an MPI search, it is important to look for multiple births.",154535,0,TRUE,1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47250,15,"In STAR during an MPI search, it is important to look for multiple births.",154536,1,FALSE,0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47251,16,"In STAR under the Medical Information form, what occurrence code will be used for OB patients?",154537,0,"a.	18",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47251,16,"In STAR under the Medical Information form, what occurrence code will be used for OB patients?",154538,1,"b.	10",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47251,16,"In STAR under the Medical Information form, what occurrence code will be used for OB patients?",154539,2,"c.	09",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47252,17,Which is a location code used in STAR for Atlanta OB deliveries?,154540,0,"a.	RADX",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47252,17,Which is a location code used in STAR for Atlanta OB deliveries?,154541,1,"b.	ERMC",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47252,17,Which is a location code used in STAR for Atlanta OB deliveries?,154542,2,"c.	LDRP",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47253,18,"POB, PFM and PCM are all considered to be?",154543,0,"a.	OB Patient types",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47253,18,"POB, PFM and PCM are all considered to be?",154544,1,"b.	OB Standard note codes",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47253,18,"POB, PFM and PCM are all considered to be?",154545,2,"c.	 Service types",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47254,19,What does the Free form note EDOD used in STAR represent?,154546,0,"a.	Expected Date of Diagnosis",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47254,19,What does the Free form note EDOD used in STAR represent?,154547,1,"b.	Experience Dates of Delivery",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47254,19,What does the Free form note EDOD used in STAR represent?,154548,2,"c.	Expected Date of Delivery",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47255,20,What is the Standard Note Code for online pre-registration -Preregistration Internet?,154549,0,"a.	SNC 674",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47255,20,What is the Standard Note Code for online pre-registration -Preregistration Internet?,154550,1,"b.	SNC 055",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47255,20,What is the Standard Note Code for online pre-registration -Preregistration Internet?,154551,2,"c.	SNC 2015",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47256,21,"When a Maternity letter is mailed out, what Standard note code is used in STAR?",154552,0,"a.	SNC 1976",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47256,21,"When a Maternity letter is mailed out, what Standard note code is used in STAR?",154553,1,"b.	SNC 8076",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47256,21,"When a Maternity letter is mailed out, what Standard note code is used in STAR?",154554,2,"c.	SNC 083",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47257,22,The admitting diagnosis code for a normal delivery is?,154555,0,"a.	O80",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47257,22,The admitting diagnosis code for a normal delivery is?,154556,1,"b.	O90",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47257,22,The admitting diagnosis code for a normal delivery is?,154557,2,"c.	O28",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47258,23,The admitting diagnosis for cesarean delivery is?,154558,0,"a.	O89",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47258,23,The admitting diagnosis for cesarean delivery is?,154559,1,"b.	O82",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47258,23,The admitting diagnosis for cesarean delivery is?,154560,2,"c.	O28",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47259,24,"In Artiva, when the account turns to AR status it will remove the account from the system.",154561,0,TRUE,1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47259,24,"In Artiva, when the account turns to AR status it will remove the account from the system.",154562,1,FALSE,0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47260,25,What does AR mean?,154563,0,"a.	Arrested Restitution",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47260,25,What does AR mean?,154564,1,"b.	Account Remaining",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47260,25,What does AR mean?,154565,2,"c.	Account Receivable",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47261,26,What Pool does the POB Team work while in Artivia?,154566,0,"a.	Labor and Delivery Pool",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47261,26,What Pool does the POB Team work while in Artivia?,154567,1,"b.	The Follow up Pool",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47261,26,What Pool does the POB Team work while in Artivia?,154568,2,"c.	Women's Center Pool",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47262,27,"If the patient has a financial responsibility, NSH will send the patient a:",154569,0,"a.	FET/Maternity Letter",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47262,27,"If the patient has a financial responsibility, NSH will send the patient a:",154570,1,"b.	A welcome letter",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47262,27,"If the patient has a financial responsibility, NSH will send the patient a:",154571,2,"c.	Instructional Letter",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47263,28,"The Maternity letter consist of the patients co-pay, deductible and:",154572,0,"a.	Plan code ID",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47263,28,"The Maternity letter consist of the patients co-pay, deductible and:",154573,1,"b.	Co-insurance",1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47263,28,"The Maternity letter consist of the patients co-pay, deductible and:",154574,2,"c.	Delivery summary",0
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47264,29,The Maternity Letter will give the patient an option to make a payment online.,154575,0,TRUE,1
9838,Questions-0000-130,RCT: PRE-REGISTRATION POB UNIVERSITY TEST (CURRENT),n9387,47264,29,The Maternity Letter will give the patient an option to make a payment online.,154576,1,FALSE,0
7973,AICC-0000-1291,PACED BOTTLE FEEDING,n9394,47265,0,When educating the mother about paced bottle feed the mother should be educated to utilize what position for the infant while pace feeding?,154577,0,a. Football hold,0
7973,AICC-0000-1291,PACED BOTTLE FEEDING,n9394,47265,0,When educating the mother about paced bottle feed the mother should be educated to utilize what position for the infant while pace feeding?,154578,1,b. Semi-upright,1
7973,AICC-0000-1291,PACED BOTTLE FEEDING,n9394,47265,0,When educating the mother about paced bottle feed the mother should be educated to utilize what position for the infant while pace feeding?,154579,2,d.Cross body hold,0
7973,AICC-0000-1291,PACED BOTTLE FEEDING,n9394,47265,0,When educating the mother about paced bottle feed the mother should be educated to utilize what position for the infant while pace feeding?,154580,3,c. Lying flat,0
7973,AICC-0000-1291,PACED BOTTLE FEEDING,n9394,47266,1,It is important to change the infant's position (change the sides you are holding the infant on) half way through the feeding to assist in preventing side preferences?,154581,0,TRUE,1
7973,AICC-0000-1291,PACED BOTTLE FEEDING,n9394,47266,1,It is important to change the infant's position (change the sides you are holding the infant on) half way through the feeding to assist in preventing side preferences?,154582,1,FALSE,0
7973,AICC-0000-1291,PACED BOTTLE FEEDING,n9394,47267,2,What is a sign the mother will observe while pace feeding the infant that indicates the infant is satiated and experiencing fullness?,154583,0,a. The infant's hands are clenched tightly in fists.,0
7973,AICC-0000-1291,PACED BOTTLE FEEDING,n9394,47267,2,What is a sign the mother will observe while pace feeding the infant that indicates the infant is satiated and experiencing fullness?,154584,1,b.  The infant is actively searching for the nipple and or bottle.,0
7973,AICC-0000-1291,PACED BOTTLE FEEDING,n9394,47267,2,What is a sign the mother will observe while pace feeding the infant that indicates the infant is satiated and experiencing fullness?,154585,2,c. The infant's sucking has slowed and the hands are relaxed (not in fists).,1
7973,AICC-0000-1291,PACED BOTTLE FEEDING,n9394,47267,2,What is a sign the mother will observe while pace feeding the infant that indicates the infant is satiated and experiencing fullness?,154586,3,d.  The infant is vigorously sucking on the nipple and turns toward the bottle.,0
7973,AICC-0000-1291,PACED BOTTLE FEEDING,n9394,47268,3,"A benefit with paced bottle feeding in infants that are SGA, LBW or < 37 weeks is?",154587,0,a.  It decreases the risk of choking,1
7973,AICC-0000-1291,PACED BOTTLE FEEDING,n9394,47268,3,"A benefit with paced bottle feeding in infants that are SGA, LBW or < 37 weeks is?",154588,1,b. It mimics breastfeeding,0
7973,AICC-0000-1291,PACED BOTTLE FEEDING,n9394,47268,3,"A benefit with paced bottle feeding in infants that are SGA, LBW or < 37 weeks is?",154589,2,c. It ensures that the infant takes at least 30mls during the feeding .,0
7973,AICC-0000-1291,PACED BOTTLE FEEDING,n9394,47268,3,"A benefit with paced bottle feeding in infants that are SGA, LBW or < 37 weeks is?",154590,3,d. It burns more calories so the infant will eat more.,0
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47515,0,"1.	Isolation should be started in Labor and Delivery prior to the infant being transferred to the newborn nursery.",155324,0,TRUE,1
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47515,0,"1.	Isolation should be started in Labor and Delivery prior to the infant being transferred to the newborn nursery.",155325,1,FALSE,0
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47516,1,"2.	If unsure of what type of isolation to start who should you contact?",155326,0,"a.	Infection Prevention",0
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47516,1,"2.	If unsure of what type of isolation to start who should you contact?",155327,1,"b.	The policy",0
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47516,1,"2.	If unsure of what type of isolation to start who should you contact?",155328,2,"c.	The Supervisor",0
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47516,1,"2.	If unsure of what type of isolation to start who should you contact?",155329,3,"d.	The Clinician/CDS",0
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47516,1,"2.	If unsure of what type of isolation to start who should you contact?",155330,4,"e.	No one, it will get figured out eventually",0
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47516,1,"2.	If unsure of what type of isolation to start who should you contact?",155331,5,"f.	A, B, C, and D",1
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47517,2,"3.	If a mother has suspected or confirmed Influenza and has not been on antiviral medications prior to delivery, the mother and infant must be separated for 48 hours.",155332,0,TRUE,1
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47517,2,"3.	If a mother has suspected or confirmed Influenza and has not been on antiviral medications prior to delivery, the mother and infant must be separated for 48 hours.",155333,1,FALSE,0
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47518,3,"4.	If a newborn is in isolation, what is the minimum amount of space that needs to be maintained between newborns to assist in the prevention of the spread of the disease?",155334,0,"a.	6 feet",0
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47518,3,"4.	If a newborn is in isolation, what is the minimum amount of space that needs to be maintained between newborns to assist in the prevention of the spread of the disease?",155335,1,"b.	3 feet",0
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47518,3,"4.	If a newborn is in isolation, what is the minimum amount of space that needs to be maintained between newborns to assist in the prevention of the spread of the disease?",155336,2,"c.	It depends on the specific disease",1
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47518,3,"4.	If a newborn is in isolation, what is the minimum amount of space that needs to be maintained between newborns to assist in the prevention of the spread of the disease?",155337,3,"d.	It does not matter as long as they are in separate cribs",0
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47518,3,"4.	If a newborn is in isolation, what is the minimum amount of space that needs to be maintained between newborns to assist in the prevention of the spread of the disease?",155338,4,"e.	They ALWAYS need to be in separate nurseries",0
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47519,4,"5.	When result copying twins the process should be to click the result copy button, click the related records button and then click next to result copy the data over. There are no additional steps that should be taken.",155339,0,TRUE,0
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47519,4,"5.	When result copying twins the process should be to click the result copy button, click the related records button and then click next to result copy the data over. There are no additional steps that should be taken.",155340,1,FALSE,1
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47520,5,"6.	What is an important step in the documentation of the result copy function?",155341,0,"a.	Two patient Identification",1
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47520,5,"6.	What is an important step in the documentation of the result copy function?",155342,1,"b.	Having the Labor and Delivery Nurse document all of her information before charting anything",0
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47520,5,"6.	What is an important step in the documentation of the result copy function?",155343,2,"c.	Do not result copy unless you have to",0
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47520,5,"6.	What is an important step in the documentation of the result copy function?",155344,3,"d.	Complete all of the admission information on the newborn prior to using the result copy function",0
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47521,6,"7.	If the result copy is documented on the wrong newborn, who can undo the documentation?",155345,0,"a.	The person who result copied",0
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47521,6,"7.	If the result copy is documented on the wrong newborn, who can undo the documentation?",155346,1,"b.	The person who documented the original results",1
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47521,6,"7.	If the result copy is documented on the wrong newborn, who can undo the documentation?",155347,2,"c.	Anyone",0
1694,ILT-0000-7261,FCC ADMISSION TEAM QUARTERLY BUNDLE FY20 Q1,n9418,47521,6,"7.	If the result copy is documented on the wrong newborn, who can undo the documentation?",155348,3,"d.	No one, it is part of the permanent record",0
9208,Elearning-0000-466,KINDNESS THROUGH COMMUNICATION - LISTENING MODULE,n9431,47594,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",155504,0,TRUE,1
9208,Elearning-0000-466,KINDNESS THROUGH COMMUNICATION - LISTENING MODULE,n9431,47594,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",155505,1,FALSE,0
9574,Elearning-0000-799,ALTEPLASE FOR PULMONARY EMBOLISM,n9487,48049,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",157035,0,TRUE,1
9574,Elearning-0000-799,ALTEPLASE FOR PULMONARY EMBOLISM,n9487,48049,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",157036,1,FALSE,0
8119,Elearning-0000-1017,MODIFIER AS,n9493,48123,0,True or False? A modifier is a 2 digit alpha-numeric indicator appended to a CPT.,157333,0,TRUE,0
8119,Elearning-0000-1017,MODIFIER AS,n9493,48123,0,True or False? A modifier is a 2 digit alpha-numeric indicator appended to a CPT.,157334,1,FALSE,1
8119,Elearning-0000-1017,MODIFIER AS,n9493,48124,1,"True or False? Because modifiers are ranked, payment modifiers are always listed first.",157335,0,TRUE,1
8119,Elearning-0000-1017,MODIFIER AS,n9493,48124,1,"True or False? Because modifiers are ranked, payment modifiers are always listed first.",157336,1,FALSE,0
8119,Elearning-0000-1017,MODIFIER AS,n9493,48125,2,"True or False?	Modifier AS is a Level II modifier that indicates a Physician, Nurse Practitioner, or Clinical Nurse Specialist was the co-surgeon.",157337,0,TRUE,0
8119,Elearning-0000-1017,MODIFIER AS,n9493,48125,2,"True or False?	Modifier AS is a Level II modifier that indicates a Physician, Nurse Practitioner, or Clinical Nurse Specialist was the co-surgeon.",157338,1,FALSE,1
8119,Elearning-0000-1017,MODIFIER AS,n9493,48126,3,Which payer does not recognize Modifier AS?,157339,0,A) Humana,0
8119,Elearning-0000-1017,MODIFIER AS,n9493,48126,3,Which payer does not recognize Modifier AS?,157340,1,B) Medicare,0
8119,Elearning-0000-1017,MODIFIER AS,n9493,48126,3,Which payer does not recognize Modifier AS?,157341,2,C) United Healthcare,0
8119,Elearning-0000-1017,MODIFIER AS,n9493,48126,3,Which payer does not recognize Modifier AS?,157342,3,D) Medicaid,1
8119,Elearning-0000-1017,MODIFIER AS,n9493,48127,4,True or False? Modifier AS is an informational modifier.,157343,0,TRUE,0
8119,Elearning-0000-1017,MODIFIER AS,n9493,48127,4,True or False? Modifier AS is an informational modifier.,157344,1,FALSE,1
8119,Elearning-0000-1017,MODIFIER AS,n9493,48128,5,Documentation for modifier AS includes:,157345,0,A) Specify in the operative report what the assistant actually does,0
8119,Elearning-0000-1017,MODIFIER AS,n9493,48128,5,Documentation for modifier AS includes:,157346,1,B) Mention why there is a need for an assistant,0
8119,Elearning-0000-1017,MODIFIER AS,n9493,48128,5,Documentation for modifier AS includes:,157347,2,C) A and B,1
8119,Elearning-0000-1017,MODIFIER AS,n9493,48128,5,Documentation for modifier AS includes:,157348,3,D) None of the above,0
8119,Elearning-0000-1017,MODIFIER AS,n9493,48129,6,True or False? Surgical assistance must be deemed medically necessary to warrant additional payment.,157349,0,TRUE,1
8119,Elearning-0000-1017,MODIFIER AS,n9493,48129,6,True or False? Surgical assistance must be deemed medically necessary to warrant additional payment.,157350,1,FALSE,0
8119,Elearning-0000-1017,MODIFIER AS,n9493,48130,7,True or False? Indicator 0 = Payment restriction does not apply for assistants at surgery to this procedure.  Therefore supporting documentation describing medical necessity does not have to be submitted with the claim.,157351,0,TRUE,0
8119,Elearning-0000-1017,MODIFIER AS,n9493,48130,7,True or False? Indicator 0 = Payment restriction does not apply for assistants at surgery to this procedure.  Therefore supporting documentation describing medical necessity does not have to be submitted with the claim.,157352,1,FALSE,1
8119,Elearning-0000-1017,MODIFIER AS,n9493,48131,8,True or False? When submitting assist at surgery claims to Medicaid append modifier 80.,157353,0,TRUE,1
8119,Elearning-0000-1017,MODIFIER AS,n9493,48131,8,True or False? When submitting assist at surgery claims to Medicaid append modifier 80.,157354,1,FALSE,0
8119,Elearning-0000-1017,MODIFIER AS,n9493,48132,9,True or False?  Modifier AS should be billed independently with the exception of the NSH internal modifier ML.,157355,0,TRUE,1
8119,Elearning-0000-1017,MODIFIER AS,n9493,48132,9,True or False?  Modifier AS should be billed independently with the exception of the NSH internal modifier ML.,157356,1,FALSE,0
1572,ILT-0000-6521,EMERGENCY SERVICES STAFF MEETING SEPTEMBER 2019,n9497,48136,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",157363,0,TRUE,1
1572,ILT-0000-6521,EMERGENCY SERVICES STAFF MEETING SEPTEMBER 2019,n9497,48136,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",157364,1,FALSE,0
8174,Elearning-0000-1067,2019.08.01- STUDY RESEARCH MISCONDUCT,n9501,48140,0,I have read and fully understand this SOP.,157371,0,TRUE,1
8174,Elearning-0000-1067,2019.08.01- STUDY RESEARCH MISCONDUCT,n9501,48140,0,I have read and fully understand this SOP.,157372,1,FALSE,0
8173,Elearning-0000-1066,2019.08.01- RESEARCH COMPLIANCE PLAN,n9502,48141,0,I have read and fully understand this SOP.,157373,0,TRUE,1
8173,Elearning-0000-1066,2019.08.01- RESEARCH COMPLIANCE PLAN,n9502,48141,0,I have read and fully understand this SOP.,157374,1,FALSE,0
8171,Elearning-0000-1064,2019.08.01- RESEARCH CONFLICT OF INTEREST DISCLOSURE,n9513,48190,0,I have read and fully understand this SOP.,157543,0,TRUE,1
8171,Elearning-0000-1064,2019.08.01- RESEARCH CONFLICT OF INTEREST DISCLOSURE,n9513,48190,0,I have read and fully understand this SOP.,157544,1,FALSE,0
8170,Elearning-0000-1063,2019.08.01- FDA SPONSOR AUDIT INSPECTIONS,n9514,48191,0,I have read and fully understand this SOP.,157545,0,TRUE,1
8170,Elearning-0000-1063,2019.08.01- FDA SPONSOR AUDIT INSPECTIONS,n9514,48191,0,I have read and fully understand this SOP.,157546,1,FALSE,0
8169,Elearning-0000-1062,2019.08.01- ARCHIVING STUDY DOCUMENTS,n9515,48192,0,I have read and fully understand this SOP.,157547,0,TRUE,1
8169,Elearning-0000-1062,2019.08.01- ARCHIVING STUDY DOCUMENTS,n9515,48192,0,I have read and fully understand this SOP.,157548,1,FALSE,0
8168,Elearning-0000-1061,2019.08.01- COMPLETING DEVIATIONS AND NOTES TO FILE,n9516,48193,0,I have read and fully understand this SOP.,157549,0,TRUE,1
10204,Elearning-0000-1975,2019.08.01- COMPLETING DEVIATIONS AND NOTES TO FILE,n9516,48193,0,I have read and fully understand this SOP.,157549,0,TRUE,1
8168,Elearning-0000-1061,2019.08.01- COMPLETING DEVIATIONS AND NOTES TO FILE,n9516,48193,0,I have read and fully understand this SOP.,157550,1,FALSE,0
10204,Elearning-0000-1975,2019.08.01- COMPLETING DEVIATIONS AND NOTES TO FILE,n9516,48193,0,I have read and fully understand this SOP.,157550,1,FALSE,0
8167,Elearning-0000-1060,2019.08.01- LOST TO FOLLOW UP,n9517,48194,0,I have read and fully understand this SOP.,157551,0,TRUE,1
8167,Elearning-0000-1060,2019.08.01- LOST TO FOLLOW UP,n9517,48194,0,I have read and fully understand this SOP.,157552,1,FALSE,0
8165,Elearning-0000-1059,2019.08.01- PATIENT CHART ORGANIZATION,n9523,48210,0,I have read and fully understand this SOP.,157592,0,TRUE,1
8165,Elearning-0000-1059,2019.08.01- PATIENT CHART ORGANIZATION,n9523,48210,0,I have read and fully understand this SOP.,157593,1,FALSE,0
8164,Elearning-0000-1058,2019.08.01- HOW TO RESPOND TO AUDIT FINDINGS,n9524,48211,0,I have read and fully understand this SOP.,157594,0,TRUE,1
8164,Elearning-0000-1058,2019.08.01- HOW TO RESPOND TO AUDIT FINDINGS,n9524,48211,0,I have read and fully understand this SOP.,157595,1,FALSE,0
8163,Elearning-0000-1057,2019.08.01- HOW TO PREPARE FOR AN AUDIT,n9525,48212,0,I have read and fully understand this SOP.,157596,0,TRUE,1
8163,Elearning-0000-1057,2019.08.01- HOW TO PREPARE FOR AN AUDIT,n9525,48212,0,I have read and fully understand this SOP.,157597,1,FALSE,0
8162,Elearning-0000-1056,2019.08.01- RESEARCH CLINICAL AND FINANCE COMMUNICATION PLAN,n9526,48213,0,I have read and fully understand this SOP.,157598,0,TRUE,1
8162,Elearning-0000-1056,2019.08.01- RESEARCH CLINICAL AND FINANCE COMMUNICATION PLAN,n9526,48213,0,I have read and fully understand this SOP.,157599,1,FALSE,0
8161,Elearning-0000-1055,2019.08.01- NHCI DESTRUCTION OF OUTDATED DRUGS AND SUPPLIES,n9541,48249,0,I have read and fully understand this SOP.,157676,0,TRUE,1
8161,Elearning-0000-1055,2019.08.01- NHCI DESTRUCTION OF OUTDATED DRUGS AND SUPPLIES,n9541,48249,0,I have read and fully understand this SOP.,157677,1,FALSE,0
8160,Elearning-0000-1054,2019.08.01- RESEARCH OVERSIGHT COMMITTEE SUBMISSION PROCESS,n9542,48250,0,I have read and fully understand this SOP.,157678,0,TRUE,1
8160,Elearning-0000-1054,2019.08.01- RESEARCH OVERSIGHT COMMITTEE SUBMISSION PROCESS,n9542,48250,0,I have read and fully understand this SOP.,157679,1,FALSE,0
8159,Elearning-0000-1053,2019.08.01- INITIAL SUBMISSION INSTITUTIONAL REVIEW BOARD,n9543,48251,0,I have read and fully understand this SOP.,157680,0,TRUE,1
8159,Elearning-0000-1053,2019.08.01- INITIAL SUBMISSION INSTITUTIONAL REVIEW BOARD,n9543,48251,0,I have read and fully understand this SOP.,157681,1,FALSE,0
8158,Elearning-0000-1052,2019.08.01- INFORMED CONSENT FORM DEVELOPMENT,n9544,48252,0,I have read and fully understand this SOP.,157682,0,TRUE,1
8158,Elearning-0000-1052,2019.08.01- INFORMED CONSENT FORM DEVELOPMENT,n9544,48252,0,I have read and fully understand this SOP.,157683,1,FALSE,0
8157,Elearning-0000-1051,2019.08.01- CONTINUING REVIEW MONITORING REPORTS,n9550,48339,0,I have read and fully understand this SOP.,158003,0,TRUE,1
10194,Elearning-0000-1965,2019.08.01- CONTINUING REVIEW MONITORING REPORTS,n9550,48339,0,I have read and fully understand this SOP.,158003,0,TRUE,1
8157,Elearning-0000-1051,2019.08.01- CONTINUING REVIEW MONITORING REPORTS,n9550,48339,0,I have read and fully understand this SOP.,158004,1,FALSE,0
10194,Elearning-0000-1965,2019.08.01- CONTINUING REVIEW MONITORING REPORTS,n9550,48339,0,I have read and fully understand this SOP.,158004,1,FALSE,0
8156,Elearning-0000-1050,2019.08.01- PROTOCOL AMENDMENT REPORTING,n9551,48340,0,I have read and fully understand this SOP.,158005,0,TRUE,1
8156,Elearning-0000-1050,2019.08.01- PROTOCOL AMENDMENT REPORTING,n9551,48340,0,I have read and fully understand this SOP.,158006,1,FALSE,0
8154,Elearning-0000-1049,2019.08.01- CLOSE OUT REPORTING,n9552,48341,0,I have read and fully understand this SOP.,158007,0,TRUE,1
8154,Elearning-0000-1049,2019.08.01- CLOSE OUT REPORTING,n9552,48341,0,I have read and fully understand this SOP.,158008,1,FALSE,0
8153,Elearning-0000-1048,2019.08.01- SERIOUS ADVERSE EVENT REPORTING,n9553,48342,0,I have read and fully understand this SOP.,158009,0,TRUE,1
8153,Elearning-0000-1048,2019.08.01- SERIOUS ADVERSE EVENT REPORTING,n9553,48342,0,I have read and fully understand this SOP.,158010,1,FALSE,0
8152,Elearning-0000-1047,2019.08.01-PROTOCOL DEVIATION REPORTING,n9554,48343,0,I have read and fully understand this SOP.,158011,0,TRUE,1
8152,Elearning-0000-1047,2019.08.01-PROTOCOL DEVIATION REPORTING,n9554,48343,0,I have read and fully understand this SOP.,158012,1,FALSE,0
8151,Elearning-0000-1046,2019.08.01- REGULATORY AUDIT PREP,n9561,48408,0,I have read and fully understand this SOP.,158228,0,TRUE,1
8151,Elearning-0000-1046,2019.08.01- REGULATORY AUDIT PREP,n9561,48408,0,I have read and fully understand this SOP.,158229,1,FALSE,0
8150,Elearning-0000-1045,2019.08.01- MASTER REGULATORY BINDER,n9562,48409,0,I have read and fully understand this SOP.,158230,0,TRUE,1
8150,Elearning-0000-1045,2019.08.01- MASTER REGULATORY BINDER,n9562,48409,0,I have read and fully understand this SOP.,158231,1,FALSE,0
8149,Elearning-0000-1044,2019.08.01- REGULATORY BINDER,n9563,48410,0,I have read and fully understand this SOP.,158232,0,TRUE,1
8149,Elearning-0000-1044,2019.08.01- REGULATORY BINDER,n9563,48410,0,I have read and fully understand this SOP.,158233,1,FALSE,0
8148,Elearning-0000-1043,2019.08.01- SITE STAFF PROTOCOL TRAINING,n9564,48411,0,I have read and fully understand this SOP.,158234,0,TRUE,1
10186,Elearning-0000-1957,2019.08.01- SITE STAFF PROTOCOL TRAINING,n9564,48411,0,I have read and fully understand this SOP.,158234,0,TRUE,1
8148,Elearning-0000-1043,2019.08.01- SITE STAFF PROTOCOL TRAINING,n9564,48411,0,I have read and fully understand this SOP.,158235,1,FALSE,0
10186,Elearning-0000-1957,2019.08.01- SITE STAFF PROTOCOL TRAINING,n9564,48411,0,I have read and fully understand this SOP.,158235,1,FALSE,0
806,ILT-0000-2922,BLOOD ADMINISTRATION,n9568,48418,0,I have read and understood the content of this module.,158252,0,TRUE,1
806,ILT-0000-2922,BLOOD ADMINISTRATION,n9568,48418,0,I have read and understood the content of this module.,158253,1,FALSE,0
8136,Elearning-0000-1032,THE BUNDLE APPROACH: NEW STRATEGEIS FOR SSI PREVENTION,n9584,48500,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed ""The Bundle Approach: new Strategies for SSI Prevention""CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",158461,0,TRUE,1
8136,Elearning-0000-1032,THE BUNDLE APPROACH: NEW STRATEGEIS FOR SSI PREVENTION,n9584,48500,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed ""The Bundle Approach: new Strategies for SSI Prevention""CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",158462,1,FALSE,0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48663,0,How many components are there to the Da Vinci Xi System?,159094,0,"a)	2",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48663,0,How many components are there to the Da Vinci Xi System?,159095,1,"b)	3",1
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48663,0,How many components are there to the Da Vinci Xi System?,159096,2,"c)	1",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48663,0,How many components are there to the Da Vinci Xi System?,159097,3,"d)	5",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48664,1,"Where can one check the ""lives"" of the Xi Instruments?",159098,0,"a)	Surgeon Console",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48664,1,"Where can one check the ""lives"" of the Xi Instruments?",159099,1,"b)	Vision Cart",1
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48664,1,"Where can one check the ""lives"" of the Xi Instruments?",159100,2,"c)	Patient-side Cart",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48664,1,"Where can one check the ""lives"" of the Xi Instruments?",159101,3,"d)	Intuitive Representative",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48665,2,All the Arms on the Patient-side cart need to be draped for the Xi system to be used properly?,159102,0,a) True,1
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48665,2,All the Arms on the Patient-side cart need to be draped for the Xi system to be used properly?,159103,1,b) False,0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48666,3,"What sizes do the Cannulas, Instruments, and Scopes come in?",159104,0,"a)	5 mm",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48666,3,"What sizes do the Cannulas, Instruments, and Scopes come in?",159105,1,"b)	8 mm",1
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48666,3,"What sizes do the Cannulas, Instruments, and Scopes come in?",159106,2,"c)	10 mm",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48666,3,"What sizes do the Cannulas, Instruments, and Scopes come in?",159107,3,"d)	All of the above",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48667,4,Which component/s will allow you to Power on/off the whole system?,159108,0,"a)	Surgeon Console",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48667,4,Which component/s will allow you to Power on/off the whole system?,159109,1,"b)	Patient-side Cart",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48667,4,Which component/s will allow you to Power on/off the whole system?,159110,2,"c)	Vision Cart",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48667,4,Which component/s will allow you to Power on/off the whole system?,159111,3,"d)	Erbe Generator",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48667,4,Which component/s will allow you to Power on/off the whole system?,159112,4,"e)	A,B and C",1
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48667,4,Which component/s will allow you to Power on/off the whole system?,159113,5,"f)	All of the above",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48668,5,How many cases can the Instruments be used for?,159114,0,"a)	1",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48668,5,How many cases can the Instruments be used for?,159115,1,"b)	5",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48668,5,How many cases can the Instruments be used for?,159116,2,"c)	8",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48668,5,How many cases can the Instruments be used for?,159117,3,"d)	10",1
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48668,5,How many cases can the Instruments be used for?,159118,4,"e)	Infinite",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48669,6,The Surgeon needs to dock all arms for the system to work properly?,159119,0,a) True,0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48669,6,The Surgeon needs to dock all arms for the system to work properly?,159120,1,b) False,1
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48670,7,Which components give you access to the Emergency Stop button?,159121,0,"a)	Surgeon Console and Vision Cart",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48670,7,Which components give you access to the Emergency Stop button?,159122,1,"b)	Surgeon Console and Patient-side Cart",1
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48670,7,Which components give you access to the Emergency Stop button?,159123,2,"c)	Vision Cart and Patient-side Cart",0
8131,Elearning-0000-1028,DA VINCI XI GUIDELINES,n9603,48670,7,Which components give you access to the Emergency Stop button?,159124,3,"d)	All of the above",0
9782,Elearning-0000-988,ED FIRSTNET DOWNTIME 2020,n9607,48678,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the ""ED FirstNet Downtime 2020"" CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159129,0,TRUE,1
9782,Elearning-0000-988,ED FIRSTNET DOWNTIME 2020,n9607,48678,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the ""ED FirstNet Downtime 2020"" CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159130,1,FALSE,0
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48679,0,"Transitional Care Management (TCM) includes services provided to a patient who have complicated social, psychosocial or medical needs that require moderate to high-complexity medical decision making when transitioning from a facility setting to the patient's home setting.",159131,0,TRUE,1
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48679,0,"Transitional Care Management (TCM) includes services provided to a patient who have complicated social, psychosocial or medical needs that require moderate to high-complexity medical decision making when transitioning from a facility setting to the patient's home setting.",159132,1,FALSE,0
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48680,1,"The provider (MD, DO, NP, PA, CNS, or CNM) is to ""oversee management and coordination of services, as needed, for all medical conditions, psycho-social needs and activity of daily living support"""" for 30 days post discharge.",159133,0,TRUE,1
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48680,1,"The provider (MD, DO, NP, PA, CNS, or CNM) is to ""oversee management and coordination of services, as needed, for all medical conditions, psycho-social needs and activity of daily living support"""" for 30 days post discharge.",159134,1,FALSE,0
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48681,2,TCM involves transition of care from Emergency Department.,159135,0,TRUE,0
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48681,2,TCM involves transition of care from Emergency Department.,159136,1,FALSE,1
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48682,3,Which of the following healthcare professional may NOT furnish TCM services:,159137,0,A) Physicians,0
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48682,3,Which of the following healthcare professional may NOT furnish TCM services:,159138,1,B) Physician Assistants,0
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48682,3,Which of the following healthcare professional may NOT furnish TCM services:,159139,2,C) Clinical Nurse Specialists,0
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48682,3,Which of the following healthcare professional may NOT furnish TCM services:,159140,3,D) Registered Medical Assistants,1
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48682,3,Which of the following healthcare professional may NOT furnish TCM services:,159141,4,E) Nurse Practitioners,0
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48683,4,"When a patient discharges from an approved Inpatient or Observation setting, the provider must furnish the following TCM components beginning the day of discharge up to 30 days.",159142,0,A) Certain Non Face-To-Face Services,0
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48683,4,"When a patient discharges from an approved Inpatient or Observation setting, the provider must furnish the following TCM components beginning the day of discharge up to 30 days.",159143,1,B) An Interactive Contact,0
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48683,4,"When a patient discharges from an approved Inpatient or Observation setting, the provider must furnish the following TCM components beginning the day of discharge up to 30 days.",159144,2,C) A Face-To-Face Visit,0
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48683,4,"When a patient discharges from an approved Inpatient or Observation setting, the provider must furnish the following TCM components beginning the day of discharge up to 30 days.",159145,3,D) All of the above,1
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48683,4,"When a patient discharges from an approved Inpatient or Observation setting, the provider must furnish the following TCM components beginning the day of discharge up to 30 days.",159146,4,E) None of the above,0
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48684,5,"TCM requires the transition of a patient to the patient's home setting after inpatient discharge which does not include; Skilled Nursing Facility, Inpatient Rehab, or Home with Home Health or Hospice care.",159147,0,TRUE,1
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48684,5,"TCM requires the transition of a patient to the patient's home setting after inpatient discharge which does not include; Skilled Nursing Facility, Inpatient Rehab, or Home with Home Health or Hospice care.",159148,1,FALSE,0
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48685,6,"TCM Face-To-Face visit - CPT 99495, includes HPI, Exam, and high MDM within 14 calendars of discharge.",159149,0,TRUE,0
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48685,6,"TCM Face-To-Face visit - CPT 99495, includes HPI, Exam, and high MDM within 14 calendars of discharge.",159150,1,FALSE,1
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48686,7,"TCM Face-To-Face visit - CPT 99496, includes HPI, Exam, and high MDM within 7 calendars of discharge.",159151,0,TRUE,1
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48686,7,"TCM Face-To-Face visit - CPT 99496, includes HPI, Exam, and high MDM within 7 calendars of discharge.",159152,1,FALSE,0
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48687,8,"When reporting 99495 and 99496, the provider may bill for Home Health or Hospice services.",159153,0,TRUE,0
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48687,8,"When reporting 99495 and 99496, the provider may bill for Home Health or Hospice services.",159154,1,FALSE,1
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48688,9,TCM services can be billed within a post-operative period.,159155,0,TRUE,0
9151,Elearning-0000-414,TRANSITIONAL CARE MANAGEMENT (TCM),n9608,48688,9,TCM services can be billed within a post-operative period.,159156,1,FALSE,1
9394,Elearning-0000-635,KINDNESS THROUGH COMMUNICATION: EXPLAIN AND RESPOND,n9609,48689,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159157,0,TRUE,1
9394,Elearning-0000-635,KINDNESS THROUGH COMMUNICATION: EXPLAIN AND RESPOND,n9609,48689,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159158,1,FALSE,0
9083,Elearning-0000-352,NSH1251: NEX-T CAR-T,n9610,48690,0,Steroids may be administered without restriction?,159159,0,TRUE,1
9083,Elearning-0000-352,NSH1251: NEX-T CAR-T,n9610,48690,0,Steroids may be administered without restriction?,159160,1,FALSE,0
9083,Elearning-0000-352,NSH1251: NEX-T CAR-T,n9610,48691,1,The Lymphodepleting chemotherapy administered is Fludarabine and Cyclophosphamide?,159161,0,TRUE,1
9083,Elearning-0000-352,NSH1251: NEX-T CAR-T,n9610,48691,1,The Lymphodepleting chemotherapy administered is Fludarabine and Cyclophosphamide?,159162,1,FALSE,0
9083,Elearning-0000-352,NSH1251: NEX-T CAR-T,n9610,48692,2,Side effects from CAR T administration includes CRS (Cytokine Release Syndrome)?,159163,0,TRUE,1
9083,Elearning-0000-352,NSH1251: NEX-T CAR-T,n9610,48692,2,Side effects from CAR T administration includes CRS (Cytokine Release Syndrome)?,159164,1,FALSE,0
9793,Elearning-0000-998,SECURITY AND EDUCATION TRAINING: MENTAL HEALTH,n9613,48698,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Security and Education Training CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159179,0,TRUE,1
9793,Elearning-0000-998,SECURITY AND EDUCATION TRAINING: MENTAL HEALTH,n9613,48698,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Security and Education Training CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159180,1,FALSE,0
9527,Elearning-0000-756,C-332 VERSION 10/08/19,n9615,48725,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159290,0,TRUE,1
9527,Elearning-0000-756,C-332 VERSION 10/08/19,n9615,48725,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159291,1,FALSE,0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48754,0,Multi-modal pain management includes the following:,159361,0,"a.	Anti-inflammatories",0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48754,0,Multi-modal pain management includes the following:,159362,1,"b.	Muscle relaxants",0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48754,0,Multi-modal pain management includes the following:,159363,2,"c.	Topical medications",0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48754,0,Multi-modal pain management includes the following:,159364,3,"d.	Gabapentinoids",0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48754,0,Multi-modal pain management includes the following:,159365,4,"e.	All of the above",1
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48755,1,Which IV fluid should you avoid in neurosurgical patients?,159366,0,"a.	Dextrose containing solutions",0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48755,1,Which IV fluid should you avoid in neurosurgical patients?,159367,1,"b.	Normal saline (0.9%)",0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48755,1,Which IV fluid should you avoid in neurosurgical patients?,159368,2,"c.	  Normal saline",0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48755,1,Which IV fluid should you avoid in neurosurgical patients?,159369,3,"d.	Hypertonic saline (3%)",0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48755,1,Which IV fluid should you avoid in neurosurgical patients?,159370,4,"e.	A and C",1
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48755,1,Which IV fluid should you avoid in neurosurgical patients?,159371,5,"f.	B and D",0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48756,2,Mannitol is dosed in which units of measure?,159372,0,"a.	Milligrams",0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48756,2,Mannitol is dosed in which units of measure?,159373,1,"b.	Grams",1
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48756,2,Mannitol is dosed in which units of measure?,159374,2,"c.	%",0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48756,2,Mannitol is dosed in which units of measure?,159375,3,"d.	mL",0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48757,3,What is the minimal interval for checking serum sodium in a patient receiving Hypertonic saline (3%)?,159376,0,"a.	Every 4 hours",0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48757,3,What is the minimal interval for checking serum sodium in a patient receiving Hypertonic saline (3%)?,159377,1,"b.	Every 6 hours",0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48757,3,What is the minimal interval for checking serum sodium in a patient receiving Hypertonic saline (3%)?,159378,2,"c.	Every 8 hours",1
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48757,3,What is the minimal interval for checking serum sodium in a patient receiving Hypertonic saline (3%)?,159379,3,"d.	Every 12 hours",0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48758,4,Phenytoin levels should be corrected for albumin levels.,159380,0,TRUE,1
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48758,4,Phenytoin levels should be corrected for albumin levels.,159381,1,FALSE,0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48759,5,Therapeutic range for phenytoin levels,159382,0,"a.	5 - 10 mg/L",0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48759,5,Therapeutic range for phenytoin levels,159383,1,"b.	Less than 5 mg/L",0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48759,5,Therapeutic range for phenytoin levels,159384,2,"c.	Greater than 20 mg/L",0
9193,Elearning-0000-452,MEDICATION MANAGEMENT IN NEUROSURGERY,n9622,48759,5,Therapeutic range for phenytoin levels,159385,3,"d.	10 to 20 mg/L",1
8125,Elearning-0000-1022,INTRODUCTION TO PHARMACY SERVICES 2020,n9624,48766,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Introduction to Pharmacy Services 2020 CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159388,0,TRUE,1
8125,Elearning-0000-1022,INTRODUCTION TO PHARMACY SERVICES 2020,n9624,48766,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Introduction to Pharmacy Services 2020 CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159389,1,FALSE,0
3306,ILT-0000-14673,NSC ED STAFF MEETING DECEMBER 2019,n9631,48782,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159420,0,TRUE,1
3306,ILT-0000-14673,NSC ED STAFF MEETING DECEMBER 2019,n9631,48782,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159421,1,FALSE,0
9188,Elearning-0000-448,ED METHOTREXATE DOCUMENTATION 2019,n9640,48829,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159561,0,TRUE,1
9188,Elearning-0000-448,ED METHOTREXATE DOCUMENTATION 2019,n9640,48829,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159562,1,FALSE,0
9103,Elearning-0000-370,NSH1169 VERSION 10.2,n9641,48830,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159563,0,TRUE,1
9103,Elearning-0000-370,NSH1169 VERSION 10.2,n9641,48830,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159564,1,FALSE,0
9092,Elearning-0000-360,NSH1223 AMENDMENT 3,n9647,48857,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159624,0,TRUE,1
9092,Elearning-0000-360,NSH1223 AMENDMENT 3,n9647,48857,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159625,1,FALSE,0
9061,Elearning-0000-332,NSH1164 VERSION 9,n9648,48858,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159626,0,TRUE,1
9061,Elearning-0000-332,NSH1164 VERSION 9,n9648,48858,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",159627,1,FALSE,0
9790,Elearning-0000-995,SUICIDE PREVENTION FOR THE OUTPATIENT FACILITIES - MA,n9656,48897,0,"<b>National Suicide Data</b><br><br> According to the CDC, one person dies by suicide every 15 minutes, over 40,000 suicides are completed per year as 	compared to 18,000 homicides, the highest risk group are individuals ages 18 -25 and 45 percent of people who died by 	suicide saw their primary care provider within a month of their death.",159787,0,a) True,1
9790,Elearning-0000-995,SUICIDE PREVENTION FOR THE OUTPATIENT FACILITIES - MA,n9656,48897,0,"<b>National Suicide Data</b><br><br> According to the CDC, one person dies by suicide every 15 minutes, over 40,000 suicides are completed per year as 	compared to 18,000 homicides, the highest risk group are individuals ages 18 -25 and 45 percent of people who died by 	suicide saw their primary care provider within a month of their death.",159788,1,b) False,0
9790,Elearning-0000-995,SUICIDE PREVENTION FOR THE OUTPATIENT FACILITIES - MA,n9656,48898,1,<b>Risk factors for suicide?</b><br><br> Which are risk factors for suicide?,159789,0,a) Having a history of mental health or substance use disorder,0
9790,Elearning-0000-995,SUICIDE PREVENTION FOR THE OUTPATIENT FACILITIES - MA,n9656,48898,1,<b>Risk factors for suicide?</b><br><br> Which are risk factors for suicide?,159790,1,b) Chronic or terminal medical issues and/or chronic pain,0
9790,Elearning-0000-995,SUICIDE PREVENTION FOR THE OUTPATIENT FACILITIES - MA,n9656,48898,1,<b>Risk factors for suicide?</b><br><br> Which are risk factors for suicide?,159791,2,"c) Access to lethal means, especially firearms",0
9790,Elearning-0000-995,SUICIDE PREVENTION FOR THE OUTPATIENT FACILITIES - MA,n9656,48898,1,<b>Risk factors for suicide?</b><br><br> Which are risk factors for suicide?,159792,3,d) Previous suicide attempts,0
9790,Elearning-0000-995,SUICIDE PREVENTION FOR THE OUTPATIENT FACILITIES - MA,n9656,48898,1,<b>Risk factors for suicide?</b><br><br> Which are risk factors for suicide?,159793,4,e) All of the above,1
9790,Elearning-0000-995,SUICIDE PREVENTION FOR THE OUTPATIENT FACILITIES - MA,n9656,48899,2,"<b>Screening for suicide</b><br><br> When screening for suicide, it is important to be calm, empathic, make a connection and ask patient directly about any suicidal 	thoughts or plan. Utilizing the questions in the Columbia Suicide Severity Rating Scale and not paraphrasing or summarizing is 	important.",159794,0,a) True,1
9790,Elearning-0000-995,SUICIDE PREVENTION FOR THE OUTPATIENT FACILITIES - MA,n9656,48899,2,"<b>Screening for suicide</b><br><br> When screening for suicide, it is important to be calm, empathic, make a connection and ask patient directly about any suicidal 	thoughts or plan. Utilizing the questions in the Columbia Suicide Severity Rating Scale and not paraphrasing or summarizing is 	important.",159795,1,b) False,0
9790,Elearning-0000-995,SUICIDE PREVENTION FOR THE OUTPATIENT FACILITIES - MA,n9656,48900,3,"<b>Ambivalence</b><br><br> Suicide is preventable. Ambivalence is our in-road! A patient who has told his/her family that he/she no longer want to live while 	planning a future family vacation is an example of what?",159796,0,a) Ambivalence,1
9790,Elearning-0000-995,SUICIDE PREVENTION FOR THE OUTPATIENT FACILITIES - MA,n9656,48900,3,"<b>Ambivalence</b><br><br> Suicide is preventable. Ambivalence is our in-road! A patient who has told his/her family that he/she no longer want to live while 	planning a future family vacation is an example of what?",159797,1,b) Manipulation,0
9790,Elearning-0000-995,SUICIDE PREVENTION FOR THE OUTPATIENT FACILITIES - MA,n9656,48900,3,"<b>Ambivalence</b><br><br> Suicide is preventable. Ambivalence is our in-road! A patient who has told his/her family that he/she no longer want to live while 	planning a future family vacation is an example of what?",159798,2,c) Confusion,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49033,1,The content was interesting to me.,160354,0,1. Strongly Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49033,1,The content was interesting to me.,160355,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49033,1,The content was interesting to me.,160356,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49033,1,The content was interesting to me.,160357,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49033,1,The content was interesting to me.,160358,4,5 Strongly Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49034,0,The content expanded my knowledge of the topic.,160359,0,1 Strongly disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49034,0,The content expanded my knowledge of the topic.,160360,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49034,0,The content expanded my knowledge of the topic.,160361,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49034,0,The content expanded my knowledge of the topic.,160362,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49034,0,The content expanded my knowledge of the topic.,160363,4,5 Strongly agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49035,2,The content was consistent with the objectives.,160364,0,1 Strongly disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49035,2,The content was consistent with the objectives.,160365,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49035,2,The content was consistent with the objectives.,160366,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49035,2,The content was consistent with the objectives.,160367,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49035,2,The content was consistent with the objectives.,160368,4,5 Strongly agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49036,3,The content will help me do my job better.,160369,0,1 Strongly disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49036,3,The content will help me do my job better.,160370,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49036,3,The content will help me do my job better.,160371,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49036,3,The content will help me do my job better.,160372,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49036,3,The content will help me do my job better.,160373,4,5 Strongly agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49037,4,The room and environment was conducive to learning.,160374,0,1 Strongly disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49037,4,The room and environment was conducive to learning.,160375,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49037,4,The room and environment was conducive to learning.,160376,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49037,4,The room and environment was conducive to learning.,160377,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49037,4,The room and environment was conducive to learning.,160378,4,5 Strongly agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49038,5,Please rate instructor Jenny Flanagan: The material presented was clear and to the point.,160379,0,1 Strongly disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49038,5,Please rate instructor Jenny Flanagan: The material presented was clear and to the point.,160380,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49038,5,Please rate instructor Jenny Flanagan: The material presented was clear and to the point.,160381,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49038,5,Please rate instructor Jenny Flanagan: The material presented was clear and to the point.,160382,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49038,5,Please rate instructor Jenny Flanagan: The material presented was clear and to the point.,160383,4,5 Strongly agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49039,6,Please rate instructor Jenny Flanagan: The presenter demonstrated mastery of the topic.,160384,0,1 Strongly disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49039,6,Please rate instructor Jenny Flanagan: The presenter demonstrated mastery of the topic.,160385,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49039,6,Please rate instructor Jenny Flanagan: The presenter demonstrated mastery of the topic.,160386,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49039,6,Please rate instructor Jenny Flanagan: The presenter demonstrated mastery of the topic.,160387,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49039,6,Please rate instructor Jenny Flanagan: The presenter demonstrated mastery of the topic.,160388,4,5 Strongly agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49040,7,Please rate instructor Jenny Flanagan:  The method used to present the material was engaging and held my attention.,160389,0,1 Strongly disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49040,7,Please rate instructor Jenny Flanagan:  The method used to present the material was engaging and held my attention.,160390,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49040,7,Please rate instructor Jenny Flanagan:  The method used to present the material was engaging and held my attention.,160391,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49040,7,Please rate instructor Jenny Flanagan:  The method used to present the material was engaging and held my attention.,160392,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49040,7,Please rate instructor Jenny Flanagan:  The method used to present the material was engaging and held my attention.,160393,4,5 Strongly agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49041,8,Please rate instructor Jenny Flanagan: The presenter was responsive to participant concerns.,160394,0,1 Strongly disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49041,8,Please rate instructor Jenny Flanagan: The presenter was responsive to participant concerns.,160395,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49041,8,Please rate instructor Jenny Flanagan: The presenter was responsive to participant concerns.,160396,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49041,8,Please rate instructor Jenny Flanagan: The presenter was responsive to participant concerns.,160397,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49041,8,Please rate instructor Jenny Flanagan: The presenter was responsive to participant concerns.,160398,4,5 Strongly agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49042,9,Please rate instructor Kristen Foshee: The material presented was clear and to the point.,160399,0,1 Strongly disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49042,9,Please rate instructor Kristen Foshee: The material presented was clear and to the point.,160400,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49042,9,Please rate instructor Kristen Foshee: The material presented was clear and to the point.,160401,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49042,9,Please rate instructor Kristen Foshee: The material presented was clear and to the point.,160402,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49042,9,Please rate instructor Kristen Foshee: The material presented was clear and to the point.,160403,4,5 Strongly agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49043,10,Please rate instructor Kristen Foshee: The presenter demonstrated mastery of the topic,160404,0,1 Strongly disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49043,10,Please rate instructor Kristen Foshee: The presenter demonstrated mastery of the topic,160405,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49043,10,Please rate instructor Kristen Foshee: The presenter demonstrated mastery of the topic,160406,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49043,10,Please rate instructor Kristen Foshee: The presenter demonstrated mastery of the topic,160407,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49043,10,Please rate instructor Kristen Foshee: The presenter demonstrated mastery of the topic,160408,4,5 Strongly agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49044,11,Please rate instructor Kristen Foshee: The method used to present the material was engaging and held my attention.,160409,0,1 Strongly disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49044,11,Please rate instructor Kristen Foshee: The method used to present the material was engaging and held my attention.,160410,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49044,11,Please rate instructor Kristen Foshee: The method used to present the material was engaging and held my attention.,160411,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49044,11,Please rate instructor Kristen Foshee: The method used to present the material was engaging and held my attention.,160412,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49044,11,Please rate instructor Kristen Foshee: The method used to present the material was engaging and held my attention.,160413,4,5 Strongly agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49045,12,Please rate instructor Kristen Foshee: The presenter was responsive to participant questions,160414,0,1 Strongly disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49045,12,Please rate instructor Kristen Foshee: The presenter was responsive to participant questions,160415,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49045,12,Please rate instructor Kristen Foshee: The presenter was responsive to participant questions,160416,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49045,12,Please rate instructor Kristen Foshee: The presenter was responsive to participant questions,160417,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49045,12,Please rate instructor Kristen Foshee: The presenter was responsive to participant questions,160418,4,5 Strongly agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49046,13,"After this class, I can summarize the physiologic impact of pregnancy on the body systems",160419,0,1 Strongly disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49046,13,"After this class, I can summarize the physiologic impact of pregnancy on the body systems",160420,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49046,13,"After this class, I can summarize the physiologic impact of pregnancy on the body systems",160421,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49046,13,"After this class, I can summarize the physiologic impact of pregnancy on the body systems",160422,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49046,13,"After this class, I can summarize the physiologic impact of pregnancy on the body systems",160423,4,5 Strongly agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49047,14,After this class I can identify significant medical and surgical historical events with a potential to negatively impact the labor or delivery process,160424,0,1 Strongly disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49047,14,After this class I can identify significant medical and surgical historical events with a potential to negatively impact the labor or delivery process,160425,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49047,14,After this class I can identify significant medical and surgical historical events with a potential to negatively impact the labor or delivery process,160426,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49047,14,After this class I can identify significant medical and surgical historical events with a potential to negatively impact the labor or delivery process,160427,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49047,14,After this class I can identify significant medical and surgical historical events with a potential to negatively impact the labor or delivery process,160428,4,5 Strongly agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49048,15,"After this class, I can accurately identify the stage and phase of labor based upon cervical dilation and behavioral changes.",160429,0,1 Strongly disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49048,15,"After this class, I can accurately identify the stage and phase of labor based upon cervical dilation and behavioral changes.",160430,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49048,15,"After this class, I can accurately identify the stage and phase of labor based upon cervical dilation and behavioral changes.",160431,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49048,15,"After this class, I can accurately identify the stage and phase of labor based upon cervical dilation and behavioral changes.",160432,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49048,15,"After this class, I can accurately identify the stage and phase of labor based upon cervical dilation and behavioral changes.",160433,4,5 Strongly agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49049,16,"After this class, I can prioritize nursing assessments during rupture of membranes",160434,0,1 Strongly disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49049,16,"After this class, I can prioritize nursing assessments during rupture of membranes",160435,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49049,16,"After this class, I can prioritize nursing assessments during rupture of membranes",160436,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49049,16,"After this class, I can prioritize nursing assessments during rupture of membranes",160437,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49049,16,"After this class, I can prioritize nursing assessments during rupture of membranes",160438,4,5 Strongly agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49050,17,"After this class, I can Verbalize the importance of position changes during labor to positively impact delivery of the fetus",160439,0,1 Strongly disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49050,17,"After this class, I can Verbalize the importance of position changes during labor to positively impact delivery of the fetus",160440,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49050,17,"After this class, I can Verbalize the importance of position changes during labor to positively impact delivery of the fetus",160441,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49050,17,"After this class, I can Verbalize the importance of position changes during labor to positively impact delivery of the fetus",160442,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49050,17,"After this class, I can Verbalize the importance of position changes during labor to positively impact delivery of the fetus",160443,4,5 Strongly agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49051,18,"After this class, I can list 2 non-pharmacological strategies for reducing pain and anxiety during labor",160444,0,1 Strongly disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49051,18,"After this class, I can list 2 non-pharmacological strategies for reducing pain and anxiety during labor",160445,1,2 Disagree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49051,18,"After this class, I can list 2 non-pharmacological strategies for reducing pain and anxiety during labor",160446,2,3 Neutral,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49051,18,"After this class, I can list 2 non-pharmacological strategies for reducing pain and anxiety during labor",160447,3,4 Agree,0
2546,ILT-0000-11947,LD RESIDENCY CLASS ONE PREGNANCY AND LABOR,n9664,49051,18,"After this class, I can list 2 non-pharmacological strategies for reducing pain and anxiety during labor",160448,4,5 Strongly agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49053,0,The content was interesting to me.,160449,0,1. Strongly Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49053,0,The content was interesting to me.,160450,1,2 Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49053,0,The content was interesting to me.,160451,2,3 Neutral,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49053,0,The content was interesting to me.,160452,3,4 Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49053,0,The content was interesting to me.,160453,4,5 Strongly Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49054,1,The content was consistent with the objectives.,160454,0,1 Strongly disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49054,1,The content was consistent with the objectives.,160455,1,2 Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49054,1,The content was consistent with the objectives.,160456,2,3 Neutral,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49054,1,The content was consistent with the objectives.,160457,3,4 Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49054,1,The content was consistent with the objectives.,160458,4,5 Strongly agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49055,2,The content expanded my knowledge of the topic.,160459,0,1 Strongly disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49055,2,The content expanded my knowledge of the topic.,160460,1,2 Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49055,2,The content expanded my knowledge of the topic.,160461,2,3 Neutral,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49055,2,The content expanded my knowledge of the topic.,160462,3,4 Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49055,2,The content expanded my knowledge of the topic.,160463,4,5 Strongly agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49056,3,The content will help me do my job better.,160464,0,1 Strongly disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49056,3,The content will help me do my job better.,160465,1,2 Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49056,3,The content will help me do my job better.,160466,2,3 Neutral,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49056,3,The content will help me do my job better.,160467,3,4 Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49056,3,The content will help me do my job better.,160468,4,5 Strongly agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49057,4,The room and environment was conducive to learning.,160469,0,1 Strongly disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49057,4,The room and environment was conducive to learning.,160470,1,2 Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49057,4,The room and environment was conducive to learning.,160471,2,3 Neutral,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49057,4,The room and environment was conducive to learning.,160472,3,4 Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49057,4,The room and environment was conducive to learning.,160473,4,5 Strongly agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49058,5,Please rate instructor Cathy Sharpsteen: The material presented was clear and to the point.,160474,0,1 Strongly disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49058,5,Please rate instructor Cathy Sharpsteen: The material presented was clear and to the point.,160475,1,2 Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49058,5,Please rate instructor Cathy Sharpsteen: The material presented was clear and to the point.,160476,2,3 Neutral,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49058,5,Please rate instructor Cathy Sharpsteen: The material presented was clear and to the point.,160477,3,4 Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49058,5,Please rate instructor Cathy Sharpsteen: The material presented was clear and to the point.,160478,4,5 Strongly agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49059,6,Please rate instructor Cathy Sharpsteen: The presenter demonstrated mastery of the topic.,160479,0,1 Strongly disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49059,6,Please rate instructor Cathy Sharpsteen: The presenter demonstrated mastery of the topic.,160480,1,2 Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49059,6,Please rate instructor Cathy Sharpsteen: The presenter demonstrated mastery of the topic.,160481,2,3 Neutral,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49059,6,Please rate instructor Cathy Sharpsteen: The presenter demonstrated mastery of the topic.,160482,3,4 Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49059,6,Please rate instructor Cathy Sharpsteen: The presenter demonstrated mastery of the topic.,160483,4,5 Strongly agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49060,7,Please rate instructor Cathy Sharpsteen:  The method used to present the material was engaging and held my attention.,160484,0,1 Strongly disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49060,7,Please rate instructor Cathy Sharpsteen:  The method used to present the material was engaging and held my attention.,160485,1,2 Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49060,7,Please rate instructor Cathy Sharpsteen:  The method used to present the material was engaging and held my attention.,160486,2,3 Neutral,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49060,7,Please rate instructor Cathy Sharpsteen:  The method used to present the material was engaging and held my attention.,160487,3,4 Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49060,7,Please rate instructor Cathy Sharpsteen:  The method used to present the material was engaging and held my attention.,160488,4,5 Strongly agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49061,8,Please rate instructor Cathy Sharpsteen: The presenter was responsive to participant concerns.,160489,0,1 Strongly disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49061,8,Please rate instructor Cathy Sharpsteen: The presenter was responsive to participant concerns.,160490,1,2 Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49061,8,Please rate instructor Cathy Sharpsteen: The presenter was responsive to participant concerns.,160491,2,3 Neutral,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49061,8,Please rate instructor Cathy Sharpsteen: The presenter was responsive to participant concerns.,160492,3,4 Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49061,8,Please rate instructor Cathy Sharpsteen: The presenter was responsive to participant concerns.,160493,4,5 Strongly agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49062,9,Please rate instructor Kristen Foshee: The material presented was clear and to the point.,160494,0,1 Strongly disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49062,9,Please rate instructor Kristen Foshee: The material presented was clear and to the point.,160495,1,2 Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49062,9,Please rate instructor Kristen Foshee: The material presented was clear and to the point.,160496,2,3 Neutral,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49062,9,Please rate instructor Kristen Foshee: The material presented was clear and to the point.,160497,3,4 Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49062,9,Please rate instructor Kristen Foshee: The material presented was clear and to the point.,160498,4,5 Strongly agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49063,10,Please rate instructor Kristen Foshee: The presenter demonstrated mastery of the topic,160499,0,1 Strongly disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49063,10,Please rate instructor Kristen Foshee: The presenter demonstrated mastery of the topic,160500,1,2 Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49063,10,Please rate instructor Kristen Foshee: The presenter demonstrated mastery of the topic,160501,2,3 Neutral,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49063,10,Please rate instructor Kristen Foshee: The presenter demonstrated mastery of the topic,160502,3,4 Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49063,10,Please rate instructor Kristen Foshee: The presenter demonstrated mastery of the topic,160503,4,5 Strongly agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49064,11,Please rate instructor Kristen Foshee: The method used to present the material was engaging and held my attention.,160504,0,1 Strongly disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49064,11,Please rate instructor Kristen Foshee: The method used to present the material was engaging and held my attention.,160505,1,2 Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49064,11,Please rate instructor Kristen Foshee: The method used to present the material was engaging and held my attention.,160506,2,3 Neutral,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49064,11,Please rate instructor Kristen Foshee: The method used to present the material was engaging and held my attention.,160507,3,4 Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49064,11,Please rate instructor Kristen Foshee: The method used to present the material was engaging and held my attention.,160508,4,5 Strongly agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49065,12,Please rate instructor Kristen Foshee: The presenter was responsive to participant questions,160509,0,1 Strongly disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49065,12,Please rate instructor Kristen Foshee: The presenter was responsive to participant questions,160510,1,2 Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49065,12,Please rate instructor Kristen Foshee: The presenter was responsive to participant questions,160511,2,3 Neutral,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49065,12,Please rate instructor Kristen Foshee: The presenter was responsive to participant questions,160512,3,4 Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49065,12,Please rate instructor Kristen Foshee: The presenter was responsive to participant questions,160513,4,5 Strongly agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49067,13,"After this class, I can differentiate between normal and abnormal assessment findings in the pregnant patient",160514,0,1 Strongly disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49067,13,"After this class, I can differentiate between normal and abnormal assessment findings in the pregnant patient",160515,1,2 Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49067,13,"After this class, I can differentiate between normal and abnormal assessment findings in the pregnant patient",160516,2,3 Neutral,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49067,13,"After this class, I can differentiate between normal and abnormal assessment findings in the pregnant patient",160517,3,4 Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49067,13,"After this class, I can differentiate between normal and abnormal assessment findings in the pregnant patient",160518,4,5 Strongly agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49068,14,"After this class, I can correctly perform deep tendon reflexes on one upper extremity reflex and one lower extremity reflex",160519,0,1 Strongly disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49068,14,"After this class, I can correctly perform deep tendon reflexes on one upper extremity reflex and one lower extremity reflex",160520,1,2 Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49068,14,"After this class, I can correctly perform deep tendon reflexes on one upper extremity reflex and one lower extremity reflex",160521,2,3 Neutral,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49068,14,"After this class, I can correctly perform deep tendon reflexes on one upper extremity reflex and one lower extremity reflex",160522,3,4 Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49068,14,"After this class, I can correctly perform deep tendon reflexes on one upper extremity reflex and one lower extremity reflex",160523,4,5 Strongly agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49069,15,"After this class, I can summarize the mechanism of action, side effects, and contraindications for labor inducing agents",160524,0,1 Strongly disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49069,15,"After this class, I can summarize the mechanism of action, side effects, and contraindications for labor inducing agents",160525,1,2 Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49069,15,"After this class, I can summarize the mechanism of action, side effects, and contraindications for labor inducing agents",160526,2,3 Neutral,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49069,15,"After this class, I can summarize the mechanism of action, side effects, and contraindications for labor inducing agents",160527,3,4 Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49069,15,"After this class, I can summarize the mechanism of action, side effects, and contraindications for labor inducing agents",160528,4,5 Strongly disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49070,16,"After this class, I can verbalize the benefits of skin to skin contact for mothers and babies",160529,0,1 Strongly disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49070,16,"After this class, I can verbalize the benefits of skin to skin contact for mothers and babies",160530,1,2 Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49070,16,"After this class, I can verbalize the benefits of skin to skin contact for mothers and babies",160531,2,3 Neutral,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49070,16,"After this class, I can verbalize the benefits of skin to skin contact for mothers and babies",160532,3,4 Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49070,16,"After this class, I can verbalize the benefits of skin to skin contact for mothers and babies",160533,4,5 Strongly agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49071,17,"After this class, I can demonstrate proper technique in latching a newborn and in hand expression.",160534,0,1 Strongly disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49071,17,"After this class, I can demonstrate proper technique in latching a newborn and in hand expression.",160535,1,2 Disagree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49071,17,"After this class, I can demonstrate proper technique in latching a newborn and in hand expression.",160536,2,3 Neutral,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49071,17,"After this class, I can demonstrate proper technique in latching a newborn and in hand expression.",160537,3,4 Agree,0
2549,ILT-0000-11950,LD RESIDENCY CLASS TWO ASSESSMENT AND NEWBORN FEEDING,n9665,49071,17,"After this class, I can demonstrate proper technique in latching a newborn and in hand expression.",160538,4,5 Strongly agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49148,0,The content was interesting to me.,160785,0,1. Strongly Disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49148,0,The content was interesting to me.,160786,1,2 Disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49148,0,The content was interesting to me.,160787,2,3 Neutral,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49148,0,The content was interesting to me.,160788,3,4 Agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49148,0,The content was interesting to me.,160789,4,5 Strongly Agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49149,1,The content expanded my knowledge of the topic.,160790,0,1 Strongly disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49149,1,The content expanded my knowledge of the topic.,160791,1,2 Disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49149,1,The content expanded my knowledge of the topic.,160792,2,3 Neutral,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49149,1,The content expanded my knowledge of the topic.,160793,3,4 Agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49149,1,The content expanded my knowledge of the topic.,160794,4,5 Strongly agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49150,2,The content was consistent with the objectives.,160795,0,1 Strongly disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49150,2,The content was consistent with the objectives.,160796,1,2 Disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49150,2,The content was consistent with the objectives.,160797,2,3 Neutral,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49150,2,The content was consistent with the objectives.,160798,3,4 Agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49150,2,The content was consistent with the objectives.,160799,4,5 Strongly agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49151,3,The content will help me do my job better.,160800,0,1 Strongly disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49151,3,The content will help me do my job better.,160801,1,2 Disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49151,3,The content will help me do my job better.,160802,2,3 Neutral,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49151,3,The content will help me do my job better.,160803,3,4 Agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49151,3,The content will help me do my job better.,160804,4,5 Strongly agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49152,4,The room and environment was conducive to learning.,160805,0,1 Strongly disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49152,4,The room and environment was conducive to learning.,160806,1,2 Disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49152,4,The room and environment was conducive to learning.,160807,2,3 Neutral,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49152,4,The room and environment was conducive to learning.,160808,3,4 Agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49152,4,The room and environment was conducive to learning.,160809,4,5 Strongly agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49153,5,Please rate instructor Jenny Flanagan: The material presented was clear and to the point.,160810,0,1 Strongly disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49153,5,Please rate instructor Jenny Flanagan: The material presented was clear and to the point.,160811,1,2 Disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49153,5,Please rate instructor Jenny Flanagan: The material presented was clear and to the point.,160812,2,3 Neutral,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49153,5,Please rate instructor Jenny Flanagan: The material presented was clear and to the point.,160813,3,4 Agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49153,5,Please rate instructor Jenny Flanagan: The material presented was clear and to the point.,160814,4,5 Strongly agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49154,6,Please rate instructor Jenny Flanagan: The presenter demonstrated mastery of the topic.,160815,0,1 Strongly disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49154,6,Please rate instructor Jenny Flanagan: The presenter demonstrated mastery of the topic.,160816,1,2 Disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49154,6,Please rate instructor Jenny Flanagan: The presenter demonstrated mastery of the topic.,160817,2,3 Neutral,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49154,6,Please rate instructor Jenny Flanagan: The presenter demonstrated mastery of the topic.,160818,3,4 Agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49154,6,Please rate instructor Jenny Flanagan: The presenter demonstrated mastery of the topic.,160819,4,5 Strongly agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49155,7,Please rate instructor Jenny Flanagan:  The method used to present the material was engaging and held my attention.,160820,0,1 Strongly disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49155,7,Please rate instructor Jenny Flanagan:  The method used to present the material was engaging and held my attention.,160821,1,2 Disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49155,7,Please rate instructor Jenny Flanagan:  The method used to present the material was engaging and held my attention.,160822,2,3 Neutral,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49155,7,Please rate instructor Jenny Flanagan:  The method used to present the material was engaging and held my attention.,160823,3,4 Agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49155,7,Please rate instructor Jenny Flanagan:  The method used to present the material was engaging and held my attention.,160824,4,5 Strongly agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49156,8,Please rate instructor Jenny Flanagan: The presenter was responsive to participant concerns.,160825,0,1 Strongly disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49156,8,Please rate instructor Jenny Flanagan: The presenter was responsive to participant concerns.,160826,1,2 Disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49156,8,Please rate instructor Jenny Flanagan: The presenter was responsive to participant concerns.,160827,2,3 Neutral,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49156,8,Please rate instructor Jenny Flanagan: The presenter was responsive to participant concerns.,160828,3,4 Agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49156,8,Please rate instructor Jenny Flanagan: The presenter was responsive to participant concerns.,160829,4,5 Strongly agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49158,9,"After this class, I can interpret baseline fetal heart rate, variability, accelerations, and decelerations",160830,0,1 Strongly disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49158,9,"After this class, I can interpret baseline fetal heart rate, variability, accelerations, and decelerations",160831,1,2 Disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49158,9,"After this class, I can interpret baseline fetal heart rate, variability, accelerations, and decelerations",160832,2,3 Neutral,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49158,9,"After this class, I can interpret baseline fetal heart rate, variability, accelerations, and decelerations",160833,3,4 Agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49158,9,"After this class, I can interpret baseline fetal heart rate, variability, accelerations, and decelerations",160834,4,5 Strongly agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49159,10,"After this class, I can differentiate between normal and abnormal contraction patterns.",160835,0,1 Strongly disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49159,10,"After this class, I can differentiate between normal and abnormal contraction patterns.",160836,1,2 Disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49159,10,"After this class, I can differentiate between normal and abnormal contraction patterns.",160837,2,3 Neutral,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49159,10,"After this class, I can differentiate between normal and abnormal contraction patterns.",160838,3,4 Agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49159,10,"After this class, I can differentiate between normal and abnormal contraction patterns.",160839,4,5 Strongly agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49160,11,After this class I can list the physiologic interventions to be employed for FHR tracings with an indeterminate or abnormal acid-base status.,160840,0,1 Strongly disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49160,11,After this class I can list the physiologic interventions to be employed for FHR tracings with an indeterminate or abnormal acid-base status.,160841,1,2 Disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49160,11,After this class I can list the physiologic interventions to be employed for FHR tracings with an indeterminate or abnormal acid-base status.,160842,2,3 Neutral,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49160,11,After this class I can list the physiologic interventions to be employed for FHR tracings with an indeterminate or abnormal acid-base status.,160843,3,4 Agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49160,11,After this class I can list the physiologic interventions to be employed for FHR tracings with an indeterminate or abnormal acid-base status.,160844,4,5 Strongly disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49161,12,"After this class, I can describe the determinants of uterine blood flow",160845,0,1 Strongly disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49161,12,"After this class, I can describe the determinants of uterine blood flow",160846,1,2 Disagree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49161,12,"After this class, I can describe the determinants of uterine blood flow",160847,2,3 Neutral,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49161,12,"After this class, I can describe the determinants of uterine blood flow",160848,3,4 Agree,0
2548,ILT-0000-11949,LD RESIDENCY CLASS THREE FETAL MONITORING,n9672,49161,12,"After this class, I can describe the determinants of uterine blood flow",160849,4,5 Strongly agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49162,0,The content was interesting to me.,160850,0,1. Strongly Disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49162,0,The content was interesting to me.,160851,1,2 Disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49162,0,The content was interesting to me.,160852,2,3 Neutral,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49162,0,The content was interesting to me.,160853,3,4 Agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49162,0,The content was interesting to me.,160854,4,5 Strongly Agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49163,1,The content expanded my knowledge of the topic.,160855,0,1 Strongly disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49163,1,The content expanded my knowledge of the topic.,160856,1,2 Disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49163,1,The content expanded my knowledge of the topic.,160857,2,3 Neutral,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49163,1,The content expanded my knowledge of the topic.,160858,3,4 Agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49163,1,The content expanded my knowledge of the topic.,160859,4,5 Strongly agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49164,2,The content was consistent with the objectives.,160860,0,1 Strongly disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49164,2,The content was consistent with the objectives.,160861,1,2 Disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49164,2,The content was consistent with the objectives.,160862,2,3 Neutral,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49164,2,The content was consistent with the objectives.,160863,3,4 Agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49164,2,The content was consistent with the objectives.,160864,4,5 Strongly agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49165,3,The content will help me do my job better.,160865,0,1 Strongly disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49165,3,The content will help me do my job better.,160866,1,2 Disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49165,3,The content will help me do my job better.,160867,2,3 Neutral,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49165,3,The content will help me do my job better.,160868,3,4 Agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49165,3,The content will help me do my job better.,160869,4,5 Strongly agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49166,4,The room and environment was conducive to learning.,160870,0,1 Strongly disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49166,4,The room and environment was conducive to learning.,160871,1,2 Disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49166,4,The room and environment was conducive to learning.,160872,2,3 Neutral,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49166,4,The room and environment was conducive to learning.,160873,3,4 Agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49166,4,The room and environment was conducive to learning.,160874,4,5 Strongly agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49167,5,Please rate instructor Kristen Foshee: The material presented was clear and to the point.,160875,0,1 Strongly disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49167,5,Please rate instructor Kristen Foshee: The material presented was clear and to the point.,160876,1,2 Disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49167,5,Please rate instructor Kristen Foshee: The material presented was clear and to the point.,160877,2,3 Neutral,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49167,5,Please rate instructor Kristen Foshee: The material presented was clear and to the point.,160878,3,4 Agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49167,5,Please rate instructor Kristen Foshee: The material presented was clear and to the point.,160879,4,5 Strongly agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49168,6,Please rate instructor Kristen Foshee: The presenter demonstrated mastery of the topic,160880,0,1 Strongly disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49168,6,Please rate instructor Kristen Foshee: The presenter demonstrated mastery of the topic,160881,1,2 Disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49168,6,Please rate instructor Kristen Foshee: The presenter demonstrated mastery of the topic,160882,2,3 Neutral,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49168,6,Please rate instructor Kristen Foshee: The presenter demonstrated mastery of the topic,160883,3,4 Agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49168,6,Please rate instructor Kristen Foshee: The presenter demonstrated mastery of the topic,160884,4,5 Strongly agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49169,7,Please rate instructor Kristen Foshee: The method used to present the material was engaging and held my attention.,160885,0,1 Strongly disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49169,7,Please rate instructor Kristen Foshee: The method used to present the material was engaging and held my attention.,160886,1,2 Disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49169,7,Please rate instructor Kristen Foshee: The method used to present the material was engaging and held my attention.,160887,2,3 Neutral,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49169,7,Please rate instructor Kristen Foshee: The method used to present the material was engaging and held my attention.,160888,3,4 Agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49169,7,Please rate instructor Kristen Foshee: The method used to present the material was engaging and held my attention.,160889,4,5 Strongly agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49170,8,Please rate instructor Kristen Foshee: The presenter was responsive to participant questions,160890,0,1 Strongly disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49170,8,Please rate instructor Kristen Foshee: The presenter was responsive to participant questions,160891,1,2 Disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49170,8,Please rate instructor Kristen Foshee: The presenter was responsive to participant questions,160892,2,3 Neutral,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49170,8,Please rate instructor Kristen Foshee: The presenter was responsive to participant questions,160893,3,4 Agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49170,8,Please rate instructor Kristen Foshee: The presenter was responsive to participant questions,160894,4,5 Strongly agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49172,9,"After this class, I can list 3 clinical manifestations of placental abruption, placenta previa, and uterine rupture.",160895,0,1 Strongly disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49172,9,"After this class, I can list 3 clinical manifestations of placental abruption, placenta previa, and uterine rupture.",160896,1,2 Disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49172,9,"After this class, I can list 3 clinical manifestations of placental abruption, placenta previa, and uterine rupture.",160897,2,3 Neutral,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49172,9,"After this class, I can list 3 clinical manifestations of placental abruption, placenta previa, and uterine rupture.",160898,3,4 Agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49172,9,"After this class, I can list 3 clinical manifestations of placental abruption, placenta previa, and uterine rupture.",160899,4,5 Strongly agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49173,10,"After this class, I can List 3 nursing actions for active postpartum hemorrhage",160900,0,1 Strongly disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49173,10,"After this class, I can List 3 nursing actions for active postpartum hemorrhage",160901,1,2 Disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49173,10,"After this class, I can List 3 nursing actions for active postpartum hemorrhage",160902,2,3 Neutral,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49173,10,"After this class, I can List 3 nursing actions for active postpartum hemorrhage",160903,3,4 Agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49173,10,"After this class, I can List 3 nursing actions for active postpartum hemorrhage",160904,4,5 Strongly agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49174,11,"After this class, I can verbalize what GBS prophylaxis to give to a mother who is penicillin-allergic.",160905,0,1 Strongly disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49174,11,"After this class, I can verbalize what GBS prophylaxis to give to a mother who is penicillin-allergic.",160906,1,2 Disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49174,11,"After this class, I can verbalize what GBS prophylaxis to give to a mother who is penicillin-allergic.",160907,2,3 Neutral,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49174,11,"After this class, I can verbalize what GBS prophylaxis to give to a mother who is penicillin-allergic.",160908,3,4 Agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49174,11,"After this class, I can verbalize what GBS prophylaxis to give to a mother who is penicillin-allergic.",160909,4,5 Strongly agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49175,13,After this class I can summarize the physiology of thermoregulation of the newborn,160910,0,1 Strongly disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49175,13,After this class I can summarize the physiology of thermoregulation of the newborn,160911,1,2 Disagree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49175,13,After this class I can summarize the physiology of thermoregulation of the newborn,160912,2,3 Neutral,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49175,13,After this class I can summarize the physiology of thermoregulation of the newborn,160913,3,4 Agree,0
2545,ILT-0000-11946,LD RESIDENCY CLASS FOUR ADVANCED LABOR TOPICS,n9673,49175,13,After this class I can summarize the physiology of thermoregulation of the newborn,160914,4,5 Strongly agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49176,0,The content was interesting to me.,160915,0,1. Strongly Disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49176,0,The content was interesting to me.,160916,1,2 Disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49176,0,The content was interesting to me.,160917,2,3 Neutral,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49176,0,The content was interesting to me.,160918,3,4 Agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49176,0,The content was interesting to me.,160919,4,5 Strongly Agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49177,1,The content expanded my knowledge of the topic.,160920,0,1 Strongly disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49177,1,The content expanded my knowledge of the topic.,160921,1,2 Disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49177,1,The content expanded my knowledge of the topic.,160922,2,3 Neutral,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49177,1,The content expanded my knowledge of the topic.,160923,3,4 Agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49177,1,The content expanded my knowledge of the topic.,160924,4,5 Strongly agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49178,2,The content was consistent with the objectives.,160925,0,1 Strongly disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49178,2,The content was consistent with the objectives.,160926,1,2 Disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49178,2,The content was consistent with the objectives.,160927,2,3 Neutral,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49178,2,The content was consistent with the objectives.,160928,3,4 Agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49178,2,The content was consistent with the objectives.,160929,4,5 Strongly agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49179,3,The content will help me do my job better.,160930,0,1 Strongly disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49179,3,The content will help me do my job better.,160931,1,2 Disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49179,3,The content will help me do my job better.,160932,2,3 Neutral,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49179,3,The content will help me do my job better.,160933,3,4 Agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49179,3,The content will help me do my job better.,160934,4,5 Strongly agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49180,4,The room and environment was conducive to learning.,160935,0,1 Strongly disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49180,4,The room and environment was conducive to learning.,160936,1,2 Disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49180,4,The room and environment was conducive to learning.,160937,2,3 Neutral,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49180,4,The room and environment was conducive to learning.,160938,3,4 Agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49180,4,The room and environment was conducive to learning.,160939,4,5 Strongly agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49181,5,Please rate instructor Brooke Wynn: The material presented was clear and to the point.,160940,0,1 Strongly disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49181,5,Please rate instructor Brooke Wynn: The material presented was clear and to the point.,160941,1,2 Disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49181,5,Please rate instructor Brooke Wynn: The material presented was clear and to the point.,160942,2,3 Neutral,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49181,5,Please rate instructor Brooke Wynn: The material presented was clear and to the point.,160943,3,4 Agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49181,5,Please rate instructor Brooke Wynn: The material presented was clear and to the point.,160944,4,5 Strongly agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49182,6,Please rate instructor Brooke Wynn: The presenter demonstrated mastery of the topic.,160945,0,1 Strongly disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49182,6,Please rate instructor Brooke Wynn: The presenter demonstrated mastery of the topic.,160946,1,2 Disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49182,6,Please rate instructor Brooke Wynn: The presenter demonstrated mastery of the topic.,160947,2,3 Neutral,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49182,6,Please rate instructor Brooke Wynn: The presenter demonstrated mastery of the topic.,160948,3,4 Agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49182,6,Please rate instructor Brooke Wynn: The presenter demonstrated mastery of the topic.,160949,4,5 Strongly agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49183,7,Please rate instructor Brooke Wynn The method used to present the material was engaging and held my attention.,160950,0,1 Strongly disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49183,7,Please rate instructor Brooke Wynn The method used to present the material was engaging and held my attention.,160951,1,2 Disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49183,7,Please rate instructor Brooke Wynn The method used to present the material was engaging and held my attention.,160952,2,3 Neutral,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49183,7,Please rate instructor Brooke Wynn The method used to present the material was engaging and held my attention.,160953,3,4 Agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49183,7,Please rate instructor Brooke Wynn The method used to present the material was engaging and held my attention.,160954,4,5 Strongly agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49184,8,Please rate instructor Brooke Wynn: The presenter was responsive to participant concerns.,160955,0,1 Strongly disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49184,8,Please rate instructor Brooke Wynn: The presenter was responsive to participant concerns.,160956,1,2 Disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49184,8,Please rate instructor Brooke Wynn: The presenter was responsive to participant concerns.,160957,2,3 Neutral,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49184,8,Please rate instructor Brooke Wynn: The presenter was responsive to participant concerns.,160958,3,4 Agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49184,8,Please rate instructor Brooke Wynn: The presenter was responsive to participant concerns.,160959,4,5 Strongly agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49186,9,"After this class, I can discuss the signs and symptoms of preterm labor",160960,0,1 Strongly disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49186,9,"After this class, I can discuss the signs and symptoms of preterm labor",160961,1,2 Disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49186,9,"After this class, I can discuss the signs and symptoms of preterm labor",160962,2,3 Neutral,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49186,9,"After this class, I can discuss the signs and symptoms of preterm labor",160963,3,4 Agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49186,9,"After this class, I can discuss the signs and symptoms of preterm labor",160964,4,5 Strongly disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49187,10,Relate the underlying pathophysiology of preeclampsia to the organ system involvement.,160965,0,1 Strongly disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49187,10,Relate the underlying pathophysiology of preeclampsia to the organ system involvement.,160966,1,2 Disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49187,10,Relate the underlying pathophysiology of preeclampsia to the organ system involvement.,160967,2,3 Neutral,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49187,10,Relate the underlying pathophysiology of preeclampsia to the organ system involvement.,160968,3,4 Agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49187,10,Relate the underlying pathophysiology of preeclampsia to the organ system involvement.,160969,4,5 Strongly agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49188,11,"After this class, I can describe the strategy for confirming that different fetuses are being monitored with multiple gestation.",160970,0,1 Strongly disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49188,11,"After this class, I can describe the strategy for confirming that different fetuses are being monitored with multiple gestation.",160971,1,2 Disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49188,11,"After this class, I can describe the strategy for confirming that different fetuses are being monitored with multiple gestation.",160972,2,3 Neutral,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49188,11,"After this class, I can describe the strategy for confirming that different fetuses are being monitored with multiple gestation.",160973,3,4 Agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49188,11,"After this class, I can describe the strategy for confirming that different fetuses are being monitored with multiple gestation.",160974,4,5 Strongly agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49189,12,"After this class, I can list 3 complications of diabetes",160975,0,1 Strongly agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49189,12,"After this class, I can list 3 complications of diabetes",160976,1,2 Disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49189,12,"After this class, I can list 3 complications of diabetes",160977,2,3 Neutral,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49189,12,"After this class, I can list 3 complications of diabetes",160978,3,4 Agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49189,12,"After this class, I can list 3 complications of diabetes",160979,4,5 Strongly agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49190,13,"After this class, I can calculate insulin dosages for an IV drip and a pen.",160980,0,1 Strongly disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49190,13,"After this class, I can calculate insulin dosages for an IV drip and a pen.",160981,1,2 Disagree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49190,13,"After this class, I can calculate insulin dosages for an IV drip and a pen.",160982,2,3 Neutral,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49190,13,"After this class, I can calculate insulin dosages for an IV drip and a pen.",160983,3,4 Agree,0
2544,ILT-0000-11945,LD RESIDENCY CLASS FIVE HIGH RISK TOPICS,n9674,49190,13,"After this class, I can calculate insulin dosages for an IV drip and a pen.",160984,4,5 Strongly disagree,0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49249,0,"Which of the following treatments can be used for C. diff initial episodes, severe and non-severe?",161205,0,"a.	Vancomycin 125mg po QID x 10 days",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49249,0,"Which of the following treatments can be used for C. diff initial episodes, severe and non-severe?",161206,1,"b.	Fidaxomicin 200mg po BID x 10 days",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49249,0,"Which of the following treatments can be used for C. diff initial episodes, severe and non-severe?",161207,2,"c.	Metronidazole 500mg po TID x 10 days",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49249,0,"Which of the following treatments can be used for C. diff initial episodes, severe and non-severe?",161208,3,"d.	A and B",1
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49249,0,"Which of the following treatments can be used for C. diff initial episodes, severe and non-severe?",161209,4,"e.	All of the above",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49250,1,Which of the following treatments may be used for fulminant C. diff?,161210,0,"a.	Vancomycin 500mg PO/Per tube QID",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49250,1,Which of the following treatments may be used for fulminant C. diff?,161211,1,"b.	Metronidazole 500mg IV Q8H",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49250,1,Which of the following treatments may be used for fulminant C. diff?,161212,2,"c.	If ileus, consider Vancomycin enemas",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49250,1,Which of the following treatments may be used for fulminant C. diff?,161213,3,"d.	All of the above are appropriate in fulminant C. diff",1
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49251,2,What are some risk factors for patients to acquire C. diff?,161214,0,"a.	Antibiotic exposure",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49251,2,What are some risk factors for patients to acquire C. diff?,161215,1,"b.	Extended stays in healthcare settings",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49251,2,What are some risk factors for patients to acquire C. diff?,161216,2,"c.	Any manipulation of the GI tract including bowel prep and tube feedings",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49251,2,What are some risk factors for patients to acquire C. diff?,161217,3,"d.	All of the above",1
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49252,3,Which of the following patients are appropriate to test for C. diff?,161218,0,"a.	54 year old female with history of C. diff with no diarrhea who wants her stool tested to see if she is cured of C. diff.",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49252,3,Which of the following patients are appropriate to test for C. diff?,161219,1,"b.	38 year old male admitted with abdominal pain, liquid diarrhea 10 times per day, WBCs = 15,000, and recently took augmentin 2 months ago for a sinus infection.",1
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49252,3,Which of the following patients are appropriate to test for C. diff?,161220,2,"c.	ICU patient from the VA who hasn't had a BM in 7 days is given Relistor and has massive stool that smells like C. diff.",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49252,3,Which of the following patients are appropriate to test for C. diff?,161221,3,"d.	All of the above",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49253,4,Where can you find C. diff testing results in Cerner?,161222,0,"a.	Microbiology viewer",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49253,4,Where can you find C. diff testing results in Cerner?,161223,1,"b.	Form Browser",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49253,4,Where can you find C. diff testing results in Cerner?,161224,2,"c.	Documentation",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49253,4,Where can you find C. diff testing results in Cerner?,161225,3,"d.	Results Review>Lab extended>Microbiology PCR or Microbiology miscellaneous",1
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49254,5,What statement is true about Bezlotoxumab (Zinplava) administration at Northside Hospital?,161226,0,"a.	Zinplava does not require an Infectious Disease Consult.",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49254,5,What statement is true about Bezlotoxumab (Zinplava) administration at Northside Hospital?,161227,1,"b.	Zinplava requires an ID physician consult and must be reviewed by the ID pharmacist prior to administration.",1
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49254,5,What statement is true about Bezlotoxumab (Zinplava) administration at Northside Hospital?,161228,2,"c.	Zinplava is administered alone for the treatment of C. diff.",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49254,5,What statement is true about Bezlotoxumab (Zinplava) administration at Northside Hospital?,161229,3,"d.	Zinplava must always be treated as a STAT medication.",0
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49255,6,"Northside hospital has a C. diff power plan in cerner to guide practitioners on the most appropriate C. diff treatment.  Pharmacists are consulted to discontinue all scheduled laxatives, stool softeners, anti-motility agents, and binding agents.",161230,0,TRUE,1
9533,Elearning-0000-761,FY20 PHARMACY C DIFF EDUCATION,n9683,49255,6,"Northside hospital has a C. diff power plan in cerner to guide practitioners on the most appropriate C. diff treatment.  Pharmacists are consulted to discontinue all scheduled laxatives, stool softeners, anti-motility agents, and binding agents.",161231,1,FALSE,0
9467,Elearning-0000-701,CLEFT LIP & PALATE 2020,n9687,49329,0,"How many babies are born annually with a cleft lip, with or without a palate defect?",161534,0,"a.	3500",0
9467,Elearning-0000-701,CLEFT LIP & PALATE 2020,n9687,49329,0,"How many babies are born annually with a cleft lip, with or without a palate defect?",161535,1,"b.	7000",1
9467,Elearning-0000-701,CLEFT LIP & PALATE 2020,n9687,49329,0,"How many babies are born annually with a cleft lip, with or without a palate defect?",161536,2,"c.	6000",0
9467,Elearning-0000-701,CLEFT LIP & PALATE 2020,n9687,49329,0,"How many babies are born annually with a cleft lip, with or without a palate defect?",161537,3,"d.	2000",0
9467,Elearning-0000-701,CLEFT LIP & PALATE 2020,n9687,49330,1,True or false: A baby with a cleft palate is able to exclusively breastfeed?,161538,0,TRUE,0
9467,Elearning-0000-701,CLEFT LIP & PALATE 2020,n9687,49330,1,True or false: A baby with a cleft palate is able to exclusively breastfeed?,161539,1,FALSE,1
9467,Elearning-0000-701,CLEFT LIP & PALATE 2020,n9687,49331,2,What is a disadvantage or con of using the Medela SNF (Haberman) bottle?,161540,0,"a.	Difficult to clean and sterilize",1
9467,Elearning-0000-701,CLEFT LIP & PALATE 2020,n9687,49331,2,What is a disadvantage or con of using the Medela SNF (Haberman) bottle?,161541,1,"b.	Only system to allow assist-delivery",0
9467,Elearning-0000-701,CLEFT LIP & PALATE 2020,n9687,49331,2,What is a disadvantage or con of using the Medela SNF (Haberman) bottle?,161542,2,"c.	Has variable flow rate controlled by the feeder",0
9467,Elearning-0000-701,CLEFT LIP & PALATE 2020,n9687,49331,2,What is a disadvantage or con of using the Medela SNF (Haberman) bottle?,161543,3,"d.	They have a smaller teat for premature infants",0
9467,Elearning-0000-701,CLEFT LIP & PALATE 2020,n9687,49332,3,What surgery may be done before the child reaches school age?,161544,0,"a.	Final repairs to the lip or palate",0
9467,Elearning-0000-701,CLEFT LIP & PALATE 2020,n9687,49332,3,What surgery may be done before the child reaches school age?,161545,1,"b.	Repair of scar tissue",0
9467,Elearning-0000-701,CLEFT LIP & PALATE 2020,n9687,49332,3,What surgery may be done before the child reaches school age?,161546,2,"c.	Upper gum repair using a bone graft",0
9467,Elearning-0000-701,CLEFT LIP & PALATE 2020,n9687,49332,3,What surgery may be done before the child reaches school age?,161547,3,"d.	Nasal tip reconstruction and a revision of the lip scar",1
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49303,0,Please list the location for this activity.,161425,0,Atlanta,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49303,0,Please list the location for this activity.,161426,1,Forsyth,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49303,0,Please list the location for this activity.,161427,2,Cherokee,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49303,0,Please list the location for this activity.,161428,3,Other,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49304,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of "" Life is Why "" campaign by AHA. </ol>",161429,0,Strongly Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49304,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of "" Life is Why "" campaign by AHA. </ol>",161430,1,Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49304,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of "" Life is Why "" campaign by AHA. </ol>",161431,2,No Opinion,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49304,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of "" Life is Why "" campaign by AHA. </ol>",161432,3,Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49304,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of "" Life is Why "" campaign by AHA. </ol>",161433,4,Strongly Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49305,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",161434,0,Strongly Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49305,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",161435,1,Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49305,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",161436,2,No Opinion,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49305,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",161437,3,Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49305,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",161438,4,Strongly Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49306,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",161439,0,Strongly Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49306,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",161440,1,Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49306,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",161441,2,No Opinion,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49306,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",161442,3,Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49306,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",161443,4,Strongly Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49307,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",161444,0,Strongly Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49307,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",161445,1,Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49307,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",161446,2,No Opinion,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49307,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",161447,3,Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49307,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",161448,4,Strongly Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49308,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",161449,0,Strongly Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49308,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",161450,1,Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49308,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",161451,2,No Opinion,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49308,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",161452,3,Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49308,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",161453,4,Strongly Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49309,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",161454,0,Strongly Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49309,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",161455,1,Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49309,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",161456,2,No Opinion,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49309,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",161457,3,Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49309,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",161458,4,Strongly Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49310,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",161459,0,Strongly Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49310,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",161460,1,Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49310,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",161461,2,No Opinion,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49310,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",161462,3,Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49310,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",161463,4,Strongly Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49311,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",161464,0,Strongly Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49311,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",161465,1,Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49311,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",161466,2,No Opinion,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49311,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",161467,3,Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49311,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",161468,4,Strongly Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49312,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",161469,0,Strongly Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49312,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",161470,1,Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49312,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",161471,2,No Opinion,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49312,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",161472,3,Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49312,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",161473,4,Strongly Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49313,10,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",161474,0,Strongly Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49313,10,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",161475,1,Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49313,10,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",161476,2,No Opinion,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49313,10,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",161477,3,Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49313,10,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",161478,4,Strongly Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49314,11,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",161479,0,Strongly Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49314,11,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",161480,1,Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49314,11,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",161481,2,No Opinion,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49314,11,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",161482,3,Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49314,11,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",161483,4,Strongly Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49315,12,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",161484,0,Strongly Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49315,12,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",161485,1,Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49315,12,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",161486,2,No Opinion,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49315,12,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",161487,3,Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49315,12,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",161488,4,Strongly Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49316,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,161489,0,Strongly Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49316,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,161490,1,Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49316,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,161491,2,No Opinion,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49316,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,161492,3,Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49316,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,161493,4,Strongly Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49317,14,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",161494,0,Strongly Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49317,14,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",161495,1,Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49317,14,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",161496,2,No Opinion,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49317,14,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",161497,3,Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49317,14,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",161498,4,Strongly Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49318,15,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,161499,0,Strongly Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49318,15,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,161500,1,Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49318,15,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,161501,2,No Opinion,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49318,15,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,161502,3,Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49318,15,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,161503,4,Strongly Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49319,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,161504,0,Strongly Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49319,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,161505,1,Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49319,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,161506,2,No Opinion,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49319,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,161507,3,Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49319,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,161508,4,Strongly Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49320,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,161509,0,Strongly Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49320,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,161510,1,Agree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49320,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,161511,2,No Opinion,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49320,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,161512,3,Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49320,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,161513,4,Strongly Disagree,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49321,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN</ol>",161514,0,Excellent,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49321,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN</ol>",161515,1,Very Good,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49321,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN</ol>",161516,2,Good,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49321,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN</ol>",161517,3,Fair,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49321,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN</ol>",161518,4,Poor,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49322,19,"Overall, this activity was:",161519,0,Excellent,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49322,19,"Overall, this activity was:",161520,1,Very Good,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49322,19,"Overall, this activity was:",161521,2,Good,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49322,19,"Overall, this activity was:",161522,3,Fair,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49322,19,"Overall, this activity was:",161523,4,Poor,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49323,20,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",161524,0,Yes,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49323,20,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",161525,1,No,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49323,20,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",161526,2,N/A,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49326,23,How would you improve this class?,161527,0,Reduce content covered in class,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49326,23,How would you improve this class?,161528,1,Increase content covered in class,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49326,23,How would you improve this class?,161529,2,Update content covered in class,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49326,23,How would you improve this class?,161530,3,Improve the instructional methods,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49326,23,How would you improve this class?,161531,4,Make course activities more stimulating,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49326,23,How would you improve this class?,161532,5,Slow the pace of the class,0
9870,Questions-0000-16,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020",n9686,49326,23,How would you improve this class?,161533,6,"Other: (No changes needed; appropriate speaker, content, handouts, etc.)",0
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49399,0,The Court order should be provided by the attorney to the legal department prior to the surrogates admission to the hospital.,161803,0,TRUE,1
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49399,0,The Court order should be provided by the attorney to the legal department prior to the surrogates admission to the hospital.,161804,1,FALSE,0
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49400,1,The surrogate signs the consents for the infant(s).,161805,0,"A.	True",0
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49400,1,The surrogate signs the consents for the infant(s).,161806,1,"B.	False",0
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49400,1,The surrogate signs the consents for the infant(s).,161807,2,"C.	Only in the event that the court order is not yet on file.",0
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49400,1,The surrogate signs the consents for the infant(s).,161808,3,"D.	Only if the court order is not on file and she has not signed a POA for the infant(s).",1
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49401,2,The baby bands are placed on ________,161809,0,"A.	The surrogate and one legal parent",0
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49401,2,The baby bands are placed on ________,161810,1,"B.	The legal parents",1
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49401,2,The baby bands are placed on ________,161811,2,"C.	The surrogate",0
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49402,3,If the legal parents are not in the hospital at the time of birth what is done with the bands?,161812,0,"A.	The surrogate receives both bands until the legal parents arrival, at which time one band is removed and placed on one of the legal parents.",0
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49402,3,If the legal parents are not in the hospital at the time of birth what is done with the bands?,161813,1,"B.	The surrogate receives both bands and they remain in place until her discharge.",0
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49402,3,If the legal parents are not in the hospital at the time of birth what is done with the bands?,161814,2,"C.	The surrogate receives both bands until the legal parents arrival, at which time her bands are removed and the legal parents are banded.",1
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49403,4,Once the baby(s) are banded they are admitted in _____________.,161815,0,"A.	The surrogates room",0
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49403,4,Once the baby(s) are banded they are admitted in _____________.,161816,1,"B.	The Nursery",0
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49403,4,Once the baby(s) are banded they are admitted in _____________.,161817,2,"C.	The Nursery, unless the legal parents request for the baby to remain in the surrogates room.",1
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49404,5,Visitation with the baby by the surrogate_________________.,161818,0,"A.	Is at the discretion of the legal parents in the nursery.",0
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49404,5,Visitation with the baby by the surrogate_________________.,161819,1,"B.	Is at the discretion of the legal parents in their room.",0
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49404,5,Visitation with the baby by the surrogate_________________.,161820,2,"C.	Is at the discretion of the legal parents in the surrogates room.",0
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49404,5,Visitation with the baby by the surrogate_________________.,161821,3,D. Both A & B,1
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49405,6,Can the surrogate bring her family in to see the infant(s)?,161822,0,"A.	Yes",0
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49405,6,Can the surrogate bring her family in to see the infant(s)?,161823,1,"B.	No",0
9111,Elearning-0000-378,NSC LD - SURROGACY IN LD,n9694,49405,6,Can the surrogate bring her family in to see the infant(s)?,161824,2,"C.	Only with the permission of the legal parents",1
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49423,0,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Care Coordination:,161897,0,No needs identified,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49423,0,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Care Coordination:,161898,1,Adolescent 17 years or younger,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49423,0,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Care Coordination:,161899,2,Identify need for community resources,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49423,0,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Care Coordination:,161900,3,Pt/neonate with possible alcohol/drug screen,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49423,0,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Care Coordination:,161901,4,Pt verbalizes drug use during pregnancy,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49423,0,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Care Coordination:,161902,5,Both A and B,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49423,0,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Care Coordination:,161903,6,"B, D and E",1
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49423,0,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Care Coordination:,161904,7,All of the above,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49424,1,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Behavioral Health:,161905,0,No needs identified,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49424,1,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Behavioral Health:,161906,1,Substance abuse,1
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49424,1,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Behavioral Health:,161907,2,Displays disorientation inconsistent with diagnosis,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49424,1,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Behavioral Health:,161908,3,Displays delusional/disorganized thinking,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49424,1,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Behavioral Health:,161909,4,Receiving outpatient Mental Health Services,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49424,1,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Behavioral Health:,161910,5,Active suicidal/homicidal thoughts or plans,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49424,1,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Behavioral Health:,161911,6,Pt has experienced catastrophic diagnosis,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49424,1,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Behavioral Health:,161912,7,Depressed mood,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49424,1,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Behavioral Health:,161913,8,Prominent anxiety,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49425,2,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Physical Therapy:,161914,0,No needs identified,1
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49425,2,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Physical Therapy:,161915,1,"Decline in gait, transfer, balance, or mobility skills",0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49425,2,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Physical Therapy:,161916,2,"Decrease in strength, ROM or endurance",0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49425,2,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Physical Therapy:,161917,3,Acute increase in musculoskeletal pain,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49426,3,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Occupational Therapy:,161918,0,No needs identified,1
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49426,3,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Occupational Therapy:,161919,1,Adaptive equipment,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49426,3,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Occupational Therapy:,161920,2,Diminishing self care,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49426,3,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Occupational Therapy:,161921,3,Impaired movement UE,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49426,3,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Occupational Therapy:,161922,4,Impaired movement LE,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49426,3,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Occupational Therapy:,161923,5,Unable to dress,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49426,3,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Occupational Therapy:,161924,6,Unable to feed,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49427,4,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Clinical Nutrition:,161925,0,No needs identified,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49427,4,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Clinical Nutrition:,161926,1,Multiple gestation,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49427,4,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Clinical Nutrition:,161927,2,Excessive weight gain,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49427,4,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Clinical Nutrition:,161928,3,Progressive weight loss,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49427,4,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Clinical Nutrition:,161929,4,Pregnant less than 17 years old,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49427,4,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Clinical Nutrition:,161930,5,All of the above,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49427,4,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Clinical Nutrition:,161931,6,Only B and E,1
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49428,5,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Diabetes Education:,161932,0,No needs identified,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49428,5,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Diabetes Education:,161933,1,Diabetic Ketoacidosis,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49428,5,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Diabetes Education:,161934,2,Gestational Diabetes Mellitus,1
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49428,5,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Diabetes Education:,161935,3,Pre Diabetes,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49428,5,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Diabetes Education:,161936,4,PCOS,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49428,5,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Diabetes Education:,161937,5,Type 1 Diabetes Mellitus,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49428,5,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Diabetes Education:,161938,6,Type 2 Diabetes Mellitus,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49429,6,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Respiratory Therapy:,161939,0,No needs identified,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49429,6,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Respiratory Therapy:,161940,1,CPAP check,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49429,6,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Respiratory Therapy:,161941,2,CPAP order,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49429,6,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Respiratory Therapy:,161942,3,Smoking cessation,1
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49430,7,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Pastoral Care:,161943,0,No needs identified,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49430,7,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Pastoral Care:,161944,1,Perinatal loss,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49430,7,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Pastoral Care:,161945,2,Newborn with congenital anomaly,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49430,7,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Pastoral Care:,161946,3,Pt/family request,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49430,7,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Pastoral Care:,161947,4,Pt/family experiencing spiritual distress,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49430,7,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Pastoral Care:,161948,5,Pt/family experiencing catastrophic diagnosis,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49430,7,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Pastoral Care:,161949,6,Newborn for adoption,1
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49431,8,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Lactation:,161950,0,No needs identified,1
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49431,8,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Lactation:,161951,1,History of breast surgery/biopsy,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49432,9,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Pharmacy:,161952,0,No needs identified,1
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49432,9,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for Consults/Referrals on admission. Select all that apply to Pharmacy:,161953,1,Medication Education,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49433,10,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Tdap vaccine on discharge. Patricia states she received the Tdap vaccine at 30 weeks gestation in the office. You confirm this is true on her prenatal record. Make the appropriate selection for the screening.,161954,0,No history of receiving Tdap vaccine this pregnancy AND patient is pregnant between 27 and 0/7 weeks and 38 and 0/7 weeks,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49433,10,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Tdap vaccine on discharge. Patricia states she received the Tdap vaccine at 30 weeks gestation in the office. You confirm this is true on her prenatal record. Make the appropriate selection for the screening.,161955,1,Patient is currently pregnant at 26 and 6/7 weeks gestation or earlier,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49433,10,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Tdap vaccine on discharge. Patricia states she received the Tdap vaccine at 30 weeks gestation in the office. You confirm this is true on her prenatal record. Make the appropriate selection for the screening.,161956,2,Patient is currently pregnant at 38 and 1/7 weeks or greater,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49433,10,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Tdap vaccine on discharge. Patricia states she received the Tdap vaccine at 30 weeks gestation in the office. You confirm this is true on her prenatal record. Make the appropriate selection for the screening.,161957,3,Has received Tdap vaccine this pregnancy,1
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49433,10,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Tdap vaccine on discharge. Patricia states she received the Tdap vaccine at 30 weeks gestation in the office. You confirm this is true on her prenatal record. Make the appropriate selection for the screening.,161958,4,"History of previous serious reaction to tetanus, diphtheria, or pertussis vaccine",0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49433,10,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Tdap vaccine on discharge. Patricia states she received the Tdap vaccine at 30 weeks gestation in the office. You confirm this is true on her prenatal record. Make the appropriate selection for the screening.,161959,5,Patient educated but declines vaccine,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49434,11,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Influenza vaccine on discharge. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,161960,0,No history of immunization this flu season (October1-March 31),0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49434,11,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Influenza vaccine on discharge. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,161961,1,Patient uncertain of history of immunization unreliable this flu season (October 1- March 31),0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49434,11,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Influenza vaccine on discharge. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,161962,2,Not currently flu Season (April 1- September 30),1
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49434,11,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Influenza vaccine on discharge. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,161963,3,Previously immunized this flu season,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49434,11,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Influenza vaccine on discharge. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,161964,4,Anaphylactic reaction to eggs,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49434,11,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Influenza vaccine on discharge. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,161965,5,History of Guillain Barre Syndrome,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49434,11,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Influenza vaccine on discharge. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,161966,6,Bone marrow transplant within last 6 months,0
9769,Elearning-0000-976,NSF PRETERM LABOR COMPETENCY 2019-2020,n9700,49434,11,You are completing the antepartum portion of patient Patricia Peterson's OB Screening for the Influenza vaccine on discharge. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,161967,7,Patient educated but declines vaccine,0
8120,Elearning-0000-1018,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT,n9706,49570,0,What is <b><u>NOT</u></b> a component of a shunt system for Hydrocephalus?,162431,0,"1.	A valve mechanism",0
8120,Elearning-0000-1018,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT,n9706,49570,0,What is <b><u>NOT</u></b> a component of a shunt system for Hydrocephalus?,162432,1,"2.	An IV catheter",1
8120,Elearning-0000-1018,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT,n9706,49570,0,What is <b><u>NOT</u></b> a component of a shunt system for Hydrocephalus?,162433,2,"3.	An outflow or distal catheter",0
8120,Elearning-0000-1018,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT,n9706,49570,0,What is <b><u>NOT</u></b> a component of a shunt system for Hydrocephalus?,162434,3,"4.	An inflow or proximal catheter",0
8120,Elearning-0000-1018,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT,n9706,49571,1,What are complications of a shunt placement?,162435,0,"1.	Malfunction",0
8120,Elearning-0000-1018,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT,n9706,49571,1,What are complications of a shunt placement?,162436,1,"2.	Infection",0
8120,Elearning-0000-1018,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT,n9706,49571,1,What are complications of a shunt placement?,162437,2,"3.	Material Degradation",0
8120,Elearning-0000-1018,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT,n9706,49571,1,What are complications of a shunt placement?,162438,3,"4.	Seizures",0
8120,Elearning-0000-1018,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT,n9706,49571,1,What are complications of a shunt placement?,162439,4,"5.	All of the above",1
8120,Elearning-0000-1018,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT,n9706,49572,2,"A patient presenting to the ED with vomiting, headache, vision problems. Lethargy, irritability and new onset of gait problems, he had a VP shunt placed 6 month ago after a subarachnoid hemorrhage. Do you expect one of the differential diagnosis to be <i>shunt malfunction</i>?",162440,0,1. Yes,1
8120,Elearning-0000-1018,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT,n9706,49572,2,"A patient presenting to the ED with vomiting, headache, vision problems. Lethargy, irritability and new onset of gait problems, he had a VP shunt placed 6 month ago after a subarachnoid hemorrhage. Do you expect one of the differential diagnosis to be <i>shunt malfunction</i>?",162441,1,2. No,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49688,0,Please list the location for this activity.,162892,0,Atlanta,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49688,0,Please list the location for this activity.,162893,1,Forsyth,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49688,0,Please list the location for this activity.,162894,2,Cherokee,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49688,0,Please list the location for this activity.,162895,3,Other,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49689,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the American Heart Association  "" Life is Why "" campaign. </ol>",162896,0,Strongly Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49689,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the American Heart Association  "" Life is Why "" campaign. </ol>",162897,1,Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49689,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the American Heart Association  "" Life is Why "" campaign. </ol>",162898,2,No Opinion,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49689,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the American Heart Association  "" Life is Why "" campaign. </ol>",162899,3,Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49689,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the American Heart Association  "" Life is Why "" campaign. </ol>",162900,4,Strongly Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49690,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe major PALS science changes in 2015. </ol>",162901,0,Strongly Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49690,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe major PALS science changes in 2015. </ol>",162902,1,Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49690,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe major PALS science changes in 2015. </ol>",162903,2,No Opinion,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49690,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe major PALS science changes in 2015. </ol>",162904,3,Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49690,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe major PALS science changes in 2015. </ol>",162905,4,Strongly Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49691,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to perform pediatric assessment to include primary and secondary assessment. </ol>",162906,0,Strongly Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49691,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to perform pediatric assessment to include primary and secondary assessment. </ol>",162907,1,Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49691,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to perform pediatric assessment to include primary and secondary assessment. </ol>",162908,2,No Opinion,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49691,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to perform pediatric assessment to include primary and secondary assessment. </ol>",162909,3,Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49691,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to perform pediatric assessment to include primary and secondary assessment. </ol>",162910,4,Strongly Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49692,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early management of peri - arrest conditions that may result in respiratory/cardiac arrest or complicate resuscitation outcomes. </ol>",162911,0,Strongly Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49692,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early management of peri - arrest conditions that may result in respiratory/cardiac arrest or complicate resuscitation outcomes. </ol>",162912,1,Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49692,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early management of peri - arrest conditions that may result in respiratory/cardiac arrest or complicate resuscitation outcomes. </ol>",162913,2,No Opinion,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49692,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early management of peri - arrest conditions that may result in respiratory/cardiac arrest or complicate resuscitation outcomes. </ol>",162914,3,Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49692,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early management of peri - arrest conditions that may result in respiratory/cardiac arrest or complicate resuscitation outcomes. </ol>",162915,4,Strongly Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49693,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",162916,0,Strongly Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49693,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",162917,1,Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49693,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",162918,2,No Opinion,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49693,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",162919,3,Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49693,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",162920,4,Strongly Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49694,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the four categories of respiratory issues in the pediatric population along with causes, signs and symptoms of different respiratory disorders as well as management.</ol>",162921,0,Strongly Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49694,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the four categories of respiratory issues in the pediatric population along with causes, signs and symptoms of different respiratory disorders as well as management.</ol>",162922,1,Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49694,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the four categories of respiratory issues in the pediatric population along with causes, signs and symptoms of different respiratory disorders as well as management.</ol>",162923,2,No Opinion,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49694,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the four categories of respiratory issues in the pediatric population along with causes, signs and symptoms of different respiratory disorders as well as management.</ol>",162924,3,Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49694,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the four categories of respiratory issues in the pediatric population along with causes, signs and symptoms of different respiratory disorders as well as management.</ol>",162925,4,Strongly Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49695,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the four categories of shock seen in pediatric patients to include causes, signs and symptoms and management of the different types of shock.</ol>",162926,0,Strongly Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49695,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the four categories of shock seen in pediatric patients to include causes, signs and symptoms and management of the different types of shock.</ol>",162927,1,Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49695,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the four categories of shock seen in pediatric patients to include causes, signs and symptoms and management of the different types of shock.</ol>",162928,2,No Opinion,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49695,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the four categories of shock seen in pediatric patients to include causes, signs and symptoms and management of the different types of shock.</ol>",162929,3,Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49695,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the four categories of shock seen in pediatric patients to include causes, signs and symptoms and management of the different types of shock.</ol>",162930,4,Strongly Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49696,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe compensated versus uncompensated shock.</ol>",162931,0,Strongly Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49696,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe compensated versus uncompensated shock.</ol>",162932,1,Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49696,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe compensated versus uncompensated shock.</ol>",162933,2,No Opinion,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49696,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe compensated versus uncompensated shock.</ol>",162934,3,Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49696,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe compensated versus uncompensated shock.</ol>",162935,4,Strongly Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49697,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest to include dysrhythmias that cause cardiac arrest, bradycardias and tachycardias, manage cardiac arrest until termination of resuscitation or transfer of care.</ol>",162936,0,Strongly Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49697,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest to include dysrhythmias that cause cardiac arrest, bradycardias and tachycardias, manage cardiac arrest until termination of resuscitation or transfer of care.</ol>",162937,1,Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49697,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest to include dysrhythmias that cause cardiac arrest, bradycardias and tachycardias, manage cardiac arrest until termination of resuscitation or transfer of care.</ol>",162938,2,No Opinion,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49697,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest to include dysrhythmias that cause cardiac arrest, bradycardias and tachycardias, manage cardiac arrest until termination of resuscitation or transfer of care.</ol>",162939,3,Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49697,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest to include dysrhythmias that cause cardiac arrest, bradycardias and tachycardias, manage cardiac arrest until termination of resuscitation or transfer of care.</ol>",162940,4,Strongly Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49698,10,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",162941,0,Strongly Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49698,10,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",162942,1,Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49698,10,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",162943,2,No Opinion,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49698,10,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",162944,3,Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49698,10,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",162945,4,Strongly Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49699,11,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage immediate post - resuscitation care.</ol>",162946,0,Strongly Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49699,11,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage immediate post - resuscitation care.</ol>",162947,1,Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49699,11,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage immediate post - resuscitation care.</ol>",162948,2,No Opinion,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49699,11,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage immediate post - resuscitation care.</ol>",162949,3,Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49699,11,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage immediate post - resuscitation care.</ol>",162950,4,Strongly Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49700,12,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe resuscitative skills required to complete the megacode station. </ol>",162951,0,Strongly Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49700,12,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe resuscitative skills required to complete the megacode station. </ol>",162952,1,Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49700,12,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe resuscitative skills required to complete the megacode station. </ol>",162953,2,No Opinion,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49700,12,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe resuscitative skills required to complete the megacode station. </ol>",162954,3,Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49700,12,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe resuscitative skills required to complete the megacode station. </ol>",162955,4,Strongly Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49701,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,162956,0,Strongly Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49701,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,162957,1,Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49701,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,162958,2,No Opinion,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49701,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,162959,3,Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49701,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,162960,4,Strongly Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49702,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence in dealing with pediatric emergencies and cardiac arrest.</OL>,162961,0,Strongly Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49702,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence in dealing with pediatric emergencies and cardiac arrest.</OL>,162962,1,Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49702,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence in dealing with pediatric emergencies and cardiac arrest.</OL>,162963,2,No Opinion,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49702,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence in dealing with pediatric emergencies and cardiac arrest.</OL>,162964,3,Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49702,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence in dealing with pediatric emergencies and cardiac arrest.</OL>,162965,4,Strongly Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49703,15,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,162966,0,Strongly Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49703,15,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,162967,1,Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49703,15,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,162968,2,No Opinion,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49703,15,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,162969,3,Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49703,15,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,162970,4,Strongly Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49704,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to pass the Megacode station and the post-test. </OL>,162971,0,Strongly Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49704,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to pass the Megacode station and the post-test. </OL>,162972,1,Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49704,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to pass the Megacode station and the post-test. </OL>,162973,2,No Opinion,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49704,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to pass the Megacode station and the post-test. </OL>,162974,3,Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49704,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to pass the Megacode station and the post-test. </OL>,162975,4,Strongly Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49705,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,162976,0,Strongly Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49705,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,162977,1,Agree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49705,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,162978,2,No Opinion,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49705,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,162979,3,Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49705,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,162980,4,Strongly Disagree,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49706,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",162981,0,Excellent,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49706,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",162982,1,Very Good,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49706,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",162983,2,Good,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49706,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",162984,3,Fair,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49706,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",162985,4,Poor,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49707,19,"Overall, this activity was:",162986,0,Excellent,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49707,19,"Overall, this activity was:",162987,1,Very Good,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49707,19,"Overall, this activity was:",162988,2,Good,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49707,19,"Overall, this activity was:",162989,3,Fair,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49707,19,"Overall, this activity was:",162990,4,Poor,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49708,20,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",162991,0,Yes,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49708,20,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",162992,1,No,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49708,20,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",162993,2,N/A,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49711,23,How would you improve this class?,162994,0,Reduce content covered in class,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49711,23,How would you improve this class?,162995,1,Increase content covered in class,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49711,23,How would you improve this class?,162996,2,Update content covered in class,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49711,23,How would you improve this class?,162997,3,Improve the instructional methods,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49711,23,How would you improve this class?,162998,4,Make course activities more stimulating,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49711,23,How would you improve this class?,162999,5,Slow the pace of the class,0
9962,Questions-0000-96,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020",n9728,49711,23,How would you improve this class?,163000,6,"Other: (No changes needed; appropriate speaker, content, handouts, etc.)",0
9519,Elearning-0000-749,C-378 VERSION 11.15.19,n9729,49713,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",163001,0,TRUE,1
9519,Elearning-0000-749,C-378 VERSION 11.15.19,n9729,49713,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",163002,1,FALSE,0
9099,Elearning-0000-367,NSH1205 AMENDMENT 4,n9731,49736,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",163092,0,TRUE,1
9099,Elearning-0000-367,NSH1205 AMENDMENT 4,n9731,49736,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",163093,1,FALSE,0
9095,Elearning-0000-363,NSH1208 AMENDMENT 2,n9732,49737,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",163094,0,TRUE,1
9095,Elearning-0000-363,NSH1208 AMENDMENT 2,n9732,49737,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",163095,1,FALSE,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49760,0,Please list the location for this activity.,163180,0,Atlanta,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49760,0,Please list the location for this activity.,163181,1,Forsyth,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49760,0,Please list the location for this activity.,163182,2,Cherokee,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49760,0,Please list the location for this activity.,163183,3,Other,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49761,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the relationship between the electrical physiology and functional anatomy of the heart.</ol>",163184,0,Strongly Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49761,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the relationship between the electrical physiology and functional anatomy of the heart.</ol>",163185,1,Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49761,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the relationship between the electrical physiology and functional anatomy of the heart.</ol>",163186,2,No Opinion,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49761,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the relationship between the electrical physiology and functional anatomy of the heart.</ol>",163187,3,Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49761,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the relationship between the electrical physiology and functional anatomy of the heart.</ol>",163188,4,Strongly Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49762,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the basic premise of electrophysiology and waveform deflection.   </ol>",163189,0,Strongly Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49762,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the basic premise of electrophysiology and waveform deflection.   </ol>",163190,1,Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49762,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the basic premise of electrophysiology and waveform deflection.   </ol>",163191,2,No Opinion,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49762,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the basic premise of electrophysiology and waveform deflection.   </ol>",163192,3,Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49762,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the basic premise of electrophysiology and waveform deflection.   </ol>",163193,4,Strongly Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49763,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",163194,0,Strongly Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49763,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",163195,1,Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49763,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",163196,2,No Opinion,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49763,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",163197,3,Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49763,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",163198,4,Strongly Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49764,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between zones of ischemia, injury and infarction.</ol>",163199,0,Strongly Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49764,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between zones of ischemia, injury and infarction.</ol>",163200,1,Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49764,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between zones of ischemia, injury and infarction.</ol>",163201,2,No Opinion,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49764,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between zones of ischemia, injury and infarction.</ol>",163202,3,Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49764,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between zones of ischemia, injury and infarction.</ol>",163203,4,Strongly Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49765,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the EKG characteristic differences of the patterns of ischemia, injury and infarction. </ol>",163204,0,Strongly Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49765,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the EKG characteristic differences of the patterns of ischemia, injury and infarction. </ol>",163205,1,Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49765,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the EKG characteristic differences of the patterns of ischemia, injury and infarction. </ol>",163206,2,No Opinion,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49765,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the EKG characteristic differences of the patterns of ischemia, injury and infarction. </ol>",163207,3,Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49765,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the EKG characteristic differences of the patterns of ischemia, injury and infarction. </ol>",163208,4,Strongly Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49766,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify areas of myocardial ischemia by assessment of the 12 lead EKG. </ol>",163209,0,Strongly Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49766,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify areas of myocardial ischemia by assessment of the 12 lead EKG. </ol>",163210,1,Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49766,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify areas of myocardial ischemia by assessment of the 12 lead EKG. </ol>",163211,2,No Opinion,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49766,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify areas of myocardial ischemia by assessment of the 12 lead EKG. </ol>",163212,3,Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49766,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify areas of myocardial ischemia by assessment of the 12 lead EKG. </ol>",163213,4,Strongly Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49767,7,<OL><B>ACTIVITY CONTENT</B></OL> <OL><OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL> .</OL>,163214,0,Strongly Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49767,7,<OL><B>ACTIVITY CONTENT</B></OL> <OL><OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL> .</OL>,163215,1,Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49767,7,<OL><B>ACTIVITY CONTENT</B></OL> <OL><OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL> .</OL>,163216,2,No Opinion,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49767,7,<OL><B>ACTIVITY CONTENT</B></OL> <OL><OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL> .</OL>,163217,3,Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49767,7,<OL><B>ACTIVITY CONTENT</B></OL> <OL><OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL> .</OL>,163218,4,Strongly Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49768,8,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of 12 Lead EKG analysis and will help me to identify patterns of ischemia, injury and infarction as well as identify the area of myocardial damage by assessment and analysis of the 12 Lead EKG.</OL>",163219,0,Strongly Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49768,8,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of 12 Lead EKG analysis and will help me to identify patterns of ischemia, injury and infarction as well as identify the area of myocardial damage by assessment and analysis of the 12 Lead EKG.</OL>",163220,1,Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49768,8,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of 12 Lead EKG analysis and will help me to identify patterns of ischemia, injury and infarction as well as identify the area of myocardial damage by assessment and analysis of the 12 Lead EKG.</OL>",163221,2,No Opinion,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49768,8,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of 12 Lead EKG analysis and will help me to identify patterns of ischemia, injury and infarction as well as identify the area of myocardial damage by assessment and analysis of the 12 Lead EKG.</OL>",163222,3,Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49768,8,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of 12 Lead EKG analysis and will help me to identify patterns of ischemia, injury and infarction as well as identify the area of myocardial damage by assessment and analysis of the 12 Lead EKG.</OL>",163223,4,Strongly Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49769,9,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",163224,0,Strongly Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49769,9,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",163225,1,Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49769,9,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",163226,2,No Opinion,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49769,9,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",163227,3,Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49769,9,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",163228,4,Strongly Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49770,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",163229,0,Strongly Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49770,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",163230,1,Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49770,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",163231,2,No Opinion,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49770,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",163232,3,Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49770,10,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",163233,4,Strongly Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49771,11,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,163234,0,Strongly Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49771,11,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,163235,1,Agree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49771,11,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,163236,2,No Opinion,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49771,11,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,163237,3,Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49771,11,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,163238,4,Strongly Disagree,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49772,12,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",163239,0,Excellent,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49772,12,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",163240,1,Very Good,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49772,12,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",163241,2,Good,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49772,12,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",163242,3,Fair,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49772,12,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",163243,4,Poor,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49773,13,"Overall, this activity was:",163244,0,Excellent,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49773,13,"Overall, this activity was:",163245,1,Very Good,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49773,13,"Overall, this activity was:",163246,2,Good,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49773,13,"Overall, this activity was:",163247,3,Fair,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49773,13,"Overall, this activity was:",163248,4,Poor,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49774,14,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",163249,0,Yes,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49774,14,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",163250,1,No,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49774,14,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",163251,2,N/A,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49777,17,How would you improve this class?,163252,0,Reduce content covered in class,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49777,17,How would you improve this class?,163253,1,Increase content covered in class,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49777,17,How would you improve this class?,163254,2,Update content covered in class,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49777,17,How would you improve this class?,163255,3,Improve the instructional methods,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49777,17,How would you improve this class?,163256,4,Make course activities more stimulating,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49777,17,How would you improve this class?,163257,5,Slow the pace of the class,0
9797,Questions-0000-03,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)",n9735,49777,17,How would you improve this class?,163258,6,Other,0
8124,Elearning-0000-1021,IPPE/AWV,n9738,49807,0,The Initial Preventive Physical Exam is an introduction to Medicare.,163370,0,TRUE,1
8124,Elearning-0000-1021,IPPE/AWV,n9738,49807,0,The Initial Preventive Physical Exam is an introduction to Medicare.,163371,1,FALSE,0
8124,Elearning-0000-1021,IPPE/AWV,n9738,49808,1,IPPE should be completed within the first 8 months of Medicare Part B coverage.,163372,0,TRUE,0
8124,Elearning-0000-1021,IPPE/AWV,n9738,49808,1,IPPE should be completed within the first 8 months of Medicare Part B coverage.,163373,1,FALSE,1
8124,Elearning-0000-1021,IPPE/AWV,n9738,49809,2,IPPE is a one-time benefit for new Medicare beneficiaries.,163374,0,TRUE,1
8124,Elearning-0000-1021,IPPE/AWV,n9738,49809,2,IPPE is a one-time benefit for new Medicare beneficiaries.,163375,1,FALSE,0
8124,Elearning-0000-1021,IPPE/AWV,n9738,49810,3,IPPE is billed with HCPCS code:,163376,0,A) G0402,1
8124,Elearning-0000-1021,IPPE/AWV,n9738,49810,3,IPPE is billed with HCPCS code:,163377,1,B) G0403,0
8124,Elearning-0000-1021,IPPE/AWV,n9738,49810,3,IPPE is billed with HCPCS code:,163378,2,C) 99387,0
8124,Elearning-0000-1021,IPPE/AWV,n9738,49810,3,IPPE is billed with HCPCS code:,163379,3,D) G0439,0
8124,Elearning-0000-1021,IPPE/AWV,n9738,49810,3,IPPE is billed with HCPCS code:,163380,4,E) G0438,0
8124,Elearning-0000-1021,IPPE/AWV,n9738,49811,4,Which component of the IPPE must be performed prior to submitting a claim for the service?,163381,0,A) Review the patient's medical and social history,0
8124,Elearning-0000-1021,IPPE/AWV,n9738,49811,4,Which component of the IPPE must be performed prior to submitting a claim for the service?,163382,1,B) Review of functional ability and level of safety,0
8124,Elearning-0000-1021,IPPE/AWV,n9738,49811,4,Which component of the IPPE must be performed prior to submitting a claim for the service?,163383,2,C) Examination,0
8124,Elearning-0000-1021,IPPE/AWV,n9738,49811,4,Which component of the IPPE must be performed prior to submitting a claim for the service?,163384,3,"D) End-of-life planning, upon agreement of individual",0
8124,Elearning-0000-1021,IPPE/AWV,n9738,49811,4,Which component of the IPPE must be performed prior to submitting a claim for the service?,163385,4,E) All of the above,1
8124,Elearning-0000-1021,IPPE/AWV,n9738,49812,5,"If patient is no longer within first 12 months after the effective date of their first Medicare Part B coverage period and has not received either an IPPE or AWV within the past 12 months, Medicare will cover an initial AWV.",163386,0,TRUE,1
8124,Elearning-0000-1021,IPPE/AWV,n9738,49812,5,"If patient is no longer within first 12 months after the effective date of their first Medicare Part B coverage period and has not received either an IPPE or AWV within the past 12 months, Medicare will cover an initial AWV.",163387,1,FALSE,0
8124,Elearning-0000-1021,IPPE/AWV,n9738,49813,6,The <u>Routine</u> AWV Component applies to the first time a patient receives an AWV.,163388,0,TRUE,0
8124,Elearning-0000-1021,IPPE/AWV,n9738,49813,6,The <u>Routine</u> AWV Component applies to the first time a patient receives an AWV.,163389,1,FALSE,1
8124,Elearning-0000-1021,IPPE/AWV,n9738,49814,7,The <u>Subsequent</u> AWV Component applies for all subsequent AWVs after a patient's first AWV.,163390,0,TRUE,1
8124,Elearning-0000-1021,IPPE/AWV,n9738,49814,7,The <u>Subsequent</u> AWV Component applies for all subsequent AWVs after a patient's first AWV.,163391,1,FALSE,0
8124,Elearning-0000-1021,IPPE/AWV,n9738,49815,8,"Generally, other services may be reported on the same day as long as there is sufficient stand alone documentation to support these services.",163392,0,TRUE,1
8124,Elearning-0000-1021,IPPE/AWV,n9738,49815,8,"Generally, other services may be reported on the same day as long as there is sufficient stand alone documentation to support these services.",163393,1,FALSE,0
8124,Elearning-0000-1021,IPPE/AWV,n9738,49816,9,An additional Evaluation and Management (E/M) service may not be billed when a significant and separately identifiable service is performed along with the IPPE/AWV.,163394,0,TRUE,0
8124,Elearning-0000-1021,IPPE/AWV,n9738,49816,9,An additional Evaluation and Management (E/M) service may not be billed when a significant and separately identifiable service is performed along with the IPPE/AWV.,163395,1,FALSE,1
9152,Elearning-0000-415,2020 CPT UPDATES,n9742,49818,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",163398,0,TRUE,1
9152,Elearning-0000-415,2020 CPT UPDATES,n9742,49818,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",163399,1,FALSE,0
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50022,0,Which of the following can influence a patient's perception of pain?,164054,0,Culture,0
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50022,0,Which of the following can influence a patient's perception of pain?,164055,1,Anxiety,0
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50022,0,Which of the following can influence a patient's perception of pain?,164056,2,Previous experiences,0
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50022,0,Which of the following can influence a patient's perception of pain?,164057,3,Physiologic factors,0
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50022,0,Which of the following can influence a patient's perception of pain?,164058,4,All of the above,1
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50023,1,"What does it mean if a patient is ""opioid nave""?",164059,0,The patient has previously taken opioids and their body may require larger doses Medication to achieve pain relief,0
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50023,1,"What does it mean if a patient is ""opioid nave""?",164060,1,The patient has had no previous exposure to opioids and may require less medication to achieve pain relief.,1
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50023,1,"What does it mean if a patient is ""opioid nave""?",164061,2,The patient does not know what opioids are.,0
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50023,1,"What does it mean if a patient is ""opioid nave""?",164062,3,The patient is allergic to opioids.,0
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50024,2,How frequently should pain be assessed?,164063,0,Within the first two hours of your shift,0
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50024,2,How frequently should pain be assessed?,164064,1,With every assessment,0
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50024,2,How frequently should pain be assessed?,164065,2,Within 1 hour after any intervention for pain,0
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50024,2,How frequently should pain be assessed?,164066,3,All of the above,1
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50025,3,All scheduled medications (i.e. Motrin) should be reassessed within 1 hour after administration.,164067,0,TRUE,1
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50025,3,All scheduled medications (i.e. Motrin) should be reassessed within 1 hour after administration.,164068,1,FALSE,0
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50026,4,Which of the following situations always requires a second RN co-signature?,164069,0,Changing an epidural cassette,1
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50026,4,Which of the following situations always requires a second RN co-signature?,164070,1,Administration of a narcotic,0
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50026,4,Which of the following situations always requires a second RN co-signature?,164071,2,Discontinuing an epidural,0
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50026,4,Which of the following situations always requires a second RN co-signature?,164072,3,Documentation of a pain score,0
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50027,5,How frequently should a patient with an epidural be assessed?,164073,0,Every shift,0
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50027,5,How frequently should a patient with an epidural be assessed?,164074,1,Every 2 hours,0
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50027,5,How frequently should a patient with an epidural be assessed?,164075,2,Every 4 hours,1
9372,Elearning-0000-615,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020,n9777,50027,5,How frequently should a patient with an epidural be assessed?,164076,3,Every 8 hours,0
9609,Elearning-0000-830,FY2021 URINARY CATHETER REMOVAL PROTOCOL,n9784,50111,0,"True or False: If the ""Removal Instructions"" field on the patient's urinary catheter order says ""DC per Urinary Catheter Removal Protocol"", then the MD has opted in to the nurse-driven removal protocol for that patient.",164323,0,TRUE,1
9609,Elearning-0000-830,FY2021 URINARY CATHETER REMOVAL PROTOCOL,n9784,50111,0,"True or False: If the ""Removal Instructions"" field on the patient's urinary catheter order says ""DC per Urinary Catheter Removal Protocol"", then the MD has opted in to the nurse-driven removal protocol for that patient.",164324,1,FALSE,0
9609,Elearning-0000-830,FY2021 URINARY CATHETER REMOVAL PROTOCOL,n9784,50112,1,How often should you assess the indication for indwelling urinary catheter if your patient is on the nurse-driven removal protocol?,164325,0,a. Once a shift,1
9609,Elearning-0000-830,FY2021 URINARY CATHETER REMOVAL PROTOCOL,n9784,50112,1,How often should you assess the indication for indwelling urinary catheter if your patient is on the nurse-driven removal protocol?,164326,1,b. Once a day,0
9609,Elearning-0000-830,FY2021 URINARY CATHETER REMOVAL PROTOCOL,n9784,50112,1,How often should you assess the indication for indwelling urinary catheter if your patient is on the nurse-driven removal protocol?,164327,2,c. None of the above,0
9609,Elearning-0000-830,FY2021 URINARY CATHETER REMOVAL PROTOCOL,n9784,50113,2,"If your patient does not spontaneously void within 6 hours after indwelling urinary catheter removal, you should:",190576,0,"a.	Follow the ""Bladder Scan Guidelines"" and bladder scan & straight catheterize the patient as appropriate",1
9609,Elearning-0000-830,FY2021 URINARY CATHETER REMOVAL PROTOCOL,n9784,50113,2,"If your patient does not spontaneously void within 6 hours after indwelling urinary catheter removal, you should:",190577,1,"b.	Re-insert the indwelling urinary catheter",0
9609,Elearning-0000-830,FY2021 URINARY CATHETER REMOVAL PROTOCOL,n9784,57539,3,The algorithm for the Urinary Catheter Removal Protocol is available in:,190578,0,"a.	Cerner",0
9609,Elearning-0000-830,FY2021 URINARY CATHETER REMOVAL PROTOCOL,n9784,57539,3,The algorithm for the Urinary Catheter Removal Protocol is available in:,190579,1,"b.	Lucidoc",0
9609,Elearning-0000-830,FY2021 URINARY CATHETER REMOVAL PROTOCOL,n9784,57539,3,The algorithm for the Urinary Catheter Removal Protocol is available in:,190580,2,"c.	Both of the above",1
251,SCORM-0000-61,KINDNESS THROUGH COMMUNICATION: CONNECT,n9785,50114,0,I acknowledge that I have read this CBL in its entirety and understand that I am responsible for its content.,164331,0,TRUE,1
251,SCORM-0000-61,KINDNESS THROUGH COMMUNICATION: CONNECT,n9785,50114,0,I acknowledge that I have read this CBL in its entirety and understand that I am responsible for its content.,164332,1,FALSE,0
9373,Elearning-0000-616,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020,n9786,50115,0,How frequently must vital signs be assessed after administering a PCA clinician bolus?,164333,0,Q 2 hours x 4,0
9373,Elearning-0000-616,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020,n9786,50115,0,How frequently must vital signs be assessed after administering a PCA clinician bolus?,164334,1,Q 5 minutes x 5,0
9373,Elearning-0000-616,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020,n9786,50115,0,How frequently must vital signs be assessed after administering a PCA clinician bolus?,164335,2,Q 15 minutes x 2,1
9373,Elearning-0000-616,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020,n9786,50115,0,How frequently must vital signs be assessed after administering a PCA clinician bolus?,164336,3,Q 1 hour x 2,0
9373,Elearning-0000-616,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020,n9786,50116,1,What are common side effects of an epidural or PCA?,164337,0,Nausea,0
9373,Elearning-0000-616,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020,n9786,50116,1,What are common side effects of an epidural or PCA?,164338,1,Vomiting,0
9373,Elearning-0000-616,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020,n9786,50116,1,What are common side effects of an epidural or PCA?,164339,2,Numbness,0
9373,Elearning-0000-616,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020,n9786,50116,1,What are common side effects of an epidural or PCA?,164340,3,All of the above,1
9373,Elearning-0000-616,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020,n9786,50117,2,What 2 criteria must a patient meet prior to weaning from an epidural or PCA?,164341,0,Greater than 24 hours post-delivery and no reports of numbness,0
9373,Elearning-0000-616,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020,n9786,50117,2,What 2 criteria must a patient meet prior to weaning from an epidural or PCA?,164342,1,Able to tolerate solid food and pain should be under control per patient pain goal,1
9373,Elearning-0000-616,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020,n9786,50117,2,What 2 criteria must a patient meet prior to weaning from an epidural or PCA?,164343,2,Normal EKG and pain under control per patient goal,0
9373,Elearning-0000-616,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020,n9786,50117,2,What 2 criteria must a patient meet prior to weaning from an epidural or PCA?,164344,3,Vital signs stable and patient able to tolerate solid food,0
9373,Elearning-0000-616,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020,n9786,50118,3,Severe or escalating pain out of proportion to the patient's progression towards recovery is a NEWT trigger.,164345,0,TRUE,1
9373,Elearning-0000-616,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020,n9786,50118,3,Severe or escalating pain out of proportion to the patient's progression towards recovery is a NEWT trigger.,164346,1,FALSE,0
9373,Elearning-0000-616,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020,n9786,50119,4,Which of the following are potential interventions for a patient experiencing epidural breakthrough pain?,164347,0,Clinician bolus 2 x the PCA dose,0
9373,Elearning-0000-616,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020,n9786,50119,4,Which of the following are potential interventions for a patient experiencing epidural breakthrough pain?,164348,1,Morphine 2mg IV,0
9373,Elearning-0000-616,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020,n9786,50119,4,Which of the following are potential interventions for a patient experiencing epidural breakthrough pain?,164349,2,All of the above,1
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50120,0,"1.	What does NEWT-OB stand for?",164350,0,"a.	New Triggers for OB",0
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50120,0,"1.	What does NEWT-OB stand for?",164351,1,"b.	Northside Early Warning Triggers for Obstetrics",1
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50120,0,"1.	What does NEWT-OB stand for?",164352,2,"c.	Northside OB Early Warning",0
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50120,0,"1.	What does NEWT-OB stand for?",164353,3,"d.	None of the Above",0
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50121,1,"2.	A patient currently has a BP of 165/95. You repeat in 15 minutes and the BP is 166/98. You know patient has orders for IV Labetalol for BP's >/= 160/110. According to NEWT-OB what will your next actions be?",164354,0,"a.	Notify the provider and request them to come to the bedside.",0
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50121,1,"2.	A patient currently has a BP of 165/95. You repeat in 15 minutes and the BP is 166/98. You know patient has orders for IV Labetalol for BP's >/= 160/110. According to NEWT-OB what will your next actions be?",164355,1,"b.	The patient has chronic hypertension so this is an expected BP. Continue to monitor.",0
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50121,1,"2.	A patient currently has a BP of 165/95. You repeat in 15 minutes and the BP is 166/98. You know patient has orders for IV Labetalol for BP's >/= 160/110. According to NEWT-OB what will your next actions be?",164356,2,"c.	Treat the patient according to the Labetalol orders and notify the provider.",1
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50121,1,"2.	A patient currently has a BP of 165/95. You repeat in 15 minutes and the BP is 166/98. You know patient has orders for IV Labetalol for BP's >/= 160/110. According to NEWT-OB what will your next actions be?",164357,3,"d.	Treat the patient according to the Labetalol orders.",0
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50122,2,"3.	Your patient has an elevated BP above the threshold of 160/110 that is sustained for 15 mins. This patient does not currently have an antihypertensive guideline order. What would your next nursing action be?",164358,0,"a.	Notify the provider to request an emergent antihypertensive medication.",1
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50122,2,"3.	Your patient has an elevated BP above the threshold of 160/110 that is sustained for 15 mins. This patient does not currently have an antihypertensive guideline order. What would your next nursing action be?",164359,1,"b.	Recheck the BP in 15 more minutes",0
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50122,2,"3.	Your patient has an elevated BP above the threshold of 160/110 that is sustained for 15 mins. This patient does not currently have an antihypertensive guideline order. What would your next nursing action be?",164360,2,"c.	Turn the patient on their left side and recheck BP in one hour",0
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50122,2,"3.	Your patient has an elevated BP above the threshold of 160/110 that is sustained for 15 mins. This patient does not currently have an antihypertensive guideline order. What would your next nursing action be?",164361,3,"d.	This patient has chronic hypertension so continue to monitor VS every 4 hours.",0
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50123,3,"4.	The patient has a temperature elevation that is outside of the parameters set for your population and/or department. There are no other positive parameters. What should your nursing actions be?",164362,0,"a.	Notify the provider and assess VS every 4 hours until temperature abnormality resolves",1
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50123,3,"4.	The patient has a temperature elevation that is outside of the parameters set for your population and/or department. There are no other positive parameters. What should your nursing actions be?",164363,1,"b.	Repeat a temperature only and notify provider if still elevated.",0
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50123,3,"4.	The patient has a temperature elevation that is outside of the parameters set for your population and/or department. There are no other positive parameters. What should your nursing actions be?",164364,2,"c.	Check temperature hourly for the rest of your shift",0
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50123,3,"4.	The patient has a temperature elevation that is outside of the parameters set for your population and/or department. There are no other positive parameters. What should your nursing actions be?",164365,3,"d.	Continue to monitor until the patient has 2 or more positive parameters.",0
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50124,4,"5.	If MAP is the only positive parameter, the nurse should assess patient meets the sepsis criteria and notify the provider.",164366,0,TRUE,1
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50124,4,"5.	If MAP is the only positive parameter, the nurse should assess patient meets the sepsis criteria and notify the provider.",164367,1,FALSE,0
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50125,5,"6.	Documentation of if a NEWT-OB parameter is met should occur with each set of VS?",164368,0,TRUE,1
9375,Elearning-0000-618,FCC RESIDENCY NEWT-OB FY2020,n9787,50125,5,"6.	Documentation of if a NEWT-OB parameter is met should occur with each set of VS?",164369,1,FALSE,0
8117,Elearning-0000-1015,NEUROSURGERY NURSING DOCUMENTATION - SURGICAL SERVICES,n9792,50171,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Neurosurgery Nursing Documentation - Surgical Services CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",164548,0,TRUE,1
8117,Elearning-0000-1015,NEUROSURGERY NURSING DOCUMENTATION - SURGICAL SERVICES,n9792,50171,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Neurosurgery Nursing Documentation - Surgical Services CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",164549,1,FALSE,0
8118,Elearning-0000-1016,NEUROSURGERY NURSING DOCUMENTATION - INPATIENT,n9793,50172,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Neurosurgery Nursing Documentation - Inpatient CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",164550,0,TRUE,1
8118,Elearning-0000-1016,NEUROSURGERY NURSING DOCUMENTATION - INPATIENT,n9793,50172,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Neurosurgery Nursing Documentation - Inpatient CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",164551,1,FALSE,0
9342,Elearning-0000-588,FY20 PRACTICE AUDITS IN SURGICAL SERVICES,n9801,50240,0,I verify that I have read and understand the expectations for practice audits in Surgical Services at Northside Hospital.,164849,0,TRUE,1
9342,Elearning-0000-588,FY20 PRACTICE AUDITS IN SURGICAL SERVICES,n9801,50240,0,I verify that I have read and understand the expectations for practice audits in Surgical Services at Northside Hospital.,164850,1,FALSE,0
9474,Elearning-0000-708,CHEMOTHERAPY SPILL PROCEDURE,n9809,50281,0,I acknowledge that I have read this CBL in its entirety and understand that I am responsible for its content.,164905,0,TRUE,1
9474,Elearning-0000-708,CHEMOTHERAPY SPILL PROCEDURE,n9809,50281,0,I acknowledge that I have read this CBL in its entirety and understand that I am responsible for its content.,164906,1,FALSE,0
9039,Elearning-0000-312,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS,n9811,50282,0,The OB Triage PowerForm is completed within the first two hours of the patient's admission and now the MD wants to transfer the patient to the high risk unit. What should be done prior to transfer?,164907,0,Consult/referral screening,0
9039,Elearning-0000-312,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS,n9811,50282,0,The OB Triage PowerForm is completed within the first two hours of the patient's admission and now the MD wants to transfer the patient to the high risk unit. What should be done prior to transfer?,164908,1,Patient transfer to new unit,0
9039,Elearning-0000-312,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS,n9811,50282,0,The OB Triage PowerForm is completed within the first two hours of the patient's admission and now the MD wants to transfer the patient to the high risk unit. What should be done prior to transfer?,164909,2,Complete the entire OB Patient History PowerForm,1
9039,Elearning-0000-312,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS,n9811,50283,1,Information that is documented in the OB Triage PowerForm will flow into the OB Patient History PowerForm.,164910,0,TRUE,1
9039,Elearning-0000-312,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS,n9811,50283,1,Information that is documented in the OB Triage PowerForm will flow into the OB Patient History PowerForm.,164911,1,FALSE,0
9039,Elearning-0000-312,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS,n9811,50284,2,The OB Triage PowerForm can be utilized in the following departments:,164912,0,L&D,1
9039,Elearning-0000-312,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS,n9811,50284,2,The OB Triage PowerForm can be utilized in the following departments:,164913,1,HRP,0
9039,Elearning-0000-312,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS,n9811,50284,2,The OB Triage PowerForm can be utilized in the following departments:,164914,2,FCC,0
9039,Elearning-0000-312,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS,n9811,50284,2,The OB Triage PowerForm can be utilized in the following departments:,164915,3,All of above,0
9039,Elearning-0000-312,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS,n9811,50285,3,"When completing the OB Risk Factors section of the admission PowerForm, you should:",164916,0,Select the header,0
9039,Elearning-0000-312,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS,n9811,50285,3,"When completing the OB Risk Factors section of the admission PowerForm, you should:",164917,1,Select the individual risk factors,1
9039,Elearning-0000-312,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS,n9811,50285,3,"When completing the OB Risk Factors section of the admission PowerForm, you should:",164918,2,Select both the header and the risk factors,0
9039,Elearning-0000-312,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS,n9811,50286,4,The expectation is that the entire OB Patient History PowerForm will be completed prior to transfer to another unit.,164919,0,TRUE,1
9039,Elearning-0000-312,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS,n9811,50286,4,The expectation is that the entire OB Patient History PowerForm will be completed prior to transfer to another unit.,164920,1,FALSE,0
9039,Elearning-0000-312,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS,n9811,50287,5,The entire OB Patient History PowerForm must be completed if the patient is not discharged within  ____  hours:,164921,0,2 hours,0
9039,Elearning-0000-312,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS,n9811,50287,5,The entire OB Patient History PowerForm must be completed if the patient is not discharged within  ____  hours:,164922,1,4 hours,1
9039,Elearning-0000-312,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS,n9811,50287,5,The entire OB Patient History PowerForm must be completed if the patient is not discharged within  ____  hours:,164923,2,6 hours,0
9503,Elearning-0000-734,CARE COORDINATION COPD EDUCATION,n9816,50290,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",164928,0,TRUE,1
9503,Elearning-0000-734,CARE COORDINATION COPD EDUCATION,n9816,50290,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",164929,1,FALSE,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50306,0,Approximately how many targeted oral antineoplastic agents have gained FDA approval in the last decade?,164978,0,0 - 9,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50306,0,Approximately how many targeted oral antineoplastic agents have gained FDA approval in the last decade?,164979,1,20-Oct,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50306,0,Approximately how many targeted oral antineoplastic agents have gained FDA approval in the last decade?,164980,2,50 - 60,1
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50306,0,Approximately how many targeted oral antineoplastic agents have gained FDA approval in the last decade?,164981,3,> 100,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50307,1,TKIs directly interfere with tyrosine kinase enzymes that are activated in tumor cells and are critical to tumor growth.,164982,0,TRUE,1
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50307,1,TKIs directly interfere with tyrosine kinase enzymes that are activated in tumor cells and are critical to tumor growth.,164983,1,FALSE,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50308,2,Which one of these are considered key oncogenic kinase drug targets:,164984,0,EGFR,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50308,2,Which one of these are considered key oncogenic kinase drug targets:,164985,1,HER2,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50308,2,Which one of these are considered key oncogenic kinase drug targets:,164986,2,BRAF,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50308,2,Which one of these are considered key oncogenic kinase drug targets:,164987,3,A and B,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50308,2,Which one of these are considered key oncogenic kinase drug targets:,164988,4,A and C,1
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50309,3,Which statement is false?,164989,0,Concomitant use of acid suppressive drugs can alter the bioavailability of some TKIs and significantly affect their absorption,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50309,3,Which statement is false?,164990,1,"If possible, the combination of alectinib and an H2-antagonist, proton-pump inhibitor, or antacid should be avoided",0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50309,3,Which statement is false?,164991,2,"All TKIs are fairly highly bound to plasma proteins (>90%), therefore these inhibitors are prone to interactions with other highly bound drugs",0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50309,3,Which statement is false?,164992,3,Most TKIs undergo renal metabolism,1
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50310,4,Antineoplastic agents generally have a wide therapeutic window.,164993,0,TRUE,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50310,4,Antineoplastic agents generally have a wide therapeutic window.,164994,1,FALSE,1
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50311,5,Which of the following factors is not related to DDIs:,164995,0,Pharmaceutic,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50311,5,Which of the following factors is not related to DDIs:,164996,1,Pharmacoeconomic,1
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50311,5,Which of the following factors is not related to DDIs:,164997,2,Pharmacodynamic,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50311,5,Which of the following factors is not related to DDIs:,164998,3,Pharmacokinetic,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50312,6,Proton pump inhibitors (PPIs) lower gastric pH; therefore increase the absorption and bioavailability of certain oral antineoplastic agents.,164999,0,TRUE,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50312,6,Proton pump inhibitors (PPIs) lower gastric pH; therefore increase the absorption and bioavailability of certain oral antineoplastic agents.,165000,1,FALSE,1
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50313,7,"Which of the following TKIs is most likely to cause digoxin toxicity due to PGP inhibition, if taken concurrently?",165001,0,Ruxolitinib,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50313,7,"Which of the following TKIs is most likely to cause digoxin toxicity due to PGP inhibition, if taken concurrently?",165002,1,Sorafenib,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50313,7,"Which of the following TKIs is most likely to cause digoxin toxicity due to PGP inhibition, if taken concurrently?",165003,2,Pazopanib,1
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50313,7,"Which of the following TKIs is most likely to cause digoxin toxicity due to PGP inhibition, if taken concurrently?",165004,3,Afatinib,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50314,8,"Using a drug information resource, you determine that the administration of afatinib and a strong CYP3A4 inhibitor, such as posaconazole, is unsafe and should be avoided due to the risk of increased serum concentrations of afatinib:",165005,0,TRUE,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50314,8,"Using a drug information resource, you determine that the administration of afatinib and a strong CYP3A4 inhibitor, such as posaconazole, is unsafe and should be avoided due to the risk of increased serum concentrations of afatinib:",165006,1,FALSE,1
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50315,9,The concurrent use of dasatinib and ondansetron IV may warrant close monitoring of which clinically significant toxicity due to a potential DDI:,165007,0,Severe myelosuppression secondary to inhibition of CYP3A4,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50315,9,The concurrent use of dasatinib and ondansetron IV may warrant close monitoring of which clinically significant toxicity due to a potential DDI:,165008,1,Prolonged QTc interval,1
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50315,9,The concurrent use of dasatinib and ondansetron IV may warrant close monitoring of which clinically significant toxicity due to a potential DDI:,165009,2,Lack of disease response due to induction of CYP3A4,0
9129,Elearning-0000-394,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY,n9824,50315,9,The concurrent use of dasatinib and ondansetron IV may warrant close monitoring of which clinically significant toxicity due to a potential DDI:,165010,3,None of the above,0
9502,Elearning-0000-733,CARE COORDINATION PNEUMONIA EDUCATION,n9817,50291,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",164930,0,TRUE,1
9502,Elearning-0000-733,CARE COORDINATION PNEUMONIA EDUCATION,n9817,50291,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",164931,1,FALSE,0
9535,Elearning-0000-763,ECHO WITH BUBBLE STUDY EDUCATION FY20,n9831,50325,0,What gauge IV is preferred to perform a bubble study?,165037,0,20G,1
9535,Elearning-0000-763,ECHO WITH BUBBLE STUDY EDUCATION FY20,n9831,50325,0,What gauge IV is preferred to perform a bubble study?,165038,1,22G,0
9535,Elearning-0000-763,ECHO WITH BUBBLE STUDY EDUCATION FY20,n9831,50325,0,What gauge IV is preferred to perform a bubble study?,165039,2,18G,0
9535,Elearning-0000-763,ECHO WITH BUBBLE STUDY EDUCATION FY20,n9831,50326,1,Why do we perform bubble studies?,165040,0,To evaluate ejection fraction,0
9535,Elearning-0000-763,ECHO WITH BUBBLE STUDY EDUCATION FY20,n9831,50326,1,Why do we perform bubble studies?,165041,1,to evaluate for possible ASD or other intracardiac shunts,1
9535,Elearning-0000-763,ECHO WITH BUBBLE STUDY EDUCATION FY20,n9831,50326,1,Why do we perform bubble studies?,165042,2,To assess for blood clots prior to cardioversion,0
9535,Elearning-0000-763,ECHO WITH BUBBLE STUDY EDUCATION FY20,n9831,50327,2,Should you ever inject an air bolus,165043,0,Yes,0
9535,Elearning-0000-763,ECHO WITH BUBBLE STUDY EDUCATION FY20,n9831,50327,2,Should you ever inject an air bolus,165044,1,No,1
9535,Elearning-0000-763,ECHO WITH BUBBLE STUDY EDUCATION FY20,n9831,50328,3,How many attempts can you perform prior to notifying the physician for additional studies.,165045,0,2,0
9535,Elearning-0000-763,ECHO WITH BUBBLE STUDY EDUCATION FY20,n9831,50328,3,How many attempts can you perform prior to notifying the physician for additional studies.,165046,1,3,1
9535,Elearning-0000-763,ECHO WITH BUBBLE STUDY EDUCATION FY20,n9831,50328,3,How many attempts can you perform prior to notifying the physician for additional studies.,165047,2,4,0
9535,Elearning-0000-763,ECHO WITH BUBBLE STUDY EDUCATION FY20,n9831,50328,3,How many attempts can you perform prior to notifying the physician for additional studies.,165048,3,5,0
9535,Elearning-0000-763,ECHO WITH BUBBLE STUDY EDUCATION FY20,n9831,50329,4,You are injecting macro bubbles,165049,0,TRUE,0
9535,Elearning-0000-763,ECHO WITH BUBBLE STUDY EDUCATION FY20,n9831,50329,4,You are injecting macro bubbles,165050,1,FALSE,1
9338,Elearning-0000-584,FY2020 EDUCATION ON CHAIN OF COMMAND,n9838,50366,0,"I acknowledge that I have read the FY2020 Education Chain of Command CBL in its entirety, I understand the actions that I need to take to implement the chain of command as well as understanding the importance of communicating and expressing concerns and issues.  I also understand when an incident report needs to be submitted.",165174,0,TRUE,1
9338,Elearning-0000-584,FY2020 EDUCATION ON CHAIN OF COMMAND,n9838,50366,0,"I acknowledge that I have read the FY2020 Education Chain of Command CBL in its entirety, I understand the actions that I need to take to implement the chain of command as well as understanding the importance of communicating and expressing concerns and issues.  I also understand when an incident report needs to be submitted.",165175,1,FALSE,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50536,0,Please list the location for this activity.,165842,0,Atlanta,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50536,0,Please list the location for this activity.,165843,1,Forsyth,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50536,0,Please list the location for this activity.,165844,2,Cherokee,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50536,0,Please list the location for this activity.,165845,3,Other,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50537,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of "" Life is Why "" campaign by AHA. </ol>",165846,0,Strongly Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50537,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of "" Life is Why "" campaign by AHA. </ol>",165847,1,Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50537,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of "" Life is Why "" campaign by AHA. </ol>",165848,2,No Opinion,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50537,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of "" Life is Why "" campaign by AHA. </ol>",165849,3,Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50537,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of "" Life is Why "" campaign by AHA. </ol>",165850,4,Strongly Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50538,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",165851,0,Strongly Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50538,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",165852,1,Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50538,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",165853,2,No Opinion,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50538,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",165854,3,Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50538,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",165855,4,Strongly Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50539,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",165856,0,Strongly Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50539,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",165857,1,Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50539,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",165858,2,No Opinion,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50539,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",165859,3,Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50539,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",165860,4,Strongly Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50540,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",165861,0,Strongly Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50540,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",165862,1,Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50540,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",165863,2,No Opinion,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50540,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",165864,3,Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50540,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",165865,4,Strongly Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50541,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",165866,0,Strongly Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50541,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",165867,1,Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50541,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",165868,2,No Opinion,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50541,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",165869,3,Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50541,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",165870,4,Strongly Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50542,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",165871,0,Strongly Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50542,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",165872,1,Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50542,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",165873,2,No Opinion,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50542,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",165874,3,Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50542,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",165875,4,Strongly Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50543,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",165876,0,Strongly Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50543,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",165877,1,Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50543,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",165878,2,No Opinion,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50543,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",165879,3,Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50543,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",165880,4,Strongly Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50544,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",165881,0,Strongly Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50544,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",165882,1,Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50544,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",165883,2,No Opinion,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50544,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",165884,3,Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50544,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",165885,4,Strongly Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50545,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",165886,0,Strongly Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50545,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",165887,1,Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50545,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",165888,2,No Opinion,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50545,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",165889,3,Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50545,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",165890,4,Strongly Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50546,10,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",165891,0,Strongly Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50546,10,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",165892,1,Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50546,10,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",165893,2,No Opinion,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50546,10,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",165894,3,Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50546,10,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",165895,4,Strongly Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50547,11,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",165896,0,Strongly Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50547,11,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",165897,1,Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50547,11,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",165898,2,No Opinion,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50547,11,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",165899,3,Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50547,11,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",165900,4,Strongly Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50548,12,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",165901,0,Strongly Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50548,12,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",165902,1,Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50548,12,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",165903,2,No Opinion,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50548,12,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",165904,3,Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50548,12,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",165905,4,Strongly Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50549,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,165906,0,Strongly Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50549,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,165907,1,Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50549,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,165908,2,No Opinion,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50549,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,165909,3,Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50549,13,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,165910,4,Strongly Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50550,14,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",165911,0,Strongly Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50550,14,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",165912,1,Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50550,14,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",165913,2,No Opinion,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50550,14,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",165914,3,Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50550,14,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",165915,4,Strongly Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50551,15,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,165916,0,Strongly Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50551,15,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,165917,1,Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50551,15,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,165918,2,No Opinion,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50551,15,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,165919,3,Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50551,15,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,165920,4,Strongly Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50552,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,165921,0,Strongly Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50552,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,165922,1,Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50552,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,165923,2,No Opinion,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50552,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,165924,3,Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50552,16,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,165925,4,Strongly Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50553,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,165926,0,Strongly Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50553,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,165927,1,Agree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50553,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,165928,2,No Opinion,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50553,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,165929,3,Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50553,17,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,165930,4,Strongly Disagree,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50554,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",165931,0,Excellent,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50554,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",165932,1,Very Good,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50554,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",165933,2,Good,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50554,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",165934,3,Fair,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50554,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",165935,4,Poor,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50555,19,"Overall, this activity was:",165936,0,Excellent,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50555,19,"Overall, this activity was:",165937,1,Very Good,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50555,19,"Overall, this activity was:",165938,2,Good,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50555,19,"Overall, this activity was:",165939,3,Fair,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50555,19,"Overall, this activity was:",165940,4,Poor,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50556,20,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",165941,0,Yes,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50556,20,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",165942,1,No,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50556,20,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",165943,2,N/A,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50559,23,How would you improve this class?,165944,0,Reduce content covered in class,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50559,23,How would you improve this class?,165945,1,Increase content covered in class,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50559,23,How would you improve this class?,165946,2,Update content covered in class,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50559,23,How would you improve this class?,165947,3,Improve the instructional methods,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50559,23,How would you improve this class?,165948,4,Make course activities more stimulating,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50559,23,How would you improve this class?,165949,5,Slow the pace of the class,0
9881,Questions-0000-17,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020",n9852,50559,23,How would you improve this class?,165950,6,"Other: (No changes needed; appropriate speaker, content, handouts, etc.)",0
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50596,0,What is data Security?,166096,0,a.  Protecting data from destructive forces and the unwanted actions of unauthorized users,1
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50596,0,What is data Security?,166094,1,"b.  Sharing data from your home computer, only if you are connected to your personal secure wifi network",0
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50596,0,What is data Security?,166095,2,"c.  Ensuring that any tablet, phone or personal laptop that contains employees data is password protected",0
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50597,1,What departments are responsible for managing the integrity of Human Resource Data?,166097,0,a.  Human Resource Department,0
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50597,1,What departments are responsible for managing the integrity of Human Resource Data?,166098,1,b.  Position Management,0
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50597,1,What departments are responsible for managing the integrity of Human Resource Data?,166099,2,c.  Position Control,0
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50597,1,What departments are responsible for managing the integrity of Human Resource Data?,166100,3,d.  All Northside Hospital Departments,1
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50598,2,What should you do if you feel like you are a victim of phishing?,166101,0,a.  Clear your computer history,0
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50598,2,What should you do if you feel like you are a victim of phishing?,166102,1,b.  Delete the email,0
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50598,2,What should you do if you feel like you are a victim of phishing?,166103,2,c.  Immediately notify the IS helpdesk,1
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50599,3,When is it appropriate to send patient information via personal email?,166104,0,"a.  If the patient grants written and verbal permission, it is acceptable",0
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50599,3,When is it appropriate to send patient information via personal email?,166105,1,b.  If you are working from home and the information is requested by your supervisor,0
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50599,3,When is it appropriate to send patient information via personal email?,166106,2,c.  You should never send patient information via personal email,1
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50600,4,"If a caller requests information regarding NSH employees, patients or data and you are unsure of the callers identity, how should you proceed?",166107,0,a.  Provide the information and verify the callers identity at a later time,0
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50600,4,"If a caller requests information regarding NSH employees, patients or data and you are unsure of the callers identity, how should you proceed?",166108,1,b.  Inform the caller that you cannot assist them and disconnect the call,0
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50600,4,"If a caller requests information regarding NSH employees, patients or data and you are unsure of the callers identity, how should you proceed?",166109,2,c.  Request to call the customer back by using the number that is on the customer's file to verify the request.,1
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50601,5,What needs to be encrypted?,166110,0,a.  All emails sent from a Northside email account,0
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50601,5,What needs to be encrypted?,166112,1,"b.  Any message that contains sensitive material, such as personal health information (PHI), financial information, electronic medical records (EMRs), employee data, or just about anything related to patient care.",1
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50601,5,What needs to be encrypted?,166111,2,c.  No emails are required to be encrypted,0
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50602,6,How can you manually encrypt messages from Northside?,166115,0,a.  Type the phrase [secure] anywhere in the subject line of an email,1
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50602,6,How can you manually encrypt messages from Northside?,166113,1,b.  Type the phrase [secure] in the body of the email,0
8127,Elearning-0000-1024,2020 HUMAN RESOURCE DATA SECURITY,n9855,50602,6,How can you manually encrypt messages from Northside?,166114,2,c.  Call the recipient and communicate to the recipient that the content of the email is secure,0
9374,Elearning-0000-617,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020,n9860,50661,0,"During the first 24 hours Post-Partum, soaking an entire pad (side to side, top to bottom) every 15 minutes would be classified as a Post-Partum Hemorrhage",166358,0,TRUE,1
9374,Elearning-0000-617,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020,n9860,50661,0,"During the first 24 hours Post-Partum, soaking an entire pad (side to side, top to bottom) every 15 minutes would be classified as a Post-Partum Hemorrhage",166359,1,FALSE,0
9374,Elearning-0000-617,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020,n9860,50662,1,"If you think your patient is hemorrhaging, you should begin vital sign assessments every 5 minutes.",166360,0,TRUE,1
9374,Elearning-0000-617,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020,n9860,50662,1,"If you think your patient is hemorrhaging, you should begin vital sign assessments every 5 minutes.",166361,1,FALSE,0
9374,Elearning-0000-617,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020,n9860,50663,2,"What physical signs and symptoms might a PPH patient exhibit that would make you suspicious of internal blood loss, even when there is no obvious external bleeding?",166362,0,"Low BP, high MAP, Fatigue, Low H&H",0
9374,Elearning-0000-617,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020,n9860,50663,2,"What physical signs and symptoms might a PPH patient exhibit that would make you suspicious of internal blood loss, even when there is no obvious external bleeding?",166363,1,"Low BP, high HR, low MAP, Pain",1
9374,Elearning-0000-617,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020,n9860,50663,2,"What physical signs and symptoms might a PPH patient exhibit that would make you suspicious of internal blood loss, even when there is no obvious external bleeding?",166364,2,"Low BP, high HR, high MAP, Pain",0
9374,Elearning-0000-617,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020,n9860,50663,2,"What physical signs and symptoms might a PPH patient exhibit that would make you suspicious of internal blood loss, even when there is no obvious external bleeding?",166365,3,"Low BP, low HR, low MAP, decreased output",0
9374,Elearning-0000-617,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020,n9860,50664,3,Which of the following are considered post-partum emergencies?,166366,0,"Hemorrhage, sepsis and pneumonia",0
9374,Elearning-0000-617,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020,n9860,50664,3,Which of the following are considered post-partum emergencies?,166367,1,"Hemorrhage, pulmonary embolism and hypertensive crisis",1
9374,Elearning-0000-617,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020,n9860,50664,3,Which of the following are considered post-partum emergencies?,166368,2,"Hematoma, infection and sepsis",0
9374,Elearning-0000-617,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020,n9860,50664,3,Which of the following are considered post-partum emergencies?,166369,3,"Pulmonary edema, hematoma, and infection",0
9374,Elearning-0000-617,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020,n9860,50665,4,The 4 T's of hemorrhage etiology are:,166370,0,"Tone, trauma, trickle, thermoregulation",0
9374,Elearning-0000-617,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020,n9860,50665,4,The 4 T's of hemorrhage etiology are:,166371,1,"Tone, trauma, tissue, thrombosis",1
9374,Elearning-0000-617,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020,n9860,50665,4,The 4 T's of hemorrhage etiology are:,166372,2,"t-cells, trauma, trickle, thrombosis",0
9374,Elearning-0000-617,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020,n9860,50665,4,The 4 T's of hemorrhage etiology are:,166373,3,"Tone, tolerance, tear, tension",0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50666,0,Sepsis is defined as which of the following:,166374,0,SIRS + infection,1
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50666,0,Sepsis is defined as which of the following:,166375,1,Presence of highly infectious bacteria in the blood,0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50666,0,Sepsis is defined as which of the following:,166376,2,System wide infection causing organ dysfunction,0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50666,0,Sepsis is defined as which of the following:,166377,3,Septic shock,0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50667,1,Risk factors for sepsis in the post-partum population include which of the following:,166378,0,Diabetes,0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50667,1,Risk factors for sepsis in the post-partum population include which of the following:,166379,1,Hypertension,0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50667,1,Risk factors for sepsis in the post-partum population include which of the following:,166380,2,Obesity,0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50667,1,Risk factors for sepsis in the post-partum population include which of the following:,166381,3,Use of antibiotics within 2 weeks before delivery,0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50667,1,Risk factors for sepsis in the post-partum population include which of the following:,166382,4,All of the above,1
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50668,2,Which of the following lab results indicates cell injury?,166383,0,"Platelets  80,000",0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50668,2,Which of the following lab results indicates cell injury?,166384,1,Creatinine 4,0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50668,2,Which of the following lab results indicates cell injury?,166385,2,"WBC 3,500",0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50668,2,Which of the following lab results indicates cell injury?,166386,3,All of the above,1
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50669,3,You are caring for a patient and her heart rate is 95 and respiratory rate is 22. She tells you that she was taking Macrobid for a UTI a week before she delivered. What is the appropriate nursing action?,166387,0,Notify MD for further orders,0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50669,3,You are caring for a patient and her heart rate is 95 and respiratory rate is 22. She tells you that she was taking Macrobid for a UTI a week before she delivered. What is the appropriate nursing action?,166388,1,Draw a stat serum lactate,1
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50669,3,You are caring for a patient and her heart rate is 95 and respiratory rate is 22. She tells you that she was taking Macrobid for a UTI a week before she delivered. What is the appropriate nursing action?,166389,2,Notify the Clinical Supervisor and assess patient's vital signs every 4 hour,0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50669,3,You are caring for a patient and her heart rate is 95 and respiratory rate is 22. She tells you that she was taking Macrobid for a UTI a week before she delivered. What is the appropriate nursing action?,166390,3,None of the above,0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50670,4,A serum lactate was drawn on your patient for suspected sepsis and it is 3. What is the appropriate nursing action?,166391,0,Notify MD and clinical supervisor,0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50670,4,A serum lactate was drawn on your patient for suspected sepsis and it is 3. What is the appropriate nursing action?,166392,1,"Nothing, a serum lactate of 3 is normal",0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50670,4,A serum lactate was drawn on your patient for suspected sepsis and it is 3. What is the appropriate nursing action?,166393,2,"Notify MD, get orders for blood cultures, broad spectrum antibiotics, and repeat lactate for 2 hrs",1
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50670,4,A serum lactate was drawn on your patient for suspected sepsis and it is 3. What is the appropriate nursing action?,166394,3,Notify rapid response,0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50671,5,Your patient weighs 75 kg. What is the appropriate amount for a fluid bolus according to the sepsis bundle?,166395,0,2250 mls,1
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50671,5,Your patient weighs 75 kg. What is the appropriate amount for a fluid bolus according to the sepsis bundle?,166396,1,500mls,0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50671,5,Your patient weighs 75 kg. What is the appropriate amount for a fluid bolus according to the sepsis bundle?,166397,2,225 mls,0
9379,Elearning-0000-621,FCC RESIDENCY MATERNAL SEPSIS FY2020,n9861,50671,5,Your patient weighs 75 kg. What is the appropriate amount for a fluid bolus according to the sepsis bundle?,166398,3,1000 mls,0
9380,Elearning-0000-622,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020,n9862,50672,0,Which of the following describes indirect/unconjugated bilirubin?,166399,0,Fat soluble,1
9380,Elearning-0000-622,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020,n9862,50672,0,Which of the following describes indirect/unconjugated bilirubin?,166400,1,Non-toxic,0
9380,Elearning-0000-622,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020,n9862,50672,0,Which of the following describes indirect/unconjugated bilirubin?,166401,2,Water soluble,0
9380,Elearning-0000-622,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020,n9862,50672,0,Which of the following describes indirect/unconjugated bilirubin?,166402,3,Excreted in the urine and stool,0
9380,Elearning-0000-622,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020,n9862,50673,1,Which of the following describes direct/conjugated bilirubin?,166403,0,Water soluble,0
9380,Elearning-0000-622,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020,n9862,50673,1,Which of the following describes direct/conjugated bilirubin?,166404,1,Non-toxic,0
9380,Elearning-0000-622,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020,n9862,50673,1,Which of the following describes direct/conjugated bilirubin?,166405,2,Excreted from the liver as a component of bile,0
9380,Elearning-0000-622,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020,n9862,50673,1,Which of the following describes direct/conjugated bilirubin?,166406,3,All of the above,1
9380,Elearning-0000-622,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020,n9862,50674,2,If you see jaundice before the infant is 24 hours of age it is pathological jaundice.,166407,0,TRUE,1
9380,Elearning-0000-622,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020,n9862,50674,2,If you see jaundice before the infant is 24 hours of age it is pathological jaundice.,166408,1,FALSE,0
9380,Elearning-0000-622,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020,n9862,50675,3,f you see jaundice after 24 hours of life it is physiological and it is not clinically significant.,166409,0,TRUE,0
9380,Elearning-0000-622,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020,n9862,50675,3,f you see jaundice after 24 hours of life it is physiological and it is not clinically significant.,166410,1,FALSE,1
9380,Elearning-0000-622,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020,n9862,50676,4,Physiological jaundice is the result of which of the following?,166411,0,Increased red blood cell destruction,0
9380,Elearning-0000-622,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020,n9862,50676,4,Physiological jaundice is the result of which of the following?,166412,1,Immature liver function in the newborn,0
9380,Elearning-0000-622,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020,n9862,50676,4,Physiological jaundice is the result of which of the following?,166413,2,Another disease process,0
9380,Elearning-0000-622,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020,n9862,50676,4,Physiological jaundice is the result of which of the following?,166414,3,A and B only,1
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50752,0,Please list the location for this activity.,166724,0,Atlanta,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50752,0,Please list the location for this activity.,166725,1,Cherokee,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50752,0,Please list the location for this activity.,166726,2,Forsyth,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50752,0,Please list the location for this activity.,166727,3,Other,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50753,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss evidenced based diagnosis and treatment strategies for COPD.  </ol>",166728,0,Strongly Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50753,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss evidenced based diagnosis and treatment strategies for COPD.  </ol>",166729,1,Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50753,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss evidenced based diagnosis and treatment strategies for COPD.  </ol>",166730,2,No Opinion,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50753,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss evidenced based diagnosis and treatment strategies for COPD.  </ol>",166731,3,Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50753,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss evidenced based diagnosis and treatment strategies for COPD.  </ol>",166732,4,Strongly Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50754,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the impact of inspiratory flow on device selection.</ol>",166733,0,Strongly Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50754,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the impact of inspiratory flow on device selection.</ol>",166734,1,Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50754,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the impact of inspiratory flow on device selection.</ol>",166735,2,No Opinion,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50754,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the impact of inspiratory flow on device selection.</ol>",166736,3,Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50754,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the impact of inspiratory flow on device selection.</ol>",166737,4,Strongly Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50755,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the importance of GOLD guidelines to improving outcomes for patients with COPD.</ol>",166738,0,Strongly Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50755,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the importance of GOLD guidelines to improving outcomes for patients with COPD.</ol>",166739,1,Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50755,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the importance of GOLD guidelines to improving outcomes for patients with COPD.</ol>",166740,2,No Opinion,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50755,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the importance of GOLD guidelines to improving outcomes for patients with COPD.</ol>",166741,3,Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50755,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the importance of GOLD guidelines to improving outcomes for patients with COPD.</ol>",166742,4,Strongly Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50756,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to match device selection with patient capabilities and state critical steps in inhaler device education. </ol>",166743,0,Strongly Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50756,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to match device selection with patient capabilities and state critical steps in inhaler device education. </ol>",166744,1,Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50756,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to match device selection with patient capabilities and state critical steps in inhaler device education. </ol>",166745,2,No Opinion,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50756,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to match device selection with patient capabilities and state critical steps in inhaler device education. </ol>",166746,3,Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50756,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to match device selection with patient capabilities and state critical steps in inhaler device education. </ol>",166747,4,Strongly Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50757,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the impact of nicotine dependency and vaping on the pulmonary system.</ol>",166748,0,Strongly Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50757,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the impact of nicotine dependency and vaping on the pulmonary system.</ol>",166749,1,Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50757,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the impact of nicotine dependency and vaping on the pulmonary system.</ol>",166750,2,No Opinion,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50757,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the impact of nicotine dependency and vaping on the pulmonary system.</ol>",166751,3,Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50757,5,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the impact of nicotine dependency and vaping on the pulmonary system.</ol>",166752,4,Strongly Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50758,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify steps for engaging patients in successful management of their COPD.</ol>",166753,0,Strongly Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50758,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify steps for engaging patients in successful management of their COPD.</ol>",166754,1,Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50758,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify steps for engaging patients in successful management of their COPD.</ol>",166755,2,No Opinion,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50758,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify steps for engaging patients in successful management of their COPD.</ol>",166756,3,Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50758,6,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify steps for engaging patients in successful management of their COPD.</ol>",166757,4,Strongly Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50759,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify COPD ""masqueraders"" and/or co-existent conditions to monitor. </ol>",166758,0,Strongly Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50759,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify COPD ""masqueraders"" and/or co-existent conditions to monitor. </ol>",166759,1,Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50759,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify COPD ""masqueraders"" and/or co-existent conditions to monitor. </ol>",166760,2,No Opinion,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50759,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify COPD ""masqueraders"" and/or co-existent conditions to monitor. </ol>",166761,3,Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50759,7,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify COPD ""masqueraders"" and/or co-existent conditions to monitor. </ol>",166762,4,Strongly Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50760,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss prognostication and symptom management for end-stage COPD.</ol>",166763,0,Strongly Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50760,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss prognostication and symptom management for end-stage COPD.</ol>",166764,1,Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50760,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss prognostication and symptom management for end-stage COPD.</ol>",166765,2,No Opinion,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50760,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss prognostication and symptom management for end-stage COPD.</ol>",166766,3,Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50760,8,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss prognostication and symptom management for end-stage COPD.</ol>",166767,4,Strongly Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50761,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss goals of care with patients and families impacted by COPD.</ol>",166768,0,Strongly Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50761,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss goals of care with patients and families impacted by COPD.</ol>",166769,1,Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50761,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss goals of care with patients and families impacted by COPD.</ol>",166770,2,No Opinion,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50761,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss goals of care with patients and families impacted by COPD.</ol>",166771,3,Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50761,9,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss goals of care with patients and families impacted by COPD.</ol>",166772,4,Strongly Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50762,10,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,166773,0,Strongly Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50762,10,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,166774,1,Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50762,10,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,166775,2,No Opinion,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50762,10,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,166776,3,Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50762,10,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,166777,4,Strongly Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50763,12,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",166778,0,Strongly Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50763,12,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",166779,1,Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50763,12,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",166780,2,No Opinion,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50763,12,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",166781,3,Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50763,12,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",166782,4,Strongly Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50764,11,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge and confidence in caring for and coaching patients with COPD. </OL>,166783,0,Strongly Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50764,11,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge and confidence in caring for and coaching patients with COPD. </OL>,166784,1,Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50764,11,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge and confidence in caring for and coaching patients with COPD. </OL>,166785,2,No Opinion,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50764,11,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge and confidence in caring for and coaching patients with COPD. </OL>,166786,3,Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50764,11,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge and confidence in caring for and coaching patients with COPD. </OL>,166787,4,Strongly Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50765,13,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",166788,0,Strongly Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50765,13,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",166789,1,Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50765,13,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",166790,2,No Opinion,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50765,13,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",166791,3,Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50765,13,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",166792,4,Strongly Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50766,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</OL>,166793,0,Strongly Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50766,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</OL>,166794,1,Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50766,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</OL>,166795,2,No Opinion,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50766,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</OL>,166796,3,Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50766,14,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</OL>,166797,4,Strongly Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50767,15,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,166798,0,Strongly Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50767,15,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,166799,1,Agree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50767,15,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,166800,2,No Opinion,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50767,15,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,166801,3,Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50767,15,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,166802,4,Strongly Disagree,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50768,16,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Brad Drummond, MD</ol>",166803,0,Excellent,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50768,16,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Brad Drummond, MD</ol>",166804,1,Very Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50768,16,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Brad Drummond, MD</ol>",166805,2,Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50768,16,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Brad Drummond, MD</ol>",166806,3,Fair,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50768,16,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Brad Drummond, MD</ol>",166807,4,Poor,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50769,17,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Matthew Haack, MD</ol>",166808,0,Excellent,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50769,17,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Matthew Haack, MD</ol>",166809,1,Very Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50769,17,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Matthew Haack, MD</ol>",166810,2,Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50769,17,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Matthew Haack, MD</ol>",166811,3,Fair,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50769,17,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Matthew Haack, MD</ol>",166812,4,Poor,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50770,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Sunil Vallurupalli, MD</ol>",166813,0,Excellent,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50770,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Sunil Vallurupalli, MD</ol>",166814,1,Very Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50770,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Sunil Vallurupalli, MD</ol>",166815,2,Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50770,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Sunil Vallurupalli, MD</ol>",166816,3,Fair,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50770,18,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Sunil Vallurupalli, MD</ol>",166817,4,Poor,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50771,19,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Alanna Breckinridge, PharmD</ol>",166818,0,Excellent,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50771,19,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Alanna Breckinridge, PharmD</ol>",166819,1,Very Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50771,19,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Alanna Breckinridge, PharmD</ol>",166820,2,Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50771,19,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Alanna Breckinridge, PharmD</ol>",166821,3,Fair,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50771,19,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Alanna Breckinridge, PharmD</ol>",166822,4,Poor,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50772,20,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Justin Henao, MD</ol>",166823,0,Excellent,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50772,20,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Justin Henao, MD</ol>",166824,1,Very Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50772,20,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Justin Henao, MD</ol>",166825,2,Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50772,20,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Justin Henao, MD</ol>",166826,3,Fair,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50772,20,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Justin Henao, MD</ol>",166827,4,Poor,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50773,21,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Haider Ali, MD</ol>",166828,0,Excellent,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50773,21,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Haider Ali, MD</ol>",166829,1,Very Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50773,21,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Haider Ali, MD</ol>",166830,2,Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50773,21,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Haider Ali, MD</ol>",166831,3,Fair,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50773,21,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Haider Ali, MD</ol>",166832,4,Poor,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50774,22,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Gregory Mauldin, MD</ol>",166833,0,Excellent,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50774,22,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Gregory Mauldin, MD</ol>",166834,1,Very Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50774,22,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Gregory Mauldin, MD</ol>",166835,2,Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50774,22,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Gregory Mauldin, MD</ol>",166836,3,Fair,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50774,22,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Gregory Mauldin, MD</ol>",166837,4,Poor,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50775,23,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Paul Weinberg, MD</ol>",166838,0,Excellent,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50775,23,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Paul Weinberg, MD</ol>",166839,1,Very Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50775,23,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Paul Weinberg, MD</ol>",166840,2,Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50775,23,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Paul Weinberg, MD</ol>",166841,3,Fair,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50775,23,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Paul Weinberg, MD</ol>",166842,4,Poor,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50776,24,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Raxit Patel, MD</ol>",166843,0,Excellent,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50776,24,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Raxit Patel, MD</ol>",166844,1,Very Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50776,24,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Raxit Patel, MD</ol>",166845,2,Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50776,24,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Raxit Patel, MD</ol>",166846,3,Fair,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50776,24,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Raxit Patel, MD</ol>",166847,4,Poor,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50777,25,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rani Kumaran, MD</ol>",166848,0,Excellent,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50777,25,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rani Kumaran, MD</ol>",166849,1,Very Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50777,25,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rani Kumaran, MD</ol>",166850,2,Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50777,25,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rani Kumaran, MD</ol>",166851,3,Fair,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50777,25,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rani Kumaran, MD</ol>",166852,4,Poor,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50778,26,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Simha Jagadeesh, MD</ol>",166853,0,Excellent,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50778,26,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Simha Jagadeesh, MD</ol>",166854,1,Very Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50778,26,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Simha Jagadeesh, MD</ol>",166855,2,Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50778,26,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Simha Jagadeesh, MD</ol>",166856,3,Fair,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50778,26,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Simha Jagadeesh, MD</ol>",166857,4,Poor,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50779,27,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Huda Sayeed, MD</ol>",166858,0,Excellent,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50779,27,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Huda Sayeed, MD</ol>",166859,1,Very Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50779,27,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Huda Sayeed, MD</ol>",166860,2,Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50779,27,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Huda Sayeed, MD</ol>",166861,3,Fair,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50779,27,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Huda Sayeed, MD</ol>",166862,4,Poor,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50780,28,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Jill Rossrucker, MD</ol>",166863,0,Excellent,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50780,28,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Jill Rossrucker, MD</ol>",166864,1,Very Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50780,28,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Jill Rossrucker, MD</ol>",166865,2,Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50780,28,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Jill Rossrucker, MD</ol>",166866,3,Fair,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50780,28,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Jill Rossrucker, MD</ol>",166867,4,Poor,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50781,29,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Steven Accarino, MD</ol>",166868,0,Excellent,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50781,29,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Steven Accarino, MD</ol>",166869,1,Very Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50781,29,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Steven Accarino, MD</ol>",166870,2,Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50781,29,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Steven Accarino, MD</ol>",166871,3,Fair,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50781,29,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Steven Accarino, MD</ol>",166872,4,Poor,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50782,30,"Overall, this activity was:",166873,0,Excellent,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50782,30,"Overall, this activity was:",166874,1,Very Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50782,30,"Overall, this activity was:",166875,2,Good,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50782,30,"Overall, this activity was:",166876,3,Fair,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50782,30,"Overall, this activity was:",166877,4,Poor,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50783,31,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",166878,0,Yes,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50783,31,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",166879,1,No,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50783,31,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",166880,2,N/A,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50786,34,How would you improve this class?,166881,0,Reduce content covered in class,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50786,34,How would you improve this class?,166882,1,Increase content covered in class,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50786,34,How would you improve this class?,166883,2,Update content covered in class,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50786,34,How would you improve this class?,166884,3,Improve the instructional methods,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50786,34,How would you improve this class?,166885,4,Make course activities more stimulating,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50786,34,How would you improve this class?,166886,5,Slow the pace of the class,0
1196,ILT-0000-4819,COPD SYMPOSIUM: STATE OF THE ART CARE (EVALUATION SURVEY)  ALPHARETTA  3.7.20,n9867,50786,34,How would you improve this class?,166887,6,"Nothing: (appropriate speakers, content, facility, etc.)",0
9383,Elearning-0000-625,FCC RESIDENCY ABO FY2020,n9868,50789,0,Select the antigens below that are the frameworks of the ABO system:,166888,0,A,0
9383,Elearning-0000-625,FCC RESIDENCY ABO FY2020,n9868,50789,0,Select the antigens below that are the frameworks of the ABO system:,166889,1,B,0
9383,Elearning-0000-625,FCC RESIDENCY ABO FY2020,n9868,50789,0,Select the antigens below that are the frameworks of the ABO system:,166890,2,O,0
9383,Elearning-0000-625,FCC RESIDENCY ABO FY2020,n9868,50789,0,Select the antigens below that are the frameworks of the ABO system:,166891,3,A and B only,1
9383,Elearning-0000-625,FCC RESIDENCY ABO FY2020,n9868,50790,1,If someone is Rh positive this means they have a D antigen on their red blood cell.,166892,0,TRUE,1
9383,Elearning-0000-625,FCC RESIDENCY ABO FY2020,n9868,50790,1,If someone is Rh positive this means they have a D antigen on their red blood cell.,166893,1,FALSE,0
9383,Elearning-0000-625,FCC RESIDENCY ABO FY2020,n9868,50791,2,An antibody is a protein produced by the immune system in response to the presence of an antigen.,166894,0,TRUE,1
9383,Elearning-0000-625,FCC RESIDENCY ABO FY2020,n9868,50791,2,An antibody is a protein produced by the immune system in response to the presence of an antigen.,166895,1,FALSE,0
9383,Elearning-0000-625,FCC RESIDENCY ABO FY2020,n9868,50792,3,"If someone's blood phenotype is A, what are their possible genotypes?",166896,0,AA,0
9383,Elearning-0000-625,FCC RESIDENCY ABO FY2020,n9868,50792,3,"If someone's blood phenotype is A, what are their possible genotypes?",166897,1,AO,0
9383,Elearning-0000-625,FCC RESIDENCY ABO FY2020,n9868,50792,3,"If someone's blood phenotype is A, what are their possible genotypes?",166898,2,AB,0
9383,Elearning-0000-625,FCC RESIDENCY ABO FY2020,n9868,50792,3,"If someone's blood phenotype is A, what are their possible genotypes?",166899,3,AA and AO,1
9383,Elearning-0000-625,FCC RESIDENCY ABO FY2020,n9868,50793,4,Rh sensitization occurs when an Rh negative mother comes in contact with Rh positive blood.,166900,0,TRUE,1
9383,Elearning-0000-625,FCC RESIDENCY ABO FY2020,n9868,50793,4,Rh sensitization occurs when an Rh negative mother comes in contact with Rh positive blood.,166901,1,FALSE,0
9383,Elearning-0000-625,FCC RESIDENCY ABO FY2020,n9868,50794,5,Newborn consequences of maternal newborn blood incompatibility include which of the following:,166902,0,Anemia,0
9383,Elearning-0000-625,FCC RESIDENCY ABO FY2020,n9868,50794,5,Newborn consequences of maternal newborn blood incompatibility include which of the following:,166903,1,Jaundice,0
9383,Elearning-0000-625,FCC RESIDENCY ABO FY2020,n9868,50794,5,Newborn consequences of maternal newborn blood incompatibility include which of the following:,166904,2,Hydrops Fetalis,0
9383,Elearning-0000-625,FCC RESIDENCY ABO FY2020,n9868,50794,5,Newborn consequences of maternal newborn blood incompatibility include which of the following:,166905,3,All of the above,1
9792,Elearning-0000-997,SURGICAL SERVICES: STANDARD PRECAUTIONS AND ISOLATION POLICY UPDATES,n9869,50795,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the ""Surgical Services: Standard Precautions and Isolation Policy Updates"" CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",166906,0,TRUE,1
9792,Elearning-0000-997,SURGICAL SERVICES: STANDARD PRECAUTIONS AND ISOLATION POLICY UPDATES,n9869,50795,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the ""Surgical Services: Standard Precautions and Isolation Policy Updates"" CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",166907,1,FALSE,0
9409,Elearning-0000-649,ED OBSTETRICAL HEMORRHAGE AND HYPERTENSION,n9885,50914,0,A patient who delivered a baby a month ago is no longer considered an obstetric patient?,167338,0,TRUE,0
9409,Elearning-0000-649,ED OBSTETRICAL HEMORRHAGE AND HYPERTENSION,n9885,50914,0,A patient who delivered a baby a month ago is no longer considered an obstetric patient?,167339,1,FALSE,1
9409,Elearning-0000-649,ED OBSTETRICAL HEMORRHAGE AND HYPERTENSION,n9885,50915,1,A 32-year-old female reports vaginal bleeding in triage.  What should you ask her?,167340,0,A. Could you be pregnant?,0
9409,Elearning-0000-649,ED OBSTETRICAL HEMORRHAGE AND HYPERTENSION,n9885,50915,1,A 32-year-old female reports vaginal bleeding in triage.  What should you ask her?,167341,1,B. Have you been pregnant within the last 6 weeks?,0
9409,Elearning-0000-649,ED OBSTETRICAL HEMORRHAGE AND HYPERTENSION,n9885,50915,1,A 32-year-old female reports vaginal bleeding in triage.  What should you ask her?,167342,2,C. Both A & B,1
9409,Elearning-0000-649,ED OBSTETRICAL HEMORRHAGE AND HYPERTENSION,n9885,50915,1,A 32-year-old female reports vaginal bleeding in triage.  What should you ask her?,167343,3,D. None of the above,0
9409,Elearning-0000-649,ED OBSTETRICAL HEMORRHAGE AND HYPERTENSION,n9885,50916,2,A patient who is two weeks post-partum presents with heavy vaginal bleeding.  What does the initial treatment for this patient include?,167344,0,Notify physician,0
9409,Elearning-0000-649,ED OBSTETRICAL HEMORRHAGE AND HYPERTENSION,n9885,50916,2,A patient who is two weeks post-partum presents with heavy vaginal bleeding.  What does the initial treatment for this patient include?,167345,1,Obtain IV access and rainbow draw labs,0
9409,Elearning-0000-649,ED OBSTETRICAL HEMORRHAGE AND HYPERTENSION,n9885,50916,2,A patient who is two weeks post-partum presents with heavy vaginal bleeding.  What does the initial treatment for this patient include?,167346,2,Anticipate transfer to OR,0
9409,Elearning-0000-649,ED OBSTETRICAL HEMORRHAGE AND HYPERTENSION,n9885,50916,2,A patient who is two weeks post-partum presents with heavy vaginal bleeding.  What does the initial treatment for this patient include?,167347,3,All of the above,1
9409,Elearning-0000-649,ED OBSTETRICAL HEMORRHAGE AND HYPERTENSION,n9885,50917,3,A patient who is 4 weeks post-partum presents to triage with a headache.  Initial blood pressure is 164/92.  A re-check of her BP later is 168/98.  What is your FIRST action?,167348,0,Take her to Labor & Delivery,0
9409,Elearning-0000-649,ED OBSTETRICAL HEMORRHAGE AND HYPERTENSION,n9885,50917,3,A patient who is 4 weeks post-partum presents to triage with a headache.  Initial blood pressure is 164/92.  A re-check of her BP later is 168/98.  What is your FIRST action?,167349,1,Notify the ED physician,1
9409,Elearning-0000-649,ED OBSTETRICAL HEMORRHAGE AND HYPERTENSION,n9885,50917,3,A patient who is 4 weeks post-partum presents to triage with a headache.  Initial blood pressure is 164/92.  A re-check of her BP later is 168/98.  What is your FIRST action?,167350,2,Give Labetalol 40mg IVP,0
9409,Elearning-0000-649,ED OBSTETRICAL HEMORRHAGE AND HYPERTENSION,n9885,50917,3,A patient who is 4 weeks post-partum presents to triage with a headache.  Initial blood pressure is 164/92.  A re-check of her BP later is 168/98.  What is your FIRST action?,167351,3,Wait 60 minutes and re-check the blood pressure,0
9409,Elearning-0000-649,ED OBSTETRICAL HEMORRHAGE AND HYPERTENSION,n9885,50918,4,Which of the following is NOT a medication typically used to treat obstetrical hypertension?,167352,0,SL Nitroglycerin,1
9409,Elearning-0000-649,ED OBSTETRICAL HEMORRHAGE AND HYPERTENSION,n9885,50918,4,Which of the following is NOT a medication typically used to treat obstetrical hypertension?,167353,1,IV Labetalol,0
9409,Elearning-0000-649,ED OBSTETRICAL HEMORRHAGE AND HYPERTENSION,n9885,50918,4,Which of the following is NOT a medication typically used to treat obstetrical hypertension?,167354,2,IV Hydralazine,0
9409,Elearning-0000-649,ED OBSTETRICAL HEMORRHAGE AND HYPERTENSION,n9885,50918,4,Which of the following is NOT a medication typically used to treat obstetrical hypertension?,167355,3,PO Nifedipine,0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50816,0,The Global Surgical Package is a single payment for all care associate with a surgical procedure.,166964,0,TRUE,1
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50816,0,The Global Surgical Package is a single payment for all care associate with a surgical procedure.,166965,1,FALSE,0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50817,1,Payment is based on which phase of the surgical procedure.,166966,0,A) Preoperative evaluation,0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50817,1,Payment is based on which phase of the surgical procedure.,166967,1,B) Intra-operative procedure,0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50817,1,Payment is based on which phase of the surgical procedure.,166968,2,"C) Postoperative care for either 0, 10, 90 days",0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50817,1,Payment is based on which phase of the surgical procedure.,166969,3,D) All of the above,1
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50817,1,Payment is based on which phase of the surgical procedure.,166970,4,E) C only,0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50818,2,"Services that are normally a ""usual and necessary"" part of the surgical procedure are considered a part of the Postoperative Care phase.",166971,0,TRUE,0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50818,2,"Services that are normally a ""usual and necessary"" part of the surgical procedure are considered a part of the Postoperative Care phase.",166972,1,FALSE,1
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50819,3,The following services are included in the postoperative care:,166973,0,A) Local incision care,0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50819,3,The following services are included in the postoperative care:,166974,1,B) Decision for surgery,0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50819,3,The following services are included in the postoperative care:,166975,2,C) Postoperative pain management,0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50819,3,The following services are included in the postoperative care:,166976,3,D) A and B,0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50819,3,The following services are included in the postoperative care:,166977,4,E) A and C,1
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50820,4,Which surgical indicator represents Endoscopies?,166978,0,"A) ""ZZZ""",0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50820,4,Which surgical indicator represents Endoscopies?,166979,1,"B) ""000""",1
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50820,4,Which surgical indicator represents Endoscopies?,166980,2,"C) ""090""",0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50820,4,Which surgical indicator represents Endoscopies?,166981,3,"D) ""YYY""",0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50820,4,Which surgical indicator represents Endoscopies?,166982,4,"E) ""010""",0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50821,5,"An endoscopy represents a simple procedure, wherein there is no preoperative/postoperative period and the global period is only the day of the procedure.",166983,0,TRUE,1
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50821,5,"An endoscopy represents a simple procedure, wherein there is no preoperative/postoperative period and the global period is only the day of the procedure.",166984,1,FALSE,0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50822,6,There are 92 days in the global surgical period for major surgical procedures.,166985,0,TRUE,1
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50822,6,There are 92 days in the global surgical period for major surgical procedures.,166986,1,FALSE,0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50823,7,The global surgical package <u>includes</u> return trips to the operating room for complications from surgery.,166987,0,TRUE,0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50823,7,The global surgical package <u>includes</u> return trips to the operating room for complications from surgery.,166988,1,FALSE,1
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50824,8,Global surgery only applies in the inpatient hospital setting.,166989,0,TRUE,0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50824,8,Global surgery only applies in the inpatient hospital setting.,166990,1,FALSE,1
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50825,9,Postoperative E/M visits included in the global period are reported with:,166991,0,A) 99204,0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50825,9,Postoperative E/M visits included in the global period are reported with:,166992,1,B) 99214,0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50825,9,Postoperative E/M visits included in the global period are reported with:,166993,2,C) 99244,0
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50825,9,Postoperative E/M visits included in the global period are reported with:,166994,3,D) 99024,1
8128,Elearning-0000-1025,REV INT - GLOBAL SURGICAL PACKAGE,n9878,50825,9,Postoperative E/M visits included in the global period are reported with:,166995,4,E) Not reported,0
1212,ILT-0000-4902,COVID-19,n9882,50870,0,"I acknowledge that I have read and understand the ""UPDATE ON COVID-19"" CBL in its entirety.",167171,0,TRUE,1
1212,ILT-0000-4902,COVID-19,n9882,50870,0,"I acknowledge that I have read and understand the ""UPDATE ON COVID-19"" CBL in its entirety.",167172,1,FALSE,0
9376,Elearning-0000-619,FCC RESIDENCY NEWBORN EMERGENCIES FY2020,n9899,51006,0,What assessments are performed if the newborn is exhibiting signs of respiratory distress?,167686,0,"Respiratory rate, pulse oximetry, breath sounds, work of breathing, and color.",1
9376,Elearning-0000-619,FCC RESIDENCY NEWBORN EMERGENCIES FY2020,n9899,51006,0,What assessments are performed if the newborn is exhibiting signs of respiratory distress?,167687,1,"Heart rate, blood sugar, temperature, and capillary refill.",0
9376,Elearning-0000-619,FCC RESIDENCY NEWBORN EMERGENCIES FY2020,n9899,51006,0,What assessments are performed if the newborn is exhibiting signs of respiratory distress?,167688,2,"Weight, feeding status, amount of time in between feedings, and regurgitations of feedings.",0
9376,Elearning-0000-619,FCC RESIDENCY NEWBORN EMERGENCIES FY2020,n9899,51006,0,What assessments are performed if the newborn is exhibiting signs of respiratory distress?,167689,3,"Temperature, sweating, maternal labs, method of delivery.",0
9376,Elearning-0000-619,FCC RESIDENCY NEWBORN EMERGENCIES FY2020,n9899,51007,1,Pallor is more concerning than cyanosis in an infant.,167690,0,TRUE,1
9376,Elearning-0000-619,FCC RESIDENCY NEWBORN EMERGENCIES FY2020,n9899,51007,1,Pallor is more concerning than cyanosis in an infant.,167691,1,FALSE,0
9376,Elearning-0000-619,FCC RESIDENCY NEWBORN EMERGENCIES FY2020,n9899,51008,2,How do we call a code for a baby that is in distress?,167692,0,Dial 8911.,0
9376,Elearning-0000-619,FCC RESIDENCY NEWBORN EMERGENCIES FY2020,n9899,51008,2,How do we call a code for a baby that is in distress?,167693,1,Call 911.,0
9376,Elearning-0000-619,FCC RESIDENCY NEWBORN EMERGENCIES FY2020,n9899,51008,2,How do we call a code for a baby that is in distress?,167694,2,Obtain help from your supervisor only.,0
9376,Elearning-0000-619,FCC RESIDENCY NEWBORN EMERGENCIES FY2020,n9899,51008,2,How do we call a code for a baby that is in distress?,167695,3,Call the Resus team by the white phone or dial 7323.,1
9376,Elearning-0000-619,FCC RESIDENCY NEWBORN EMERGENCIES FY2020,n9899,51009,3,One way to determine if the baby is seizing vs. jitteriness is to place a hand on the affected area. If the movement stops it does not indicate a seizure.,167696,0,TRUE,1
9376,Elearning-0000-619,FCC RESIDENCY NEWBORN EMERGENCIES FY2020,n9899,51009,3,One way to determine if the baby is seizing vs. jitteriness is to place a hand on the affected area. If the movement stops it does not indicate a seizure.,167697,1,FALSE,0
9376,Elearning-0000-619,FCC RESIDENCY NEWBORN EMERGENCIES FY2020,n9899,51010,4,"If a baby is dropped, or their head is hit on an object, it needs to be reported immediately for further evaluation to ensure no harm has come to the baby.",167698,0,TRUE,1
9376,Elearning-0000-619,FCC RESIDENCY NEWBORN EMERGENCIES FY2020,n9899,51010,4,"If a baby is dropped, or their head is hit on an object, it needs to be reported immediately for further evaluation to ensure no harm has come to the baby.",167699,1,FALSE,0
9376,Elearning-0000-619,FCC RESIDENCY NEWBORN EMERGENCIES FY2020,n9899,51011,5,A mother falls asleep with her baby and accidently drops the baby onto the floor. She is too embarrassed to tell and does not inform the staff until many hours later. The newborn is transferred to special care nursery for observation and further testing. How will you discuss this matter with the parents?,167700,0,"Educate the parents on the process that is going to take place with the baby. The location of the baby, and the contact information on how to reach the area that the baby is located.",1
9376,Elearning-0000-619,FCC RESIDENCY NEWBORN EMERGENCIES FY2020,n9899,51011,5,A mother falls asleep with her baby and accidently drops the baby onto the floor. She is too embarrassed to tell and does not inform the staff until many hours later. The newborn is transferred to special care nursery for observation and further testing. How will you discuss this matter with the parents?,167701,1,Place blame on the parents for not telling staff earlier.,0
9376,Elearning-0000-619,FCC RESIDENCY NEWBORN EMERGENCIES FY2020,n9899,51011,5,A mother falls asleep with her baby and accidently drops the baby onto the floor. She is too embarrassed to tell and does not inform the staff until many hours later. The newborn is transferred to special care nursery for observation and further testing. How will you discuss this matter with the parents?,167702,2,Tell the parents that only Special Care nursery staff has the information they need and will be in touch with them when they figure out what is wrong with the baby.,0
9376,Elearning-0000-619,FCC RESIDENCY NEWBORN EMERGENCIES FY2020,n9899,51011,5,A mother falls asleep with her baby and accidently drops the baby onto the floor. She is too embarrassed to tell and does not inform the staff until many hours later. The newborn is transferred to special care nursery for observation and further testing. How will you discuss this matter with the parents?,167703,3,Transfer the baby and do not discuss anything with the parents. It's not your place.,0
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51012,0,Which of the following BP values is considered hypertension?,167704,0,145/85,0
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51012,0,Which of the following BP values is considered hypertension?,167705,1,136/92,0
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51012,0,Which of the following BP values is considered hypertension?,167706,2,166/95,0
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51012,0,Which of the following BP values is considered hypertension?,167707,3,All of the above,1
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51013,1,According to NEWT when should the provider be notified for new onset elevated BP (not hypertensive emergency)?,167708,0,One occasion of elevated blood pressure,0
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51013,1,According to NEWT when should the provider be notified for new onset elevated BP (not hypertensive emergency)?,167709,1,2 consecutive occasions of elevated blood pressure,0
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51013,1,According to NEWT when should the provider be notified for new onset elevated BP (not hypertensive emergency)?,167710,2,2 separate occasions of elevated blood pressure within 4 hours,1
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51013,1,According to NEWT when should the provider be notified for new onset elevated BP (not hypertensive emergency)?,167711,3,A minimum of 3 elevated blood pressure occasions and evidence of organ involvement,0
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51014,2,What does HELLP stand for?,167712,0,"Hemolysis, Elevated Liver Enzymes, Low Platelets",1
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51014,2,What does HELLP stand for?,167713,1,"Hemoglobin, Eosinophils, Lung sounds, Liver enzymes, Proteinuria",0
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51014,2,What does HELLP stand for?,167714,2,"Hematocrit, Elevated BP, Low Liver Enzymes, Platelets",0
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51014,2,What does HELLP stand for?,167715,3,"Headache, Elevated BP, Liver Enzymes, Low Platelets",0
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51015,3,How is Acute Hypertensive Emergency defined?,167716,0,BP greater than or equal to 185/110,0
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51015,3,How is Acute Hypertensive Emergency defined?,167717,1,Systolic BP greater than or equal to 140 or Diastolic BP greater than or equal to 90,0
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51015,3,How is Acute Hypertensive Emergency defined?,167718,2,Systolic BP greater than or equal to 160 or Diastolic BP greater than or equal to 110,0
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51015,3,How is Acute Hypertensive Emergency defined?,167719,3,"Systolic BP greater than or equal to 160 or Diastolic BP greater than or equal to 110, sustained for 15 minutes",1
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51016,4,What is the best way to predict that your patient will develop eclampsia?,167720,0,There is no way to predict who will develop eclampsia,1
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51016,4,What is the best way to predict that your patient will develop eclampsia?,167721,1,Patients presenting with headache and visual disturbances,0
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51016,4,What is the best way to predict that your patient will develop eclampsia?,167722,2,Patients whose BP is greater than 160/110,0
9381,Elearning-0000-623,FCC RESIDENCY HYPERTENSION IN PREGNANCY FY2020,n9900,51016,4,What is the best way to predict that your patient will develop eclampsia?,167723,3,Patient whose BP is greater than 200/100,0
9378,Elearning-0000-620,FCC RESIDENCY NAS FY2020,n9904,51041,0,"Drug withdrawal is a process, with symptoms that are expected to be temporary. It is NOT a birth defect.",167818,0,TRUE,1
9378,Elearning-0000-620,FCC RESIDENCY NAS FY2020,n9904,51041,0,"Drug withdrawal is a process, with symptoms that are expected to be temporary. It is NOT a birth defect.",167819,1,FALSE,0
9378,Elearning-0000-620,FCC RESIDENCY NAS FY2020,n9904,51042,1,Clinical features of NAS neurological excitability include which of the following:,167820,0,Tremors,0
9378,Elearning-0000-620,FCC RESIDENCY NAS FY2020,n9904,51042,1,Clinical features of NAS neurological excitability include which of the following:,167821,1,Irritability,0
9378,Elearning-0000-620,FCC RESIDENCY NAS FY2020,n9904,51042,1,Clinical features of NAS neurological excitability include which of the following:,167822,2,Frequent yawning,0
9378,Elearning-0000-620,FCC RESIDENCY NAS FY2020,n9904,51042,1,Clinical features of NAS neurological excitability include which of the following:,167823,3,All of the above,1
9378,Elearning-0000-620,FCC RESIDENCY NAS FY2020,n9904,51043,2,Which of the following is the gold standard test for drug screening in the neonate?,167824,0,Urine collected soon after birth,0
9378,Elearning-0000-620,FCC RESIDENCY NAS FY2020,n9904,51043,2,Which of the following is the gold standard test for drug screening in the neonate?,167825,1,Meconium,1
9378,Elearning-0000-620,FCC RESIDENCY NAS FY2020,n9904,51043,2,Which of the following is the gold standard test for drug screening in the neonate?,167826,2,Umbilical cord,0
9378,Elearning-0000-620,FCC RESIDENCY NAS FY2020,n9904,51043,2,Which of the following is the gold standard test for drug screening in the neonate?,167827,3,All of the above,0
9378,Elearning-0000-620,FCC RESIDENCY NAS FY2020,n9904,51044,3,You discover that a mother used Percocet 5mg daily throughout her pregnancy for chronic back pain. What is the appropriate nursing action?,167828,0,Nothing since it is a prescribed medication.,0
9378,Elearning-0000-620,FCC RESIDENCY NAS FY2020,n9904,51044,3,You discover that a mother used Percocet 5mg daily throughout her pregnancy for chronic back pain. What is the appropriate nursing action?,167829,1,Notify pediatrician and begin NAS scoring every 4 hours.,1
9378,Elearning-0000-620,FCC RESIDENCY NAS FY2020,n9904,51044,3,You discover that a mother used Percocet 5mg daily throughout her pregnancy for chronic back pain. What is the appropriate nursing action?,167830,2,Instruct the mother to not breastfeed.,0
9378,Elearning-0000-620,FCC RESIDENCY NAS FY2020,n9904,51044,3,You discover that a mother used Percocet 5mg daily throughout her pregnancy for chronic back pain. What is the appropriate nursing action?,167831,3,All of the above,0
4355,ILT-0000-19567,STAFF MEETING ONCOLOGY DEPT 611,n10011,51386,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",169015,0,TRUE,1
4355,ILT-0000-19567,STAFF MEETING ONCOLOGY DEPT 611,n10011,51386,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",169016,1,FALSE,0
99,SCORM-0000-181,TEMPORARY TELECOMMUTING GUIDELINES,n9943,51253,0,"I acknowledge that I have read and understand the ""Temporary Telecommuting Guidelines"" in its entirety.",168616,0,TRUE,1
99,SCORM-0000-181,TEMPORARY TELECOMMUTING GUIDELINES,n9943,51253,0,"I acknowledge that I have read and understand the ""Temporary Telecommuting Guidelines"" in its entirety.",168617,1,FALSE,0
245,SCORM-0000-55,INTERNET SECURITY ACCESS AND EXTERNAL EMAIL POLICY,n9945,51255,0,"I acknowledge that I have read and understand the ""Internet Security Access and External Email Policy"" in its entirety.",168620,0,TRUE,1
245,SCORM-0000-55,INTERNET SECURITY ACCESS AND EXTERNAL EMAIL POLICY,n9945,51255,0,"I acknowledge that I have read and understand the ""Internet Security Access and External Email Policy"" in its entirety.",168621,1,FALSE,0
253,SCORM-0000-63,LAPTOP COMPUTER AND PORTABLE STORAGE POLICY,n9946,51256,0,"I acknowledge that I have read and understand the ""Laptop Computer and Portable Storage Policy"" in its entirety.",168622,0,TRUE,1
253,SCORM-0000-63,LAPTOP COMPUTER AND PORTABLE STORAGE POLICY,n9946,51256,0,"I acknowledge that I have read and understand the ""Laptop Computer and Portable Storage Policy"" in its entirety.",168623,1,FALSE,0
258,SCORM-0000-68,NETWORK SECURITY POLICY,n9947,51257,0,"I acknowledge that I have read and understand the ""Network Security Policy"" in its entirety.",168624,0,TRUE,1
258,SCORM-0000-68,NETWORK SECURITY POLICY,n9947,51257,0,"I acknowledge that I have read and understand the ""Network Security Policy"" in its entirety.",168625,1,FALSE,0
8359,Elearning-0000-1233,COVID-19 GUIDELINES FOR WOMEN'S SERVICES,n9951,51266,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the ""COVID-19 Guidelines for Women's Services"" CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",168648,0,TRUE,1
8359,Elearning-0000-1233,COVID-19 GUIDELINES FOR WOMEN'S SERVICES,n9951,51266,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the ""COVID-19 Guidelines for Women's Services"" CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",168649,1,FALSE,0
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51277,0,What is a reason for delayed Postpartum Hemorrhage (PPH)?,168656,0,A. Infection,0
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51277,0,What is a reason for delayed Postpartum Hemorrhage (PPH)?,168657,1,B. Subinvolution of uterus,0
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51277,0,What is a reason for delayed Postpartum Hemorrhage (PPH)?,168658,2,C. Retained products of conception,0
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51277,0,What is a reason for delayed Postpartum Hemorrhage (PPH)?,168659,3,D. All of the above,1
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51278,1,What medications are used for Postpartum Hemorrhage (PPH)?,168660,0,A. Tranexamic acid,0
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51278,1,What medications are used for Postpartum Hemorrhage (PPH)?,168661,1,B. Oxytocin,0
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51278,1,What medications are used for Postpartum Hemorrhage (PPH)?,168662,2,C. Hemabate,0
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51278,1,What medications are used for Postpartum Hemorrhage (PPH)?,168663,3,D. Cytotec,0
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51278,1,What medications are used for Postpartum Hemorrhage (PPH)?,168664,4,E. Methergine,0
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51278,1,What medications are used for Postpartum Hemorrhage (PPH)?,168665,5,F. All of the above,1
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51279,2,There is a policy in Lucidoc addressing Postpartum Hemorrhage (PPH).,168666,0,A. True,1
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51279,2,There is a policy in Lucidoc addressing Postpartum Hemorrhage (PPH).,168667,1,B. False,0
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51280,3,"Postpartum Hemorrhage (PPH) is defined as a cumulative blood loss of greater than or equal to 1,000 mL or blood loss accompanied by signs or symptoms of hypovolemia within 24 hours after the birth process.",168668,0,A. True,1
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51280,3,"Postpartum Hemorrhage (PPH) is defined as a cumulative blood loss of greater than or equal to 1,000 mL or blood loss accompanied by signs or symptoms of hypovolemia within 24 hours after the birth process.",168669,1,B. False,0
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51281,4,Which of the following would be reasons for late recognition of OB Hemorrhage?,168670,0,A. Under recognition of blood loss,0
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51281,4,Which of the following would be reasons for late recognition of OB Hemorrhage?,168671,1,B. Lack of attention to vital signs indicating hypovolemia,0
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51281,4,Which of the following would be reasons for late recognition of OB Hemorrhage?,168672,2,C. Failure to act decisively/failure to restore blood volume,0
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51281,4,Which of the following would be reasons for late recognition of OB Hemorrhage?,168673,3,D. All of the above,1
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51282,5,What increases a women's risk for Postpartum Hemorrhage (PPH)?,168674,0,"A. Greater than 4 pregnancies, multiple gestation, advanced maternal age, and rapid delivery",0
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51282,5,What increases a women's risk for Postpartum Hemorrhage (PPH)?,168675,1,"B. Prolonged labor, preeclampsia, and history of PPH",0
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51282,5,What increases a women's risk for Postpartum Hemorrhage (PPH)?,168676,2,"C. Cesarean section, operative vaginal delivery, retained products of conception, undiagnosed placenta accreta spectrum, and placenta previa",0
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51282,5,What increases a women's risk for Postpartum Hemorrhage (PPH)?,168677,3,D. A and C,0
8109,Elearning-0000-1008,SURGICAL SERVICES: FY2020 OBSTETRICAL HEMORRHAGE EDUCATION,n9957,51282,5,What increases a women's risk for Postpartum Hemorrhage (PPH)?,168678,4,E. All of the above,1
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51283,0,"As you sit down to chart you notice a message with a threat written on it, you should""",168679,0,Throw it in the trash can immediately,0
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51283,0,"As you sit down to chart you notice a message with a threat written on it, you should""",168680,1,Pick it up and take it to your charge RN or supervisor,0
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51283,0,"As you sit down to chart you notice a message with a threat written on it, you should""",168681,2,"Handle the message as little as possible, call security and place message in clean plastic bag",0
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51283,0,"As you sit down to chart you notice a message with a threat written on it, you should""",168682,3,"Call charge RN, supervisor and security and sweep the area for anything that looks suspicious",0
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51283,0,"As you sit down to chart you notice a message with a threat written on it, you should""",168683,4,Both C and D,1
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51284,1,The best place to find policies for any emergency is,168684,0,Lucidoc,1
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51284,1,The best place to find policies for any emergency is,168685,1,Netlearning,0
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51284,1,The best place to find policies for any emergency is,168686,2,The news,0
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51285,2,You are consulting on a woman who has preeclampsia and gestational diabetes when she begins to have difficulty speaking and facial drooping. You expect that she may be having a stroke related to high blood pressure. What would you do first?,168687,0,Attempt to get her to talk to you. Maybe this is temporary,0
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51285,2,You are consulting on a woman who has preeclampsia and gestational diabetes when she begins to have difficulty speaking and facial drooping. You expect that she may be having a stroke related to high blood pressure. What would you do first?,168688,1,"Call for help immediately, a stroke needs to be treated as soon as possible",1
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51285,2,You are consulting on a woman who has preeclampsia and gestational diabetes when she begins to have difficulty speaking and facial drooping. You expect that she may be having a stroke related to high blood pressure. What would you do first?,168689,2,Get a blood sugar,0
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51286,3,"The correct steps to a successful resuscitation in order of priority are""",168690,0,"Activate Emergency Response, defibrillate, chest compressions, ventilate and suction",0
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51286,3,"The correct steps to a successful resuscitation in order of priority are""",168691,1,"Activate Emergency Response, chest compressions, defibrillate, ventilate, and suction",1
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51286,3,"The correct steps to a successful resuscitation in order of priority are""",168692,2,"Chest compressions, defibrillate, activate emergency response, ventilate and suction",0
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51286,3,"The correct steps to a successful resuscitation in order of priority are""",168693,3,"Ventilate and suction, chest compressions, activate emergency response and defibrillate",0
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51287,4,The correct rate for chest compressions on an adult is 100-120 compressions per minute,168694,0,TRUE,1
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51287,4,The correct rate for chest compressions on an adult is 100-120 compressions per minute,168695,1,FALSE,0
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51288,5,What is a special consideration when performing CPR on a pregnant woman?,168696,0,Call 911 faster,0
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51288,5,What is a special consideration when performing CPR on a pregnant woman?,168697,1,Displace the gravid uterus to the left with a pillow or clothing item to help facilitate blood flow to the baby,1
9403,Elearning-0000-643,EMERGENCIES IN DNE,n9958,51288,5,What is a special consideration when performing CPR on a pregnant woman?,168698,2,Consider they are more tolerant to compressions because of increased blood flow,0
9085,Elearning-0000-354,NSH 1251 AMENDMENT 2,n9967,51301,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",168733,0,TRUE,1
9085,Elearning-0000-354,NSH 1251 AMENDMENT 2,n9967,51301,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",168734,1,FALSE,0
4057,ILT-0000-18039,RCT: CONFIDENT COLLECTOR UNIVERSITY,n9970,51304,0,I acknowledge that I have read and understand this CBL,168739,0,TRUE,1
4057,ILT-0000-18039,RCT: CONFIDENT COLLECTOR UNIVERSITY,n9970,51304,0,I acknowledge that I have read and understand this CBL,168740,1,FALSE,0
9060,Elearning-0000-331,NSH 1170 AMENDMENT 7,n9966,51299,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",168729,0,TRUE,1
9060,Elearning-0000-331,NSH 1170 AMENDMENT 7,n9966,51299,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",168730,1,FALSE,0
9055,Elearning-0000-327,NSH 1184 VERSION 4.0,n9964,51298,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",168727,0,TRUE,1
9055,Elearning-0000-327,NSH 1184 VERSION 4.0,n9964,51298,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",168728,1,FALSE,0
4074,ILT-0000-18057,RCT: INSURANCE UNIVERSITY,n9971,51305,0,I acknowledge that I have read and understand this CBL,168741,0,TRUE,1
4074,ILT-0000-18057,RCT: INSURANCE UNIVERSITY,n9971,51305,0,I acknowledge that I have read and understand this CBL,168742,1,FALSE,0
9052,Elearning-0000-324,NSH 1216 AMENDMENT 2,n9963,51297,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",168725,0,TRUE,1
9052,Elearning-0000-324,NSH 1216 AMENDMENT 2,n9963,51297,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",168726,1,FALSE,0
289,SCORM-0000-99,PREVENTION OF INFORMATION BLOCKING,n9965,51300,0,"I acknowledge that I have read and understand the ""Prevention of Information Blocking"" CBL in its entirety.",168731,0,TRUE,1
289,SCORM-0000-99,PREVENTION OF INFORMATION BLOCKING,n9965,51300,0,"I acknowledge that I have read and understand the ""Prevention of Information Blocking"" CBL in its entirety.",168732,1,FALSE,0
8942,Elearning-0000-224,RCT: ACCOUNT RESOLUTION UNIVERSITY CBL,n9969,51303,0,I acknowledge that I have read and completely understand this CBL.,168737,0,TRUE,1
8942,Elearning-0000-224,RCT: ACCOUNT RESOLUTION UNIVERSITY CBL,n9969,51303,0,I acknowledge that I have read and completely understand this CBL.,168738,1,FALSE,0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51309,0,Identify types of hypertensive disorders related to Pregnancy.,168749,0,A. Gestational,0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51309,0,Identify types of hypertensive disorders related to Pregnancy.,168750,1,B. Preeclampsia-Eclampsia,0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51309,0,Identify types of hypertensive disorders related to Pregnancy.,168751,2,C. Chronic Hypertension,0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51309,0,Identify types of hypertensive disorders related to Pregnancy.,168752,3,D. Chronic Hypertension with pre-eclampsia,0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51309,0,Identify types of hypertensive disorders related to Pregnancy.,168753,4,E. All of the above,1
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51310,1,What is the blood pressure range for hypertension in the obstetric patient?,168754,0,"A. Systolic above 130 or diastolic of 90 on 3 occasions, 4 hours apart.",0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51310,1,What is the blood pressure range for hypertension in the obstetric patient?,168755,1,"B. Systolic above 140 or diastolic of 90 on 2 occasions, 4 hours apart.",1
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51310,1,What is the blood pressure range for hypertension in the obstetric patient?,168756,2,"C. Systolic above 140 or diastolic of 90 on 3 occasions, 3 hours apart.",0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51310,1,What is the blood pressure range for hypertension in the obstetric patient?,168757,3,"D. Systolic above 140 or diastolic of 95 on 2 occasions, 4 hours apart.",0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51311,2,"What is considered acute, severe hypertension in the obstetric patient?",168758,0,"A. Systolic BP greater than 160, sustained for 15 mins or diastolic greater than 110, sustained for  15 mins",1
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51311,2,"What is considered acute, severe hypertension in the obstetric patient?",168759,1,"B. Systolic BP greater than 150, sustained for 15 mins or diastolic greater than 100, sustained for  15 mins",0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51311,2,"What is considered acute, severe hypertension in the obstetric patient?",168760,2,"C. Systolic BP greater than 160, sustained for 10 mins or diastolic greater than 110, sustained for  10 mins",0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51311,2,"What is considered acute, severe hypertension in the obstetric patient?",168761,3,"D. Systolic BP greater than 170, sustained for 15 mins or diastolic greater than 120, sustained for 15 mins",0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51312,3,"If your patient had a sustained blood pressure of 140-150 /90-95 for 15 minutes, what would be your next actions?",168762,0,A. Call Anesthesia,0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51312,3,"If your patient had a sustained blood pressure of 140-150 /90-95 for 15 minutes, what would be your next actions?",168763,1,B. Call Anesthesia and OB physician STAT,0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51312,3,"If your patient had a sustained blood pressure of 140-150 /90-95 for 15 minutes, what would be your next actions?",168764,2,"C. Call Anesthesia, refer to Acute Management of Hypertension in the Obstetrical Patient Guidelines located in Lucidoc and initiate communication with OB.",1
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51312,3,"If your patient had a sustained blood pressure of 140-150 /90-95 for 15 minutes, what would be your next actions?",168765,3,D. Inform your charge nurse,0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51313,4,"What are the first-line antihypertensive agents used for the acute, severe hypertensive pregnant patient.",168766,0,A. LabetaloL,0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51313,4,"What are the first-line antihypertensive agents used for the acute, severe hypertensive pregnant patient.",168767,1,B. Betapace,0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51313,4,"What are the first-line antihypertensive agents used for the acute, severe hypertensive pregnant patient.",168768,2,C. Hydralazine,0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51313,4,"What are the first-line antihypertensive agents used for the acute, severe hypertensive pregnant patient.",168769,3,D. Nifedipine,0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51313,4,"What are the first-line antihypertensive agents used for the acute, severe hypertensive pregnant patient.",168770,4,"E. A, B, C",0
8121,Elearning-0000-1019,SURGICAL SERVICES: FY2020 MANAGEMENT OF HYPERTENSION IN THE OBSTETRIC PATIENT EDUCATION,n9975,51313,4,"What are the first-line antihypertensive agents used for the acute, severe hypertensive pregnant patient.",168771,5,"F. A, C, D",1
6978,AICC-0000-247,WOLTERS KLUWER 2019 NOVEL CORONAVIRUS: COVID-19,n9983,51356,0,I have reviewed and understand the information provided in this activity.,168922,0,Yes,1
6978,AICC-0000-247,WOLTERS KLUWER 2019 NOVEL CORONAVIRUS: COVID-19,n9983,51356,0,I have reviewed and understand the information provided in this activity.,168921,1,No,0
9382,Elearning-0000-624,FCC RESIDENCY AGE SPECIFIC CARE OF THE NEWBORN FY2020,n9999,51357,0,What are three risk factors for Low Birth Weight babies?,168923,0,"Hypoglycemia, jaundice, and sepsis",1
9382,Elearning-0000-624,FCC RESIDENCY AGE SPECIFIC CARE OF THE NEWBORN FY2020,n9999,51357,0,What are three risk factors for Low Birth Weight babies?,168924,1,"Weight loss, fast breathing, and erythematous skin",0
9382,Elearning-0000-624,FCC RESIDENCY AGE SPECIFIC CARE OF THE NEWBORN FY2020,n9999,51357,0,What are three risk factors for Low Birth Weight babies?,168925,2,"Poor sleeping, bruising, and shoulder dystocia",0
9382,Elearning-0000-624,FCC RESIDENCY AGE SPECIFIC CARE OF THE NEWBORN FY2020,n9999,51357,0,What are three risk factors for Low Birth Weight babies?,168926,3,"Hyperthermia, cephalohematoma, and lethargy",0
9382,Elearning-0000-624,FCC RESIDENCY AGE SPECIFIC CARE OF THE NEWBORN FY2020,n9999,51358,1,The husband of a patient is trying to blame the staff for making his son jaundiced. The infant is 36 weeks gestation. How do you educate the patient and family regarding this?,168927,0,Validate his concerns regarding his son and then educate the parents regarding the different risk factors their baby has for jaundice.,1
9382,Elearning-0000-624,FCC RESIDENCY AGE SPECIFIC CARE OF THE NEWBORN FY2020,n9999,51358,1,The husband of a patient is trying to blame the staff for making his son jaundiced. The infant is 36 weeks gestation. How do you educate the patient and family regarding this?,168928,1,"Tell him he is wrong, and that his wife isn't feeding the baby properly.",0
9382,Elearning-0000-624,FCC RESIDENCY AGE SPECIFIC CARE OF THE NEWBORN FY2020,n9999,51358,1,The husband of a patient is trying to blame the staff for making his son jaundiced. The infant is 36 weeks gestation. How do you educate the patient and family regarding this?,168929,2,"Address how their baby is starving, and needs formula to combat this problem.",0
9382,Elearning-0000-624,FCC RESIDENCY AGE SPECIFIC CARE OF THE NEWBORN FY2020,n9999,51358,1,The husband of a patient is trying to blame the staff for making his son jaundiced. The infant is 36 weeks gestation. How do you educate the patient and family regarding this?,168930,3,"Tell the parents that the baby is very sick, and will probably need to be transferred to Special Care Nursery for treatment.",0
9382,Elearning-0000-624,FCC RESIDENCY AGE SPECIFIC CARE OF THE NEWBORN FY2020,n9999,51359,2,What are the three parts of the energy triad?,168931,0,"Small for gestational age, average for gestational age, and large for gestational age.",0
9382,Elearning-0000-624,FCC RESIDENCY AGE SPECIFIC CARE OF THE NEWBORN FY2020,n9999,51359,2,What are the three parts of the energy triad?,168932,1,"Genetics, weight gain, and gender.",0
9382,Elearning-0000-624,FCC RESIDENCY AGE SPECIFIC CARE OF THE NEWBORN FY2020,n9999,51359,2,What are the three parts of the energy triad?,168933,2,"Temperature, Glucose, and Respiratory",1
9382,Elearning-0000-624,FCC RESIDENCY AGE SPECIFIC CARE OF THE NEWBORN FY2020,n9999,51359,2,What are the three parts of the energy triad?,168934,3,"Restlessness, hyperthermia, sepsis.",0
9382,Elearning-0000-624,FCC RESIDENCY AGE SPECIFIC CARE OF THE NEWBORN FY2020,n9999,51360,3,Non Shivering Thermogenesis is the main source of heat generation in newborns.,168935,0,TRUE,1
9382,Elearning-0000-624,FCC RESIDENCY AGE SPECIFIC CARE OF THE NEWBORN FY2020,n9999,51360,3,Non Shivering Thermogenesis is the main source of heat generation in newborns.,168936,1,FALSE,0
9382,Elearning-0000-624,FCC RESIDENCY AGE SPECIFIC CARE OF THE NEWBORN FY2020,n9999,51361,4,"Sweating, vasodilation, irritability, and tachypnea are sign of what?",168937,0,Crying,0
9382,Elearning-0000-624,FCC RESIDENCY AGE SPECIFIC CARE OF THE NEWBORN FY2020,n9999,51361,4,"Sweating, vasodilation, irritability, and tachypnea are sign of what?",168938,1,Normal newborn health,0
9382,Elearning-0000-624,FCC RESIDENCY AGE SPECIFIC CARE OF THE NEWBORN FY2020,n9999,51361,4,"Sweating, vasodilation, irritability, and tachypnea are sign of what?",168939,2,Hypoglycemia,0
9382,Elearning-0000-624,FCC RESIDENCY AGE SPECIFIC CARE OF THE NEWBORN FY2020,n9999,51361,4,"Sweating, vasodilation, irritability, and tachypnea are sign of what?",168940,3,Hyperthermia,1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51388,0,I have reviewed the purpose of the available SOPs for the Inpatient unit of the Blood and Marrow Transplant Program of GA at Northside Hospital and are aware of their location in the BMT Conference room located on 4N.,169019,0,TRUE,1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51388,0,I have reviewed the purpose of the available SOPs for the Inpatient unit of the Blood and Marrow Transplant Program of GA at Northside Hospital and are aware of their location in the BMT Conference room located on 4N.,169020,1,FALSE,0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51389,1,It is not necessary to scrub the hub for 15 seconds prior to each insertion when drawing blood form the Central Line. True or False?,169021,0,TRUE,0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51389,1,It is not necessary to scrub the hub for 15 seconds prior to each insertion when drawing blood form the Central Line. True or False?,169022,1,FALSE,1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51390,2,What is the correct order of draw for the following labs:,169023,0,"a.	Chemistry (Green top), Coagulation (Blue top), Hematology (Lavender top), Lactate (Grey top), Type and Screen (Pink top)",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51390,2,What is the correct order of draw for the following labs:,169024,1,"b.	Coagulation (Blue top), Chemistry (Green top), Hematology (Lavender top), Type and Screen (Pink top) Lactate (Grey top)",1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51390,2,What is the correct order of draw for the following labs:,169025,2,"c.	Type and Screen (Pink top), Hematology (Lavender top), Chemistry (Green top), Coagulation (Blue top), Lactate (Grey top)",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51390,2,What is the correct order of draw for the following labs:,169026,3,"d.	Lactate (Grey top), Coagulation (Blue tops), Chemistry (Green top), Hematology (Lavender top), Type and Screen (Pink top)",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51391,3,When drawing noon or midnight labs what is the appropriate time frame to draw?,169027,0,"a.	1 hour before and up to one hour after the designated time",1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51391,3,When drawing noon or midnight labs what is the appropriate time frame to draw?,169028,1,"b.	Per patient preference",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51391,3,When drawing noon or midnight labs what is the appropriate time frame to draw?,169029,2,"c.	Whenever it is the most convenient time for the RN",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51392,4,The risk to the patient during the PICC removal process is,169030,0,"a.	Air embolism",1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51392,4,The risk to the patient during the PICC removal process is,169031,1,"b.	DVT",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51392,4,The risk to the patient during the PICC removal process is,169032,2,"c.	Acute pain",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51392,4,The risk to the patient during the PICC removal process is,169033,3,"d.	There is no risk associated with PICC removal",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51393,5,When PICC line tip culture is ordered the appropriate cleaning agent to use prior to PICC removal is:,169034,0,"a.	Chlorhexidine gluconate",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51393,5,When PICC line tip culture is ordered the appropriate cleaning agent to use prior to PICC removal is:,169035,1,"b.	Alcohol",1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51393,5,When PICC line tip culture is ordered the appropriate cleaning agent to use prior to PICC removal is:,169036,2,"c.	Betadine",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51394,6,Pick the most appropriate education to give to the patient during PICC removal:,169037,0,"a.	Take a deep breath in and hold or slowly breathe out while I remove the PICC line. You have to lay flat for 30 minutes after.",1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51394,6,Pick the most appropriate education to give to the patient during PICC removal:,169038,1,"b.	Breathe in and out continuously as I pull out your PICC line. You will be ready for discharge thereafter.",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51394,6,Pick the most appropriate education to give to the patient during PICC removal:,169039,2,"c.	Let me administer some pain medicine before I pull out your PICC line.",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51395,7,It is ok to access a Power port with a regular needle but not ok to access a regular port with a Power needle. True or False?,169040,0,TRUE,1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51395,7,It is ok to access a Power port with a regular needle but not ok to access a regular port with a Power needle. True or False?,169041,1,FALSE,0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51396,8,"When in doubt whether the patient's port is a Power port or not, the best course of action is to:",169042,0,"a.	Listen to and rely on the patient's word because it is their body",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51396,8,"When in doubt whether the patient's port is a Power port or not, the best course of action is to:",169043,1,"b.	Rely on what is documented by the previous shift",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51396,8,"When in doubt whether the patient's port is a Power port or not, the best course of action is to:",169044,2,"c.	Palpate the port and check to see if you feel the 3 nubs. If unable to palpate the nubs, try to search in the procedure history. If unable to obtain any information, talk to your midlevel and obtain a CXR to confirm whether the patient's port is a regular port or a power port.",1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51396,8,"When in doubt whether the patient's port is a Power port or not, the best course of action is to:",169045,3,"d.	Talk to your Clinician or the IV team and have them tell you.",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51397,9,How many mls of blood must you draw as a waste before drawing blood cultures?,169046,0,"a.	5mls",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51397,9,How many mls of blood must you draw as a waste before drawing blood cultures?,169047,1,"b.	10mls",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51397,9,How many mls of blood must you draw as a waste before drawing blood cultures?,169048,2,"c.	You do not draw a waste before drawing blood cultures",1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51398,10,Which type of blood culture bottle should you not instill air in?,169049,0,"a.	Aerobic",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51398,10,Which type of blood culture bottle should you not instill air in?,169050,1,"b.	Anaerobic",1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51399,11,"True or False? Per policy, it is necessary to allow the tops of blood culture bottles to air dry for 30 seconds before instilling blood sample.",169051,0,TRUE,1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51399,11,"True or False? Per policy, it is necessary to allow the tops of blood culture bottles to air dry for 30 seconds before instilling blood sample.",169052,1,FALSE,0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51400,12,"Select all that apply. The responsibility of the second checker with the CADD pump is:   a) Verify the drug with the order in the computer,  b) Collect the pump and the bag from the Clinic or the Infusion Center, c) Verify that the pump is accurately programmed and the drug along with its cassette is appropriately attached to the pump, d) Co-sign the label and the discharge instructions once pump settings are verified to be programmed accurately and the label is filled out correctly, e) Grab 2 or 3 extra sets of batteries for the patient,  f) Go with the primary nurse to the bedside, co-sign the scanned drug in the computer after verifying again that it is accurately attached to the patient's CL and programmed to RUN at the correct settings, or g) Educate the patient regarding the medication on the CADD.",169053,0,"a)	a, b, c, d",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51400,12,"Select all that apply. The responsibility of the second checker with the CADD pump is:   a) Verify the drug with the order in the computer,  b) Collect the pump and the bag from the Clinic or the Infusion Center, c) Verify that the pump is accurately programmed and the drug along with its cassette is appropriately attached to the pump, d) Co-sign the label and the discharge instructions once pump settings are verified to be programmed accurately and the label is filled out correctly, e) Grab 2 or 3 extra sets of batteries for the patient,  f) Go with the primary nurse to the bedside, co-sign the scanned drug in the computer after verifying again that it is accurately attached to the patient's CL and programmed to RUN at the correct settings, or g) Educate the patient regarding the medication on the CADD.",169054,1,"b)	a, c, d, f",1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51400,12,"Select all that apply. The responsibility of the second checker with the CADD pump is:   a) Verify the drug with the order in the computer,  b) Collect the pump and the bag from the Clinic or the Infusion Center, c) Verify that the pump is accurately programmed and the drug along with its cassette is appropriately attached to the pump, d) Co-sign the label and the discharge instructions once pump settings are verified to be programmed accurately and the label is filled out correctly, e) Grab 2 or 3 extra sets of batteries for the patient,  f) Go with the primary nurse to the bedside, co-sign the scanned drug in the computer after verifying again that it is accurately attached to the patient's CL and programmed to RUN at the correct settings, or g) Educate the patient regarding the medication on the CADD.",169055,2,"c)	All of the above",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51401,13,"If the CADD pump order does not specify a dose volume, the correct action for the nurse to take is:",169056,0,"a.	Contact pharmacy and obtain clarification of the order",1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51401,13,"If the CADD pump order does not specify a dose volume, the correct action for the nurse to take is:",169057,1,"b.	Program the pump based on an estimated dose volume",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51401,13,"If the CADD pump order does not specify a dose volume, the correct action for the nurse to take is:",169058,2,"c.	Leave that portion of the programming unaddressed",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51402,14,"True or False? If a patient is admitted with a CADD pump, the RN is supposed to check the CADD pump to see what medication is infusing through it and whether the pump is programmed accurately",169059,0,TRUE,1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51402,14,"True or False? If a patient is admitted with a CADD pump, the RN is supposed to check the CADD pump to see what medication is infusing through it and whether the pump is programmed accurately",169060,1,FALSE,0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51403,15,Pick the correct response. CL Dressing (Trifusion and PICC) should be changed:,169061,0,"a.	Every 7 days",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51403,15,Pick the correct response. CL Dressing (Trifusion and PICC) should be changed:,169062,1,"b.	After 5 days if there is no biopatch on the insertion site.",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51403,15,Pick the correct response. CL Dressing (Trifusion and PICC) should be changed:,169063,2,"c.	If it is soiled or loose",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51403,15,Pick the correct response. CL Dressing (Trifusion and PICC) should be changed:,169064,3,"d.	If the lumens are not giving blood return even after changing the valves",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51403,15,Pick the correct response. CL Dressing (Trifusion and PICC) should be changed:,169065,4,"e.	All of the above",1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51404,16,You do not need to place a biopatch if this kind of dressing is covering the Central line,169066,0,"a.	Sorbaview",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51404,16,You do not need to place a biopatch if this kind of dressing is covering the Central line,169067,1,"b.	IV 3000",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51404,16,You do not need to place a biopatch if this kind of dressing is covering the Central line,169068,2,"c.	IV Clear",1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51405,17,"Select all that apply. Valves on CL are changed a) With every dressing change,  b) On admission, c) Before drawing Blood Cultures, or d) Before infusing chemotherapy.",169069,0,"a)	All of the above",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51405,17,"Select all that apply. Valves on CL are changed a) With every dressing change,  b) On admission, c) Before drawing Blood Cultures, or d) Before infusing chemotherapy.",169070,1,"b)	a, b, c",1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51405,17,"Select all that apply. Valves on CL are changed a) With every dressing change,  b) On admission, c) Before drawing Blood Cultures, or d) Before infusing chemotherapy.",169071,2,"c)	c & d",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51406,18,"Before de-accessing a port, it has to be flushed:",169072,0,"a.	First with 30 mls or saline and then with 250 units of Heparin",1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51406,18,"Before de-accessing a port, it has to be flushed:",169073,1,"b.	First with 10mls of saline and then with 5 mls of Heparin",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51406,18,"Before de-accessing a port, it has to be flushed:",169074,2,"c.	First with 30 mls of saline and then with 500 units of Heparin",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51406,18,"Before de-accessing a port, it has to be flushed:",169075,3,"d.	First with 30 mls of saline and then with 50 units of Heparin",0
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51407,19,"When documenting on a double lumen port in Cerner, you should chart on each port as a separate CL. True or False?",169076,0,TRUE,1
8137,Elearning-0000-1033,FY2021 BMT SKILLS EDUCATON FOR BMT AND CROSS-TRAINED RNS: NURSING,n10013,51407,19,"When documenting on a double lumen port in Cerner, you should chart on each port as a separate CL. True or False?",169077,1,FALSE,0
8106,Elearning-0000-1005,SURGICAL SERVICES: FY2020 PCA PROCESS IN PACU,n10019,51453,0,A second RN verification at bedside is required for all except:,169233,0,A. Initiation of therapy,0
8106,Elearning-0000-1005,SURGICAL SERVICES: FY2020 PCA PROCESS IN PACU,n10019,51453,0,A second RN verification at bedside is required for all except:,169234,1,B. Changing  of the dose,0
8106,Elearning-0000-1005,SURGICAL SERVICES: FY2020 PCA PROCESS IN PACU,n10019,51453,0,A second RN verification at bedside is required for all except:,169235,2,C. Initiating a new cassette or bag,0
8106,Elearning-0000-1005,SURGICAL SERVICES: FY2020 PCA PROCESS IN PACU,n10019,51453,0,A second RN verification at bedside is required for all except:,169236,3,D. Every shift change,0
8106,Elearning-0000-1005,SURGICAL SERVICES: FY2020 PCA PROCESS IN PACU,n10019,51453,0,A second RN verification at bedside is required for all except:,169237,4,E. During handoff for break relief,1
8106,Elearning-0000-1005,SURGICAL SERVICES: FY2020 PCA PROCESS IN PACU,n10019,51454,1,RN obtaining PCA medication is in charge of initiating medication and flowsheet within 30 minutes of dispensed medication.,169238,0,A. True,1
8106,Elearning-0000-1005,SURGICAL SERVICES: FY2020 PCA PROCESS IN PACU,n10019,51454,1,RN obtaining PCA medication is in charge of initiating medication and flowsheet within 30 minutes of dispensed medication.,169239,1,B. False,0
8106,Elearning-0000-1005,SURGICAL SERVICES: FY2020 PCA PROCESS IN PACU,n10019,51455,2,Patient education about PCA should include:,169240,0,A. The purpose of IV PCA,0
8106,Elearning-0000-1005,SURGICAL SERVICES: FY2020 PCA PROCESS IN PACU,n10019,51455,2,Patient education about PCA should include:,169241,1,B. The type of medication,0
8106,Elearning-0000-1005,SURGICAL SERVICES: FY2020 PCA PROCESS IN PACU,n10019,51455,2,Patient education about PCA should include:,169242,2,C. Side effects to report,0
8106,Elearning-0000-1005,SURGICAL SERVICES: FY2020 PCA PROCESS IN PACU,n10019,51455,2,Patient education about PCA should include:,169243,3,D. How to self- dose,0
8106,Elearning-0000-1005,SURGICAL SERVICES: FY2020 PCA PROCESS IN PACU,n10019,51455,2,Patient education about PCA should include:,169244,4,E. Safety precautions,0
8106,Elearning-0000-1005,SURGICAL SERVICES: FY2020 PCA PROCESS IN PACU,n10019,51455,2,Patient education about PCA should include:,169245,5,F. All the above,1
8106,Elearning-0000-1005,SURGICAL SERVICES: FY2020 PCA PROCESS IN PACU,n10019,51456,3,Patient Education must be charted in OneChart when PCA is initiated.,169246,0,A. True,1
8106,Elearning-0000-1005,SURGICAL SERVICES: FY2020 PCA PROCESS IN PACU,n10019,51456,3,Patient Education must be charted in OneChart when PCA is initiated.,169247,1,B. False,0
8106,Elearning-0000-1005,SURGICAL SERVICES: FY2020 PCA PROCESS IN PACU,n10019,51457,4,Select correct Process order.,169248,0,"A. Obtain and review PCA order Power Plan, Initiate Power Plan order, Document PCA including patient education, Obtain medication and Initiate medication ,Initiate flowsheet, clear pump before PACU discharge and document PCA dose.",0
8106,Elearning-0000-1005,SURGICAL SERVICES: FY2020 PCA PROCESS IN PACU,n10019,51457,4,Select correct Process order.,169249,1,"B. Obtain and review PCA order Power Plan, Initiate Power Plan order, Obtain medication and Initiates medication ,Initiates flowsheet, Documents including patient education, clear pump before PACU discharge and document PCA dose.",1
8106,Elearning-0000-1005,SURGICAL SERVICES: FY2020 PCA PROCESS IN PACU,n10019,51457,4,Select correct Process order.,169250,2,"C. Obtain medication and Initiates medication ,Initiates flowsheet, Obtain and review PCA order Power Plan, Initiate Power Plan order, Document PCA including patient education, ,Initiate flowsheet, clear pump before PACU discharge and document PCA dose.",0
9768,Elearning-0000-975,EOC: AIRFLOW,n10018,51452,0,I have read this CBL in its entirety and understand that I am responsible for its content.,169232,0,TRUE,1
9768,Elearning-0000-975,EOC: AIRFLOW,n10018,51452,0,I have read this CBL in its entirety and understand that I am responsible for its content.,169231,1,FALSE,0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51491,0,A patient's overall experience with their hospital stay is based on which of the following:,169310,0,"a.	Communication",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51491,0,A patient's overall experience with their hospital stay is based on which of the following:,169311,1,"b.	Connection with the Care Provider",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51491,0,A patient's overall experience with their hospital stay is based on which of the following:,169312,2,"c.	Our engagement/interest in the patient",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51491,0,A patient's overall experience with their hospital stay is based on which of the following:,169313,3,"d.	Our verbal and non-verbal communication",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51491,0,A patient's overall experience with their hospital stay is based on which of the following:,169314,4,"e.	All of the above",1
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51491,0,A patient's overall experience with their hospital stay is based on which of the following:,169315,5,"f.	None of the above",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51492,1,What emotions and feelings may patients who are coming to Northside to deliver their baby feel?,169316,0,"a.	Excitement",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51492,1,What emotions and feelings may patients who are coming to Northside to deliver their baby feel?,169317,1,"b.	Joy",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51492,1,What emotions and feelings may patients who are coming to Northside to deliver their baby feel?,169318,2,"c.	Anxiety",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51492,1,What emotions and feelings may patients who are coming to Northside to deliver their baby feel?,169319,3,"d.	Only A and B",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51492,1,What emotions and feelings may patients who are coming to Northside to deliver their baby feel?,169320,4,"e.	All of the above",1
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51493,2,"In the video in module one, how did patients describe their interactions with caregivers?",169321,0,"a.	Patient knew within seconds of walking into the patient's room if the caregiver was engaged",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51493,2,"In the video in module one, how did patients describe their interactions with caregivers?",169322,1,"b.	Looked forward to the 5 - 10 minutes they spent with the nurses and techs each day",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51493,2,"In the video in module one, how did patients describe their interactions with caregivers?",169323,2,"c.	Wished that their physician could have been more thoughtful and compassionate in delivering difficult news",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51493,2,"In the video in module one, how did patients describe their interactions with caregivers?",169324,3,"d.	Only C",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51493,2,"In the video in module one, how did patients describe their interactions with caregivers?",169325,4,"e.	All of the above",1
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51494,3,What is your role in creating an exceptional patient experience at Northside?,169326,0,"a.	Take the time to connect with your patient",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51494,3,What is your role in creating an exceptional patient experience at Northside?,169327,1,"b.	Address your patient by their preferred name",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51494,3,What is your role in creating an exceptional patient experience at Northside?,169328,2,"c.	Communicate what you are doing in a way that the patient understands",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51494,3,What is your role in creating an exceptional patient experience at Northside?,169329,3,"d.	Try to see things from the patient's perspective",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51494,3,What is your role in creating an exceptional patient experience at Northside?,169330,4,"e.	Present yourself with professional and positive verbal and non-verbal communication",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51494,3,What is your role in creating an exceptional patient experience at Northside?,169331,5,"f.	Only A",0
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51494,3,What is your role in creating an exceptional patient experience at Northside?,169332,6,"g.	All of the above",1
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51495,4,"I acknowledge that I have reviewed and understand the ""NRO Module One: Creating the Patient Experience"" CBL in its entirety.",169333,0,TRUE,1
265,SCORM-0000-75,NRO MODULE ONE: CREATING THE PATIENT EXPERIENCE,n11850,51495,4,"I acknowledge that I have reviewed and understand the ""NRO Module One: Creating the Patient Experience"" CBL in its entirety.",169334,1,FALSE,0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51466,0,AIDET is a communication standard for introducing yourself and providing thorough explanations to patients.,169276,0,a. True,1
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51466,0,AIDET is a communication standard for introducing yourself and providing thorough explanations to patients.,169277,1,b. False,0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51467,1,Which of the following are steps in  A - Acknowledge the patient?,169278,0,"a.	Make eye contact with the patient and family members or visitors",0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51467,1,Which of the following are steps in  A - Acknowledge the patient?,169279,1,"b.	Greet the patient by their preferred name",0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51467,1,Which of the following are steps in  A - Acknowledge the patient?,169280,2,"c.	Greet family members and visitors with a hello or other appropriate greeting",0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51467,1,Which of the following are steps in  A - Acknowledge the patient?,169281,3,"d.	A and B",0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51467,1,Which of the following are steps in  A - Acknowledge the patient?,169282,4,"e.	All of the above",1
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51468,2,Which of the following should be included in I - Introduce?,169283,0,"a.	Provide your name and role",0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51468,2,Which of the following should be included in I - Introduce?,169284,1,"b.	Let the patient know when you will be working with her for example 7a - 7 p",0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51468,2,Which of the following should be included in I - Introduce?,169285,2,"c.	Share information about your experience or certification",0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51468,2,Which of the following should be included in I - Introduce?,169286,3,"d.	Use your name all the time upon entering the patient's room",0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51468,2,Which of the following should be included in I - Introduce?,169287,4,"e.	A, B and C",0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51468,2,Which of the following should be included in I - Introduce?,169288,5,"f.	All of the above",1
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51469,3,D in AIDET is for Duration. Which of the following are elements of Duration?,169289,0,"a.	Provide an estimate of how long something will take to complete",0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51469,3,D in AIDET is for Duration. Which of the following are elements of Duration?,169290,1,"b.	If you cannot provide an estimate of time, provide a time in which you will follow-up",0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51469,3,D in AIDET is for Duration. Which of the following are elements of Duration?,169291,2,"c.	Don't provide information about time  -- it will only back fire on you",0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51469,3,D in AIDET is for Duration. Which of the following are elements of Duration?,169292,3,"d.	A and B",1
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51469,3,D in AIDET is for Duration. Which of the following are elements of Duration?,169293,4,"e.	All of the above",0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51470,4,Which of the following are part of E - Explanation?,169294,0,"a.	Tell the patient what you are doing",0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51470,4,Which of the following are part of E - Explanation?,169295,1,"b.	Tell the patient why you are doing something",0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51470,4,Which of the following are part of E - Explanation?,169296,2,"c.	Encourage the patient to ask questions about what you are doing",0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51470,4,Which of the following are part of E - Explanation?,169297,3,"d.	Answer the patient's questions",0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51470,4,Which of the following are part of E - Explanation?,169298,4,"e.	A and B",0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51470,4,Which of the following are part of E - Explanation?,169299,5,"f.	All of the above",1
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51471,5,The purpose of T in AIDET is to thank the patient for choosing Northside and providing the opportunity to care for her and her new baby.,169300,0,a. True,1
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51471,5,The purpose of T in AIDET is to thank the patient for choosing Northside and providing the opportunity to care for her and her new baby.,169301,1,b. False,0
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51472,6,I acknowledge that I have reviewed and understand the NRO Module Two: AIDET CBL in its entirety.,169302,0,a. True,1
269,SCORM-0000-79,NRO MODULE TWO: AIDET,n11851,51472,6,I acknowledge that I have reviewed and understand the NRO Module Two: AIDET CBL in its entirety.,169303,1,b. False,0
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51496,0,The HCAHPS survey is a standardized survey that is used by all hospitals in the United States.,169335,0,a. True,1
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51496,0,The HCAHPS survey is a standardized survey that is used by all hospitals in the United States.,169336,1,b. False,0
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51497,1,What percentage of patients discharge from Northside FCC units receive a survey?,169337,0,"a.	25%",0
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51497,1,What percentage of patients discharge from Northside FCC units receive a survey?,169338,1,"b.	50%",0
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51497,1,What percentage of patients discharge from Northside FCC units receive a survey?,169339,2,"c.	75%",0
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51497,1,What percentage of patients discharge from Northside FCC units receive a survey?,169340,3,"d.	100%",1
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51498,2,Which of the following responses is considered a good response to an HCAHPS survey question?,169341,0,"a.	Never",0
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51498,2,Which of the following responses is considered a good response to an HCAHPS survey question?,169342,1,"b.	Sometimes",0
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51498,2,Which of the following responses is considered a good response to an HCAHPS survey question?,169343,2,"c.	Usually",0
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51498,2,Which of the following responses is considered a good response to an HCAHPS survey question?,169344,3,"d.	Always",1
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51498,2,Which of the following responses is considered a good response to an HCAHPS survey question?,169345,4,"e.	Both C and D",0
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51499,3,Which of the following question areas has the most influence on a patient's likeliness to give an overall rating of 9 - 10?,169346,0,"a.	Nurse Communication",1
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51499,3,Which of the following question areas has the most influence on a patient's likeliness to give an overall rating of 9 - 10?,169347,1,"b.	Physician Communication",0
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51499,3,Which of the following question areas has the most influence on a patient's likeliness to give an overall rating of 9 - 10?,169348,2,"c.	Responsiveness",0
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51499,3,Which of the following question areas has the most influence on a patient's likeliness to give an overall rating of 9 - 10?,169349,3,"d.	Communication about Medications",0
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51500,4,The rating scale used in Labor and Delivery is the same as the scale used on the HCAHPS questions.,169350,0,a. True,0
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51500,4,The rating scale used in Labor and Delivery is the same as the scale used on the HCAHPS questions.,169351,1,b. False,1
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51501,5,Survey results are publicly reported for consumers to compare hospitals.,169352,0,a. True,1
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51501,5,Survey results are publicly reported for consumers to compare hospitals.,169353,1,b. False,0
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51502,6,Patient satisfaction results are publicly reported on which website?,169354,0,"a.	Atlanta area hospital rankings",0
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51502,6,Patient satisfaction results are publicly reported on which website?,169355,1,"b.	Hospital Compare",1
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51502,6,Patient satisfaction results are publicly reported on which website?,169356,2,"c.	Find the best hospital",0
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51502,6,Patient satisfaction results are publicly reported on which website?,169357,3,"d.	Hospital 4-1-1",0
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51503,7,Northside hospital updates patient satisfaction scores weekly and reports scores to department managers.,169358,0,a. True,1
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51503,7,Northside hospital updates patient satisfaction scores weekly and reports scores to department managers.,169359,1,b. False,0
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51504,8,"I acknowledge that I have reviewed and understand the ""NRO Module Five: The Patient Survey - HCAHPS"" CBL in its entirety.",169360,0,a. True,1
263,SCORM-0000-73,NRO MODULE FIVE: THE PATIENT SURVEY - HCAHPS,n11852,51504,8,"I acknowledge that I have reviewed and understand the ""NRO Module Five: The Patient Survey - HCAHPS"" CBL in its entirety.",169361,1,b. False,0
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51515,0,Which of the following are Northside's Caring Behaviors?,169388,0,"a.	Demonstrate Empathy and show you care",0
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51515,0,Which of the following are Northside's Caring Behaviors?,169389,1,"b.	Provide Exceptional Communication",0
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51515,0,Which of the following are Northside's Caring Behaviors?,169390,2,"c.	Provide Personalized Care",0
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51515,0,Which of the following are Northside's Caring Behaviors?,169391,3,"d.	Make a Connection",0
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51515,0,Which of the following are Northside's Caring Behaviors?,169392,4,"e.	All of the above",1
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51516,1,Empathy and Sympathy are the same thing.,169393,0,a. True,0
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51516,1,Empathy and Sympathy are the same thing.,169394,1,b. False,1
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51517,2,Which of the following statements conveys empathy?,169395,0,"a.	I know exactly how you feel",0
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51517,2,Which of the following statements conveys empathy?,169396,1,"b.	This must be difficult for you",1
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51517,2,Which of the following statements conveys empathy?,169397,2,"c.	I think I can make this better",0
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51517,2,Which of the following statements conveys empathy?,169398,3,"d.	A lot of people feel the same way you do",0
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51518,3,Which element of communication has the most impact?,169399,0,"a.	Your words",0
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51518,3,Which element of communication has the most impact?,169400,1,"b.	Your body language",1
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51518,3,Which element of communication has the most impact?,169401,2,"c.	Tone of voice",0
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51518,3,Which element of communication has the most impact?,169402,3,"d.	All of the above",0
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51519,4,Explanations and coordinated care are elements of exceptional communication.,169403,0,a. True,1
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51519,4,Explanations and coordinated care are elements of exceptional communication.,169404,1,b. False,0
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51520,5,When is a good time to identify what is most important to your patient so that you can personalize her care?,169405,0,"a.	When you first meet your patient",0
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51520,5,When is a good time to identify what is most important to your patient so that you can personalize her care?,169406,1,"b.	At change of shift",0
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51520,5,When is a good time to identify what is most important to your patient so that you can personalize her care?,169407,2,"c.	As part of your hourly rounds",0
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51520,5,When is a good time to identify what is most important to your patient so that you can personalize her care?,169408,3,"d.	All of the above",1
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51521,6,"I acknowledge that I have reviewed and understand ""NRO Module Four: Caring Behaviors - Part Two"" CBL in its entirety.",169409,0,a. True,1
264,SCORM-0000-74,NRO MODULE FOUR: CARING BEHAVIORS - PART TWO,n11853,51521,6,"I acknowledge that I have reviewed and understand ""NRO Module Four: Caring Behaviors - Part Two"" CBL in its entirety.",169410,1,b. False,0
267,SCORM-0000-77,NRO MODULE SIX: EVIDENCE BASED BEHAVIORS,n11856,51523,0,"Which evidence-based behavior is designed to reduce patient calls, reduce falls, increase patient satisfaction and place more control of workflow with the nurse and PCT?",169413,0,"a.	Bedside shift report",0
267,SCORM-0000-77,NRO MODULE SIX: EVIDENCE BASED BEHAVIORS,n11856,51523,0,"Which evidence-based behavior is designed to reduce patient calls, reduce falls, increase patient satisfaction and place more control of workflow with the nurse and PCT?",169414,1,"b.	Hourly rounding /Purposeful patient check-in",1
267,SCORM-0000-77,NRO MODULE SIX: EVIDENCE BASED BEHAVIORS,n11856,51523,0,"Which evidence-based behavior is designed to reduce patient calls, reduce falls, increase patient satisfaction and place more control of workflow with the nurse and PCT?",169415,2,"c.	AIDET",0
267,SCORM-0000-77,NRO MODULE SIX: EVIDENCE BASED BEHAVIORS,n11856,51523,0,"Which evidence-based behavior is designed to reduce patient calls, reduce falls, increase patient satisfaction and place more control of workflow with the nurse and PCT?",169416,3,"d.	All of the above",0
267,SCORM-0000-77,NRO MODULE SIX: EVIDENCE BASED BEHAVIORS,n11856,51524,1,Bedside shift report takes place at the start of every shift and/or a change of primary nurse.,169417,0,a. True,1
267,SCORM-0000-77,NRO MODULE SIX: EVIDENCE BASED BEHAVIORS,n11856,51524,1,Bedside shift report takes place at the start of every shift and/or a change of primary nurse.,169418,1,b. False,0
267,SCORM-0000-77,NRO MODULE SIX: EVIDENCE BASED BEHAVIORS,n11856,51525,2,Which of the following is considered part of FCC hourly rounding?,169419,0,"a.	Assistance with toileting",0
267,SCORM-0000-77,NRO MODULE SIX: EVIDENCE BASED BEHAVIORS,n11856,51525,2,Which of the following is considered part of FCC hourly rounding?,169420,1,"b.	Check on pain",0
267,SCORM-0000-77,NRO MODULE SIX: EVIDENCE BASED BEHAVIORS,n11856,51525,2,Which of the following is considered part of FCC hourly rounding?,169421,2,"c.	Help with breastfeeding",0
267,SCORM-0000-77,NRO MODULE SIX: EVIDENCE BASED BEHAVIORS,n11856,51525,2,Which of the following is considered part of FCC hourly rounding?,169422,3,"d.	Check on supplies",0
267,SCORM-0000-77,NRO MODULE SIX: EVIDENCE BASED BEHAVIORS,n11856,51525,2,Which of the following is considered part of FCC hourly rounding?,169423,4,"e.	See if there is anything mom or baby needs",0
267,SCORM-0000-77,NRO MODULE SIX: EVIDENCE BASED BEHAVIORS,n11856,51525,2,Which of the following is considered part of FCC hourly rounding?,169424,5,"f.	All of the above",1
267,SCORM-0000-77,NRO MODULE SIX: EVIDENCE BASED BEHAVIORS,n11856,51526,3,Bedside shift report is recognized as a nursing best practice.,169425,0,a. True,1
267,SCORM-0000-77,NRO MODULE SIX: EVIDENCE BASED BEHAVIORS,n11856,51526,3,Bedside shift report is recognized as a nursing best practice.,169426,1,b. False,0
267,SCORM-0000-77,NRO MODULE SIX: EVIDENCE BASED BEHAVIORS,n11856,51527,4,"Bedside shift report is considered the first safety check of your shift.  As such, you should wake the patient to participant in BSSR unless there is a clinical reason to not do so.",169427,0,a. True,1
267,SCORM-0000-77,NRO MODULE SIX: EVIDENCE BASED BEHAVIORS,n11856,51527,4,"Bedside shift report is considered the first safety check of your shift.  As such, you should wake the patient to participant in BSSR unless there is a clinical reason to not do so.",169428,1,b. False,0
267,SCORM-0000-77,NRO MODULE SIX: EVIDENCE BASED BEHAVIORS,n11856,51528,5,"I acknowledge that I have reviewed and understand the ""NRO Module Six: Evidence Based Behaviors"" CBL in its entirety.",169429,0,a. True,1
267,SCORM-0000-77,NRO MODULE SIX: EVIDENCE BASED BEHAVIORS,n11856,51528,5,"I acknowledge that I have reviewed and understand the ""NRO Module Six: Evidence Based Behaviors"" CBL in its entirety.",169430,1,b. False,0
268,SCORM-0000-78,NRO MODULE THREE: CARING BEHAVIORS - PART ONE,n11858,51522,0,"I acknowledge that I have reviewed and understand the ""NRO Module Three: Caring Behaviors - Part One"" CBL in its entirety.",169411,0,a. True,1
268,SCORM-0000-78,NRO MODULE THREE: CARING BEHAVIORS - PART ONE,n11858,51522,0,"I acknowledge that I have reviewed and understand the ""NRO Module Three: Caring Behaviors - Part One"" CBL in its entirety.",169412,1,b. False,0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51544,0,Patient with evidence of Latent tuberculosis infection (LTBI) should initiate LTBI therapy prior to starting a TNF-alpha inhibitor.,169476,0,TRUE,1
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51544,0,Patient with evidence of Latent tuberculosis infection (LTBI) should initiate LTBI therapy prior to starting a TNF-alpha inhibitor.,169477,1,FALSE,0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51545,1,Which one of these agents require Hepatitis B screening ?,169478,0,A) Infliximab,0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51545,1,Which one of these agents require Hepatitis B screening ?,169479,1,B) Rituximab,0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51545,1,Which one of these agents require Hepatitis B screening ?,169480,2,C) Tocilizumab,0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51545,1,Which one of these agents require Hepatitis B screening ?,169481,3,D) A & B,1
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51545,1,Which one of these agents require Hepatitis B screening ?,169482,4,E) B &C,0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51546,2,QuantiFERON-TB Gold and T-SPOT are different types of IGRA assays which are used to test for TB.,169483,0,TRUE,1
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51546,2,QuantiFERON-TB Gold and T-SPOT are different types of IGRA assays which are used to test for TB.,169484,1,FALSE,0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51547,3,Which option is not appropriate for treatment of hepatitis B ?,169485,0,A) Lamivudine 100 mg PO daily,0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51547,3,Which option is not appropriate for treatment of hepatitis B ?,169486,1,B) Tenofovir Alafenamide 25mg PO daily,0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51547,3,Which option is not appropriate for treatment of hepatitis B ?,169487,2,C) Tenofovir Disoproxil fumarate 25 mg PO daily,1
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51547,3,Which option is not appropriate for treatment of hepatitis B ?,169488,3,D) Entecavir 0.5 mg PO daily,0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51548,4,Which statement is false ?,169489,0,A) Interferon-gamma release assay ( IGRA) blood test is preferred for individuals with low to intermediate risk of progression to active disease,0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51548,4,Which statement is false ?,169490,1,B) Tuberculin Skin Test will be False-positive in individual with prior BCG vaccination,0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51548,4,Which statement is false ?,169491,2,C) Interferon-gamma release assay ( IGRA) blood test will be False-positive in individual with prior BCG vaccination,1
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51548,4,Which statement is false ?,169492,3,D) Tuberculin Skin Test is inexpensive and does not require lab equipment in comparison with Interferon-Gamma release Assay ( IGRA),0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51549,5,Which one of these agents require TB screening ?,169493,0,A) Tocilizumab,0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51549,5,Which one of these agents require TB screening ?,169494,1,B) Ofatumumab,0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51549,5,Which one of these agents require TB screening ?,169495,2,C) Golimumab,0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51549,5,Which one of these agents require TB screening ?,169496,3,D) Etanercept,0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51549,5,Which one of these agents require TB screening ?,169497,4,"E) A,B,C",0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51549,5,Which one of these agents require TB screening ?,169498,5,"F) A,C,D",1
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51549,5,Which one of these agents require TB screening ?,169499,6,G) All of the above,0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51550,6,When should we order HBV DNA test ?,169500,0,A) Hep B core AB (+) & Hep B Surf AG (-),0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51550,6,When should we order HBV DNA test ?,169501,1,B) Hep B core AB (-) & Hep B Surf AG (-),0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51550,6,When should we order HBV DNA test ?,169502,2,C) Hep B core AB (+) & Hep B Surf AB (+) & Hep Hep B Surf AG (-),0
8994,Elearning-0000-271,FY2020 PHARMACY HEPB AND TB MONITORING EDUCATION FOR ONCOLOGY,n11868,51550,6,When should we order HBV DNA test ?,169503,3,D) A & C,1
9141,Elearning-0000-405,NEWBORN L&D UCS ADMISSION PROCESS,n11876,51594,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",169659,0,TRUE,1
9141,Elearning-0000-405,NEWBORN L&D UCS ADMISSION PROCESS,n11876,51594,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",169660,1,FALSE,0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51595,0,What minimum tube size (diameter) is recommended for the administration of dissolved or crushed dosage forms?,169661,0,"A.	8 French",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51595,0,What minimum tube size (diameter) is recommended for the administration of dissolved or crushed dosage forms?,169662,1,"B.	10 French",1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51595,0,What minimum tube size (diameter) is recommended for the administration of dissolved or crushed dosage forms?,169663,2,"C.	12 French",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51595,0,What minimum tube size (diameter) is recommended for the administration of dissolved or crushed dosage forms?,169664,3,"D.	16 French",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51596,1,Liquid formulations are the ideal formulation for enteral route administration?,169665,0,TRUE,0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51596,1,Liquid formulations are the ideal formulation for enteral route administration?,169666,1,FALSE,1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51597,2,Medications may be mixed in enteral nutrition products to minimize side effects.,169667,0,TRUE,0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51597,2,Medications may be mixed in enteral nutrition products to minimize side effects.,169668,1,FALSE,1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51598,3,Examples of enteral medication preparation errors include,169669,0,"A.	Crushing and mixing drugs separately",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51598,3,Examples of enteral medication preparation errors include,169670,1,"B.	Shaking suspensions",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51598,3,Examples of enteral medication preparation errors include,169671,2,"C.	Diluting medications appropriately",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51598,3,Examples of enteral medication preparation errors include,169672,3,"D.	Crushing modified release dosage forms",1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51599,4,A pharmacist receives an order from a physician for sucralfate suspension 1000mg ac&hs via J-tube. Can this order be verified as written?,169673,0,TRUE,0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51599,4,A pharmacist receives an order from a physician for sucralfate suspension 1000mg ac&hs via J-tube. Can this order be verified as written?,169674,1,FALSE,1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51600,5,A pharmacist receives an order for Phenytoin suspension 100mg q8h via J-tube. Can this order be verified as written?,169675,0,TRUE,0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51600,5,A pharmacist receives an order for Phenytoin suspension 100mg q8h via J-tube. Can this order be verified as written?,169676,1,FALSE,1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51601,6,Which of the following drugs is not recommended for administration via feeding tubes?,169677,0,"A.	Valproic acid",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51601,6,Which of the following drugs is not recommended for administration via feeding tubes?,169678,1,"B.	Phenytoin",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51601,6,Which of the following drugs is not recommended for administration via feeding tubes?,169679,2,"C.	Pancreatitic  enzymes",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51601,6,Which of the following drugs is not recommended for administration via feeding tubes?,169680,3,"D.	Lanthanum",1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51602,7,Which of the following BPH drugs may be administered via feeding tube?,169681,0,"A.	Dutasteride",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51602,7,Which of the following BPH drugs may be administered via feeding tube?,169682,1,"B.	Alfuzosin",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51602,7,Which of the following BPH drugs may be administered via feeding tube?,169683,2,"C.	Finasteride",1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51602,7,Which of the following BPH drugs may be administered via feeding tube?,169684,3,"D.	Tamsulosin",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51603,8,What is the most effective therapy to clear clogged feeding tubes?,169685,0,"A.	Coke",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51603,8,What is the most effective therapy to clear clogged feeding tubes?,169686,1,"B.	Meat tenderizer",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51603,8,What is the most effective therapy to clear clogged feeding tubes?,169687,2,"C.	Ginger ale",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51603,8,What is the most effective therapy to clear clogged feeding tubes?,169688,3,"D.	Pancreatic enzyme products and sodium bicarbonate",1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51604,9,The vitamin K content of enteral feedings can interfere with the action of warfarin resulting in sub therapeutic INRS?,169689,0,TRUE,0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51604,9,The vitamin K content of enteral feedings can interfere with the action of warfarin resulting in sub therapeutic INRS?,169690,1,FALSE,1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51605,10,Which of the following medications is not recommended for administration via feeding tubes?,169691,0,"A.	Phenytoin",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51605,10,Which of the following medications is not recommended for administration via feeding tubes?,169692,1,"B.	Risedronate",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51605,10,Which of the following medications is not recommended for administration via feeding tubes?,169693,2,"C.	Sucralfate",1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51605,10,Which of the following medications is not recommended for administration via feeding tubes?,169694,3,"D.	Warfarin",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51606,11,FDA approval is required for drug administration via feeding tubes?,169695,0,TRUE,0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51606,11,FDA approval is required for drug administration via feeding tubes?,169696,1,FALSE,1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51607,12,Which of the following medication are not a high risk medication for clogging feeding tubes?,169697,0,"A.	Lanthanum tablets",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51607,12,Which of the following medication are not a high risk medication for clogging feeding tubes?,169698,1,"B.	Sevelamer tablets",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51607,12,Which of the following medication are not a high risk medication for clogging feeding tubes?,169699,2,"C.	Risedronate tablets",1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51607,12,Which of the following medication are not a high risk medication for clogging feeding tubes?,169700,3,"D.	Sucralfate tablets and suspension.",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51608,13,A pharmacist is doing an IV to enteral conversion for Ciprofloxacin via PEG tube. Which formulation should be picked?,169701,0,"A.	Suspension",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51608,13,A pharmacist is doing an IV to enteral conversion for Ciprofloxacin via PEG tube. Which formulation should be picked?,169702,1,"B.	Crushed tablets",1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51609,14,What is the best method to prevent clogging of feeding tubes?,169703,0,"A.	Change all medication to a non-enteral route such as IV, SQ, or rectal.",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51609,14,What is the best method to prevent clogging of feeding tubes?,169704,1,"B.	Avoid liquid medications due to osmolality and viscosity issues",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51609,14,What is the best method to prevent clogging of feeding tubes?,169705,2,"C.	Flush the feeding tube on a regular basis and after medications.",1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51609,14,What is the best method to prevent clogging of feeding tubes?,169706,3,"D.	There is no need to flush feeding tubes. Enteral nutrition formulas are composed of 70-85% water.",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51610,15,Which of the following medications can be administered via J-tube?,169707,0,"A.	Phenytoin",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51610,15,Which of the following medications can be administered via J-tube?,169708,1,"B.	Sucralfate",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51610,15,Which of the following medications can be administered via J-tube?,169709,2,"C.	Iron",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51610,15,Which of the following medications can be administered via J-tube?,169710,3,"D.	Levothyroxine",1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51611,16,Po (oral) and enteral routes are synonymous.,169711,0,TRUE,0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51611,16,Po (oral) and enteral routes are synonymous.,169712,1,FALSE,1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51612,17,Which medication is not one of the classic drug enteral interactions?,169713,0,"A.	Phenytoin",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51612,17,Which medication is not one of the classic drug enteral interactions?,169714,1,"B.	Fluoroquinolones",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51612,17,Which medication is not one of the classic drug enteral interactions?,169715,2,"C.	Levothyroxine",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51612,17,Which medication is not one of the classic drug enteral interactions?,169716,3,"D.	Valproic acid products",1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51613,18,DOACS and LMWHS are alternatives to warfarin in enteral nutrition patients.,169717,0,TRUE,1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51613,18,DOACS and LMWHS are alternatives to warfarin in enteral nutrition patients.,169718,1,FALSE,0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51614,19,Which of the following hazardous medications may not be administered via feeding tubes?,169719,0,"A.	Cyclosporine",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51614,19,Which of the following hazardous medications may not be administered via feeding tubes?,169720,1,"B.	Finasteride",0
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51614,19,Which of the following hazardous medications may not be administered via feeding tubes?,169721,2,"C.	Ribavirin",1
9416,Elearning-0000-655,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR PHARMACISTS,n11877,51614,19,Which of the following hazardous medications may not be administered via feeding tubes?,169722,3,"D.	Valganciclovir",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51615,0,What minimum tube size (diameter) is recommended for the administration of dissolved or crushed dosage forms?,169723,0,"A.	8 French",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51615,0,What minimum tube size (diameter) is recommended for the administration of dissolved or crushed dosage forms?,169724,1,"B.	10 French",1
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51615,0,What minimum tube size (diameter) is recommended for the administration of dissolved or crushed dosage forms?,169725,2,"C.	12 French",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51615,0,What minimum tube size (diameter) is recommended for the administration of dissolved or crushed dosage forms?,169726,3,"D.	16 French",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51616,1,Liquid formulations are the ideal formulation for enteral route administration?,169727,0,TRUE,0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51616,1,Liquid formulations are the ideal formulation for enteral route administration?,169728,1,FALSE,1
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51617,2,Medications may be mixed in enteral nutrition products to minimize side effects.,169729,0,TRUE,0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51617,2,Medications may be mixed in enteral nutrition products to minimize side effects.,169730,1,FALSE,1
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51618,3,Examples of enteral medication preparation errors include,169731,0,"A.	Crushing and mixing drugs separately",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51618,3,Examples of enteral medication preparation errors include,169732,1,"B.	Shaking suspensions",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51618,3,Examples of enteral medication preparation errors include,169733,2,"C.	Diluting medications appropriately",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51618,3,Examples of enteral medication preparation errors include,169734,3,"D.	Crushing  modified release dosage forms",1
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51619,4,What is the most effective therapy to clear clogged feeding tubes?,169735,0,"A.	Coke",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51619,4,What is the most effective therapy to clear clogged feeding tubes?,169736,1,"B.	Meat tenderizer",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51619,4,What is the most effective therapy to clear clogged feeding tubes?,169737,2,"C.	Ginger ale",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51619,4,What is the most effective therapy to clear clogged feeding tubes?,169738,3,"D.	Pancreatic enzyme products and sodium bicarbonate",1
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51620,5,FDA approval is required for drug administration via feeding tubes?,169739,0,TRUE,0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51620,5,FDA approval is required for drug administration via feeding tubes?,169740,1,FALSE,1
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51621,6,All of the following are methods to the manage the Levodopa interaction with proteins except,169741,0,"A.	Convert to bolus feedings",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51621,6,All of the following are methods to the manage the Levodopa interaction with proteins except,169742,1,"B.	Convert to cyclic feedings",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51621,6,All of the following are methods to the manage the Levodopa interaction with proteins except,169743,2,"C.	Separate enteral feedings from levodopa administration by 2 hours",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51621,6,All of the following are methods to the manage the Levodopa interaction with proteins except,169744,3,"D.	Increase protein intake from the enteral feeding to greater than 1gram/kg/day.",1
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51622,7,What is the best method to prevent clogging of feeding tubes?,169745,0,"A.	Change all medication to a non-enteral route such as IV, SQ, or rectal.",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51622,7,What is the best method to prevent clogging of feeding tubes?,169746,1,"B.	Avoid liquid medications due to osmolality and viscosity issues",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51622,7,What is the best method to prevent clogging of feeding tubes?,169747,2,"C.	Flush the feeding tube on a regular basis and after medications.",1
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51622,7,What is the best method to prevent clogging of feeding tubes?,169748,3,"D.	There is no need to flush feeding tubes. Enteral nutrition formulas are composed of 70-85% water.",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51623,8,Which of the following medications require holding around administration?,169749,0,"A.	Azithromycin",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51623,8,Which of the following medications require holding around administration?,169750,1,"B.	Carbamazepine",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51623,8,Which of the following medications require holding around administration?,169751,2,"C.	Valproic acid",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51623,8,Which of the following medications require holding around administration?,169752,3,"D.	Phenytoin",1
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51624,9,Which of the following medications may be administered via a J-tube?,169753,0,"A.	Phenytoin",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51624,9,Which of the following medications may be administered via a J-tube?,169754,1,"B.	Sucralfate",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51624,9,Which of the following medications may be administered via a J-tube?,169755,2,"C.	Iron",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51624,9,Which of the following medications may be administered via a J-tube?,169756,3,"D.	Levothyroxine",1
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51625,10,"Undiluted administration of liquid medications and inactive ingredients such as sugars, preservatives, and thickening agents can cause GI side effects that can be interpreted as intolerance to tube feeding.",169757,0,TRUE,1
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51625,10,"Undiluted administration of liquid medications and inactive ingredients such as sugars, preservatives, and thickening agents can cause GI side effects that can be interpreted as intolerance to tube feeding.",169758,1,FALSE,0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51626,11,What is the minimum flush volume for an adult enteral nutrition patient?,169759,0,"A.	3mls",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51626,11,What is the minimum flush volume for an adult enteral nutrition patient?,169760,1,"B.	5mls",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51626,11,What is the minimum flush volume for an adult enteral nutrition patient?,169761,2,"C.	15mls",1
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51626,11,What is the minimum flush volume for an adult enteral nutrition patient?,169762,3,"D.	20mls",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51627,12,Enteral feedings have a high Vitamin K content resulting in interference with the anticoagulant effects of Warfarin,169763,0,TRUE,0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51627,12,Enteral feedings have a high Vitamin K content resulting in interference with the anticoagulant effects of Warfarin,169764,1,FALSE,1
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51628,13,Hazardous drugs may not be administered via feeding tubes.,169765,0,TRUE,0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51628,13,Hazardous drugs may not be administered via feeding tubes.,169766,1,FALSE,1
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51629,14,Which of the following medications may be give via a feeding tube?,169767,0,"A.	Tamsulosin",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51629,14,Which of the following medications may be give via a feeding tube?,169768,1,"B.	Enteric coated aspirin",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51629,14,Which of the following medications may be give via a feeding tube?,169769,2,"C.	Guaifenesin LA",0
9417,Elearning-0000-656,FY2020: DRUG ADMINISTRATION IN ENTERAL NUTRITION PATIENTS FOR NST,n11878,51629,14,Which of the following medications may be give via a feeding tube?,169770,3,"D.	 Finasteride suspension",1
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51643,0,Contaminated sharps are considered Regulated Medical Waste.,169808,0,a. True,1
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51643,0,Contaminated sharps are considered Regulated Medical Waste.,169809,1,b. False,0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51644,1,Which of the following are not considered Regulated Medical Waste?,169810,0,"a.	Covid - 19 patient waste b.	Urine",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51644,1,Which of the following are not considered Regulated Medical Waste?,169811,1,"b.	Urine",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51644,1,Which of the following are not considered Regulated Medical Waste?,169812,2,"c.	Vomitus",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51644,1,Which of the following are not considered Regulated Medical Waste?,169813,3,"d.	All of the above",1
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51645,2,Which of the following cannot be disposed of with Regulated Medical Waste?,169814,0,"a.	Body parts",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51645,2,Which of the following cannot be disposed of with Regulated Medical Waste?,169815,1,"b.	Sharps",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51645,2,Which of the following cannot be disposed of with Regulated Medical Waste?,169816,2,"c.	Radioactive Waste/Hot Trash",1
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51645,2,Which of the following cannot be disposed of with Regulated Medical Waste?,169817,3,"d.	Non-liquid tissue",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51646,3,Loose sharps are not allowed to go in a red bag?,169818,0,"a.	True",1
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51646,3,Loose sharps are not allowed to go in a red bag?,169819,1,"b.	False",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51647,4,Biomedical red waste bags are allowed to be filled to what capacity?,169820,0,"a.	100% full",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51647,4,Biomedical red waste bags are allowed to be filled to what capacity?,169821,1,"b.	50% full",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51647,4,Biomedical red waste bags are allowed to be filled to what capacity?,169822,2,"c.	75% full",1
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51648,5,Liquid/fluids must have what added before placement in a red bag?,169823,0,"a.	More liquid",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51648,5,Liquid/fluids must have what added before placement in a red bag?,169824,1,"b.	A solidifier",1
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51648,5,Liquid/fluids must have what added before placement in a red bag?,169825,2,"c.	A disinfectant",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51649,6,Pathological and Trace Chemotherapy RMW must be segregated and marked for what?,169826,0,"a.	Transportation",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51649,6,Pathological and Trace Chemotherapy RMW must be segregated and marked for what?,169827,1,"b.	Illumination",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51649,6,Pathological and Trace Chemotherapy RMW must be segregated and marked for what?,169828,2,"c.	Life Cycle Assessment",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51649,6,Pathological and Trace Chemotherapy RMW must be segregated and marked for what?,169829,3,"d.	Incineration",1
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51650,7,Manifests for transportation should include all of the following except which one of the following?,169830,0,"a.	Driver's address",1
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51650,7,Manifests for transportation should include all of the following except which one of the following?,169831,1,"b.	Transporter's signature",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51650,7,Manifests for transportation should include all of the following except which one of the following?,169832,2,"c.	Shipper's certification",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51650,7,Manifests for transportation should include all of the following except which one of the following?,169833,3,"d.	Emergency response number",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51651,8,Regulated Medical Waste records should be maintained for how long?,169834,0,"a.	2 years",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51651,8,Regulated Medical Waste records should be maintained for how long?,169835,1,"b.	4 years",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51651,8,Regulated Medical Waste records should be maintained for how long?,169836,2,"c.	3 years",1
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51651,8,Regulated Medical Waste records should be maintained for how long?,169837,3,"d.	1 year",0
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51652,9,"I have read and understand all aspects of identifying, managing, and disposing Regulated Medical Waste.",169838,0,a. True,1
8102,Elearning-0000-1001,"REGULATED MEDICAL WASTE - IDENTIFYING, MANAGING, AND DISPOSAL",n12064,51652,9,"I have read and understand all aspects of identifying, managing, and disposing Regulated Medical Waste.",169839,1,b. False,0
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51665,0,Which of the following patients are considered an obstetric patient?,169884,0,A woman who is 8 weeks pregnant,0
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51665,0,Which of the following patients are considered an obstetric patient?,169885,1,A woman who is 37 weeks pregnant,0
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51665,0,Which of the following patients are considered an obstetric patient?,169886,2,A woman who delivered a baby within the past 6 weeks,0
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51665,0,Which of the following patients are considered an obstetric patient?,169887,3,All of the above,1
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51666,1,"What is the definition of ""acute, severe hypertension?""",169888,0,SBP > 140 mmHg on two occasions at least four hours apart OR DBP > 90 mmHg on two occasions at least four hours apart occurring at any time during pregnancy or hospitalization,0
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51666,1,"What is the definition of ""acute, severe hypertension?""",169889,1,SBP > 160 mmHg OR DBP > 110 mmHg,0
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51666,1,"What is the definition of ""acute, severe hypertension?""",169890,2,SBP > 160 mmHg sustained for 15 minutes OR DBP > 110 mmHg sustained for 15 minutes,1
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51667,2,"If an antepartum or postpartum patient has a current diagnosis of hypertension, at a minimum, how frequently should their blood pressure be assessed?",169891,0,Hourly,0
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51667,2,"If an antepartum or postpartum patient has a current diagnosis of hypertension, at a minimum, how frequently should their blood pressure be assessed?",169892,1,Every 4 hours,1
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51667,2,"If an antepartum or postpartum patient has a current diagnosis of hypertension, at a minimum, how frequently should their blood pressure be assessed?",169893,2,Once per shift,0
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51667,2,"If an antepartum or postpartum patient has a current diagnosis of hypertension, at a minimum, how frequently should their blood pressure be assessed?",169894,3,"Every 10min x 1hr, then every 15min x 1hr, then every 30min x 1hr, then every hour x 4 hrs",0
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51668,3,"A first line antihypertensive medication should be administered to a patient experiencing acute, severe hypertension within what time frame?",169895,0,"As soon as possible, but no later than 30 minutes",0
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51668,3,"A first line antihypertensive medication should be administered to a patient experiencing acute, severe hypertension within what time frame?",169896,1,"As soon as possible, but no later than 60 minutes",1
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51668,3,"A first line antihypertensive medication should be administered to a patient experiencing acute, severe hypertension within what time frame?",169897,2,"As soon as possible, but no later than 90 minutes",0
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51669,4,Which of the following are first line antihypertensive medications?,169898,0,IV labetalol,0
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51669,4,Which of the following are first line antihypertensive medications?,169899,1,IV hydralazine,0
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51669,4,Which of the following are first line antihypertensive medications?,169900,2,PO Nifedipine (immediate release),0
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51669,4,Which of the following are first line antihypertensive medications?,169901,3,All of the above,1
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51670,5,"You are providing discharge education to patient who was diagnosed with preeclampsia during her pregnancy and experienced acute, severe hypertension during her hospitalization.  She should be educated to follow up in her provider's office:",169902,0,In 3-7 days,1
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51670,5,"You are providing discharge education to patient who was diagnosed with preeclampsia during her pregnancy and experienced acute, severe hypertension during her hospitalization.  She should be educated to follow up in her provider's office:",169903,1,Within 4 weeks,0
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51670,5,"You are providing discharge education to patient who was diagnosed with preeclampsia during her pregnancy and experienced acute, severe hypertension during her hospitalization.  She should be educated to follow up in her provider's office:",169904,2,In 6-8 weeks,0
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51671,6,A debriefing should occur after which of the following hypertensive events:,169905,0,Eclamptic seizure; magnesium toxicity; admission to ICU as a result of a hypertensive event,1
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51671,6,A debriefing should occur after which of the following hypertensive events:,169906,1,"All acute, severe hypertensive events",0
9202,Elearning-0000-460,MANAGEMENT OF HYPERTENSION IN THE OB PATIENT,n12069,51671,6,A debriefing should occur after which of the following hypertensive events:,169907,2,Magnesium toxicity; hemorrhage; STAT delivery as a result of a hypertensive event,0
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51672,0,When should PP oxytocin be started?,169908,0,At delivery of the baby,1
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51672,0,When should PP oxytocin be started?,169909,1,At delivery of the placenta,0
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51672,0,When should PP oxytocin be started?,169910,2,Following delivery of the placenta,0
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51673,1,When should PPH risk assessments be completed?,169911,0,"Admission, pre-birth, post-birth",1
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51673,1,When should PPH risk assessments be completed?,169912,1,"Pre-birth, post-birth",0
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51673,1,When should PPH risk assessments be completed?,169913,2,"Admission, post-birth",0
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51674,2,PPH risk assessment scores should be communicated with postpartum nurse.,169914,0,TRUE,1
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51674,2,PPH risk assessment scores should be communicated with postpartum nurse.,169915,1,FALSE,0
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51675,3,How long should IV access be maintained in the PP patient with a PPH Risk Score of = 2?,169916,0,6 hours,0
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51675,3,How long should IV access be maintained in the PP patient with a PPH Risk Score of = 2?,169917,1,12 hours,0
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51675,3,How long should IV access be maintained in the PP patient with a PPH Risk Score of = 2?,169918,2,24 hours,1
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51676,4,All patients should receive PPH preventative measures.,169919,0,TRUE,1
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51676,4,All patients should receive PPH preventative measures.,169920,1,FALSE,0
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51677,5,Which medication is an antifibrinolytic?,169921,0,Misoprostol,0
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51677,5,Which medication is an antifibrinolytic?,169922,1,Tranexamic acid,1
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51677,5,Which medication is an antifibrinolytic?,169923,2,Hemabate,0
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51678,6,When is a debrief required following a PPH?,169924,0,All patients who experience a PPH require a debrief,0
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51678,6,When is a debrief required following a PPH?,169925,1,All patients requiring an MTP require a debrief,1
9218,Elearning-0000-475,LD_OBSTETRICAL HEMORRHAGE ROLE SPECIFIC EDUCATION,n12070,51678,6,When is a debrief required following a PPH?,169926,2,Only patients with Stage 2 or Stage 3 hemorrhage require a debrief,0
8973,Elearning-0000-252,PP HEMORRHAGE EDUCATION,n12073,51683,0,When should PPH risk assessments be completed?,169939,0,"Admission, pre-birth, post-birth",1
8973,Elearning-0000-252,PP HEMORRHAGE EDUCATION,n12073,51683,0,When should PPH risk assessments be completed?,169940,1,"Pre-birth, post-birth",0
8973,Elearning-0000-252,PP HEMORRHAGE EDUCATION,n12073,51684,1,PPH risk assessment scores should be communicated with postpartum nurse.,169941,0,TRUE,1
8973,Elearning-0000-252,PP HEMORRHAGE EDUCATION,n12073,51684,1,PPH risk assessment scores should be communicated with postpartum nurse.,169942,1,FALSE,0
8973,Elearning-0000-252,PP HEMORRHAGE EDUCATION,n12073,51685,2,How long should IV access be maintained in the PP patient with a PPH Risk Score of = 2?,169943,0,6 hours,0
8973,Elearning-0000-252,PP HEMORRHAGE EDUCATION,n12073,51685,2,How long should IV access be maintained in the PP patient with a PPH Risk Score of = 2?,169944,1,12 hours,0
8973,Elearning-0000-252,PP HEMORRHAGE EDUCATION,n12073,51685,2,How long should IV access be maintained in the PP patient with a PPH Risk Score of = 2?,169945,2,24 hours,1
8973,Elearning-0000-252,PP HEMORRHAGE EDUCATION,n12073,51686,3,All patients receive PPH preventative measures.,169946,0,TRUE,1
8973,Elearning-0000-252,PP HEMORRHAGE EDUCATION,n12073,51686,3,All patients receive PPH preventative measures.,169947,1,FALSE,0
8973,Elearning-0000-252,PP HEMORRHAGE EDUCATION,n12073,51687,4,Which medication is an antifibrinolytic?,169948,0,Misoprostol,0
8973,Elearning-0000-252,PP HEMORRHAGE EDUCATION,n12073,51687,4,Which medication is an antifibrinolytic?,169949,1,Tranexamic acid,1
8973,Elearning-0000-252,PP HEMORRHAGE EDUCATION,n12073,51687,4,Which medication is an antifibrinolytic?,169950,2,Hemabate,0
8973,Elearning-0000-252,PP HEMORRHAGE EDUCATION,n12073,51688,5,When is a debrief required following a PPH?,169951,0,All patients who experience a PPH require a debrief,0
8973,Elearning-0000-252,PP HEMORRHAGE EDUCATION,n12073,51688,5,When is a debrief required following a PPH?,169952,1,All patients requiring an MTP require a debrief,1
8973,Elearning-0000-252,PP HEMORRHAGE EDUCATION,n12073,51688,5,When is a debrief required following a PPH?,169953,2,Only patients with Stage 2 or Stage 3 hemorrhage require a debrief,0
9205,Elearning-0000-463,NSC ICU LUCAS DEVICE,n12075,51689,0,I have read this CBL in its entirety and understand that I am responsible for the all content contained.  If I have questions I can direct them to my leadership team on the unit.,169955,0,TRUE,1
9205,Elearning-0000-463,NSC ICU LUCAS DEVICE,n12075,51689,0,I have read this CBL in its entirety and understand that I am responsible for the all content contained.  If I have questions I can direct them to my leadership team on the unit.,169954,1,FALSE,0
9120,Elearning-0000-386,NSC ICU COVID MATERNAL CODE BLUE 4.30.20,n12076,51690,0,I have read this CBL in its entirety and understand that I am responsible for the all content contained.  If I have questions I can direct them to my leadership team on the unit.,169957,0,TRUE,1
9120,Elearning-0000-386,NSC ICU COVID MATERNAL CODE BLUE 4.30.20,n12076,51690,0,I have read this CBL in its entirety and understand that I am responsible for the all content contained.  If I have questions I can direct them to my leadership team on the unit.,169956,1,FALSE,0
9046,Elearning-0000-319,NSH 1230 AMENDMENT 4,n12086,51722,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",170067,0,TRUE,1
9046,Elearning-0000-319,NSH 1230 AMENDMENT 4,n12086,51722,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",170068,1,FALSE,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51761,0,All intubated babies must have two healthcare providers at the bedside for repositioning to reduce unplanned extubations.,170170,0,TRUE,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51761,0,All intubated babies must have two healthcare providers at the bedside for repositioning to reduce unplanned extubations.,170171,1,FALSE,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51762,1,What is the primary role of the second person that is needed for repositioning an intubated baby?,170172,0,A. To give the other person some company,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51762,1,What is the primary role of the second person that is needed for repositioning an intubated baby?,170173,1,B. To offer encouragement to the primary caregiver,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51762,1,What is the primary role of the second person that is needed for repositioning an intubated baby?,170174,2,"C. To maintain the airway before, during, and after patient repositioning",1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51763,2,When should the bedside bag & mask and/or the t-piece resuscitator circuit be replaced?,170175,0,A. When damaged or visibly soiled,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51763,2,When should the bedside bag & mask and/or the t-piece resuscitator circuit be replaced?,170176,1,B. After it is used to deliver PPV,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51763,2,When should the bedside bag & mask and/or the t-piece resuscitator circuit be replaced?,170177,2,C. When admitting a new patient,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51763,2,When should the bedside bag & mask and/or the t-piece resuscitator circuit be replaced?,170178,3,D. All of the above,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51764,3,"When changing or setting-up the bedside bag and mask and/or t-piece resuscitator, the storage bag should be labeled with the date the equipment was set up.",170179,0,TRUE,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51764,3,"When changing or setting-up the bedside bag and mask and/or t-piece resuscitator, the storage bag should be labeled with the date the equipment was set up.",170180,1,FALSE,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51765,4,When should the closed suction setup for ET tubes be replaced?,170181,0,A. Every night,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51765,4,When should the closed suction setup for ET tubes be replaced?,170182,1,B. When visibly soiled or damaged,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51765,4,When should the closed suction setup for ET tubes be replaced?,170183,2,C. Weekly on Sunday nights,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51765,4,When should the closed suction setup for ET tubes be replaced?,170184,3,D. None of the above,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51765,4,When should the closed suction setup for ET tubes be replaced?,170185,4,E. B & C,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51766,5,Effective hand hygiene is the single most important intervention in decreasing the incidence of infection and disease.  When should proper hand hygiene be performed?,170186,0,A. Entering the unit before shift report.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51766,5,Effective hand hygiene is the single most important intervention in decreasing the incidence of infection and disease.  When should proper hand hygiene be performed?,170187,1,B. Before and after patient contact.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51766,5,Effective hand hygiene is the single most important intervention in decreasing the incidence of infection and disease.  When should proper hand hygiene be performed?,170188,2,C. Before putting on gloves and after removal of gloves,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51766,5,Effective hand hygiene is the single most important intervention in decreasing the incidence of infection and disease.  When should proper hand hygiene be performed?,170189,3,D. Before touching anything in the infant's bed space.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51766,5,Effective hand hygiene is the single most important intervention in decreasing the incidence of infection and disease.  When should proper hand hygiene be performed?,170190,4,E. When moving from a contaminated body site to a clean site during care.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51766,5,Effective hand hygiene is the single most important intervention in decreasing the incidence of infection and disease.  When should proper hand hygiene be performed?,170191,5,F. All of the above.,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51767,6,Which of the following does maintaining NCPAP promote?,170192,0,A.  FRC,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51767,6,Which of the following does maintaining NCPAP promote?,170193,1,B.  Endogenous surfactant production,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51767,6,Which of the following does maintaining NCPAP promote?,170194,2,C.  Oxygenation,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51767,6,Which of the following does maintaining NCPAP promote?,170195,3,D.  All of the above,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51768,7,ALL babies < 30 weeks should have CPAP placed on them immediately in the delivery room.,170196,0,TRUE,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51768,7,ALL babies < 30 weeks should have CPAP placed on them immediately in the delivery room.,170197,1,FALSE,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51769,8,Any interruption of CPAP when admitting a patient to SCN should be avoided.  Which of the following may be caused by interruption of CPAP?,170198,0,A.  Over distention,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51769,8,Any interruption of CPAP when admitting a patient to SCN should be avoided.  Which of the following may be caused by interruption of CPAP?,170199,1,B.  Decreased oxygenation,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51769,8,Any interruption of CPAP when admitting a patient to SCN should be avoided.  Which of the following may be caused by interruption of CPAP?,170200,2,C.  Atelectasis or loss of FRC,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51769,8,Any interruption of CPAP when admitting a patient to SCN should be avoided.  Which of the following may be caused by interruption of CPAP?,170201,3,D.  B and C,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51770,9,The initial blood gas for an infant/neonate that is admitted on CPAP should be obtained:,170202,0,A. Immediately upon admission to the unit,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51770,9,The initial blood gas for an infant/neonate that is admitted on CPAP should be obtained:,170203,1,B. After lines are placed by the physician,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51770,9,The initial blood gas for an infant/neonate that is admitted on CPAP should be obtained:,170204,2,"C. After 1 hour of continuous, uninterrupted time on CPAP",1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51770,9,The initial blood gas for an infant/neonate that is admitted on CPAP should be obtained:,170205,3,"D. After length, head, and chest are measured",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51771,10,"Any nasal redness, bruising, or skin breakdown due to nasal prong therapyrequires the MD and RN to be notified and results charted.",170206,0,TRUE,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51771,10,"Any nasal redness, bruising, or skin breakdown due to nasal prong therapyrequires the MD and RN to be notified and results charted.",170207,1,FALSE,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51772,11,How do you determine the correct size nasal prongs for CPAP or NIPPV?,170208,0,A. Use the INCA Nasal Sizing Gauge,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51772,11,How do you determine the correct size nasal prongs for CPAP or NIPPV?,170209,1,B. Use the prong size that fill the nares without dilating or causing blanching,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51772,11,How do you determine the correct size nasal prongs for CPAP or NIPPV?,170210,2,C. Doesn't matter because the Cannulaide provides a seal,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51772,11,How do you determine the correct size nasal prongs for CPAP or NIPPV?,170211,3,D. A & B,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51772,11,How do you determine the correct size nasal prongs for CPAP or NIPPV?,170212,4,E. None of the above,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51773,12,"Normal saline should only be used to clear the in-line suction catheter and NOT instilled down the endotracheal tube as a lavage, UNLESS ordered by a physician.",170213,0,TRUE,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51773,12,"Normal saline should only be used to clear the in-line suction catheter and NOT instilled down the endotracheal tube as a lavage, UNLESS ordered by a physician.",170214,1,FALSE,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51774,13,"Prior to being placed on a patient, the device check and breathing circuit check must be performed on the Drager VN 500.",170215,0,TRUE,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51774,13,"Prior to being placed on a patient, the device check and breathing circuit check must be performed on the Drager VN 500.",170216,1,FALSE,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51775,14,Which statement best describes the Volume Guarantee mode?,170217,0,"A.  Set volume, variable pressure",1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51775,14,Which statement best describes the Volume Guarantee mode?,170218,1,"B.  Set pressure, variable volume",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51775,14,Which statement best describes the Volume Guarantee mode?,170219,2,"C.  Set volume, set pressure",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51776,15,"Your 1000g patient has an arterial PCO2 of 69 and is on the following settings: PC-AC/VG = 7.0mL, PMAX = 25, PEEP = 5, Ti = 0.4s, Back-up Rate=30, total rate of 60.Based on the ventilator weaning guidelines, what actions should be taken?",170220,0,A. Increase VG to blow-off CO2,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51776,15,"Your 1000g patient has an arterial PCO2 of 69 and is on the following settings: PC-AC/VG = 7.0mL, PMAX = 25, PEEP = 5, Ti = 0.4s, Back-up Rate=30, total rate of 60.Based on the ventilator weaning guidelines, what actions should be taken?",170221,1,B. Call MD for high PCO2,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51776,15,"Your 1000g patient has an arterial PCO2 of 69 and is on the following settings: PC-AC/VG = 7.0mL, PMAX = 25, PEEP = 5, Ti = 0.4s, Back-up Rate=30, total rate of 60.Based on the ventilator weaning guidelines, what actions should be taken?",170222,2,C. Call MD due to max VG,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51776,15,"Your 1000g patient has an arterial PCO2 of 69 and is on the following settings: PC-AC/VG = 7.0mL, PMAX = 25, PEEP = 5, Ti = 0.4s, Back-up Rate=30, total rate of 60.Based on the ventilator weaning guidelines, what actions should be taken?",170223,3,D. None of the above,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51777,16,"In the PC-SIMV/VG mode, only the set breaths are full ventilator breaths.",170224,0,TRUE,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51777,16,"In the PC-SIMV/VG mode, only the set breaths are full ventilator breaths.",170225,1,FALSE,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51778,17,"The vent settings are: PC-AC/VG = 3.0mL 	PMAX= 25	 PEEP = 5.Rate = 30 	Set Ti = 0.5 seconds Your patient requires a PIP of 22 to deliver this volume. How will the delivered PIP change if your patient becomes more compliant?",170226,0,A.  Delivered PIP will increase,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51778,17,"The vent settings are: PC-AC/VG = 3.0mL 	PMAX= 25	 PEEP = 5.Rate = 30 	Set Ti = 0.5 seconds Your patient requires a PIP of 22 to deliver this volume. How will the delivered PIP change if your patient becomes more compliant?",170227,1,B.  Delivered PIP will decrease,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51778,17,"The vent settings are: PC-AC/VG = 3.0mL 	PMAX= 25	 PEEP = 5.Rate = 30 	Set Ti = 0.5 seconds Your patient requires a PIP of 22 to deliver this volume. How will the delivered PIP change if your patient becomes more compliant?",170228,2,C.  No change,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51779,18,Where should the initial flow trigger be set for patients on the Drager VN-500?,170229,0,A.  0.2 for initial setting,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51779,18,Where should the initial flow trigger be set for patients on the Drager VN-500?,170230,1,B.  High enough to stop the patient from being tachypneic,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51779,18,Where should the initial flow trigger be set for patients on the Drager VN-500?,170231,2,"C.  Adjusted to prevent auto-cycling, but allow for easy patient triggering",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51779,18,Where should the initial flow trigger be set for patients on the Drager VN-500?,170232,3,D.  A and C,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51780,19,"Your 1000 gram infant is on PC-SIMV with the following settings: P Insp = 22	PEEP = 5 cmH2O	Rate = 30 breaths/min	Ti = 0.4 seconds	Measured Vte = 12 cc	PCO2 on ABG = 40. What change would you make to the ventilator settings?",170233,0,A.  Increase the rate to 34,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51780,19,"Your 1000 gram infant is on PC-SIMV with the following settings: P Insp = 22	PEEP = 5 cmH2O	Rate = 30 breaths/min	Ti = 0.4 seconds	Measured Vte = 12 cc	PCO2 on ABG = 40. What change would you make to the ventilator settings?",170234,1,B.  Wean P Insp to maintain VT  5 to 7 cc per kg,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51780,19,"Your 1000 gram infant is on PC-SIMV with the following settings: P Insp = 22	PEEP = 5 cmH2O	Rate = 30 breaths/min	Ti = 0.4 seconds	Measured Vte = 12 cc	PCO2 on ABG = 40. What change would you make to the ventilator settings?",170235,2,C.  Extubate to Bubble CPAP,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51780,19,"Your 1000 gram infant is on PC-SIMV with the following settings: P Insp = 22	PEEP = 5 cmH2O	Rate = 30 breaths/min	Ti = 0.4 seconds	Measured Vte = 12 cc	PCO2 on ABG = 40. What change would you make to the ventilator settings?",170236,3,D.  Decrease rate to 25,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51781,20,The Ventilator Performance Check and Circuit Calibration on the 3100A needs to be performed:,170237,0,A. Every 500 hours of use,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51781,20,The Ventilator Performance Check and Circuit Calibration on the 3100A needs to be performed:,170238,1,B. After each patient use,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51781,20,The Ventilator Performance Check and Circuit Calibration on the 3100A needs to be performed:,170239,2,C. Before setting up for use on a new patient,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51782,21,"If the PCO2 on the blood gas for a baby on HFOV is too high, you can increase ventilation on the HFOV by:",170240,0,A. Decreasing the Hz/Frequency,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51782,21,"If the PCO2 on the blood gas for a baby on HFOV is too high, you can increase ventilation on the HFOV by:",170241,1,B. Increasing the Amps/Power,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51782,21,"If the PCO2 on the blood gas for a baby on HFOV is too high, you can increase ventilation on the HFOV by:",170242,2,C. Increasing the Hz/Frequency,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51782,21,"If the PCO2 on the blood gas for a baby on HFOV is too high, you can increase ventilation on the HFOV by:",170243,3,D. Increasing the MAP,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51782,21,"If the PCO2 on the blood gas for a baby on HFOV is too high, you can increase ventilation on the HFOV by:",170244,4,E. A & B,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51782,21,"If the PCO2 on the blood gas for a baby on HFOV is too high, you can increase ventilation on the HFOV by:",170245,5,F. All of the above,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51783,22,How do you assess adequate lung inflation for babies on HFOV?,170246,0,A.  Auscultate for bilateral and equal breath sounds,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51783,22,How do you assess adequate lung inflation for babies on HFOV?,170247,1,B.  Assess the amount of chest wiggle,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51783,22,How do you assess adequate lung inflation for babies on HFOV?,170248,2,C.  Lung expansion on chest X-ray (diaphragm sits between 8 to 10 ribs),1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51784,23,How do you assess the baby for proper Power/Amplitude on 3100A?,170249,0,A. Chest wiggle to mid-thigh,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51784,23,How do you assess the baby for proper Power/Amplitude on 3100A?,170250,1,B. Chest wiggle to umbilicus,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51784,23,How do you assess the baby for proper Power/Amplitude on 3100A?,170251,2,C. Auscultate for oscillations equally throughout all lobes,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51784,23,How do you assess the baby for proper Power/Amplitude on 3100A?,170252,3,D. Chest X-ray,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51785,24,"When would you call the doctor for a baby with a chest x-ray that shows the 	lungs as under or over inflated?",170253,0,A.   When the lung expansion is = 10 ribs.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51785,24,"When would you call the doctor for a baby with a chest x-ray that shows the 	lungs as under or over inflated?",170254,1,B.   When the lung expansion is < 8 ribs.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51785,24,"When would you call the doctor for a baby with a chest x-ray that shows the 	lungs as under or over inflated?",170255,2,C.   When the MAP is > 30.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51785,24,"When would you call the doctor for a baby with a chest x-ray that shows the 	lungs as under or over inflated?",170256,3,D.   All of the above,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51785,24,"When would you call the doctor for a baby with a chest x-ray that shows the 	lungs as under or over inflated?",170257,4,E.   Just A & B,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51786,25,"According to the Ventilator Weaning Guidelines, when should the therapist 	increase ventilator support?",170258,0,A. When PCO2 is > 65,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51786,25,"According to the Ventilator Weaning Guidelines, when should the therapist 	increase ventilator support?",170259,1,B. When ordered by the MD,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51786,25,"According to the Ventilator Weaning Guidelines, when should the therapist 	increase ventilator support?",170260,2,"C. When an ETCO2 or TcCO2 tracing, that has been correlated to a blood gas, trends higher than a stable level",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51786,25,"According to the Ventilator Weaning Guidelines, when should the therapist 	increase ventilator support?",170261,3,D. All of the above,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51787,26,"Any unopened and unused vials of surfactant should be returned to pharmacy, whereas any used or unused portion of an opened vial or syringe should be discarded appropriately, per policy.",170262,0,TRUE,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51787,26,"Any unopened and unused vials of surfactant should be returned to pharmacy, whereas any used or unused portion of an opened vial or syringe should be discarded appropriately, per policy.",170263,1,FALSE,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51788,27,"A 32 week, 1 day old patient is on BCPAP of +9 cmH2O.  The baby has an increased work of breathing with FiO2 of 75% with SpO2 of 88%.  The RT notifies the physician and is ordered to intubate and give surfactant.  Which of the following is the most likely effect of surfactant administration?",170264,0,A. Decrease alveolar surface tension,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51788,27,"A 32 week, 1 day old patient is on BCPAP of +9 cmH2O.  The baby has an increased work of breathing with FiO2 of 75% with SpO2 of 88%.  The RT notifies the physician and is ordered to intubate and give surfactant.  Which of the following is the most likely effect of surfactant administration?",170265,1,B. Maintain bronchiolar patency,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51788,27,"A 32 week, 1 day old patient is on BCPAP of +9 cmH2O.  The baby has an increased work of breathing with FiO2 of 75% with SpO2 of 88%.  The RT notifies the physician and is ordered to intubate and give surfactant.  Which of the following is the most likely effect of surfactant administration?",170266,2,C. Preferentially improve the surface tension of collapsed alveoli,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51788,27,"A 32 week, 1 day old patient is on BCPAP of +9 cmH2O.  The baby has an increased work of breathing with FiO2 of 75% with SpO2 of 88%.  The RT notifies the physician and is ordered to intubate and give surfactant.  Which of the following is the most likely effect of surfactant administration?",170267,3,D. Increase the pressure needed to keep alveoli open,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51789,28,"The dose number of Curosurf (1st, 2nd, or 3rd dose) should be noted in the comments field of OneChart MAR and Respiratory Therapy iView.",170268,0,TRUE,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51789,28,"The dose number of Curosurf (1st, 2nd, or 3rd dose) should be noted in the comments field of OneChart MAR and Respiratory Therapy iView.",170269,1,FALSE,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51790,29,What supplies are needed for drawing a blood sample from a Peripheral Arterial Line (PAL)?,170270,0,"A. Sterile gloves, clean chux or 4 x 4 gauze, unvented syringe for waste, vented syringe for blood sampling, 4 Site scrubs, heparin flush syringe and Curos green cap.",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51790,29,What supplies are needed for drawing a blood sample from a Peripheral Arterial Line (PAL)?,170271,1,"B. Gloves, clean chux or 4 x 4 gauze, vented syringe for waste, vented syringe for blood sampling, 4 Site scrubs, heparin flush syringe and Curos green cap.",1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51790,29,What supplies are needed for drawing a blood sample from a Peripheral Arterial Line (PAL)?,170272,2,"C. Gloves, clean chux only, vented syringe for waste, vented syringe for blood sampling, 2 Site scrubs, heparin flush syringe and Curos green cap.",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51790,29,What supplies are needed for drawing a blood sample from a Peripheral Arterial Line (PAL)?,170273,3,"D. Gloves, 4 x 4 gauze, unvented syringe for waste, unvented syringe for blood sampling, 4 Site scrubs, heparin flush syringe and Curos green cap.",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51791,30,How much heparin is required to flush an umbilical artery catheter in the SCN?,170274,0,A. 1cc over 30 - 60 seconds,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51791,30,How much heparin is required to flush an umbilical artery catheter in the SCN?,170275,1,B. 0.3 - 0.5cc over 30 - 60 seconds,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51791,30,How much heparin is required to flush an umbilical artery catheter in the SCN?,170276,2,C. 0.5cc rapidly,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51791,30,How much heparin is required to flush an umbilical artery catheter in the SCN?,170277,3,D. Until the line is clear,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51792,31,"There must be a new MD order to use the RAM prongs on a HFNC, BCPAP or NIPPV patient, even if the baby was already on RAM prongs during previous therapies.",170278,0,TRUE,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51792,31,"There must be a new MD order to use the RAM prongs on a HFNC, BCPAP or NIPPV patient, even if the baby was already on RAM prongs during previous therapies.",170279,1,FALSE,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51793,32,"When RAM prongs are ordered to be used with HFNC, the prongs used should not occlude the nares.",170280,0,TRUE,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51793,32,"When RAM prongs are ordered to be used with HFNC, the prongs used should not occlude the nares.",170281,1,FALSE,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51794,33,Which statement best describes the indication for use of inhaled nitric oxide?,170282,0,A. Hypoxic Respiratory Failure associated with clinical or echocardiographic evidence of pulmonary hypertension,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51794,33,Which statement best describes the indication for use of inhaled nitric oxide?,170283,1,B. Meconium Aspiration Syndrome requiring FiO2 > 50%,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51794,33,Which statement best describes the indication for use of inhaled nitric oxide?,170284,2,C. Pulmonary Interstitial Ephysema requiring HFOV,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51795,34,Which of the following shows the correct placement and adaptors for the nitric injector module on a 3100 A/B HFOV?,170285,0,A.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51795,34,Which of the following shows the correct placement and adaptors for the nitric injector module on a 3100 A/B HFOV?,170286,1,B.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51795,34,Which of the following shows the correct placement and adaptors for the nitric injector module on a 3100 A/B HFOV?,170287,2,C.,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51796,35,Which of the following shows the correct placement of the nitric sample line on HFOV? (sample line has a yellow tag),170288,0,A.,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51796,35,Which of the following shows the correct placement of the nitric sample line on HFOV? (sample line has a yellow tag),170289,1,B.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51796,35,Which of the following shows the correct placement of the nitric sample line on HFOV? (sample line has a yellow tag),170290,2,C.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51797,36,Which of the following shows correct placement of the nitric injector module on the Drager VN-500?,170291,0,A.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51797,36,Which of the following shows correct placement of the nitric injector module on the Drager VN-500?,170292,1,B.,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51797,36,Which of the following shows correct placement of the nitric injector module on the Drager VN-500?,170293,2,C.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51798,37,Which of the following shows correct placement of the nitric sampling line for the Drager?,170294,0,A.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51798,37,Which of the following shows correct placement of the nitric sampling line for the Drager?,170295,1,B.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51798,37,Which of the following shows correct placement of the nitric sampling line for the Drager?,170296,2,C.,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51799,38,"When connecting the iNOBlender to a gas source, what is the proper way to connect for the SCN?",170297,0,A.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51799,38,"When connecting the iNOBlender to a gas source, what is the proper way to connect for the SCN?",170298,1,B.,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51799,38,"When connecting the iNOBlender to a gas source, what is the proper way to connect for the SCN?",170299,2,C.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51799,38,"When connecting the iNOBlender to a gas source, what is the proper way to connect for the SCN?",170300,3,D.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51800,39,How often should the orange resus bags be checked for inventory?,170301,0,A.  Once per shift by the Resus RT,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51800,39,How often should the orange resus bags be checked for inventory?,170302,1,B. Once per day by the charge therapist,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51800,39,How often should the orange resus bags be checked for inventory?,170303,2,"C. After each use, if an item is used",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51800,39,How often should the orange resus bags be checked for inventory?,170304,3,D. A & C,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51801,40,All unplanned extubations need to be followed up with an incident report.,170305,0,TRUE,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51801,40,All unplanned extubations need to be followed up with an incident report.,170306,1,FALSE,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51802,41,What is the proper starting temperature for the TC probe when placing on a neonate?,170307,0,A. 41 C,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51802,41,What is the proper starting temperature for the TC probe when placing on a neonate?,170308,1,"B. 	37 C",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51802,41,What is the proper starting temperature for the TC probe when placing on a neonate?,170309,2,"C. 	39 C",1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51802,41,What is the proper starting temperature for the TC probe when placing on a neonate?,170310,3,"D. 	42 C",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51803,42,What is the maximum temperature for the TC probe on a term neonate?,170311,0,"A. 	42 C",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51803,42,What is the maximum temperature for the TC probe on a term neonate?,170312,1,"B. 	41 C",1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51803,42,What is the maximum temperature for the TC probe on a term neonate?,170313,2,"C. 	40 C",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51803,42,What is the maximum temperature for the TC probe on a term neonate?,170314,3,"D. 	39 C",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51804,43,"Unless the physician orders to NOT use a TC monitor, EVERY baby on HFOV must have a TC monitor.",170315,0,TRUE,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51804,43,"Unless the physician orders to NOT use a TC monitor, EVERY baby on HFOV must have a TC monitor.",170316,1,FALSE,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51805,44,"If condensation persistently develops in the respiratory circuit, what are the proper steps to be taken?",170317,0,"A.  If the baby is in an open crib or radiant warmer, remove the unheated portion of the 	inspiratory limb.",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51805,44,"If condensation persistently develops in the respiratory circuit, what are the proper steps to be taken?",170318,1,"B.  If the baby is in a Caleo isolette, remove the unheated portion of the inspiratory limb if 	the air temperature of the Caleo is < 34 C.",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51805,44,"If condensation persistently develops in the respiratory circuit, what are the proper steps to be taken?",170319,2,C.  Make sure temp probes are pushed all the way into the ports.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51805,44,"If condensation persistently develops in the respiratory circuit, what are the proper steps to be taken?",170320,3,"D.  If flow is < 5 Lpm, set heater to Non-Invasive.",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51805,44,"If condensation persistently develops in the respiratory circuit, what are the proper steps to be taken?",170321,4,E.  All of the above,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51806,45,"According to NRP, what is the single most effective way to reverse bradycardia?",170322,0,"A.	Chest Compressions",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51806,45,"According to NRP, what is the single most effective way to reverse bradycardia?",170323,1,"B.	Blow-by Therapy",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51806,45,"According to NRP, what is the single most effective way to reverse bradycardia?",170324,2,"C.	Effective PPV confirmed by MRSOPA",1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51806,45,"According to NRP, what is the single most effective way to reverse bradycardia?",170325,3,"D.	CPAP",0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51807,48,How often should the air/oxygen tanks be checked on the infant transporters in L&D?,170326,0,A.  Transporters in OR/PACU Q Day by dayshift,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51807,48,How often should the air/oxygen tanks be checked on the infant transporters in L&D?,170327,1,B.  Transporters in L&D Care Teams A through F Q Day by nightshift,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51807,48,How often should the air/oxygen tanks be checked on the infant transporters in L&D?,170328,2,C.  Transporters in SCN Q shift by assigned Pod Therapists,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51807,48,How often should the air/oxygen tanks be checked on the infant transporters in L&D?,170329,3,D.  All of the above,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51808,49,Which babies require an oxygen tracker to be placed in-line with their respiratory support device?,170330,0,A. Any baby placed on a vent,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51808,49,Which babies require an oxygen tracker to be placed in-line with their respiratory support device?,170331,1,B. Any baby less than 28 weeks gestation,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51808,49,Which babies require an oxygen tracker to be placed in-line with their respiratory support device?,170332,2,C. Any baby less than 1000g birthweight,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51808,49,Which babies require an oxygen tracker to be placed in-line with their respiratory support device?,170333,3,D. Just B & C,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51808,49,Which babies require an oxygen tracker to be placed in-line with their respiratory support device?,170334,4,E. All of the above,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51809,46,How often should the Cannulaide be checked on patients who are on BCPAP and NIPPV?,170335,0,A. Once per day.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51809,46,How often should the Cannulaide be checked on patients who are on BCPAP and NIPPV?,170336,1,B. Every 6 hours.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51809,46,How often should the Cannulaide be checked on patients who are on BCPAP and NIPPV?,170337,2,C. Every 3 to 4 hours.,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51809,46,How often should the Cannulaide be checked on patients who are on BCPAP and NIPPV?,170338,3,D. Once a shift.,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51810,47,What is the correct mode to use when placing a patient on Non Invasive Positive Pressure Ventilation on the Drager VN-500 and what color should be displayed on the monitor?,170339,0,A. P-CMV and orange,1
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51810,47,What is the correct mode to use when placing a patient on Non Invasive Positive Pressure Ventilation on the Drager VN-500 and what color should be displayed on the monitor?,170340,1,B. P-CPAP and green,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51810,47,What is the correct mode to use when placing a patient on Non Invasive Positive Pressure Ventilation on the Drager VN-500 and what color should be displayed on the monitor?,170341,2,C. P-SIMV and yellow,0
9924,Questions-0000-58,FY2020 NICU RESPIRATORY COMPETENCY NSC,n12095,51810,47,What is the correct mode to use when placing a patient on Non Invasive Positive Pressure Ventilation on the Drager VN-500 and what color should be displayed on the monitor?,170342,3,D. P-AC and blue,0
8101,Elearning-0000-1000,HAP/VAP IN THE NICU,n12097,51811,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",170343,0,TRUE,1
8101,Elearning-0000-1000,HAP/VAP IN THE NICU,n12097,51811,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",170344,1,FALSE,0
8932,Elearning-0000-215,RESPIRATORY PERIPHERAL ARTERIAL LINE MANAGEMENT,n12098,51812,0,"When obtaining labs, one must connect a vented syringe to the stopcock and manually aspirate the amount of blood necessary.",170345,0,TRUE,0
8932,Elearning-0000-215,RESPIRATORY PERIPHERAL ARTERIAL LINE MANAGEMENT,n12098,51812,0,"When obtaining labs, one must connect a vented syringe to the stopcock and manually aspirate the amount of blood necessary.",170346,1,FALSE,1
8932,Elearning-0000-215,RESPIRATORY PERIPHERAL ARTERIAL LINE MANAGEMENT,n12098,51813,1,1 and 3mL vented syringes are both heparinized to minimize clotting during blood sampling.,170347,0,TRUE,0
8932,Elearning-0000-215,RESPIRATORY PERIPHERAL ARTERIAL LINE MANAGEMENT,n12098,51813,1,1 and 3mL vented syringes are both heparinized to minimize clotting during blood sampling.,170348,1,FALSE,1
8932,Elearning-0000-215,RESPIRATORY PERIPHERAL ARTERIAL LINE MANAGEMENT,n12098,51814,2,"When obtaining labs, before connecting the vented syringe to the stopcock, one must first aspirate into the vented syringe the amount of air equal to the amount of blood required for sampling.",170349,0,TRUE,1
8932,Elearning-0000-215,RESPIRATORY PERIPHERAL ARTERIAL LINE MANAGEMENT,n12098,51814,2,"When obtaining labs, before connecting the vented syringe to the stopcock, one must first aspirate into the vented syringe the amount of air equal to the amount of blood required for sampling.",170350,1,FALSE,0
8932,Elearning-0000-215,RESPIRATORY PERIPHERAL ARTERIAL LINE MANAGEMENT,n12098,51815,3,The radial artery is most often used as it is readily accessible and not immediately adjacent to other nerves and veins.,170351,0,TRUE,1
8932,Elearning-0000-215,RESPIRATORY PERIPHERAL ARTERIAL LINE MANAGEMENT,n12098,51815,3,The radial artery is most often used as it is readily accessible and not immediately adjacent to other nerves and veins.,170352,1,FALSE,0
8932,Elearning-0000-215,RESPIRATORY PERIPHERAL ARTERIAL LINE MANAGEMENT,n12098,51816,4,Rapid flushing after PAL blood sampling ensures that residual blood does not adhere to the side of the angio-cath or T-connector thereby minimizing clot formation.,170353,0,TRUE,0
8932,Elearning-0000-215,RESPIRATORY PERIPHERAL ARTERIAL LINE MANAGEMENT,n12098,51816,4,Rapid flushing after PAL blood sampling ensures that residual blood does not adhere to the side of the angio-cath or T-connector thereby minimizing clot formation.,170354,1,FALSE,1
8932,Elearning-0000-215,RESPIRATORY PERIPHERAL ARTERIAL LINE MANAGEMENT,n12098,51817,5,Blood collected in a waste syringe via a PAL should be infused slowly back into the patient so as to avoid unnecessary blood expenditures/losses.,170355,0,TRUE,0
8932,Elearning-0000-215,RESPIRATORY PERIPHERAL ARTERIAL LINE MANAGEMENT,n12098,51817,5,Blood collected in a waste syringe via a PAL should be infused slowly back into the patient so as to avoid unnecessary blood expenditures/losses.,170356,1,FALSE,1
8932,Elearning-0000-215,RESPIRATORY PERIPHERAL ARTERIAL LINE MANAGEMENT,n12098,51818,6,"Most PAL complications can be minimized by utilizing effective hand hygiene, standard precautions and aseptic technique during line insertion and assess in conjunction with continuous monitoring and observation of the PAL site post-insertion.",170357,0,TRUE,1
8932,Elearning-0000-215,RESPIRATORY PERIPHERAL ARTERIAL LINE MANAGEMENT,n12098,51818,6,"Most PAL complications can be minimized by utilizing effective hand hygiene, standard precautions and aseptic technique during line insertion and assess in conjunction with continuous monitoring and observation of the PAL site post-insertion.",170358,1,FALSE,0
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51828,0,ABHRs have greater bactericidal and residual properties than that of soap and water handwashing.,170390,0,TRUE,1
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51828,0,ABHRs have greater bactericidal and residual properties than that of soap and water handwashing.,170391,1,FALSE,0
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51829,1,Hand hygiene is effective against bacteria present on natural and artificial nails if soap and water or hand rubs are used as recommended by manufacturers.,170392,0,TRUE,0
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51829,1,Hand hygiene is effective against bacteria present on natural and artificial nails if soap and water or hand rubs are used as recommended by manufacturers.,170393,1,FALSE,1
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51830,2,Thumbs and fingertips are areas frequently missed during both handwashing and when using an ABHR.,170394,0,TRUE,1
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51830,2,Thumbs and fingertips are areas frequently missed during both handwashing and when using an ABHR.,170395,1,FALSE,0
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51831,3,"At a minimum, HH should be performed and gloves put on immediately before inserting, accessing, or manipulating any indwelling device.",170396,0,TRUE,1
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51831,3,"At a minimum, HH should be performed and gloves put on immediately before inserting, accessing, or manipulating any indwelling device.",170397,1,FALSE,0
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51832,4,"Part of the ""Commitment to Care"" is performing handwashing for 30 full seconds when initially entering the SCN.",170398,0,TRUE,1
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51832,4,"Part of the ""Commitment to Care"" is performing handwashing for 30 full seconds when initially entering the SCN.",170399,1,FALSE,0
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51833,5,Performing LLD twice each shift is a component of the SCN's Cleaner Hands initiative.,170400,0,TRUE,1
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51833,5,Performing LLD twice each shift is a component of the SCN's Cleaner Hands initiative.,170401,1,FALSE,0
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51834,6,"Illustrated in this CBL are the ""8 Moments for Hand Hygiene""",170402,0,TRUE,0
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51834,6,"Illustrated in this CBL are the ""8 Moments for Hand Hygiene""",170403,1,FALSE,1
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51835,7,It is ok for an MD to place a PAL without gloves as it is necessary that they are able to palpate the artery effectively.,170404,0,TRUE,1
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51835,7,It is ok for an MD to place a PAL without gloves as it is necessary that they are able to palpate the artery effectively.,170405,1,FALSE,0
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51836,8,ABHRs are effective sporacidals if 1-2 full pumps are used and hands are rubbed until completely dry,170406,0,TRUE,0
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51836,8,ABHRs are effective sporacidals if 1-2 full pumps are used and hands are rubbed until completely dry,170407,1,FALSE,1
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51837,9,Shakira is changing an infant's pulse oximeter probe when the resus phone rings.  She can waive performing hand hygiene to answer the phone as it may be an emergency.,170408,0,TRUE,0
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51837,9,Shakira is changing an infant's pulse oximeter probe when the resus phone rings.  She can waive performing hand hygiene to answer the phone as it may be an emergency.,170409,1,FALSE,1
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51838,10,"It is crucial to perform hand hygiene before and after touching any patient, the patient's equipment, or items within the patient's bedspace.",170410,0,TRUE,1
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51838,10,"It is crucial to perform hand hygiene before and after touching any patient, the patient's equipment, or items within the patient's bedspace.",170411,1,FALSE,0
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51839,11,I have reviewed the contents of this CBL and am responsible for adhering to the infection prevention and hand hygiene guidelines herein.,170412,0,TRUE,1
8917,Elearning-0000-201,SCN HAND HYGIENE,n12100,51839,11,I have reviewed the contents of this CBL and am responsible for adhering to the infection prevention and hand hygiene guidelines herein.,170413,1,FALSE,0
9485,Elearning-0000-718,NSH 1246: GM-CSF,n12107,51853,0,Patients must be receiving:,170441,0,"a)	A matched unrelated donor transplant.",0
9485,Elearning-0000-718,NSH 1246: GM-CSF,n12107,51853,0,Patients must be receiving:,170442,1,"b)	A matched related donor transplant.",0
9485,Elearning-0000-718,NSH 1246: GM-CSF,n12107,51853,0,Patients must be receiving:,170443,2,"c)	A cord blood transplant.",0
9485,Elearning-0000-718,NSH 1246: GM-CSF,n12107,51853,0,Patients must be receiving:,170444,3,"d)	A mismatched/haplo donor transplant.",1
9485,Elearning-0000-718,NSH 1246: GM-CSF,n12107,51854,1,Sargramostim will begin on Day +5 and continue until ANC >1.0 x 3 days or >1.5 x 1 day.,170445,0,TRUE,1
9485,Elearning-0000-718,NSH 1246: GM-CSF,n12107,51854,1,Sargramostim will begin on Day +5 and continue until ANC >1.0 x 3 days or >1.5 x 1 day.,170446,1,FALSE,0
9485,Elearning-0000-718,NSH 1246: GM-CSF,n12107,51855,2,A 59-year old female with a KPS of 60% undergoing a matched-related donor transplant for CML is eligible for this study.,170447,0,TRUE,0
9485,Elearning-0000-718,NSH 1246: GM-CSF,n12107,51855,2,A 59-year old female with a KPS of 60% undergoing a matched-related donor transplant for CML is eligible for this study.,170448,1,FALSE,1
8611,Elearning-0000-148,STRESS TEST UPDATES 2020,n12116,51938,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",170740,0,TRUE,1
8611,Elearning-0000-148,STRESS TEST UPDATES 2020,n12116,51938,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",170741,1,FALSE,0
9496,Elearning-0000-728,NSH 1242: CPX-351+VENETOCLAX,n12118,51939,0,Patients must have:,170742,0,"a)	Relapsed/refractory AML",0
9496,Elearning-0000-728,NSH 1242: CPX-351+VENETOCLAX,n12118,51939,0,Patients must have:,170743,1,"b)	Relapsed/refractory NHL",0
9496,Elearning-0000-728,NSH 1242: CPX-351+VENETOCLAX,n12118,51939,0,Patients must have:,170744,2,"c)	Newly diagnosed AML",1
9496,Elearning-0000-728,NSH 1242: CPX-351+VENETOCLAX,n12118,51939,0,Patients must have:,170745,3,"d)	Newly diagnosed ALL",0
9496,Elearning-0000-728,NSH 1242: CPX-351+VENETOCLAX,n12118,51940,1,Patients must be unfit for intensive chemotherapy in order to enroll on the study.,170746,0,TRUE,1
9496,Elearning-0000-728,NSH 1242: CPX-351+VENETOCLAX,n12118,51940,1,Patients must be unfit for intensive chemotherapy in order to enroll on the study.,170747,1,FALSE,0
9496,Elearning-0000-728,NSH 1242: CPX-351+VENETOCLAX,n12118,51941,2,Vital signs and PK samples are required only pre-dose and at the end of the infusion for all cycles.,170748,0,TRUE,1
9496,Elearning-0000-728,NSH 1242: CPX-351+VENETOCLAX,n12118,51941,2,Vital signs and PK samples are required only pre-dose and at the end of the infusion for all cycles.,170749,1,FALSE,0
9271,Elearning-0000-523,OBSTETRICAL HEMORRHAGE & HYPERTENSION MGMT FOR ICU,n12124,51949,0,"What is the definition of ""acute, severe hypertension?""",170767,0,A. SBP > 140 mmHg on two occasions at least four hours apart OR DBP > 90 mmHg on two occasions at least four hours apart occurring at any time during pregnancy or hospitalization,0
9271,Elearning-0000-523,OBSTETRICAL HEMORRHAGE & HYPERTENSION MGMT FOR ICU,n12124,51949,0,"What is the definition of ""acute, severe hypertension?""",170768,1,B. SBP > 160 mmHg OR DBP > 110 mmHg,0
9271,Elearning-0000-523,OBSTETRICAL HEMORRHAGE & HYPERTENSION MGMT FOR ICU,n12124,51949,0,"What is the definition of ""acute, severe hypertension?""",170769,2,C. SBP > 160 mmHg sustained for 15 minutes OR DBP > 110 mmHg sustained for 15 minutes,1
9271,Elearning-0000-523,OBSTETRICAL HEMORRHAGE & HYPERTENSION MGMT FOR ICU,n12124,51950,1,When is a debrief required following a PPH?,170770,0,A. All patients who experience a PPH require a debrief,0
9271,Elearning-0000-523,OBSTETRICAL HEMORRHAGE & HYPERTENSION MGMT FOR ICU,n12124,51950,1,When is a debrief required following a PPH?,170771,1,B. All patients requiring an MTP require a debrief,1
9271,Elearning-0000-523,OBSTETRICAL HEMORRHAGE & HYPERTENSION MGMT FOR ICU,n12124,51950,1,When is a debrief required following a PPH?,170772,2,C. Only patients with Stage 2 or Stage 3 hemorrhage require a debrief,0
9271,Elearning-0000-523,OBSTETRICAL HEMORRHAGE & HYPERTENSION MGMT FOR ICU,n12124,51951,2,"A first line antihypertensive medication should be administered to a patient experiencing acute, severe hypertension within what time frame?",170773,0,"A. As soon as possible, but no later than 30 minutes",0
9271,Elearning-0000-523,OBSTETRICAL HEMORRHAGE & HYPERTENSION MGMT FOR ICU,n12124,51951,2,"A first line antihypertensive medication should be administered to a patient experiencing acute, severe hypertension within what time frame?",170774,1,"B. As soon as possible, but no later than 60 minutes",1
9271,Elearning-0000-523,OBSTETRICAL HEMORRHAGE & HYPERTENSION MGMT FOR ICU,n12124,51951,2,"A first line antihypertensive medication should be administered to a patient experiencing acute, severe hypertension within what time frame?",170775,2,"C. As soon as possible, but no later than 90 minutes",0
9271,Elearning-0000-523,OBSTETRICAL HEMORRHAGE & HYPERTENSION MGMT FOR ICU,n12124,51952,3,Which of the following patients are considered an obstetric patient?,170776,0,A. A woman who is 8 weeks pregnant,0
9271,Elearning-0000-523,OBSTETRICAL HEMORRHAGE & HYPERTENSION MGMT FOR ICU,n12124,51952,3,Which of the following patients are considered an obstetric patient?,170777,1,B. A woman who is 37 weeks pregnant,0
9271,Elearning-0000-523,OBSTETRICAL HEMORRHAGE & HYPERTENSION MGMT FOR ICU,n12124,51952,3,Which of the following patients are considered an obstetric patient?,170778,2,C. A woman who delivered a baby within the past 6 weeks,0
9271,Elearning-0000-523,OBSTETRICAL HEMORRHAGE & HYPERTENSION MGMT FOR ICU,n12124,51952,3,Which of the following patients are considered an obstetric patient?,170779,3,D. All of the above,1
9294,Elearning-0000-544,C-426: GSK EAP,n12132,52007,0,Patients must have:,170987,0,"a)	Relapsed/refractory AML",0
9294,Elearning-0000-544,C-426: GSK EAP,n12132,52007,0,Patients must have:,170988,1,"b)	Relapsed/refractory MM",1
9294,Elearning-0000-544,C-426: GSK EAP,n12132,52007,0,Patients must have:,170989,2,"c)	Newly diagnosed AML",0
9294,Elearning-0000-544,C-426: GSK EAP,n12132,52007,0,Patients must have:,170990,3,"d)	Relapsed/refractory NHL",0
9294,Elearning-0000-544,C-426: GSK EAP,n12132,52008,1,"Patients must be refractory to an anti-CD38 antibody (e.g., daratumumab), an IMiD (e.g., lenalidomide or pomalidomide), and a proteasome inhibitor (e.g., bortezomib, ixazomib, or carfilzomib).",170991,0,TRUE,1
9294,Elearning-0000-544,C-426: GSK EAP,n12132,52008,1,"Patients must be refractory to an anti-CD38 antibody (e.g., daratumumab), an IMiD (e.g., lenalidomide or pomalidomide), and a proteasome inhibitor (e.g., bortezomib, ixazomib, or carfilzomib).",170992,1,FALSE,0
9294,Elearning-0000-544,C-426: GSK EAP,n12132,52010,2,Ocular exams are not required but optional before each dose of GSK 2857915.,170995,0,TRUE,0
9294,Elearning-0000-544,C-426: GSK EAP,n12132,52010,2,Ocular exams are not required but optional before each dose of GSK 2857915.,170996,1,FALSE,1
9484,Elearning-0000-717,NSH 1259: ADCT-301-201 HD,n12147,52178,0,Patients must have:,171512,0,"a)	Relapsed/refractory AML",0
9484,Elearning-0000-717,NSH 1259: ADCT-301-201 HD,n12147,52178,0,Patients must have:,171513,1,"b)	Relapsed/refractory NHL",0
9484,Elearning-0000-717,NSH 1259: ADCT-301-201 HD,n12147,52178,0,Patients must have:,171514,2,"c)	Relapsed/refractory HD",1
9484,Elearning-0000-717,NSH 1259: ADCT-301-201 HD,n12147,52178,0,Patients must have:,171515,3,"d)	Relapsed/refractory MM",0
9484,Elearning-0000-717,NSH 1259: ADCT-301-201 HD,n12147,52179,1,Patients must have received at least 1 prior lines of systemic therapy.,171516,0,TRUE,0
9484,Elearning-0000-717,NSH 1259: ADCT-301-201 HD,n12147,52179,1,Patients must have received at least 1 prior lines of systemic therapy.,171517,1,FALSE,1
9484,Elearning-0000-717,NSH 1259: ADCT-301-201 HD,n12147,52180,2,Patients will receive Cami-T every week as an IV infusion over 30 minutes.,171518,0,TRUE,0
9484,Elearning-0000-717,NSH 1259: ADCT-301-201 HD,n12147,52180,2,Patients will receive Cami-T every week as an IV infusion over 30 minutes.,171519,1,FALSE,1
8956,Elearning-0000-237,QUARTER 4 EKG EDUCATION PCCU,n12148,52181,0,WHAT IS CONSIDERED THE PACEMAKER OF THE HEART,171520,0,AV NODE,0
8956,Elearning-0000-237,QUARTER 4 EKG EDUCATION PCCU,n12148,52181,0,WHAT IS CONSIDERED THE PACEMAKER OF THE HEART,171521,1,BUNDLE OF HIS,0
8956,Elearning-0000-237,QUARTER 4 EKG EDUCATION PCCU,n12148,52181,0,WHAT IS CONSIDERED THE PACEMAKER OF THE HEART,171522,2,VENTRICLES,0
8956,Elearning-0000-237,QUARTER 4 EKG EDUCATION PCCU,n12148,52181,0,WHAT IS CONSIDERED THE PACEMAKER OF THE HEART,171523,3,SA NODE,1
8956,Elearning-0000-237,QUARTER 4 EKG EDUCATION PCCU,n12148,52184,3,SINUS BRADY IS CHARACTERIZED BY A RATE OF LESS THAN 60 AND A RHYTHM THAT IS REGULAR,171532,0,TRUE,1
8956,Elearning-0000-237,QUARTER 4 EKG EDUCATION PCCU,n12148,52184,3,SINUS BRADY IS CHARACTERIZED BY A RATE OF LESS THAN 60 AND A RHYTHM THAT IS REGULAR,171533,1,FALSE,0
8956,Elearning-0000-237,QUARTER 4 EKG EDUCATION PCCU,n12148,52185,4,SINUS ARRHYTHMIAS ARE ASSOCIATED WITH  RESPIRATORY PATTERNS,171534,0,TRUE,1
8956,Elearning-0000-237,QUARTER 4 EKG EDUCATION PCCU,n12148,52185,4,SINUS ARRHYTHMIAS ARE ASSOCIATED WITH  RESPIRATORY PATTERNS,171535,1,FALSE,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52756,0,Which of the following is NOT a normal adaptation of pregnancy?,173782,0,Normal pregnancy increases blood volume by 30-50%,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52756,0,Which of the following is NOT a normal adaptation of pregnancy?,173783,1,Hemoglobin levels double,1
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52756,0,Which of the following is NOT a normal adaptation of pregnancy?,173784,2,Fibrinogen and clotting factors increase,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52756,0,Which of the following is NOT a normal adaptation of pregnancy?,173785,3,Fibrinolysis process suppression,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52757,1,Uterine atony is the most common cause of postpartum hemorrhage,173786,0,TRUE,1
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52757,1,Uterine atony is the most common cause of postpartum hemorrhage,173787,1,FALSE,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52758,2,Which of the following is one of the first indicators that a patient might be having a PPH?,173788,0,Tachypnea and tachycardia,1
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52758,2,Which of the following is one of the first indicators that a patient might be having a PPH?,173789,1,Hypotension and tachycardia,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52758,2,Which of the following is one of the first indicators that a patient might be having a PPH?,173790,2,Level of consciousness changes,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52758,2,Which of the following is one of the first indicators that a patient might be having a PPH?,173791,3,Lab values,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52759,3,Which of the following best explains why it is so important to keep a patient warm during a PPH?,173792,0,It is an easy nursing intervention to do,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52759,3,Which of the following best explains why it is so important to keep a patient warm during a PPH?,173793,1,It decreases the patient's oxygen consumption and decreases her risk for death,1
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52759,3,Which of the following best explains why it is so important to keep a patient warm during a PPH?,173794,2,It helps the TXA work better,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52759,3,Which of the following best explains why it is so important to keep a patient warm during a PPH?,173795,3,"It is not important, but if you have time you can do it",0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52760,4,Which of the following is NOT a time when PPH assessment should be done?,173796,0,On admission,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52760,4,Which of the following is NOT a time when PPH assessment should be done?,173797,1,On initiation of pushing,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52760,4,Which of the following is NOT a time when PPH assessment should be done?,173798,2,Within the first hour of recovery,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52760,4,Which of the following is NOT a time when PPH assessment should be done?,173799,3,Immediately prior to discharge,1
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52761,5,All of the following are first-line medications EXCEPT,173800,0,Cytotec,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52761,5,All of the following are first-line medications EXCEPT,173801,1,Hemabate,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52761,5,All of the following are first-line medications EXCEPT,173802,2,Methergine,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52761,5,All of the following are first-line medications EXCEPT,173803,3,TXA,1
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52762,6,MTP can be run in the labor room as long as anesthesia is there.,173804,0,TRUE,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52762,6,MTP can be run in the labor room as long as anesthesia is there.,173805,1,FALSE,1
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52763,7,Transfer to the OR (for PPH in the labor room) is important because most procedures to treat PPH need to occur in the OR with better visibility and access to instruments.,173806,0,TRUE,1
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52763,7,Transfer to the OR (for PPH in the labor room) is important because most procedures to treat PPH need to occur in the OR with better visibility and access to instruments.,173807,1,FALSE,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52764,8,How often should QBL be run AND CALLED OUT TO THE TEAM in a PPH?,173808,0,Every 5 minutes,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52764,8,How often should QBL be run AND CALLED OUT TO THE TEAM in a PPH?,173809,1,Every 15 minutes,1
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52764,8,How often should QBL be run AND CALLED OUT TO THE TEAM in a PPH?,173810,2,Every hour,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52764,8,How often should QBL be run AND CALLED OUT TO THE TEAM in a PPH?,173811,3,Once at the end to summarize total loss,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52765,9,"If you do not understand the role you have been given in a PPH, what should you do?",173812,0,Clarify and ask questions with the Charge RN or Clinician in the room,1
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52765,9,"If you do not understand the role you have been given in a PPH, what should you do?",173813,1,Refuse to accept the role,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52765,9,"If you do not understand the role you have been given in a PPH, what should you do?",173814,2,Walk out of the room so they know there's no one there to do that role anymore,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52765,9,"If you do not understand the role you have been given in a PPH, what should you do?",173815,3,Just try it: you can probably figure it out,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52766,10,Which of the following is the ONLY penicillin reaction for which a patient should NOT receive cefazolin (Ancef)?,173816,0,Hives,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52766,10,Which of the following is the ONLY penicillin reaction for which a patient should NOT receive cefazolin (Ancef)?,173817,1,End-organ failure,1
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52766,10,Which of the following is the ONLY penicillin reaction for which a patient should NOT receive cefazolin (Ancef)?,173818,2,Anything more severe than nausea or vomiting,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52766,10,Which of the following is the ONLY penicillin reaction for which a patient should NOT receive cefazolin (Ancef)?,173819,3,Facial swelling,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52767,11,Annie P. is a 34 week G2P0. She is 32 years old and has gestational diabetes that is diet controlled. She comes into triage from the office for elevated blood pressures and a headache. Her initial BP on admission is 160/104. What is the best next step?,173820,0,Immediately adjust the cuff and patient position and repeat the blood pressure.,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52767,11,Annie P. is a 34 week G2P0. She is 32 years old and has gestational diabetes that is diet controlled. She comes into triage from the office for elevated blood pressures and a headache. Her initial BP on admission is 160/104. What is the best next step?,173821,1,Immediately call the provider for an antihypertensive regimen,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52767,11,Annie P. is a 34 week G2P0. She is 32 years old and has gestational diabetes that is diet controlled. She comes into triage from the office for elevated blood pressures and a headache. Her initial BP on admission is 160/104. What is the best next step?,173822,2,Ensure appropriate cuff fit and repeat blood pressure in 15 minutes while at the bedside to check patient position,1
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52767,11,Annie P. is a 34 week G2P0. She is 32 years old and has gestational diabetes that is diet controlled. She comes into triage from the office for elevated blood pressures and a headache. Her initial BP on admission is 160/104. What is the best next step?,173823,3,Repeat the blood pressure at the next ordered interval,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52768,12,"Annie P. is a 34 week G2P0. She is 32 years old and has gestational diabetes that is diet controlled. She comes into triage from the office for elevated blood pressures and a headache. Her initial BP on admission is 160/104. Her repeat BP is 172/109. Her provider has ordered the IV Labetalol regimen. However, you cannot get a successful IV stick. What is the best next step?",173824,0,Position patient on her side and continue to take blood pressures to see if you can get her below range,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52768,12,"Annie P. is a 34 week G2P0. She is 32 years old and has gestational diabetes that is diet controlled. She comes into triage from the office for elevated blood pressures and a headache. Her initial BP on admission is 160/104. Her repeat BP is 172/109. Her provider has ordered the IV Labetalol regimen. However, you cannot get a successful IV stick. What is the best next step?",173825,1,"Wait for IV team to come start an IV, then administer the medication",0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52768,12,"Annie P. is a 34 week G2P0. She is 32 years old and has gestational diabetes that is diet controlled. She comes into triage from the office for elevated blood pressures and a headache. Her initial BP on admission is 160/104. Her repeat BP is 172/109. Her provider has ordered the IV Labetalol regimen. However, you cannot get a successful IV stick. What is the best next step?",173826,2,Call the provider back and request nifedipine PO regimen,1
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52769,13,Annie P. is a 34 week G2P0. She is 32 years old and has gestational diabetes that is diet controlled. She comes into triage from the office for elevated blood pressures and a headache. Her initial BP on admission is 160/104. Her repeat BP is 172/109. Her provider states to change her parameters to SBP =180 or DBP =120. What is the best next step?,173827,0,Complete the telephone order for the parameter change,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52769,13,Annie P. is a 34 week G2P0. She is 32 years old and has gestational diabetes that is diet controlled. She comes into triage from the office for elevated blood pressures and a headache. Her initial BP on admission is 160/104. Her repeat BP is 172/109. Her provider states to change her parameters to SBP =180 or DBP =120. What is the best next step?,173828,1,Hang up the phone and immediately initiate Chain of Command,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52769,13,Annie P. is a 34 week G2P0. She is 32 years old and has gestational diabetes that is diet controlled. She comes into triage from the office for elevated blood pressures and a headache. Her initial BP on admission is 160/104. Her repeat BP is 172/109. Her provider states to change her parameters to SBP =180 or DBP =120. What is the best next step?,173829,2,Refuse to change the parameters as that is against  the NEWT-OB policy,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52769,13,Annie P. is a 34 week G2P0. She is 32 years old and has gestational diabetes that is diet controlled. She comes into triage from the office for elevated blood pressures and a headache. Her initial BP on admission is 160/104. Her repeat BP is 172/109. Her provider states to change her parameters to SBP =180 or DBP =120. What is the best next step?,173830,3,"Clearly state the patient's vital signs that are out of NEWT-OB range and request that, if the provider does not want to order an antihypertensive regimen, they need to come to the bedside to evaluate their patient",1
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52770,14,All of the following describe why normalizing deviance is concerning EXCEPT,173831,0,It is illegal and you could lose your license,1
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52770,14,All of the following describe why normalizing deviance is concerning EXCEPT,173832,1,"It is the false belief that nothing bad has happened before in this situation, so nothing bad will happen now",0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52770,14,All of the following describe why normalizing deviance is concerning EXCEPT,173833,2,It can cause you to make assumptions and miss other red flags in this patient,0
9243,Elearning-0000-498,LD CETT FY 2020 ONLINE CONTENT,n12183,52770,14,All of the following describe why normalizing deviance is concerning EXCEPT,173834,3,It is a socially accepted norm that actually goes against policy or the standard of care,0
9242,Elearning-0000-497,LD CETT FY 2020 INSULIN NSA,n12150,52194,0,Blood glucose levels must be obtained using a Northside Hospital glucometer.,171560,0,TRUE,1
9242,Elearning-0000-497,LD CETT FY 2020 INSULIN NSA,n12150,52194,0,Blood glucose levels must be obtained using a Northside Hospital glucometer.,171559,1,FALSE,0
9242,Elearning-0000-497,LD CETT FY 2020 INSULIN NSA,n12150,52195,1,"Two RNs or 1 RN and 1 Pharmacist are required to verify and cosign during initiation of the insulin drip, rate changes, and shift change.",171562,0,TRUE,1
9242,Elearning-0000-497,LD CETT FY 2020 INSULIN NSA,n12150,52195,1,"Two RNs or 1 RN and 1 Pharmacist are required to verify and cosign during initiation of the insulin drip, rate changes, and shift change.",171561,1,FALSE,0
9242,Elearning-0000-497,LD CETT FY 2020 INSULIN NSA,n12150,52196,2,Inpatient insulin pump consults with a Diabetes Educator should be completed within 12 hours of placing the order.,171564,0,TRUE,1
9242,Elearning-0000-497,LD CETT FY 2020 INSULIN NSA,n12150,52196,2,Inpatient insulin pump consults with a Diabetes Educator should be completed within 12 hours of placing the order.,171563,1,FALSE,0
9242,Elearning-0000-497,LD CETT FY 2020 INSULIN NSA,n12150,52197,3,Insulin flowsheet forms can be found where?,171565,0,In the paper room,0
9242,Elearning-0000-497,LD CETT FY 2020 INSULIN NSA,n12150,52197,3,Insulin flowsheet forms can be found where?,171566,1,In the chart pack,0
9242,Elearning-0000-497,LD CETT FY 2020 INSULIN NSA,n12150,52197,3,Insulin flowsheet forms can be found where?,171568,2,In Forms on Demand by searching for key word insulin,1
9242,Elearning-0000-497,LD CETT FY 2020 INSULIN NSA,n12150,52197,3,Insulin flowsheet forms can be found where?,171567,3,Only by contacting Diabetes Education,0
9242,Elearning-0000-497,LD CETT FY 2020 INSULIN NSA,n12150,52198,4,"The insulin pump consent forms are found in the paper room, not Forms on Demand.",171569,0,TRUE,1
9242,Elearning-0000-497,LD CETT FY 2020 INSULIN NSA,n12150,52198,4,"The insulin pump consent forms are found in the paper room, not Forms on Demand.",171570,1,FALSE,0
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52749,0,"1.	Vital signs for patients on vasoactive gtts should be monitored and documented every _________ minutes while titrating.",173757,0,"a.	5",0
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52749,0,"1.	Vital signs for patients on vasoactive gtts should be monitored and documented every _________ minutes while titrating.",173758,1,"b.	10",0
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52749,0,"1.	Vital signs for patients on vasoactive gtts should be monitored and documented every _________ minutes while titrating.",173781,2,c. 15,1
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52749,0,"1.	Vital signs for patients on vasoactive gtts should be monitored and documented every _________ minutes while titrating.",173760,3,"d.	30",0
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52750,1,"2.	Vasoactive gtt orders are considered complete if the following are stated in the order:",173761,0,"a.	Medication name and route, initial starting rate, titration increments, frequency of titration, infusion dose range, clinical objective",1
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52750,1,"2.	Vasoactive gtt orders are considered complete if the following are stated in the order:",173762,1,"b.	Medication name and route, initial starting rate, dietary orders, infusion dose range, clinical objective",0
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52750,1,"2.	Vasoactive gtt orders are considered complete if the following are stated in the order:",173763,2,"c.	Medication name and route, initial starting rate, frequency of titration, infusion dose range, clinical objective",0
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52750,1,"2.	Vasoactive gtt orders are considered complete if the following are stated in the order:",173764,3,"d.	Medication name and route, initial starting rate, titration increments, frequency of titration, infusion dose range, clinical objective, ECG frequency",0
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52751,2,"3.	The following order is complete:  Start Cardizem. Initial rate = 5mg/hr.  Titrate by 2.5 mg/hr every 15 minutes as needed up to a maximum of 15 mg/hr.  Maintain HR below 110.  Hold for SBP < 90 and notify MD.",173765,0,TRUE,0
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52751,2,"3.	The following order is complete:  Start Cardizem. Initial rate = 5mg/hr.  Titrate by 2.5 mg/hr every 15 minutes as needed up to a maximum of 15 mg/hr.  Maintain HR below 110.  Hold for SBP < 90 and notify MD.",173766,1,FALSE,1
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52752,3,"4.	A patient is on an Amiodarone gtt and it is running at the initial rate of 60 mg/hr.  It has been six hours and per the order, you must reduce the dose down to 30 mg/hr.  After changing the rate you must monitor and document vital signs:",173767,0,"a.	Every 15 minutes x1 hr, then every 30 minutes x4, then every 4 hrs if stable",0
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52752,3,"4.	A patient is on an Amiodarone gtt and it is running at the initial rate of 60 mg/hr.  It has been six hours and per the order, you must reduce the dose down to 30 mg/hr.  After changing the rate you must monitor and document vital signs:",173768,1,"b.	Every 15 min x2 hr, then every 2 hrs if stable",0
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52752,3,"4.	A patient is on an Amiodarone gtt and it is running at the initial rate of 60 mg/hr.  It has been six hours and per the order, you must reduce the dose down to 30 mg/hr.  After changing the rate you must monitor and document vital signs:",173769,2,"c.	You may continue to monitor and document vitals every 2 hours since the patient has been on the gtt for several hours and is stable.",0
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52752,3,"4.	A patient is on an Amiodarone gtt and it is running at the initial rate of 60 mg/hr.  It has been six hours and per the order, you must reduce the dose down to 30 mg/hr.  After changing the rate you must monitor and document vital signs:",173770,3,"d.	Every 15 minutes x 1 hr, then every 1 hr x4 once clinical objective is met at one rate, then every 2 hrs if stable",1
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52753,4,"5.	The following order is complete:  Cardene 40mg/ 200 mL - Initial rate 5 mg/hr, IV.  Titrate by 2.5 mg/hr as needed up to a maximum of 15 mg/hr.  Maintain SBP between 120-160 mmHg. Drip concentration 0.2 mg/mL.  Hold and notify provider for SBP less than 90 mmHg.  Do not bolus.",173771,0,TRUE,0
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52753,4,"5.	The following order is complete:  Cardene 40mg/ 200 mL - Initial rate 5 mg/hr, IV.  Titrate by 2.5 mg/hr as needed up to a maximum of 15 mg/hr.  Maintain SBP between 120-160 mmHg. Drip concentration 0.2 mg/mL.  Hold and notify provider for SBP less than 90 mmHg.  Do not bolus.",173772,1,FALSE,1
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52754,5,"6.	When reviewing the vasoactive gtt orders for your patient, you notice that the order states to ""maintain HR <110"".  What is your plan of action?",173773,0,"a.	Titrate the gtt per the order until the patient's HR is <110",0
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52754,5,"6.	When reviewing the vasoactive gtt orders for your patient, you notice that the order states to ""maintain HR <110"".  What is your plan of action?",173774,1,"b.	Contact the provider for clarification",1
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52754,5,"6.	When reviewing the vasoactive gtt orders for your patient, you notice that the order states to ""maintain HR <110"".  What is your plan of action?",173775,2,"c.	Contact the pharmacy for clarification",0
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52754,5,"6.	When reviewing the vasoactive gtt orders for your patient, you notice that the order states to ""maintain HR <110"".  What is your plan of action?",173776,3,"d.	Be certain to monitor and document VS every 15 minutes until the HR is <110",0
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52755,6,"7.	Three components that must be documented every time while your patient is on a vasoactive gtt are:",173777,0,"a.	IV gtt (rate and dose), respiratory rate, vital signs (including HR and BP/MAP)",0
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52755,6,"7.	Three components that must be documented every time while your patient is on a vasoactive gtt are:",173778,1,"b.	IV gtt (rate), BP/ MAP, temp",0
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52755,6,"7.	Three components that must be documented every time while your patient is on a vasoactive gtt are:",173779,2,"c.	IV gtt (dose), O2 sat, vital signs (including HR and BP/MAP)",0
9108,Elearning-0000-375,NSC PCU CARDIAC DRIP ORDERS AND DOCUMENTATION,n12182,52755,6,"7.	Three components that must be documented every time while your patient is on a vasoactive gtt are:",173780,3,"d.	IV gtt (rate and dose), vital signs (including HR and BP/MAP), rhythm",1
286,SCORM-0000-96,PPE COVID-19 TRAINING,n12192,52782,0,"I acknowledge that I have read and understand the ""PPE COVID-19 Training"" CBL in its entirety.",173874,0,TRUE,1
286,SCORM-0000-96,PPE COVID-19 TRAINING,n12192,52782,0,"I acknowledge that I have read and understand the ""PPE COVID-19 Training"" CBL in its entirety.",173875,1,FALSE,0
9537,Elearning-0000-765,BONE CEMENT,n12195,52808,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",173971,0,TRUE,1
9537,Elearning-0000-765,BONE CEMENT,n12195,52808,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",173972,1,FALSE,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52811,0,What are the predominate risk factors for pressure injuries in ICU patients?,173977,0,Advanced Age,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52811,0,What are the predominate risk factors for pressure injuries in ICU patients?,173978,1,Altered Mobility,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52811,0,What are the predominate risk factors for pressure injuries in ICU patients?,173979,2,Poor Perfusion,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52811,0,What are the predominate risk factors for pressure injuries in ICU patients?,173980,3,Vasopressor Infusion,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52811,0,What are the predominate risk factors for pressure injuries in ICU patients?,173981,4,all of the above,1
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52812,1,Vasopressors increase vasoconstriction which can increase perfusion to distal tissue like skin,173982,0,TRUE,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52812,1,Vasopressors increase vasoconstriction which can increase perfusion to distal tissue like skin,173983,1,FALSE,1
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52813,2,Which vasopressors have tissue ischemia as a side effect?,173984,0,none,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52813,2,Which vasopressors have tissue ischemia as a side effect?,173985,1,norepinephrine and vasopressin,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52813,2,Which vasopressors have tissue ischemia as a side effect?,173986,2,dopamine and epinephrine,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52813,2,Which vasopressors have tissue ischemia as a side effect?,173987,3,norepinephrine and phenylephrine,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52813,2,Which vasopressors have tissue ischemia as a side effect?,173988,4,"norepinephrine, vasopressin, dopamine, epinephrine and phenylephrine",1
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52814,3,What is the most common mistake made in regards to not completing titrations correctly (according to the randomized audit completed for NSF ICU Sept 2019)?,173989,0,2 consecutive MAPs > ordered upper parameter without decreasing the vasopressor gtt,1
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52814,3,What is the most common mistake made in regards to not completing titrations correctly (according to the randomized audit completed for NSF ICU Sept 2019)?,173990,1,titrating gtts every time a MAP is outside of ordered range,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52814,3,What is the most common mistake made in regards to not completing titrations correctly (according to the randomized audit completed for NSF ICU Sept 2019)?,173991,2,increasing the vasoactive gtt when the MAP is above the ordered upper parameter,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52815,4,"MAP ordered range is to maintain MAP 65-80; patient has MAP of 64 followed by a MAP of 65, what should you do? (2 consecutive MAPs)",173992,0,Titrate vasopressor up by ordered dose,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52815,4,"MAP ordered range is to maintain MAP 65-80; patient has MAP of 64 followed by a MAP of 65, what should you do? (2 consecutive MAPs)",173993,1,Titrate vasopressor down by ordered dose,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52815,4,"MAP ordered range is to maintain MAP 65-80; patient has MAP of 64 followed by a MAP of 65, what should you do? (2 consecutive MAPs)",173994,2,Continue to monitor VS every 15 minutes until 2 consecutive MAPs are out of range and then titrate according to order,1
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52816,5,"To aggressively wean vasopressor gtts, what is the recommended MAP range? (Goal is aggressively wean for a brief amount of time to achieve minimal vasoactive medication required)",173995,0,MAP 65-70 for the majority of patients,1
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52816,5,"To aggressively wean vasopressor gtts, what is the recommended MAP range? (Goal is aggressively wean for a brief amount of time to achieve minimal vasoactive medication required)",173996,1,"Map 70-80, higher is better",0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52816,5,"To aggressively wean vasopressor gtts, what is the recommended MAP range? (Goal is aggressively wean for a brief amount of time to achieve minimal vasoactive medication required)",173997,2,MAP 60-65,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52816,5,"To aggressively wean vasopressor gtts, what is the recommended MAP range? (Goal is aggressively wean for a brief amount of time to achieve minimal vasoactive medication required)",173998,3,MAP 60-70,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52817,6,"The following are strategies to consider to increase timely vasopressor management for nursing:  use of ""remote view"" on bedside monitors, setting correlating upper alarm limit of clinical alarms on bedside monitors, and using a buddy RN (to assist with close monitoring and charting assistance)",173999,0,TRUE,1
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52817,6,"The following are strategies to consider to increase timely vasopressor management for nursing:  use of ""remote view"" on bedside monitors, setting correlating upper alarm limit of clinical alarms on bedside monitors, and using a buddy RN (to assist with close monitoring and charting assistance)",174000,1,FALSE,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52818,7,2 Consecutive MAPs outside of ordered parameters (or other ordered titration parameters) requires titration (increase or decrease drip),174001,0,TRUE,1
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52818,7,2 Consecutive MAPs outside of ordered parameters (or other ordered titration parameters) requires titration (increase or decrease drip),174002,1,FALSE,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52819,8,What is the Gold Standard to address order modification in the EMR?,174003,0,"Modification of primary order (initiation, amount, frequency, goals, max dose)",1
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52819,8,What is the Gold Standard to address order modification in the EMR?,174004,1,Communication orders,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52819,8,What is the Gold Standard to address order modification in the EMR?,174005,2,Do not pay attention to physician orders,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52819,8,What is the Gold Standard to address order modification in the EMR?,174006,3,One Time Titration orders,0
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52820,9,ALL Vital signs should be reviewed and validated BEFORE saving into the EMR and must correlate with all Vasoactive drip titrations.  Enter VS manually if needed to correlate with drip titrations if necessary for accuracy and a true reflection of actions.  Grab a RN titration buddy if needed.,174007,0,TRUE,1
8112,Elearning-0000-1010,2020 NSF ICU TITRATIONS AND HAPI,n12199,52820,9,ALL Vital signs should be reviewed and validated BEFORE saving into the EMR and must correlate with all Vasoactive drip titrations.  Enter VS manually if needed to correlate with drip titrations if necessary for accuracy and a true reflection of actions.  Grab a RN titration buddy if needed.,174008,1,FALSE,0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52821,0,Which type of functional tumor causes hyperglycemia?,174009,0,"a.	Carcinoid",0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52821,0,Which type of functional tumor causes hyperglycemia?,174010,1,"b.	Glucagonoma",1
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52821,0,Which type of functional tumor causes hyperglycemia?,174011,2,"c.	Insulinoma",0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52821,0,Which type of functional tumor causes hyperglycemia?,174012,3,"d.	VIPoma",0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52822,1,PR is a 67-year-old patient with who was recently diagnosed with a NET of the ileum which has metastasized to the liver.  He reports that he has 7-10 watery bowel movements a day and he has episodes where his face turns red.  What would you recommend to treat this patient's symptoms?,174013,0,"a.	Lanreotide 120 mcg IM every 4 weeks",0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52822,1,PR is a 67-year-old patient with who was recently diagnosed with a NET of the ileum which has metastasized to the liver.  He reports that he has 7-10 watery bowel movements a day and he has episodes where his face turns red.  What would you recommend to treat this patient's symptoms?,174014,1,"b.	Lanreotide 120 mcg SC every 4 weeks with telotristat 500 mg TID",0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52822,1,PR is a 67-year-old patient with who was recently diagnosed with a NET of the ileum which has metastasized to the liver.  He reports that he has 7-10 watery bowel movements a day and he has episodes where his face turns red.  What would you recommend to treat this patient's symptoms?,174015,2,"c.	Octreotide LAR 30 mg IM every 4 weeks with omeprazole 60 mg daily",0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52822,1,PR is a 67-year-old patient with who was recently diagnosed with a NET of the ileum which has metastasized to the liver.  He reports that he has 7-10 watery bowel movements a day and he has episodes where his face turns red.  What would you recommend to treat this patient's symptoms?,174016,3,"d.	Octreotide LAR 30 mg IM every 4 weeks with short-acting octreotide 150 mcg SC every 8 hours prn",1
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52823,2,Which of the following patients would be an appropriate candidate for PRRT therapy with Lu 177-Dotatate?,174017,0,"a.	An 50-year-old male with a poorly differentiated, somatostatin-receptor negative, neuroendocrine tumor of the lung",0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52823,2,Which of the following patients would be an appropriate candidate for PRRT therapy with Lu 177-Dotatate?,174018,1,"b.	A 60-year-old female with a low-grade, somatostatin-receptor positive, metastatic pancreatic NET who is treatment-nave",0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52823,2,Which of the following patients would be an appropriate candidate for PRRT therapy with Lu 177-Dotatate?,174019,2,"c.	A 67-year-old male with intermediate-grade, metastatic NET of the ileum who has progressed on octreotide",1
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52823,2,Which of the following patients would be an appropriate candidate for PRRT therapy with Lu 177-Dotatate?,174020,3,"d.	A 45-year-old female with a local, somatostatin-receptor positive, low-grade NET of the appendix",0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52824,3,"A 67-year-old patient diagnosed with a non-functional, metastatic pancreatic tumor.  She was receiving lanreotide but recently had significant tumor progression.  She has a past medical history of heart failure, atrial fibrillation, and coronary artery disease.  After a discussion with her, she states that she would prefer to take something oral to treat her tumor.  What is the best option for her?",174021,0,"a.	Everolimus",1
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52824,3,"A 67-year-old patient diagnosed with a non-functional, metastatic pancreatic tumor.  She was receiving lanreotide but recently had significant tumor progression.  She has a past medical history of heart failure, atrial fibrillation, and coronary artery disease.  After a discussion with her, she states that she would prefer to take something oral to treat her tumor.  What is the best option for her?",174022,1,"b.	Lu 177-dotatate",0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52824,3,"A 67-year-old patient diagnosed with a non-functional, metastatic pancreatic tumor.  She was receiving lanreotide but recently had significant tumor progression.  She has a past medical history of heart failure, atrial fibrillation, and coronary artery disease.  After a discussion with her, she states that she would prefer to take something oral to treat her tumor.  What is the best option for her?",174023,2,"c.	Octreotide",0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52824,3,"A 67-year-old patient diagnosed with a non-functional, metastatic pancreatic tumor.  She was receiving lanreotide but recently had significant tumor progression.  She has a past medical history of heart failure, atrial fibrillation, and coronary artery disease.  After a discussion with her, she states that she would prefer to take something oral to treat her tumor.  What is the best option for her?",174024,3,"d.	Sunitinib",0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52825,4,Which hold parameters for SSA therapy are correct with regards to Lu 177-dotatate therapy?,174025,0,"a.	Hold long-acting SSA for at least 4 weeks prior to Lu 177-dotatate",0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52825,4,Which hold parameters for SSA therapy are correct with regards to Lu 177-dotatate therapy?,174026,1,"b.	Hold short-acting SSA for at least 24 hours prior to Lu 177-dotatate",0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52825,4,Which hold parameters for SSA therapy are correct with regards to Lu 177-dotatate therapy?,174027,2,"c.	Long-acting SSA may be administered within 4-24 hours after administration of Lu 177-dotatate",0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52825,4,Which hold parameters for SSA therapy are correct with regards to Lu 177-dotatate therapy?,174028,3,"d.	All of the above",1
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52826,5,T / F Sunitinib may be used as first-line therapy in patients with pancreatic NET,174029,0,TRUE,0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52826,5,T / F Sunitinib may be used as first-line therapy in patients with pancreatic NET,174030,1,FALSE,1
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52827,6,T / F All neuroendocrine tumors are somatostatin receptor positive and will respond to SSA therapy,174031,0,TRUE,0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52827,6,T / F All neuroendocrine tumors are somatostatin receptor positive and will respond to SSA therapy,174032,1,FALSE,1
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52828,7,T / F Almost all neuroendocrine tumors secrete hormones but only functional tumors cause symptoms related to hormone hypersecretion,174033,0,TRUE,1
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52828,7,T / F Almost all neuroendocrine tumors secrete hormones but only functional tumors cause symptoms related to hormone hypersecretion,174034,1,FALSE,0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52829,8,Which of the following are indications for treatment with telotristat ethyl?,174035,0,"a.	First-line treatment of carcinoid syndrome",0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52829,8,Which of the following are indications for treatment with telotristat ethyl?,174036,1,"b.	Flushing associated with carcinoid syndrome that is inadequately controlled with SSA therapy",0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52829,8,Which of the following are indications for treatment with telotristat ethyl?,174037,2,"c.	Diarrhea associated with carcinoid syndrome that is inadequately controlled with SSA therapy",1
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52829,8,Which of the following are indications for treatment with telotristat ethyl?,174038,3,"d.	All of the above",0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52830,9,T / F Octreotide LAR and lanreotide are equally efficacious and are interchangeable at a 1:1 dose,174039,0,TRUE,0
9150,Elearning-0000-413,FY2020 PHARMACY NET AND CARCINOID SYNDROME EDUCATION FOR ONCOLOGY,n12200,52830,9,T / F Octreotide LAR and lanreotide are equally efficacious and are interchangeable at a 1:1 dose,174040,1,FALSE,1
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52847,0,(True False)  The CDC adopted a wound classification in 1980's.,174082,0,TRUE,1
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52847,0,(True False)  The CDC adopted a wound classification in 1980's.,174083,1,FALSE,0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52848,1,(True False)  An example of a Class I Clean Wound would be a Thyroidectomy.,174084,0,TRUE,1
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52848,1,(True False)  An example of a Class I Clean Wound would be a Thyroidectomy.,174085,1,FALSE,0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52849,2,(True False)  AORN's Surgical Wound Classification is not a good resource to learn what questions to ask when assigning a wound classification.,174086,0,TRUE,0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52849,2,(True False)  AORN's Surgical Wound Classification is not a good resource to learn what questions to ask when assigning a wound classification.,174087,1,FALSE,1
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52850,3,(True False) A patient with a wound class of Class II Clean /Contaminated has a 5-15% chance of developing a surgical site infection.,174088,0,TRUE,1
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52850,3,(True False) A patient with a wound class of Class II Clean /Contaminated has a 5-15% chance of developing a surgical site infection.,174089,1,FALSE,0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52851,4,(True False) If you have multiple procedures performed on different sites you would assign wound class on the primary procedure.,174090,0,TRUE,1
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52851,4,(True False) If you have multiple procedures performed on different sites you would assign wound class on the primary procedure.,174091,1,FALSE,0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52852,5,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Cholecystitis with Cholelithiasis<br> <b>Procedure:</b>  	Laparoscopic Cholecystectomy with Intraoperative Cholangiogram <br> <b>Operative Debrief:</b>  	During resection of the gallbladder from the liver bed, there was puncture of the gallbladder with subsequent bile and stone spillage. The abdomen was irrigated with 2 liters of NS and visible stones extracted<br>  <b>Post op Diagnosis:</b>	Cholecystitis with Cholelithiasis<br><br> <b>Wound Classification would be:</b>",174092,0,"a.	Class II Clean / Contaminated",0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52852,5,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Cholecystitis with Cholelithiasis<br> <b>Procedure:</b>  	Laparoscopic Cholecystectomy with Intraoperative Cholangiogram <br> <b>Operative Debrief:</b>  	During resection of the gallbladder from the liver bed, there was puncture of the gallbladder with subsequent bile and stone spillage. The abdomen was irrigated with 2 liters of NS and visible stones extracted<br>  <b>Post op Diagnosis:</b>	Cholecystitis with Cholelithiasis<br><br> <b>Wound Classification would be:</b>",174093,1,"b.	Class III Contaminated",1
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52852,5,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Cholecystitis with Cholelithiasis<br> <b>Procedure:</b>  	Laparoscopic Cholecystectomy with Intraoperative Cholangiogram <br> <b>Operative Debrief:</b>  	During resection of the gallbladder from the liver bed, there was puncture of the gallbladder with subsequent bile and stone spillage. The abdomen was irrigated with 2 liters of NS and visible stones extracted<br>  <b>Post op Diagnosis:</b>	Cholecystitis with Cholelithiasis<br><br> <b>Wound Classification would be:</b>",174094,2,"c.	Class IV Dirty",0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52852,5,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Cholecystitis with Cholelithiasis<br> <b>Procedure:</b>  	Laparoscopic Cholecystectomy with Intraoperative Cholangiogram <br> <b>Operative Debrief:</b>  	During resection of the gallbladder from the liver bed, there was puncture of the gallbladder with subsequent bile and stone spillage. The abdomen was irrigated with 2 liters of NS and visible stones extracted<br>  <b>Post op Diagnosis:</b>	Cholecystitis with Cholelithiasis<br><br> <b>Wound Classification would be:</b>",174095,3,"d.	Class I Clean",0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52853,6,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Tonsillitis<br> <b>Procedure:</b>  	Bilateral Tonsillectomy<br> <b>Operative Debrief:</b>  	 Tonsils removed with blunt and electrocoagulation dissection. They were exudative. There was a considerable amount of purulent material. Once accomplished, the stomach was suctioned and the tonsillar beds were free of bleeding.  Antibiotics and steroids continued post operatively.<br> <b>Post op Diagnosis:</b>	Tonsillitis<br><br> <b>Wound Classification would be:</b>",174096,0,"a.	Class II Clean / Contaminated",0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52853,6,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Tonsillitis<br> <b>Procedure:</b>  	Bilateral Tonsillectomy<br> <b>Operative Debrief:</b>  	 Tonsils removed with blunt and electrocoagulation dissection. They were exudative. There was a considerable amount of purulent material. Once accomplished, the stomach was suctioned and the tonsillar beds were free of bleeding.  Antibiotics and steroids continued post operatively.<br> <b>Post op Diagnosis:</b>	Tonsillitis<br><br> <b>Wound Classification would be:</b>",174097,1,"b.	Class III Contaminated",0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52853,6,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Tonsillitis<br> <b>Procedure:</b>  	Bilateral Tonsillectomy<br> <b>Operative Debrief:</b>  	 Tonsils removed with blunt and electrocoagulation dissection. They were exudative. There was a considerable amount of purulent material. Once accomplished, the stomach was suctioned and the tonsillar beds were free of bleeding.  Antibiotics and steroids continued post operatively.<br> <b>Post op Diagnosis:</b>	Tonsillitis<br><br> <b>Wound Classification would be:</b>",174098,2,"c.	Class IV Dirty",1
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52853,6,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Tonsillitis<br> <b>Procedure:</b>  	Bilateral Tonsillectomy<br> <b>Operative Debrief:</b>  	 Tonsils removed with blunt and electrocoagulation dissection. They were exudative. There was a considerable amount of purulent material. Once accomplished, the stomach was suctioned and the tonsillar beds were free of bleeding.  Antibiotics and steroids continued post operatively.<br> <b>Post op Diagnosis:</b>	Tonsillitis<br><br> <b>Wound Classification would be:</b>",174099,3,"d.	Class I Clean",0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52854,7,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Right Carpal Tunnel Impingement, Mass in Left Breast<br> <b>Primary Procedure:</b>  	Right Carpal Tunnel Release<br> <b>Secondary Procedure:</b>	Left Breast Biopsy<br> <b>Operative Debrief:</b>  	Patient consented to breast biopsy in pre op when recent mammogram revealed a 2 cm mass in the left lateral breast.  Patient wanted to take advantage of one anesthetic process for both surgeries. No inflammation or purulence encountered intraop.<br> <b>Post op Diagnosis:</b>	Right Carpal Tunnel Impingement, Mass in Left Breast<br><br> <b>Wound Classification would be:<b>",174100,0,"a.	Class II Clean / Contaminated",0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52854,7,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Right Carpal Tunnel Impingement, Mass in Left Breast<br> <b>Primary Procedure:</b>  	Right Carpal Tunnel Release<br> <b>Secondary Procedure:</b>	Left Breast Biopsy<br> <b>Operative Debrief:</b>  	Patient consented to breast biopsy in pre op when recent mammogram revealed a 2 cm mass in the left lateral breast.  Patient wanted to take advantage of one anesthetic process for both surgeries. No inflammation or purulence encountered intraop.<br> <b>Post op Diagnosis:</b>	Right Carpal Tunnel Impingement, Mass in Left Breast<br><br> <b>Wound Classification would be:<b>",174101,1,"b.	Class III Contaminated",0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52854,7,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Right Carpal Tunnel Impingement, Mass in Left Breast<br> <b>Primary Procedure:</b>  	Right Carpal Tunnel Release<br> <b>Secondary Procedure:</b>	Left Breast Biopsy<br> <b>Operative Debrief:</b>  	Patient consented to breast biopsy in pre op when recent mammogram revealed a 2 cm mass in the left lateral breast.  Patient wanted to take advantage of one anesthetic process for both surgeries. No inflammation or purulence encountered intraop.<br> <b>Post op Diagnosis:</b>	Right Carpal Tunnel Impingement, Mass in Left Breast<br><br> <b>Wound Classification would be:<b>",174102,2,"c.	Class IV Dirty",0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52854,7,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Right Carpal Tunnel Impingement, Mass in Left Breast<br> <b>Primary Procedure:</b>  	Right Carpal Tunnel Release<br> <b>Secondary Procedure:</b>	Left Breast Biopsy<br> <b>Operative Debrief:</b>  	Patient consented to breast biopsy in pre op when recent mammogram revealed a 2 cm mass in the left lateral breast.  Patient wanted to take advantage of one anesthetic process for both surgeries. No inflammation or purulence encountered intraop.<br> <b>Post op Diagnosis:</b>	Right Carpal Tunnel Impingement, Mass in Left Breast<br><br> <b>Wound Classification would be:<b>",174103,3,"d.	Class I Clean",1
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52855,8,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Ascites, Small Bowel Obstruction<br> <b>Procedure:</b>  	Exploratory Laparotomy with Lysis of Adhesions TAH, BSO, Omentectomy, Pelvic Lymph Node Dissection, Colon Resection with Ileostomy, <br> <b>Operative Debrief:</b>  	Patient admitted through ED with abdominal pain. CT revealed Ascites.  GYN oncologist assisted in procedure.  Upon incision, 3 liters of yellow ascetic fluid suctioned, multiple masses palpated.  No infection (pus) noted, cytology and pathology reports positive for cancer. <br> <b>Post op Diagnosis:</b>	Metastatic Cancer-Staging Pending<br><br> <b>Wound Classification would be:</b>",174104,0,"a.	Class II Clean / Contaminated",0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52855,8,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Ascites, Small Bowel Obstruction<br> <b>Procedure:</b>  	Exploratory Laparotomy with Lysis of Adhesions TAH, BSO, Omentectomy, Pelvic Lymph Node Dissection, Colon Resection with Ileostomy, <br> <b>Operative Debrief:</b>  	Patient admitted through ED with abdominal pain. CT revealed Ascites.  GYN oncologist assisted in procedure.  Upon incision, 3 liters of yellow ascetic fluid suctioned, multiple masses palpated.  No infection (pus) noted, cytology and pathology reports positive for cancer. <br> <b>Post op Diagnosis:</b>	Metastatic Cancer-Staging Pending<br><br> <b>Wound Classification would be:</b>",174105,1,"b.	Class III Contaminated",1
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52855,8,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Ascites, Small Bowel Obstruction<br> <b>Procedure:</b>  	Exploratory Laparotomy with Lysis of Adhesions TAH, BSO, Omentectomy, Pelvic Lymph Node Dissection, Colon Resection with Ileostomy, <br> <b>Operative Debrief:</b>  	Patient admitted through ED with abdominal pain. CT revealed Ascites.  GYN oncologist assisted in procedure.  Upon incision, 3 liters of yellow ascetic fluid suctioned, multiple masses palpated.  No infection (pus) noted, cytology and pathology reports positive for cancer. <br> <b>Post op Diagnosis:</b>	Metastatic Cancer-Staging Pending<br><br> <b>Wound Classification would be:</b>",174106,2,"c.	Class IV Dirty",0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52855,8,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Ascites, Small Bowel Obstruction<br> <b>Procedure:</b>  	Exploratory Laparotomy with Lysis of Adhesions TAH, BSO, Omentectomy, Pelvic Lymph Node Dissection, Colon Resection with Ileostomy, <br> <b>Operative Debrief:</b>  	Patient admitted through ED with abdominal pain. CT revealed Ascites.  GYN oncologist assisted in procedure.  Upon incision, 3 liters of yellow ascetic fluid suctioned, multiple masses palpated.  No infection (pus) noted, cytology and pathology reports positive for cancer. <br> <b>Post op Diagnosis:</b>	Metastatic Cancer-Staging Pending<br><br> <b>Wound Classification would be:</b>",174107,3,"d.	Class I Clean",0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52856,9,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Impaired Vision right eye, Right Cataract<br> <b>Procedure:</b>  	Right Cataract Extraction with Intraocular lens Insertion<br> <b>Operative Debrief:</b>  	No inflammation or infection detected<br> <b>Post op Diagnosis:</b>	Right Cataract<br><br> <b>Wound Classification would be:</b><br>",174108,0,"a.	Class II Clean / Contaminated",0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52856,9,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Impaired Vision right eye, Right Cataract<br> <b>Procedure:</b>  	Right Cataract Extraction with Intraocular lens Insertion<br> <b>Operative Debrief:</b>  	No inflammation or infection detected<br> <b>Post op Diagnosis:</b>	Right Cataract<br><br> <b>Wound Classification would be:</b><br>",174109,1,"b.	Class III Contaminated",0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52856,9,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Impaired Vision right eye, Right Cataract<br> <b>Procedure:</b>  	Right Cataract Extraction with Intraocular lens Insertion<br> <b>Operative Debrief:</b>  	No inflammation or infection detected<br> <b>Post op Diagnosis:</b>	Right Cataract<br><br> <b>Wound Classification would be:</b><br>",174110,2,"c.	Class IV Dirty",0
8138,Elearning-0000-1034,SURGICAL SERVICES: FY2020 ASSIGNING SURGICAL WOUND CLASSIFICATION,n12205,52856,9,"<b>Scenario:</b><br><br> <b>Pre op Diagnosis:</b>  	Impaired Vision right eye, Right Cataract<br> <b>Procedure:</b>  	Right Cataract Extraction with Intraocular lens Insertion<br> <b>Operative Debrief:</b>  	No inflammation or infection detected<br> <b>Post op Diagnosis:</b>	Right Cataract<br><br> <b>Wound Classification would be:</b><br>",174111,3,"d.	Class I Clean",1
9078,Elearning-0000-348,NSH 1261: XENCOR NHL,n12209,52863,0,Patients must have:,174128,0,"a)	Relapsed/refractory AML",0
9078,Elearning-0000-348,NSH 1261: XENCOR NHL,n12209,52863,0,Patients must have:,174129,1,"b)	Relapsed/refractory NHL",1
9078,Elearning-0000-348,NSH 1261: XENCOR NHL,n12209,52863,0,Patients must have:,174130,2,"c)	Relapsed/refractory HD",0
9078,Elearning-0000-348,NSH 1261: XENCOR NHL,n12209,52863,0,Patients must have:,174131,3,"d)	Relapsed/refractory MM",0
9078,Elearning-0000-348,NSH 1261: XENCOR NHL,n12209,52864,1,"XmAb13676 is given once per week (Days 1, 8, 15, and 22) of a 28-day cycle and can continue until the patient is no longer receiving clinical benefit.",174132,0,a) True,1
9078,Elearning-0000-348,NSH 1261: XENCOR NHL,n12209,52864,1,"XmAb13676 is given once per week (Days 1, 8, 15, and 22) of a 28-day cycle and can continue until the patient is no longer receiving clinical benefit.",174133,1,b) False,0
9078,Elearning-0000-348,NSH 1261: XENCOR NHL,n12209,52865,2,Patients are not required to be hospitalized for the first dose of XmAb13676.,174134,0,a) True,0
9078,Elearning-0000-348,NSH 1261: XENCOR NHL,n12209,52865,2,Patients are not required to be hospitalized for the first dose of XmAb13676.,174135,1,b) False,1
8105,Elearning-0000-1004,FY2020 PHARMACY BLOOD PRODUCT CONSENT PROCESS,n12224,52907,0,True/False: Pharmacists must review every blood consent form.,174269,0,TRUE,0
8105,Elearning-0000-1004,FY2020 PHARMACY BLOOD PRODUCT CONSENT PROCESS,n12224,52907,0,True/False: Pharmacists must review every blood consent form.,174270,1,FALSE,1
8105,Elearning-0000-1004,FY2020 PHARMACY BLOOD PRODUCT CONSENT PROCESS,n12224,52908,1,How often is a new consent required for an inpatient admission?,174271,0,"a)	Every admission",1
8105,Elearning-0000-1004,FY2020 PHARMACY BLOOD PRODUCT CONSENT PROCESS,n12224,52908,1,How often is a new consent required for an inpatient admission?,174272,1,"b)	Every 3 months",0
8105,Elearning-0000-1004,FY2020 PHARMACY BLOOD PRODUCT CONSENT PROCESS,n12224,52908,1,How often is a new consent required for an inpatient admission?,174273,2,"c)	Every 6 months",0
8105,Elearning-0000-1004,FY2020 PHARMACY BLOOD PRODUCT CONSENT PROCESS,n12224,52908,1,How often is a new consent required for an inpatient admission?,174274,3,"d.)	Annually",0
8105,Elearning-0000-1004,FY2020 PHARMACY BLOOD PRODUCT CONSENT PROCESS,n12224,52909,2,"If a patient refuses blood products, how should that refusal be documented by pharmacy?",174275,0,"a)	As an allergy",1
8105,Elearning-0000-1004,FY2020 PHARMACY BLOOD PRODUCT CONSENT PROCESS,n12224,52909,2,"If a patient refuses blood products, how should that refusal be documented by pharmacy?",174276,1,"b)	As a pharmacist intervention",0
8105,Elearning-0000-1004,FY2020 PHARMACY BLOOD PRODUCT CONSENT PROCESS,n12224,52909,2,"If a patient refuses blood products, how should that refusal be documented by pharmacy?",174277,2,"c)	In a clinical note",0
8105,Elearning-0000-1004,FY2020 PHARMACY BLOOD PRODUCT CONSENT PROCESS,n12224,52909,2,"If a patient refuses blood products, how should that refusal be documented by pharmacy?",174278,3,"d)	As a patient education",0
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52910,0,Which of the following best explains why it is so important to keep a patient warm during a PPH?,174279,0,It is an easy nursing intervention to do,0
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52910,0,Which of the following best explains why it is so important to keep a patient warm during a PPH?,174282,1,It decreases the patient's oxygen consumption and decreases her risk for death,1
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52910,0,Which of the following best explains why it is so important to keep a patient warm during a PPH?,174280,2,It helps the TXA work better,0
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52910,0,Which of the following best explains why it is so important to keep a patient warm during a PPH?,174281,3,"It is not important, but if you have time you can do it",0
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52911,1,Transfer to the OR (for PPH in the labor room) is important because most procedures to treat PPH need to occur in the OR with better visibility and access to instruments.,174284,0,TRUE,1
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52911,1,Transfer to the OR (for PPH in the labor room) is important because most procedures to treat PPH need to occur in the OR with better visibility and access to instruments.,174283,1,FALSE,0
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52912,2,How often should QBL be run AND CALLED OUT TO THE TEAM in a PPH?,174285,0,Every 5 minutes,0
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52912,2,How often should QBL be run AND CALLED OUT TO THE TEAM in a PPH?,174288,1,Every 15 minutes,1
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52912,2,How often should QBL be run AND CALLED OUT TO THE TEAM in a PPH?,174286,2,Every hour,0
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52912,2,How often should QBL be run AND CALLED OUT TO THE TEAM in a PPH?,174287,3,Once at the end to summarize total loss,0
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52913,3,"If you do not understand the role you have been given in a PPH, what should you do?",174292,0,Clarify and ask questions with the Charge RN or Clinician in the room,1
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52913,3,"If you do not understand the role you have been given in a PPH, what should you do?",174289,1,Refuse to accept the role,0
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52913,3,"If you do not understand the role you have been given in a PPH, what should you do?",174290,2,Walk out of the room so they know there's no one there to do that role anymore,0
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52913,3,"If you do not understand the role you have been given in a PPH, what should you do?",174291,3,Just try it: you can probably figure it out,0
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52914,4,MTP can be run in the labor room as long as anesthesia is there.,174293,0,TRUE,0
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52914,4,MTP can be run in the labor room as long as anesthesia is there.,174294,1,FALSE,1
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52915,5,Which of the following best describes a role a surgical tech might be expected to play in a D&C?,174295,0,Assist with instruments and lap/raytec management,0
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52915,5,Which of the following best describes a role a surgical tech might be expected to play in a D&C?,174296,1,Assist with QBL and running supplies,0
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52915,5,Which of the following best describes a role a surgical tech might be expected to play in a D&C?,174297,2,Act as blood runner if blood is ordered,0
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52915,5,Which of the following best describes a role a surgical tech might be expected to play in a D&C?,174298,3,All of the above,1
9241,Elearning-0000-496,LD CETT FY 2020 PCT ST,n12225,52915,5,Which of the following best describes a role a surgical tech might be expected to play in a D&C?,174299,4,None of the above. The nurse does everything in a D&C.,0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52922,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",174318,0,TRUE,1
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52922,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",174319,1,FALSE,0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52923,1,When can you draw ABGs Per RT Protocol?,174320,0,A.    Any patient who is in distress or has had a change in status.,0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52923,1,When can you draw ABGs Per RT Protocol?,174321,1,B.    Any patient who was on low flow and suddenly requires high flow oxygen > or = to 50%.,0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52923,1,When can you draw ABGs Per RT Protocol?,174322,2,C.    Any patient with an exacerbation of their pulmonary condition in which their Acid/Base or PCO2 status is questionable.,0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52923,1,When can you draw ABGs Per RT Protocol?,174323,3,D.    Any patient in which oximetry results are questionable.,0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52923,1,When can you draw ABGs Per RT Protocol?,174324,4,E.    ABGs may be obtained on a PRN basis based on the clinical presentation of the patient on the Ventilator.,0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52923,1,When can you draw ABGs Per RT Protocol?,174325,5,F.    All of the above.,1
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52924,2,Which statement about AM ABG in ICU is FALSE?,174326,0,A.   ABGs in the ICU are ALWAYS a Complete Panel unless other wise ordered.,0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52924,2,Which statement about AM ABG in ICU is FALSE?,174327,1,B.   AM ABGs in the ICU are done if there is an active order in the system.,0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52924,2,Which statement about AM ABG in ICU is FALSE?,174328,2,"C. If there is no order for QAM or ""until discontinued"" ask the Mid-Level or MD if they would like an ABG OR if they would like to wait until we do the ""Sedation Vacation/SBT"".",0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52924,2,Which statement about AM ABG in ICU is FALSE?,174329,3,D. Do the Daily ABG every day on all Vented patients.,1
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52925,3,Which statement about doing an ABG without an order is TRUE?,174330,0,"A. If you get an ABG, make sure someone places the order in the system! Or, you can put it in yourself under the DR. who gave you that order.",0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52925,3,Which statement about doing an ABG without an order is TRUE?,174331,1,"B. Verbal orders can only be taken in EMERGENCY situations.(Code, Rapid Response, physician in a procedure"""")",0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52925,3,Which statement about doing an ABG without an order is TRUE?,174332,2,C. Both are true statements.,1
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52926,4,"If it is not feasible to take an ABG machine to the bedside, a Pt chart label can be used to label the sample and scan at the analyzer verifying two Pt Identifiers with the Patient's armband.",174333,0,TRUE,1
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52926,4,"If it is not feasible to take an ABG machine to the bedside, a Pt chart label can be used to label the sample and scan at the analyzer verifying two Pt Identifiers with the Patient's armband.",174334,1,FALSE,0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52927,5,"You have run the ABG sample. After putting in all the information, you find that there are no results, only question marks. What can you do to troubleshoot?",174335,0,"A.  Press the Log, then Message button for more information about the questioned results.",0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52927,5,"You have run the ABG sample. After putting in all the information, you find that there are no results, only question marks. What can you do to troubleshoot?",174336,1,B.   Check to make sure that the Draw Time entered is at least 1 minute before the Analyzed Time.,0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52927,5,"You have run the ABG sample. After putting in all the information, you find that there are no results, only question marks. What can you do to troubleshoot?",174337,2,C. Both A and B,1
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52928,6,Which statement is TRUE?,174338,0,A.  YOU DO NOT HAVE TO HAVE AN ABG TO WEAN!!,0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52928,6,Which statement is TRUE?,174339,1,B.  USE YOUR SpO2 AND EtCo2 as long as they have been correlating with previous gases.,0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52928,6,Which statement is TRUE?,174340,2,C.  None of the above.,0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52928,6,Which statement is TRUE?,174341,3,D.  Both a and b are true statements.,1
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52929,7,Which statement regarding notification of CRITICAL ABG RESULTS is TRUE?,174342,0,A. RAV(READ BACK AND VERIFIED) TO DR. H. SILVERBOARD,0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52929,7,Which statement regarding notification of CRITICAL ABG RESULTS is TRUE?,174343,1,B.  WNL(WITHIN NORMAL LIMITS FOR PT) DR. C HEART,0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52929,7,Which statement regarding notification of CRITICAL ABG RESULTS is TRUE?,174344,2,C.  RESULTS HAND DELIVERED TO DR. CHIEU,0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52929,7,Which statement regarding notification of CRITICAL ABG RESULTS is TRUE?,174345,3,"D.  RESULTS CAN ONLY BE GIVEN TO A LICENSED HEALTH CARE        PROFESSIONAL(SO""..NOT THE UNIT SECRETARY OR PT CARE TECH)",0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52929,7,Which statement regarding notification of CRITICAL ABG RESULTS is TRUE?,174346,4,E.  All of the above.,1
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52930,8,"If collateral circulation cannot be verified as positive Allen's test on either hand, you can do Brachial stick per protocol.",174347,0,TRUE,0
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52930,8,"If collateral circulation cannot be verified as positive Allen's test on either hand, you can do Brachial stick per protocol.",174348,1,FALSE,1
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52931,9,"Verification of orders, correct patient identification, proper technique in obtaining and preparing the blood sample, confirmation of demographic information, pertinent data entry and reporting of Critical Values are all integral parts of the quality assurance process in ABG analysis.",174349,0,TRUE,1
8139,Elearning-0000-1035,2020 ABG COMPETENCY,n12227,52931,9,"Verification of orders, correct patient identification, proper technique in obtaining and preparing the blood sample, confirmation of demographic information, pertinent data entry and reporting of Critical Values are all integral parts of the quality assurance process in ABG analysis.",174350,1,FALSE,0
8129,Elearning-0000-1026,FY2020 EXPAREL (MED-SURG AND ICU): NURSING,n12233,53056,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the"" FY2020 Exparel (MED-SURG AND ICU): Nursing"" CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",174807,0,TRUE,1
8129,Elearning-0000-1026,FY2020 EXPAREL (MED-SURG AND ICU): NURSING,n12233,53056,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the"" FY2020 Exparel (MED-SURG AND ICU): Nursing"" CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",174808,1,FALSE,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53057,0,"When a rapid response is called, you should ALWAYS inform your Charge RT/ 45300 and the nurse taking care of the patient.",174809,0,1. True,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53057,0,"When a rapid response is called, you should ALWAYS inform your Charge RT/ 45300 and the nurse taking care of the patient.",174810,1,2. False,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53058,1,On the code sheet you should ALWAYS make sure the Airway and ETC02 section is filled out correctly before signing the sheet.,174811,0,1. True,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53058,1,On the code sheet you should ALWAYS make sure the Airway and ETC02 section is filled out correctly before signing the sheet.,174812,1,2. False,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53059,2,You are called to the PACU to set up a CPAP on a gastric sleeve patient.  You first confirm the MD order and it states CPAP per RT Protocol.  You would then place the patient on which of the following settings?,174813,0,1.  5 cm,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53059,2,You are called to the PACU to set up a CPAP on a gastric sleeve patient.  You first confirm the MD order and it states CPAP per RT Protocol.  You would then place the patient on which of the following settings?,174814,1,2. 10 cm,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53059,2,You are called to the PACU to set up a CPAP on a gastric sleeve patient.  You first confirm the MD order and it states CPAP per RT Protocol.  You would then place the patient on which of the following settings?,174815,2,3. 15 cm,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53059,2,You are called to the PACU to set up a CPAP on a gastric sleeve patient.  You first confirm the MD order and it states CPAP per RT Protocol.  You would then place the patient on which of the following settings?,174816,3,4. Auto set mode with high pressure limit of 10cm.,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53060,3,"What do you do when a post-op patient on a PCA pump has a history of OSA but is not compliant with CPAP, Home or Hospital unit?",174817,0,1. Do nothing.  The patient has the right to refuse treatment.,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53060,3,"What do you do when a post-op patient on a PCA pump has a history of OSA but is not compliant with CPAP, Home or Hospital unit?",174818,1,2. Notify the Physician and place them on a Capnography Remote Monitor. Document in the EMR and write a Progress Note.,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53060,3,"What do you do when a post-op patient on a PCA pump has a history of OSA but is not compliant with CPAP, Home or Hospital unit?",174819,2,3.  Place them on 3 l/m nasal oxygen,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53060,3,"What do you do when a post-op patient on a PCA pump has a history of OSA but is not compliant with CPAP, Home or Hospital unit?",174820,3,4.  Place them on an Optiflow at 50 l/min & 50% Fio2,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53061,4,"Patients on CPAP, home unit or hospital unit that require more than 40% / >5 lpm bled into the unit to maintain SpO2 within the oxygen policy guidelines will need to be placed on:",174821,0,1. Remote Capnography,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53061,4,"Patients on CPAP, home unit or hospital unit that require more than 40% / >5 lpm bled into the unit to maintain SpO2 within the oxygen policy guidelines will need to be placed on:",174822,1,2. Remote Pulse Ox,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53062,5,When do you need to call the MD for a CPAP order?<br><br>  A.   When the patient is requiring 50% FIO2.<br>  B.   When the patient states they are on specific CPAP pressures at home but did not bring their CPAP device<br>  C.   When the patients Sats are < 88% in PACU.,174823,0,1. A & B,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53062,5,When do you need to call the MD for a CPAP order?<br><br>  A.   When the patient is requiring 50% FIO2.<br>  B.   When the patient states they are on specific CPAP pressures at home but did not bring their CPAP device<br>  C.   When the patients Sats are < 88% in PACU.,174824,1,2. B & C,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53062,5,When do you need to call the MD for a CPAP order?<br><br>  A.   When the patient is requiring 50% FIO2.<br>  B.   When the patient states they are on specific CPAP pressures at home but did not bring their CPAP device<br>  C.   When the patients Sats are < 88% in PACU.,174825,2,3. B only,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53062,5,When do you need to call the MD for a CPAP order?<br><br>  A.   When the patient is requiring 50% FIO2.<br>  B.   When the patient states they are on specific CPAP pressures at home but did not bring their CPAP device<br>  C.   When the patients Sats are < 88% in PACU.,174826,3,4. All of the above,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53063,6,"If an order reads ""Respiratory CPAP (Hospital Owned Device) Therapy Protocol"", you should set up:",174827,0,"A. Air-sense or Lumis in auto mode with a minimum pressure of 4cmH20, max of 18cmH20",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53063,6,"If an order reads ""Respiratory CPAP (Hospital Owned Device) Therapy Protocol"", you should set up:",174828,1,B. Fixed CPAP of 15cmH20,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53063,6,"If an order reads ""Respiratory CPAP (Hospital Owned Device) Therapy Protocol"", you should set up:",174829,2,C. Up to 15lpm of 02 bled inline,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53063,6,"If an order reads ""Respiratory CPAP (Hospital Owned Device) Therapy Protocol"", you should set up:",174830,3,D. Up to 4lpm of 02 bled inline,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53063,6,"If an order reads ""Respiratory CPAP (Hospital Owned Device) Therapy Protocol"", you should set up:",174831,4,E. A and D,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53064,7,"When using the Hamilton C-2/C-3 for BiPAP, it is important to set the following :",174832,0,"1. I- time lower than I- time Max and ETS to 50% to compensate for mask leaks, promoting synchrony and patient comfort",1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53064,7,"When using the Hamilton C-2/C-3 for BiPAP, it is important to set the following :",174833,1,2.  I-time needs to be higher than I time Max & ETS at 25%,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53065,8,"Per the Oxygen Administration Protocol, you can obtain ABGs when a patient is on = 50% FiO2 without a physician order:",174834,0,1. True,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53065,8,"Per the Oxygen Administration Protocol, you can obtain ABGs when a patient is on = 50% FiO2 without a physician order:",174835,1,2. False,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53066,9,All post-op thoracic patients for the first 24 hours will receive:,174836,0,1. SMI/Accupap (+10cm) and Bronchodilator (Duoneb) Q8,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53066,9,All post-op thoracic patients for the first 24 hours will receive:,174837,1,2. Accupap only Q8,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53066,9,All post-op thoracic patients for the first 24 hours will receive:,174838,2,3. SMI only Q8,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53066,9,All post-op thoracic patients for the first 24 hours will receive:,174839,3,4. Aerosol treatments with Duoneb and Mucomyst Q8,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53067,10,"Post-op esophageal surgical patients are started on the Thoracic Protocol, including the Accupap, but only if verified with Physician.",174840,0,1. True,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53067,10,"Post-op esophageal surgical patients are started on the Thoracic Protocol, including the Accupap, but only if verified with Physician.",174841,1,2. False,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53068,11,Home oxygen assessment includes documenting under respiratory assessment tab which of the following:,174842,0,"a.  If room air sat at rest is < 89, place patient on oxygen to get their sat >or = 89.  If able to ambulate, see what o2 is needed to keep > 88 on exertion(pt at home might need higher o2 when ambulating)",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53068,11,Home oxygen assessment includes documenting under respiratory assessment tab which of the following:,174843,1,"b.  If room air sat is > or = to  89% at rest, you need to do a room air sat with exertion",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53068,11,Home oxygen assessment includes documenting under respiratory assessment tab which of the following:,174844,2,c.  If exertional sat is lower than <89% you need to document how much o2 is needed to keep sat > 89%. Please relay to RN and Case Management,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53068,11,Home oxygen assessment includes documenting under respiratory assessment tab which of the following:,174845,3,d.  Write a Progress Note,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53068,11,Home oxygen assessment includes documenting under respiratory assessment tab which of the following:,174846,4,e.  All of the above,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53069,12,Any trach outside the ICU needs to be on a remote pulse oximeter:,174847,0,1. True,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53069,12,Any trach outside the ICU needs to be on a remote pulse oximeter:,174848,1,2. False,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53070,13,When a trach patient on the floor is de-cannulated you must :,174849,0,1.   Stay in room with the patient for 24 hours,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53070,13,When a trach patient on the floor is de-cannulated you must :,174850,1,2.   Place on a remote pulse ox for 24 hours per policy,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53070,13,When a trach patient on the floor is de-cannulated you must :,174851,2,3.  Place on a remote capnography for 24 hours,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53071,14,Which of these statements is TRUE regarding the Remote monitors?,174852,0,A.  The Capnography monitor attaches to the probe with blue end,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53071,14,Which of these statements is TRUE regarding the Remote monitors?,174853,1,B.  The Remote Pulse-ox monitor attaches to the probe with the white end,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53071,14,Which of these statements is TRUE regarding the Remote monitors?,174854,2,C.  The sensor with Sp02 and RR attaches to the Remote Pulse-ox monitor,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53071,14,Which of these statements is TRUE regarding the Remote monitors?,174855,3,D.  All statements are true,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53072,15,"According to the bronchodilator protocol, a patient's home nebulizer or medication regimen can be changed without a MD order.",174856,0,1. True,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53072,15,"According to the bronchodilator protocol, a patient's home nebulizer or medication regimen can be changed without a MD order.",174857,1,2. False,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53073,16,Which Statement regarding the Bronchodilator Therapy Protocol is <b>FALSE</b>?,174858,0,"1.  If the frequency is increased or the patient calls more often for a treatment than ordered, the Physician or Mid-level must be contacted by phone to notify them of changes in the patient status.",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53073,16,Which Statement regarding the Bronchodilator Therapy Protocol is <b>FALSE</b>?,174859,1,2.  Budesonide (Pulmicort) ordered by the physician or mid-level can not be discontinued or made PRN by the RT.,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53073,16,Which Statement regarding the Bronchodilator Therapy Protocol is <b>FALSE</b>?,174860,2,"3.  If a physician or midlevel enters an order for concurrent therapy with Brovana , Pulmicort, Albuterol and Atrovent, the medications can be administered per RT discretion or patient preference.",1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53073,16,Which Statement regarding the Bronchodilator Therapy Protocol is <b>FALSE</b>?,174861,3,"4.  If the physician does not specify the medications and only writes for Respiratory to Evaluate and Treat, the RT may order albuterol 2.5mg at the following frequencies:  Q4, Q6, BID, TID, QID, Q4 w/a or Q6 w/a.",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53074,17,"If the patient has an adverse reaction to albuterol, Levalbuterol (Xopenex) 1.25mg may be substituted for albuterol with MD order.",174862,0,1. True,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53074,17,"If the patient has an adverse reaction to albuterol, Levalbuterol (Xopenex) 1.25mg may be substituted for albuterol with MD order.",174863,1,2. False,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53075,18,"Per the Bronchodilator protocol, when can Respiratory Therapy order Ipratropium (Atrovent 0.5mg)?<br><br>  A. It may be added to albuterol/Levabuterol therapy at the same frequency if the patient is on home ipratropium therapy<br> B. If the physician does not specify the medications and only writes for Respiratory to Evaluate and Treat for Bronchodilator therapy and the patient has a diagnosis of COPD<br> C. When the patient is in persistent respiratory distress after initial bronchodilator treatment requiring treatments more often than every six hours<br> D. RT cannot order Atrovent 0.5mg.",174864,0,1. B and C,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53075,18,"Per the Bronchodilator protocol, when can Respiratory Therapy order Ipratropium (Atrovent 0.5mg)?<br><br>  A. It may be added to albuterol/Levabuterol therapy at the same frequency if the patient is on home ipratropium therapy<br> B. If the physician does not specify the medications and only writes for Respiratory to Evaluate and Treat for Bronchodilator therapy and the patient has a diagnosis of COPD<br> C. When the patient is in persistent respiratory distress after initial bronchodilator treatment requiring treatments more often than every six hours<br> D. RT cannot order Atrovent 0.5mg.",174865,1,"2. A, B, C",1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53075,18,"Per the Bronchodilator protocol, when can Respiratory Therapy order Ipratropium (Atrovent 0.5mg)?<br><br>  A. It may be added to albuterol/Levabuterol therapy at the same frequency if the patient is on home ipratropium therapy<br> B. If the physician does not specify the medications and only writes for Respiratory to Evaluate and Treat for Bronchodilator therapy and the patient has a diagnosis of COPD<br> C. When the patient is in persistent respiratory distress after initial bronchodilator treatment requiring treatments more often than every six hours<br> D. RT cannot order Atrovent 0.5mg.",174866,2,3. A and C,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53075,18,"Per the Bronchodilator protocol, when can Respiratory Therapy order Ipratropium (Atrovent 0.5mg)?<br><br>  A. It may be added to albuterol/Levabuterol therapy at the same frequency if the patient is on home ipratropium therapy<br> B. If the physician does not specify the medications and only writes for Respiratory to Evaluate and Treat for Bronchodilator therapy and the patient has a diagnosis of COPD<br> C. When the patient is in persistent respiratory distress after initial bronchodilator treatment requiring treatments more often than every six hours<br> D. RT cannot order Atrovent 0.5mg.",174867,3,4. B only,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53076,19,"The SMI policy:<br><br> <p> A.  Instruct patient on use and purpose of incentive spirometer.       Mark goal and 50% with yellow sticker /Place name on unit </p> <p> B.   Perform Smi: if patient reaches > 75% of their goal, turn over to nursing       and <b>inform them</b>. Inform patient they are to do exercise q2 wa on own.       Perform SMI daily as long as the patient is in the 50-75% range</p> <p> C.   If patient is less than 50% of predicted value, initiate IPPB with SMI BID  or       with scheduled treatment until they can achieve greater than 50% of their        goal for 2 consecutive visits  </p><p> E.   Document Education/Document Goal/Document number of attempts</pP",174868,0,1.   All of the above,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53076,19,"The SMI policy:<br><br> <p> A.  Instruct patient on use and purpose of incentive spirometer.       Mark goal and 50% with yellow sticker /Place name on unit </p> <p> B.   Perform Smi: if patient reaches > 75% of their goal, turn over to nursing       and <b>inform them</b>. Inform patient they are to do exercise q2 wa on own.       Perform SMI daily as long as the patient is in the 50-75% range</p> <p> C.   If patient is less than 50% of predicted value, initiate IPPB with SMI BID  or       with scheduled treatment until they can achieve greater than 50% of their        goal for 2 consecutive visits  </p><p> E.   Document Education/Document Goal/Document number of attempts</pP",174869,1,"2.   A, C, & D",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53076,19,"The SMI policy:<br><br> <p> A.  Instruct patient on use and purpose of incentive spirometer.       Mark goal and 50% with yellow sticker /Place name on unit </p> <p> B.   Perform Smi: if patient reaches > 75% of their goal, turn over to nursing       and <b>inform them</b>. Inform patient they are to do exercise q2 wa on own.       Perform SMI daily as long as the patient is in the 50-75% range</p> <p> C.   If patient is less than 50% of predicted value, initiate IPPB with SMI BID  or       with scheduled treatment until they can achieve greater than 50% of their        goal for 2 consecutive visits  </p><p> E.   Document Education/Document Goal/Document number of attempts</pP",174870,2,"3.   A, B, & D",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53076,19,"The SMI policy:<br><br> <p> A.  Instruct patient on use and purpose of incentive spirometer.       Mark goal and 50% with yellow sticker /Place name on unit </p> <p> B.   Perform Smi: if patient reaches > 75% of their goal, turn over to nursing       and <b>inform them</b>. Inform patient they are to do exercise q2 wa on own.       Perform SMI daily as long as the patient is in the 50-75% range</p> <p> C.   If patient is less than 50% of predicted value, initiate IPPB with SMI BID  or       with scheduled treatment until they can achieve greater than 50% of their        goal for 2 consecutive visits  </p><p> E.   Document Education/Document Goal/Document number of attempts</pP",174871,3,"4.   B, C, & D",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53077,20,"Which statement about Heliox is true? <br><br> <p> A. The mixture generates less resistance than atmospheric air when passing  through the airways of the lungs, and thus requires less effort by a patient</p><p> B.  Heliox is a breathing gas composed of a mixture of helium (He) and oxygen (O2) </p><p> C.  Heliox is mainly used in conditions of large airway narrowing (upper airway  obstruction from tumors or foreign bodies and vocal cord dysfunction).</p><p> D.  Heliox can also be used in conditions of the medium airways  such as croup, asthma and chronic obstructive pulmonary disease</p>",174872,0,1. Statement B only,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53077,20,"Which statement about Heliox is true? <br><br> <p> A. The mixture generates less resistance than atmospheric air when passing  through the airways of the lungs, and thus requires less effort by a patient</p><p> B.  Heliox is a breathing gas composed of a mixture of helium (He) and oxygen (O2) </p><p> C.  Heliox is mainly used in conditions of large airway narrowing (upper airway  obstruction from tumors or foreign bodies and vocal cord dysfunction).</p><p> D.  Heliox can also be used in conditions of the medium airways  such as croup, asthma and chronic obstructive pulmonary disease</p>",174873,1,"2. Statement A, C",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53077,20,"Which statement about Heliox is true? <br><br> <p> A. The mixture generates less resistance than atmospheric air when passing  through the airways of the lungs, and thus requires less effort by a patient</p><p> B.  Heliox is a breathing gas composed of a mixture of helium (He) and oxygen (O2) </p><p> C.  Heliox is mainly used in conditions of large airway narrowing (upper airway  obstruction from tumors or foreign bodies and vocal cord dysfunction).</p><p> D.  Heliox can also be used in conditions of the medium airways  such as croup, asthma and chronic obstructive pulmonary disease</p>",174874,2,"3. Statement A, B",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53077,20,"Which statement about Heliox is true? <br><br> <p> A. The mixture generates less resistance than atmospheric air when passing  through the airways of the lungs, and thus requires less effort by a patient</p><p> B.  Heliox is a breathing gas composed of a mixture of helium (He) and oxygen (O2) </p><p> C.  Heliox is mainly used in conditions of large airway narrowing (upper airway  obstruction from tumors or foreign bodies and vocal cord dysfunction).</p><p> D.  Heliox can also be used in conditions of the medium airways  such as croup, asthma and chronic obstructive pulmonary disease</p>",174875,3,4. All statements are true,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53079,21,When should you consider weaning your patient off Optiflow?,174878,0,A. At the earliest appropriate time,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53079,21,When should you consider weaning your patient off Optiflow?,174879,1,B. When the Fi02 is <= to 50% and the flow <= 20L?,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53079,21,When should you consider weaning your patient off Optiflow?,174880,2,C. Per physician order,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53079,21,When should you consider weaning your patient off Optiflow?,174881,3,D. All of the above,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53080,22,Which statement about CPAP documentation is <b>FALSE</b>?,174882,0,A. A hospital owned CPAP device will be checked Q12 and with any change in settings or status of the patient,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53080,22,Which statement about CPAP documentation is <b>FALSE</b>?,174883,1,B. Home CPAP units will be checked Qshift.,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53080,22,Which statement about CPAP documentation is <b>FALSE</b>?,174884,2,C. CPAP documentation includes skin integrity and the use of any skin barrier,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53081,23,"When using a BiPAP, Physician will be notified when:",174885,0,A. Heart rate increases or decreases to > 20% from pre therapy heart rate.,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53081,23,"When using a BiPAP, Physician will be notified when:",174886,1,B. Therapist is unable to achieve an adequate mask seal.,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53081,23,"When using a BiPAP, Physician will be notified when:",174887,2,C. Tachydysrhythmias or Brachyarrhythmias occur.,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53081,23,"When using a BiPAP, Physician will be notified when:",174888,3,D. All of the above,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53082,24,Which are components of the fresh trach protocol?,174889,0,A. Sign on the door with the date and time the 48 hour observation ends.,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53082,24,Which are components of the fresh trach protocol?,174890,1,B. ETC02 and breath sounds documentation with any patient repositioning.,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53082,24,Which are components of the fresh trach protocol?,174891,2,C. Same size trach and one size smaller.,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53082,24,Which are components of the fresh trach protocol?,174892,3,D. Obturator at the HOB.,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53082,24,Which are components of the fresh trach protocol?,174893,4,E. Airway box at bedside.,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53082,24,Which are components of the fresh trach protocol?,174894,5,F. Ambu bag/mask at bedside.,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53082,24,Which are components of the fresh trach protocol?,174895,6,G. All of the above.,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53083,25,How often do you change an inner cannula?<br><br> A.  Qshift on nightshift and as needed<br> B.  BID and as needed<br> C.  Q24 on dayshift and as needed<br> D.  Not during the 48 hour fresh trach protocol,174896,0,1. C and D,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53083,25,How often do you change an inner cannula?<br><br> A.  Qshift on nightshift and as needed<br> B.  BID and as needed<br> C.  Q24 on dayshift and as needed<br> D.  Not during the 48 hour fresh trach protocol,174897,1,2. A and D,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53083,25,How often do you change an inner cannula?<br><br> A.  Qshift on nightshift and as needed<br> B.  BID and as needed<br> C.  Q24 on dayshift and as needed<br> D.  Not during the 48 hour fresh trach protocol,174898,2,3.  B only,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53083,25,How often do you change an inner cannula?<br><br> A.  Qshift on nightshift and as needed<br> B.  BID and as needed<br> C.  Q24 on dayshift and as needed<br> D.  Not during the 48 hour fresh trach protocol,174899,3,4.  C only,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53084,26,"A BioMed work order, found on the Intranet under requests, should include which of the following information?<br><br> A.  Facility<br> B.  Tag<br> C.  Patient name and DOB<br> D.  Problem <br> E.  Location /Room",174900,0,"1. A, B, C ,D",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53084,26,"A BioMed work order, found on the Intranet under requests, should include which of the following information?<br><br> A.  Facility<br> B.  Tag<br> C.  Patient name and DOB<br> D.  Problem <br> E.  Location /Room",174901,1,"2. A, B, D, E",1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53084,26,"A BioMed work order, found on the Intranet under requests, should include which of the following information?<br><br> A.  Facility<br> B.  Tag<br> C.  Patient name and DOB<br> D.  Problem <br> E.  Location /Room",174902,2,"3. B, D, E",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53084,26,"A BioMed work order, found on the Intranet under requests, should include which of the following information?<br><br> A.  Facility<br> B.  Tag<br> C.  Patient name and DOB<br> D.  Problem <br> E.  Location /Room",174903,3,4. All of the above,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53085,27,Which of the following items will you find on the P-drive?<br><br> A.  How to change a CPAP from variable to fixed.<br> B.  Equipment manuals<br> C.  Release of liability forms<br> D.  Hand hygiene results<br> E.  EMMA / Code blue statistics,174904,0,1.  B and C,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53085,27,Which of the following items will you find on the P-drive?<br><br> A.  How to change a CPAP from variable to fixed.<br> B.  Equipment manuals<br> C.  Release of liability forms<br> D.  Hand hygiene results<br> E.  EMMA / Code blue statistics,174905,1,"2.  A, B, C",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53085,27,Which of the following items will you find on the P-drive?<br><br> A.  How to change a CPAP from variable to fixed.<br> B.  Equipment manuals<br> C.  Release of liability forms<br> D.  Hand hygiene results<br> E.  EMMA / Code blue statistics,174906,2,"3.  A, D, E",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53085,27,Which of the following items will you find on the P-drive?<br><br> A.  How to change a CPAP from variable to fixed.<br> B.  Equipment manuals<br> C.  Release of liability forms<br> D.  Hand hygiene results<br> E.  EMMA / Code blue statistics,174907,3,"4.  A, B, C, D, E",1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53086,28,"Lucidoc, found on the Northside Intranet, contains which of the following?<br><br> A.  Interdisciplinary Professional Practice (IPP) System-wide<br> B.  Human Resources Policies<br> C.  Respiratory Therapy Protocols<br> D.  Centricity Web<br> E.  Corporate Compliance<br>",174908,0,"1.  A, C, E",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53086,28,"Lucidoc, found on the Northside Intranet, contains which of the following?<br><br> A.  Interdisciplinary Professional Practice (IPP) System-wide<br> B.  Human Resources Policies<br> C.  Respiratory Therapy Protocols<br> D.  Centricity Web<br> E.  Corporate Compliance<br>",174909,1,"2.  A, B, C, E",1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53086,28,"Lucidoc, found on the Northside Intranet, contains which of the following?<br><br> A.  Interdisciplinary Professional Practice (IPP) System-wide<br> B.  Human Resources Policies<br> C.  Respiratory Therapy Protocols<br> D.  Centricity Web<br> E.  Corporate Compliance<br>",174910,2,3.  B and C,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53086,28,"Lucidoc, found on the Northside Intranet, contains which of the following?<br><br> A.  Interdisciplinary Professional Practice (IPP) System-wide<br> B.  Human Resources Policies<br> C.  Respiratory Therapy Protocols<br> D.  Centricity Web<br> E.  Corporate Compliance<br>",174911,3,4.  All of the above,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53087,29,"To place a Remote Pulse ox monitor in standby, you disconnect the pulse ox sensor from the cable then press DISMISS from the drop down menu and silence the alarm.",174912,0,A. True,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53087,29,"To place a Remote Pulse ox monitor in standby, you disconnect the pulse ox sensor from the cable then press DISMISS from the drop down menu and silence the alarm.",174913,1,B. False,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53088,30,Which of the following items are located in the bottom drawer of every code cart labelled Miscellaneous?<br><br> A.  14 Fr suction kit with gloves<br> B.  Suction canister with lid<br> C. Suction tubing both long and short<br> D.  Yankeur <br> E.  Wall suction regulator,174914,0,"1. B, C, D, E",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53088,30,Which of the following items are located in the bottom drawer of every code cart labelled Miscellaneous?<br><br> A.  14 Fr suction kit with gloves<br> B.  Suction canister with lid<br> C. Suction tubing both long and short<br> D.  Yankeur <br> E.  Wall suction regulator,174915,1,"2. A, B, C, D",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53088,30,Which of the following items are located in the bottom drawer of every code cart labelled Miscellaneous?<br><br> A.  14 Fr suction kit with gloves<br> B.  Suction canister with lid<br> C. Suction tubing both long and short<br> D.  Yankeur <br> E.  Wall suction regulator,174916,2,3. All of the above,1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53088,30,Which of the following items are located in the bottom drawer of every code cart labelled Miscellaneous?<br><br> A.  14 Fr suction kit with gloves<br> B.  Suction canister with lid<br> C. Suction tubing both long and short<br> D.  Yankeur <br> E.  Wall suction regulator,174917,3,4. None of the above,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53089,31,All of the following are contraindications of using MetaNeb <b>EXCEPT</b>:,174918,0,A.   Head or neck injury that has not been stabilized,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53089,31,All of the following are contraindications of using MetaNeb <b>EXCEPT</b>:,174919,1,B.   Active pulmonary hemorrhaging,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53089,31,All of the following are contraindications of using MetaNeb <b>EXCEPT</b>:,174920,2,"C.   Presence of ICP >20, recent facial/oral surgery or trauma",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53089,31,All of the following are contraindications of using MetaNeb <b>EXCEPT</b>:,174921,3,D.   Esophageal surgery and/or gastric sleeve surgery,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53089,31,All of the following are contraindications of using MetaNeb <b>EXCEPT</b>:,174922,4,E.    Neuromuscular disorders,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53089,31,All of the following are contraindications of using MetaNeb <b>EXCEPT</b>:,174923,5,F.    COPD,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53089,31,All of the following are contraindications of using MetaNeb <b>EXCEPT</b>:,174924,6,G.   Post-Op Management of Atelectasis,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53089,31,All of the following are contraindications of using MetaNeb <b>EXCEPT</b>:,174925,7,H.  All of the above,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53089,31,All of the following are contraindications of using MetaNeb <b>EXCEPT</b>:,174926,8,"I.   E, F and G",1
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53090,32,Which statement regarding the delivery of IPV therapy is <b>FALSE</b>?,174927,0,1.   The RT must remain with the patient while therapy is in progress.  Therapy must    be stopped before RT can leave the room.,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53090,32,Which statement regarding the delivery of IPV therapy is <b>FALSE</b>?,174928,1,2. Alternate between CPEP and CHFO modes every 2.5 minutes until the treatment is complete and the nebulizer is empty.,0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53090,32,Which statement regarding the delivery of IPV therapy is <b>FALSE</b>?,174929,2,"3. IPV facilitates the mobilization of secretions, lung expansion therapy,  and the treatment and prevention of pulmonary atelectasis",0
8135,Elearning-0000-1031,2020 CHEROKEE RESPIRATORY FLOOR COMPETENCY,n12234,53090,32,Which statement regarding the delivery of IPV therapy is <b>FALSE</b>?,174930,3,"4. If the physician does not order medications for nebulization, RT will order Duoneb Q6 and document in the EMR",1
